{"after": {"end": 40, "start": 0, "text": "Do not store above 25 °C. Do not freeze.", "truncated": false}, "after_length": 40, "after_sha256": "5b83cffac35f0dd891ac8dbf4d0a5bc16ebc5aa87f24a3e3fc70a4c0901c566b", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Do not store above 25ºC. Do not freeze.", "truncated": false}, "before_length": 39, "before_sha256": "0048cc2e3482eed0ec1e9d6a6ad3ff466985a7aaf27e8a96ed008491dff61b0e", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 21, "before_end": 22, "before_start": 21, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0005a4e7fdfd035b9b7f1dbb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 928}
{"after": {"end": 37, "start": 0, "text": "N.V. BristolMyers Squibb Belgium S.A.", "truncated": false}, "after_length": 37, "after_sha256": "feeebdb54667cd864ac3ce52dc07c49e265c3b042233fe6691e3f074fda776c2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-000affec7d336c2d83e36b21", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2818}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "18. UNIQUE IDENTIFIER - HUMAN READABLE DATA", "truncated": false}, "before_length": 43, "before_sha256": "f53a050d196b2672592e40916a0229bf083d27961b6b2f41758dcee0da55378d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0044bdc07a2566957d4b40b6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4871}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 20, "start": 0, "text": "Novartis Pharma GmbH", "truncated": false}, "before_length": 20, "before_sha256": "bae642239c19e15ed2be9a6c4c5123c7ef0f4e0a79a5ece5f8c2cf22e6047d3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-00804475e642b38c3e73b17e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1669}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 12, "start": 0, "text": "Manufacturer", "truncated": false}, "before_length": 12, "before_sha256": "1af384c577f294d4164a7ea49f3021259e2b92802eac577722d14066b2bbd5ce", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-00b5ccee0ba85d5bd2d1f106", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3122}
{"after": {"end": 9, "start": 0, "text": "Slovenija", "truncated": false}, "after_length": 9, "after_sha256": "fa267dd198bd52b588eff3ae1ccd7c7ea1ac67b4d621fd44e50742c91809cac3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-00c73694a1e237e886b6c577", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3268}
{"after": {"end": 322, "start": 0, "text": "In vitro, le niraparib induit le CYP1A2. Par conséquent, la prudence est recommandée lorsque le niraparib est administré en concomitance avec des substances actives dont le métabolisme est dépendant du CYP1A2 et, notamment, celles ayant une plage thérapeutique étroite (par exemple, clozapine, théophylline et ropinirole).", "truncated": false}, "after_length": 322, "after_sha256": "44268a2c6559ffc47aa2120e9b3202ae81633e63848bcc8f9fe659f7999d332a", "annex": "I", "before": {"end": 537, "start": 0, "text": "Ni le niraparib ni M1 ne sont des inducteurs du CYP3A4 in vitro. In vitro, le niraparib induit faiblement le CYP1A2 aux concentrations élevées et l’importance clinique de cet effet ne doit pas être totalement négligée. M1 n’est pas un inducteur du CYP1A2. Par conséquent, la prudence est recommandée lorsque le niraparib est administré en concomitance avec des substances actives dont le métabolisme est dépendant du CYP1A2 et, notamment, celles ayant une plage thérapeutique étroite (par exemple, clozapine, théophylline et ropinirole).", "truncated": false}, "before_length": 537, "before_sha256": "ab84b53ba8f7cd768fbbbfeb2987ca69345d616e1abfee4554a6181b26d75315", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 65, "before_start": 0, "kind": "delete"}, {"after_end": 30, "after_start": 30, "before_end": 99, "before_start": 95, "kind": "delete"}, {"after_end": 32, "after_start": 32, "before_end": 247, "before_start": 101, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 215, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0117f18eac5c8fe905e9297c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1154}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0118d07cb25f7d9a14c940e3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2905}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 45, "start": 0, "text": "• eating a lot more than your diet allows; or", "truncated": false}, "before_length": 45, "before_sha256": "98a2c492fddf7a409117e4df9abbc55d007b8387ebc5df2fd58b9883340a80bf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 45, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 45, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0121c5a87f802eff2bee75fb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9407}
{"after": {"end": 61, "start": 0, "text": "Each tablet contains 139.63 mg of lactose monohydrate (E 24).", "truncated": false}, "after_length": 61, "after_sha256": "df22abb589cdec6c18f5e8791a61bdc4572c6a47c5045af9203875d5acfc67d3", "annex": "I", "before": {"end": 66, "start": 0, "text": "Each soft capsule contains no more than 44 mg of sorbitol (E 420).", "truncated": false}, "before_length": 66, "before_sha256": "61ab4cbe80c674fd24d113f22351016d7d5eb50b8b81f82bfb1cb3f1fcbb795f", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 5, "before_end": 8, "before_start": 5, "kind": "delete"}, {"after_end": 6, "after_start": 6, "before_end": 11, "before_start": 9, "kind": "delete"}, {"after_end": 8, "after_start": 7, "before_end": 15, "before_start": 12, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 17, "before_start": 17, "kind": "insert"}, {"after_end": 27, "after_start": 21, "before_end": 42, "before_start": 27, "kind": "replace"}, {"after_end": 37, "after_start": 34, "before_end": 54, "before_start": 49, "kind": "replace"}, {"after_end": 53, "after_start": 39, "before_end": 57, "before_start": 56, "kind": "replace"}, {"after_end": 58, "after_start": 57, "before_end": 61, "before_start": 61, "kind": "insert"}, {"after_end": 59, "after_start": 59, "before_end": 64, "before_start": 62, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 31, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-017d1560c79e791fd097ae43", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "2", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 929}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "Medicinal product subject to medical prescription.", "truncated": false}, "before_length": 50, "before_sha256": "f59e60a405cd29d8de0d0cfa2c4fd5c87e80574c3dbf7354e143c03cfe8789e6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 50, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 50, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-018b57505f854a2a5419c4e9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 856}
{"after": {"end": 12, "start": 0, "text": "Magyarország", "truncated": false}, "after_length": 12, "after_sha256": "5206a7f7063a77a35861f95e022dafc37f3b3cf27ed423b1118e3fe580841b19", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-01b243091738fedb0964b8b9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2511}
{"after": {"end": 38, "start": 0, "text": "N.V. Bristol-Myers Squibb Belgium S.A.", "truncated": false}, "after_length": 38, "after_sha256": "aed62c6e6383ee3130a6851382813dabc668847cc45474eecb9eae19fd27a962", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-01f5266d34af67ce25634666", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2814}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 80, "start": 0, "text": "Inhibition of CYPs (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4)", "truncated": false}, "before_length": 80, "before_sha256": "f4e3984e34e4abd129d4111bc2a0654aa6e8d3e9311b08ee836a8d5faaa34241", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 80, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 80, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-02840ff83c13566795041ce3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 248}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 36, "start": 0, "text": "Store in a refrigerator (2°C - 8°C).", "truncated": false}, "before_length": 36, "before_sha256": "da46e7ec5af6b520bf23f97fab0435900e7b6407916f2e228ee83266f9359e2a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 36, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 36, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-02a0a024d1291cd2f0bf44d4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4631}
{"after": {"end": 20, "start": 0, "text": "Swixx Biopharma EOOD", "truncated": false}, "after_length": 20, "after_sha256": "27f5284d414219f28c8c91886b89df13d6ef413ca05a03cdd596d9c697d6c0ea", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-02df12cb4d63d7aaf0d4b004", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3177}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 32, "start": 0, "text": "1. NAME OF THE MEDICINAL PRODUCT", "truncated": false}, "before_length": 32, "before_sha256": "8141899f95166cc499efb2acfa403d9d6b8ae4eed4239eff8b6c08bd2be8913c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-03413b916b8414dc339f1cb2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4587}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 25, "start": 0, "text": "Dioxyde de titane (E 171)", "truncated": false}, "before_length": 25, "before_sha256": "8bd66dde83cd8277df57809b4997d2b6141aca832dee59e35c9e39b93df9ecca", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-035154ac20dc70ca07b4f369", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1920}
{"after": {"end": 33, "start": 0, "text": "Bristol-Myers Squibb spol. s r.o.", "truncated": false}, "after_length": 33, "after_sha256": "3abea3460809987d2906fa40ab370a496bbee801d456a93f8afaeb35776f9233", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0372c921261c64b76a0b3fad", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2819}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 83, "start": 0, "text": "– DO NOT dial your dose by counting the clicks because you may dial the wrong dose.", "truncated": false}, "before_length": 83, "before_sha256": "cde12115ba26d2aa05b82fa87a130ecdf600e5614bd5c50e5b30aeb025531fef", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 83, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 83, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-03a1c7423b3e05d7b2fb4ea3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9692}
{"after": {"end": 20, "start": 0, "text": "Viatris Germany GmbH", "truncated": false}, "after_length": 20, "after_sha256": "4c2f2a211c5c41870eee98c700979da5e888736aac1a795ab787143446de83ca", "annex": "IIIA", "before": {"end": 18, "start": 0, "text": "Mylan Germany GmbH", "truncated": false}, "before_length": 18, "before_sha256": "d7a3f7e30e2672617d153ba93a8cf1c2908da6e7dcfe6d206314ed71d4e5405a", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "replace"}, {"after_end": 7, "after_start": 3, "before_end": 5, "before_start": 4, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-03a8140ccd57dd29c615ab66", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005403", "medicine_name": "Sugammadex Mylan", "medicine_slug": "sugammadex-mylan", "observed_at": "2026-10-12T13:36:04Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "6c5163463373c99ccc880a476c1bf5361b2063cd7b687e079043070b6fb0e7f5", "source_snapshot_id": "source-c456b260a6ea2676dbd096d9", "source_updated_at": "2026-06-12", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/sugammadex-mylan-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1460}
{"after": {"end": 33, "start": 0, "text": "Τηλ: 800 92666 (+ 30 210 6074300)", "truncated": false}, "after_length": 33, "after_sha256": "3c667c31f7c324c43671bdd5606ccfdb57ec8b49816d058ab68a853627dd20b8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-03bb78f600d9598a28ec38d3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2618}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 77, "start": 0, "text": "– You should use a new needle for each injection and repeat the priming step.", "truncated": false}, "before_length": 77, "before_sha256": "6cbb75253f102d911aa7d4cd80d5c9f8885f4161d7da4e015e823734387082ac", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 77, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 77, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-03e3685dee2ffbfed826b668", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9685}
{"after": {"end": 9, "start": 0, "text": "Nederland", "truncated": false}, "after_length": 9, "after_sha256": "8a869db3fa453526573e4f2c956528743cf246af5d1b5eac4879257589776797", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-03e6c6ecd7ff1f35501e839f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3211}
{"after": {"end": 5, "start": 0, "text": "Malta", "truncated": false}, "after_length": 5, "after_sha256": "71e9eb10755c8232974d186a560f7658a1ccbdd3097877dfa1ad3436af90d46a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-03ee7476fca86aadc2ab4fba", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2833}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "– The even numbers are printed on the dial.", "truncated": false}, "before_length": 43, "before_sha256": "295c73a3c3099ada29fc945175b615e0ecd405f0f88a3d3d8b855c6c32399137", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-03fa4d797eebbb43cb8dd0af", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9694}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0403309e2fffdc2b8c42b2bb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2509}
{"after": {"end": 181, "start": 0, "text": "Based on clinical trial experience, the most frequently reported adverse reactions for rezafungin were hypokalaemia, pyrexia, anaemia, and diarrhoea (very common adverse reactions).", "truncated": false}, "after_length": 181, "after_sha256": "637374924ad55c03d8b2725edfcf4cb2cf3af5f6c47e18c56b96f24fd5cc0a8b", "annex": "I", "before": {"end": 171, "start": 0, "text": "Based on clinical trial experience, the most frequently reported adverse reactions for rezafungin were hypokalaemia, pyrexia,and diarrhoea (very common adverse reactions).", "truncated": false}, "before_length": 171, "before_sha256": "d0d5afee445ae8eb1cedcd61f1a8758d8a123a69a0319007e3b08227fda13727", "change_kind": "content", "change_operations": [{"after_end": 135, "after_start": 125, "before_end": 125, "before_start": 125, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 10}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0420347e080881b1a9454548", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.8", "section_type": "adverse_reactions", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 169}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 36 1 301 9797", "truncated": false}, "after_length": 21, "after_sha256": "646ee39f31e338f4b9b710096409242010a836db8c907826a18abfa5703a4854", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-04209bf914ff7e60c1c1697c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3193}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 51, "start": 0, "text": "Niraparib comme substrat des CYP (CYP1A2 et CYP3A4)", "truncated": false}, "before_length": 51, "before_sha256": "cd69b1f2ca050bb450c26f08263a900933f3b1aa4fc631f37b44ccfebb20ae25", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 51, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 51, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0470a8b4b0cead1b6c66a805", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 241}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "• fever, infection or emotional stress.", "truncated": false}, "before_length": 39, "before_sha256": "969a08d64cc23ef3bf97ebe57c12628a9c783105e03960439962e3fd889e48a2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0488260375a309de3cbad83b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9408}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-04d5a8ab8b9c631414b21f7c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3120}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 38, "start": 0, "text": "5. METHOD AND ROUTES OF ADMINISTRATION", "truncated": false}, "before_length": 38, "before_sha256": "4df84c8e36dde67c1450d0a07181258f1fc4c471167239340eae51e9760a4f68", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 38, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 38, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-04e5fa4994fb932f602256cc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4808}
{"after": {"end": 23, "start": 0, "text": "medinfo.austria@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "80539556a138e6e0b8efab6b438c21ba77b592fc3c2d28fdfaea7dc2bb3248d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-04f51910f6f7ad090dc43ca5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2870}
{"after": {"end": 20, "start": 0, "text": "Sími: + 354 535 7000", "truncated": false}, "after_length": 20, "after_sha256": "66fcdd056ccfbc5ba6d0c26580292977898106c90655c78208bc87c3d941892c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-04f933b8670550ae510ecdec", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2910}
{"after": {"end": 21, "start": 0, "text": "medinfo.czech@bms.com", "truncated": false}, "after_length": 21, "after_sha256": "7d80d4bfa363423e385e42b079e9a90210b1f5d622fbfe8ab954e6684db7cffd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-052c7fbc4ad7a5678684e50a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3189}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 99, "start": 0, "text": "6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "truncated": false}, "before_length": 99, "before_sha256": "455a982fe3bc6ba1eb2be1f3bcfd8517f2afe6d320280030b823f73d0bf6a1d6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 99, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 99, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0540329f953ce48f7afa3adc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4715}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Killorglin", "truncated": false}, "before_length": 10, "before_sha256": "2606b5fb607427b1a532d8cab1195d0515b4a8cf56f0eff6628b2ac9a5a04655", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-059818a462a5d5f8bc20c5c4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2004}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "Needles and swab are not included", "truncated": false}, "before_length": 33, "before_sha256": "d8c87ad19b80f387681bbc5343ed65411829c5e358f93bf33234a068ebe10c03", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-05b4c7593a3325f060dbc4e5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9627}
{"after": {"end": 264, "start": 0, "text": "In vitro, niraparib induces CYP1A2. Therefore, caution is recommended when niraparib is combined with active substances the metabolism of which is CYP1A2dependent and, notably, those having a narrow therapeutic range (e.g. clozapine, theophylline, and ropinirole).", "truncated": false}, "after_length": 264, "after_sha256": "ae1346f7a99aa9e111a3fda0f9608fe9ede359aeab5698212a0fd0638828e11c", "annex": "I", "before": {"end": 453, "start": 0, "text": "Neither niraparib nor M1 is a CYP3A4 inducer in vitro. In vitro, niraparib weakly induces CYP1A2 at high concentrations and the clinical relevance of this effect could not be completely ruled out. M1 is not a CYP1A2 inducer. Therefore, caution is recommended when niraparib is combined with active substances the metabolism of which is CYP1A2dependent and, notably, those having a narrow therapeutic range (e.g. clozapine, theophylline, and ropinirole).", "truncated": false}, "before_length": 453, "before_sha256": "ea7d68f9bee115d62f0677a834ab340ba38d70c23457aab5c2f1bcc373ef8a29", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 55, "before_start": 0, "kind": "delete"}, {"after_end": 20, "after_start": 20, "before_end": 82, "before_start": 75, "kind": "delete"}, {"after_end": 34, "after_start": 34, "before_end": 223, "before_start": 96, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 189, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-05b65cff6e99c80195358256", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 257}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Eli Lilly Benelux S.A./N.V.", "truncated": false}, "before_length": 27, "before_sha256": "f7a78bd0bea08a17a3aa98df48b777639261f6c4cd78368c6205ce433c2dc675", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-05cf53a5dcb4efc6629b6069", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9456}
{"after": {"end": 119, "start": 0, "text": "For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:", "truncated": false}, "after_length": 119, "after_sha256": "96e8e519927e4ccd767c33018abc0bb77c29439563f16049ac8a6e6cef005737", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 119, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 119}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-05fc2ba77de3f480af22ebba", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2796}
{"after": {"end": 21, "start": 0, "text": "medinfo.czech@bms.com", "truncated": false}, "after_length": 21, "after_sha256": "7d80d4bfa363423e385e42b079e9a90210b1f5d622fbfe8ab954e6684db7cffd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0624a6a6a40dcce81332507a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2821}
{"after": {"end": 23, "start": 0, "text": "Medinfo.hungary@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "a92bd76e7f8465b69646a33e5e8846376b2ea19fe10f20ea413789237a8d815a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-06458d46e525a8946403c75a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2514}
{"after": {"end": 34, "start": 0, "text": "medinfo.croatia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "59c47394700ad787801e8ce1b033fc5d63a885ddfc680677ae6b5acd89bb7df3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0653fc2dfaf5c37d63ef4553", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2891}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 8, "start": 0, "text": "ANNEX IV", "truncated": false}, "before_length": 8, "before_sha256": "29972ab77d4b1358a0bdb16d438bcde59007e95356d1f5f9ee2f7045597f9574", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-06cd1c8745df2453aa22e1a0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3440}
{"after": {"end": 21, "start": 0, "text": "Crospovidone (E 1202)", "truncated": false}, "after_length": 21, "after_sha256": "4d49593bf5155b40a07b7ee2f47a6e4610e7b8b873178ecc9d31cdf6e0f0c6ea", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-06df8b7ab139215f02f9f751", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1341}
{"after": {"end": 11, "start": 0, "text": "Deutschland", "truncated": false}, "after_length": 11, "after_sha256": "af6e56aacd8097c3fb7597b08ecb3d87a040f6ab58067a4b8ff9f5b747adb9be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0741a9f3e2f90fc230cb3997", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2842}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 44, "start": 0, "text": "Lilly Portugal - Produtos Farmacêuticos, Lda", "truncated": false}, "before_length": 44, "before_sha256": "919b2ec570becf628285d6d71fbadd3cb884f83ed106485414a9a87be1529e59", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 44, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 44, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0750cd1351f35e980abf0164", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9517}
{"after": {"end": 12, "start": 0, "text": "Id-Danimarka", "truncated": false}, "after_length": 12, "after_sha256": "ac04b6efb22ef48cbffb5f129ff3db14dac1293a9618775a5e7a6cb07d57fc19", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-07553ab613191e4e30fbc8a4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2073}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 4, "start": 0, "text": "3 ml", "truncated": false}, "before_length": 4, "before_sha256": "efb575d44c18cff107cf79338e3da4ffb779dc65ba1cebc82fc7bfc7247e472f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 4, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-078ad12dd7fdce06554c0ed8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4902}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 4, "start": 0, "text": "Body", "truncated": false}, "before_length": 4, "before_sha256": "6ccaa6415b5ee449e3c5c716f57b4608ebe3b780f5aa6b077bc5d8eee5d961f9", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 4, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-079ad42666c8f4e3a7b61828", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9596}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "GlaxoSmithKline (Ireland) Limited", "truncated": false}, "before_length": 33, "before_sha256": "aab443afe73fcfeb3384251d62635faa955ab6ace3c6efeb3f1cf79dfb706da8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0841e40f00adaba65b32801c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2614}
{"after": {"end": 35, "start": 0, "text": "Vyndaqel 61 mg comprimés pelliculés", "truncated": false}, "after_length": 35, "after_sha256": "55093309862fa7b5c2c733f79ada15c469addfee83143b78c70360e2fab36ad6", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "Vyndaqel 61 mg capsules molles", "truncated": false}, "before_length": 30, "before_sha256": "29a190adc98099f60ab7724cf32e57934aeb9ed7d194be9fbf602caa0eccc383", "change_kind": "content", "change_operations": [{"after_end": 18, "after_start": 16, "before_end": 17, "before_start": 16, "kind": "replace"}, {"after_end": 23, "after_start": 19, "before_end": 18, "before_start": 18, "kind": "insert"}, {"after_end": 31, "after_start": 24, "before_end": 19, "before_start": 19, "kind": "insert"}, {"after_end": 34, "after_start": 33, "before_end": 29, "before_start": 21, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-085ff43f10013f517e294fa7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3554}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "• wheezing • sweating", "truncated": false}, "before_length": 21, "before_sha256": "fa4fff2c5b68424395e3bb43706149df117afc4a0c41040c3c7a22c481ae39b4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-087b0986ea0cafc8763f9e15", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9370}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 235, "start": 0, "text": "Your doctor may tell you to use Humalog Tempo Pen as well as a longer-acting insulin. Each kind of insulin comes with another patient information leaflet to tell you about it. Do not change your insulin unless your doctor tells you to.", "truncated": false}, "before_length": 235, "before_sha256": "e5fd4c73c9a47e808725125e89422b64f5580d9fe3c753799b409dd1ed1a5faa", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 235, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 235, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-08c92be0c2b291a380dc2ad9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9237}
{"after": {"end": 26, "start": 0, "text": "informacion.medica@bms.com", "truncated": false}, "after_length": 26, "after_sha256": "ecc8b3fc203c9400ed5a39531e5dadc0b28244ff3abb21ff0a801eeffc0a5d0e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-08ecdc61e238dcd76b02e96c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2875}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Österreich", "truncated": false}, "before_length": 10, "before_sha256": "b1b763860d4f30c2e1feafdcd57b714a1422b4fbc1a93d94969118a0faa65288", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-08f390c6757334c67180e84a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9502}
{"after": {"end": 5, "start": 0, "text": "Dánia", "truncated": false}, "after_length": 5, "after_sha256": "6b2bf8c68ea8941b06707cb569cdff6f0c6f5f221eb2857ea1bef2fff7977063", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0912fe737be42c91435ca2d5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1764}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 31, "start": 0, "text": "- Have you recently become ill?", "truncated": false}, "before_length": 31, "before_sha256": "29180280113df0ed24c983148a1459df5510f126559f5df123942e7218cdeacd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 31, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 31, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-093e2a419d7ec711c3557940", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9255}
{"after": {"end": 45, "start": 0, "text": "The tablet may be taken with or without food.", "truncated": false}, "after_length": 45, "after_sha256": "91cec78a571a00cfa26cc3e481b36cc877c03b53f90309e4ab16510fcb3f85b6", "annex": "IIIA", "before": {"end": 46, "start": 0, "text": "The capsule may be taken with or without food.", "truncated": false}, "before_length": 46, "before_sha256": "6149f883549e1cd257acfa4ac40dc121d7d7188ad94d41283e341af86ef1b759", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 4, "before_end": 5, "before_start": 4, "kind": "replace"}, {"after_end": 7, "after_start": 6, "before_end": 9, "before_start": 6, "kind": "replace"}, {"after_end": 10, "after_start": 9, "before_end": 11, "before_start": 11, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-09763d0cff25881e86c941af", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3139}
{"after": {"end": 36, "start": 0, "text": "medinfo.lithuania@swixxbiopharma.com", "truncated": false}, "after_length": 36, "after_sha256": "70eec294d332a04f9bd82459b443a88e19b0dcce5bbd50491f56763531b2b260", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-098b471293924c90feb668fc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2806}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "{BLISTER DE PROTECTION}", "truncated": false}, "before_length": 23, "before_sha256": "54d1f31fee8d225aa1d6a4d248de79e7d762e6812f9fb5545fb6597cccde2914", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0a252f049b4de0e1d4f8285a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1100}
{"after": {"end": 47, "start": 0, "text": "Marketing Authorisation Holder and Manufacturer", "truncated": false}, "after_length": 47, "after_sha256": "4542f9bb3095abea29e124e5e4ba8ada603cefe01cb57b9ddc98b99054dc2887", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "Marketing Authorisation Holder", "truncated": false}, "before_length": 30, "before_sha256": "49b1d8044839391ca09e6bef9f9460184c586c4da018732ac3a7e596cf20e965", "change_kind": "administrative", "change_operations": [{"after_end": 47, "after_start": 30, "before_end": 30, "before_start": 30, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 17}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0a7df212cda5ea86bb5a4665", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2430}
{"after": {"end": 8, "start": 0, "text": "Portugal", "truncated": false}, "after_length": 8, "after_sha256": "4c7de2c3da6dc0ae8f9d13b107718a913859359bd30166d077c867577953865d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0a890293356aa618e8824e1b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2571}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Eli Lilly and Company (Ireland) Limited", "truncated": false}, "before_length": 39, "before_sha256": "0555e8a06c0ef36afd955d945d4997f04834690c546541adf74802bac524a0e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0a903f502d01a66ade9ca65c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9527}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 108, "start": 0, "text": "Ce médicament ne contient pas plus de 44 mg de sorbitol par capsule. Le sorbitol est une source de fructose.", "truncated": false}, "before_length": 108, "before_sha256": "af83c892c2aac4f0995ca2a9c0f33d588f558d22d9fd4de530b30e974288782a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 108, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 108, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0aab773ea77cc2ff569186fc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1283}
{"after": {"end": 305, "start": 0, "text": "If you vomit after taking this medicine and can identify the intact Vyndaqel tablet, then an additional dose of Vyndaqel should be taken in the same day; if you cannot identify the Vyndaqel tablet, then no additional dose of Vyndaqel is necessary, and you can resume taking Vyndaqel the next day as usual.", "truncated": false}, "after_length": 305, "after_sha256": "3e7eabe098a720bf6933a507f4aa1ba777ec474c338d4fdb74961e85d25f4c52", "annex": "IIIA", "before": {"end": 307, "start": 0, "text": "If you vomit after taking this medicine and can identify the intact Vyndaqel capsule, then an additional dose of Vyndaqel should be taken in the same day; if you cannot identify the Vyndaqel capsule, then no additional dose of Vyndaqel is necessary, and you can resume taking Vyndaqel the next day as usual.", "truncated": false}, "before_length": 307, "before_sha256": "4c39786e129f0f6aa97136f57c6026bb986bfaebeacf9e858ecaebc32fd2ad22", "change_kind": "content", "change_operations": [{"after_end": 78, "after_start": 77, "before_end": 78, "before_start": 77, "kind": "replace"}, {"after_end": 80, "after_start": 79, "before_end": 82, "before_start": 79, "kind": "replace"}, {"after_end": 83, "after_start": 82, "before_end": 84, "before_start": 84, "kind": "insert"}, {"after_end": 191, "after_start": 190, "before_end": 192, "before_start": 191, "kind": "replace"}, {"after_end": 193, "after_start": 192, "before_end": 196, "before_start": 193, "kind": "replace"}, {"after_end": 196, "after_start": 195, "before_end": 198, "before_start": 198, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0abe399d6f16d5e3d23f72f3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3133}
{"after": {"end": 419, "start": 0, "text": "In vitro, le niraparib est un inhibiteur de la BCRP. Une interaction cliniquement significative avec les substrats de la BCRP ne peut être exclue. Il est donc recommandé de faire preuve de prudence lorsque le niraparib est associé à des substrats de la BCRP (par exemple, l’irinotécan, la rosuvastatine, la simvastatine, l’atorvastatine et le méthotrexate) en raison du risque d’augmentation de l’exposition systémique.", "truncated": false}, "after_length": 419, "after_sha256": "98fb17496a153f0d84b541af29534c0f35792dcb321f12cfff8ecaa68d846e74", "annex": "I", "before": {"end": 199, "start": 0, "text": "Par conséquent, la prudence est recommandée lorsque le niraparib est administré en concomitance avec des substrats de la BCRP (irinotécan, rosuvastatine, simvastatine, atorvastatine et méthotrexate).", "truncated": false}, "before_length": 199, "before_sha256": "40f2ced5faf5cb8768105f50432ee516fcebc7e58aa90ba8d48424a9b45b8aec", "change_kind": "content", "change_operations": [{"after_end": 18, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 22, "after_start": 20, "before_end": 3, "before_start": 3, "kind": "insert"}, {"after_end": 28, "after_start": 23, "before_end": 6, "before_start": 4, "kind": "replace"}, {"after_end": 38, "after_start": 29, "before_end": 10, "before_start": 7, "kind": "replace"}, {"after_end": 42, "after_start": 39, "before_end": 11, "before_start": 11, "kind": "insert"}, {"after_end": 43, "after_start": 43, "before_end": 15, "before_start": 12, "kind": "delete"}, {"after_end": 61, "after_start": 47, "before_end": 20, "before_start": 19, "kind": "replace"}, {"after_end": 75, "after_start": 62, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 115, "after_start": 76, "before_end": 22, "before_start": 22, "kind": "insert"}, {"after_end": 126, "after_start": 117, "before_end": 24, "before_start": 24, "kind": "insert"}, {"after_end": 141, "after_start": 127, "before_end": 25, "before_start": 25, "kind": "insert"}, {"after_end": 144, "after_start": 142, "before_end": 26, "before_start": 26, "kind": "insert"}, {"after_end": 149, "after_start": 145, "before_end": 27, "before_start": 27, "kind": "insert"}, {"after_end": 158, "after_start": 153, "before_end": 31, "before_start": 31, "kind": "insert"}, {"after_end": 196, "after_start": 169, "before_end": 42, "before_start": 42, "kind": "insert"}, {"after_end": 228, "after_start": 224, "before_end": 72, "before_start": 70, "kind": "replace"}, {"after_end": 229, "after_start": 229, "before_end": 78, "before_start": 73, "kind": "delete"}, {"after_end": 232, "after_start": 231, "before_end": 100, "before_start": 80, "kind": "replace"}, {"after_end": 274, "after_start": 259, "before_end": 127, "before_start": 127, "kind": "insert"}, {"after_end": 288, "after_start": 285, "before_end": 138, "before_start": 138, "kind": "insert"}, {"after_end": 307, "after_start": 304, "before_end": 154, "before_start": 154, "kind": "insert"}, {"after_end": 323, "after_start": 321, "before_end": 168, "before_start": 168, "kind": "insert"}, {"after_end": 343, "after_start": 340, "before_end": 185, "before_start": 185, "kind": "insert"}, {"after_end": 418, "after_start": 356, "before_end": 198, "before_start": 198, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 37, "chars_inserted": 257}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0abea9d0fdacc93b03a37204", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1159}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 191, "start": 0, "text": "Do not share your Pen with other people, even if the needle has been changed. Do not reuse or share needles with other people. You may give an infection to them or get an infection from them.", "truncated": false}, "before_length": 191, "before_sha256": "f9f64bc2bed087ceac523de82e366f2441f8c15ac5ae2e5485dd893f67570f9b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 191, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 191, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0ada53b6be7023067cf47a33", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9581}
{"after": {"end": 7, "start": 0, "text": "Lietuva", "truncated": false}, "after_length": 7, "after_sha256": "5109820f748796128b8bafd3806d05511bc89ad77fc3cda960facf37a639bc7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0af2fb9a38447c4095831908", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3171}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 29, "start": 0, "text": "9. SPECIAL STORAGE CONDITIONS", "truncated": false}, "before_length": 29, "before_sha256": "1c7900d8ae1746afe2ef2b4a26d399b6054dc430f41e340e45f1f881197f01b2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 29, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 29, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0b214d6be90a1c2c969afbca", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4827}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 84, "start": 0, "text": "Niraparib as a substrate of efflux transporters (Pgp, BCRP, BSEP, MRP2, and MATE1/2)", "truncated": false}, "before_length": 84, "before_sha256": "6875d77cf5e688541567eae3e4b0316dd037e6544f9dc7aeed3759b84db1d1c3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 84, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 84, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0b476a6f783ce65d0988573d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 235}
{"after": {"end": 36, "start": 0, "text": "medinfo.lithuania@swixxbiopharma.com", "truncated": false}, "after_length": 36, "after_sha256": "70eec294d332a04f9bd82459b443a88e19b0dcce5bbd50491f56763531b2b260", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0b6e9b57bcc35b306d8e8c19", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3174}
{"after": {"end": 45, "start": 0, "text": "BristolMyers Squibb Marketing Services S.R.L.", "truncated": false}, "after_length": 45, "after_sha256": "be5fd3873d4974ef82d9deb306b94597f94cda5438931529a5b099349d1f12da", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 45, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 45}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0b9da7f697e687b9725f2bac", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3262}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 67, "start": 0, "text": "What Humalog 100 units/ml Tempo Pen solution for injection contains", "truncated": false}, "before_length": 67, "before_sha256": "903cac29ed522b50c2ff7ec9e8e6d0204210b8f9443b073d2ac9617c057be428", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 67, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 67, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0bc3e38bb0c7efeb0965fa2b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9438}
{"after": {"end": 37, "start": 0, "text": "5. METHOD AND ROUTE OF ADMINISTRATION", "truncated": false}, "after_length": 37, "after_sha256": "9c671e90ead72d031e0489d7a17c0d517e69200aed5e01a6faffa73ca5420b69", "annex": "IIIA", "before": {"end": 40, "start": 0, "text": "5. METHOD AND ROUTE(S) OF ADMINISTRATION", "truncated": false}, "before_length": 40, "before_sha256": "40d13857ade903416a15c2c141baf03ce80cf78bfa856e2b5de7f7b195b6d9bb", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 19, "before_end": 22, "before_start": 19, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0be4893e2b6a8d7c65376246", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 806}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 9, "start": 0, "text": "8055 Graz", "truncated": false}, "before_length": 9, "before_sha256": "765f51a390983de920b9a586c4589caab5f6398576531f438fd8301227c9ccb2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0bea84bf45efaec4a4905228", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1707}
{"after": {"end": 27, "start": 0, "text": "informacja.medyczna@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "fd724a87ca0b5fd348792afb72bf17e76991a1b17ad813c04854601dd7b9576a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0bfde790e26b3d6327eca1c9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3241}
{"after": {"end": 40, "start": 0, "text": "Do not store above 25 °C. Do not freeze.", "truncated": false}, "after_length": 40, "after_sha256": "5b83cffac35f0dd891ac8dbf4d0a5bc16ebc5aa87f24a3e3fc70a4c0901c566b", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Do not store above 25○C. Do not freeze.", "truncated": false}, "before_length": 39, "before_sha256": "4d7893aaf81b4a46a3520314f69d4f845bf96b32d8120a17fb1c9704ba039c1d", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 21, "before_end": 22, "before_start": 21, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0c04e0d599a60abef49cd4f0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1508}
{"after": {"end": 6, "start": 0, "text": "France", "truncated": false}, "after_length": 6, "after_sha256": "7a1ca4ef7515f7276bae7230545829c27810c9d9e98ab2c06066bee6270d5153", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0c5f36fc4875853de52ecc07", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2878}
{"after": {"end": 9, "start": 0, "text": "65 (56,5)", "truncated": false}, "after_length": 9, "after_sha256": "0cdc7e9ac9022f756582389aaffc19ee9b9b7c1d3daa8e849e2bc3b728f4394f", "annex": "I", "before": {"end": 9, "start": 0, "text": "55 (59,1)", "truncated": false}, "before_length": 9, "before_sha256": "bfa725db35eb0e5129b99da894be1bd93ea019d4ef3cf5e3dea9933ef4294c29", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 6, "after_start": 5, "before_end": 6, "before_start": 5, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 8, "before_start": 7, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0c7878ca998ae991d7b210b2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 308}
{"after": {"end": 34, "start": 0, "text": "2. COMPOSITION EN SUBSTANCE ACTIVE", "truncated": false}, "after_length": 34, "after_sha256": "d8d45b80cabae6182493dd6cb6cc5f7b61173e274bdf8970e0d5e4e0af28e6f6", "annex": "IIIA", "before": {"end": 40, "start": 0, "text": "2. COMPOSITION EN SUBSTANCE(S) ACTIVE(S)", "truncated": false}, "before_length": 40, "before_sha256": "4d60f4e65cd518be0591d38bf53afabde89d036bddddfa0bd55980a90810069d", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 27, "before_end": 30, "before_start": 27, "kind": "delete"}, {"after_end": 34, "after_start": 34, "before_end": 40, "before_start": 37, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0c9f5516c14f73d0c14c0cea", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 907}
{"after": {"end": 23, "start": 0, "text": "medinfo.finland@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "7029ed3ac062d546eacefe48107a23caa5547edd30d7c30335f744035bfb4ec6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0cf7ea95e41ea527b786b3de", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2620}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0d018fb78e7d7c3521586bd3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3014}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 25, "start": 0, "text": "Propylène glycol (E 1520)", "truncated": false}, "before_length": 25, "before_sha256": "29a4abc695bf8a7a6d8cfd755f254036d13a16c54e5e570317b8ff28473a7d08", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0d01b61b8d8cfa839ddaee1f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1919}
{"after": {"end": 6, "start": 0, "text": "Polska", "truncated": false}, "after_length": 6, "after_sha256": "d1974e0e3e575b6dadb40f080dae05025f574cb23e5cababcac0f50cf2619549", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0d039a99a4f9a51838d6ac2a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3238}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 34, "start": 0, "text": "Encre d’impression (Opacode blanc)", "truncated": false}, "before_length": 34, "before_sha256": "83424b0a15b7083009758c3bda685970022741581a0c9653dd14cd6b292c285a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0d0f236d22ac0b8dce4619c5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1912}
{"after": {"end": 21, "start": 0, "text": "Tel: + 385 1 2078 500", "truncated": false}, "after_length": 21, "after_sha256": "d2c4badf1d52e4fa4d9876ca25a250b52d706e4108687e5034656c1b419f6ddc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0d23adb21c5207cb0e7d2158", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3255}
{"after": {"end": 60, "start": 0, "text": "1. NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION", "truncated": false}, "after_length": 60, "after_sha256": "90beea80355511f097699f4362a4b3ef5f6c11c0c6eada7b8b50672b0a7b25a7", "annex": "IIIA", "before": {"end": 63, "start": 0, "text": "1. NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION", "truncated": false}, "before_length": 63, "before_sha256": "1b111f8832a3f702bf8b169ba4a0c12b3c629717ec63d9b3135d897996daee20", "change_kind": "content", "change_operations": [{"after_end": 42, "after_start": 42, "before_end": 45, "before_start": 42, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0d34fcd0d5ed1f3f409298b1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1114}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tel: +371 670 35 775", "truncated": false}, "before_length": 20, "before_sha256": "b680bf9f05ed1e4cf39b4fe148b3422de6b07719e12a6f388508a09cc4a5af9c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0d5cf60a63af26e00b0da805", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3851}
{"after": {"end": 115, "start": 0, "text": "No dose adjustment is required when changing from Vyndaqel 61 mg soft capsule to Vyndaqel 61 mg film-coated tablet.", "truncated": false}, "after_length": 115, "after_sha256": "f69c096914430556f828ec9e48a2bfd4887fa7c497372ec46b14ee7468161b7a", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 115, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 115}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0d6c4975597d841ed356ecb3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 961}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 375, "start": 0, "text": "Le niraparib n’est pas un substrat de la pompe d’exportation des sels biliaires (BSEP), ou de la protéine de multirésistance aux médicaments 2 (MRP2). Le métabolite principal M1 n’est pas un substrat de la P-gp, de la BCRP, de la BSEP ou de la MRP2. Le niraparib n’est pas un substrat de MATE 1 ou 2 (« multidrug and toxin extrusion »), alors que M1 est un substrat des deux.", "truncated": false}, "before_length": 375, "before_sha256": "2e0e3f9c45bde19eae51d0459dac350226baf3d5d250f28d4de730140ffb2f82", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 375, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 375, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0e2dc34e7458b3b60fdb02b1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 247}
{"after": {"end": 252, "start": 0, "text": "Les femmes en âge de procréer doivent utiliser une contraception efficace lorsqu’elles sont traitées par tafamidis et doivent continuer à utiliser une contraception efficace pendant un mois après l’arrêt du traitement par tafamidis (voir rubrique 4.6).", "truncated": false}, "after_length": 252, "after_sha256": "a489d2da136b79e32ed3a2cf3b84c5eab490d2946a60c258aded2862ac16b67d", "annex": "I", "before": {"end": 251, "start": 0, "text": "Les femmes en âge de procréer doivent utiliser une contraception efficace lorsqu’elles sont traitées par tafamidis et doivent continuer à utiliser une contraception efficace pendant 1 mois après l’arrêt du traitement par tafamidis (voir rubrique 4.6).", "truncated": false}, "before_length": 251, "before_sha256": "c5e01a1edf9a4c0ed4bc87d03f3214d0f58a69fe25f05353f9f1c00ccdf0da00", "change_kind": "content", "change_operations": [{"after_end": 184, "after_start": 182, "before_end": 183, "before_start": 182, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0e3c0d184172528f0894449f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1275}
{"after": {"end": 298, "start": 0, "text": "Zejula peut influencer le fonctionnement d'autres médicaments. Il est particulièrement important que vous mentionniez tout médicament contenant la substance active, la metformine (utilisée pour réduire le taux de sucre dans le sang), car votre médecin pourrait devoir ajuster la dose de metformine.", "truncated": false}, "after_length": 298, "after_sha256": "c1826af2adacd7a1ce2f1d60bdfacacf264435166f694366dd85bf19e0e42431", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 298, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 298}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0e67d94749d954ab7442aa9f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2291}
{"after": {"end": 7, "start": 0, "text": "România", "truncated": false}, "after_length": 7, "after_sha256": "633e193d7e05828a893d02a6273755ed0d417cc14abf5ecfc2b6328c71ddcc7e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0e9cc14bce5ae6bb8c254179", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2897}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 568, "start": 0, "text": "Le niraparib est un substrat de la glycoprotéine-P (P-gp) et de la protéine de résistance du cancer du sein (BCRP). Toutefois, en raison de sa perméabilité et biodisponibilité élevées, le risque d’interactions cliniquement importantes avec des médicaments qui inhibent ces transporteurs est peu probable. Par conséquent, aucun ajustement posologique n’est nécessaire pour Zejula en cas d’administration concomitante avec des médicaments connus pour inhiber la P-gp (par exemple, amiodarone, vérapamil) ou la BCRP (par exemple, osimertinib, velpatasvir et eltrombopag).", "truncated": false}, "before_length": 568, "before_sha256": "8e59b2ae8ea8ecdc6fd3867003a36d4c2b3f377e5bec56c892aa1d39d64417d6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 568, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 568, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0ec301a42f3be56b6bea5169", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 245}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 6, "start": 0, "text": "Κύπρος", "truncated": false}, "before_length": 6, "before_sha256": "7f8ef8a379e33810aefd13f344f489d85e8902de6fdcd1b46a4e856985b5e14e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 6, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0ed787a3209c700369b3d963", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9550}
{"after": {"end": 26, "start": 0, "text": "Lactose monohydrate (E 24)", "truncated": false}, "after_length": 26, "after_sha256": "bf4bff2605c5a6296d9cdecd027d95775b210257f616f2529f143dcb63c332a7", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0eed56dc6645fdca508e2b8a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1340}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "Roonstraße 25", "truncated": false}, "before_length": 13, "before_sha256": "72b80df998792e1d92189a290d82759fb839b17a555226b67f667c759822bfa7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0f3374f18e918984ee1ea52d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3823}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 119, "start": 0, "text": "Do not try to inject your insulin by turning the dose knob. You will NOT receive your insulin by turning the dose knob.", "truncated": false}, "before_length": 119, "before_sha256": "c350db935c4d042c0cce1060629f81a5175e71700ed25b018f17b455cfb4bc67", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 119, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 119, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0f7ae0485623fde8b1cca8f8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9752}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 168, "start": 0, "text": "While you are not confident about recognising your warning symptoms, avoid situations, e.g. driving a car, in which you or others would be put at risk by hypoglycaemia.", "truncated": false}, "before_length": 168, "before_sha256": "4d15f45e353826bd587dc0b17eecd0315d03ecbbffeb4932047b2b2877543183", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 168, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 168, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0f7b12584e80db361f36831e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9401}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 103, "start": 0, "text": "The major primary metabolite M1 does not appear to be an inhibitor of Pgp, BCRP, BSEP, MRP2 or MATE1/2.", "truncated": false}, "before_length": 103, "before_sha256": "4a738731cb95391ab20f8eccf19c9fe68fa565c5ac0f68b32d10138986763e65", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 103, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 103, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0f8001e03e63a0a8217812b8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1129}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 16, "start": 0, "text": "Gelatine (E 441)", "truncated": false}, "before_length": 16, "before_sha256": "023ab45a214bd24b037e72e065548088dc5dc12a02c0ed7f7a049bbdd7385ec6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0f80a0afa2dd7c47eae6a3d4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1355}
{"after": {"end": 6, "start": 0, "text": "Danija", "truncated": false}, "after_length": 6, "after_sha256": "bc6a7343d3e198e003189dc965ded9d843ad23a091832eaa358b67171d90166d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0f8f87258958afff5c464001", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2022}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0f924535bb1b4d2e1b90a27a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2488}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 70, "start": 0, "text": "Inhibition of hepatic uptake transporters (OATP1B1, OATP1B3, and OCT1)", "truncated": false}, "before_length": 70, "before_sha256": "a7f0c1a3e7985235db8ba8fec6c3494aa04c3616ec52a69f29e540581f019c7e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 70, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 70, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0f95c56cb97f5c5f28df76e0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1131}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 45, "start": 0, "text": "• you take too much Humalog or other insulin;", "truncated": false}, "before_length": 45, "before_sha256": "c43307c637fd5aa8d284da93df9c8f853f545d770dcf262f46ecb10396a85eb3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 45, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 45, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-0fb9a76c5f89292bfa6250a0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9387}
{"after": {"end": 170, "start": 0, "text": "Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’autorisation de mise sur le marché :", "truncated": false}, "after_length": 170, "after_sha256": "3d33a6b4a45572c6d201e5b64d04d70230f33eb5f235e4cf7ed24c3872500500", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 170, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 170}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-101663a3b84d88110da0960e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2800}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Tél/Tel: + 32-(0)2 548 84 84", "truncated": false}, "before_length": 28, "before_sha256": "0ea6c3d792328cdb3ad266c1aab6ba94ad02b214a39db7b75eff8aceade0438c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-101e735f005d884966955ddd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9457}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 68, "start": 0, "text": "The amount of insulin you need may also change if you drink alcohol.", "truncated": false}, "before_length": 68, "before_sha256": "aff7cb664b9e7c8f897c3d3c2e9aa38e74182592aabdf8b5f692adf63630dff7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 68, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 68, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1035d7f80c841ac9debd0eea", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9258}
{"after": {"end": 21, "start": 0, "text": "Τηλ: + 30 210 6074300", "truncated": false}, "after_length": 21, "after_sha256": "c10bf95f55d88eadacbbac2970ab7bef5bd625d01122a54ba6a3bd30eae65368", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-10689610bdca9857afc3e6d6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2554}
{"after": {"end": 22, "start": 0, "text": "Tel: + 421 2 20833 600", "truncated": false}, "after_length": 22, "after_sha256": "06545090f6b6777d6143e84f408247cee2424d81a40db0a2693eff093cfe9ec8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-108f22c483bae867cd2f5c42", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2919}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Mylan IRE Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "35f93c261e1c23366cb104ad58005b2a5415120196df611fa95117f89eb960ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-10bfaca9040158b915c9386f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2695}
{"after": {"end": 123, "start": 0, "text": "Titulaire de l'Autorisation de mise sur le marché : Eli Lilly Nederland B.V., Orteliuslaan 1000, 3528 BD Utrecht, Pays-Bas.", "truncated": false}, "after_length": 123, "after_sha256": "c9360159827bd94b8452261891b0f98066b989ff2cdfd5b65fd7a73b98e1e192", "annex": "III", "before": {"end": 123, "start": 0, "text": "Titulaire de l'Autorisation de mise sur le marché : Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Pays-Bas.", "truncated": false}, "before_length": 123, "before_sha256": "24244fac23f7c655b5cf0249efb6324cf790a7ba49b33b42d12cc4dbef87a7b4", "change_kind": "administrative", "change_operations": [{"after_end": 87, "after_start": 78, "before_end": 79, "before_start": 78, "kind": "replace"}, {"after_end": 89, "after_start": 88, "before_end": 82, "before_start": 80, "kind": "replace"}, {"after_end": 90, "after_start": 90, "before_end": 92, "before_start": 83, "kind": "delete"}, {"after_end": 95, "after_start": 91, "before_end": 95, "before_start": 93, "kind": "replace"}, {"after_end": 104, "after_start": 103, "before_end": 104, "before_start": 103, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-111cff0803dc80c8ce4054cb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2785}
{"after": {"end": 21, "start": 0, "text": "Tlf.: +45 45 26 60 00", "truncated": false}, "after_length": 21, "after_sha256": "6bdd3c845f6a6e520023cbb8b3726e2eefc4bc4ac00ae57245f3055e31d53895", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tlf: +45 45 26 60 00", "truncated": false}, "before_length": 20, "before_sha256": "7932ef9452966b997a4a22618abb01fb644277c9ab041214e6264730772b2d64", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-114cc66dbf7f5cd1518bfde2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3342}
{"after": {"end": 23, "start": 0, "text": "medinfo.romania@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "9ae697b67f3c854a077ca894d99400f1de79e31bd9bf61321fc7c4030bf8a213", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-11a25c12c42f397d88fb0fed", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2900}
{"after": {"end": 11, "start": 0, "text": "Deutschland", "truncated": false}, "after_length": 11, "after_sha256": "af6e56aacd8097c3fb7597b08ecb3d87a040f6ab58067a4b8ff9f5b747adb9be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-11bef0feedc9b3909caac504", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3206}
{"after": {"end": 21, "start": 0, "text": "Tel: + 46 8 704 71 00", "truncated": false}, "after_length": 21, "after_sha256": "313eaeeb04c88c002b748323fb801826225906f557247264c0fcb9fc87c873fc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-11c017ecea59b9f83b3d71ba", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2629}
{"after": {"end": 24, "start": 0, "text": "portugal.medinfo@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "9ec8b32b2035c90c423af74fa150dca23880201d448d46da35a42d2a862c8345", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-11caf18d68ff2ce3dee98d54", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2886}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Belgique/België/Belgien", "truncated": false}, "before_length": 23, "before_sha256": "d4fc969e3a5d3f43b33bb4b36da827d60707c2b316e8d0e4d0239a9b57dfbf2a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-11ed95d36359818cb5e078c7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9455}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "• Tempo Pen containing your insulin", "truncated": false}, "before_length": 35, "before_sha256": "c7eada57301479ccf3a05eeda418d07ba5f184647f1486eb6d9dc3a1b1b10a1d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-121673510906ce1242070a1a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9624}
{"after": {"end": 62, "start": 0, "text": "Titulaire de l’Autorisation de mise sur le marché et fabricant", "truncated": false}, "after_length": 62, "after_sha256": "5eb30fa63ee39d5d0a9744c66dc0cac4f6a5cbcfe786b3057e9cfb022517a46f", "annex": "IIIA", "before": {"end": 49, "start": 0, "text": "Titulaire de l’Autorisation de mise sur le marché", "truncated": false}, "before_length": 49, "before_sha256": "e6862501ae974515f409229ac48889a881f5d48257cce71c9b21dd7551f5c918", "change_kind": "administrative", "change_operations": [{"after_end": 62, "after_start": 49, "before_end": 49, "before_start": 49, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-125be158acabce502dd35651", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2448}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma s.r.o.", "truncated": false}, "after_length": 22, "after_sha256": "e26ccdddfb0893074547931bd19474d6541a45958e27c35b776e8f18abf48a36", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1272ff4e4b4bc4e1aed9cbd0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3282}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "4. BATCH NUMBER", "truncated": false}, "before_length": 15, "before_sha256": "6fa5630bc9464cbe676efd047d46dd215fcb186e00aa2c4ff44dbada77cb3b27", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-128c95436efa5b504a6ad2e1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4895}
{"after": {"end": 533, "start": 0, "text": "The following table includes adverse reactions from 173 subjects that received rezafungin 400/200 mg listed by system organ class (SOC) and MedDRA preferred terms with frequency corresponding to very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1 000 to < 1/100), rare (≥ 1/10 000 to < 1/1 000), very rare (< 1/10 000) and from spontaneous reports with frequency not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.", "truncated": false}, "after_length": 533, "after_sha256": "04aadb13f15f41faf44cbc62295be4382135316177b66e538b7ad8b5b997d6ad", "annex": "I", "before": {"end": 533, "start": 0, "text": "The following table includes adverse reactions from 151 subjects that received rezafungin 400/200 mg listed by system organ class (SOC) and MedDRA preferred terms with frequency corresponding to very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1 000 to < 1/100), rare (≥ 1/10 000 to < 1/1 000), very rare (< 1/10 000) and from spontaneous reports with frequency not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.", "truncated": false}, "before_length": 533, "before_sha256": "8de836d1bbffbb073f28bba7ffecea91bac332b831311e00225de7a7265ef379", "change_kind": "content", "change_operations": [{"after_end": 55, "after_start": 53, "before_end": 55, "before_start": 53, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1296216213dea081d8c9a0f0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.8", "section_type": "adverse_reactions", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 175}
{"after": {"end": 21, "start": 0, "text": "medinfo.czech@bms.com", "truncated": false}, "after_length": 21, "after_sha256": "7d80d4bfa363423e385e42b079e9a90210b1f5d622fbfe8ab954e6684db7cffd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-12962897f2f77d9460d9f129", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2825}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Tel: +386 (0) 1 580 00 10", "truncated": false}, "before_length": 25, "before_sha256": "d734765dfca5da6b9eed3ff8e3aec2f3e5b46cafd4f59ffcbf006dd142f16c3a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-12b9dcda59bf84b71900ec4a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9532}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "– Do not remove the Pen label.", "truncated": false}, "before_length": 30, "before_sha256": "64a24af2b26348c7b21e9cafabe46f17dc5d9cc1aaa33b93c9960c804ce5b06f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 30, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 30, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-12c350339bd7e6f30cdb804f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9636}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 99, "start": 0, "text": "If you answer YES to any of the following questions, tell your doctor, pharmacist or diabetes nurse", "truncated": false}, "before_length": 99, "before_sha256": "2ca07e35b17d361d8c7a9bb6ea63de6cc098f30d30423dbd960abe2f58c856da", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 99, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 99, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-12e100d7bd6d511c45cdcce2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9254}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 188, "start": 0, "text": "if you think hypoglycaemia (low blood sugar) is starting. Further in this leaflet it tells you how to deal with mild hypoglycaemia (see Section 3: If you use more Humalog than you should).", "truncated": false}, "before_length": 188, "before_sha256": "47bb71d18a91297eb9ad9081de2ddc20983225a4d9709ea52453e1c6788c44c4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 188, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 188, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-12e1f131986429b4069813eb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9247}
{"after": {"end": 35, "start": 0, "text": "medinfo.bulgaria@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7905c486c458386eb1a26649ec5c649de6cbd59270b3b28715f74ada40ed9166", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-12ee4176fe13fdc1701a026b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3179}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-13e9b6cb3026ae798557963e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3344}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 21, "start": 0, "text": "Macrogol 400 (E 1521)", "truncated": false}, "before_length": 21, "before_sha256": "e706c372cbe268a129abfe719a7a7498e83b3f218b4477352a0e8f6a8820f6f7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1404670d84f6381c18de80b7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1375}
{"after": {"end": 27, "start": 0, "text": "Puh/Tel: + 358 9 251 21 230", "truncated": false}, "after_length": 27, "after_sha256": "115859cfeab013cc7da2aa72c6645b7c1a35594595b929820235610cd0afa5fd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-142f7c8f79fe1c3cd1fdf646", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2925}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Astellas Ireland Co. Ltd.", "truncated": false}, "before_length": 25, "before_sha256": "1d98a06d2f724f3f69491c40480991ee287d2e3806d862b6ab226d0b620c6885", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1434f657baaff6e50719b878", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1727}
{"after": {"end": 22, "start": 0, "text": "medinfo.sweden@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "b564c1a351ab9a2c3f444753cdc78f0306131b829474e9874a876fc1a90d4b7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-14a2be42fc832961bf8d4935", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2940}
{"after": {"end": 25, "start": 0, "text": "BristolMyers Squibb, S.A.", "truncated": false}, "after_length": 25, "after_sha256": "88e5c5115dcefbb042e25eed814626af9715f5463760d1a01269da8ccc06cd7e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-14be571d7f8686c9abb0bbf0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3237}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Vistor hf.", "truncated": false}, "before_length": 10, "before_sha256": "4b40dfc2a19551f982dad779994a624f3432207c4666bbd66f0ec59c2f229b32", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 7, "before_end": 7, "before_start": 7, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-14d26cc06b13957b0cee3461", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2982}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "1932 Zaventem", "truncated": false}, "before_length": 13, "before_sha256": "cffe4475a5de91da7a3a6363a4d41ccfd1405766d95ae182d89bf39b29686221", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-14d99e8e61e2a5c0655d83d3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3714}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Do NOT use Humalog Tempo Pen", "truncated": false}, "before_length": 28, "before_sha256": "153da418d1d51c9b07bf256f5f50cc8ab0b81476d030fd534591379346b6d167", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-14e6096c47cd40c304e91f74", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9246}
{"after": {"end": 34, "start": 0, "text": "2. COMPOSITION EN SUBSTANCE ACTIVE", "truncated": false}, "after_length": 34, "after_sha256": "d8d45b80cabae6182493dd6cb6cc5f7b61173e274bdf8970e0d5e4e0af28e6f6", "annex": "IIIA", "before": {"end": 40, "start": 0, "text": "2. COMPOSITION EN SUBSTANCE(S) ACTIVE(S)", "truncated": false}, "before_length": 40, "before_sha256": "4d60f4e65cd518be0591d38bf53afabde89d036bddddfa0bd55980a90810069d", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 27, "before_end": 30, "before_start": 27, "kind": "delete"}, {"after_end": 34, "after_start": 34, "before_end": 40, "before_start": 37, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-14f07b5ae80ace244b567362", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 809}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 27, "start": 0, "text": "Fresenius Kabi Austria GmbH", "truncated": false}, "before_length": 27, "before_sha256": "fa59d2b0c9ce4abc55a3051cb227907a12a3a3e7fc63908aaebeb76ac9f651ef", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-14f18c4ff89e682e8e8658ce", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1678}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "After your injection", "truncated": false}, "before_length": 20, "before_sha256": "5f4a48c5bf82a429003c150f521da6f3a1a3909057403ed50cb828e746ac0128", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1533e96e2ad56125e9604e5a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9769}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 62, "start": 0, "text": "Plaquettes (PVC/PA/alu/PVC-alu) prédécoupées en dose unitaire.", "truncated": false}, "before_length": 62, "before_sha256": "c0ca1e0333ab7411166fdbd3136840dd49776fa7e2f31ed6d7b465939ff39c56", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 62, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 62, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1572c617e640efff5addee43", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.5", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1938}
{"after": {"end": 12, "start": 0, "text": "Magyarország", "truncated": false}, "after_length": 12, "after_sha256": "5206a7f7063a77a35861f95e022dafc37f3b3cf27ed423b1118e3fe580841b19", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-157c74178d11fe9b93be4385", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3191}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-15813fdda1e986da3e6eafe8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3266}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 31, "start": 0, "text": "3. How to use Humalog Tempo Pen", "truncated": false}, "before_length": 31, "before_sha256": "12f068253fe24d20f4ad645aef8a19ab67c3b190f40c1103db14393f47072c7f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 31, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 31, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-15a2cedf6e4846524db44f5a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9302}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 53, "start": 0, "text": "Humalog 100 units/ml Tempo Pen solution for injection", "truncated": false}, "before_length": 53, "before_sha256": "5d54a4196ca1fc4483354e596e2e110f613a9ecf4335059d9b37d0b3b1576cbf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 53, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 53, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-15b492447a20503da5b367ae", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4882}
{"after": {"end": 136, "start": 0, "text": "Additional injection site reactions (pressure sensation, bruising, reduced sensation and/or numbness, raised itchy skin rash and warmth)", "truncated": false}, "after_length": 136, "after_sha256": "f8903e4136fc99ff03dc94b54eedffb776f2ce7fdfea5d3a9d2cc033d6ce7981", "annex": "IIIA", "before": {"end": 137, "start": 0, "text": "Additional injection site reactions (pressure sensation, bruising, reduced sensation and/or numbness, raised itchy skin rash and warmth).", "truncated": false}, "before_length": 137, "before_sha256": "7dacd36b66dc29c2a4966279b86b44c6d6b3c70a8a84691046996baf99602711", "change_kind": "content", "change_operations": [{"after_end": 136, "after_start": 136, "before_end": 137, "before_start": 136, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-15c96f9dd0ffb69dc7262af3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1478}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 139, "start": 0, "text": "Compte tenu du rapport d’évaluation du PRAC sur les PSUR concernant le tadalafil, les conclusions scientifiques du CHMP sont les suivantes:", "truncated": false}, "before_length": 139, "before_sha256": "689a34954c0adc1b1f3054f6acadf98c4765fa80fc84dd7b3ee991591aff46e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 139, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 139, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-15e8f112d89da880c63b0687", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3496}
{"after": {"end": 142, "start": 0, "text": "Do not use this medicine after the expiry date stated on the label and carton after EXP. The expiry date refers to the last day of that month.", "truncated": false}, "after_length": 142, "after_sha256": "f682e86d4bc0c3db01e5410bbd719d4cf6bd248ba5160b2a505212258beb4d8e", "annex": "IIIA", "before": {"end": 133, "start": 0, "text": "Do not use this medicine after the expiry date stated on the label after ‘EXP’. The expiry date refers to the last day of that month.", "truncated": false}, "before_length": 133, "before_sha256": "46fa800a72c7fb08dbc6339a18d950b65fd6ddac4cc49ad7a88416365b39ce56", "change_kind": "content", "change_operations": [{"after_end": 79, "after_start": 68, "before_end": 68, "before_start": 68, "kind": "insert"}, {"after_end": 84, "after_start": 84, "before_end": 74, "before_start": 73, "kind": "delete"}, {"after_end": 87, "after_start": 87, "before_end": 78, "before_start": 77, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-161625393250c551ba909f1a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1506}
{"after": {"end": 21, "start": 0, "text": "Tel: + 39 06 50 39 61", "truncated": false}, "after_length": 21, "after_sha256": "6ac0b442dd41c62cad589a5c348c5781354f651196f78692c420568d264ff7f0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-16483e359df28635de69836a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2608}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 63, "start": 0, "text": "– The odd numbers, after the number 1, are shown as full lines.", "truncated": false}, "before_length": 63, "before_sha256": "afca7afaf04185427dcdad939dab437e87397dea8af9a3dc35b605c65690488e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 63, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 63, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-165a341c16454a82b6f7ec2e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9696}
{"after": {"end": 6, "start": 0, "text": "Ísland", "truncated": false}, "after_length": 6, "after_sha256": "5801902efe8b92c2ace1332f4cca2ea1fcb704712e2fe7ca66654d2a826e8451", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-165db400cdd9040c5ac6d252", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3276}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Solution for injection.", "truncated": false}, "before_length": 23, "before_sha256": "f96c7ce4de1e08aa045db6e55fef8c3a01b890a853a3ee8570ad1f9ba2ca6c55", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-167039d0c9970c4f92860665", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4605}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Pfizer Service Company BV", "truncated": false}, "before_length": 25, "before_sha256": "6d0e726cfdc1afe8527891b46cdc3cc61a445bad75ceb250725385c322d4383d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1692ba4fa0d9d7ac342ccba7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3712}
{"after": {"end": 38, "start": 0, "text": "N.V. Bristol-Myers Squibb Belgium S.A.", "truncated": false}, "after_length": 38, "after_sha256": "aed62c6e6383ee3130a6851382813dabc668847cc45474eecb9eae19fd27a962", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-16ea349ea3e43e3e7e2add88", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2799}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Mylan IRE Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "35f93c261e1c23366cb104ad58005b2a5415120196df611fa95117f89eb960ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1708c834a44aa4dbfb5ae13a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3019}
{"after": {"end": 584, "start": 0, "text": "Dans l’analyse pharmacocinétique d’une population de patientes ayant une insuffisance rénale légère (clairance à la créatinine 60-90 mL/min) ou modérée (clairance à la créatinine 30-60 mL/min), la clairance du niraparib a été légèrement réduite, comparativement aux individus ayant une fonction rénale normale. Cette différence d’exposition n’est pas considérée comme justifiant un ajustement posologique. Aucune patiente avec insuffisance rénale sévère préexistante ou d’insuffisance rénale terminale sous hémodialyse n’a été identifiée dans les études cliniques (voir rubrique 4.2).", "truncated": false}, "after_length": 584, "after_sha256": "9a0d8eb054c569ac53038919105d0fb07a4f58d0bd3a40bc3399f4659d5bf85d", "annex": "I", "before": {"end": 725, "start": 0, "text": "Dans l’analyse pharmacocinétique d’une population de patientes ayant une insuffisance rénale légère (clairance à la créatinine 60-90 mL/min) ou modérée (clairance à la créatinine 30-60 mL/min), la clairance du niraparib a été légèrement réduite, comparativement aux individus ayant une fonction rénale normale (7-17% d’exposition plus élevée chez les insuffisants rénaux légers et 17-38% d’exposition plus élevée chez les insuffisants rénaux modérés). Cette différence d’exposition n’est pas considérée comme justifiant un ajustement posologique. Aucune patiente avec insuffisance rénale sévère préexistante ou d’insuffisance rénale terminale sous hémodialyse n’a été identifiée dans les études cliniques (voir rubrique 4.2).", "truncated": false}, "before_length": 725, "before_sha256": "78634fa1454d66d6e09bf0887d5c9af2a94aaa6ae68eba7da7770d3a695cda8a", "change_kind": "content", "change_operations": [{"after_end": 309, "after_start": 309, "before_end": 450, "before_start": 309, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 141, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-170e8af9ade0ad4fa2f50c72", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1700}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb A.E.", "truncated": false}, "after_length": 25, "after_sha256": "43a0521fcec8db403e6fb060ae3b147a3107583a8df9b3a28208c9a4bd0d8fba", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1785d22f645d555089045227", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3294}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Cap Clip", "truncated": false}, "before_length": 8, "before_sha256": "b36579c2ee8ca3b5829e646fe62dd141cdda241c6205e128d0745b37a1ccf2c8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-17bc68b43aaf63833febd07d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9586}
{"after": {"end": 47, "start": 0, "text": "Marketing Authorisation Holder and Manufacturer", "truncated": false}, "after_length": 47, "after_sha256": "4542f9bb3095abea29e124e5e4ba8ada603cefe01cb57b9ddc98b99054dc2887", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "Marketing Authorisation Holder", "truncated": false}, "before_length": 30, "before_sha256": "49b1d8044839391ca09e6bef9f9460184c586c4da018732ac3a7e596cf20e965", "change_kind": "administrative", "change_operations": [{"after_end": 47, "after_start": 30, "before_end": 30, "before_start": 30, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 17}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-17bcffd078d6e7b2c4e85648", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2736}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 88, "start": 0, "text": "Niraparib comme substrat des transporteurs d’influx hépatique (OATP1B1, OATP1B3 et OCT1)", "truncated": false}, "before_length": 88, "before_sha256": "937894bdc6cac5307488993f4f2e8a90500681035be6bbd0431e25bd394310f5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 88, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-17cba08665243a3874e2d67a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 249}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "3. DATE DE PÉREMPTION", "truncated": false}, "before_length": 21, "before_sha256": "85c6f427b593f0849a14f3b4eddc1cc1e7c620b6f728e9b76a2d41d644c8e1a2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-17e8f07fa0212f681d9a64ca", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1116}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma SIA", "truncated": false}, "after_length": 19, "after_sha256": "6da5006887c3e11cf19ecbe52bdc7a386838e93f6e63f315e575cb7df7747f15", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-18521c47a72e9787889fa13b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2627}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 12, "start": 0, "text": "Eau purifiée", "truncated": false}, "before_length": 12, "before_sha256": "749c72b8ea6ef8e2d300b8b62e85a5c5968d249c07631d7100b00874cf8fca47", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1853ae13bdd31e3e1cb55897", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1916}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 110, "start": 0, "text": "This medicinal product contains no more than 44 mg sorbitol in each capsule. Sorbitol is a source of fructose.", "truncated": false}, "before_length": 110, "before_sha256": "99c35f218bd16efe4df1caa15b65ad1800d7172f1b4801319510dae799a738ca", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 110, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 110, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-187170f7b2de3c3f55ef9164", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1001}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 26, "start": 0, "text": "Tel: + 31-(0) 30 60 25 800", "truncated": false}, "before_length": 26, "before_sha256": "dd48a47d9eee2b75f8892352ab76d301bc8cb5408021bdd9710fbc33134aa6da", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 26, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 26, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-18b8875c7efa607a0ee3c394", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9490}
{"after": {"end": 8, "start": 0, "text": "България", "truncated": false}, "after_length": 8, "after_sha256": "a7215e5aa55f878990c076bb8195d75ca42044d4d5c7d2ba90af610508b643d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-18f94e0f9d97239762854626", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3173}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 119, "start": 0, "text": "• Do not store the Pen with the needle attached to prevent leaking, blocking the needle, and air from entering the Pen.", "truncated": false}, "before_length": 119, "before_sha256": "1ccea541138b4e2df407f1554df1a854acee23ca5fbafd3a631851fbea56f253", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 119, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 119, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1906767b47d23097283d6701", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9775}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 41, "start": 0, "text": "PLEASE READ THESE INSTRUCTIONS BEFORE USE", "truncated": false}, "before_length": 41, "before_sha256": "e89c4134c5edc730fcd3188d0c88117a922ab3f875d6cedbea2fec6191a7c151", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 41, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 41, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-19174b0bb13532ae98e81ed1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9576}
{"after": {"end": 124, "start": 0, "text": "Inhibition des transporteurs d’efflux [Glycoprotéine P (P-gp), protéine de résistance du cancer du sein (BCRP) et MATE 1/2K]", "truncated": false}, "after_length": 124, "after_sha256": "0a68f8a888c0a6bc2c92655285ee603f783e6a63ff1743aaa0db237aaddc900a", "annex": "I", "before": {"end": 74, "start": 0, "text": "Inhibition des transporteurs d’efflux (P-gp, BCRP, BSEP, MRP2 et MATE 1/2)", "truncated": false}, "before_length": 74, "before_sha256": "31bd1c27f0909792ef6156a5205b9d8fe29a67f59ec780219483f7b5448d223c", "change_kind": "content", "change_operations": [{"after_end": 55, "after_start": 38, "before_end": 38, "before_start": 38, "kind": "insert"}, {"after_end": 61, "after_start": 60, "before_end": 43, "before_start": 43, "kind": "insert"}, {"after_end": 105, "after_start": 63, "before_end": 45, "before_start": 45, "kind": "insert"}, {"after_end": 110, "after_start": 109, "before_end": 61, "before_start": 49, "kind": "replace"}, {"after_end": 124, "after_start": 122, "before_end": 74, "before_start": 73, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 63}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-193352f739b1304607dcd000", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 268}
{"after": {"end": 6, "start": 0, "text": "Ísland", "truncated": false}, "after_length": 6, "after_sha256": "5801902efe8b92c2ace1332f4cca2ea1fcb704712e2fe7ca66654d2a826e8451", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-195f0a58447254ff689068a6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2596}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 63, "start": 0, "text": "Les études d’interaction n’ont été réalisées que chez l’adulte.", "truncated": false}, "before_length": 63, "before_sha256": "c5778411640aed1def9826b178c1eb02020867a5d5584de21a18695b9da07758", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 63, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 63, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-196f15b88662e4fcdd208dbe", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1173}
{"after": {"end": 5, "start": 0, "text": "Malta", "truncated": false}, "after_length": 5, "after_sha256": "71e9eb10755c8232974d186a560f7658a1ccbdd3097877dfa1ad3436af90d46a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1976cb7ff0084a86af8b0698", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3201}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 45 45 93 05 06", "truncated": false}, "after_length": 21, "after_sha256": "61983c14390c5d0df2153e10740a9b1eb429e8c0b05c3ebe705431c827a32b81", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-198731be906af0a52d5e6720", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2834}
{"after": {"end": 18, "start": 0, "text": "Swixx Biopharma OÜ", "truncated": false}, "after_length": 18, "after_sha256": "94bc5f3c43fc9da5715250d66202d3b6e108127762e4f8e413b99fc19e24a395", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 18, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 18}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-19b4298bb96af2628f4b36ad", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3214}
{"after": {"end": 34, "start": 0, "text": "Cellulose microcristalline (E 460)", "truncated": false}, "after_length": 34, "after_sha256": "590f3718aa045a6f09c5569aa2926d9a8e22267a72b9d4ce01215fe8aaabb395", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1a1d5894fdf635c00bf19738", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1883}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 75, "start": 0, "text": "INTERMEDIATE CARTON (without blue box) component of a multipack – Tempo Pen", "truncated": false}, "before_length": 75, "before_sha256": "7391b2e57dde265adad66975a6c4af26942760164caf8a1f0259fbbbc2c829c3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 75, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 75, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1a3502b62badd4227d6a38c9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4781}
{"after": {"end": 20, "start": 0, "text": "Sími: + 354 535 7000", "truncated": false}, "after_length": 20, "after_sha256": "66fcdd056ccfbc5ba6d0c26580292977898106c90655c78208bc87c3d941892c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1a9012b9cd551c00c644b79f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2914}
{"after": {"end": 39, "start": 0, "text": "Bristol-Myers Squibb Pharmaceuticals uc", "truncated": false}, "after_length": 39, "after_sha256": "ab72fdea8b5fe2eaa4c98886b1cf7afbfde7133a0ee1d1e04fc9d573c1885b5c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 39, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 39}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1aa92114d4798717e6747116", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2899}
{"after": {"end": 5, "start": 0, "text": "Norge", "truncated": false}, "after_length": 5, "after_sha256": "882f535a7da00cd72aec9957f14113085717f72c791945420043b48876276628", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1ab2a77eba9562e02bc176e6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2857}
{"after": {"end": 33, "start": 0, "text": "Τηλ: 800 92666 (+ 30 210 6074300)", "truncated": false}, "after_length": 33, "after_sha256": "3c667c31f7c324c43671bdd5606ccfdb57ec8b49816d058ab68a853627dd20b8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1aba823023df848ee03e788f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2930}
{"after": {"end": 27, "start": 0, "text": "informacja.medyczna@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "fd724a87ca0b5fd348792afb72bf17e76991a1b17ad813c04854601dd7b9576a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1af36f33a026c0204617baf4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2564}
{"after": {"end": 9, "start": 0, "text": "29 (25.2)", "truncated": false}, "after_length": 9, "after_sha256": "76c2bcc47d223d07d1b5346d5f2032ac2c4cf4c7fe69f8ffcdda0dd6f8d000fc", "annex": "I", "before": {"end": 10, "start": 0, "text": "(22 (23.7)", "truncated": false}, "before_length": 10, "before_sha256": "26f7b4abe3d8ba016ea52018c3fb18e8a8ef1f1141c7eb40cbe8f9e6a99ed277", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "delete"}, {"after_end": 2, "after_start": 1, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 6, "after_start": 5, "before_end": 7, "before_start": 6, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 9, "before_start": 8, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1afd9f861f04f717587af4ca", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 310}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "before_length": 7, "before_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1b1d419f8230530c4623516f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3849}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Lietuva", "truncated": false}, "before_length": 7, "before_sha256": "5109820f748796128b8bafd3806d05511bc89ad77fc3cda960facf37a639bc7f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1b273cafc5a5d4c674e6b0b8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9459}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 21, "start": 0, "text": "Macrogol 400 (E 1521)", "truncated": false}, "before_length": 21, "before_sha256": "e706c372cbe268a129abfe719a7a7498e83b3f218b4477352a0e8f6a8820f6f7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1b3614029f3d44d26571b709", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1907}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 26, "start": 0, "text": "Oxyde de fer rouge (E 172)", "truncated": false}, "before_length": 26, "before_sha256": "f057ffbcc12bbba4f31359800d148be9b2f196190333a0be2f1a1d520b11564d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 26, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 26, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1b4a1755daf9d7e1c3487fee", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1899}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht", "truncated": false}, "before_length": 34, "before_sha256": "46a90fc46ae308c2beeb35ead613fcf3ade5a51e2217a834de3fa5972dab9eec", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1b828ded899caccab85d2cb7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4840}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 32, "start": 0, "text": "• thirst • feeling or being sick", "truncated": false}, "before_length": 32, "before_sha256": "b9959e90ad2246d98da36253572232ae4e2d25f83e6f4aac3fff38691e8f0376", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1b89b2cf49ecf2858f84b89e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9413}
{"after": {"end": 33, "start": 0, "text": "Τηλ: 800 92666 (+ 30 210 6074300)", "truncated": false}, "after_length": 33, "after_sha256": "3c667c31f7c324c43671bdd5606ccfdb57ec8b49816d058ab68a853627dd20b8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1c14a355693b4339562087c7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2624}
{"after": {"end": 105, "start": 0, "text": "There are insufficient data across races to conclude on the impact of race on niraparib pharmacokinetics.", "truncated": false}, "after_length": 105, "after_sha256": "07850a5a0e876287443d9ba639ad6ca909cfba75d953fdce319de3808f7e2f7d", "annex": "I", "before": {"end": 104, "start": 0, "text": "There is insufficient data across races to conclude on the impact of race on niraparib pharmacokinetics.", "truncated": false}, "before_length": 104, "before_sha256": "368aa8e1f7371818b5eda591ce70ddc0e6b56681412fa1bd0573b8eaf4036b77", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 6, "before_end": 8, "before_start": 6, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1c2b805a052f6e727d00052a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 801}
{"after": {"end": 15, "start": 0, "text": "3528 BD Utrecht", "truncated": false}, "after_length": 15, "after_sha256": "4ea402b0be2ffd43624e79f5ad9706ad796af820c845df2a7158d607c083d913", "annex": "I", "before": {"end": 15, "start": 0, "text": "3528 BJ Utrecht", "truncated": false}, "before_length": 15, "before_sha256": "c83d25e8ea65101ad8ea274a07e2114705ecd244e7a6dba61eb7b4d1ba592ecb", "change_kind": "administrative", "change_operations": [{"after_end": 7, "after_start": 6, "before_end": 7, "before_start": 6, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1c788729864c8cee8dbca416", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 10 mg comprimés pelliculés CIALIS 20 mg comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1602}
{"after": {"end": 6, "start": 0, "text": "France", "truncated": false}, "after_length": 6, "after_sha256": "7a1ca4ef7515f7276bae7230545829c27810c9d9e98ab2c06066bee6270d5153", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1c7ef203d82ff905a4681af9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2566}
{"after": {"end": 110, "start": 0, "text": "Marketing Authorisation Holder: Eli Lilly Nederland B.V., Orteliuslaan 1000, 3528 BD Utrecht, The Netherlands.", "truncated": false}, "after_length": 110, "after_sha256": "e2ef698638f86423386a55d95b0167d0a5ee39297d86c39e1c4a1335b36f2d1c", "annex": "IIIA", "before": {"end": 110, "start": 0, "text": "Marketing Authorisation Holder: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.", "truncated": false}, "before_length": 110, "before_sha256": "31bde930103fd90462092a47ede6325cfe7229cd2cfce1a06a1e8fbb3caea2e0", "change_kind": "administrative", "change_operations": [{"after_end": 67, "after_start": 58, "before_end": 59, "before_start": 58, "kind": "replace"}, {"after_end": 69, "after_start": 68, "before_end": 62, "before_start": 60, "kind": "replace"}, {"after_end": 70, "after_start": 70, "before_end": 72, "before_start": 63, "kind": "delete"}, {"after_end": 75, "after_start": 71, "before_end": 75, "before_start": 73, "kind": "replace"}, {"after_end": 84, "after_start": 83, "before_end": 84, "before_start": 83, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1ca6b1f5e876c6007c0ca1b0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2443}
{"after": {"end": 123, "start": 0, "text": "Titulaire de l'Autorisation de mise sur le marché : Eli Lilly Nederland B.V., Orteliuslaan 1000, 3528 BD Utrecht, Pays-Bas.", "truncated": false}, "after_length": 123, "after_sha256": "c9360159827bd94b8452261891b0f98066b989ff2cdfd5b65fd7a73b98e1e192", "annex": "III", "before": {"end": 123, "start": 0, "text": "Titulaire de l'Autorisation de mise sur le marché : Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Pays-Bas.", "truncated": false}, "before_length": 123, "before_sha256": "24244fac23f7c655b5cf0249efb6324cf790a7ba49b33b42d12cc4dbef87a7b4", "change_kind": "administrative", "change_operations": [{"after_end": 87, "after_start": 78, "before_end": 79, "before_start": 78, "kind": "replace"}, {"after_end": 89, "after_start": 88, "before_end": 82, "before_start": 80, "kind": "replace"}, {"after_end": 90, "after_start": 90, "before_end": 92, "before_start": 83, "kind": "delete"}, {"after_end": 95, "after_start": 91, "before_end": 95, "before_start": 93, "kind": "replace"}, {"after_end": 104, "after_start": 103, "before_end": 104, "before_start": 103, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1ca91553ba0c688cc811e7fe", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2482}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Step 12:", "truncated": false}, "before_length": 8, "before_sha256": "6d861ee0204b8897d2b74a074541932c898c33b6674cdc97fb4e790aaa686397", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1cd3968cdc429a2e5f096c87", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9770}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 32, "start": 0, "text": "1. NAME OF THE MEDICINAL PRODUCT", "truncated": false}, "before_length": 32, "before_sha256": "8141899f95166cc499efb2acfa403d9d6b8ae4eed4239eff8b6c08bd2be8913c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1cd6a6105c9a1b06a8b25333", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4686}
{"after": {"end": 5, "start": 0, "text": "Malta", "truncated": false}, "after_length": 5, "after_sha256": "71e9eb10755c8232974d186a560f7658a1ccbdd3097877dfa1ad3436af90d46a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1cdd242a9d087bdaae5dd1ba", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2527}
{"after": {"end": 207, "start": 0, "text": "priapism, a prolonged and possibly painful erection after taking CIALIS (frequency rare). If you have such an erection, which lasts continuously for more than 4 hours you should contact a doctor immediately.", "truncated": false}, "after_length": 207, "after_sha256": "c4068e021fb2c596b0bf4c2087e1226de8e0ce0e5dffeece63b984b3e43e62c8", "annex": "IIIA", "before": {"end": 207, "start": 0, "text": "priapsim, a prolonged and possibly painful erection after taking CIALIS (frequency rare). If you have such an erection, which lasts continuously for more than 4 hours you should contact a doctor immediately.", "truncated": false}, "before_length": 207, "before_sha256": "a042b2a055050b3b404a7e8bda2201584f5e389f3f7319622a3cabb89ff5b1af", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 5, "before_end": 5, "before_start": 5, "kind": "insert"}, {"after_end": 7, "after_start": 7, "before_end": 7, "before_start": 6, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1cf42b5fb24195a605055f46", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2975}
{"after": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l'Agence européenne des médicaments : https://www.ema.europa.eu", "truncated": false}, "after_length": 150, "after_sha256": "7a57f3971964eb7bea4ed295986ca64649117ce6b1ea800c91cdf0ed4877b711", "annex": "III", "before": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l'Agence européenne des médicaments : http://www.ema.europa.eu.", "truncated": false}, "before_length": 150, "before_sha256": "6272fb3d1bf208f727e3ec8521cb6d15c24e42031d06a96b3c4d43ff5b48aa11", "change_kind": "technical", "change_operations": [{"after_end": 130, "after_start": 129, "before_end": 129, "before_start": 129, "kind": "insert"}, {"after_end": 150, "after_start": 150, "before_end": 150, "before_start": 149, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1d813bde1375f231f5ad5892", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2884}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Step 10:", "truncated": false}, "before_length": 8, "before_sha256": "1824051a0010e8c7e99386eb9526e6830181fb2f9d83c5d5fb74a28f5d787973", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1da89bc3eaaf7252a060b7c4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9743}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 113, "start": 0, "text": "Capsules de couleur brun rougeâtre, opaques, de forme oblongue (environ 21 mm), avec « VYN 61 » imprimé en blanc.", "truncated": false}, "before_length": 113, "before_sha256": "55856933479e573414005cdba7555b9f8701dd7a515bdc890477aaf3c9e58951", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 113, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 113, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1db5f2690ddc398ae6009207", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "3", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1220}
{"after": {"end": 40, "start": 0, "text": "Tel: 1 800 749 749 (+ 353 (0)1 483 3625)", "truncated": false}, "after_length": 40, "after_sha256": "0509d2a1806f188ecbce2c353425cb70d883d4c07f6e695eacf4b8a2ec65feef", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 40, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 40}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1dc15b439362581eb44e3a9b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2904}
{"after": {"end": 36, "start": 0, "text": "Vyndaqel 61 mg, comprimés pelliculés", "truncated": false}, "after_length": 36, "after_sha256": "70d3e9c94874ff78e6ff1e940cdf64cbf06bd8e778cf4abb4c78ce4ca876c4cb", "annex": "IIIA", "before": {"end": 31, "start": 0, "text": "Vyndaqel 61 mg, capsules molles", "truncated": false}, "before_length": 31, "before_sha256": "d2f9e9daee0a55f7e5e88fddbba4b5456460e01edb642a0357e0b087ef8086af", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 17, "before_end": 18, "before_start": 17, "kind": "replace"}, {"after_end": 24, "after_start": 20, "before_end": 19, "before_start": 19, "kind": "insert"}, {"after_end": 32, "after_start": 25, "before_end": 20, "before_start": 20, "kind": "insert"}, {"after_end": 35, "after_start": 34, "before_end": 30, "before_start": 22, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1dd00f75493127070be6a028", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2793}
{"after": {"end": 7, "start": 0, "text": "România", "truncated": false}, "after_length": 7, "after_sha256": "633e193d7e05828a893d02a6273755ed0d417cc14abf5ecfc2b6328c71ddcc7e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1de0de9eb50daa6ff95fe547", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3261}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Tel: +44 (0) 2830 640 902", "truncated": false}, "before_length": 25, "before_sha256": "b88b96210695837bad06b797847554435ccbba7fa290892fcb6eb47dd56a6625", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1df4cf1c36c585e7ff2bbdf1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1712}
{"after": {"end": 195, "start": 0, "text": "Increasing weight was found to increase niraparib volume of distribution in the population pharmacokinetic analysis. No impact of weight was identified on niraparib clearance or overall exposure.", "truncated": false}, "after_length": 195, "after_sha256": "8dc9e4df792f34d7888f05d9cd2cf8a2742fb19a243ea13b354055f7c69a0971", "annex": "I", "before": {"end": 291, "start": 0, "text": "Increasing weight was found to increase niraparib volume of distribution in the population pharmacokinetic analysis. No impact of weight was identified on niraparib clearance or overall exposure. Dose adjustment according to body weight is not warranted from a pharmacokinetic point of view.", "truncated": false}, "before_length": 291, "before_sha256": "c60bb3650fcb92999d75f3c9ba5efca6ddeadc9d51fb0b595baf26cd442eec89", "change_kind": "content", "change_operations": [{"after_end": 195, "after_start": 195, "before_end": 291, "before_start": 195, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 96, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1dfe3b06473ef665f144346d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 797}
{"after": {"end": 22, "start": 0, "text": "Teл.: + 359 2 4942 480", "truncated": false}, "after_length": 22, "after_sha256": "71df057e61352cd6e548ee210b03d0adc43d1e9ef00311b1d7ac8fce15871b09", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1e495b81f914a864aba586fd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2504}
{"after": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "after_length": 7, "after_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1e5e0a3713df197e6f0377e6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3739}
{"after": {"end": 117, "start": 0, "text": "This medicine contains less than 1 mmol sodium (23 milligrams) per syringe, that is to say essentially ‘sodium-free’.", "truncated": false}, "after_length": 117, "after_sha256": "406553114958a91a6a131d57e33a64784ce3ca179a450e743c99c6eaad01b8af", "annex": "IIIA", "before": {"end": 123, "start": 0, "text": "The injection solution contains less than 1 mmol (23 milligrams) of sodium per syringe, so it is essentially ‘sodium-free’.", "truncated": false}, "before_length": 123, "before_sha256": "052c7b4035c9c4138a7a38bd19bf23e5f4d7665c434b68e4f8d869353a4f90c4", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 2, "before_end": 2, "before_start": 2, "kind": "insert"}, {"after_end": 10, "after_start": 7, "before_end": 4, "before_start": 3, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 7, "before_start": 6, "kind": "delete"}, {"after_end": 13, "after_start": 13, "before_end": 22, "before_start": 8, "kind": "delete"}, {"after_end": 47, "after_start": 40, "before_end": 49, "before_start": 49, "kind": "insert"}, {"after_end": 63, "after_start": 63, "before_end": 75, "before_start": 65, "kind": "delete"}, {"after_end": 79, "after_start": 76, "before_end": 92, "before_start": 88, "kind": "replace"}, {"after_end": 90, "after_start": 83, "before_end": 96, "before_start": 96, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 30, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1e63f5d196e6b58ea5b26d4d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1247}
{"after": {"end": 23, "start": 0, "text": "medinfo.austria@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "80539556a138e6e0b8efab6b438c21ba77b592fc3c2d28fdfaea7dc2bb3248d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1e8ef07990a5e191b7601214", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2560}
{"after": {"end": 21, "start": 0, "text": "Crospovidone (E 1202)", "truncated": false}, "after_length": 21, "after_sha256": "4d49593bf5155b40a07b7ee2f47a6e4610e7b8b873178ecc9d31cdf6e0f0c6ea", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1e9d1d86aaa835b9b3e9831e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1885}
{"after": {"end": 408, "start": 0, "text": "After oral administration of the film-coated tablet once daily, the maximum peak concentration (Cmax) is achieved within a median time (tmax) of 4 hours for tafamidis 61 mg after dosing in the fasted state. Concomitant administration of a high fat, high calorie meal altered the rate of absorption, but not the extent of absorption. These results support the administration of tafamidis with or without food.", "truncated": false}, "after_length": 408, "after_sha256": "2eb87299304fe85f5711a7c9c783dd5be6782c0b91199b84cb73ca2187046634", "annex": "I", "before": {"end": 456, "start": 0, "text": "After oral administration of the soft capsule once daily, the maximum peak concentration (Cmax) is achieved within a median time (tmax) of 4 hours for tafamidis 61 mg and 2 hours for tafamidis meglumine 80 mg (4 x 20 mg) after dosing in the fasted state. Concomitant administration of a high fat, high calorie meal altered the rate of absorption, but not the extent of absorption. These results support the administration of tafamidis with or without food.", "truncated": false}, "before_length": 456, "before_sha256": "c0fef2a2cca48a55bcbd834f14b8fe38351b2786fda7d9638674353335fca4bb", "change_kind": "content", "change_operations": [{"after_end": 39, "after_start": 33, "before_end": 34, "before_start": 33, "kind": "replace"}, {"after_end": 41, "after_start": 40, "before_end": 36, "before_start": 35, "kind": "replace"}, {"after_end": 44, "after_start": 42, "before_end": 37, "before_start": 37, "kind": "insert"}, {"after_end": 46, "after_start": 45, "before_end": 39, "before_start": 38, "kind": "replace"}, {"after_end": 48, "after_start": 47, "before_end": 43, "before_start": 40, "kind": "replace"}, {"after_end": 51, "after_start": 50, "before_end": 45, "before_start": 45, "kind": "insert"}, {"after_end": 172, "after_start": 172, "before_end": 220, "before_start": 166, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 60, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1eb43a35e00f1a252840f84a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1280}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 301, "start": 0, "text": "As soon as you have done the injection, unscrew the needle from the Tempo Pen using the outer needle cap. This will keep the insulin sterile and stop it leaking. It also stops air entering the pen and your needle clogging. Do not share your needles. Do not share your pen. Replace the cap on your pen.", "truncated": false}, "before_length": 301, "before_sha256": "0b543d70ec111d81e4273ad81b09756a9525ada46766d8d6a004f1c57b822f44", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 301, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 301, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1eca4651202d16dc8a8a5254", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9326}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 118, "start": 0, "text": "Once in use pens may be used for up to 28 days. Pens in use should be stored below 30C and should not be refrigerated.", "truncated": false}, "before_length": 118, "before_sha256": "5e0de42f5447f77b92faef6ecfe53fdea23a714da6b654f20c1a75cdad7b12ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 118, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 118, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1f0380a5562509c1fada44a9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4633}
{"after": {"end": 31, "start": 0, "text": "Bristol-Myers Squibb Aktiebolag", "truncated": false}, "after_length": 31, "after_sha256": "18b315bcb0bae7d4352ec0e47ec43f18641696fe38dba2d6458c7c2188f9abdc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 31, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 31}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1f2c8cf400f89ba74a5d22c5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2934}
{"after": {"end": 34, "start": 0, "text": "Vyndaqel 61 mg film-coated tablets", "truncated": false}, "after_length": 34, "after_sha256": "0ab1707af4a63192366906aad4f1c11a8821c9edf7f91b23f417bf90186d02d2", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1f606e86946813542499f316", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1492}
{"after": {"end": 10, "start": 0, "text": "Excipients", "truncated": false}, "after_length": 10, "after_sha256": "4eb806067f42ea6d1295212c67a84650b548bacfd28d5a90b568721c534f821d", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 10}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1f7099d9e9826294d9e5d5c9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1289}
{"after": {"end": 122, "start": 0, "text": "Conditionnements : un conditionnement de 3 x 10 comprimés pelliculés et un conditionnement de 9 x 10 comprimés pelliculés.", "truncated": false}, "after_length": 122, "after_sha256": "ea3e20d42ebcb2ddccece5e4980444a96d32430d3a322d01db29c4645ef7a84b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 122, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 122}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1f81d3f8b2cb0fdbbfc78a93", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3701}
{"after": {"end": 40, "start": 0, "text": "Do not store above 25 °C. Do not freeze.", "truncated": false}, "after_length": 40, "after_sha256": "5b83cffac35f0dd891ac8dbf4d0a5bc16ebc5aa87f24a3e3fc70a4c0901c566b", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Do not store above 25ºC. Do not freeze.", "truncated": false}, "before_length": 39, "before_sha256": "0048cc2e3482eed0ec1e9d6a6ad3ff466985a7aaf27e8a96ed008491dff61b0e", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 21, "before_end": 22, "before_start": 21, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1f95cea05689f29ca1e6e047", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 828}
{"after": {"end": 22, "start": 0, "text": "Tel: + 421 2 20833 600", "truncated": false}, "after_length": 22, "after_sha256": "06545090f6b6777d6143e84f408247cee2424d81a40db0a2693eff093cfe9ec8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1f97c4f39dfa21b6d6035ac8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3280}
{"after": {"end": 20, "start": 0, "text": "Viatris Germany GmbH", "truncated": false}, "after_length": 20, "after_sha256": "4c2f2a211c5c41870eee98c700979da5e888736aac1a795ab787143446de83ca", "annex": "IIIA", "before": {"end": 18, "start": 0, "text": "Mylan Germany GmbH", "truncated": false}, "before_length": 18, "before_sha256": "d7a3f7e30e2672617d153ba93a8cf1c2908da6e7dcfe6d206314ed71d4e5405a", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "replace"}, {"after_end": 7, "after_start": 3, "before_end": 5, "before_start": 4, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1fed62e5616465bc3e2a5ce5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005403", "medicine_name": "Sugammadex Mylan", "medicine_slug": "sugammadex-mylan", "observed_at": "2026-10-12T13:36:03Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "3d1f09d9bcfb1d2bba4f610b61ad692a3a78dc1ae2800f83497a954f8545d5a0", "source_snapshot_id": "source-ccd6e4297624ea024166e969", "source_updated_at": "2026-06-12", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/sugammadex-mylan-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1439}
{"after": {"end": 23, "start": 0, "text": "medinfo.romania@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "9ae697b67f3c854a077ca894d99400f1de79e31bd9bf61321fc7c4030bf8a213", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-1ff67f7ee051ffb016e122b9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2584}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 13, "start": 0, "text": "Capsule shell", "truncated": false}, "before_length": 13, "before_sha256": "88ce877fc585eaf7f5a1a1dbaa901dc3247425d64028865daecce95c9e7b3b43", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2012291a813d82368db77381", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1353}
{"after": {"end": 32, "start": 0, "text": "2. STATEMENT OF ACTIVE SUBSTANCE", "truncated": false}, "after_length": 32, "after_sha256": "9e169b908eb1d9fc1ed6e233dacad6af86b2c8a043fa81faef38a02382a9c8e3", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "2. STATEMENT OF ACTIVE SUBSTANCE(S)", "truncated": false}, "before_length": 35, "before_sha256": "a98caee7a99385f0fdf38e1fb123885d279b9ccfdb6ba18007e43f93a9a479ee", "change_kind": "content", "change_operations": [{"after_end": 32, "after_start": 32, "before_end": 35, "before_start": 32, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2075ba459148e92910eb03ac", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 989}
{"after": {"end": 15, "start": 0, "text": "Mooswaldallee 1", "truncated": false}, "after_length": 15, "after_sha256": "1e40171920c816abab0899460801029151a2b4c2a16616d1073209a0db469b6a", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2080fc0da68102cc345605db", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2036}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Eli Lilly România S.R.L.", "truncated": false}, "before_length": 24, "before_sha256": "478ccdd55738e9f6c41476724f94bb693c34d7e7db661a71899a2c0e2fa4beaa", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-20c6296c48cd06ebb5e13fb8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9524}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 84, "start": 0, "text": "Niraparib as a substrate of efflux transporters (Pgp, BCRP, BSEP, MRP2, and MATE1/2)", "truncated": false}, "before_length": 84, "before_sha256": "6875d77cf5e688541567eae3e4b0316dd037e6544f9dc7aeed3759b84db1d1c3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 84, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 84, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-20c8754fa6db7dd62dd0c49d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1098}
{"after": {"end": 147, "start": 0, "text": "You should not have more than 3 injections in a 24hour period and if you require more than 8 injections in a month, you should seek medical advice.", "truncated": false}, "after_length": 147, "after_sha256": "780a42c57a1243a06a3178cae38cdb260718193096d20290b28a8657dcf1cf39", "annex": "IIIA", "before": {"end": 148, "start": 0, "text": "You should not have more than 3 injections in a 24 hour period and if you require more than 8 injections in a month, you should seek medical advice.", "truncated": false}, "before_length": 148, "before_sha256": "211000ca94af9e7835c4cf6a849a2156ef3881536234281a11a36b0decabb8f6", "change_kind": "content", "change_operations": [{"after_end": 50, "after_start": 50, "before_end": 51, "before_start": 50, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-20ce3c6a64f5f16f83aafd10", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1266}
{"after": {"end": 6, "start": 0, "text": "Ísland", "truncated": false}, "after_length": 6, "after_sha256": "5801902efe8b92c2ace1332f4cca2ea1fcb704712e2fe7ca66654d2a826e8451", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2101b430bc70d8642685cc80", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2908}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 51, "start": 0, "text": "Humalog is suitable for use in adults and children.", "truncated": false}, "before_length": 51, "before_sha256": "224b7de6a463afc74a544193a7875ebf86c720ada0e3ec1d04c6e2121fc18328", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 51, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 51, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-211487c67ac5bc28cc77974c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9239}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "Marketing Authorisation Holder", "truncated": false}, "before_length": 30, "before_sha256": "49b1d8044839391ca09e6bef9f9460184c586c4da018732ac3a7e596cf20e965", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 30, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 30, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-211a6da0db1070f3160b6a75", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9445}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Tlf: + 47 22 88 18 00", "truncated": false}, "before_length": 21, "before_sha256": "3f60eddd0ba1d7ff37af3eb73ca0519eac3332eb15f3ba06c586a1c7debf428a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-21271183f2cb3105acceff7e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9497}
{"after": {"end": 37, "start": 0, "text": "N.V. BristolMyers Squibb Belgium S.A.", "truncated": false}, "after_length": 37, "after_sha256": "feeebdb54667cd864ac3ce52dc07c49e265c3b042233fe6691e3f074fda776c2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2174a564073ab2db2629bb34", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3182}
{"after": {"end": 49, "start": 0, "text": "BristolMyers Squibb Farmacêutica Portuguesa, S.A.", "truncated": false}, "after_length": 49, "after_sha256": "320289b9df354f466bcd06811a5bc06e5246b53241d28a0499699328d55fe681", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 49, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 49}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-217e14346c8d51738cf9b9fa", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3252}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 2, "start": 0, "text": "Ou", "truncated": false}, "before_length": 2, "before_sha256": "fb2c7d8dd35f85951b7c92b4b4c3b7332d67bb93c82a2b3303eb2106251bc75c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-21b5971811b4ad8b318b3b41", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3725}
{"after": {"end": 9, "start": 0, "text": "Danemarca", "truncated": false}, "after_length": 9, "after_sha256": "aa62ca811afd7d8cbf62b0601ca860863bdb18df68b1426acf2862cb7a82b5ac", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-21b833d923037411d31f8a3d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1799}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 48, "start": 0, "text": "You should see insulin at the tip of the needle.", "truncated": false}, "before_length": 48, "before_sha256": "d136e00dad9d8f05f07e8d5ec803703391e5cd33234e3b3434a377f079f8b0e8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 48, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 48, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-21e183270aa89e233ef5cf48", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9671}
{"after": {"end": 27, "start": 0, "text": "CPO Pharmaceuticals Limited", "truncated": false}, "after_length": 27, "after_sha256": "94b644443752e2cb52916b23f8141fbd44c47055b3416af333e12ac18e101b87", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "GPA Pharmaceuticals Ltd", "truncated": false}, "before_length": 23, "before_sha256": "ece7127e303c91e9501d2cedd822476265aae86acb9f96ef1553ab3a6954afe1", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 21, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2264c9858551484fa07a8722", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3015}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 11, "start": 0, "text": "Rubber Seal", "truncated": false}, "before_length": 11, "before_sha256": "17288c5cab7d7d64edc675c7936c9cdbd117c0d2f5e03f436a8e29102bd2b76c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 11, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 11, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-228169ded509b6eaa19eac3a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9593}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-22a5be7f4c6c71952b9d65ec", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2605}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Warnings and precautions", "truncated": false}, "before_length": 24, "before_sha256": "7c50a9f032d2bc78cb5840e24dc5db22ab4301d6230e27ee968e39233617a1c4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-22b63f3b634f567513c33890", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9250}
{"after": {"end": 20, "start": 0, "text": "Luxembourg/Luxemburg", "truncated": false}, "after_length": 20, "after_sha256": "28ac4fa3aba2dfb4b228bd072edb8cc818b04e6f4b87f37114caa6154e0e706b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-22e247bdf913aacc32d61878", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2813}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 160, "start": 0, "text": "– You may have dust, food, or liquid inside the Pen. Throw the Pen away and get a new Pen. You may need to get a prescription from your healthcare professional.", "truncated": false}, "before_length": 160, "before_sha256": "b3a3f81c06240d193495c1ab72d136b241f2a603978080a6512c18206794c1a8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 160, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 160, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-22e4782752ff75e939d71159", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9805}
{"after": {"end": 35, "start": 0, "text": "BristolMyers Squibb GmbH & Co. KGaA", "truncated": false}, "after_length": 35, "after_sha256": "35ff9638226ceee7106ecbdfa1f34c1363018c276e5f126171bb1c80c9dbf877", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-22f26140d2d10f645dae8fbd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2843}
{"after": {"end": 131, "start": 0, "text": "Comprimé pelliculé rond, de couleur blanche à blanc cassé, portant l’inscription « 61 » sur une face et mesurant 11 mm de diamètre.", "truncated": false}, "after_length": 131, "after_sha256": "f2f37c37b38365527832b44c4d08b03591608a15b596e78898ae45d7ee7d16d7", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 131, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 131}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-234ba5d6615810155bc3448d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "3", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1221}
{"after": {"end": 33, "start": 0, "text": "medicalinformation.italia@bms.com", "truncated": false}, "after_length": 33, "after_sha256": "7fa3fd14eb9bcefdd405cdea61ff603a046dbbe0f3ada36eb2fd672402b4e33b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-237d276fc2aae45c0adb557f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3286}
{"after": {"end": 90, "start": 0, "text": "Pack sizes: a pack of 3 x 10 film-coated tablets and a pack of 9 x 10 film-coated tablets.", "truncated": false}, "after_length": 90, "after_sha256": "bea4cad97ebc554f47e4dcbdda961894b380cb9eb40f377aa3a460a2aea671c0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 90, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 90}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-237f152d5cf8bedc339fbf7b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3198}
{"after": {"end": 20, "start": 0, "text": "Swixx Biopharma EOOD", "truncated": false}, "after_length": 20, "after_sha256": "27f5284d414219f28c8c91886b89df13d6ef413ca05a03cdd596d9c697d6c0ea", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-23904f62bcb1675f0718381b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2813}
{"after": {"end": 101, "start": 0, "text": "The recommended dose is one tablet of Vyndaqel 61 mg (tafamidis) orally once daily (see section 5.1).", "truncated": false}, "after_length": 101, "after_sha256": "5dc82fcd34f2921d846cbcd02dbfdad0067cbb59132854526e2551fdb61ead79", "annex": "I", "before": {"end": 102, "start": 0, "text": "The recommended dose is one capsule of Vyndaqel 61 mg (tafamidis) orally once daily (see section 5.1).", "truncated": false}, "before_length": 102, "before_sha256": "68300fa64f8b788f4e44fc089340e75e6108a680fcbd72341c0c80815f646042", "change_kind": "content", "change_operations": [{"after_end": 29, "after_start": 28, "before_end": 29, "before_start": 28, "kind": "replace"}, {"after_end": 31, "after_start": 30, "before_end": 33, "before_start": 30, "kind": "replace"}, {"after_end": 34, "after_start": 33, "before_end": 35, "before_start": 35, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-23ad92e726de1f50b15a3d3c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 957}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 38, "start": 0, "text": "5. METHOD AND ROUTES OF ADMINISTRATION", "truncated": false}, "before_length": 38, "before_sha256": "4df84c8e36dde67c1450d0a07181258f1fc4c471167239340eae51e9760a4f68", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 38, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 38, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-23c90c40c1a39e63feeb50ce", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4610}
{"after": {"end": 334, "start": 0, "text": "Firazyr is not known to interact with other medicines. If you are taking a medicine known as an angiotensin converting enzyme (ACE) inhibitor (for example: captopril, enalapril, ramipril, quinapril, lisinopril) which is used to lower your blood pressure or for any other reason, you should inform your doctor before receiving Firazyr.", "truncated": false}, "after_length": 334, "after_sha256": "578e5f137f9e1ecfe0a2604f6ef6519cbb4f5271f43f1aef2439a7a695339d68", "annex": "IIIA", "before": {"end": 334, "start": 0, "text": "Firazyr is not known to interact with other medicines. If you are taking a medicine known as an Angiotensin Converting Enzyme (ACE) inhibitor (for example: captopril, enalapril, ramipril, quinapril, lisinopril) which is used to lower your blood pressure or for any other reason, you should inform your doctor before receiving Firazyr.", "truncated": false}, "before_length": 334, "before_sha256": "9796f9b263b61f552dddb3839eddb068feca738c097b77ca102febde26d2cda6", "change_kind": "content", "change_operations": [{"after_end": 97, "after_start": 96, "before_end": 97, "before_start": 96, "kind": "replace"}, {"after_end": 109, "after_start": 108, "before_end": 109, "before_start": 108, "kind": "replace"}, {"after_end": 120, "after_start": 119, "before_end": 120, "before_start": 119, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-23e16c725dc1df308eab692a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1233}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "Česká republika", "truncated": false}, "before_length": 15, "before_sha256": "c768c215f215c71e7ffcbffe06cb1a66fa3c379a86285d5da65cef3c627bc09d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-23e1a18110ffdbd741acd5b3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9470}
{"after": {"end": 34, "start": 0, "text": "medinfo.estonia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "e47c511a7367c6c7b4b4d54b0660bf70577f18e3fe0bcef938db762d7981dd1e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-23fca2e22e27ac33066e3669", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2855}
{"after": {"end": 18, "start": 0, "text": "Swixx Biopharma OÜ", "truncated": false}, "after_length": 18, "after_sha256": "94bc5f3c43fc9da5715250d66202d3b6e108127762e4f8e413b99fc19e24a395", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 18, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 18}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-24601e5694727630f6f86cd1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2849}
{"after": {"end": 321, "start": 0, "text": "In vitro, le niraparib est un inhibiteur de la P-gp. Comme aucune donnée clinique n'est disponible, il ne peut être exclu que le niraparib puisse augmenter l'exposition systémique d'autres médicaments transportés par la P-gp qui sont sensibles à l'inhibition intestinale de la P-gp (par exemple, le dabigatran étexilate).", "truncated": false}, "after_length": 321, "after_sha256": "76a01b01f642a05f6fd8f023a19722c42fb168d1532120a95f28fa35d6096936", "annex": "I", "before": {"end": 328, "start": 0, "text": "Le niraparib n’est pas un inhibiteur de la BSEP ou de la MRP2. In vitro, le niraparib inhibe très faiblement la P-gp et la BCRP avec un IC50 = 161 µM et 5,8 µM, respectivement. Par conséquent, bien qu’improbable, une interaction cliniquement significative liée à une inhibition de ces transporteurs d’efflux ne peut être exclue.", "truncated": false}, "before_length": 328, "before_sha256": "157a20315e0fe489d40d113d19f7aebaec70e120aa610f694bc063e98a7db085", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 63, "before_start": 0, "kind": "delete"}, {"after_end": 30, "after_start": 23, "before_end": 86, "before_start": 86, "kind": "insert"}, {"after_end": 37, "after_start": 35, "before_end": 91, "before_start": 91, "kind": "insert"}, {"after_end": 40, "after_start": 38, "before_end": 92, "before_start": 92, "kind": "insert"}, {"after_end": 42, "after_start": 41, "before_end": 103, "before_start": 93, "kind": "replace"}, {"after_end": 43, "after_start": 43, "before_end": 108, "before_start": 104, "kind": "delete"}, {"after_end": 52, "after_start": 51, "before_end": 116, "before_start": 116, "kind": "insert"}, {"after_end": 57, "after_start": 53, "before_end": 117, "before_start": 117, "kind": "insert"}, {"after_end": 58, "after_start": 58, "before_end": 127, "before_start": 118, "kind": "delete"}, {"after_end": 61, "after_start": 60, "before_end": 131, "before_start": 129, "kind": "replace"}, {"after_end": 62, "after_start": 62, "before_end": 213, "before_start": 132, "kind": "delete"}, {"after_end": 67, "after_start": 66, "before_end": 226, "before_start": 217, "kind": "replace"}, {"after_end": 72, "after_start": 69, "before_end": 228, "before_start": 228, "kind": "insert"}, {"after_end": 84, "after_start": 81, "before_end": 238, "before_start": 237, "kind": "replace"}, {"after_end": 86, "after_start": 85, "before_end": 240, "before_start": 239, "kind": "replace"}, {"after_end": 89, "after_start": 88, "before_end": 243, "before_start": 242, "kind": "replace"}, {"after_end": 90, "after_start": 90, "before_end": 289, "before_start": 244, "kind": "delete"}, {"after_end": 97, "after_start": 93, "before_end": 294, "before_start": 292, "kind": "replace"}, {"after_end": 99, "after_start": 98, "before_end": 298, "before_start": 295, "kind": "replace"}, {"after_end": 101, "after_start": 100, "before_end": 304, "before_start": 299, "kind": "replace"}, {"after_end": 102, "after_start": 102, "before_end": 307, "before_start": 305, "kind": "delete"}, {"after_end": 124, "after_start": 121, "before_end": 326, "before_start": 326, "kind": "insert"}, {"after_end": 320, "after_start": 125, "before_end": 327, "before_start": 327, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 238, "chars_inserted": 231}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-246585e45b0b928817883d12", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 269}
{"after": {"end": 9, "start": 0, "text": "29 (24,8)", "truncated": false}, "after_length": 9, "after_sha256": "5d89f6f267524b519fe014cc0366cd92c532e012c7c587e8fe00b477f81172a5", "annex": "I", "before": {"end": 9, "start": 0, "text": "20 (21,3)", "truncated": false}, "before_length": 9, "before_sha256": "1eacd225bb00358ef347304cc66d0489302469507c6970bcaa2c1e2f09329ef1", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 1, "before_end": 2, "before_start": 1, "kind": "replace"}, {"after_end": 6, "after_start": 5, "before_end": 6, "before_start": 5, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 8, "before_start": 7, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-24b632426d7026b862306c06", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 317}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "The Netherlands", "truncated": false}, "before_length": 15, "before_sha256": "91729ff7107ee698fe168dc62d5b2020678fcfcf55b4ea9065982ce1d071ba31", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-24ce0967349bc7b3a4af5555", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4841}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma UAB", "truncated": false}, "after_length": 19, "after_sha256": "0fa5997c653449c2ebe445618eaeedc027096662095bc4bf48a609ec757f79cd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-24d2dcd12542224805047e87", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2804}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 111, "start": 0, "text": "Neither niraparib nor M1 is an inhibitor of organic anion transport polypeptide 1B1 (OATP1B1) or 1B3 (OATP1B3).", "truncated": false}, "before_length": 111, "before_sha256": "90aa5ff75a1911a8128d5e8890d88ddf52fe34f52914f93856e3ce3df12a02ad", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 111, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 111, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-24defa8ee93ec2af2a2336dd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 269}
{"after": {"end": 5, "start": 0, "text": "Dánia", "truncated": false}, "after_length": 5, "after_sha256": "6b2bf8c68ea8941b06707cb569cdff6f0c6f5f221eb2857ea1bef2fff7977063", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-24eb05a26d313d76fd258d27", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2064}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 482, "start": 0, "text": "Niraparib is a substrate of Pglycoprotein (Pgp) and Breast Cancer Resistance Protein (BCRP). However, due to its high permeability and bioavailability, the risk of clinically relevant interactions with medicinal products that inhibit these transporters is unlikely. Therefore, no dose adjustment for Zejula is required when administered concomitantly with medicinal products known to inhibit Pgp (e.g. amiodarone, verapamil) or BCRP (e.g. osimertinib, velpatasvir, and eltrombopag).", "truncated": false}, "before_length": 482, "before_sha256": "f1fae21894698e3a359cc1396ed1c637eb5cb1f8e0c62d05ebd5b86896b61617", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 482, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 482, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-24f12accc92140d3b89c64f3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1099}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Fabricant", "truncated": false}, "before_length": 9, "before_sha256": "169067cf6ab90924cd5082a7a6d0aac85081d5b4f04e0d28ba8141fab5cbbda6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-24f67941e33bb915907c81f8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2762}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma s.r.o.", "truncated": false}, "after_length": 22, "after_sha256": "e26ccdddfb0893074547931bd19474d6541a45958e27c35b776e8f18abf48a36", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-25019b4b521dd044873716a5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2918}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Astellas Ireland Co. Ltd.", "truncated": false}, "before_length": 25, "before_sha256": "1d98a06d2f724f3f69491c40480991ee287d2e3806d862b6ab226d0b620c6885", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-25035215bdb0d3a3113ea733", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2027}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 60, "start": 0, "text": "• you exercise or work too hard just before or after a meal;", "truncated": false}, "before_length": 60, "before_sha256": "4b7d811641dc3425d1c2a8291bf11bccc9e397502cdb7e95c9ba2a827067ff6a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 60, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 60, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2509379c5cd0467015d3b4a0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9389}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 47, "start": 0, "text": "Effect of other medicinal products on niraparib", "truncated": false}, "before_length": 47, "before_sha256": "6864403957b3778828df6588077232300cfc94cd5cfefe63a69918773792e39c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 47, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 47, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-254629838dfb6cfba8d45575", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1093}
{"after": {"end": 170, "start": 0, "text": "This document is the approved product information for Viagra, with the changes since the previous procedure affecting the product information (EMA/VR/0000247514) tracked.", "truncated": false}, "after_length": 170, "after_sha256": "57fff72d4fa67b72c3fcbced26b61b897769fc1bfd0d5afb1c1c2dda6bc86ff0", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 170, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 170}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2563fcfda2a454839ff7c939", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1}
{"after": {"end": 22, "start": 0, "text": "Tel: + 34 91 456 53 00", "truncated": false}, "after_length": 22, "after_sha256": "c59845f4e2b4a96548adda4dbf16851ff33a89874560e491da6b05aee33b646a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2595c514050312e1034b4630", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3235}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 10, "start": 0, "text": "Killorglin", "truncated": false}, "before_length": 10, "before_sha256": "2606b5fb607427b1a532d8cab1195d0515b4a8cf56f0eff6628b2ac9a5a04655", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-25c7c823ff88f9eaff7d8f46", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1004}
{"after": {"end": 6, "start": 0, "text": "Κύπρος", "truncated": false}, "after_length": 6, "after_sha256": "7f8ef8a379e33810aefd13f344f489d85e8902de6fdcd1b46a4e856985b5e14e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-25c91a956b6a11954132e4fd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2616}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "diminution des globules rouges (anémie)", "truncated": false}, "before_length": 39, "before_sha256": "582ec73ef06cce5624fee97288f8a2f59c8a86a0cb7d939babcb252c4b416e8b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-25e2a97869abc454cc8513c0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 899}
{"after": {"end": 131, "start": 0, "text": "Ce médicament contient moins de 1 mmol (23 milligrammes) de sodium par seringue, c.-à-d. qu’il est essentiellement « sans sodium ».", "truncated": false}, "after_length": 131, "after_sha256": "10898bea2154b7d861ef43aa9e1d014e1bf948e7e5c99fdfbfb5d18de2f9bbe9", "annex": "IIIA", "before": {"end": 133, "start": 0, "text": "La solution injectable contient moins de 1 mmol (23 milligrammes) de sodium par seringue et est donc essentiellement « sans sodium ».", "truncated": false}, "before_length": 133, "before_sha256": "28e546ff59c363f1c52ff7daf88365012c313b71351a61a757f9dd8a25dd38a6", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 12, "after_start": 9, "before_end": 7, "before_start": 2, "kind": "replace"}, {"after_end": 13, "after_start": 13, "before_end": 22, "before_start": 8, "kind": "delete"}, {"after_end": 80, "after_start": 79, "before_end": 88, "before_start": 88, "kind": "insert"}, {"after_end": 94, "after_start": 81, "before_end": 91, "before_start": 89, "kind": "replace"}, {"after_end": 98, "after_start": 98, "before_end": 100, "before_start": 95, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-25f7352faa424f286b4ef9ff", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1266}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 32, "start": 0, "text": "1. NAME OF THE MEDICINAL PRODUCT", "truncated": false}, "before_length": 32, "before_sha256": "8141899f95166cc499efb2acfa403d9d6b8ae4eed4239eff8b6c08bd2be8913c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2609ce1dff06443cedee8dd9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4785}
{"after": {"end": 25, "start": 0, "text": "BristolMyers Squibb, S.A.", "truncated": false}, "after_length": 25, "after_sha256": "88e5c5115dcefbb042e25eed814626af9715f5463760d1a01269da8ccc06cd7e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2617217352887a457f65b688", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2873}
{"after": {"end": 26, "start": 0, "text": "BristolMyers Squibb S.r.l.", "truncated": false}, "after_length": 26, "after_sha256": "f44e170b34d2109b4908eb0ce3e17a4d6452169164e3f8ef3869b0c2498f1974", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-262e4ee0b962bfd880aee06e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2923}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Pen Cap", "truncated": false}, "before_length": 7, "before_sha256": "c3e86aa370b0648bd66e94254501f98c2aa237e9ae28f332a6526bcd32af7a15", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2675c80286fe9be805de03bd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9592}
{"after": {"end": 222, "start": 0, "text": "Niraparib is a substrate of Pgp and BCRP. However, due to niraparib’s high permeability and bioavailability, the risk of clinically relevant interactions with medicinal products that inhibit these transporters is unlikely.", "truncated": false}, "after_length": 222, "after_sha256": "c4aa6e51dd945089b63d99cfa75d9f5d24ce6b92b5b5931c2cb3d7f6746a00ef", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 222, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 222}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-26ac1a5563ad7c4cbcfc89f2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1648}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Eli Lilly Nederland B.V.", "truncated": false}, "before_length": 24, "before_sha256": "58e60ac126dd39b4930580291c64d7770a0db93150c4173b7e7d8a8642fe64e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-26c4bf4a57ffd5e2e9740fd9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9492}
{"after": {"end": 6, "start": 0, "text": "Dānija", "truncated": false}, "after_length": 6, "after_sha256": "ea1cda0e8df08e5d6b3894d37121d5928828a343cc4691a9a2dc4bf87f7ec80d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-26ea65bcf254aa7b8f101b86", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1837}
{"after": {"end": 684, "start": 0, "text": "If you have never received Firazyr previously, your first dose of Firazyr will always be injected by your doctor or nurse. Your doctor will tell you when it is safe for you to go home. After discussion with your doctor or nurse and after training in subcutaneous (under the skin) injection technique, you may be able to inject yourself with Firazyr or your caregiver may inject Firazyr for you when you have an HAE attack. It is important that Firazyr is injected subcutaneously (under the skin) as soon as you notice an attack of angioedema. Your healthcare provider will teach you and your caregiver how to safely inject Firazyr by following the instructions in the package leaflet.", "truncated": false}, "after_length": 684, "after_sha256": "7d6005adff6f5fc72ddf0d87f6c9573266638101eab224d9e3d0d5728a4efb52", "annex": "IIIA", "before": {"end": 684, "start": 0, "text": "If you have never received Firazyr previously, your first dose of Firazyr will always be injected by your doctor or nurse. Your doctor will tell you when it is safe for you to go home. After discussion with your doctor or nurse and after training in subcutaneous (under the skin) injection technique, you may be able to inject yourself with Firazyr or your caregiver may inject Firazyr for you when you have an HAE attack. It is important that Firazyr is injected subcutaneously (under the skin) as soon as you notice an attack of angioedema. Your healthcare provider will teach you and your caregiver how to safely inject Firazyr by following the instructions in the Package Leaflet.", "truncated": false}, "before_length": 684, "before_sha256": "f119f7e56d5bc6f78fbf7e6992b37f43c96f7c13b6fd34beaa352c3578eb5b55", "change_kind": "content", "change_operations": [{"after_end": 669, "after_start": 668, "before_end": 669, "before_start": 668, "kind": "replace"}, {"after_end": 677, "after_start": 676, "before_end": 677, "before_start": 676, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-26edc072ab02fa63432f827d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1254}
{"after": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "after_length": 7, "after_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-26f0714a196f636efb5c9d74", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3303}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 3, "start": 0, "text": "EXP", "truncated": false}, "before_length": 3, "before_sha256": "06a1ad637e7f4fbad56e29164490368f0526f429ee39a31dd1180c3722af1e4e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-26ffa918898ab5c8343fa074", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4725}
{"after": {"end": 15, "start": 0, "text": "3528 BD Utrecht", "truncated": false}, "after_length": 15, "after_sha256": "4ea402b0be2ffd43624e79f5ad9706ad796af820c845df2a7158d607c083d913", "annex": "III", "before": {"end": 15, "start": 0, "text": "3528 BJ Utrecht", "truncated": false}, "before_length": 15, "before_sha256": "c83d25e8ea65101ad8ea274a07e2114705ecd244e7a6dba61eb7b4d1ba592ecb", "change_kind": "unassigned", "change_operations": [{"after_end": 7, "after_start": 6, "before_end": 7, "before_start": 6, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2700c6391bd84d9f25b8ec75", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2197}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "1930 Zaventem", "truncated": false}, "before_length": 13, "before_sha256": "ed9ea9385e3e50f6278214da5d7483a8543c36d1261df263d35022c5936c74db", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-270189bce7fde865c625b36f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3211}
{"after": {"end": 20, "start": 0, "text": "Tel: + 370 52 369140", "truncated": false}, "after_length": 20, "after_sha256": "8a995c3bfc3c0427235c993d1d1f2ebdd1b1443c434cbb3e015f99728e5b363f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-274884341705bef93b6f5cb4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3170}
{"after": {"end": 18, "start": 0, "text": "Orteliuslaan 1000,", "truncated": false}, "after_length": 18, "after_sha256": "21c621c6366151fa349c8db45d9fcbb9c94e9eb157e7b6a12761b6c45f5a91c4", "annex": "I", "before": {"end": 18, "start": 0, "text": "Papendorpseweg 83,", "truncated": false}, "before_length": 18, "before_sha256": "93fe807c935894269f90415a7510e03bd5cb998b5478f2bec793675a6a09dafb", "change_kind": "administrative", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-279a8c076ca06643a42bc28c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 5 mg comprimés pelliculés", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1061}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb Kft.", "truncated": false}, "after_length": 24, "after_sha256": "4abe932008f2c73ead9e4e160ff0712dc599168363223ab6a9c2b7e9e433c4d7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-27a4b0e74d1ba7e4de743aef", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2828}
{"after": {"end": 245, "start": 0, "text": "A concomitant high-fat meal did not significantly affect the pharmacokinetics of niraparib after administration of 300 mg of niraparib capsule (Cmax decreased by 22% and AUCinf increased by 10% compared with fasting conditions; see section 4.2).", "truncated": false}, "after_length": 245, "after_sha256": "7607f67bdabda091f0566ce1d4739241240b2a9012494a691310b0c238c5c6fe", "annex": "I", "before": {"end": 143, "start": 0, "text": "A concomitant high-fat meal did not significantly affect the pharmacokinetics of niraparib after administration of 300 mg of niraparib capsule.", "truncated": false}, "before_length": 143, "before_sha256": "6fb8a6e389c897f81bbc6cf087cbe24db9c2e9cafcc62dcd11b7c7dcce8f9be5", "change_kind": "content", "change_operations": [{"after_end": 244, "after_start": 142, "before_end": 142, "before_start": 142, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 102}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-27b68f7f694f8a7a314cbe20", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 761}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Dose Knob", "truncated": false}, "before_length": 9, "before_sha256": "a20cc7665b42baee21dd248e2b47f343376758f69f6c42f26e3d8f4dddf3a2c5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-27c59553d90ef78cbbc6eda4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9591}
{"after": {"end": 27, "start": 0, "text": "informacja.medyczna@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "fd724a87ca0b5fd348792afb72bf17e76991a1b17ad813c04854601dd7b9576a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-27fa1ae138c418a0d30a78dd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2570}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tel: + 36 1 328 5100", "truncated": false}, "before_length": 20, "before_sha256": "9749cad8092021ae87eb8c900e2d72c5ef31b4fa3340bbffffc2f0a6b00c1ccf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-28035605fcd71846dffa3f89", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9476}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb Kft.", "truncated": false}, "after_length": 24, "after_sha256": "4abe932008f2c73ead9e4e160ff0712dc599168363223ab6a9c2b7e9e433c4d7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-28681ae799168243b315681a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3192}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Vistor hf.", "truncated": false}, "before_length": 10, "before_sha256": "4b40dfc2a19551f982dad779994a624f3432207c4666bbd66f0ec59c2f229b32", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 7, "before_end": 7, "before_start": 7, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-286ca63f76c4707174234434", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1651}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 84, "start": 0, "text": "Motifs de la modification des termes de la/des autorisation(s) de mise sur le marché", "truncated": false}, "before_length": 84, "before_sha256": "4ae2391ae7d822fcc157b2047bb5fc98dea0742b977efc28a87cde01dda2e02a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 84, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 84, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2893e8dfd511e7394bc2d836", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3501}
{"after": {"end": 20, "start": 0, "text": "Luxembourg/Luxemburg", "truncated": false}, "after_length": 20, "after_sha256": "28ac4fa3aba2dfb4b228bd072edb8cc818b04e6f4b87f37114caa6154e0e706b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-28a10b047aff92eebd28ecc4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3181}
{"after": {"end": 25, "start": 0, "text": "Tel: + 40 (0)21 272 16 19", "truncated": false}, "after_length": 25, "after_sha256": "502a8c5996880f462bf382bf033fc5a4e73041db59d3a638fd11052ee7eef1a8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-28ab54a3312ff60fd09b39b6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2899}
{"after": {"end": 23, "start": 0, "text": "BristolMyers Squibb SAS", "truncated": false}, "after_length": 23, "after_sha256": "077c1bdf9d06b6ebea2cef6e6ab8ff5604c7feba155cc10d71a17f6fa240342e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-28ae9e48928365f8a7712a37", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2573}
{"after": {"end": 49, "start": 0, "text": "BristolMyers Squibb Farmacêutica Portuguesa, S.A.", "truncated": false}, "after_length": 49, "after_sha256": "320289b9df354f466bcd06811a5bc06e5246b53241d28a0499699328d55fe681", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 49, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 49}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-28baddaed29fe7613a79a8c8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2888}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 49, "start": 0, "text": "Inhibition of UDP-glucuronosyltransferases (UGTs)", "truncated": false}, "before_length": 49, "before_sha256": "89cff031758125e9578d4c56981b1915e08d9f97c87ba058c995744d19ea7e55", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 49, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 49, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-28e9d2b90f066e50f979b0df", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 253}
{"after": {"end": 9, "start": 0, "text": "57 (48,7)", "truncated": false}, "after_length": 9, "after_sha256": "9094d7e7b52643ccab9e83a091b6183900dbee0dc51efedff7d2ab95a135407f", "annex": "I", "before": {"end": 9, "start": 0, "text": "49 (52,1)", "truncated": false}, "before_length": 9, "before_sha256": "6d27f5063d59793e7395ee9d025737cef6d8e12e0babb33a50a5e55c6ab3cb9c", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "replace"}, {"after_end": 6, "after_start": 4, "before_end": 6, "before_start": 4, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 8, "before_start": 7, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-29263d50c710e44306d66dbf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 305}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2934019e90ec97045cc254e3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2815}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 289, "start": 0, "text": "In vitro, le niraparib inhibe faiblement le transporteur de cations organiques 1 (OCT1) avec un IC50 = 34,4 µM. La prudence est recommandée lorsque le niraparib est administré en concomitance avec des substances actives qui subissent un transport d’absorption par OCT1 comme la metformine.", "truncated": false}, "before_length": 289, "before_sha256": "78ddb18067d666d53aef85b22571691db3eded899b788c55de14b9c20ed04ebb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 289, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 289, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-293fccb59d6dcfa071e89509", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1168}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 167, "start": 0, "text": "The additive effect of concomitantly administered products containing sorbitol (or fructose) and dietary intake of sorbitol (or fructose) should be taken into account.", "truncated": false}, "before_length": 167, "before_sha256": "5c3b4504c2880eb58e08bf60d7182351f22cbb61d5d9f7c0618d541ec5062c31", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 167, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 167, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-294d40999e1b41874bb7c35b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1003}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "8055 Graz", "truncated": false}, "before_length": 9, "before_sha256": "765f51a390983de920b9a586c4589caab5f6398576531f438fd8301227c9ccb2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-294f2cb32ca48e4d82d126ef", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3125}
{"after": {"end": 22, "start": 0, "text": "Tel: + 420 221 016 111", "truncated": false}, "after_length": 22, "after_sha256": "4d518854d9706e629e406bc93cfad10898d14ad223a3d403070c562115da215f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-295f1de32b0951453fa65194", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3188}
{"after": {"end": 38, "start": 0, "text": "Bristol-Myers Squibb Polska Sp. z o.o.", "truncated": false}, "after_length": 38, "after_sha256": "9c8a588d350dd39a6a46453574156c70a2d3d726d29ae6874b04bb3acd6f1d64", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-297afa4d3a1415885829e91e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2874}
{"after": {"end": 8, "start": 0, "text": "Portugal", "truncated": false}, "after_length": 8, "after_sha256": "4c7de2c3da6dc0ae8f9d13b107718a913859359bd30166d077c867577953865d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-29a8ccc04d9e9985b1c45b47", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3248}
{"after": {"end": 232, "start": 0, "text": "Zejula can affect how other medicines work. It is particularly important that you mention any medicines containing the active substance, metformin (used to lower blood sugar), as your doctor may need to adjust the dose of metformin.", "truncated": false}, "after_length": 232, "after_sha256": "0a299877fc024062a9f38ecae89279375f22280139a333e9ebe8a87f6617bca5", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 232, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 232}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-29cbe02b6c43263c0226cc55", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2619}
{"after": {"end": 5, "start": 0, "text": "Дания", "truncated": false}, "after_length": 5, "after_sha256": "15c4c56ca2ad5dd4518ae08c37f15cbda6da8ac77d78fb2b6e974b7d6667351e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-29d19fa57cdc9d00db021992", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1727}
{"after": {"end": 6, "start": 0, "text": "France", "truncated": false}, "after_length": 6, "after_sha256": "7a1ca4ef7515f7276bae7230545829c27810c9d9e98ab2c06066bee6270d5153", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2a0ea2effda506ab9ae8387a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2882}
{"after": {"end": 7, "start": 0, "text": "Danmark", "truncated": false}, "after_length": 7, "after_sha256": "b2bebaaf55198f3166a7d7089112d30e245d6cf4a3249ae87b597fa988e7f1be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2a14bc64fa98075e0f51f76a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3193}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 9, "start": 0, "text": "8055 Graz", "truncated": false}, "before_length": 9, "before_sha256": "765f51a390983de920b9a586c4589caab5f6398576531f438fd8301227c9ccb2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2a1a5ba273a2e2fe726e8402", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1680}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 17, "start": 0, "text": "D-90429 Nuremberg", "truncated": false}, "before_length": 17, "before_sha256": "e947a9c523ae55d462208c17464751e497403938b7fe52dead7696ca6851269b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2a4c502e74f18fbc9c305870", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1671}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Fresenius Kabi Austria GmbH", "truncated": false}, "before_length": 27, "before_sha256": "fa59d2b0c9ce4abc55a3051cb227907a12a3a3e7fc63908aaebeb76ac9f651ef", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2a65d93fe5411faa7864c38d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2455}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 120, "start": 0, "text": "• Turn the dose knob to select the number of units you need to inject. The dose indicator should line up with your dose.", "truncated": false}, "before_length": 120, "before_sha256": "3031c3956a238e459a48483776bc526cb278e8da8cd24869591e8483496e7b94", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 120, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 120, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2ad35558dea82e8db02bc737", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9688}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 99, "start": 0, "text": "6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "truncated": false}, "before_length": 99, "before_sha256": "455a982fe3bc6ba1eb2be1f3bcfd8517f2afe6d320280030b823f73d0bf6a1d6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 99, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 99, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2af716a69bffde2df36aa9b5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4616}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 38, "start": 0, "text": "Pfizer Luxembourg SARL filiāle Latvijā", "truncated": false}, "before_length": 38, "before_sha256": "0faf5c92c10d6b843893cb7c41ee4ab7c87fec3cd38cd32c1b8ebce28c790790", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 38, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 38, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2afdcf4604704d270ebbd8c2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3850}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2b0ab01d2c080e9328a9fe23", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3279}
{"after": {"end": 23, "start": 0, "text": "Tel: + 351 21 440 70 00", "truncated": false}, "after_length": 23, "after_sha256": "051a50965400ccbc97e96d9606564d6ef751251b31d5cd81aa4f430414a32099", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2b238bda530fe1d39ba4fd61", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2885}
{"after": {"end": 34, "start": 0, "text": "2. COMPOSITION EN SUBSTANCE ACTIVE", "truncated": false}, "after_length": 34, "after_sha256": "d8d45b80cabae6182493dd6cb6cc5f7b61173e274bdf8970e0d5e4e0af28e6f6", "annex": "IIIA", "before": {"end": 40, "start": 0, "text": "2. COMPOSITION EN SUBSTANCE(S) ACTIVE(S)", "truncated": false}, "before_length": 40, "before_sha256": "4d60f4e65cd518be0591d38bf53afabde89d036bddddfa0bd55980a90810069d", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 27, "before_end": 30, "before_start": 27, "kind": "delete"}, {"after_end": 34, "after_start": 34, "before_end": 40, "before_start": 37, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2b54cb6e0c42f3b9404adda5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1006}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Autriche", "truncated": false}, "before_length": 8, "before_sha256": "dea55da9d453f7a5125a553d05297c736f00626d1baa09e099247c0e7937d0cf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2b596ccd22a6d9f996117142", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2458}
{"after": {"end": 6, "start": 0, "text": "Polska", "truncated": false}, "after_length": 6, "after_sha256": "d1974e0e3e575b6dadb40f080dae05025f574cb23e5cababcac0f50cf2619549", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2b7ba1942837436827bc02c3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2873}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 161, "start": 0, "text": "Neither niraparib nor M1 is an inhibitor of any active substancemetabolising CYP enzymes, namely CYP1A1/2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5.", "truncated": false}, "before_length": 161, "before_sha256": "e3d1e536d915c8822f15fdf6c57b149152d6ef61e737d8266b907d4510e6fd7d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 161, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 161, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2b7c62859ce2acb5eccbe12d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1112}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "8. EXPIRY DATE", "truncated": false}, "before_length": 14, "before_sha256": "d71d14e8d4b94ef3a8f8363df6900202ede93977214348173fe46b41f9ab80aa", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2b7f620c763e0ec415b71e61", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4624}
{"after": {"end": 36, "start": 0, "text": "Read the package leaflet before use.", "truncated": false}, "after_length": 36, "after_sha256": "5523bc203c0d15a42e51f1f2084990ce77593674ceb9b20d974654fb13a8f72b", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "Read the package leaflet before use", "truncated": false}, "before_length": 35, "before_sha256": "507cbe4bd01d082cb8b1d6b89039f65a5c71739015aad79203bdc9f43571b36e", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 35, "before_end": 35, "before_start": 35, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2bdb5e57e5cb95e63231a634", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1010}
{"after": {"end": 21, "start": 0, "text": "Tel: + 385 1 2078 500", "truncated": false}, "after_length": 21, "after_sha256": "d2c4badf1d52e4fa4d9876ca25a250b52d706e4108687e5034656c1b419f6ddc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2bef670ceb9fecda7a181f74", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2584}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Eli Lilly and Company (Ireland) Limited", "truncated": false}, "before_length": 39, "before_sha256": "0555e8a06c0ef36afd955d945d4997f04834690c546541adf74802bac524a0e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2c08c1bc8da15437a87b24bf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2834}
{"after": {"end": 19, "start": 0, "text": "Tel: + 371 66164750", "truncated": false}, "after_length": 19, "after_sha256": "113b9b6ac49a6f4bdbe379f2d1e85b2d125b75611b91111c888ec73bacdd0230", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2c2e8baf3bd9970d9fcb36e1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2628}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 114, "start": 0, "text": "Your insulin is injected under the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper arms.", "truncated": false}, "before_length": 114, "before_sha256": "7bef58b42da74eaf75f4c2ced6369c572dadcaad7bd411b178c57de6034252c2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 114, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 114, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2c4651c525e5b152d08f0509", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9739}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 12, "start": 0, "text": "County Kerry", "truncated": false}, "before_length": 12, "before_sha256": "eb7356a4494d39c472b712704605178f5a5ec97da0fc0b32f904fa38c0a2cdcc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2cb17925d7f3e6cf88c3d0ac", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 987}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Humalog with alcohol", "truncated": false}, "before_length": 20, "before_sha256": "101ee9cbd1dc6723e885e1307d3efe68f3c0b6404a8d05963442232fdb48ccdf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2cd9df56ab72d399cc586420", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9286}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 3, "start": 0, "text": "Lot", "truncated": false}, "before_length": 3, "before_sha256": "23ea1b1beb5529f4f4cbe47df67ef01587f29229a112e020eff530d5033fbcff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2d7189970ae355f72a513e8e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4653}
{"after": {"end": 50, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht The Netherlands", "truncated": false}, "after_length": 50, "after_sha256": "de386d3b3aeebba1dff0a070ffc767173cbc1fa354dbcd29dd86469dc23d8ff6", "annex": "I", "before": {"end": 50, "start": 0, "text": "Papendorpseweg 83, 3528 BJ Utrecht The Netherlands", "truncated": false}, "before_length": 50, "before_sha256": "5d621ef45df9c1911e6b63f15edb513d80fad3ee63f11fe58a733f65b67cd3cd", "change_kind": "administrative", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}, {"after_end": 26, "after_start": 25, "before_end": 26, "before_start": 25, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2d8a132dcb59c109cee98ffb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 10 mg film-coated tablets CIALIS 20 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1547}
{"after": {"end": 409, "start": 0, "text": "Le niraparib était modérément lié aux protéines du plasma humain (83 %), principalement avec l’albumine sérique. Dans une analyse pharmacocinétique de population de niraparib, le volume apparent de distribution (Vd/F) était de 1,206 L (sur la base d’une patiente de 70kg) chez les patientes atteintes de cancer (coefficient de variation (CV) 18,4%), indiquant une distribution tissulaire étendue du niraparib.", "truncated": false}, "after_length": 409, "after_sha256": "14955eace18a3b925797c97a8c55b256fdd543377550e7334aba4fdb83ab02e6", "annex": "I", "before": {"end": 408, "start": 0, "text": "Le niraparib était modérément lié aux protéines du plasma humain (83 %), principalement avec l’albumine sérique. Dans une analyse pharmacocinétique de population de niraparib, le volume apparent de distribution (Vd/F) était de 1,311 L (sur la base d’une patiente de 70kg) chez les patientes atteintes de cancer (coefficient de variation (CV) 116%), indiquant une distribution tissulaire étendue du niraparib.", "truncated": false}, "before_length": 408, "before_sha256": "078639dbb8542a725792e2a523d3f03c1793cc91bae044f53490868e5b9ede1a", "change_kind": "content", "change_operations": [{"after_end": 232, "after_start": 229, "before_end": 232, "before_start": 229, "kind": "replace"}, {"after_end": 346, "after_start": 343, "before_end": 345, "before_start": 343, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2d8bd0dd2e2bb55b3550fbdb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 789}
{"after": {"end": 23, "start": 0, "text": "OPA/Al/PVC-alu blisters", "truncated": false}, "after_length": 23, "after_sha256": "f999e876d367748d4b97163640261f744adbcffb86a77dfb8d5bc04bca0a3cbc", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2de0a06fc9df468663748f2e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.5", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1395}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 91, "start": 0, "text": "Like all medicines, this medicine can cause side effects, although not everybody gets them.", "truncated": false}, "before_length": 91, "before_sha256": "0cf6b1a03e0594346c5da6b6c243dac5dcfbbc0b32f042e77c9b3e59fafa65af", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 91, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 91, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2df78a6d6a322b247021cda0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9365}
{"after": {"end": 47, "start": 0, "text": "12. NUMÉRO D’AUTORISATION DE MISE SUR LE MARCHÉ", "truncated": false}, "after_length": 47, "after_sha256": "3bc4f55c2ee1c489f7ed5e6a0843eb330efac627a7189aef3c56b927e59f15aa", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "12. NUMÉRO(S) D’AUTORISATION DE MISE SUR LE MARCHÉ", "truncated": false}, "before_length": 50, "before_sha256": "f9f5012b03069c8eb354120fea917486fb6f5e68726fed05ea66cd3d636f2c4b", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 10, "before_end": 13, "before_start": 10, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2e1516ab40050d1c53784d8f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 863}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 84, "start": 0, "text": "Severe symptoms are heavy breathing and a rapid pulse. Get medical help immediately.", "truncated": false}, "before_length": 84, "before_sha256": "ef4ccb0e3c32d0aa19c91a321230eb4b18da1e9e84a79d965e9e5c0925918d0b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 84, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 84, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2e1f45f50def59f4200adc96", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9415}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Tel: + 353-(0) 1 661 4377", "truncated": false}, "before_length": 25, "before_sha256": "48fde288146f4033a2172164570180a8f875f4e361fcf85a8e43ff77834511cc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2e44ca2b65d295a0966b4b46", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3411}
{"after": {"end": 26, "start": 0, "text": "informacion.medica@bms.com", "truncated": false}, "after_length": 26, "after_sha256": "ecc8b3fc203c9400ed5a39531e5dadc0b28244ff3abb21ff0a801eeffc0a5d0e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2e4931ea737c804183df52c9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2871}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 358, "start": 0, "text": "Neither niraparib nor M1 is a substrate of organic anion transport polypeptide 1B1 (OATP1B1), 1B3 (OATP1B3), or organic cation transporter 1 (OCT1). No dose adjustment for Zejula is required when administered concomitantly with medicinal products known to inhibit OATP1B1 or 1B3 (e.g. gemfibrozil, ritonavir), or OCT1 (e.g. dolutegravir) uptake transporters.", "truncated": false}, "before_length": 358, "before_sha256": "7b8c1b7c8101ccc3797bf671f29adf418b7931ec99440abe439c4b3ce5742442", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 358, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 358, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2e4f1faf30cf835ae3b6acc3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 241}
{"after": {"end": 33, "start": 0, "text": "Τηλ: 800 92666 (+ 30 210 6074300)", "truncated": false}, "after_length": 33, "after_sha256": "3c667c31f7c324c43671bdd5606ccfdb57ec8b49816d058ab68a853627dd20b8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2e789684c666f34f9ae119b5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2934}
{"after": {"end": 117, "start": 0, "text": "Niraparib is an inhibitor of P-gp, BCRP, MATE1/2K and organic cation transporter 1 (OCT1) in vitro (see section 4.5).", "truncated": false}, "after_length": 117, "after_sha256": "fe6cdfadc654a86407c34968439e7d7f6230ef0081d958a1359b6b81515d868a", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 117, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 117}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2e7d12d3c7d0caf8a64eb47f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 785}
{"after": {"end": 241, "start": 0, "text": "If you forget to take a dose, take your tablets as soon as you remember. If it is within 6 hours before your next dose, skip the missed dose and take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.", "truncated": false}, "after_length": 241, "after_sha256": "d35348f332d0a38b8f5e3342b49d123c7501cff48e2d8bbedd863775e674f7b3", "annex": "IIIA", "before": {"end": 242, "start": 0, "text": "If you forget to take a dose, take your capsules as soon as you remember. If it is within 6 hours before your next dose, skip the missed dose and take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.", "truncated": false}, "before_length": 242, "before_sha256": "07876ce26f1103f9b8702f49c98b81acdccc3cdbff3a68ad2411aaf230c066cc", "change_kind": "content", "change_operations": [{"after_end": 41, "after_start": 40, "before_end": 41, "before_start": 40, "kind": "replace"}, {"after_end": 43, "after_start": 42, "before_end": 45, "before_start": 42, "kind": "replace"}, {"after_end": 46, "after_start": 45, "before_end": 47, "before_start": 47, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2e94b186b3933db8093b7d74", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3152}
{"after": {"end": 78, "start": 0, "text": "MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES OU LES FILMS THERMOSOUDÉS", "truncated": false}, "after_length": 78, "after_sha256": "936698de91fcb2e7208e9618e06c753fdcba895d52cfdd4bce7b5589a54d64c9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 78, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 78}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2ea7ee8dbce35fb6f1bece0f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1095}
{"after": {"end": 6, "start": 0, "text": "Dānija", "truncated": false}, "after_length": 6, "after_sha256": "ea1cda0e8df08e5d6b3894d37121d5928828a343cc4691a9a2dc4bf87f7ec80d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2eddf945c83c5246cec9674f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2160}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "Humalog Tempo Pen contains sodium", "truncated": false}, "before_length": 33, "before_sha256": "77a436ac3e99b2599c53e75f57712b09b15d0d94de7b44130e2444aa93a8c66c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2f07062b1aa6a274acc137a4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9298}
{"after": {"end": 22, "start": 0, "text": "Tel: + 421 2 20833 600", "truncated": false}, "after_length": 22, "after_sha256": "06545090f6b6777d6143e84f408247cee2424d81a40db0a2693eff093cfe9ec8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2f0a3c04236225b5830aa79a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3283}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 80, "start": 0, "text": "Tear off one individual blister from the blister card along the perforated line.", "truncated": false}, "before_length": 80, "before_sha256": "d1c3a6dd16c5773e7b8445917e454de928929cd0a1201281a8ea8285c89b82e5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 80, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 80, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2f1cc518adfd341a7dd78119", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3143}
{"after": {"end": 22, "start": 0, "text": "Tel: + 420 221 016 111", "truncated": false}, "after_length": 22, "after_sha256": "4d518854d9706e629e406bc93cfad10898d14ad223a3d403070c562115da215f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2f2a48ac761626cb3f4581b1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2820}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "The Netherlands", "truncated": false}, "before_length": 15, "before_sha256": "91729ff7107ee698fe168dc62d5b2020678fcfcf55b4ea9065982ce1d071ba31", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2f3e10c8df6bb4ffe425dba5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4643}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 175, "start": 0, "text": "• Do not use your Pen past the expiration date printed on the label. After you start using the Pen, throw your Pen away after the in-use time specified in the package leaflet.", "truncated": false}, "before_length": 175, "before_sha256": "2a99af61ef3d031bf18aa361b3cbcbb34893da8d5f9d9309600d5afcb4589662", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 175, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 175, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2f485d0c398a5e310f0ce445", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9631}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb Kft.", "truncated": false}, "after_length": 25, "after_sha256": "8eee29e152f27da674ed6460d204f723bf6a9c596f41572a08e4e678a83674cb", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2f5c5c7e02a616c9492f0e50", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3189}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "LEO Laboratories Ltd", "truncated": false}, "before_length": 20, "before_sha256": "88c803e41685f3f9af10a32ea47829718c391a3d4b0b4b43a151753aa8cf8bbc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2f7ea72e05bac9111cd65930", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2138}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 84, "start": 0, "text": "• If your dose is more than 60 units, you will need to give more than one injection.", "truncated": false}, "before_length": 84, "before_sha256": "6da833efa55f53074d4c999bbd0367d066019be44e787b1bd825eba044171b4f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 84, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 84, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2f90fd809ec9be7b64b8d49c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9683}
{"after": {"end": 15, "start": 0, "text": "3528 BD Utrecht", "truncated": false}, "after_length": 15, "after_sha256": "4ea402b0be2ffd43624e79f5ad9706ad796af820c845df2a7158d607c083d913", "annex": "I", "before": {"end": 15, "start": 0, "text": "3528 BJ Utrecht", "truncated": false}, "before_length": 15, "before_sha256": "c83d25e8ea65101ad8ea274a07e2114705ecd244e7a6dba61eb7b4d1ba592ecb", "change_kind": "administrative", "change_operations": [{"after_end": 7, "after_start": 6, "before_end": 7, "before_start": 6, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2fae201f8480365e2f5ebf7f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 5 mg comprimés pelliculés", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1062}
{"after": {"end": 18, "start": 0, "text": "-1.0 (-13.5, 11.6)", "truncated": false}, "after_length": 18, "after_sha256": "27b6e761e8d72318720422d45a99bd8246cab262725034d343e9cc4f65aa9447", "annex": "I", "before": {"end": 18, "start": 0, "text": "-1.1 (-14.9, 12.7)", "truncated": false}, "before_length": 18, "before_sha256": "d6082af739721d361baaa5183a98a8fca4118312c6123b126c4db1fc005b0e87", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 4, "before_start": 3, "kind": "replace"}, {"after_end": 9, "after_start": 8, "before_end": 9, "before_start": 8, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 11, "before_start": 10, "kind": "replace"}, {"after_end": 15, "after_start": 14, "before_end": 15, "before_start": 14, "kind": "replace"}, {"after_end": 17, "after_start": 16, "before_end": 17, "before_start": 16, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2fc4519e5e3e98f031f4cfa1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 304}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Eli Lilly Nederland B.V.", "truncated": false}, "before_length": 24, "before_sha256": "58e60ac126dd39b4930580291c64d7770a0db93150c4173b7e7d8a8642fe64e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-2fec20688e99b4a6302cf5da", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9489}
{"after": {"end": 7, "start": 0, "text": "România", "truncated": false}, "after_length": 7, "after_sha256": "633e193d7e05828a893d02a6273755ed0d417cc14abf5ecfc2b6328c71ddcc7e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3006d9bfe138b743af033588", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2893}
{"after": {"end": 9, "start": 0, "text": "Nederland", "truncated": false}, "after_length": 9, "after_sha256": "8a869db3fa453526573e4f2c956528743cf246af5d1b5eac4879257589776797", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3043819010060622cb700773", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3208}
{"after": {"end": 36, "start": 0, "text": "medinfo.lithuania@swixxbiopharma.com", "truncated": false}, "after_length": 36, "after_sha256": "70eec294d332a04f9bd82459b443a88e19b0dcce5bbd50491f56763531b2b260", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-307253b8ef5872d3d36e03ec", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2810}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "Keep out of the sight and reach of children", "truncated": false}, "before_length": 43, "before_sha256": "034982a6fd4368f93bb56faf8a1eeaa94e38c9c9c5e4ffcc97d89ccfdbbe07fb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-307812785946487909a37584", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4717}
{"after": {"end": 47, "start": 0, "text": "12. NUMÉRO D’AUTORISATION DE MISE SUR LE MARCHÉ", "truncated": false}, "after_length": 47, "after_sha256": "3bc4f55c2ee1c489f7ed5e6a0843eb330efac627a7189aef3c56b927e59f15aa", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "12. NUMÉRO(S) D’AUTORISATION DE MISE SUR LE MARCHÉ", "truncated": false}, "before_length": 50, "before_sha256": "f9f5012b03069c8eb354120fea917486fb6f5e68726fed05ea66cd3d636f2c4b", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 10, "before_end": 13, "before_start": 10, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3094b9979e0eff74465cb469", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1062}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 44, "start": 0, "text": "• Carefully replace the outer needle shield.", "truncated": false}, "before_length": 44, "before_sha256": "c3b89d95507581864f34db3de24adecd7dadbbe1dd6019bf74fe34d90765efd3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 44, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 44, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3099c5d7214549fcc8a02e85", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9771}
{"after": {"end": 5, "start": 0, "text": "None.", "truncated": false}, "after_length": 5, "after_sha256": "903ea500e7ccf842c1312b6c2f964e3e98ff146456cecec717e9a0e122bf735f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-30b509641ad4f14f52009c89", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2325}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 45 45 93 05 06", "truncated": false}, "after_length": 21, "after_sha256": "61983c14390c5d0df2153e10740a9b1eb429e8c0b05c3ebe705431c827a32b81", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-30c48f486220b8f3e6ebb4ca", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3198}
{"after": {"end": 46, "start": 0, "text": "Bristol-Myers Squibb Marketing Services S.R.L.", "truncated": false}, "after_length": 46, "after_sha256": "6c38be302b7d5963ce12172acd656a3cb654f698a1ffaa2a83410a1393313cb6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 46, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 46}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3138fa2278754f4664946ed3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2582}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 358, "start": 0, "text": "Neither niraparib nor M1 is a substrate of organic anion transport polypeptide 1B1 (OATP1B1), 1B3 (OATP1B3), or organic cation transporter 1 (OCT1). No dose adjustment for Zejula is required when administered concomitantly with medicinal products known to inhibit OATP1B1 or 1B3 (e.g. gemfibrozil, ritonavir), or OCT1 (e.g. dolutegravir) uptake transporters.", "truncated": false}, "before_length": 358, "before_sha256": "7b8c1b7c8101ccc3797bf671f29adf418b7931ec99440abe439c4b3ce5742442", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 358, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 358, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3162dd45270f4837756e1d95", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1104}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: + 353 18711600", "truncated": false}, "before_length": 19, "before_sha256": "f39469e1bbd519f10406ae27e104b0e2fb101791df45c4e53cc539ee02b84821", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3165831367edc0c6c0bcfe88", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3020}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Lilly Hungária Kft.", "truncated": false}, "before_length": 19, "before_sha256": "4b6f212c70ab2ae4f1b0d0fedd4f33fe3518aeabc30bbb3a07cd6f82eb08de6b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-316c040cf7285c795265ec51", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9475}
{"after": {"end": 26, "start": 0, "text": "Tél: + 33 (0)1 58 83 84 96", "truncated": false}, "after_length": 26, "after_sha256": "331bde6d3ceed373ca2a62d0d499d6fe72853e6ae69fb08f092c7712a9ad1d3e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-317730ad8cd02870dc4bdda6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2884}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 57, "start": 0, "text": "• Change (rotate) your injection site for each injection.", "truncated": false}, "before_length": 57, "before_sha256": "71b3612442e7391bbac1422e49562c5eebba7e30cc7d8cc2af059e21ee84c06c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 57, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 57, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-317874583f587eff4805704d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9734}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 290, "start": 0, "text": "Are you pregnant or thinking about becoming pregnant, or are you breast-feeding? The amount of insulin you need usually falls during the first three months of pregnancy and increases for the remaining six months. If you are breast-feeding, you may need to alter your insulin intake or diet.", "truncated": false}, "before_length": 290, "before_sha256": "0ba2a88261e005a1222c0092f8eecd8f20ef4f8474ab4610fd22553269124ddd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 290, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 290, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3178c64932b830b8b2b6e085", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9290}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 13, "start": 0, "text": "Roonstraße 25", "truncated": false}, "before_length": 13, "before_sha256": "72b80df998792e1d92189a290d82759fb839b17a555226b67f667c759822bfa7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-31874f891eb50eda50fd58fe", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1670}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Eli Lilly and Company (Ireland) Limited", "truncated": false}, "before_length": 39, "before_sha256": "0555e8a06c0ef36afd955d945d4997f04834690c546541adf74802bac524a0e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-318ad0dac48e3d99322d3d56", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3121}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "Roonstraße 25", "truncated": false}, "before_length": 13, "before_sha256": "72b80df998792e1d92189a290d82759fb839b17a555226b67f667c759822bfa7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-319ca9d289e47332bbb9e35d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3431}
{"after": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "after_length": 7, "after_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-31a16cb529933e3c233ee34a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2592}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 65, "start": 0, "text": "Inhibition des transporteurs d’influx rénaux (OAT1, OAT3 et OCT2)", "truncated": false}, "before_length": 65, "before_sha256": "ce7d116b56e90382de55c2a6c0148613b81713cd033eb1295972e3784bc3dfbc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 65, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 65, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-31aef5f3031aebccdb309ca3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1170}
{"after": {"end": 120, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu.", "truncated": false}, "after_length": 120, "after_sha256": "4531b88088f201341aeac319894fe4addc485ddec7289bfb799fa5bfa043c6bb", "annex": "IIIA", "before": {"end": 119, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.", "truncated": false}, "before_length": 119, "before_sha256": "253f2622a30bdfc9897323503e26a15d261cb9d4155934bd9ad1b75da0a2cd9a", "change_kind": "technical", "change_operations": [{"after_end": 99, "after_start": 98, "before_end": 98, "before_start": 98, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3204e3427a1a97e7ab8890a0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2555}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 354, "start": 0, "text": "Type I glass cartridges, sealed with halobutyl disc seals secured with aluminium seals and bromobutyl plunger heads. Dimeticone or silicone emulsion may be used to treat the cartridge plunger. The 3 ml cartridges are sealed in a disposable pen injector, called the “Tempo Pen”. The Tempo Pen contains a magnet (see section 4.4). Needles are not included.", "truncated": false}, "before_length": 354, "before_sha256": "10de43852c3d74170ac913cfe8f188a6d7121e2ff35668013f56dd9fb33db436", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 354, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 354, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-321914f3588d0537b59ceb51", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.5", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 443}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-32895f4258a881bdac2c237f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2589}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 10, "start": 0, "text": "Killorglin", "truncated": false}, "before_length": 10, "before_sha256": "2606b5fb607427b1a532d8cab1195d0515b4a8cf56f0eff6628b2ac9a5a04655", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-328ee821204b996133ab182e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 986}
{"after": {"end": 21, "start": 0, "text": "Tel: + 385 1 2078 500", "truncated": false}, "after_length": 21, "after_sha256": "d2c4badf1d52e4fa4d9876ca25a250b52d706e4108687e5034656c1b419f6ddc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3296cfa69e9826fe30bae597", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2578}
{"after": {"end": 54, "start": 0, "text": "1. DÉNOMINATION DU MÉDICAMENT ET VOIE D’ADMINISTRATION", "truncated": false}, "after_length": 54, "after_sha256": "3a8c5027cfbc2cf6ba92972244c6c0f4169577a979deecce50af4fd71e6a8b98", "annex": "IIIA", "before": {"end": 57, "start": 0, "text": "1. DÉNOMINATION DU MÉDICAMENT ET VOIE(S) D’ADMINISTRATION", "truncated": false}, "before_length": 57, "before_sha256": "7f29bd212b9880b9eab54eecb41f115b0e1564078c59fe5094969d724fe83851", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 37, "before_end": 40, "before_start": 37, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-32a0ec88b86a5aba407f563b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1137}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "Takeda UK Ltd", "truncated": false}, "before_length": 13, "before_sha256": "baf3815891882f756e27c4ab785d1f1864d45f1a993c33b3d78122dd2499b6e2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-32b3f7c2b537001963f0a977", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1685}
{"after": {"end": 34, "start": 0, "text": "12. MARKETING AUTHORISATION NUMBER", "truncated": false}, "after_length": 34, "after_sha256": "a60532285d3f2ae8ae6f1bf2efe60e8f4d80a3914ffa0fe294c7a05c7841017d", "annex": "IIIA", "before": {"end": 37, "start": 0, "text": "12. MARKETING AUTHORISATION NUMBER(S)", "truncated": false}, "before_length": 37, "before_sha256": "b6071fb293faef2077f6465142b105eff6f52c83477531a9aef260fa8ed61e46", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 34, "before_end": 37, "before_start": 34, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-32d837cf97586676830a8335", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 944}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "LABEL TEXT", "truncated": false}, "before_length": 10, "before_sha256": "847e69feb841d5269a7d58c38a78405ba71a32e49e49afc955c5db61d57cb9f7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-330c3e8876453ba72de84785", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4877}
{"after": {"end": 128, "start": 0, "text": "Vyndaqel is indicated for the treatment of wildtype transthyretin amyloidosis in adult patients with cardiomyopathy (ATTRwt-CM).", "truncated": false}, "after_length": 128, "after_sha256": "88dabe11269899ec0b35df614cb7edd47d581d8c9d1882225e6b737010de29bf", "annex": "I", "before": {"end": 140, "start": 0, "text": "Vyndaqel is indicated for the treatment of wildtype or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM).", "truncated": false}, "before_length": 140, "before_sha256": "94cd154f2a76e3080b6c891b0e0e7cd55c98d68359a465295077793e8fbbf74f", "change_kind": "content", "change_operations": [{"after_end": 52, "after_start": 52, "before_end": 66, "before_start": 52, "kind": "delete"}, {"after_end": 123, "after_start": 121, "before_end": 135, "before_start": 135, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3315510c24b19aebb39318c2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.1", "section_type": "indication", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 947}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 59, "start": 0, "text": "Small air bubbles are normal and will not affect your dose.", "truncated": false}, "before_length": 59, "before_sha256": "77b6b84dac1515527864dc7b0c6b9c47690820209f271208fa6db0d0c3ddd215", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 59, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 59, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3361abf4037196a9b1e45273", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9674}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Eli Lilly Nederland B.V.", "truncated": false}, "before_length": 24, "before_sha256": "58e60ac126dd39b4930580291c64d7770a0db93150c4173b7e7d8a8642fe64e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-337acb572333ffbcc90ac93e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4839}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Fresenius Kabi Austria GmbH", "truncated": false}, "before_length": 27, "before_sha256": "fa59d2b0c9ce4abc55a3051cb227907a12a3a3e7fc63908aaebeb76ac9f651ef", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-337c80952e10b9c6684cabc2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2437}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "15. INSTRUCTIONS ON USE", "truncated": false}, "before_length": 23, "before_sha256": "f8a07f0f5a6fad5f13ef5dcced3946c03a5890329dd08710b94d8c5258ad3e23", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3382986222b4bb7ab5ecf342", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4857}
{"after": {"end": 33, "start": 0, "text": "medinfo.latvia@swixxbiopharma.com", "truncated": false}, "after_length": 33, "after_sha256": "c0a77882a6e33a348e9fb5e2a3006e8250b7d628f17c35efbaf3212a5e6e1c2d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-338682d8d4c45a1dca239d14", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2945}
{"after": {"end": 20, "start": 0, "text": "Luxembourg/Luxemburg", "truncated": false}, "after_length": 20, "after_sha256": "28ac4fa3aba2dfb4b228bd072edb8cc818b04e6f4b87f37114caa6154e0e706b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-33a4a39ab564901baffd06fd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2501}
{"after": {"end": 136, "start": 0, "text": "Aucun ajustement posologique n’est nécessaire lors du passage de Vyndaqel 61 mg, capsules molles à Vyndaqel 61 mg, comprimés pelliculés.", "truncated": false}, "after_length": 136, "after_sha256": "e1db47a250f50f629a309f97e46a053e0028f4f45e8128365fee2fd86dab1ccd", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 136, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 136}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-33c3faa8c96343620335d2a5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1243}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 36 1 301 9797", "truncated": false}, "after_length": 21, "after_sha256": "646ee39f31e338f4b9b710096409242010a836db8c907826a18abfa5703a4854", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-33cd7fbc3873f92608922d1a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2519}
{"after": {"end": 6, "start": 0, "text": "Κύπρος", "truncated": false}, "after_length": 6, "after_sha256": "7f8ef8a379e33810aefd13f344f489d85e8902de6fdcd1b46a4e856985b5e14e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-33fd1267e4d7eed0988ff43a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2932}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 3, "start": 0, "text": "Pen", "truncated": false}, "before_length": 3, "before_sha256": "a04bd35be16789649a70cf2e6712d8e76ffbf2d993ad23db84c6e12539150e8d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3405e91e4805b6859f3d68da", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9595}
{"after": {"end": 22, "start": 0, "text": "medinfo.sweden@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "b564c1a351ab9a2c3f444753cdc78f0306131b829474e9874a876fc1a90d4b7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-340aaa6add43d75da1735dc7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2630}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "• Insert the needle into your skin.", "truncated": false}, "before_length": 35, "before_sha256": "32529ab5739e965140a20f15f7402f087271daf16602b37aab14f5fa56121b9f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-342f724b1941ae62930b78cb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9744}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb A.E.", "truncated": false}, "after_length": 25, "after_sha256": "43a0521fcec8db403e6fb060ae3b147a3107583a8df9b3a28208c9a4bd0d8fba", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-343589b40ea09cb21ba18d0f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2617}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: + 353 18711600", "truncated": false}, "before_length": 19, "before_sha256": "f39469e1bbd519f10406ae27e104b0e2fb101791df45c4e53cc539ee02b84821", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-34786e446a7dc7383a92903e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3677}
{"after": {"end": 19, "start": 0, "text": "Tel: + 371 66164750", "truncated": false}, "after_length": 19, "after_sha256": "113b9b6ac49a6f4bdbe379f2d1e85b2d125b75611b91111c888ec73bacdd0230", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-34a104489c76c402c0447605", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2634}
{"after": {"end": 34, "start": 0, "text": "Vyndaqel 61 mg film-coated tablets", "truncated": false}, "after_length": 34, "after_sha256": "0ab1707af4a63192366906aad4f1c11a8821c9edf7f91b23f417bf90186d02d2", "annex": "I", "before": {"end": 28, "start": 0, "text": "Vyndaqel 61 mg soft capsules", "truncated": false}, "before_length": 28, "before_sha256": "49bdba5164eda37f05fe333e01328a0bed1d697f60d2a6f5cdbb879ef3b76026", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 15, "before_end": 16, "before_start": 15, "kind": "replace"}, {"after_end": 23, "after_start": 22, "before_end": 18, "before_start": 17, "kind": "replace"}, {"after_end": 26, "after_start": 24, "before_end": 19, "before_start": 19, "kind": "insert"}, {"after_end": 28, "after_start": 27, "before_end": 21, "before_start": 20, "kind": "replace"}, {"after_end": 30, "after_start": 29, "before_end": 25, "before_start": 22, "kind": "replace"}, {"after_end": 33, "after_start": 32, "before_end": 27, "before_start": 27, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-34a34f0405f7f89e1a8e8c94", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 920}
{"after": {"end": 40, "start": 0, "text": "Tel: 1 800 749 749 (+ 353 (0)1 483 3625)", "truncated": false}, "after_length": 40, "after_sha256": "0509d2a1806f188ecbce2c353425cb70d883d4c07f6e695eacf4b8a2ec65feef", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 40, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 40}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-34a3c9be460c615e91483a50", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2594}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 47 67 55 53 50", "truncated": false}, "after_length": 21, "after_sha256": "d1b594f6660af0e3776951e66e526813a270ea883650a47e68423146b1d67dd7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-34b6ef00b9585ee3c393b513", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3220}
{"after": {"end": 61, "start": 0, "text": "Niraparib is an inducer of CYP1A2 in vitro (see section 4.5).", "truncated": false}, "after_length": 61, "after_sha256": "4d7a22dc60761c836b6ccb06b69c54ee2f3d9e45e883b61c9458576d6cb5e243", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 61, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 61}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-34bd01326bc48e90ac47660e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1646}
{"after": {"end": 6, "start": 0, "text": "Κύπρος", "truncated": false}, "after_length": 6, "after_sha256": "7f8ef8a379e33810aefd13f344f489d85e8902de6fdcd1b46a4e856985b5e14e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-34c061ba5b53d48924501511", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2928}
{"after": {"end": 8, "start": 0, "text": "България", "truncated": false}, "after_length": 8, "after_sha256": "a7215e5aa55f878990c076bb8195d75ca42044d4d5c7d2ba90af610508b643d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-34df4b95af9b31a28e0f73e0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2502}
{"after": {"end": 8, "start": 0, "text": "Hrvatska", "truncated": false}, "after_length": 8, "after_sha256": "08c5546cc42a9be9368bdd6a99ed02c97b9163c173b1e97dd49b785cb49740bc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-34ea63c4c449f39f30ca684e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2888}
{"after": {"end": 31, "start": 0, "text": "Rezafungine (R) (N = 115) n (%)", "truncated": false}, "after_length": 31, "after_sha256": "fceaad8083f77bed8389985022c00b17fe66187d0d216384201182d6f65d0409", "annex": "I", "before": {"end": 30, "start": 0, "text": "Rezafungine (R) (N = 93) n (%)", "truncated": false}, "before_length": 30, "before_sha256": "a075a45d19ae622e77bb6a97408348f7dae2880ccbef6004201d8e49c493b7cf", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 21, "before_end": 23, "before_start": 21, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-350b5fedd8f613ac9f535c01", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 292}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma SIA", "truncated": false}, "after_length": 19, "after_sha256": "6da5006887c3e11cf19ecbe52bdc7a386838e93f6e63f315e575cb7df7747f15", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-353318de9b42d65df61a58c5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2633}
{"after": {"end": 9, "start": 0, "text": "Slovenija", "truncated": false}, "after_length": 9, "after_sha256": "fa267dd198bd52b588eff3ae1ccd7c7ea1ac67b4d621fd44e50742c91809cac3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-35455eed5aefc07a546667e8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2591}
{"after": {"end": 22, "start": 0, "text": "Tel: + 420 221 016 111", "truncated": false}, "after_length": 22, "after_sha256": "4d518854d9706e629e406bc93cfad10898d14ad223a3d403070c562115da215f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3547e1289abcfc20b37287d6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3185}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-356eb57c78ed468b4cb4e73c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2503}
{"after": {"end": 27, "start": 0, "text": "Bristol-Myers Squibb S.r.l.", "truncated": false}, "after_length": 27, "after_sha256": "f08fe5c808135fbbe673c4341ecaf78ddf1d45b6db60dc8f7534b838f176c63e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-357d7dd0ff4db4baa4b58586", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3284}
{"after": {"end": 311, "start": 0, "text": "Niraparib is an inhibitor of MATE1 and -2K in vitro. Plasma concentrations of metformin may increase when concomitantly administered with niraparib. Close monitoring of glycaemia is recommended when starting or stopping niraparib in patients receiving metformin. A dose adjustment of metformin may be necessary.", "truncated": false}, "after_length": 311, "after_sha256": "0a72db82d9a4938ca1e4a3f878258b386b15fd5aeda14b997062c194046fd31a", "annex": "I", "before": {"end": 239, "start": 0, "text": "Niraparib is an inhibitor of MATE1 and -2 with IC50 of 0.18 µM and ≤0.14 µM, respectively. Increased plasma concentrations of co-administered medicinal products that are substrates of these transporters (e.g. metformin) cannot be excluded.", "truncated": false}, "before_length": 239, "before_sha256": "00f31228d04e7b6cd97793fc9684b4c70242fe9aca1150e425865dda6bc4b70f", "change_kind": "content", "change_operations": [{"after_end": 42, "after_start": 41, "before_end": 41, "before_start": 41, "kind": "insert"}, {"after_end": 47, "after_start": 43, "before_end": 43, "before_start": 42, "kind": "replace"}, {"after_end": 50, "after_start": 49, "before_end": 52, "before_start": 45, "kind": "replace"}, {"after_end": 51, "after_start": 51, "before_end": 89, "before_start": 53, "kind": "delete"}, {"after_end": 54, "after_start": 53, "before_end": 102, "before_start": 91, "kind": "replace"}, {"after_end": 106, "after_start": 78, "before_end": 126, "before_start": 126, "kind": "insert"}, {"after_end": 120, "after_start": 108, "before_end": 129, "before_start": 128, "kind": "replace"}, {"after_end": 155, "after_start": 133, "before_end": 142, "before_start": 142, "kind": "insert"}, {"after_end": 158, "after_start": 156, "before_end": 145, "before_start": 143, "kind": "replace"}, {"after_end": 162, "after_start": 159, "before_end": 147, "before_start": 146, "kind": "replace"}, {"after_end": 165, "after_start": 164, "before_end": 180, "before_start": 149, "kind": "replace"}, {"after_end": 195, "after_start": 169, "before_end": 185, "before_start": 184, "kind": "replace"}, {"after_end": 199, "after_start": 197, "before_end": 187, "before_start": 187, "kind": "insert"}, {"after_end": 207, "after_start": 200, "before_end": 189, "before_start": 188, "kind": "replace"}, {"after_end": 212, "after_start": 208, "before_end": 190, "before_start": 190, "kind": "insert"}, {"after_end": 222, "after_start": 213, "before_end": 191, "before_start": 191, "kind": "insert"}, {"after_end": 231, "after_start": 224, "before_end": 193, "before_start": 193, "kind": "insert"}, {"after_end": 233, "after_start": 232, "before_end": 195, "before_start": 194, "kind": "replace"}, {"after_end": 235, "after_start": 234, "before_end": 198, "before_start": 196, "kind": "replace"}, {"after_end": 237, "after_start": 236, "before_end": 199, "before_start": 199, "kind": "insert"}, {"after_end": 240, "after_start": 238, "before_end": 201, "before_start": 200, "kind": "replace"}, {"after_end": 243, "after_start": 242, "before_end": 204, "before_start": 203, "kind": "replace"}, {"after_end": 250, "after_start": 244, "before_end": 206, "before_start": 205, "kind": "replace"}, {"after_end": 251, "after_start": 251, "before_end": 208, "before_start": 207, "kind": "delete"}, {"after_end": 262, "after_start": 261, "before_end": 219, "before_start": 218, "kind": "replace"}, {"after_end": 270, "after_start": 263, "before_end": 221, "before_start": 220, "kind": "replace"}, {"after_end": 278, "after_start": 271, "before_end": 222, "before_start": 222, "kind": "insert"}, {"after_end": 292, "after_start": 279, "before_end": 223, "before_start": 223, "kind": "insert"}, {"after_end": 297, "after_start": 293, "before_end": 226, "before_start": 224, "kind": "replace"}, {"after_end": 302, "after_start": 301, "before_end": 230, "before_start": 230, "kind": "insert"}, {"after_end": 303, "after_start": 303, "before_end": 232, "before_start": 231, "kind": "delete"}, {"after_end": 304, "after_start": 304, "before_end": 236, "before_start": 233, "kind": "delete"}, {"after_end": 310, "after_start": 305, "before_end": 238, "before_start": 237, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 108, "chars_inserted": 180}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-357dfba91e9d30c88fe2bb21", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 264}
{"after": {"end": 23, "start": 0, "text": "België/Belgique/Belgien", "truncated": false}, "after_length": 23, "after_sha256": "4646bb1028d1508f87afd915f6c144536b764795c7df5858f4eaa35881bb797d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3597de660d26d16e6f41c7a8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2798}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "A. Hypoglycaemia", "truncated": false}, "before_length": 16, "before_sha256": "d70ff87136367829657fc920443f274a49bb66f3f82b6a79ad6fa5d5ca0ca80d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-35c2d88a819cb8b8b469546c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9385}
{"after": {"end": 34, "start": 0, "text": "medinfo.estonia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "e47c511a7367c6c7b4b4d54b0660bf70577f18e3fe0bcef938db762d7981dd1e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-35c7d24f00d68b5d0f7676ff", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2539}
{"after": {"end": 9, "start": 0, "text": "57 (48.7)", "truncated": false}, "after_length": 9, "after_sha256": "135c88558441cdee2f62dfb9d5006f12f87b4938efbc5307ab77ea3c5ee4cba4", "annex": "I", "before": {"end": 10, "start": 0, "text": "(49 (52.1)", "truncated": false}, "before_length": 10, "before_sha256": "7a0d3abe6cf4eaabf7a365728cd789d697d947bfba4508aa14f70d2ccad0c0d9", "change_kind": "content", "change_operations": [{"after_end": 3, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}, {"after_end": 6, "after_start": 5, "before_end": 7, "before_start": 2, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 9, "before_start": 8, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-362ec9dca756383dfca0f1d0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 299}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 58, "start": 0, "text": "11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "truncated": false}, "before_length": 58, "before_sha256": "f673fc8d85353a41392579def66f2174386940ef53d65631a983cd19732f9497", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 58, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 58, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3654f2072f87c2656ba0102a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4738}
{"after": {"end": 19, "start": 0, "text": "Tel: + 356 23976333", "truncated": false}, "after_length": 19, "after_sha256": "f8bfa43651e282e3e99ee42fa339e414e57dea721306efb985d46dcd3b4656c4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3668529e3f229c0d5298ab13", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2835}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 32, "start": 0, "text": "2. STATEMENT OF ACTIVE SUBSTANCE", "truncated": false}, "before_length": 32, "before_sha256": "9e169b908eb1d9fc1ed6e233dacad6af86b2c8a043fa81faef38a02382a9c8e3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3671c34c55e9e2439276f5b3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4791}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 22, "start": 0, "text": "Red iron oxide (E 172)", "truncated": false}, "before_length": 22, "before_sha256": "58e9290a6bd1351d630b61c62baab73008f375070e4ffb0c93cdbb69e144d81d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3674785917a22362ee485a74", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1357}
{"after": {"end": 33, "start": 0, "text": "medicalinformation.italia@bms.com", "truncated": false}, "after_length": 33, "after_sha256": "7fa3fd14eb9bcefdd405cdea61ff603a046dbbe0f3ada36eb2fd672402b4e33b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3680d537b3828d34f10feb7d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2609}
{"after": {"end": 6, "start": 0, "text": "Anémie", "truncated": false}, "after_length": 6, "after_sha256": "b6ab55c14cd437a835ac6dfc0957296bc885f42a1da4c36192c5687c655e98a7", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-36abcd0a9ab0a90454811bad", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.8", "section_type": "adverse_reactions", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 189}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 80, "start": 0, "text": "Inhibition of CYPs (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4)", "truncated": false}, "before_length": 80, "before_sha256": "f4e3984e34e4abd129d4111bc2a0654aa6e8d3e9311b08ee836a8d5faaa34241", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 80, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 80, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-36b34795b104f0efdf91aa56", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1111}
{"after": {"end": 21, "start": 0, "text": "Tel: + 385 1 2078 500", "truncated": false}, "after_length": 21, "after_sha256": "d2c4badf1d52e4fa4d9876ca25a250b52d706e4108687e5034656c1b419f6ddc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-36b5254c27a6645128a877a8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2890}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "Humalog Tempo Pen", "truncated": false}, "before_length": 17, "before_sha256": "328b8ad146aa9789b611fca56a42e321b79e5aecd24d0cc297eae30f99fae229", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-36bb09fb898f1c55df3242f5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4665}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "8055 Graz", "truncated": false}, "before_length": 9, "before_sha256": "765f51a390983de920b9a586c4589caab5f6398576531f438fd8301227c9ccb2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-36ebbfc82dddd42d8a3c396b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3164}
{"after": {"end": 30, "start": 0, "text": "Bristol-Myers Squibb Norway AS", "truncated": false}, "after_length": 30, "after_sha256": "4d312e57cb670ef0ce508bd73d4efdf4538b212e677408590a67036924ff5e9b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 30, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 30}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3701bd4cc48de3c95f7a0413", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2542}
{"after": {"end": 22, "start": 0, "text": "Tlf.: + 45 36 35 91 00", "truncated": false}, "after_length": 22, "after_sha256": "ee5cfc7acaf9dfe8868ac7e8cd8079d0cb8f85922089533a08d33e515be7aea6", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Tlf: + 45 36 35 91 00", "truncated": false}, "before_length": 21, "before_sha256": "18d8cf6a57f2048255a4474230a78ae1192c8bd63af3a4aa0c409cccfeafcba9", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-37b757578847b0cf46481f6c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2507}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma s.r.o.", "truncated": false}, "after_length": 22, "after_sha256": "e26ccdddfb0893074547931bd19474d6541a45958e27c35b776e8f18abf48a36", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-37f14b2104e928aff8ada150", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3279}
{"after": {"end": 26, "start": 0, "text": "BristolMyers Squibb S.r.l.", "truncated": false}, "after_length": 26, "after_sha256": "f44e170b34d2109b4908eb0ce3e17a4d6452169164e3f8ef3869b0c2498f1974", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-381ed2cc1517927ff08e4938", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2613}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 589, "start": 0, "text": "If your blood sugar is low (mild hypoglycaemia), eat glucose tablets, sugar or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your doctor has advised you and have some rest. This will often get you over mild hypoglycaemia or a minor insulin overdose. If you get worse and your breathing is shallow and your skin gets pale, tell your doctor at once. A glucagon injection can treat quite severe hypoglycaemia. Eat glucose or sugar after the glucagon injection. If you do not respond to glucagon, you will have to go to hospital. Ask your doctor to tell you about glucagon.", "truncated": false}, "before_length": 589, "before_sha256": "74d777ced143b1250fc90f90aa9599dfb4a9ea959eb64f1b1c60727bc488ee3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 589, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 589, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-382821830d1fe80c6c8c18fb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9345}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Tel: +44 (0) 1844 347333", "truncated": false}, "before_length": 24, "before_sha256": "3e66f974ec29433df45716bf73117a6d11dd49271609c4d153b59d502de5d353", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-382ecb94afae5856bdcc6977", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2139}
{"after": {"end": 24, "start": 0, "text": "medischeafdeling@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "3815a916e71fc353b4410b37e0a85dede1ac350e08b8ab1461a12a1b0da71bb9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3837682cfe5436cefd326b8d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2850}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 57, "start": 0, "text": "Each Tempo Pen delivers 1 – 60 units in steps of 1 units.", "truncated": false}, "before_length": 57, "before_sha256": "32c12a4678bfcf080d79cce841b6729df59a1500c9732df8dce1560eec875577", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 57, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 57, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-384e46d78a1dbe61721b72d5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9213}
{"after": {"end": 6, "start": 0, "text": "Ελλάδα", "truncated": false}, "after_length": 6, "after_sha256": "e6f7401e81c9b2a3c1f082d0c9a0183287a6f7b4ecded4f4d3ac5e1efefa9ce5", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-387f2ce3e1c296fbc2cf884e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2858}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 310, "start": 0, "text": "Your ability to concentrate and react may be reduced if you have hypoglycaemia. Please keep this possible problem in mind in all situations where you might put yourself and others at risk (e.g. driving a car or operating machinery). You should contact your doctor about the advisability of driving if you have:", "truncated": false}, "before_length": 310, "before_sha256": "54635650eafd351c654ad51004a2b3ab4f3f9a0f37e4050bbcb7005dc7ca65e1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 310, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 310, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-38818477190ef9fd44c6a897", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9294}
{"after": {"end": 13, "start": 0, "text": "Suomi/Finland", "truncated": false}, "after_length": 13, "after_sha256": "5bea43a11ae0d0e9706443422f6eb9b6107624ceb18d16ec89005011c62699dd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 13, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-38828b826d7bc594e41da0cf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3291}
{"after": {"end": 21, "start": 0, "text": "Tel: + 386 1 2355 100", "truncated": false}, "after_length": 21, "after_sha256": "dac6f0be4f23d749d801d499c013eab48028544c9f89af72365ef4fdc2e94efc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-389480816a17a34ee9c2a6ea", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3270}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 46, "start": 0, "text": "• difficulty in breathing • heart beating fast", "truncated": false}, "before_length": 46, "before_sha256": "6365bd50102ee3cb4a1c55122c515ea1b5f959fec776f2271baf9c083e10bde7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 46, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 46, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3957d46bfec7656a233f6ac8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9369}
{"after": {"end": 27, "start": 0, "text": "Bristol-Myers Squibb S.r.l.", "truncated": false}, "after_length": 27, "after_sha256": "f08fe5c808135fbbe673c4341ecaf78ddf1d45b6db60dc8f7534b838f176c63e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-39744cfce731367b5d9eaab1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2919}
{"after": {"end": 35, "start": 0, "text": "Oy BristolMyers Squibb (Finland) Ab", "truncated": false}, "after_length": 35, "after_sha256": "ec1e651ed7eac79d1bf600f594e4c106251ee62cf1c76346a86d003d9870c3c9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-39a416ce0fa42db3541c7968", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3292}
{"after": {"end": 24, "start": 0, "text": "medischeafdeling@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "3815a916e71fc353b4410b37e0a85dede1ac350e08b8ab1461a12a1b0da71bb9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-39d342faace2090eda28cf57", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3211}
{"after": {"end": 23, "start": 0, "text": "medinfo.finland@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "7029ed3ac062d546eacefe48107a23caa5547edd30d7c30335f744035bfb4ec6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-39dfcd72cb5cc2d41c037c71", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2930}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "5 sec5 sec", "truncated": false}, "before_length": 10, "before_sha256": "46323d1f1637fae744c91c719fa3e43a9947654306b5000bde6441bd233c8780", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-39f61d8b9bc4cc52e502e114", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9748}
{"after": {"end": 36, "start": 0, "text": "Bristol-Myers Squibb GmbH & Co. KGaA", "truncated": false}, "after_length": 36, "after_sha256": "ad8ff4e5d779e654815cece3aff395170ae92937b281de17f06549278ae2dc0d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3a059fbeaafed94d5890942f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2839}
{"after": {"end": 195, "start": 0, "text": "This medicinal product contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucosegalactose malabsorption should not take this medicine.", "truncated": false}, "after_length": 195, "after_sha256": "837a8e5b9e6bd5708c43d2833edd4a231036825fb5d12e5804e8ebbeb6ca34a9", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 195, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 195}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3a133f5e244e120751a289aa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1010}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 3, "start": 0, "text": "EXP", "truncated": false}, "before_length": 3, "before_sha256": "06a1ad637e7f4fbad56e29164490368f0526f429ee39a31dd1180c3722af1e4e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3a9c4551245364485087722d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4626}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma UAB", "truncated": false}, "after_length": 19, "after_sha256": "0fa5997c653449c2ebe445618eaeedc027096662095bc4bf48a609ec757f79cd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3aafb96158de90d88ab1e020", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2492}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "ELI LILLY ČR, s.r.o.", "truncated": false}, "before_length": 20, "before_sha256": "bb0cd2ffe80112c3cd0115202056b0c5b2cbf50b8201aa419dcc2e1fa52bd8a4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3abcc8e60a121806ed624fdc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9471}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 18, "start": 0, "text": "Preparing your Pen", "truncated": false}, "before_length": 18, "before_sha256": "7f1ec05ff71b48d84c486ac36c551d88ef30ced72160e94d971c739d0cc808b3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 18, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 18, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3b36b742ff6b17cb826f5b12", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9628}
{"after": {"end": 26, "start": 0, "text": "BristolMyers Squibb GesmbH", "truncated": false}, "after_length": 26, "after_sha256": "45a0d9cd544a5f19296a3fa84647df081ac4cb2a9c4935681d9f34e18f6803a7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3b5ca05ca43028ed6776f3c4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2558}
{"after": {"end": 123, "start": 0, "text": "For more information, see the European Medicines Agency’s website: https://www.ema.europa.eu/en/medicines/human/EPAR/cialis", "truncated": false}, "after_length": 123, "after_sha256": "536da86f7ba2ac5f7efe293fca21af259edfbe846c7f2f78e61950ce88fe8aec", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 123, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 123}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3b857ff18a935ff152cc2241", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2}
{"after": {"end": 23, "start": 0, "text": "België/Belgique/Belgien", "truncated": false}, "after_length": 23, "after_sha256": "4646bb1028d1508f87afd915f6c144536b764795c7df5858f4eaa35881bb797d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3b9195a3a67dedf2cd08a376", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2492}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb A.E.", "truncated": false}, "after_length": 25, "after_sha256": "43a0521fcec8db403e6fb060ae3b147a3107583a8df9b3a28208c9a4bd0d8fba", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3b99b8e2b70fb768ce27a8ad", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3224}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Tel: + 43-(0) 1 711 780", "truncated": false}, "before_length": 23, "before_sha256": "3ceb80b8eca6a0b88f3c5b1419974b645618595baa49cba50ac59c1f96396d66", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3ba20d610e61e8114327876e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9504}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Eli Lilly Norge A.S.", "truncated": false}, "before_length": 20, "before_sha256": "d3b8811c527971a600d1a9a71a79213bff532e2309f18da110357fd01e114225", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3ba5cac3a09660e3d0133cfc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9496}
{"after": {"end": 25, "start": 0, "text": "Tel: + 40 (0)21 272 16 19", "truncated": false}, "after_length": 25, "after_sha256": "502a8c5996880f462bf382bf033fc5a4e73041db59d3a638fd11052ee7eef1a8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3bb69beea3c64711a519fca6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2583}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 191, "start": 0, "text": "Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.", "truncated": false}, "before_length": 191, "before_sha256": "034fbda5bf2ac345bb3f5dcb82eeaf09f34d698035a90deebbe22271b71f4833", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 191, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 191, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3bd601d283ef15255bd6e6dc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9433}
{"after": {"end": 21, "start": 0, "text": "Tel: + 39 06 50 39 61", "truncated": false}, "after_length": 21, "after_sha256": "6ac0b442dd41c62cad589a5c348c5781354f651196f78692c420568d264ff7f0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3bf1fc9af503aa260b360fad", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2924}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 88, "start": 0, "text": "• Wipe the skin with a swab, and let the injection site dry before you inject your dose.", "truncated": false}, "before_length": 88, "before_sha256": "cd74c0ef09ea3f6dd936690ba39e4448c6c5ce1bda4907e4d070be6c118b2662", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 88, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3c540cfbadd2db9159ef8158", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9740}
{"after": {"end": 30, "start": 0, "text": "Comprimé pelliculé (comprimé).", "truncated": false}, "after_length": 30, "after_sha256": "20275e8d37bde72ea83faede281a3c423bfbe6f8287ea65e275bfb1c6e3104f9", "annex": "I", "before": {"end": 14, "start": 0, "text": "Capsule molle.", "truncated": false}, "before_length": 14, "before_sha256": "66ce2f79525b7f35af7c82f28ced830087b71edc78c7428ffa44da2ca36d350b", "change_kind": "content", "change_operations": [{"after_end": 3, "after_start": 1, "before_end": 2, "before_start": 1, "kind": "replace"}, {"after_end": 15, "after_start": 4, "before_end": 4, "before_start": 3, "kind": "replace"}, {"after_end": 18, "after_start": 17, "before_end": 7, "before_start": 6, "kind": "replace"}, {"after_end": 22, "after_start": 19, "before_end": 8, "before_start": 8, "kind": "insert"}, {"after_end": 29, "after_start": 23, "before_end": 13, "before_start": 9, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3c60c54fa7fb6571c76c66eb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "3", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1218}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 9, "start": 0, "text": "Allemagne", "truncated": false}, "before_length": 9, "before_sha256": "6b58dbd6a994339b48d8446597da22402857b3409613459c7e3a293788fbe66a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3c8a132b877757986017a7a8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1674}
{"after": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l'Agence européenne des médicaments : https://www.ema.europa.eu", "truncated": false}, "after_length": 150, "after_sha256": "7a57f3971964eb7bea4ed295986ca64649117ce6b1ea800c91cdf0ed4877b711", "annex": "III", "before": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l'Agence européenne des médicaments : http://www.ema.europa.eu.", "truncated": false}, "before_length": 150, "before_sha256": "6272fb3d1bf208f727e3ec8521cb6d15c24e42031d06a96b3c4d43ff5b48aa11", "change_kind": "technical", "change_operations": [{"after_end": 130, "after_start": 129, "before_end": 129, "before_start": 129, "kind": "insert"}, {"after_end": 150, "after_start": 150, "before_end": 150, "before_start": 149, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3ca0880ce9b6b6753f0d5d94", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3465}
{"after": {"end": 9, "start": 0, "text": "Slovenija", "truncated": false}, "after_length": 9, "after_sha256": "fa267dd198bd52b588eff3ae1ccd7c7ea1ac67b4d621fd44e50742c91809cac3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3cebbfcb793bda2f4016827e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2903}
{"after": {"end": 99, "start": 0, "text": "Humalog 100 units/ml is available in vials if administration of intravenous injection is necessary.", "truncated": false}, "after_length": 99, "after_sha256": "1381533722021721f56364e83867f11c164c4d57fe6b1ca36facea084d51c5c3", "annex": "I", "before": {"end": 100, "start": 0, "text": "Humalog 100 units /ml is available in vials if administration of intravenous injection is necessary.", "truncated": false}, "before_length": 100, "before_sha256": "02b8d2b58e39f1bf27db32e769c596d7efe45bd18b0c15fb24e56423a94d1b17", "change_kind": "content", "change_operations": [{"after_end": 17, "after_start": 17, "before_end": 18, "before_start": 17, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3d2f7e4420c2560d290f6bab", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 133}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Cartridge Holder", "truncated": false}, "before_length": 16, "before_sha256": "2647f05390d9f5b7750fae29b53e61b3ff5d0c9ffa54c216a29bd5a5b9f514a3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3d3fb5664682d5856533c848", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9587}
{"after": {"end": 401, "start": 0, "text": "Following a singledose administration of 300 mg niraparib under fasting conditions, niraparib was measurable in plasma within 30 minutes and the mean peak plasma concentration (Cmax) for niraparib was reached within 3 to 5 hours (ranged 508-875 ng/mL across studies). Following multiple oral doses of niraparib from 30 mg to 400 mg once daily, accumulation of niraparib was approximately 2 to 3 folds.", "truncated": false}, "after_length": 401, "after_sha256": "b47a1792b4cbbedb792fc47c4196d70540999fd384e8643013732cae41d4c0d7", "annex": "I", "before": {"end": 386, "start": 0, "text": "Following a singledose administration of 300 mg niraparib under fasting conditions, niraparib was measurable in plasma within 30 minutes and the mean peak plasma concentration (Cmax) for niraparib was reached in about 3 hours [804 ng/mL (% CV: 50.2%)]. Following multiple oral doses of niraparib from 30 mg to 400 mg once daily, accumulation of niraparib was approximately 2 to 3 folds.", "truncated": false}, "before_length": 386, "before_sha256": "7542950a34acfc3e089ccabd7db9666db4cca022e2570aa6e344aa6b1deb441a", "change_kind": "content", "change_operations": [{"after_end": 213, "after_start": 209, "before_end": 209, "before_start": 209, "kind": "insert"}, {"after_end": 219, "after_start": 216, "before_end": 214, "before_start": 212, "kind": "replace"}, {"after_end": 220, "after_start": 220, "before_end": 217, "before_start": 215, "kind": "delete"}, {"after_end": 222, "after_start": 221, "before_end": 219, "before_start": 218, "kind": "replace"}, {"after_end": 239, "after_start": 229, "before_end": 227, "before_start": 226, "kind": "replace"}, {"after_end": 244, "after_start": 240, "before_end": 230, "before_start": 228, "kind": "replace"}, {"after_end": 257, "after_start": 251, "before_end": 239, "before_start": 237, "kind": "replace"}, {"after_end": 265, "after_start": 258, "before_end": 249, "before_start": 240, "kind": "replace"}, {"after_end": 266, "after_start": 266, "before_end": 251, "before_start": 250, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3d52585b9be29aafe6ebb544", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1622}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tel: + 39- 055 42571", "truncated": false}, "before_length": 20, "before_sha256": "77ae57a88eb1db4872e58777d28cbe323ad9b9979edbf4a408f33a3464f9dba6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3d8b685be621105814a61bbc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9544}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 73, "start": 0, "text": "Humalog 100 units/ml Tempo Pen solution for injection in a pre-filled pen", "truncated": false}, "before_length": 73, "before_sha256": "51230eb86540e3f2989a8d72fae57656b7c456fc2ba7375eaa3efbd8b0d89f0f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 73, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 73, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3da1dffcf3ad2852d24c80b0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4688}
{"after": {"end": 358, "start": 0, "text": "Efficacy data for tafamidis 61 mg are not available as this formulation was not evaluated in the doubleblind, placebocontrolled, randomised phase 3 study. The relative bioavailability of tafamidis 61 mg is similar to tafamidis meglumine 80 mg at steadystate (see section 5.2). The relative bioavailability of the 61 mg tablet is similar to the 61 mg capsule.", "truncated": false}, "after_length": 358, "after_sha256": "b85673ae64f2394f181ca53bf3c3ea6b5b4c67e2fa0810eccd84d0a490f3e514", "annex": "I", "before": {"end": 276, "start": 0, "text": "Efficacy data for tafamidis 61 mg are not available as this formulation was not evaluated in the doubleblind, placebocontrolled, randomised phase 3 study. The relative bioavailability of tafamidis 61 mg is similar to tafamidis meglumine 80 mg at steadystate (see section 5.2).", "truncated": false}, "before_length": 276, "before_sha256": "a1521dac14d5b152039f81da5f2c7ea9a346705c58d69cf27e1e8f2339ce4f41", "change_kind": "content", "change_operations": [{"after_end": 358, "after_start": 276, "before_end": 276, "before_start": 276, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 82}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3db52f925c217566591b26b7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1270}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 3, "start": 0, "text": "Lot", "truncated": false}, "before_length": 3, "before_sha256": "23ea1b1beb5529f4f4cbe47df67ef01587f29229a112e020eff530d5033fbcff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3dcffa9698ae0d8911dcc60d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4851}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 9, "start": 0, "text": "Tempo Pen", "truncated": false}, "before_length": 9, "before_sha256": "bbaa539d8be51b8c4a68814d8f14baf6584114fa65db0d19590da5646f182385", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3ddc4637140b45c6a32701ee", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.5", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 441}
{"after": {"end": 7, "start": 0, "text": "Lietuva", "truncated": false}, "after_length": 7, "after_sha256": "5109820f748796128b8bafd3806d05511bc89ad77fc3cda960facf37a639bc7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3e34e71d1fe8fb5530ace816", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2803}
{"after": {"end": 35, "start": 0, "text": "medinfo.bulgaria@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7905c486c458386eb1a26649ec5c649de6cbd59270b3b28715f74ada40ed9166", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3e935c95c0a047d9bf085d25", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2505}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 237, "start": 0, "text": "You should also tell your doctor, pharmacist or diabetes nurse if you are planning to go abroad. The time difference between countries may mean that you have to have your injections and meals at different times from when you are at home.", "truncated": false}, "before_length": 237, "before_sha256": "fb802656ac6e87907c73a49451644d40c51041f5150c3fcda577cf6ef7f17b4b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 237, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 237, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3e9b4db43f102d972ed940eb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9259}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 32, "start": 0, "text": "This leaflet was last revised in", "truncated": false}, "before_length": 32, "before_sha256": "4bafa791d649e51df13e2b5f204437c9d72920aee9439698c1304cf214da3cde", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3ea89e601f4557f25472ce77", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9563}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 72, "start": 0, "text": "Grounds for the variation to the terms of the Marketing Authorisation(s)", "truncated": false}, "before_length": 72, "before_sha256": "59c5b7c6be2c1cdd2a3b5bd48ba2e514fce918d283a5223bfeb2942763bc962e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 72, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 72, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3ec03879f76fbc22851952e7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3464}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "Suomi/Finland", "truncated": false}, "before_length": 13, "before_sha256": "5bea43a11ae0d0e9706443422f6eb9b6107624ceb18d16ec89005011c62699dd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3ee493882bbc4aef3229ea74", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9546}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "4. PHARMACEUTICAL FORM AND CONTENTS", "truncated": false}, "before_length": 35, "before_sha256": "103cfd4c3e9c7bb9b46998faaa21a391b50f062b5f82b4f79f73e1aa06fb67fc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3eed2f6b1f3b0f94cb31d7a0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4603}
{"after": {"end": 9, "start": 0, "text": "(95 % CI)", "truncated": false}, "after_length": 9, "after_sha256": "edc362e94921b5846e4c87af3470fcdbf6e65ff6b9dececca1a640357371f29c", "annex": "I", "before": {"end": 13, "start": 0, "text": "(95 % CI) [1]", "truncated": false}, "before_length": 13, "before_sha256": "469a13c15c10e5873d1240a914c9b41a97c2056bd4c5475739ef05828b260522", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 9, "before_end": 13, "before_start": 9, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3f08a2e0eb56f8322e98d95e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 292}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 7, "start": 0, "text": "09/2025", "truncated": false}, "before_length": 7, "before_sha256": "af408ea4193825b319dee21ce3d430242b25bc7610193b67571de6a795d9d670", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3f20ba32ceed382ac403553c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "Firazyr 30 mg solution for injection in prefilled syringe", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 651}
{"after": {"end": 5, "start": 0, "text": "Taani", "truncated": false}, "after_length": 5, "after_sha256": "b71f1b4c32927bd5f0694b003e2d1c67809beb4e798f042c99d04d09792a3a6f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3f673d068193694d94245a94", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1762}
{"after": {"end": 26, "start": 0, "text": "Bristol-Myers Squibb, S.A.", "truncated": false}, "after_length": 26, "after_sha256": "bcb96132907136675c68fa09511b755bbd39c0ca74a2983c8bbb77830f8f61b2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3fdd02f37aa135fc74084f80", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3234}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Astellas Ireland Co. Ltd.", "truncated": false}, "before_length": 25, "before_sha256": "1d98a06d2f724f3f69491c40480991ee287d2e3806d862b6ab226d0b620c6885", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3fdf539e3950e6727044d0f0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2003}
{"after": {"end": 21, "start": 0, "text": "Tel: + 39 06 50 39 61", "truncated": false}, "after_length": 21, "after_sha256": "6ac0b442dd41c62cad589a5c348c5781354f651196f78692c420568d264ff7f0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-3fedb2b6a733bb088f630678", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3285}
{"after": {"end": 38, "start": 0, "text": "Tel: 0800 0752002 (+ 49 89 121 42 350)", "truncated": false}, "after_length": 38, "after_sha256": "a6e565b385c2fd58348adaaec0d48f14b092e8ceadc07f5c2358d6c3e3ac6b0f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4005abe3d9b469c26132cb87", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3205}
{"after": {"end": 16, "start": 0, "text": "A.M. Mangion Ltd", "truncated": false}, "after_length": 16, "after_sha256": "24f7ac6ac947e8ef3e36c6f6c1f51219647e1477dfe330121521ec39faf6cb0c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-400b67fe12e706d9808c8f62", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2834}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: + 353 18711600", "truncated": false}, "before_length": 19, "before_sha256": "f39469e1bbd519f10406ae27e104b0e2fb101791df45c4e53cc539ee02b84821", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-401016243cd694ed60edb728", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3697}
{"after": {"end": 265, "start": 0, "text": "If vomiting occurs after dosing, and the intact Vyndaqel tablet is identified, then an additional dose of Vyndaqel should be administered if possible. If no tablet is identified, then no additional dose is necessary, with resumption of dosing the next day as usual.", "truncated": false}, "after_length": 265, "after_sha256": "9e7943cf3a9cac8ee92c43ad61e8effecc960a52b1e1cac492aeebf0f3400606", "annex": "I", "before": {"end": 267, "start": 0, "text": "If vomiting occurs after dosing, and the intact Vyndaqel capsule is identified, then an additional dose of Vyndaqel should be administered if possible. If no capsule is identified, then no additional dose is necessary, with resumption of dosing the next day as usual.", "truncated": false}, "before_length": 267, "before_sha256": "9717f2a08ee46b956dd906c13d9df1676e7307e8e4d4e41624fd6ab0817f5f52", "change_kind": "content", "change_operations": [{"after_end": 58, "after_start": 57, "before_end": 58, "before_start": 57, "kind": "replace"}, {"after_end": 60, "after_start": 59, "before_end": 62, "before_start": 59, "kind": "replace"}, {"after_end": 63, "after_start": 62, "before_end": 64, "before_start": 64, "kind": "insert"}, {"after_end": 158, "after_start": 157, "before_end": 159, "before_start": 158, "kind": "replace"}, {"after_end": 160, "after_start": 159, "before_end": 163, "before_start": 160, "kind": "replace"}, {"after_end": 163, "after_start": 162, "before_end": 165, "before_start": 165, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-401478c8313428b5806b6266", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 965}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Tel: + 353-(0) 1 661 4377", "truncated": false}, "before_length": 25, "before_sha256": "48fde288146f4033a2172164570180a8f875f4e361fcf85a8e43ff77834511cc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-403eba33ce0a10bbd24357a1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2538}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 36, "start": 0, "text": "thyroid hormone replacement therapy,", "truncated": false}, "before_length": 36, "before_sha256": "86b0ff977d235189ea31f43065fbc89f7cc762c1fc9723c1498042dbc4301778", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 36, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 36, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-403f6e7ecfbef16243e59723", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9272}
{"after": {"end": 35, "start": 0, "text": "BristolMyers Squibb GmbH & Co. KGaA", "truncated": false}, "after_length": 35, "after_sha256": "35ff9638226ceee7106ecbdfa1f34c1363018c276e5f126171bb1c80c9dbf877", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-405effefa63fb2e6e3d988b3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3207}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-407c1fe160675d44b125c994", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3254}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "Hafnerstraße 36", "truncated": false}, "before_length": 15, "before_sha256": "2fcce2f98396d52bbfd5728e1a018b4f5e6a7c25edffb18410df25f808883c4f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-40d99a5350a9466c69f591e3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2744}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 44, "start": 0, "text": "Pack of 30 x 1 soft capsules – WITH BLUE BOX", "truncated": false}, "before_length": 44, "before_sha256": "73a4c3326645a58c857853790120a91f580a5439b4a3e2459c9cbf6b07c39cd3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 44, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 44, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-40f19e74b9512010d57c349d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2277}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "First wash your hands.", "truncated": false}, "before_length": 22, "before_sha256": "d30efe586aa48349bec3b98a27e02a28ad7604d314895091a39046e42c5cb2b4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-412dc8944e7ab463dabd568f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9316}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-41673cc25ffde7b07edda934", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3409}
{"after": {"end": 22, "start": 0, "text": "Tel: + 34 91 456 53 00", "truncated": false}, "after_length": 22, "after_sha256": "c59845f4e2b4a96548adda4dbf16851ff33a89874560e491da6b05aee33b646a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4190516bde9c6c321c201a27", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2870}
{"after": {"end": 7, "start": 0, "text": "România", "truncated": false}, "after_length": 7, "after_sha256": "633e193d7e05828a893d02a6273755ed0d417cc14abf5ecfc2b6328c71ddcc7e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-41a0391e7a865b87a0764154", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2587}
{"after": {"end": 40, "start": 0, "text": "Do not store above 25 °C. Do not freeze.", "truncated": false}, "after_length": 40, "after_sha256": "5b83cffac35f0dd891ac8dbf4d0a5bc16ebc5aa87f24a3e3fc70a4c0901c566b", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Do not store above 25ºC. Do not freeze.", "truncated": false}, "before_length": 39, "before_sha256": "0048cc2e3482eed0ec1e9d6a6ad3ff466985a7aaf27e8a96ed008491dff61b0e", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 21, "before_end": 22, "before_start": 21, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-41aa8db2339d9a980efa6c64", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1029}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "Skin changes at the injection site", "truncated": false}, "before_length": 34, "before_sha256": "9a3566bace11383cab033377b08cded1134f3c6c0f4f71b8e0b3083ac9c77535", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-41bb58f2f83b8cfd00e5679c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9264}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 88, "start": 0, "text": "Niraparib comme substrat des transporteurs d’efflux (P-gp, BCRP, BSEP, MRP2 et MATE 1/2)", "truncated": false}, "before_length": 88, "before_sha256": "ae7f06654a170f9eabe1e66a07ffddbe4992241c964cbc85208e9c3ae8ad6a3e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 88, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-41d1c661072443960054e13c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1132}
{"after": {"end": 27, "start": 0, "text": "informacja.medyczna@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "fd724a87ca0b5fd348792afb72bf17e76991a1b17ad813c04854601dd7b9576a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-41d2ab5a289cfecaefcfe898", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2880}
{"after": {"end": 23, "start": 0, "text": "medinfo.romania@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "9ae697b67f3c854a077ca894d99400f1de79e31bd9bf61321fc7c4030bf8a213", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-41f5dfe5689174e2a8891d10", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2590}
{"after": {"end": 12, "start": 0, "text": "Id-Danimarka", "truncated": false}, "after_length": 12, "after_sha256": "ac04b6efb22ef48cbffb5f129ff3db14dac1293a9618775a5e7a6cb07d57fc19", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-42475ca881395bc32079a8ce", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2049}
{"after": {"end": 6, "start": 0, "text": "Ελλάδα", "truncated": false}, "after_length": 6, "after_sha256": "e6f7401e81c9b2a3c1f082d0c9a0183287a6f7b4ecded4f4d3ac5e1efefa9ce5", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-42483db07eebdab0c3a7e600", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3226}
{"after": {"end": 22, "start": 0, "text": "Tel: + 421 2 20833 600", "truncated": false}, "after_length": 22, "after_sha256": "06545090f6b6777d6143e84f408247cee2424d81a40db0a2693eff093cfe9ec8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-42685c5f6eeba1e0cdb73db4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2609}
{"after": {"end": 20, "start": 0, "text": "Sími: + 354 535 7000", "truncated": false}, "after_length": 20, "after_sha256": "66fcdd056ccfbc5ba6d0c26580292977898106c90655c78208bc87c3d941892c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-42739faaf69e67d6cb4ba9cf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2598}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "2. METHOD OF ADMINISTRATION", "truncated": false}, "before_length": 27, "before_sha256": "f242390a222af8cd5516484a5dec4afb15474b37724481a26f0b4e550c411488", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-42815a49d7d0ba706221fa47", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4887}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 78, "start": 0, "text": "Inhibition des CYP (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 et CYP3A4)", "truncated": false}, "before_length": 78, "before_sha256": "196c71870b34b303fee071ff2b3f9be117b50cbdd0de57b2a547924e74f29851", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 78, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 78, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-42831bb2a0e63e95a98c7aea", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 257}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 49, "start": 0, "text": "• Do not try to change your dose while injecting.", "truncated": false}, "before_length": 49, "before_sha256": "8fe0bebfcda26223deb4597f7cfb247b7ca1b709e053f29f487089eb095c4116", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 49, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 49, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4287acac13f87e28810274b1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9735}
{"after": {"end": 264, "start": 0, "text": "In vitro, niraparib induces CYP1A2. Therefore, caution is recommended when niraparib is combined with active substances the metabolism of which is CYP1A2dependent and, notably, those having a narrow therapeutic range (e.g. clozapine, theophylline, and ropinirole).", "truncated": false}, "after_length": 264, "after_sha256": "ae1346f7a99aa9e111a3fda0f9608fe9ede359aeab5698212a0fd0638828e11c", "annex": "I", "before": {"end": 453, "start": 0, "text": "Neither niraparib nor M1 is a CYP3A4 inducer in vitro. In vitro, niraparib weakly induces CYP1A2 at high concentrations and the clinical relevance of this effect could not be completely ruled out. M1 is not a CYP1A2 inducer. Therefore, caution is recommended when niraparib is combined with active substances the metabolism of which is CYP1A2dependent and, notably, those having a narrow therapeutic range (e.g. clozapine, theophylline, and ropinirole).", "truncated": false}, "before_length": 453, "before_sha256": "ea7d68f9bee115d62f0677a834ab340ba38d70c23457aab5c2f1bcc373ef8a29", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 55, "before_start": 0, "kind": "delete"}, {"after_end": 20, "after_start": 20, "before_end": 82, "before_start": 75, "kind": "delete"}, {"after_end": 34, "after_start": 34, "before_end": 223, "before_start": 96, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 189, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-42ae0598d860df40027464ff", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1120}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 42, "start": 0, "text": "Médicament soumis à prescription médicale.", "truncated": false}, "before_length": 42, "before_sha256": "750563bceec650756547672930cecdeae621fc507c505c9da059b6b3a66df134", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 42, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 42, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-42d4da166eb657a9e8b261b8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1074}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 5, "start": 0, "text": "Eesti", "truncated": false}, "before_length": 5, "before_sha256": "ed7477d6100948d0d4e6b914d9769159823c21b23bf4846b1676338b9b439b72", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 5, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-42f7db728e027d25ee00cec7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9491}
{"after": {"end": 39, "start": 0, "text": "EU/1/11/717/005 30 comprimés pelliculés", "truncated": false}, "after_length": 39, "after_sha256": "14b9802836b767211a957b3344c49b6dcd26e980fde33aaaee5818db41155442", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "EU/1/11/717/003", "truncated": false}, "before_length": 15, "before_sha256": "33df5f48219bd2551b78dae07893271e4475ba3b184a73338ee9e17e4dfb94cf", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 14, "before_end": 14, "before_start": 14, "kind": "insert"}, {"after_end": 39, "after_start": 17, "before_end": 15, "before_start": 15, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-431152e20d15a4678b73d49b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2851}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 171, "start": 0, "text": "Si vous ressentez un quelconque effet indésirable, parlez-en à votre médecin. Ceci s’applique aussi à tout effet indésirable qui ne serait pas mentionné dans cette notice.", "truncated": false}, "before_length": 171, "before_sha256": "3294ac710780e81a7df59b004c427527efb2fc7b935aaa15bbaed5442911882d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 171, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 171, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4367a93e3d1d5630b878441f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1521}
{"after": {"end": 23, "start": 0, "text": "BristolMyers Squibb SAS", "truncated": false}, "after_length": 23, "after_sha256": "077c1bdf9d06b6ebea2cef6e6ab8ff5604c7feba155cc10d71a17f6fa240342e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-436dbec79c72e96023dc858d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3247}
{"after": {"end": 13, "start": 0, "text": "Hermeslaan 11", "truncated": false}, "after_length": 13, "after_sha256": "6426889eacea87c88f1e0405aad54515d8a889ca0f1b2ab39e2039040651e7d3", "annex": "IIIA", "before": {"end": 11, "start": 0, "text": "Hoge Wei 10", "truncated": false}, "before_length": 11, "before_sha256": "ba5c0cab58e83e9dc6ec41e55e6acc00077e1be63c8a1ed970723221f2f12ba4", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 1, "before_end": 3, "before_start": 1, "kind": "delete"}, {"after_end": 4, "after_start": 2, "before_end": 6, "before_start": 4, "kind": "replace"}, {"after_end": 10, "after_start": 5, "before_end": 8, "before_start": 7, "kind": "replace"}, {"after_end": 13, "after_start": 12, "before_end": 11, "before_start": 10, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-437e0da186905542b9ee9c63", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2901}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "Read the package leaflet before use", "truncated": false}, "before_length": 35, "before_sha256": "507cbe4bd01d082cb8b1d6b89039f65a5c71739015aad79203bdc9f43571b36e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-438feddd389bf23e0db913f9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4711}
{"after": {"end": 53, "start": 0, "text": "taux élevé de phosphates sanguins (hyperphosphatémie)", "truncated": false}, "after_length": 53, "after_sha256": "9dd49c454039a087de731a74fd166c741c81a3ee1b0cd5232f615f73054bc853", "annex": "IIIA", "before": {"end": 54, "start": 0, "text": "taux élevé de phosphates sanguines (hyperphosphatémie)", "truncated": false}, "before_length": 54, "before_sha256": "80f89a0c7961ff6d45b6281c74cce86ff48dc30b1779b3859ed6140a27dfba31", "change_kind": "content", "change_operations": [{"after_end": 32, "after_start": 32, "before_end": 33, "before_start": 32, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-43c2bd30b7f2f3400f396f49", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 915}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 303, "start": 0, "text": "You should normally inject Humalog within 15 minutes of a meal. If you need to, you can inject soon after a meal. But your doctor will have told you exactly how much to use, when to use it, and how often. These instructions are only for you. Follow them exactly and visit your diabetes clinic regularly.", "truncated": false}, "before_length": 303, "before_sha256": "e831e2ae3731fa0f33e313d646e9760690c38965097b4cd4dc3454e579ed1dc8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 303, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 303, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-43c2f026c576167f3dc07f9c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9308}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Millmount Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "4327529987c61beb05b89459f321ff89fd08e90a03878c8a0e235da0308d7dad", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-43ce9a6ebd9dceedcbf451ef", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3216}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "decreased red blood cells (anaemia)", "truncated": false}, "before_length": 35, "before_sha256": "32d316607e49ab5b6ad5885c3751925b2432f2778ea2abec4e467790f36e5ea1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-43fa689761c5850e6a02f315", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 896}
{"after": {"end": 34, "start": 0, "text": "medinfo.estonia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "e47c511a7367c6c7b4b4d54b0660bf70577f18e3fe0bcef938db762d7981dd1e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-440cf1252196821e1ce4b4d2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3219}
{"after": {"end": 22, "start": 0, "text": "Tel: + 34 91 456 53 00", "truncated": false}, "after_length": 22, "after_sha256": "c59845f4e2b4a96548adda4dbf16851ff33a89874560e491da6b05aee33b646a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-440e45cba99351b4a660e4bc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2558}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4419e271c48a11636b325352", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3018}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Tel: + 44 (0)800 221441", "truncated": false}, "before_length": 23, "before_sha256": "61482b81443a3ca39c7759aba2468d8a55e72bb438cb673a32ba3b1dac130262", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-441c88191e2f0741ec267abb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2924}
{"after": {"end": 6, "start": 0, "text": "Danska", "truncated": false}, "after_length": 6, "after_sha256": "99ab62517b3bb8298a9c40a2538a2769b0c2c8637a432d58e84bd537a117f8d4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-443cc94512924d9a7c34a601", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2118}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 305, "start": 0, "text": "You must not administer Humalog by the intravenous route. Inject Humalog as your physician or nurse has taught you. Only your physician can administer Humalog by the intravenous route. He will only do this under special circumstances such as surgery or if you are ill and your glucose levels are too high.", "truncated": false}, "before_length": 305, "before_sha256": "11fab16654a66d63e50a40f255902febcdd0e0af5ed5cb18effb246ae039a207", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 305, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 305, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-44529a97ea24a709c16b0480", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9323}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 37, "start": 0, "text": "- Are you exercising more than usual?", "truncated": false}, "before_length": 37, "before_sha256": "8fa4d8e7a5c20e5d930ed298a0c8423626b547b387750bf89da58b2c932d48e7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 37, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 37, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4489a03a723c0aba3331a001", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9257}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 18, "start": 0, "text": "Tempo Smart Button", "truncated": false}, "before_length": 18, "before_sha256": "4353c78334f9e8dbe3eceae7b4f5490e00a2ed513653b92f825d70eda704c695", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 18, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 18, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-448de6262ac62d4ffea9024a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9335}
{"after": {"end": 23, "start": 0, "text": "medinfo.finland@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "7029ed3ac062d546eacefe48107a23caa5547edd30d7c30335f744035bfb4ec6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-44947093d25bb8cedf9f49b9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3294}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Mylan IRE Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "35f93c261e1c23366cb104ad58005b2a5415120196df611fa95117f89eb960ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-449869d8e316182cc77951e7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4019}
{"after": {"end": 36, "start": 0, "text": "medinfo.lithuania@swixxbiopharma.com", "truncated": false}, "after_length": 36, "after_sha256": "70eec294d332a04f9bd82459b443a88e19b0dcce5bbd50491f56763531b2b260", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-44a5c019237233728a869e69", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2500}
{"after": {"end": 66, "start": 0, "text": "For more information, see the European Medicines Agency’s website:", "truncated": false}, "after_length": 66, "after_sha256": "8da7088a6eca66a2ae1a2bd8189afa46fa290c56c54c0076ee93bf891abacdcc", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 66, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 66}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-44df384f4d373f3ee3c59625", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 7}
{"after": {"end": 409, "start": 0, "text": "Le niraparib était modérément lié aux protéines du plasma humain (83 %), principalement avec l’albumine sérique. Dans une analyse pharmacocinétique de population de niraparib, le volume apparent de distribution (Vd/F) était de 1,206 L (sur la base d’une patiente de 70kg) chez les patientes atteintes de cancer (coefficient de variation (CV) 18,4%), indiquant une distribution tissulaire étendue du niraparib.", "truncated": false}, "after_length": 409, "after_sha256": "14955eace18a3b925797c97a8c55b256fdd543377550e7334aba4fdb83ab02e6", "annex": "I", "before": {"end": 408, "start": 0, "text": "Le niraparib était modérément lié aux protéines du plasma humain (83 %), principalement avec l’albumine sérique. Dans une analyse pharmacocinétique de population de niraparib, le volume apparent de distribution (Vd/F) était de 1,311 L (sur la base d’une patiente de 70kg) chez les patientes atteintes de cancer (coefficient de variation (CV) 116%), indiquant une distribution tissulaire étendue du niraparib.", "truncated": false}, "before_length": 408, "before_sha256": "078639dbb8542a725792e2a523d3f03c1793cc91bae044f53490868e5b9ede1a", "change_kind": "content", "change_operations": [{"after_end": 232, "after_start": 229, "before_end": 232, "before_start": 229, "kind": "replace"}, {"after_end": 346, "after_start": 343, "before_end": 345, "before_start": 343, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4506141dae380378381c949a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1677}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-452edc407e066aaf2b790fbf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2820}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 32, "start": 0, "text": "2. STATEMENT OF ACTIVE SUBSTANCE", "truncated": false}, "before_length": 32, "before_sha256": "9e169b908eb1d9fc1ed6e233dacad6af86b2c8a043fa81faef38a02382a9c8e3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-455344e5a60ccfd1bad179a5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4593}
{"after": {"end": 24, "start": 0, "text": "Tel: + 31 (0)30 300 2222", "truncated": false}, "after_length": 24, "after_sha256": "df26f07876232a3ba50861e46ee103ea04d50c8b384a64d52078fdc518ae52ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4583ff350e2a28361daded5b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2845}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma SIA", "truncated": false}, "after_length": 19, "after_sha256": "6da5006887c3e11cf19ecbe52bdc7a386838e93f6e63f315e575cb7df7747f15", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-45e5fea87a423840b81e1c9c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3304}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 58, "start": 0, "text": "• To prime your Pen, turn the dose knob to select 2 units.", "truncated": false}, "before_length": 58, "before_sha256": "a4c154c915bce43e38601f6788924409b87af6c56c39813828a1f663fa518a8a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 58, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 58, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4601fa90ae40279d5a0f05c5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9664}
{"after": {"end": 27, "start": 0, "text": "CPO Pharmaceuticals Limited", "truncated": false}, "after_length": 27, "after_sha256": "94b644443752e2cb52916b23f8141fbd44c47055b3416af333e12ac18e101b87", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "GPA Pharmaceuticals Ltd", "truncated": false}, "before_length": 23, "before_sha256": "ece7127e303c91e9501d2cedd822476265aae86acb9f96ef1553ab3a6954afe1", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 21, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-46024b1cf4ce153b7f6ba066", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4009}
{"after": {"end": 674, "start": 0, "text": "In vitro tafamidis inhibits the efflux transporter BCRP at the 61 mg/day tafamidis dose with IC50=1.16 µM and may cause drug-drug interactions at clinically relevant concentrations with substrates of this transporter (e.g. methotrexate, rosuvastatin, atorvastatin, apixaban, rivaroxaban, imatinib). In a clinical study in healthy participants, the exposure of the BCRP substrate rosuvastatin increased approximately 2-fold following multiple daily doses of 61 mg tafamidis. Therefore, patients should be monitored for BCRP substrate related adverse reactions when used concomitantly with tafamidis. A dose reduction of the BCRP substrate may be considered (see section 4.4).", "truncated": false}, "after_length": 674, "after_sha256": "c9081c3177c1e2e72845dd3aab0283a48858939ceb090b9d3422cf3173bd27c8", "annex": "I", "before": {"end": 477, "start": 0, "text": "In vitro tafamidis inhibits the efflux transporter BCRP (breast cancer resistant protein) at the 61 mg/day tafamidis dose with IC50=1.16 µM and may cause drug-drug interactions at clinically relevant concentrations with substrates of this transporter (e.g. methotrexate, rosuvastatin, imatinib). In a clinical study in healthy participants, the exposure of the BCRP substrate rosuvastatin increased approximately 2-fold following multiple doses of 61 mg tafamidis daily dosing.", "truncated": false}, "before_length": 477, "before_sha256": "8aab3995e9313efb020da7483c44cc1b3b2bf9f5d1029565023a446f773c5bbc", "change_kind": "content", "change_operations": [{"after_end": 56, "after_start": 56, "before_end": 90, "before_start": 56, "kind": "delete"}, {"after_end": 288, "after_start": 251, "before_end": 285, "before_start": 285, "kind": "insert"}, {"after_end": 449, "after_start": 443, "before_end": 440, "before_start": 440, "kind": "insert"}, {"after_end": 473, "after_start": 472, "before_end": 463, "before_start": 463, "kind": "insert"}, {"after_end": 499, "after_start": 474, "before_end": 464, "before_start": 464, "kind": "insert"}, {"after_end": 529, "after_start": 500, "before_end": 465, "before_start": 465, "kind": "insert"}, {"after_end": 554, "after_start": 530, "before_end": 466, "before_start": 466, "kind": "insert"}, {"after_end": 580, "after_start": 555, "before_end": 467, "before_start": 467, "kind": "insert"}, {"after_end": 600, "after_start": 582, "before_end": 469, "before_start": 469, "kind": "insert"}, {"after_end": 612, "after_start": 604, "before_end": 473, "before_start": 473, "kind": "insert"}, {"after_end": 614, "after_start": 613, "before_end": 474, "before_start": 474, "kind": "insert"}, {"after_end": 673, "after_start": 615, "before_end": 476, "before_start": 475, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 232}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-461b079985fe14cd6d32d913", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1016}
{"after": {"end": 36, "start": 0, "text": "Bristol-Myers Squibb GmbH & Co. KGaA", "truncated": false}, "after_length": 36, "after_sha256": "ad8ff4e5d779e654815cece3aff395170ae92937b281de17f06549278ae2dc0d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4650a062ac6e5b045c735eb5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3204}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "K32 YD60", "truncated": false}, "before_length": 8, "before_sha256": "a912431ef5bf5f07d79f78dbc42126d9eabca27a661f0e9817b1e916e549ace1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-46582a0522ad8de7134e8073", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3722}
{"after": {"end": 23, "start": 0, "text": "medinfo.romania@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "9ae697b67f3c854a077ca894d99400f1de79e31bd9bf61321fc7c4030bf8a213", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4674b5a058f8596649100151", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3264}
{"after": {"end": 6, "start": 0, "text": "Κύπρος", "truncated": false}, "after_length": 6, "after_sha256": "7f8ef8a379e33810aefd13f344f489d85e8902de6fdcd1b46a4e856985b5e14e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-46a98e88b0f90d3d1b4c4a34", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2622}
{"after": {"end": 34, "start": 0, "text": "12. MARKETING AUTHORISATION NUMBER", "truncated": false}, "after_length": 34, "after_sha256": "a60532285d3f2ae8ae6f1bf2efe60e8f4d80a3914ffa0fe294c7a05c7841017d", "annex": "IIIA", "before": {"end": 37, "start": 0, "text": "12. MARKETING AUTHORISATION NUMBER(S)", "truncated": false}, "before_length": 37, "before_sha256": "b6071fb293faef2077f6465142b105eff6f52c83477531a9aef260fa8ed61e46", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 34, "before_end": 37, "before_start": 34, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-46d248e6821ccc645b5e242f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1045}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-46f96b3fdbf48bc85ec52512", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2161}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Tel: + 46-(0) 8 7378800", "truncated": false}, "before_length": 23, "before_sha256": "1af1c2a861d285312f0ca28a7d3780fbedcfc8cf8ee6fff25e25c75511fba9d6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-470e7e06f5e650b3aa4eb27e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9556}
{"after": {"end": 46, "start": 0, "text": "Date of first authorisation : 22 December 2023", "truncated": false}, "after_length": 46, "after_sha256": "d8634c2ebe4ade0767c3aa39d9fcae60b37fd50944e8e1802c1b7802e700f160", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 46, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 46}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-471804d9a3ecb3651e7a35d8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "9", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 494}
{"after": {"end": 21, "start": 0, "text": "Tlf.: +45 45 26 60 00", "truncated": false}, "after_length": 21, "after_sha256": "6bdd3c845f6a6e520023cbb8b3726e2eefc4bc4ac00ae57245f3055e31d53895", "annex": "III", "before": {"end": 20, "start": 0, "text": "Tlf: +45 45 26 60 00", "truncated": false}, "before_length": 20, "before_sha256": "7932ef9452966b997a4a22618abb01fb644277c9ab041214e6264730772b2d64", "change_kind": "unassigned", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-471fd0ee2fc695d2e7540c0c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3100}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 39, "start": 0, "text": "Eli Lilly and Company (Ireland) Limited", "truncated": false}, "before_length": 39, "before_sha256": "0555e8a06c0ef36afd955d945d4997f04834690c546541adf74802bac524a0e4", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4725511b763a2eee9684b186", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3168}
{"after": {"end": 37, "start": 0, "text": "N.V. BristolMyers Squibb Belgium S.A.", "truncated": false}, "after_length": 37, "after_sha256": "feeebdb54667cd864ac3ce52dc07c49e265c3b042233fe6691e3f074fda776c2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4748f46b58559db5ce724af8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2803}
{"after": {"end": 153, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments : https ://www.ema.europa.eu/.", "truncated": false}, "after_length": 153, "after_sha256": "65ae7b3bd019e142fef6b9251772e6f7b7562315079db4fd990a412be7072e5e", "annex": "IIIA", "before": {"end": 152, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments : http ://www.ema.europa.eu/.", "truncated": false}, "before_length": 152, "before_sha256": "347cbe234d1ed584927826eb1e1aa61869dce0c3b5079dd6d460e816260d16b1", "change_kind": "content", "change_operations": [{"after_end": 130, "after_start": 129, "before_end": 129, "before_start": 129, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4755ab33e6b8112effcfa2c3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2952}
{"after": {"end": 102, "start": 0, "text": "Round white to off-white film-coated tablet embossed with “61” on one side. The tablet is 11 mm round.", "truncated": false}, "after_length": 102, "after_sha256": "98d98fc5a11c180897db392904f32895fb97aa3e94a7e07bc3fba572490fedba", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 102, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 102}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-47b646c57aaaac2fb97b0eb9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "3", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 939}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 38, "start": 0, "text": "– The dose knob clicks as you turn it.", "truncated": false}, "before_length": 38, "before_sha256": "7138c968ff3179b6d50446970d022004b6c230e12febe040d92eb8df66d4ceb9", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 38, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 38, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-47d86c4cd532d7571ca9ff57", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9690}
{"after": {"end": 214, "start": 0, "text": "Réactions supplémentaires au site d’injection (sensation de pression, ecchymose (« bleu »), diminution de la sensibilité et/ou engourdissement, éruption cutanée accompagnée de démangeaisons et sensation de chaleur)", "truncated": false}, "after_length": 214, "after_sha256": "0a892942142db0efc9295de35d527a86bf2762e640e8c687ff94c26d9d1f92e8", "annex": "IIIA", "before": {"end": 215, "start": 0, "text": "Réactions supplémentaires au site d’injection (sensation de pression, ecchymose (« bleu »), diminution de la sensibilité et/ou engourdissement, éruption cutanée accompagnée de démangeaisons et sensation de chaleur).", "truncated": false}, "before_length": 215, "before_sha256": "1db88ffbcdff7f94910dc8ce7b16cfc6fc163b2efa1abd3d28eba1fdd631ca0f", "change_kind": "content", "change_operations": [{"after_end": 214, "after_start": 214, "before_end": 215, "before_start": 214, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-482e4690a7a02d6ed7c9d6a0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1504}
{"after": {"end": 33, "start": 0, "text": "medinfo.latvia@swixxbiopharma.com", "truncated": false}, "after_length": 33, "after_sha256": "c0a77882a6e33a348e9fb5e2a3006e8250b7d628f17c35efbaf3212a5e6e1c2d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4835d64795a2fc0b3370aed0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2629}
{"after": {"end": 21, "start": 0, "text": "medinfo.czech@bms.com", "truncated": false}, "after_length": 21, "after_sha256": "7d80d4bfa363423e385e42b079e9a90210b1f5d622fbfe8ab954e6684db7cffd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-486e7c7e8a5069df1f1966de", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2509}
{"after": {"end": 36, "start": 0, "text": "Oy Bristol-Myers Squibb (Finland) Ab", "truncated": false}, "after_length": 36, "after_sha256": "aca51731c0a07e098261a8dac11eaa8c8eafa1001f72c007b85c510385b01809", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-48747101ebd7d49541d5956c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2612}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 87, "start": 0, "text": "• It is normal to see a small amount of insulin left in the Pen that you cannot inject.", "truncated": false}, "before_length": 87, "before_sha256": "d318c89055bb2acb132fc95a9e842da856ffb63118727affb3421dcf2f0f0248", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 87, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 87, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-487a803bd967db534567d9f0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9731}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "angiotensin II receptor blockers.", "truncated": false}, "before_length": 33, "before_sha256": "5572a73d84960c420092cc9efe09cfe3eab573453444c5ee38f2a31f88c8c7fd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-488eaa05e899eb3955fcae9e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9282}
{"after": {"end": 16, "start": 0, "text": "Takeda Pharma OÜ", "truncated": false}, "after_length": 16, "after_sha256": "e9444a2479654caefb4bbb022acc8101ffffafcb8d32eb0944837642964cc91b", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Takeda Pharma AS", "truncated": false}, "before_length": 16, "before_sha256": "ca89ccc51987ebdf828ff31b3b63ca2c86d0d7d56200b96706b8e9e4de779862", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 14, "before_end": 16, "before_start": 14, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-48ace8db9410853327ed9681", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1591}
{"after": {"end": 6, "start": 0, "text": "Dānija", "truncated": false}, "after_length": 6, "after_sha256": "ea1cda0e8df08e5d6b3894d37121d5928828a343cc4691a9a2dc4bf87f7ec80d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-48c247942315c72f6349b507", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1860}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 44, "start": 0, "text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING", "truncated": false}, "before_length": 44, "before_sha256": "d78bb4e96a3f9f8cb58e27de8d08d455cdf9166cf22b388c3242f9a0b13158ed", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 44, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 44, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-48c55c8d64d1d1fd0385e6fb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4681}
{"after": {"end": 183, "start": 0, "text": "This document is the approved product information for Cialis, with the changes since the previous procedure affecting the product information (EMEA/H/C/PSUSA/00002841/202210) tracked.", "truncated": false}, "after_length": 183, "after_sha256": "9e7529e1da68551cd39435f16d6677f295b5125ed270fa73b75ad33b42606197", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 183, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 183}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-48d401b89ca74dd3841d824e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 0}
{"after": {"end": 17, "start": 0, "text": "Noyau du comprimé", "truncated": false}, "after_length": 17, "after_sha256": "838842799837ff7b690f0d69048e6f854e756a7b7020296f4dd4d4592076abf9", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 17, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 17}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-48fcb95a1b1687dda2476537", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1881}
{"after": {"end": 6, "start": 0, "text": "Ελλάδα", "truncated": false}, "after_length": 6, "after_sha256": "e6f7401e81c9b2a3c1f082d0c9a0183287a6f7b4ecded4f4d3ac5e1efefa9ce5", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4917130461e353d7261a3f37", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2546}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 95, "start": 0, "text": "some antidepressants (monoamine oxidase inhibitors or selective serotonin reuptake inhibitors),", "truncated": false}, "before_length": 95, "before_sha256": "231e54dd7707a729ec8d839fcbe8437ebde14b7bc561c50b4eec54355c547b2a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 95, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 95, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-492065b0aab996e1f518ff3c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9279}
{"after": {"end": 228, "start": 0, "text": "Il a été montré que l’augmentation du poids augmentait le volume de distribution du niraparib dans l’analyse pharmacocinétique de la population. Il n’a pas été identifié d’impact du poids sur la clairance ou l’exposition totale.", "truncated": false}, "after_length": 228, "after_sha256": "8a2e346bc00610d9dbf5468f4981248de861be03513bb764750566bd8dddc7bf", "annex": "I", "before": {"end": 330, "start": 0, "text": "Il a été montré que l’augmentation du poids augmentait le volume de distribution du niraparib dans l’analyse pharmacocinétique de la population. Il n’a pas été identifié d’impact du poids sur la clairance ou l’exposition totale. Un ajustement de la dose en fonction du poids n’est pas justifié d’un point de vue pharmacocinétique.", "truncated": false}, "before_length": 330, "before_sha256": "2282b1e3eb034edc7fb19812debd03aeec5eb5e9831a1bb023f185f88e1a3b2f", "change_kind": "content", "change_operations": [{"after_end": 228, "after_start": 228, "before_end": 330, "before_start": 228, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 102, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-49283ac6277025211559afcc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1706}
{"after": {"end": 26, "start": 0, "text": "Lactose monohydraté (E 24)", "truncated": false}, "after_length": 26, "after_sha256": "5423b82b171ca7f8510f696364a440686a7cc7b81748c0a15e0e17a77fd51637", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-49291d3d99997022f08d6c04", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1884}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Fabricant", "truncated": false}, "before_length": 9, "before_sha256": "169067cf6ab90924cd5082a7a6d0aac85081d5b4f04e0d28ba8141fab5cbbda6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-49b927313340a729565a89a4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2454}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-49f5e1eff44f6d416f49ebeb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3183}
{"after": {"end": 142, "start": 0, "text": "Le niraparib est un inhibiteur de la P-gp, la BCRP, de MATE1/2K et du transporteur cationique organique 1 (OCT1) in vitro (voir rubrique 4.5).", "truncated": false}, "after_length": 142, "after_sha256": "3621b16926d6b878b2c451288585ffa7c84d1766b267c5755ebe38f72b2a62f3", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 142, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 142}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-49f7bbda46bfc46dc10c06c1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 807}
{"after": {"end": 465, "start": 0, "text": "In the population pharmacokinetic analysis, patients with mild (creatinine clearance 60-90 mL/min) and moderate (30-60 mL/min) renal impairment had mildly reduced niraparib clearance compared to individuals with normal renal function. The difference in exposure is not considered to warrant dose adjustment. No patients with preexisting severe renal impairment or endstage renal disease undergoing hemodialysis were identified in clinical studies (see section 4.2).", "truncated": false}, "after_length": 465, "after_sha256": "945b08ce103758667fefa60c540722894a6f626b53a80c87e2264ea9e63bb0e4", "annex": "I", "before": {"end": 553, "start": 0, "text": "In the population pharmacokinetic analysis, patients with mild (creatinine clearance 60-90 mL/min) and moderate (30-60 mL/min) renal impairment had mildly reduced niraparib clearance compared to individuals with normal renal function (7-17% higher exposure in mild and 17-38% higher exposure in moderate renal impairment). The difference in exposure is not considered to warrant dose adjustment. No patients with preexisting severe renal impairment or endstage renal disease undergoing hemodialysis were identified in clinical studies (see section 4.2).", "truncated": false}, "before_length": 553, "before_sha256": "cb4011daf0f69761f42608933743cf0493af37c2b1ae9cc6bffd367373afd773", "change_kind": "content", "change_operations": [{"after_end": 233, "after_start": 233, "before_end": 321, "before_start": 233, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4a53ad40693f3793b518f71c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1655}
{"after": {"end": 12, "start": 0, "text": "Виатрис ЕООД", "truncated": false}, "after_length": 12, "after_sha256": "92f9a32247d19bdb1e65df1219954c43f6ad757cc355e8022e7566c35de78f1a", "annex": "IIIA", "before": {"end": 11, "start": 0, "text": "Майлан ЕООД", "truncated": false}, "before_length": 11, "before_sha256": "5770366f858d91109bdad7a5551dc97b9878455f55713851de8277df30093b62", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 7, "after_start": 3, "before_end": 6, "before_start": 2, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4a5f93413aee0fb32acee209", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005403", "medicine_name": "Sugammadex Mylan", "medicine_slug": "sugammadex-mylan", "observed_at": "2026-10-12T13:36:04Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "6c5163463373c99ccc880a476c1bf5361b2063cd7b687e079043070b6fb0e7f5", "source_snapshot_id": "source-c456b260a6ea2676dbd096d9", "source_updated_at": "2026-06-12", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/sugammadex-mylan-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1477}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 52, "start": 0, "text": "1. What Humalog Tempo Pen is and what it is used for", "truncated": false}, "before_length": 52, "before_sha256": "284aca1d91f87c735118a2dfd369350f987b5ec03165c8bffd6e6159fd1913d0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 52, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 52, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4a898e896d518e54dae2e864", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9231}
{"after": {"end": 6, "start": 0, "text": "Polska", "truncated": false}, "after_length": 6, "after_sha256": "d1974e0e3e575b6dadb40f080dae05025f574cb23e5cababcac0f50cf2619549", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4a8b365c1894871a39eedd63", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2567}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Eli Lilly Polska Sp. z o.o.", "truncated": false}, "before_length": 27, "before_sha256": "b3486909636233061722362e74352478739b2a9eec0f8e5463ca60c80e51c9fd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4aeb3f263f72ab8c7bd99281", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9510}
{"after": {"end": 18, "start": 0, "text": "Orteliuslaan 1000,", "truncated": false}, "after_length": 18, "after_sha256": "21c621c6366151fa349c8db45d9fcbb9c94e9eb157e7b6a12761b6c45f5a91c4", "annex": "I", "before": {"end": 18, "start": 0, "text": "Papendorpseweg 83,", "truncated": false}, "before_length": 18, "before_sha256": "93fe807c935894269f90415a7510e03bd5cb998b5478f2bec793675a6a09dafb", "change_kind": "administrative", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4b3940e680455701acd20127", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 10 mg comprimés pelliculés CIALIS 20 mg comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1601}
{"after": {"end": 39, "start": 0, "text": "EU/1/11/717/006 90 comprimés pelliculés", "truncated": false}, "after_length": 39, "after_sha256": "e9fe7a74be8048a525559b8ea4745c8bc9febe942d8a8c03a08180a1a1670119", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 39, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 39}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4b429cc3875b75ff67a1e36a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2852}
{"after": {"end": 15, "start": 0, "text": "Česká republika", "truncated": false}, "after_length": 15, "after_sha256": "c768c215f215c71e7ffcbffe06cb1a66fa3c379a86285d5da65cef3c627bc09d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4b6b5a5ef618a1d3f357b590", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3183}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tel: + 40 21 4023000", "truncated": false}, "before_length": 20, "before_sha256": "43c602e05b18ed7f33ff40e69157eb4e1d23c5069b3ffad501efc1c0abbc5e58", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4b6c0dc1c1006848d7fa459c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9525}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 16, "start": 0, "text": "Mannitol (E 421)", "truncated": false}, "before_length": 16, "before_sha256": "9d090257c0ab6334a6f70770003677d80dc9143d07f9048a126b9fb07f946ccf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4b82a7d5c1902d6da18b2921", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1902}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 37, "start": 0, "text": "• Check the number in the dose window", "truncated": false}, "before_length": 37, "before_sha256": "c074e98ea1fb11afffe4f949a13adff2690c6f4dc00c42988819ad8bc28b5a15", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 37, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 37, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4b87169eb82f7a0c7c3a114b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9759}
{"after": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "after_length": 7, "after_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4bc5dfc06f52e4809353f6e4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3236}
{"after": {"end": 40, "start": 0, "text": "Tel: 1 800 749 749 (+ 353 (0)1 483 3625)", "truncated": false}, "after_length": 40, "after_sha256": "0509d2a1806f188ecbce2c353425cb70d883d4c07f6e695eacf4b8a2ec65feef", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 40, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 40}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4bd3409f1883685bc69311ae", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3265}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "The Netherlands", "truncated": false}, "before_length": 15, "before_sha256": "91729ff7107ee698fe168dc62d5b2020678fcfcf55b4ea9065982ce1d071ba31", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4bde14f6d764dbb354af92f5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4742}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "Tel: + 34-91 663 50 00", "truncated": false}, "before_length": 22, "before_sha256": "24380938120fef8e663439c301a51dce84f706f8c1055a1b0bc54497eeaf7a1c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4be2ea0edbc27df8b01c6963", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9507}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb A.E.", "truncated": false}, "after_length": 25, "after_sha256": "43a0521fcec8db403e6fb060ae3b147a3107583a8df9b3a28208c9a4bd0d8fba", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4c02cbd4224ae2dfe95c124f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2929}
{"after": {"end": 27, "start": 0, "text": "Différence (RC) (IC à 95 %)", "truncated": false}, "after_length": 27, "after_sha256": "a31a341ae9229c82d4d19f3da242331878ce06888035fefbaa2c74f7283de0d0", "annex": "I", "before": {"end": 31, "start": 0, "text": "Différence (RC) (IC à 95 %) [1]", "truncated": false}, "before_length": 31, "before_sha256": "49bb125a69961e6671cb705ee3b307aa780308cc915b22d4fd660d4a1d1e8081", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 27, "before_end": 31, "before_start": 27, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4c45f041d14b024d9f32c1a8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 294}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 122, "start": 0, "text": "Le principal métabolite M1 ne semble pas être un inhibiteur de la P-gp, de la BCRP, de la BSEP, de la MRP2 ou de MATE 1/2.", "truncated": false}, "before_length": 122, "before_sha256": "abcf35c7a905366472e17d99fd36719eae31c6d77cfc8ea964ea5ae8e5a1319f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 122, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 122, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4c7ada017c5d2e58014c1cb9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1163}
{"after": {"end": 15, "start": 0, "text": "Études in vitro", "truncated": false}, "after_length": 15, "after_sha256": "ffacd06469f97fd0f1f7f8238b9b241c0b4bd9c0b0c25ee2cc9790f3133c2ac2", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4c8d0a99fcebdf99334b9714", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1689}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 126, "start": 0, "text": "If you are unsure how much you have injected then check your blood sugar levels before deciding if you need another injection.", "truncated": false}, "before_length": 126, "before_sha256": "ffe4acfd8036d3b72863d548377b87044fcf4bbb87cd2036f4c44e0a4917cc55", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 126, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 126, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4cdb70627baf93558d02607c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9328}
{"after": {"end": 19, "start": 0, "text": "Tel: + 356 23976333", "truncated": false}, "after_length": 19, "after_sha256": "f8bfa43651e282e3e99ee42fa339e414e57dea721306efb985d46dcd3b4656c4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4d1c8e6841fedf483ab29b60", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2839}
{"after": {"end": 33, "start": 0, "text": "medicalinformation.italia@bms.com", "truncated": false}, "after_length": 33, "after_sha256": "7fa3fd14eb9bcefdd405cdea61ff603a046dbbe0f3ada36eb2fd672402b4e33b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4d1d2cce4ad9e94db00173de", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3289}
{"after": {"end": 66, "start": 0, "text": "Vyndaqel 20 mg, capsules molles et Vyndaqel 61 mg, capsules molles", "truncated": false}, "after_length": 66, "after_sha256": "d0bfe46f0439287a42746da8d569907dfdf674f929783cafe2c02c5912fb33bc", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 66, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 66}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4d5c7a076b877d37c1c6e390", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2011}
{"after": {"end": 36, "start": 0, "text": "medinfo.lithuania@swixxbiopharma.com", "truncated": false}, "after_length": 36, "after_sha256": "70eec294d332a04f9bd82459b443a88e19b0dcce5bbd50491f56763531b2b260", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4d6cf9fcf1d4274af2cc25d1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3171}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovenia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "fce1e60bbc59ee3c381de461f412175da197c866a89ba45b24c7794f59b5c833", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4d83fba0996e7421720d4a89", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2594}
{"after": {"end": 17, "start": 0, "text": "3,5 (-9,4 ; 16,2)", "truncated": false}, "after_length": 17, "after_sha256": "a6b0a86697e9ec7e0895d1b929834b64e0ab5b5fbc6b32b537a6458eb912a9ab", "annex": "I", "before": {"end": 17, "start": 0, "text": "3,8 (10,5 ; 17,9)", "truncated": false}, "before_length": 17, "before_sha256": "f1225087b305345a711ff21a38b2c66536699fe8fc667e2f2f43783060341b02", "change_kind": "content", "change_operations": [{"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 7, "after_start": 5, "before_end": 7, "before_start": 5, "kind": "replace"}, {"after_end": 9, "after_start": 8, "before_end": 9, "before_start": 8, "kind": "replace"}, {"after_end": 14, "after_start": 13, "before_end": 14, "before_start": 13, "kind": "replace"}, {"after_end": 16, "after_start": 15, "before_end": 16, "before_start": 15, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4d8b574478b9d84750a848c2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 306}
{"after": {"end": 206, "start": 0, "text": "Some of the side effects connected with Firazyr are similar to the symptoms of your disease. Tell your doctor immediately if you notice that your symptoms of the attack get worse after you received Firazyr.", "truncated": false}, "after_length": 206, "after_sha256": "2557246d50287ff5b2030ae2d4eabe79c0d16aaba40e4542c59ef196f6d126d0", "annex": "IIIA", "before": {"end": 205, "start": 0, "text": "Some of the side effects connected with Firazyr are similar to the symptoms of your disease. Tell your doctor immediately if you notice that your symptoms of the attack get worse after you received Firazyr", "truncated": false}, "before_length": 205, "before_sha256": "0d3f3365ce8063ed567fd917bfda784b473ba36e8f8c0783c6ac44f6965e116d", "change_kind": "content", "change_operations": [{"after_end": 206, "after_start": 205, "before_end": 205, "before_start": 205, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4d9ffb7f1335b7eecbc41a05", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1216}
{"after": {"end": 135, "start": 0, "text": "Les comprimés pelliculés doivent être avalés entiers et sans les croquer ni les couper. Vyndaqel peut être pris avec ou sans nourriture", "truncated": false}, "after_length": 135, "after_sha256": "7c7bf6ccd95961b7c4f29bf1b7919bb39e3ad67a9f6bbb0d454328285221fc2b", "annex": "I", "before": {"end": 122, "start": 0, "text": "La capsule molle doit être avalée entière et sans la croquer ni la couper. Vyndaqel peut être pris avec ou sans nourriture", "truncated": false}, "before_length": 122, "before_sha256": "ab6c15d869356fbadefda535be2cf53910ba54dadb4b63f32ce653fd1884d701", "change_kind": "content", "change_operations": [{"after_end": 3, "after_start": 1, "before_end": 2, "before_start": 1, "kind": "replace"}, {"after_end": 7, "after_start": 5, "before_end": 5, "before_start": 4, "kind": "replace"}, {"after_end": 12, "after_start": 8, "before_end": 6, "before_start": 6, "kind": "insert"}, {"after_end": 20, "after_start": 13, "before_end": 7, "before_start": 7, "kind": "insert"}, {"after_end": 24, "after_start": 22, "before_end": 16, "before_start": 9, "kind": "replace"}, {"after_end": 31, "after_start": 28, "before_end": 20, "before_start": 20, "kind": "insert"}, {"after_end": 44, "after_start": 43, "before_end": 33, "before_start": 32, "kind": "replace"}, {"after_end": 50, "after_start": 49, "before_end": 39, "before_start": 38, "kind": "replace"}, {"after_end": 52, "after_start": 51, "before_end": 41, "before_start": 40, "kind": "replace"}, {"after_end": 64, "after_start": 62, "before_end": 52, "before_start": 51, "kind": "replace"}, {"after_end": 79, "after_start": 77, "before_end": 66, "before_start": 65, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4e01e63674e9ce84f4d54966", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1267}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 36 1 301 9797", "truncated": false}, "after_length": 21, "after_sha256": "646ee39f31e338f4b9b710096409242010a836db8c907826a18abfa5703a4854", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4e3cc65f102777b8256172be", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2513}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 29, "start": 0, "text": "• tiredness • rapid heartbeat", "truncated": false}, "before_length": 29, "before_sha256": "7634d32b9cc66e8ab542f1570ba5e12d4ff7d624796f50698a03cfd7153d33f1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 29, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 29, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4e41e08b7ea8e6c58d65f3b6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9397}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 247, "start": 0, "text": "Sur la base des conclusions scientifiques relatives au tadalafil, le CHMP estime que le rapport bénéfice-risque du/des médicament(s) contenant du tadalafil demeure inchangé, sous réserve des modifications proposées des informations sur le produit.", "truncated": false}, "before_length": 247, "before_sha256": "a4431403d0a01d31dfc949264ccd55af4d10cee945838b629e33e22d3c82951e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 247, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 247, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4e47566a622871ec56500c16", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3503}
{"after": {"end": 27, "start": 0, "text": "CPO Pharmaceuticals Limited", "truncated": false}, "after_length": 27, "after_sha256": "94b644443752e2cb52916b23f8141fbd44c47055b3416af333e12ac18e101b87", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "GPA Pharmaceuticals Ltd", "truncated": false}, "before_length": 23, "before_sha256": "ece7127e303c91e9501d2cedd822476265aae86acb9f96ef1553ab3a6954afe1", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 21, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4e70c82dc8274a9d7f7b6d17", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3685}
{"after": {"end": 451, "start": 0, "text": "Après l’administration d’une dose unique de 300 mg de niraparib, le niraparib était mesurable dans le plasma dans les 30 minutes et la concentration plasmatique maximale moyenne (Cmax) pour le niraparib était atteinte en 3 à 5 heures (variant entre 508 et 875 ng/mL selon les études). Après des doses orales multiples de niraparib comprises entre 30 mg et 400 mg une fois par jour, l’accumulation de niraparib était environ 2 à 3 fois plus importante.", "truncated": false}, "after_length": 451, "after_sha256": "abefd35c2fe4f84c3052047a096a1749a3e50723440183c09b98b7cc36134861", "annex": "I", "before": {"end": 440, "start": 0, "text": "Après l’administration d’une dose unique de 300 mg de niraparib à jeun, le niraparib était mesurable dans le plasma dans les 30 minutes et la concentration plasmatique maximale moyenne (Cmax) pour le niraparib était atteinte en 3 heures environ [804 ng/mL (% CV : 50,2 %)]. Après des doses orales multiples de niraparib comprises entre 30 mg et 400 mg une fois par jour, l’accumulation de niraparib était environ 2 à 3 fois plus importante.", "truncated": false}, "before_length": 440, "before_sha256": "56acd87f07a2b8bf33eab0527170c7bbfa52fed2fccc565b005f0843ea11edb1", "change_kind": "content", "change_operations": [{"after_end": 63, "after_start": 63, "before_end": 70, "before_start": 63, "kind": "delete"}, {"after_end": 227, "after_start": 223, "before_end": 230, "before_start": 230, "kind": "insert"}, {"after_end": 243, "after_start": 234, "before_end": 237, "before_start": 237, "kind": "insert"}, {"after_end": 246, "after_start": 245, "before_end": 241, "before_start": 239, "kind": "replace"}, {"after_end": 248, "after_start": 247, "before_end": 244, "before_start": 242, "kind": "replace"}, {"after_end": 251, "after_start": 249, "before_end": 246, "before_start": 245, "kind": "replace"}, {"after_end": 259, "after_start": 252, "before_end": 249, "before_start": 247, "kind": "replace"}, {"after_end": 271, "after_start": 266, "before_end": 258, "before_start": 256, "kind": "replace"}, {"after_end": 275, "after_start": 272, "before_end": 261, "before_start": 259, "kind": "replace"}, {"after_end": 282, "after_start": 276, "before_end": 270, "before_start": 262, "kind": "replace"}, {"after_end": 283, "after_start": 283, "before_end": 272, "before_start": 271, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4e77bc899fca766436d652c8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 779}
{"after": {"end": 20, "start": 0, "text": "Tel: + 43 1 60 14 30", "truncated": false}, "after_length": 20, "after_sha256": "06513bb4e3ff06e9885e8395f2d87e81d050e28b69385dc8158cf331179a64c6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4eb07ae89a0bd51f0771cbc6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3230}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 441, "start": 0, "text": "Ni le niraparib ni M1 ne sont des substrats des transporteurs d’anions organiques 1 (OAT1), 3 (OAT3), ou du transporteur de cations organiques 2 (OCT2). Aucun ajustement posologique n’est nécessaire pour Zejula en cas d’administration concomitante avec des médicaments connus pour inhiber les transporteurs d’influx OAT1 (par exemple, probénécide) or OAT3 (par exemple, probénécide, diclofénac), ou OCT2 (par exemple, cimétidine, quinidine).", "truncated": false}, "before_length": 441, "before_sha256": "e33e1edbd4252f57f3eadc8ab72e49abb23ca3ae46d8ff594eab50f0d3468f59", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 441, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 441, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4ecdb619b2751d0c716e698d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 253}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "17. UNIQUE IDENTIFIER – 2D BARCODE", "truncated": false}, "before_length": 34, "before_sha256": "bc158365115e0908119e4f2782a562abac5f0b5b80024210ee67676cff8a06c5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4ed52dce81f60a930c3787e6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4766}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "customercontactuk@gsk.com", "truncated": false}, "before_length": 25, "before_sha256": "73834f2ec2786ba4565d1820e07d2bb38952e8214867b143e05286042d58b0b0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4f0748fe1c5587f19072fdd1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2549}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 264, "start": 0, "text": "Every time you use a Tempo Pen you must use a new needle. Before every injection, clear any air bubbles. You can see how much insulin is left by holding the Tempo Pen with the needle pointing up. The scale on the cartridge shows about how many units you have left.", "truncated": false}, "before_length": 264, "before_sha256": "23ae01b725150b6d3dae6dd50739c5c94d7652c7bb7afdcd798f895ac8152a41", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 264, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 264, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4f10f5280e949c66af397a87", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9331}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "8055 Graz", "truncated": false}, "before_length": 9, "before_sha256": "765f51a390983de920b9a586c4589caab5f6398576531f438fd8301227c9ccb2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4f39da40ec539a0ad3f8f409", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2745}
{"after": {"end": 289, "start": 0, "text": "Les autres composants sont : cellulose microcristalline (E 460), lactose monohydraté (E 24) [voir rubrique 2 « Vyndaqel contient du lactose monohydraté »], crospovidone (E 1202), stéarate de magnésium (E 470b), carbonate de calcium, isomalt, hypromellose et triglycérides à chaîne moyenne.", "truncated": false}, "after_length": 289, "after_sha256": "c1d61ea65d543c89e8f732d46db0d2a0edda7eedb658a3349732e513f15e8a4a", "annex": "IIIA", "before": {"end": 465, "start": 0, "text": "Les autres composants sont : gélatine (E 441), glycérine (E 422), sorbitol (E 420) [voir rubrique 2 « Vyndaqel contient du sorbitol »], mannitol (E 421), sorbitane, oxyde de fer rouge (E 172), eau purifiée, macrogol 400 (E 1521), polysorbate 20 (E 432), povidone (K-valeur 90), hydroxytoluène butylé (E 321), alcool éthylique, alcool isopropylique, acétatophtalate de polyvinyle, propylène glycol (E 1520), dioxyde de titane (E 171) et hydroxyde d’ammonium (E 527).", "truncated": false}, "before_length": 465, "before_sha256": "83d944938ab3cb9e14e342e660ac75c78473f0eb43f0506b9cabf383e15e6490", "change_kind": "content", "change_operations": [{"after_end": 31, "after_start": 29, "before_end": 31, "before_start": 29, "kind": "replace"}, {"after_end": 49, "after_start": 32, "before_end": 32, "before_start": 32, "kind": "insert"}, {"after_end": 52, "after_start": 50, "before_end": 34, "before_start": 33, "kind": "replace"}, {"after_end": 62, "after_start": 60, "before_end": 44, "before_start": 42, "kind": "replace"}, {"after_end": 65, "after_start": 65, "before_end": 48, "before_start": 47, "kind": "delete"}, {"after_end": 78, "after_start": 66, "before_end": 49, "before_start": 49, "kind": "insert"}, {"after_end": 83, "after_start": 79, "before_end": 51, "before_start": 50, "kind": "replace"}, {"after_end": 84, "after_start": 84, "before_end": 56, "before_start": 52, "kind": "delete"}, {"after_end": 89, "after_start": 88, "before_end": 60, "before_start": 60, "kind": "insert"}, {"after_end": 90, "after_start": 90, "before_end": 81, "before_start": 61, "kind": "delete"}, {"after_end": 135, "after_start": 132, "before_end": 128, "before_start": 123, "kind": "replace"}, {"after_end": 151, "after_start": 137, "before_end": 131, "before_start": 130, "kind": "replace"}, {"after_end": 156, "after_start": 156, "before_end": 209, "before_start": 136, "kind": "delete"}, {"after_end": 159, "after_start": 159, "before_end": 234, "before_start": 212, "kind": "delete"}, {"after_end": 160, "after_start": 160, "before_end": 254, "before_start": 235, "kind": "delete"}, {"after_end": 171, "after_start": 170, "before_end": 272, "before_start": 264, "kind": "replace"}, {"after_end": 174, "after_start": 172, "before_end": 274, "before_start": 273, "kind": "replace"}, {"after_end": 176, "after_start": 175, "before_end": 275, "before_start": 275, "kind": "insert"}, {"after_end": 183, "after_start": 179, "before_end": 281, "before_start": 278, "kind": "replace"}, {"after_end": 184, "after_start": 184, "before_end": 361, "before_start": 282, "kind": "delete"}, {"after_end": 194, "after_start": 191, "before_end": 374, "before_start": 368, "kind": "replace"}, {"after_end": 197, "after_start": 195, "before_end": 453, "before_start": 375, "kind": "replace"}, {"after_end": 205, "after_start": 204, "before_end": 462, "before_start": 460, "kind": "replace"}, {"after_end": 208, "after_start": 206, "before_end": 463, "before_start": 463, "kind": "insert"}, {"after_end": 288, "after_start": 209, "before_end": 464, "before_start": 464, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 328, "chars_inserted": 152}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4f3b065dd713964437fb561d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3694}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 223, "start": 0, "text": "Niraparib did not exhibit inhibitory effect against the UGT isoforms (UGT1A1, UGT1A4, UGT1A9, and UGT2B7) up to 200 µM in vitro. Therefore, the potential for a clinically relevant inhibition of UGTs by niraparib is minimal.", "truncated": false}, "before_length": 223, "before_sha256": "85822242d0333c2d22a649b353f65d9e63864039bbe602d4bd040008880bd287", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 223, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 223, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4f5d34be43e58d8583559872", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 254}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4f5da989359de681c8ba9c4f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2833}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4f6b21b5a36d729ecb5d22d8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3272}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Nederland", "truncated": false}, "before_length": 9, "before_sha256": "8a869db3fa453526573e4f2c956528743cf246af5d1b5eac4879257589776797", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4fb4c672c4efea427fe33024", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9488}
{"after": {"end": 26, "start": 0, "text": "Tél: + 33 (0)1 58 83 84 96", "truncated": false}, "after_length": 26, "after_sha256": "331bde6d3ceed373ca2a62d0d499d6fe72853e6ae69fb08f092c7712a9ad1d3e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-4ff344fb8968234451539b6a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2574}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 24, "start": 0, "text": "Titanium dioxide (E 171)", "truncated": false}, "before_length": 24, "before_sha256": "2c94097b4bf6710e38ee2c7ca846a0d793de888a990e5476e16c792f07dcf8ec", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5008bc405c74118ef605e917", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1378}
{"after": {"end": 24, "start": 0, "text": "Tel: + 31 (0)30 300 2222", "truncated": false}, "after_length": 24, "after_sha256": "df26f07876232a3ba50861e46ee103ea04d50c8b384a64d52078fdc518ae52ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5011dcd5ea88c327e1ab73b5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3213}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 192, "start": 0, "text": "Please tell your doctor, if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription (see section “Warnings and precautions”).", "truncated": false}, "before_length": 192, "before_sha256": "6fe875b61ee9f165739f74a3c5cd0b456c43c3357d42def3ca0e1af026abdf78", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 192, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 192, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-501817305e43eefe0b38a6d8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9284}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 7, "start": 0, "text": "Irlande", "truncated": false}, "before_length": 7, "before_sha256": "a8cdfff5dbbda1b070a2acb339b6f0aa20b6230d9b5500c9ce066eaa89bc9a64", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-50684677c01c96a01f6c5a4d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 988}
{"after": {"end": 12, "start": 0, "text": "Magyarország", "truncated": false}, "after_length": 12, "after_sha256": "5206a7f7063a77a35861f95e022dafc37f3b3cf27ed423b1118e3fe580841b19", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-506f017c94062949808967c2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3188}
{"after": {"end": 25, "start": 0, "text": "Utilisation sous-cutanée.", "truncated": false}, "after_length": 25, "after_sha256": "fff2d0fc9e9003d4a1e00c04e7e0bb5ae61d9cf5d3ad4c04919356b6db350f7c", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Utilisation sous-cutanée", "truncated": false}, "before_length": 24, "before_sha256": "9d4e4e353ddc84d14ff6ab682d5e9b5667e6b3406e44294ca5126a692856c758", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 24, "before_end": 24, "before_start": 24, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5098899e519cafdac6bbc868", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 926}
{"after": {"end": 30, "start": 0, "text": "Film coating (Opadry TF white)", "truncated": false}, "after_length": 30, "after_sha256": "d4a2b1c0f7bf2f60e046fb130f0d290eb535653332ec7d187adde34fff4aeeba", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 30, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 30}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-50b5af8a0cbb658a58425c4f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1344}
{"after": {"end": 339, "start": 0, "text": "Si des vomissements se produisent après l’administration du médicament et que le comprimé de Vyndaqel est retrouvé intact, une nouvelle dose de Vyndaqel doit alors, si possible, être administrée. Si aucun comprimé n’est retrouvé, aucune dose supplémentaire n’est nécessaire et la prise du médicament doit se faire normalement le lendemain.", "truncated": false}, "after_length": 339, "after_sha256": "0dbe7266c51862922644a5126e20af9f91029beb253fd9070fc8fc7bcbe970f3", "annex": "I", "before": {"end": 341, "start": 0, "text": "Si des vomissements se produisent après l’administration du médicament et que la capsule de Vyndaqel est retrouvée intacte, une nouvelle dose de Vyndaqel doit alors, si possible, être administrée. Si aucune capsule n’est retrouvée, aucune dose supplémentaire n’est nécessaire et la prise du médicament doit se faire normalement le lendemain.", "truncated": false}, "before_length": 341, "before_sha256": "f3f800f71d17496940f8fa31ecdfdf16f4382c7d5611968a5dbcbad8d69dc631", "change_kind": "content", "change_operations": [{"after_end": 80, "after_start": 79, "before_end": 80, "before_start": 79, "kind": "replace"}, {"after_end": 84, "after_start": 82, "before_end": 83, "before_start": 82, "kind": "replace"}, {"after_end": 89, "after_start": 85, "before_end": 88, "before_start": 84, "kind": "replace"}, {"after_end": 114, "after_start": 114, "before_end": 114, "before_start": 113, "kind": "delete"}, {"after_end": 121, "after_start": 121, "before_end": 122, "before_start": 121, "kind": "delete"}, {"after_end": 204, "after_start": 204, "before_end": 206, "before_start": 205, "kind": "delete"}, {"after_end": 208, "after_start": 206, "before_end": 209, "before_start": 208, "kind": "replace"}, {"after_end": 213, "after_start": 209, "before_end": 214, "before_start": 210, "kind": "replace"}, {"after_end": 228, "after_start": 228, "before_end": 230, "before_start": 229, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-50d669e70ffe56f7c5e101fa", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1247}
{"after": {"end": 6, "start": 0, "text": "España", "truncated": false}, "after_length": 6, "after_sha256": "f85c9fe36948469b69f31fb5026694619ce4dc122757ece67c8584ff8f2ac008", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-50e1da430c67338284337002", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3236}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "Hermeslaan 11", "truncated": false}, "before_length": 13, "before_sha256": "6426889eacea87c88f1e0405aad54515d8a889ca0f1b2ab39e2039040651e7d3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-50e5691853dbcc32ad082d6b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3713}
{"after": {"end": 69, "start": 0, "text": "Le niraparib est un inducteur du CYP1A2 in vitro (voir rubrique 4.5).", "truncated": false}, "after_length": 69, "after_sha256": "025d086ee13cd8fcd5559dd9399f3d414e84d8c0186de8614ce1a6315508dad6", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 69, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 69}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-51360c29992147a1ae57a357", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 803}
{"after": {"end": 393, "start": 0, "text": "For rezafungin and caspofungin treatment groups, 77.0 % and 74.2 % patients, respectively, had a final diagnosis of candidaemia only. Most of them had a modified APACHE II score < 20, representing 84.4 % and 81.5 % of rezafungin and caspofungin subjects, respectively. For rezafungin and caspofungin treatment groups, 88.5 % and 91.1 % patients, respectively, had an ANC ≥ 500/mm3 at baseline.", "truncated": false}, "after_length": 393, "after_sha256": "0d977ab139c291ddaa07612527e4531dacd3df91f431e88d390142decf4d6fc0", "annex": "I", "before": {"end": 393, "start": 0, "text": "For rezafungin and caspofungin treatment groups, 70.0 % and 68.7 % patients, respectively, had a final diagnosis of candidaemia only. Most of them had a modified APACHE II score < 20, representing 84.0 % and 81.8 % of rezafungin and caspofungin subjects, respectively. For rezafungin and caspofungin treatment groups, 88.0 % and 93.9 % patients, respectively, had an ANC ≥ 500/mm3 at baseline.", "truncated": false}, "before_length": 393, "before_sha256": "ec50db0dec93f81754e7ecd80310cdc4d8408aadddd46bd48d4f7f00184299a7", "change_kind": "content", "change_operations": [{"after_end": 51, "after_start": 50, "before_end": 51, "before_start": 50, "kind": "replace"}, {"after_end": 62, "after_start": 60, "before_end": 62, "before_start": 60, "kind": "replace"}, {"after_end": 64, "after_start": 63, "before_end": 64, "before_start": 63, "kind": "replace"}, {"after_end": 201, "after_start": 200, "before_end": 201, "before_start": 200, "kind": "replace"}, {"after_end": 212, "after_start": 211, "before_end": 212, "before_start": 211, "kind": "replace"}, {"after_end": 322, "after_start": 321, "before_end": 322, "before_start": 321, "kind": "replace"}, {"after_end": 331, "after_start": 330, "before_end": 331, "before_start": 330, "kind": "replace"}, {"after_end": 333, "after_start": 332, "before_end": 333, "before_start": 332, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-51990809be94ca43d00f2f5f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 283}
{"after": {"end": 6, "start": 0, "text": "España", "truncated": false}, "after_length": 6, "after_sha256": "f85c9fe36948469b69f31fb5026694619ce4dc122757ece67c8584ff8f2ac008", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-51a44d738ac5d475222e8048", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2872}
{"after": {"end": 24, "start": 0, "text": "medischeafdeling@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "3815a916e71fc353b4410b37e0a85dede1ac350e08b8ab1461a12a1b0da71bb9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-51c339a613800a26d7640650", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2846}
{"after": {"end": 33, "start": 0, "text": "medicalinformation.italia@bms.com", "truncated": false}, "after_length": 33, "after_sha256": "7fa3fd14eb9bcefdd405cdea61ff603a046dbbe0f3ada36eb2fd672402b4e33b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-51d905d5e19d21e5508207d2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2925}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "How to use Humalog Tempo Pen", "truncated": false}, "before_length": 28, "before_sha256": "0398aa78a9e8b8401da9e8d8cff9a19d82be3780a397c43cb6ceed5489d167c6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-51d98fb4f69f3cb44730882a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9225}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovakia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7b73e721c843deabd3a181fa5d110ba6dfbdc9531c8d2e1e6545e547e02a9ef0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-523aef2b1c9d9aefa708aaa3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2920}
{"after": {"end": 50, "start": 0, "text": "Bristol-Myers Squibb Farmacêutica Portuguesa, S.A.", "truncated": false}, "after_length": 50, "after_sha256": "b45db49b9e7da10994e66b4b07970d30abee33a254211bc6a5f34f1b9db60aa0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 50, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 50}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5274b1d703aca10de1266ea0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3249}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 120, "start": 0, "text": "Your blood sugar levels may either rise or fall if you drink alcohol. Therefore the amount of insulin needed may change.", "truncated": false}, "before_length": 120, "before_sha256": "3259f09bed258c11b6dd5618b40b840fa9065929dd3e7905a2ee921fb08790a3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 120, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 120, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-52d57cec49d99f9bdbc14c0b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9287}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 62, "start": 0, "text": "Inhibition of renal uptake transporters (OAT1, OAT3, and OCT2)", "truncated": false}, "before_length": 62, "before_sha256": "41e234d73fda72d7ba37f2cda7c32abda0c5bc32f55191182f8cb08285dad024", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 62, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 62, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5368f0e10955f6ef23659cb3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1136}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "EU/1/96/007/047", "truncated": false}, "before_length": 15, "before_sha256": "f30ca5758e9452ea84ad3bb59494b72b6dc498c88b510a424c09118ac6b49046", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-53832badfc47ccac421b93d9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4747}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 47 67 55 53 50", "truncated": false}, "after_length": 21, "after_sha256": "d1b594f6660af0e3776951e66e526813a270ea883650a47e68423146b1d67dd7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-538441fb49cd3ab6f251d498", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2855}
{"after": {"end": 9, "start": 0, "text": "Slovenija", "truncated": false}, "after_length": 9, "after_sha256": "fa267dd198bd52b588eff3ae1ccd7c7ea1ac67b4d621fd44e50742c91809cac3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-53ee415d2add8e5578b77216", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3271}
{"after": {"end": 21, "start": 0, "text": "Tel: + 46 8 704 71 00", "truncated": false}, "after_length": 21, "after_sha256": "313eaeeb04c88c002b748323fb801826225906f557247264c0fcb9fc87c873fc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5424278026ae63b898cb07b3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2623}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Fabricant", "truncated": false}, "before_length": 9, "before_sha256": "169067cf6ab90924cd5082a7a6d0aac85081d5b4f04e0d28ba8141fab5cbbda6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-542de7c6dc659e8e026bfb13", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3161}
{"after": {"end": 24, "start": 0, "text": "medischeafdeling@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "3815a916e71fc353b4410b37e0a85dede1ac350e08b8ab1461a12a1b0da71bb9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-542e03199d15d69dd1905a60", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3214}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "before_length": 7, "before_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-543506aaf8d6343252e202e9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9526}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "17. UNIQUE IDENTIFIER – 2D BARCODE", "truncated": false}, "before_length": 34, "before_sha256": "bc158365115e0908119e4f2782a562abac5f0b5b80024210ee67676cff8a06c5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-54642c89929f156fa9e90690", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4668}
{"after": {"end": 19, "start": 0, "text": "Slovenská republika", "truncated": false}, "after_length": 19, "after_sha256": "8667151da5d74cf45a2b263a2f7b38e944fd51f34b51e08d79151f123b8f10b2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-547e6d782d039069a23e5a63", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2913}
{"after": {"end": 6, "start": 0, "text": "Ísland", "truncated": false}, "after_length": 6, "after_sha256": "5801902efe8b92c2ace1332f4cca2ea1fcb704712e2fe7ca66654d2a826e8451", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-548383cc75b9bc281c750316", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2912}
{"after": {"end": 13, "start": 0, "text": "1932 Zaventem", "truncated": false}, "after_length": 13, "after_sha256": "cffe4475a5de91da7a3a6363a4d41ccfd1405766d95ae182d89bf39b29686221", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "1930 Zaventem", "truncated": false}, "before_length": 13, "before_sha256": "ed9ea9385e3e50f6278214da5d7483a8543c36d1261df263d35022c5936c74db", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 4, "before_start": 3, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-548e3ca653e00b779add34ee", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2593}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 26, "start": 0, "text": "16. INFORMATION IN BRAILLE", "truncated": false}, "before_length": 26, "before_sha256": "c69cdeadf8c5d34e36f9bf5d6949c41517313f63407e7b6ac6908bbe7ad76cfd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 26, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 26, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-54a0dd925c5eff6b6dbabfc9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4663}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 131, "start": 0, "text": "Read the instructions on how to use your pre-filled insulin pen. Please follow the instructions carefully. Here are some reminders.", "truncated": false}, "before_length": 131, "before_sha256": "9610b5d3bbbe51f320ec25f993c063537ce5c3e3ebc30ee83f80149224358497", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 131, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 131, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-54b3301e17c033eab75b7ea7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9317}
{"after": {"end": 22, "start": 0, "text": "Tel: + 420 221 016 111", "truncated": false}, "after_length": 22, "after_sha256": "4d518854d9706e629e406bc93cfad10898d14ad223a3d403070c562115da215f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-54bf3f807d9704eb1db3ce9f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2514}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 22, "start": 0, "text": "Polysorbate 20 (E 432)", "truncated": false}, "before_length": 22, "before_sha256": "0ee813d934008cf7cf6398095de99b6669ab4ef22e81209ed44fe94a3563fe89", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-54d786a20d849cb0b76632bc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1366}
{"after": {"end": 311, "start": 0, "text": "Niraparib was moderately protein bound in human plasma (83%), mainly with serum albumin. In a population pharmacokinetic analysis of niraparib, the apparent volume of distribution (Vd/F) was 1,206 L (based on a 70 kg patient) in cancer patients (CV 18.4%), indicating extensive tissue distribution of niraparib.", "truncated": false}, "after_length": 311, "after_sha256": "142cd541b16a2a65c60cf37baac238c566e7f2dc07cb97cc89e14beb962360d7", "annex": "I", "before": {"end": 310, "start": 0, "text": "Niraparib was moderately protein bound in human plasma (83%), mainly with serum albumin. In a population pharmacokinetic analysis of niraparib, the apparent volume of distribution (Vd/F) was 1,311 L (based on a 70 kg patient) in cancer patients (CV 116%), indicating extensive tissue distribution of niraparib.", "truncated": false}, "before_length": 310, "before_sha256": "1a2a3565067a29cf293ee1c19310afa854aa32ae3408e9aa96b109e12b4973ec", "change_kind": "content", "change_operations": [{"after_end": 196, "after_start": 193, "before_end": 196, "before_start": 193, "kind": "replace"}, {"after_end": 253, "after_start": 250, "before_end": 252, "before_start": 250, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-54ea1bda788a792706a53f58", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 767}
{"after": {"end": 38, "start": 0, "text": "Tel: 0800 0752002 (+ 49 89 121 42 350)", "truncated": false}, "after_length": 38, "after_sha256": "a6e565b385c2fd58348adaaec0d48f14b092e8ceadc07f5c2358d6c3e3ac6b0f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5509352fdf4b33d8c61448d3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2534}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "Hafnerstraße 36", "truncated": false}, "before_length": 15, "before_sha256": "2fcce2f98396d52bbfd5728e1a018b4f5e6a7c25edffb18410df25f808883c4f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5514cd529a5f93bf11986de9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2438}
{"after": {"end": 15, "start": 0, "text": "Mooswaldallee 1", "truncated": false}, "after_length": 15, "after_sha256": "1e40171920c816abab0899460801029151a2b4c2a16616d1073209a0db469b6a", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-55268359817591505e2aa178", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1494}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 25, "start": 0, "text": "Astellas Ireland Co. Ltd.", "truncated": false}, "before_length": 25, "before_sha256": "1d98a06d2f724f3f69491c40480991ee287d2e3806d862b6ab226d0b620c6885", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-55375446e7f63410bc0ad458", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1003}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "danazol,", "truncated": false}, "before_length": 8, "before_sha256": "99e675f329a3a4764bcfa7f625406c4bdb0c9b8151c4aecf7c6685fcf62507b1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-553e70ad6b7fa7db0e2c7bb1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9280}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "sulpha antibiotics,", "truncated": false}, "before_length": 19, "before_sha256": "36ac12ba9c79cfb69e7ddbd432c4b475f5a43efcac136f91234e5393a07d9814", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-555cb01455c226051a0dbd0d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9275}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 17, "start": 0, "text": "Humalog Tempo Pen", "truncated": false}, "before_length": 17, "before_sha256": "328b8ad146aa9789b611fca56a42e321b79e5aecd24d0cc297eae30f99fae229", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5585c24ad3f34260eb033d8a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 119}
{"after": {"end": 342, "start": 0, "text": "Si vous vomissez après avoir pris ce médicament et que vous retrouvez le comprimé de Vyndaqel intact, alors vous devez prendre une dose supplémentaire le même jour ; si vous ne pouvez pas retrouver le comprimé de Vyndaqel, alors vous ne devez pas prendre de dose additionnelle, et vous devez prendre Vyndaqel le jour suivant comme d’habitude.", "truncated": false}, "after_length": 342, "after_sha256": "00063ba379dfd01bd574e90523aa62f4054338bcf0a7d2f20551e6b728f7902e", "annex": "IIIA", "before": {"end": 341, "start": 0, "text": "Si vous vomissez après avoir pris ce médicament et que vous retrouvez la capsule de Vyndaqel intacte, alors vous devez prendre une dose supplémentaire le même jour ; si vous ne pouvez pas retrouver la capsule de Vyndaqel, alors vous ne devez pas prendre de dose additionnelle, et vous devez prendre Vyndaqel le jour suivant comme d’habitude.", "truncated": false}, "before_length": 341, "before_sha256": "f463459ef4c68c3f4fdf272061f0f0ae14f17ba10ac60ff00c614261ac4168bb", "change_kind": "content", "change_operations": [{"after_end": 72, "after_start": 71, "before_end": 72, "before_start": 71, "kind": "replace"}, {"after_end": 76, "after_start": 74, "before_end": 75, "before_start": 74, "kind": "replace"}, {"after_end": 81, "after_start": 77, "before_end": 80, "before_start": 76, "kind": "replace"}, {"after_end": 100, "after_start": 100, "before_end": 100, "before_start": 99, "kind": "delete"}, {"after_end": 200, "after_start": 199, "before_end": 200, "before_start": 199, "kind": "replace"}, {"after_end": 204, "after_start": 202, "before_end": 203, "before_start": 202, "kind": "replace"}, {"after_end": 209, "after_start": 205, "before_end": 208, "before_start": 204, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-55aab866c91bf2a40c841d7b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3637}
{"after": {"end": 20, "start": 0, "text": "Tel: + 43 1 60 14 30", "truncated": false}, "after_length": 20, "after_sha256": "06513bb4e3ff06e9885e8395f2d87e81d050e28b69385dc8158cf331179a64c6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-55ce55331c6bd2a7402a67a1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3233}
{"after": {"end": 311, "start": 0, "text": "Niraparib is an inhibitor of MATE1 and -2K in vitro. Plasma concentrations of metformin may increase when concomitantly administered with niraparib. Close monitoring of glycaemia is recommended when starting or stopping niraparib in patients receiving metformin. A dose adjustment of metformin may be necessary.", "truncated": false}, "after_length": 311, "after_sha256": "0a72db82d9a4938ca1e4a3f878258b386b15fd5aeda14b997062c194046fd31a", "annex": "I", "before": {"end": 239, "start": 0, "text": "Niraparib is an inhibitor of MATE1 and -2 with IC50 of 0.18 µM and ≤0.14 µM, respectively. Increased plasma concentrations of co-administered medicinal products that are substrates of these transporters (e.g. metformin) cannot be excluded.", "truncated": false}, "before_length": 239, "before_sha256": "00f31228d04e7b6cd97793fc9684b4c70242fe9aca1150e425865dda6bc4b70f", "change_kind": "content", "change_operations": [{"after_end": 42, "after_start": 41, "before_end": 41, "before_start": 41, "kind": "insert"}, {"after_end": 47, "after_start": 43, "before_end": 43, "before_start": 42, "kind": "replace"}, {"after_end": 50, "after_start": 49, "before_end": 52, "before_start": 45, "kind": "replace"}, {"after_end": 51, "after_start": 51, "before_end": 89, "before_start": 53, "kind": "delete"}, {"after_end": 54, "after_start": 53, "before_end": 102, "before_start": 91, "kind": "replace"}, {"after_end": 106, "after_start": 78, "before_end": 126, "before_start": 126, "kind": "insert"}, {"after_end": 120, "after_start": 108, "before_end": 129, "before_start": 128, "kind": "replace"}, {"after_end": 155, "after_start": 133, "before_end": 142, "before_start": 142, "kind": "insert"}, {"after_end": 158, "after_start": 156, "before_end": 145, "before_start": 143, "kind": "replace"}, {"after_end": 162, "after_start": 159, "before_end": 147, "before_start": 146, "kind": "replace"}, {"after_end": 165, "after_start": 164, "before_end": 180, "before_start": 149, "kind": "replace"}, {"after_end": 195, "after_start": 169, "before_end": 185, "before_start": 184, "kind": "replace"}, {"after_end": 199, "after_start": 197, "before_end": 187, "before_start": 187, "kind": "insert"}, {"after_end": 207, "after_start": 200, "before_end": 189, "before_start": 188, "kind": "replace"}, {"after_end": 212, "after_start": 208, "before_end": 190, "before_start": 190, "kind": "insert"}, {"after_end": 222, "after_start": 213, "before_end": 191, "before_start": 191, "kind": "insert"}, {"after_end": 231, "after_start": 224, "before_end": 193, "before_start": 193, "kind": "insert"}, {"after_end": 233, "after_start": 232, "before_end": 195, "before_start": 194, "kind": "replace"}, {"after_end": 235, "after_start": 234, "before_end": 198, "before_start": 196, "kind": "replace"}, {"after_end": 237, "after_start": 236, "before_end": 199, "before_start": 199, "kind": "insert"}, {"after_end": 240, "after_start": 238, "before_end": 201, "before_start": 200, "kind": "replace"}, {"after_end": 243, "after_start": 242, "before_end": 204, "before_start": 203, "kind": "replace"}, {"after_end": 250, "after_start": 244, "before_end": 206, "before_start": 205, "kind": "replace"}, {"after_end": 251, "after_start": 251, "before_end": 208, "before_start": 207, "kind": "delete"}, {"after_end": 262, "after_start": 261, "before_end": 219, "before_start": 218, "kind": "replace"}, {"after_end": 270, "after_start": 263, "before_end": 221, "before_start": 220, "kind": "replace"}, {"after_end": 278, "after_start": 271, "before_end": 222, "before_start": 222, "kind": "insert"}, {"after_end": 292, "after_start": 279, "before_end": 223, "before_start": 223, "kind": "insert"}, {"after_end": 297, "after_start": 293, "before_end": 226, "before_start": 224, "kind": "replace"}, {"after_end": 302, "after_start": 301, "before_end": 230, "before_start": 230, "kind": "insert"}, {"after_end": 303, "after_start": 303, "before_end": 232, "before_start": 231, "kind": "delete"}, {"after_end": 304, "after_start": 304, "before_end": 236, "before_start": 233, "kind": "delete"}, {"after_end": 310, "after_start": 305, "before_end": 238, "before_start": 237, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 108, "chars_inserted": 180}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-55e73db364c95254df827451", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1127}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Dose Knob", "truncated": false}, "before_length": 9, "before_sha256": "a20cc7665b42baee21dd248e2b47f343376758f69f6c42f26e3d8f4dddf3a2c5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-55eca6b4a8c50e437b3a5b53", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9609}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 237, "start": 0, "text": "Le niraparib n’a pas montré d’effet inhibiteur sur les isoformes UGT (UGT1A1, UGT1A4, UGT1A9, et UGT2B7) jusqu’à 200 µM in vitro. Par conséquent, le potentiel d’une inhibition cliniquement pertinente des UGTs par le niraparib est minime.", "truncated": false}, "before_length": 237, "before_sha256": "c2857c82815bea6c36ecb1c43ea95de23cd0b692b565463efc801e80cb030364", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 237, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 237, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5603ae03b6150c8ea131cb09", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 263}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: + 353 18711600", "truncated": false}, "before_length": 19, "before_sha256": "f39469e1bbd519f10406ae27e104b0e2fb101791df45c4e53cc539ee02b84821", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-560eafa85c44656f34f29490", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3368}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "• Select a new needle.", "truncated": false}, "before_length": 22, "before_sha256": "14e89a3204a7b3555db6a8f5efdc1336b197e104cd242ca1599c3c782cc61e7e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5631b55ca4a38cea2d18dc71", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9643}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tlf.: +45 45 26 6000", "truncated": false}, "before_length": 20, "before_sha256": "a719d7ca15728f10b628e55f73243bc9f6b09ecb9989fa292f680f0fb03041c8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-56404f813e90965d19908464", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9479}
{"after": {"end": 20, "start": 0, "text": "Swixx Biopharma EOOD", "truncated": false}, "after_length": 20, "after_sha256": "27f5284d414219f28c8c91886b89df13d6ef413ca05a03cdd596d9c697d6c0ea", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-56571d3203847ece4edd6e26", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2497}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 49, "start": 0, "text": "What Humalog Tempo Pen is and what it is used for", "truncated": false}, "before_length": 49, "before_sha256": "1b7df8116f695f7816746673b25aecf42d3bbbdc9fa89e3a98c68fb0072101f9", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 49, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 49, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-56b759c567887779b3afe9c8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9223}
{"after": {"end": 10, "start": 0, "text": "Österreich", "truncated": false}, "after_length": 10, "after_sha256": "b1b763860d4f30c2e1feafdcd57b714a1422b4fbc1a93d94969118a0faa65288", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 10}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-56c96fb2c5eb028f84390be6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3228}
{"after": {"end": 222, "start": 0, "text": "Niraparib is a substrate of Pgp and BCRP. However, due to niraparib’s high permeability and bioavailability, the risk of clinically relevant interactions with medicinal products that inhibit these transporters is unlikely.", "truncated": false}, "after_length": 222, "after_sha256": "c4aa6e51dd945089b63d99cfa75d9f5d24ce6b92b5b5931c2cb3d7f6746a00ef", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 222, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 222}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-56d0014f573ffa74c3f98629", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 783}
{"after": {"end": 50, "start": 0, "text": "Bristol-Myers Squibb Farmacêutica Portuguesa, S.A.", "truncated": false}, "after_length": 50, "after_sha256": "b45db49b9e7da10994e66b4b07970d30abee33a254211bc6a5f34f1b9db60aa0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 50, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 50}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-56d2f0ee632fb9a3796a6e67", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2884}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 58, "start": 0, "text": "11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "truncated": false}, "before_length": 58, "before_sha256": "f673fc8d85353a41392579def66f2174386940ef53d65631a983cd19732f9497", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 58, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 58, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-56e7beeeae1cd9420669095e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4837}
{"after": {"end": 37, "start": 0, "text": "BristolMyers Squibb Polska Sp. z o.o.", "truncated": false}, "after_length": 37, "after_sha256": "879c6157ffdbde9480d5a62d5589e727166123ced2dd83568a6d587ba5052589", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-56ed3c5654df23730efc4b7c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2878}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-56fff0e7fcd8a07092093b54", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3299}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 2, "start": 0, "text": "Ou", "truncated": false}, "before_length": 2, "before_sha256": "fb2c7d8dd35f85951b7c92b4b4c3b7332d67bb93c82a2b3303eb2106251bc75c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-570d6608d129ce832c0ed4cf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3717}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 25, "start": 0, "text": "Astellas Ireland Co. Ltd.", "truncated": false}, "before_length": 25, "before_sha256": "1d98a06d2f724f3f69491c40480991ee287d2e3806d862b6ab226d0b620c6885", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-571f216a028936591c5dd9a4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 985}
{"after": {"end": 119, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu", "truncated": false}, "after_length": 119, "after_sha256": "0f2b81ab8009e1a279ca008eb6e21bdb2e532de63aef52b62bdac980c49555d4", "annex": "IIIA", "before": {"end": 93, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site:", "truncated": false}, "before_length": 93, "before_sha256": "1c2e788d78bca4cef615d8e7fe8e0268db2345fae4c6f39add7db65e179edffe", "change_kind": "content", "change_operations": [{"after_end": 119, "after_start": 93, "before_end": 93, "before_start": 93, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-57236325caf4dc9b652c8ca3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2839}
{"after": {"end": 30, "start": 0, "text": "BristolMyers Squibb Aktiebolag", "truncated": false}, "after_length": 30, "after_sha256": "9c7a7f4a2d4615c649fd8b61a4a516d07f947239591e0ac22650195cdcec2547", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 30, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 30}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-572c50ac2f15b2bf9db5d925", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2628}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 88, "start": 0, "text": "Niraparib comme substrat des transporteurs d’influx hépatique (OATP1B1, OATP1B3 et OCT1)", "truncated": false}, "before_length": 88, "before_sha256": "937894bdc6cac5307488993f4f2e8a90500681035be6bbd0431e25bd394310f5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 88, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-57356e305514de37fe25b615", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1137}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Fresenius Kabi Austria GmbH", "truncated": false}, "before_length": 27, "before_sha256": "fa59d2b0c9ce4abc55a3051cb227907a12a3a3e7fc63908aaebeb76ac9f651ef", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5735e9390104d6bdfd3c41f5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3123}
{"after": {"end": 29, "start": 0, "text": "Pelliculage (Opadry TF blanc)", "truncated": false}, "after_length": 29, "after_sha256": "869887d5c7a32bab33136c44aecc88ef9c27835afce30528325b45d2a13d4118", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 29, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 29}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-576e6b650f64a61bd2ba2d4b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1888}
{"after": {"end": 39, "start": 0, "text": "diminution des globules rouges (anémie)", "truncated": false}, "after_length": 39, "after_sha256": "582ec73ef06cce5624fee97288f8a2f59c8a86a0cb7d939babcb252c4b416e8b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 39, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 39}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5784bb807726f5193268685a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 896}
{"after": {"end": 11, "start": 0, "text": "Formycon AG", "truncated": false}, "after_length": 11, "after_sha256": "fccef1aaaa56a3d37990d6179dbede326f4022a38ec5c503d32cfc14c28d9608", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-57a4716e501e52c7c6f41850", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1701}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-57acdcd74a0c1a6700c1845a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2861}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma SIA", "truncated": false}, "after_length": 19, "after_sha256": "6da5006887c3e11cf19ecbe52bdc7a386838e93f6e63f315e575cb7df7747f15", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-57b9a0333c6909f8a3f8ff4d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2939}
{"after": {"end": 26, "start": 0, "text": "Tél: + 33 (0)1 58 83 84 96", "truncated": false}, "after_length": 26, "after_sha256": "331bde6d3ceed373ca2a62d0d499d6fe72853e6ae69fb08f092c7712a9ad1d3e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-57c211b710d163e9151e7716", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2568}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 40, "start": 0, "text": "• Labels: White with Burgundy colour bar", "truncated": false}, "before_length": 40, "before_sha256": "b1d4145064a504f4ede4f564c72df44101301d33d5fdf542a63d5cec4db229b7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 40, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 40, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-57d4c8a389f80582744d097a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9622}
{"after": {"end": 15, "start": 0, "text": "infomed@bms.com", "truncated": false}, "after_length": 15, "after_sha256": "66e67860f3e4742344d5e1cd7f07326ac1d6946e02f492fa89340b12edd31c8f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-57edbe54fc6b8ed30556ba05", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2881}
{"after": {"end": 17, "start": 0, "text": "Subcutaneous use.", "truncated": false}, "after_length": 17, "after_sha256": "8217ef65631178af796477e15d3ae5d09b5aa20a2ada83115f79b0fb28d140bd", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Subcutaneous use", "truncated": false}, "before_length": 16, "before_sha256": "363fd22613abec178143cdac0b1a34f04ee8ccdaa7d6988b3722fa7540374cde", "change_kind": "content", "change_operations": [{"after_end": 17, "after_start": 16, "before_end": 16, "before_start": 16, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5804b2eadaa5b51eb25cd368", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 808}
{"after": {"end": 65, "start": 0, "text": "Chaque comprimé contient 139,63 mg de lactose monohydraté (E 24).", "truncated": false}, "after_length": 65, "after_sha256": "25ad9e293cf578ec42b8446c73f6e512db6d470b8d33f2379303fd51e305cb4c", "annex": "I", "before": {"end": 71, "start": 0, "text": "Chaque capsule molle ne contient pas plus de 44 mg de sorbitol (E 420).", "truncated": false}, "before_length": 71, "before_sha256": "1de8c718eb958d1b7b51aa849cf6bd6d1fccfc51cc0617c3a854f2bc1d22a738", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 8, "before_end": 9, "before_start": 8, "kind": "replace"}, {"after_end": 13, "after_start": 11, "before_end": 15, "before_start": 10, "kind": "replace"}, {"after_end": 15, "after_start": 14, "before_end": 23, "before_start": 16, "kind": "replace"}, {"after_end": 31, "after_start": 25, "before_end": 47, "before_start": 33, "kind": "replace"}, {"after_end": 41, "after_start": 38, "before_end": 59, "before_start": 54, "kind": "replace"}, {"after_end": 57, "after_start": 43, "before_end": 62, "before_start": 61, "kind": "replace"}, {"after_end": 62, "after_start": 61, "before_end": 66, "before_start": 66, "kind": "insert"}, {"after_end": 63, "after_start": 63, "before_end": 69, "before_start": 67, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 29}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-580de864732caea497c99401", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "2", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1211}
{"after": {"end": 30, "start": 0, "text": "BristolMyers Squibb Aktiebolag", "truncated": false}, "after_length": 30, "after_sha256": "9c7a7f4a2d4615c649fd8b61a4a516d07f947239591e0ac22650195cdcec2547", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 30, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 30}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5814ab88cecde2a7677520e9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3302}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 120, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu.", "truncated": false}, "before_length": 120, "before_sha256": "4531b88088f201341aeac319894fe4addc485ddec7289bfb799fa5bfa043c6bb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 120, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 120, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-582a676fe33580c06d68a872", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9567}
{"after": {"end": 6, "start": 0, "text": "Italia", "truncated": false}, "after_length": 6, "after_sha256": "a7ca3e3d756601d5a22a4c0d8629da0c0ce425e5be526078d3e4583737150f52", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5844751a66db25d1e28134e0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2918}
{"after": {"end": 20, "start": 0, "text": "Tel: + 370 52 369140", "truncated": false}, "after_length": 20, "after_sha256": "8a995c3bfc3c0427235c993d1d1f2ebdd1b1443c434cbb3e015f99728e5b363f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5848ea14f41b2ba97e13b7f2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3173}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "insulin lispro", "truncated": false}, "before_length": 14, "before_sha256": "1ca88cfa41606b28145f703442bf3c0e5efa0967c7177f9c26ed091d4c7a140d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5862ae809ead9790e25cf0eb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4590}
{"after": {"end": 458, "start": 0, "text": "Après l’administration d’une dose unique de 300 mg de niraparib à jeun, le niraparib était mesurable dans le plasma dans les 30 minutes et la concentration plasmatique maximale moyenne (Cmax) pour le niraparib était atteinte en 3 à 5 heures (variant entre 508 et 875 ng/mL selon les études). Après des doses orales multiples de niraparib comprises entre 30 mg et 400 mg une fois par jour, l’accumulation de niraparib était environ 2 à 3 fois plus importante.", "truncated": false}, "after_length": 458, "after_sha256": "a437a2209e782f7c9b0b971215536a263548535b145477552be1da9ac1066bbd", "annex": "I", "before": {"end": 440, "start": 0, "text": "Après l’administration d’une dose unique de 300 mg de niraparib à jeun, le niraparib était mesurable dans le plasma dans les 30 minutes et la concentration plasmatique maximale moyenne (Cmax) pour le niraparib était atteinte en 3 heures environ [804 ng/mL (% CV : 50,2 %)]. Après des doses orales multiples de niraparib comprises entre 30 mg et 400 mg une fois par jour, l’accumulation de niraparib était environ 2 à 3 fois plus importante.", "truncated": false}, "before_length": 440, "before_sha256": "56acd87f07a2b8bf33eab0527170c7bbfa52fed2fccc565b005f0843ea11edb1", "change_kind": "content", "change_operations": [{"after_end": 234, "after_start": 230, "before_end": 230, "before_start": 230, "kind": "insert"}, {"after_end": 250, "after_start": 241, "before_end": 237, "before_start": 237, "kind": "insert"}, {"after_end": 253, "after_start": 252, "before_end": 241, "before_start": 239, "kind": "replace"}, {"after_end": 255, "after_start": 254, "before_end": 244, "before_start": 242, "kind": "replace"}, {"after_end": 258, "after_start": 256, "before_end": 246, "before_start": 245, "kind": "replace"}, {"after_end": 266, "after_start": 259, "before_end": 249, "before_start": 247, "kind": "replace"}, {"after_end": 278, "after_start": 273, "before_end": 258, "before_start": 256, "kind": "replace"}, {"after_end": 282, "after_start": 279, "before_end": 261, "before_start": 259, "kind": "replace"}, {"after_end": 289, "after_start": 283, "before_end": 270, "before_start": 262, "kind": "replace"}, {"after_end": 290, "after_start": 290, "before_end": 272, "before_start": 271, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-58881f081556ab2e46addfc3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1667}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-58e227173b6b90834d9c5dc3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2931}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 2, "start": 0, "text": "Or", "truncated": false}, "before_length": 2, "before_sha256": "0568bd03b8eb6cca2799770a3cb2b2d342e9ae7a8032e8aac7b948341807d7c4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5955e836f0c1eee84b27158d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3222}
{"after": {"end": 5, "start": 0, "text": "Dánia", "truncated": false}, "after_length": 5, "after_sha256": "6b2bf8c68ea8941b06707cb569cdff6f0c6f5f221eb2857ea1bef2fff7977063", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5974aff761a9d65d64e664f8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2040}
{"after": {"end": 28, "start": 0, "text": "Bristol-Myers Squibb Denmark", "truncated": false}, "after_length": 28, "after_sha256": "8501478e0a326a4274e1997e52efffb9adb21eb72ddc27015fc279a4b660a655", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 28, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 28}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5979423ec913a4f74abd24af", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2517}
{"after": {"end": 21, "start": 0, "text": "Τηλ: + 30 210 6074300", "truncated": false}, "after_length": 21, "after_sha256": "c10bf95f55d88eadacbbac2970ab7bef5bd625d01122a54ba6a3bd30eae65368", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-598882e6d38de6f7c452097f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2860}
{"after": {"end": 21, "start": 0, "text": "Tlf.: +45 45 26 60 00", "truncated": false}, "after_length": 21, "after_sha256": "6bdd3c845f6a6e520023cbb8b3726e2eefc4bc4ac00ae57245f3055e31d53895", "annex": "III", "before": {"end": 20, "start": 0, "text": "Tlf: +45 45 26 60 00", "truncated": false}, "before_length": 20, "before_sha256": "7932ef9452966b997a4a22618abb01fb644277c9ab041214e6264730772b2d64", "change_kind": "unassigned", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-598cb763436dda43191aca68", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2509}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 76, "start": 0, "text": "Niraparib as a substrate of renal uptake transporters (OAT1, OAT3, and OCT2)", "truncated": false}, "before_length": 76, "before_sha256": "034c9568bfc4d66b369e9e990b582c6c4a9a86ae4113817124df8b43913cdd33", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 76, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 76, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-59cf9071b1ca7498344cada9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1106}
{"after": {"end": 9, "start": 0, "text": "Nederland", "truncated": false}, "after_length": 9, "after_sha256": "8a869db3fa453526573e4f2c956528743cf246af5d1b5eac4879257589776797", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-59d324ba003927e4ea5a9ced", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2537}
{"after": {"end": 25, "start": 0, "text": "Utilisation sous-cutanée.", "truncated": false}, "after_length": 25, "after_sha256": "fff2d0fc9e9003d4a1e00c04e7e0bb5ae61d9cf5d3ad4c04919356b6db350f7c", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Utilisation sous-cutanée", "truncated": false}, "before_length": 24, "before_sha256": "9d4e4e353ddc84d14ff6ab682d5e9b5667e6b3406e44294ca5126a692856c758", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 24, "before_end": 24, "before_start": 24, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-59dca6a330092b06fe5b699f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1026}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 388, "start": 0, "text": "Niraparib is a substrate of carboxylesterases (CEs) and UDPglucuronosyltransferases (UGTs) in vivo. Oxidative metabolism of niraparib is minimal in vivo. No dose adjustment for Zejula is required when administered concomitantly with medicinal products known to inhibit (e.g. itraconazole, ritonavir, and clarithromycin) or induce CYP enzymes (e.g. rifampin, carbamazepine, and phenytoin).", "truncated": false}, "before_length": 388, "before_sha256": "84bc46b6b0dd077561ee7718c51b3a3306816acb4958db29a815b5b97d3a204d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 388, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 388, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5a5520b5f73f8e5381a5257c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 233}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "• If the dose knob is hard to push:", "truncated": false}, "before_length": 35, "before_sha256": "da829d797c83300983b2a01a82dee6874c19df4f15484b9740882b015acc6552", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5a60ab7e8d2767182e13bb8a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9802}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovenia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "fce1e60bbc59ee3c381de461f412175da197c866a89ba45b24c7794f59b5c833", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5a721c02460b77d588ce4c6f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2600}
{"after": {"end": 107, "start": 0, "text": "- if you are allergic to icatibant, or any of the other ingredients of this medicine (listed in section 6).", "truncated": false}, "after_length": 107, "after_sha256": "0e3b68515321dd55b53e88ecb7f1f4d598e0d08c3ae3b86446f743079ad93c94", "annex": "IIIA", "before": {"end": 107, "start": 0, "text": "- If you are allergic to icatibant, or any of the other ingredients of this medicine (listed in section 6).", "truncated": false}, "before_length": 107, "before_sha256": "ad460fd2d6056f420ea363a40659978308c2648677e7faa89ccacd195ff6bc93", "change_kind": "content", "change_operations": [{"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5ae0591567567c5ec51a6c4f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1208}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 9, "start": 0, "text": "Tempo Pen", "truncated": false}, "before_length": 9, "before_sha256": "bbaa539d8be51b8c4a68814d8f14baf6584114fa65db0d19590da5646f182385", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5b1dee035b48e6e5b3485818", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 187}
{"after": {"end": 119, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu", "truncated": false}, "after_length": 119, "after_sha256": "0f2b81ab8009e1a279ca008eb6e21bdb2e532de63aef52b62bdac980c49555d4", "annex": "IIIA", "before": {"end": 93, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site:", "truncated": false}, "before_length": 93, "before_sha256": "1c2e788d78bca4cef615d8e7fe8e0268db2345fae4c6f39add7db65e179edffe", "change_kind": "content", "change_operations": [{"after_end": 119, "after_start": 93, "before_end": 93, "before_start": 93, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5b22b71acead0bcb8a4cc119", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3415}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovakia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7b73e721c843deabd3a181fa5d110ba6dfbdc9531c8d2e1e6545e547e02a9ef0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5b33645fe9c95bd4afe26702", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2604}
{"after": {"end": 27, "start": 0, "text": "Bristol-Myers Squibb GesmbH", "truncated": false}, "after_length": 27, "after_sha256": "4916681fe99630afcd464062529e9edf6fd8370e6c9aae947ff9ed0076180f67", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5b596e94978bf0a2641689a3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2552}
{"after": {"end": 21, "start": 0, "text": "Tlf.: +45 45 26 60 00", "truncated": false}, "after_length": 21, "after_sha256": "6bdd3c845f6a6e520023cbb8b3726e2eefc4bc4ac00ae57245f3055e31d53895", "annex": "III", "before": {"end": 20, "start": 0, "text": "Tlf: +45 45 26 60 00", "truncated": false}, "before_length": 20, "before_sha256": "7932ef9452966b997a4a22618abb01fb644277c9ab041214e6264730772b2d64", "change_kind": "unassigned", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5b5a703cdf73e53f5923a954", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2811}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5b8f3f1be3e3e23bed36667a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3226}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Paper Tab", "truncated": false}, "before_length": 9, "before_sha256": "ae0981d053206f9d94ae9bb7078e0b4dd6c7df83f2ab5479ebefc8fb4d718444", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5bb58998e1714d60c44ecdb5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9607}
{"after": {"end": 9, "start": 0, "text": "Nederland", "truncated": false}, "after_length": 9, "after_sha256": "8a869db3fa453526573e4f2c956528743cf246af5d1b5eac4879257589776797", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5bc6bccb9c671760c144a0c0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2531}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 88, "start": 0, "text": "• If you do not prime before each injection, you may get too much or too little insulin.", "truncated": false}, "before_length": 88, "before_sha256": "b1e69ce20474de4c57b6fe6ad17605bd34c4d5f9f36323c96994cddf2bf1fe0c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 88, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5bcff3253008e8f7889c7a14", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9661}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovenia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "fce1e60bbc59ee3c381de461f412175da197c866a89ba45b24c7794f59b5c833", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5c17799b85e2409b8dcdba48", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3274}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "medinfoEMEA@takeda.com", "truncated": false}, "before_length": 22, "before_sha256": "0b528beef8e2100b7b7858e530b1b7c3aef82177c70474bdbac5f59bc1ba4394", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5c3bbb56dd23a4344463dc6e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1687}
{"after": {"end": 20, "start": 0, "text": "medwiss.info@bms.com", "truncated": false}, "after_length": 20, "after_sha256": "bc2238e490f9b59d01a00ccab422d2de7eb7937e564268c4e82d2e78b72b3340", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5c6ecc4d56e44cffe1016e68", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2845}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "3. EXPIRY DATE", "truncated": false}, "before_length": 14, "before_sha256": "9e5c6a238a11937a91757de657178046d1ce022e5a3e81cff963e959d332f9e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5c825bfd8b03cb92306efc5a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4890}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "acetyl salicylic acid,", "truncated": false}, "before_length": 22, "before_sha256": "a71582ddccafa5665513a322da23f98b310e29d498abf654e96ef4d101777671", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5c9640cf58b9d735df28a209", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9274}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5cb2475254a38788cd566efb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2536}
{"after": {"end": 64, "start": 0, "text": "Chaque comprimé pelliculé contient 61 mg de tafamidis micronisé.", "truncated": false}, "after_length": 64, "after_sha256": "339dd9790c9d8505120f5260ea42332d035d9cbe7be60692f47c54e91c7269a8", "annex": "I", "before": {"end": 59, "start": 0, "text": "Chaque capsule molle contient 61 mg de tafamidis micronisé.", "truncated": false}, "before_length": 59, "before_sha256": "62349ebf6caeb411e75699119a0c82956a3808b47d91005ac69c7609bb490345", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 8, "before_end": 9, "before_start": 8, "kind": "replace"}, {"after_end": 22, "after_start": 11, "before_end": 11, "before_start": 10, "kind": "replace"}, {"after_end": 25, "after_start": 24, "before_end": 20, "before_start": 13, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5cb76746fe9fa583b4df0050", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "2", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1207}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Austria", "truncated": false}, "before_length": 7, "before_sha256": "c9cab0238debc6e55498e2c0963a1d8e25bd29c95ddd53a3fff841ee636b6bc5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5cd6432e28c38892842cbd7b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2746}
{"after": {"end": 7, "start": 0, "text": "Danmark", "truncated": false}, "after_length": 7, "after_sha256": "b2bebaaf55198f3166a7d7089112d30e245d6cf4a3249ae87b597fa988e7f1be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5d00b58677e17386f6dc260d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2522}
{"after": {"end": 171, "start": 0, "text": "This document is the approved product information for Humalog, with the changes since the previous procedure affecting the product information (EMA/VR/0000315488) tracked.", "truncated": false}, "after_length": 171, "after_sha256": "712196f2d00025b37936b4289735409e20e871b6219c0303fbeb71bfd2eba833", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 171, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 171}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5d0c2845a919d3a9ee9affba", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 0}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 78, "start": 0, "text": "• Always carry a spare pen in case you lose your Tempo Pen or it gets damaged.", "truncated": false}, "before_length": 78, "before_sha256": "64e5cea9513afa1182fcee3b4ad1753f3e559bb2491c904f28d80e11c807ac6e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 78, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 78, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5d1494498da84031d1db6bfb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9353}
{"after": {"end": 19, "start": 0, "text": "Lactose monohydrate", "truncated": false}, "after_length": 19, "after_sha256": "ac72e59e3fda05d1731335e737836cb337107c92b6a03f58389ce74a0f931146", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5da6dffdb0eeae9f24136967", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1008}
{"after": {"end": 94, "start": 0, "text": "Aucune étude clinique sur les interactions médicamenteuses n'a été réalisée avec le niraparib.", "truncated": false}, "after_length": 94, "after_sha256": "2b692a66c93b68cb0c7278e688706396e7da6845710f869bb2bf611f7efb7dde", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 94, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 94}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5de0a868cda336ab99bcb84a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 237}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 66, "start": 0, "text": "– Pushing the dose knob more slowly will make it easier to inject.", "truncated": false}, "before_length": 66, "before_sha256": "46707d051fc470099d8c7403bf26a6359b24761a1181769629fb1bee78390e75", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 66, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 66, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5df726dcad04f858ed4e904e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9803}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5e0fd66aad08042986a4db38", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2595}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "4. Possible side effects", "truncated": false}, "before_length": 24, "before_sha256": "fc728d35ab4460e2263aa88c83e1a555cffb78f6bba640c71933072ffffce16d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5e239d3fe30508cb10e88521", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9363}
{"after": {"end": 19, "start": 0, "text": "Fraunhoferstraße 15", "truncated": false}, "after_length": 19, "after_sha256": "9ccfb7d105423789527cf7311fe43c201269724fe0c57028034980f9b3a83147", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5e51a9b8b09d9e63d9f5f299", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1675}
{"after": {"end": 47, "start": 0, "text": "12. NUMÉRO D’AUTORISATION DE MISE SUR LE MARCHÉ", "truncated": false}, "after_length": 47, "after_sha256": "3bc4f55c2ee1c489f7ed5e6a0843eb330efac627a7189aef3c56b927e59f15aa", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "12. NUMÉRO(S) D’AUTORISATION DE MISE SUR LE MARCHÉ", "truncated": false}, "before_length": 50, "before_sha256": "f9f5012b03069c8eb354120fea917486fb6f5e68726fed05ea66cd3d636f2c4b", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 10, "before_end": 13, "before_start": 10, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5e553a65159507fe134e2d6a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 962}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 79, "start": 0, "text": "Découper une alvéole individuelle de la plaquette le long de la ligne perforée.", "truncated": false}, "before_length": 79, "before_sha256": "17cc97ae23ea8ef6c68cb08e66fe824b1aef000422bf5327b8a25a75bb66c28d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 79, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 79, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5e56a6b33c5ee73ef78a2a58", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3647}
{"after": {"end": 325, "start": 0, "text": "In vitro, niraparib is an inhibitor of BCRP. A clinically relevant interaction with BCRP substrates cannot be excluded. Caution is therefore recommended when niraparib is combined with substrates of BCRP (e.g., irinotecan, rosuvastatin, simvastatin, atorvastatin, and methotrexate) due to risk of increased systemic exposure.", "truncated": false}, "after_length": 325, "after_sha256": "e13cc751b6072100bfb4434921acd1c0a6f6f76d69a62e52ca27f2b3d08b1bd0", "annex": "I", "before": {"end": 150, "start": 0, "text": "Caution isthen recommended when niraparib is combined with substrates of BCRP (irinotecan, rosuvastatin, simvastatin, atorvastatin, and methotrexate).", "truncated": false}, "before_length": 150, "before_sha256": "cd9ab56e7f3c37981a1f06e81bb33077fadc48cb5d289f9a8a49dd7292bd7894", "change_kind": "content", "change_operations": [{"after_end": 120, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}, {"after_end": 131, "after_start": 130, "before_end": 10, "before_start": 10, "kind": "insert"}, {"after_end": 140, "after_start": 134, "before_end": 14, "before_start": 13, "kind": "replace"}, {"after_end": 211, "after_start": 205, "before_end": 79, "before_start": 79, "kind": "insert"}, {"after_end": 324, "after_start": 281, "before_end": 149, "before_start": 149, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 176}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5e5ed3b3e36952cb96147dba", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1125}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "the contraceptive pill,", "truncated": false}, "before_length": 23, "before_sha256": "3981e2aef8e84a11a7685e44ff7ca2eb84fa29d2e1c1b3de527fc6e6448fd5aa", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5e65ee9e85bc67c3f5f0f800", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9270}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 427, "start": 0, "text": "Ni le niraparib ni M1 ne sont des substrats des polypeptides de transport d’anions organiques 1B1 (OATP1B1), 1B3 (OATP1B3), ou du transporteur de cations organiques 1 (OCT1). Aucun ajustement posologique n’est nécessaire pour Zejula en cas d’administration concomitante avec des médicaments connus pour inhiber les transporteurs d’influx OATP1B1 ou 1B3 (par exemple, gemfibrozil, ritonavir) ou OCT1 (par exemple, dolutégravir).", "truncated": false}, "before_length": 427, "before_sha256": "f0b7979c4e12236e95d231238e34abd6671ff08555dabb0de4964c79956d70a3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 427, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 427, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5e8d4592bd47bab4a8c006be", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1138}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Pregnancy and breast-feeding", "truncated": false}, "before_length": 28, "before_sha256": "989f6ecc16015ac20555f9856fd48abc02e6140dc415f8d96e4733470a272d45", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5ebf16f84be0ca49cf8718f3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9289}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "8. EXPIRY DATE", "truncated": false}, "before_length": 14, "before_sha256": "d71d14e8d4b94ef3a8f8363df6900202ede93977214348173fe46b41f9ab80aa", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5ec79801e3742a9431a627d9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4723}
{"after": {"end": 341, "start": 0, "text": "Après une dose orale unique de 300 mg de niraparib, la demi-vie terminale moyenne (t½) du niraparib était comprise entre 44 et 54 heures (environ 2 jours) selon les études. Dans une analyse pharmacocinétique de population, la clairance totale apparente (CL/F) du niraparib était de 15,9 L/h chez les patientes atteintes de cancer (CV 24,0%).", "truncated": false}, "after_length": 341, "after_sha256": "4e6f520db62d21af9c2b61d02e3e43d3cf23d7d791727208be397f072d96de0e", "annex": "I", "before": {"end": 324, "start": 0, "text": "Après une dose orale unique de 300 mg de niraparib, la demi-vie terminale moyenne (t½) du niraparib était comprise entre 48 et 51 heures (environ 2 jours). Dans une analyse pharmacocinétique de population, la clairance totale apparente (CL/F) du niraparib était de 16,5 L/h chez les patientes atteintes de cancer (CV 23,4%).", "truncated": false}, "before_length": 324, "before_sha256": "1707f42e4e2e91305ba2e767c1067d1352e343641ff6e360cc022edf6f68496d", "change_kind": "content", "change_operations": [{"after_end": 123, "after_start": 122, "before_end": 123, "before_start": 122, "kind": "replace"}, {"after_end": 129, "after_start": 128, "before_end": 129, "before_start": 128, "kind": "replace"}, {"after_end": 171, "after_start": 154, "before_end": 154, "before_start": 154, "kind": "insert"}, {"after_end": 284, "after_start": 283, "before_end": 267, "before_start": 266, "kind": "replace"}, {"after_end": 286, "after_start": 285, "before_end": 269, "before_start": 268, "kind": "replace"}, {"after_end": 336, "after_start": 335, "before_end": 319, "before_start": 318, "kind": "replace"}, {"after_end": 338, "after_start": 337, "before_end": 321, "before_start": 320, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5edb2429a40bd1243f5f6dda", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1685}
{"after": {"end": 115, "start": 0, "text": "Informez votre médecin ou pharmacien si vous prenez, avez récemment pris ou pourriez prendre tout autre médicament.", "truncated": false}, "after_length": 115, "after_sha256": "92fd0f79172627ef67d6eb52cb8e0b893e3d8475206e8a2a20a770e78f25c1f3", "annex": "IIIA", "before": {"end": 114, "start": 0, "text": "Informez votre médecin ou pharmacien si vous prenez, avez récemment pris ou pourriez prendre tout autre médicament", "truncated": false}, "before_length": 114, "before_sha256": "a4a97bb39078cc8525ea04c5565208350d1784776b888db25e2aa631228db0a3", "change_kind": "content", "change_operations": [{"after_end": 115, "after_start": 114, "before_end": 114, "before_start": 114, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5ee89d689269adbc05351263", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2686}
{"after": {"end": 56, "start": 0, "text": "https://www.ema.europa.eu/en/medicines/human/EPAR/viagra", "truncated": false}, "after_length": 56, "after_sha256": "886313ea21a179beab5d08069efa9bdd90016fe9ff52ceb2200ea200bdc1503a", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 56, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 56}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5ee96965137248a4150e935e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4}
{"after": {"end": 16, "start": 0, "text": "In vitro studies", "truncated": false}, "after_length": 16, "after_sha256": "41aa47dddd4758362e1877ba29ce7b2a560ad831af5ccdfc6b8e631df39b8c45", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5eeef0518d0e0553934981d1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1644}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 132, "start": 0, "text": "If you use more Humalog than you need or are unsure how much you have injected, a low blood sugar may occur. Check your blood sugar.", "truncated": false}, "before_length": 132, "before_sha256": "f964cd39499e1669d540edc1b32fc85e5a901ee13b6998aeeacc21843492d8fb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 132, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 132, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5ef8c7fd208a80bc844192d1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9343}
{"after": {"end": 61, "start": 0, "text": "Vyndaqel 20 mg soft capsules and Vyndaqel 61 mg soft capsules", "truncated": false}, "after_length": 61, "after_sha256": "3d169e26aa10ec66da5aa2daccb8f61c77ea829c926e5f44261f34667feec332", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 61, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 61}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5f0fc3e7d435ed09af2e5669", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1469}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5f31adee5e189f2dd40fd8c9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2613}
{"after": {"end": 27, "start": 0, "text": "Puh/Tel: + 358 9 251 21 230", "truncated": false}, "after_length": 27, "after_sha256": "115859cfeab013cc7da2aa72c6645b7c1a35594595b929820235610cd0afa5fd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5f3d3f1250b0ea4b9b43962c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2619}
{"after": {"end": 23, "start": 0, "text": "Tel: + 351 21 440 70 00", "truncated": false}, "after_length": 23, "after_sha256": "051a50965400ccbc97e96d9606564d6ef751251b31d5cd81aa4f430414a32099", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5f8c1be51d371dbe23ad6ba2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3253}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovakia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7b73e721c843deabd3a181fa5d110ba6dfbdc9531c8d2e1e6545e547e02a9ef0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5fbe6eca5064cfc6cccbd7bb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2610}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "Medicinal product subject to medical prescription.", "truncated": false}, "before_length": 50, "before_sha256": "f59e60a405cd29d8de0d0cfa2c4fd5c87e80574c3dbf7354e143c03cfe8789e6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 50, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 50, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5fcc7cbd6ca9f00dbf5dd66e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 956}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Tel: + 44 (0)800 221441", "truncated": false}, "before_length": 23, "before_sha256": "61482b81443a3ca39c7759aba2468d8a55e72bb438cb673a32ba3b1dac130262", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5feec5cdda8796f97cacecb6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3016}
{"after": {"end": 12, "start": 0, "text": "Id-Danimarka", "truncated": false}, "after_length": 12, "after_sha256": "ac04b6efb22ef48cbffb5f129ff3db14dac1293a9618775a5e7a6cb07d57fc19", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-5ff33e17ef9179ab85449efd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1773}
{"after": {"end": 207, "start": 0, "text": "priapism, a prolonged and possibly painful erection after taking CIALIS (frequency rare). If you have such an erection, which lasts continuously for more than 4 hours you should contact a doctor immediately.", "truncated": false}, "after_length": 207, "after_sha256": "c4068e021fb2c596b0bf4c2087e1226de8e0ce0e5dffeece63b984b3e43e62c8", "annex": "IIIA", "before": {"end": 207, "start": 0, "text": "priapsim, a prolonged and possibly painful erection after taking CIALIS (frequency rare). If you have such an erection, which lasts continuously for more than 4 hours you should contact a doctor immediately.", "truncated": false}, "before_length": 207, "before_sha256": "a042b2a055050b3b404a7e8bda2201584f5e389f3f7319622a3cabb89ff5b1af", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 5, "before_end": 5, "before_start": 5, "kind": "insert"}, {"after_end": 7, "after_start": 7, "before_end": 7, "before_start": 6, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6010c1170fda6d9b3af67f11", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2391}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "Tempo Pen Parts", "truncated": false}, "before_length": 15, "before_sha256": "815a6a24bbefbc6c66c54c6aa19c0d096940ebb5b1f4826624cc89c45a25e980", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6025e5c5ec92955cc0bdeb36", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9585}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "before_length": 7, "before_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-603c0b82e104e36b9b4bb704", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1730}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-604785b86ece25cf8596842d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2603}
{"after": {"end": 23, "start": 0, "text": "medinfo.denmark@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "b9a121278c8c2cc6f9be9c7a9fab0d3dee3fadaac431fdd8d5efa352410f5389", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-604b0833f87d619acc5cbe60", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2831}
{"after": {"end": 9, "start": 0, "text": "60 (52,2)", "truncated": false}, "after_length": 9, "after_sha256": "686f36ab1972d70a962f62a1667832d018d06b922359aae1b44e2168290974d7", "annex": "I", "before": {"end": 9, "start": 0, "text": "52 (55,9)", "truncated": false}, "before_length": 9, "before_sha256": "6d9402df9d8acb055e8f85d8fd58e99960eaa05f582944da20abe3cd89d533fa", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "replace"}, {"after_end": 6, "after_start": 5, "before_end": 6, "before_start": 5, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 8, "before_start": 7, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 4}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6054e36b65e6ed5a35dc2ff8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 304}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 25, "start": 0, "text": "Tel: + 353-(0) 1 661 4377", "truncated": false}, "before_length": 25, "before_sha256": "48fde288146f4033a2172164570180a8f875f4e361fcf85a8e43ff77834511cc", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-606767aa6b37315498d00c5a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2880}
{"after": {"end": 19, "start": 0, "text": "Slovenská republika", "truncated": false}, "after_length": 19, "after_sha256": "8667151da5d74cf45a2b263a2f7b38e944fd51f34b51e08d79151f123b8f10b2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-60677ea350775da4df201f99", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3278}
{"after": {"end": 24, "start": 0, "text": "Bristol-Myers Squibb SAS", "truncated": false}, "after_length": 24, "after_sha256": "b0b0c212e0ecdb35fbea1089157d2aee4526bb7547bc4dc40b2231ed4929cb66", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-607aa03d0562c78e0ea82cd8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2879}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Eli Lilly Ges. m.b.H.", "truncated": false}, "before_length": 21, "before_sha256": "1a1b71eaab1adcacdf544b04d3378de9211b6b659113517995fa7a24825647b5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-607f05ebd956fe7a269f1ff2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9503}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Belgium", "truncated": false}, "before_length": 7, "before_sha256": "348841ef53dbd5a64008a86be432973db790774fb28b59b0d99702a3188b3705", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6081f80a9c5673a52eac1db3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3212}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 82, "start": 0, "text": "– If you still do not see insulin, change the needle and repeat the priming steps.", "truncated": false}, "before_length": 82, "before_sha256": "5ce9f38f61af70a3a21cf815052fa827dccd725ba8bc684a35628e445aab3409", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 82, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 82, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-609c3e3a55309957a74b5267", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9673}
{"after": {"end": 20, "start": 0, "text": "Sími: + 354 535 7000", "truncated": false}, "after_length": 20, "after_sha256": "66fcdd056ccfbc5ba6d0c26580292977898106c90655c78208bc87c3d941892c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-60a843e304e757f6f14f16f5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3278}
{"after": {"end": 22, "start": 0, "text": "Tel: + 420 221 016 111", "truncated": false}, "after_length": 22, "after_sha256": "4d518854d9706e629e406bc93cfad10898d14ad223a3d403070c562115da215f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-60b3f613662e9c1f9ad03902", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2508}
{"after": {"end": 15, "start": 0, "text": "Česká republika", "truncated": false}, "after_length": 15, "after_sha256": "c768c215f215c71e7ffcbffe06cb1a66fa3c379a86285d5da65cef3c627bc09d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-60b88018f26d6b3824960c27", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2512}
{"after": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "after_length": 7, "after_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-60f0906b60c783e75f010bdb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3263}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Novartis Pharma GmbH", "truncated": false}, "before_length": 20, "before_sha256": "bae642239c19e15ed2be9a6c4c5123c7ef0f4e0a79a5ece5f8c2cf22e6047d3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6106ee420f9a7e2821d9e84b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3463}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 48, "start": 0, "text": "• there is a change in your need for insulin; or", "truncated": false}, "before_length": 48, "before_sha256": "83402379e701b94b6c1049d456cc0c4e103de8051f77758c51cdde3ed0b88e27", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 48, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 48, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6108116fcc3a5eaace8e8f5b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9391}
{"after": {"end": 5, "start": 0, "text": "Eesti", "truncated": false}, "after_length": 5, "after_sha256": "ed7477d6100948d0d4e6b914d9769159823c21b23bf4846b1676338b9b439b72", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-61159878d67d7cc34db46f34", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3216}
{"after": {"end": 19, "start": 0, "text": "Slovenská republika", "truncated": false}, "after_length": 19, "after_sha256": "8667151da5d74cf45a2b263a2f7b38e944fd51f34b51e08d79151f123b8f10b2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6157dd591e3d5999ba5f6422", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2601}
{"after": {"end": 26, "start": 0, "text": "Tél: + 33 (0)1 58 83 84 96", "truncated": false}, "after_length": 26, "after_sha256": "331bde6d3ceed373ca2a62d0d499d6fe72853e6ae69fb08f092c7712a9ad1d3e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-617957926b8ab97bafcf6272", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3248}
{"after": {"end": 22, "start": 0, "text": "medinfo.norway@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c4c553c0f2dbe6456fca075a3e80411c07f0926b9866f5334ba99d71d96198e2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-61cf1546473b2adc09e359c2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3224}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 169, "start": 0, "text": "Ni le niraparib ni M1 ne sont des inhibiteurs d’enzymes CYP métabolisant les substances actives, notamment CYP1A1/2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 et CYP3A4/5.", "truncated": false}, "before_length": 169, "before_sha256": "009ca2427a97d10cb3bdac28c8a30ffeb566c55e988114acb41672dcb5cd4dab", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 169, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 169, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-61de27d47f8f64e2277eb400", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1146}
{"after": {"end": 20, "start": 0, "text": "Sími: + 354 535 7000", "truncated": false}, "after_length": 20, "after_sha256": "66fcdd056ccfbc5ba6d0c26580292977898106c90655c78208bc87c3d941892c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-61e1cb169a6c92497a8327dd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2604}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 88, "start": 0, "text": "(Example: 12 units shown in the dose window)(Example: 12 units shown in the dose window)", "truncated": false}, "before_length": 88, "before_sha256": "6a045bade3ab709d5214fccb109bf978320fb952e925f074f2058470b26c5330", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 88, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-61f3208c346fc9cf0cd9bd92", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9706}
{"after": {"end": 21, "start": 0, "text": "Tlf.: +45 45 26 60 00", "truncated": false}, "after_length": 21, "after_sha256": "6bdd3c845f6a6e520023cbb8b3726e2eefc4bc4ac00ae57245f3055e31d53895", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tlf: +45 45 26 60 00", "truncated": false}, "before_length": 20, "before_sha256": "7932ef9452966b997a4a22618abb01fb644277c9ab041214e6264730772b2d64", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-627314f179003cc5b523338c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2469}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 128, "start": 0, "text": "Do NOT mix the Humalog 100 units/ml solution for injection in your pre-filled pen with any other insulins or any other medicine.", "truncated": false}, "before_length": 128, "before_sha256": "f64b261c5ec2064e470a3c9574b3b29e190bbac23b563de977bd980c76cd6ceb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 128, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 128, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6274a10925465a5c0ead6857", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9332}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 456, "start": 0, "text": "Le niraparib est un substrat des carboxylestérases (CE) et des UDP-glucuronosyltransférases (UGT) in vivo. Le métabolisme oxydatif du niraparib est minime in vivo. Aucun ajustement posologique n’est nécessaire pour Zejula en cas d’administration concomitante avec des médicaments connus pour inhiber des enzymes CYP (par exemple, itraconazole, ritonavir et clarithromycine) ou induire des enzymes CYP (par exemple rifampicine, carbamazépine et phénytoïne).", "truncated": false}, "before_length": 456, "before_sha256": "0b12e0761fe652022abfaed7cd1c21e560115781f62aec20a464d44cda1d0acd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 456, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 456, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6291457e8700171d4a3d9926", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1130}
{"after": {"end": 27, "start": 0, "text": "CPO Pharmaceuticals Limited", "truncated": false}, "after_length": 27, "after_sha256": "94b644443752e2cb52916b23f8141fbd44c47055b3416af333e12ac18e101b87", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "GPA Pharmaceuticals Ltd", "truncated": false}, "before_length": 23, "before_sha256": "ece7127e303c91e9501d2cedd822476265aae86acb9f96ef1553ab3a6954afe1", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 21, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-629c3c259b81dc35ee043ed3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3999}
{"after": {"end": 23, "start": 0, "text": "Medinfo.hungary@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "a92bd76e7f8465b69646a33e5e8846376b2ea19fe10f20ea413789237a8d815a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-62bbbe4420f3b18d16dfbd0c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3191}
{"after": {"end": 36, "start": 0, "text": "Vyndaqel 61 mg, comprimés pelliculés", "truncated": false}, "after_length": 36, "after_sha256": "70d3e9c94874ff78e6ff1e940cdf64cbf06bd8e778cf4abb4c78ce4ca876c4cb", "annex": "IIIA", "before": {"end": 31, "start": 0, "text": "Vyndaqel 61 mg, capsules molles", "truncated": false}, "before_length": 31, "before_sha256": "d2f9e9daee0a55f7e5e88fddbba4b5456460e01edb642a0357e0b087ef8086af", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 17, "before_end": 18, "before_start": 17, "kind": "replace"}, {"after_end": 24, "after_start": 20, "before_end": 19, "before_start": 19, "kind": "insert"}, {"after_end": 32, "after_start": 25, "before_end": 20, "before_start": 20, "kind": "insert"}, {"after_end": 35, "after_start": 34, "before_end": 30, "before_start": 22, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-62c408ebdb5b393e91179e53", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2893}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: + 353 18711600", "truncated": false}, "before_length": 19, "before_sha256": "f39469e1bbd519f10406ae27e104b0e2fb101791df45c4e53cc539ee02b84821", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-62d727d3819628cc03d3844f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3346}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6305e812097a5975cd4d1f9d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3296}
{"after": {"end": 27, "start": 0, "text": "CPO Pharmaceuticals Limited", "truncated": false}, "after_length": 27, "after_sha256": "94b644443752e2cb52916b23f8141fbd44c47055b3416af333e12ac18e101b87", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "GPA Pharmaceuticals Ltd", "truncated": false}, "before_length": 23, "before_sha256": "ece7127e303c91e9501d2cedd822476265aae86acb9f96ef1553ab3a6954afe1", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 21, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-631168578a1f1f6d59843597", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2691}
{"after": {"end": 20, "start": 0, "text": "Tel: + 43 1 60 14 30", "truncated": false}, "after_length": 20, "after_sha256": "06513bb4e3ff06e9885e8395f2d87e81d050e28b69385dc8158cf331179a64c6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6327d167fc9f98c266f50e93", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2865}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-632a2785950404ae5f283ee6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2694}
{"after": {"end": 217, "start": 0, "text": "REZZAYO is a powder for concentrate for solution for infusion (powder for concentrate) in a glass vial with a rubber stopper and an aluminium seal with plastic flipoff cap. It is a white to pale yellow cake or powder.", "truncated": false}, "after_length": 217, "after_sha256": "ab7c16bfdc7a091b296829e22ec2f3c7384417bc9c6acc7944bfbc2d23b3819e", "annex": "IIIA", "before": {"end": 192, "start": 0, "text": "REZZAYO is a powder for concentrate for solution for infusion in a glass vial with a rubber stopper and an aluminium seal with plastic flipoff cap. It is a white to pale yellow cake or powder.", "truncated": false}, "before_length": 192, "before_sha256": "f6162c7d2ca4d1f2181e8d71c4777b8bcd899535df80bbe886d7372cd71c7e02", "change_kind": "content", "change_operations": [{"after_end": 87, "after_start": 62, "before_end": 62, "before_start": 62, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6354087fbf8ee8a788b33ccf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 947}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 75, "start": 0, "text": "One ml solution contains 100 units of insulin lispro (equivalent to 3.5mg).", "truncated": false}, "before_length": 75, "before_sha256": "d45056525c174b2d13b93fffa7adca4d954d1856702e361c282a00031f17e769", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 75, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 75, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6367a7b71ecc788203b0c9b5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4793}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 54, "start": 0, "text": "• Pull off the paper tab from the outer needle shield.", "truncated": false}, "before_length": 54, "before_sha256": "d9bc274b35ef191aa7a0f65f3361373b8d97f07db9a73652cb47c02090f96f2e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 54, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 54, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-637d7d92c556867c249d445e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9644}
{"after": {"end": 24, "start": 0, "text": "portugal.medinfo@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "9ec8b32b2035c90c423af74fa150dca23880201d448d46da35a42d2a862c8345", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-63816ba715d10b63c1a9875f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2890}
{"after": {"end": 243, "start": 0, "text": "Ce médicament contient du lactose. Les patients présentant une intolérance au galactose, un déficit total en lactase ou un syndrome de malabsorption du glucose et du galactose (maladies héréditaires rares) ne doivent pas prendre ce médicament.", "truncated": false}, "after_length": 243, "after_sha256": "dc4adef5af36518a1422c28ed4a871429d4ee04e4a4f33124b0e3016bdd0cd12", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 243, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 243}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-63a92c9262768cc586b54c27", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1293}
{"after": {"end": 139, "start": 0, "text": "Pour plus d’informations, voir le site web de l’Agence européenne des médicaments: https://www.ema.europa.eu/en/medicines/human/EPAR/viagra", "truncated": false}, "after_length": 139, "after_sha256": "81c6f28b94747186d28fe79652dae070308932a83de35a661a9980e07ec898ec", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 139, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 139}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-63eba04969e27bcb27ad4378", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2}
{"after": {"end": 18, "start": 0, "text": "Swixx Biopharma OÜ", "truncated": false}, "after_length": 18, "after_sha256": "94bc5f3c43fc9da5715250d66202d3b6e108127762e4f8e413b99fc19e24a395", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 18, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 18}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-63fd591a77d0d8a3e0d0992b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2543}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Sverige", "truncated": false}, "before_length": 7, "before_sha256": "3a7d70b4edb982a403e97d77681309e5fb1032b12d727aa1e92b145b069b9aa4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6401be22b61577008cacfe38", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9554}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 51, "start": 0, "text": "2D barcode carrying the unique identifier included.", "truncated": false}, "before_length": 51, "before_sha256": "c70986678c932d8c3e10fe2bfc3ea6ef6401ffe24c9fb906c781f3d0ae81e19c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 51, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 51, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-641779904f3a53f317a6fc38", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4670}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 3, "start": 0, "text": "EXP", "truncated": false}, "before_length": 3, "before_sha256": "06a1ad637e7f4fbad56e29164490368f0526f429ee39a31dd1180c3722af1e4e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-641c0bd5cce483389d30e611", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4892}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6465e87c545a97b397efe42d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1861}
{"after": {"end": 19, "start": 0, "text": "Induction du CYP1A2", "truncated": false}, "after_length": 19, "after_sha256": "dc2a2f47db9a8b47978dcbba3f3e471302ae6ac7ec0c15cee90895809c9b02e8", "annex": "I", "before": {"end": 36, "start": 0, "text": "Induction des CYP (CYP1A2 et CYP3A4)", "truncated": false}, "before_length": 36, "before_sha256": "a491c555296ca52a1c725d3932d8048b310cd2ce362417cf0e03701a10d08a21", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 11, "before_end": 13, "before_start": 11, "kind": "replace"}, {"after_end": 13, "after_start": 13, "before_end": 19, "before_start": 14, "kind": "delete"}, {"after_end": 19, "after_start": 19, "before_end": 36, "before_start": 25, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 18, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6493255989233b3c7fa35679", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1153}
{"after": {"end": 121, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu/.", "truncated": false}, "after_length": 121, "after_sha256": "9d8d2148d2215735c1ca8ac769a2e0cd013fc2a2447a452d6c72e4b8fec48c3e", "annex": "IIIA", "before": {"end": 120, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/.", "truncated": false}, "before_length": 120, "before_sha256": "b7d3bba3c3d744d927e6d05f81a5139a00b9d5c4dcbc4adcdfb1949c5602b310", "change_kind": "technical", "change_operations": [{"after_end": 99, "after_start": 98, "before_end": 98, "before_start": 98, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-649b7528e457810a90c9924e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2637}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 66, "start": 0, "text": "Do not freeze. Do not expose to excessive heat or direct sunlight.", "truncated": false}, "before_length": 66, "before_sha256": "1c580aa2802ea4add64b3f99b24021870334c9d6fdba3dc7d0e7ecbae4f0d248", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 66, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 66, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-64d73acc5d05f3a79786aa67", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4632}
{"after": {"end": 38, "start": 0, "text": "EU/1/11/717/006 90 film-coated tablets", "truncated": false}, "after_length": 38, "after_sha256": "bb2ae954505c80a425e08c48e22398178ed4cfd3d99c96ca79dfc3f42ff634c9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6500eb40c353891bcb1dd0df", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2343}
{"after": {"end": 18, "start": 0, "text": "Swixx Biopharma OÜ", "truncated": false}, "after_length": 18, "after_sha256": "94bc5f3c43fc9da5715250d66202d3b6e108127762e4f8e413b99fc19e24a395", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 18, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 18}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-650f125e402f45a45d4d4205", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2853}
{"after": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "after_length": 7, "after_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-65158de89c875d3949a50aa5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2942}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 521, "start": 0, "text": "Tempo Pen (“Pen”) is a disposable prefilled Pen containing 3 ml (300 units, 100 units/ml) of insulin. You can give yourself multiple doses using one Pen. The Pen dials 1 unit at a time. You can give from 1 to 60 units in a single injection. If your dose is more than 60 units, you will need to give yourself more than one injection. The plunger only moves a little with each injection, and you may not notice that it moves. The plunger will only reach the end of the cartridge when you have used all 300 units in the Pen.", "truncated": false}, "before_length": 521, "before_sha256": "cabc16880ad17078c7a5b2c4db9b259d8af48a2072de6f2100ca0b400cf738b1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 521, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 521, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6527e0b098e0d6753d652bf0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9578}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 33, "start": 0, "text": "OF THE MARKETING AUTHORISATION(S)", "truncated": false}, "before_length": 33, "before_sha256": "42bf6debd7db4c33f448dd956d24f13ebdc3c8d138efe5cb53056c2f51c4dbaa", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-652a316ebd7f842c3534369a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3443}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 42, "start": 0, "text": "Multipack: 10 (2 packs of 5) pens of 3 ml.", "truncated": false}, "before_length": 42, "before_sha256": "f53b005644308e7bed5cd51b5894833700ba5d9074fa799c7e51f0dafa0a7027", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 42, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 42, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-65447bbfd9d2f9e7cc7a34e1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4706}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 100, "start": 0, "text": "Hypoglycaemia (low blood sugar) means there is not enough sugar in the blood. This can be caused if:", "truncated": false}, "before_length": 100, "before_sha256": "973206ece87dd609bb3ecb46915622fe2bba361d027c55c6e04033534dc6d4c4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 100, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 100, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-655a1c0992683a48fff29224", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9386}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-657fbf001be327ef1862486a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2619}
{"after": {"end": 34, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht", "truncated": false}, "after_length": 34, "after_sha256": "46a90fc46ae308c2beeb35ead613fcf3ade5a51e2217a834de3fa5972dab9eec", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-65a011bd46fc1b9f08201598", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 2.5 mg film-coated tablets", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 509}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 137, "start": 0, "text": "10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "truncated": false}, "before_length": 137, "before_sha256": "21a44745bd9deea05c5c3551ddef2c63129d14d622db066ae2815a039a68f3d2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 137, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 137, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-65aa6adf684b48f96f0f004d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4735}
{"after": {"end": 38, "start": 0, "text": "Bristol-Myers Squibb Polska Sp. z o.o.", "truncated": false}, "after_length": 38, "after_sha256": "9c8a588d350dd39a6a46453574156c70a2d3d726d29ae6874b04bb3acd6f1d64", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-65ad7a45ff668b980a4febe6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2562}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 410, "start": 0, "text": "The Humalog 100 units/ml Tempo Pen delivers 1 – 60 units in steps of 1 unit in a single injection. The number of insulin units is shown in the dose window of the pen regardless of strength and no dose conversion should be done when transferring a patient to a new strength or to a pen with a different dose step. The Tempo Pen can be used with the optional transfer module Tempo Smart Button (see section 6.6).", "truncated": false}, "before_length": 410, "before_sha256": "778828de74533a0cac5e9f8bcdaae9c0399381ad9c40ce9860fb2b4297f7a4a7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 410, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 410, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-65c609e01dafaf12bef6ba9c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 120}
{"after": {"end": 5, "start": 0, "text": "Norge", "truncated": false}, "after_length": 5, "after_sha256": "882f535a7da00cd72aec9957f14113085717f72c791945420043b48876276628", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-65e392bf027f5a5b845f783c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2853}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 169, "start": 0, "text": "Ni le niraparib ni M1 ne sont des inhibiteurs d’enzymes CYP métabolisant les substances actives, notamment CYP1A1/2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 et CYP3A4/5.", "truncated": false}, "before_length": 169, "before_sha256": "009ca2427a97d10cb3bdac28c8a30ffeb566c55e988114acb41672dcb5cd4dab", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 169, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 169, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-65e4988ae55bd0119361112e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 258}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "8055 Graz", "truncated": false}, "before_length": 9, "before_sha256": "765f51a390983de920b9a586c4589caab5f6398576531f438fd8301227c9ccb2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-661421861546a23286c7320b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2457}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 22, "start": 0, "text": "Scientific conclusions", "truncated": false}, "before_length": 22, "before_sha256": "48a176450b72da083aae0c461d4b9485bc052767229342ad7b9f3b91fb4b3641", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6615ef08c6305fe003a589ef", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3456}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 38, "start": 0, "text": "7. OTHER SPECIAL WARNING, IF NECESSARY", "truncated": false}, "before_length": 38, "before_sha256": "e919358c9e0b9ff346b04639304671281eb70c785a813ad49fe510af23b56a9e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 38, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 38, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6629e88b25eb64fd1e114c14", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4720}
{"after": {"end": 30, "start": 0, "text": "Triglycérides à chaîne moyenne", "truncated": false}, "after_length": 30, "after_sha256": "fc27b620a6ee9531fc95ce24488c12c88096ce46fcaa703ffa63e066982b2cd2", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 30, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 30}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-663259e2c6219700b21d483c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1893}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 36, "start": 0, "text": "Read the package leaflet before use.", "truncated": false}, "before_length": 36, "before_sha256": "5523bc203c0d15a42e51f1f2084990ce77593674ceb9b20d974654fb13a8f72b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 36, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 36, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6644816c73e4702eff0175cf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4810}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 2, "start": 0, "text": "NN", "truncated": false}, "before_length": 2, "before_sha256": "15c841dff8407a197a8be456d43283d973c0ba690724b24da5e5d0d6dbc70423", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-66501ed6754faaf55879e50e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4677}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 38, "start": 0, "text": "• Wash your hands with soap and water.", "truncated": false}, "before_length": 38, "before_sha256": "1ed92562059bdcc70eabc156f0d010421bf033df677f597ff027c48d7091eb55", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 38, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 38, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-66554e061a185a13c0b9f31d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9629}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "Lilly Deutschland GmbH", "truncated": false}, "before_length": 22, "before_sha256": "1195d9c4d798bc2deef07baee72980069e3e582f6d7fe6b0f7e5ca01eb12a6d5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-665690ff3d284d5d7e3572df", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9485}
{"after": {"end": 18, "start": 0, "text": "Tel.: +48223062447", "truncated": false}, "after_length": 18, "after_sha256": "d28cf2c5f0efd22cd4923b6e6052ea498b235be2df08536c0ede2f879b785b12", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "Tel: +48223062447", "truncated": false}, "before_length": 17, "before_sha256": "808aeab2c3041d246a9c5b5c09ac20d27f80c3caf2bd78d39636a294c464387a", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-667442e26b7e682fa227c7fc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1643}
{"after": {"end": 38, "start": 0, "text": "N.V. Bristol-Myers Squibb Belgium S.A.", "truncated": false}, "after_length": 38, "after_sha256": "aed62c6e6383ee3130a6851382813dabc668847cc45474eecb9eae19fd27a962", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-66fae1e46c6e69d3f05f58bb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2487}
{"after": {"end": 34, "start": 0, "text": "medinfo.estonia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "e47c511a7367c6c7b4b4d54b0660bf70577f18e3fe0bcef938db762d7981dd1e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-670ba0bc80ffd481bccd4b62", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2545}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 17, "start": 0, "text": "D-90429 Nuremberg", "truncated": false}, "before_length": 17, "before_sha256": "e947a9c523ae55d462208c17464751e497403938b7fe52dead7696ca6851269b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-671bb31ac94c7009d586bf34", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1644}
{"after": {"end": 16, "start": 0, "text": "pv@ammangion.com", "truncated": false}, "after_length": 16, "after_sha256": "53f45568239cbb258daee24319c4e0fde3bfc6917d09b88019c1cb8329ded177", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-67262ced7ad38b8fcb967103", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2836}
{"after": {"end": 465, "start": 0, "text": "In the population pharmacokinetic analysis, patients with mild (creatinine clearance 60-90 mL/min) and moderate (30-60 mL/min) renal impairment had mildly reduced niraparib clearance compared to individuals with normal renal function. The difference in exposure is not considered to warrant dose adjustment. No patients with preexisting severe renal impairment or endstage renal disease undergoing hemodialysis were identified in clinical studies (see section 4.2).", "truncated": false}, "after_length": 465, "after_sha256": "945b08ce103758667fefa60c540722894a6f626b53a80c87e2264ea9e63bb0e4", "annex": "I", "before": {"end": 553, "start": 0, "text": "In the population pharmacokinetic analysis, patients with mild (creatinine clearance 60-90 mL/min) and moderate (30-60 mL/min) renal impairment had mildly reduced niraparib clearance compared to individuals with normal renal function (7-17% higher exposure in mild and 17-38% higher exposure in moderate renal impairment). The difference in exposure is not considered to warrant dose adjustment. No patients with preexisting severe renal impairment or endstage renal disease undergoing hemodialysis were identified in clinical studies (see section 4.2).", "truncated": false}, "before_length": 553, "before_sha256": "cb4011daf0f69761f42608933743cf0493af37c2b1ae9cc6bffd367373afd773", "change_kind": "content", "change_operations": [{"after_end": 233, "after_start": 233, "before_end": 321, "before_start": 233, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6728f3978aa9c163f3f19aa7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 791}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 273, "start": 0, "text": "As with any insulin injection, when using the Tempo Pen, Smart Button and the mobile application, the patient should be instructed to check their blood sugar levels when considering or making decisions about another injection if they are unsure how much they have injected.", "truncated": false}, "before_length": 273, "before_sha256": "e783804e6b77516c33e0a287548ca5b6cec7e8df2273a5bb7d774fc2859a17c3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 273, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 273, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-678db1ae156d22af79d4c2ed", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 122}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Mylan IRE Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "35f93c261e1c23366cb104ad58005b2a5415120196df611fa95117f89eb960ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-67991a76882a8212502119c7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2712}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 45, "start": 0, "text": "Eli Lilly (Suisse) S.A Pārstāvniecība Latvijā", "truncated": false}, "before_length": 45, "before_sha256": "b48999066585c3d9a3f40313c3679b04f65d509f424290adec00ab9c652ab527", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 45, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 45, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-679f3e80f11a9d1512af535b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9558}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "12. MARKETING AUTHORISATION NUMBER", "truncated": false}, "before_length": 34, "before_sha256": "a60532285d3f2ae8ae6f1bf2efe60e8f4d80a3914ffa0fe294c7a05c7841017d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-67c5eff07332f03b64bc22fb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4844}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 45 45 93 05 06", "truncated": false}, "after_length": 21, "after_sha256": "61983c14390c5d0df2153e10740a9b1eb429e8c0b05c3ebe705431c827a32b81", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-67d58d91ce4218c526518140", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2524}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb A.E.", "truncated": false}, "after_length": 24, "after_sha256": "10b1fadbbe52c3072f4ba1903512a3a4f5cd6eb487bf016dde5246419ff972b0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-67e74b22b6ac24f7aa318581", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2933}
{"after": {"end": 10, "start": 0, "text": "Österreich", "truncated": false}, "after_length": 10, "after_sha256": "b1b763860d4f30c2e1feafdcd57b714a1422b4fbc1a93d94969118a0faa65288", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 10}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-67e802551ec32c4ffec2ed4d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2863}
{"after": {"end": 7, "start": 0, "text": "Isomalt", "truncated": false}, "after_length": 7, "after_sha256": "9b5e5e9c1ee74dd3d0dacee863fbd31e5a4c7a8b9cbb411b37c80a4ec97c513d", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6800f0427b78ef7fd488893d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1348}
{"after": {"end": 35, "start": 0, "text": "Humalog 100 units/ml Junior KwikPen", "truncated": false}, "after_length": 35, "after_sha256": "d6db74afeef28981d551080ecd35bc65079bda2ebf11ff516b090fa6430f8c84", "annex": "II", "before": {"end": 70, "start": 0, "text": "Humalog 100 units/ml Junior KwikPen and Humalog 100 units/ml Tempo Pen", "truncated": false}, "before_length": 70, "before_sha256": "c0bfa32d81365e00cb7ee6e8ea8b4bbff1019c91ab3e15faad58737adf8e7d58", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 35, "before_end": 70, "before_start": 35, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-68426bffe053256fa1d32a4f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1976}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 12, "start": 0, "text": "County Kerry", "truncated": false}, "before_length": 12, "before_sha256": "eb7356a4494d39c472b712704605178f5a5ec97da0fc0b32f904fa38c0a2cdcc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6852105025db9e7a4e8801db", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2005}
{"after": {"end": 623, "start": 0, "text": "Le tableau suivant regroupe les effets indésirables observés chez 173 patients ayant reçu 400/200 mg de rezafungine, présentés par classe de systèmes d’organes et selon les termes préférentiels MedDRA, avec une fréquence correspondant à très fréquent (≥ 1/10), fréquent (≥ 1/100, < 1/10), peu fréquent (≥ 1/1 000, < 1/100), rare (≥ 1/10 000, < 1/1 000), très rare (< 1/10 000) et provenant des notifications spontanées à une fréquence indéterminée (qui ne peut être estimée sur la base des données disponibles). Au sein de chaque groupe de fréquence, les effets indésirables sont présentés par ordre décroissant de gravité.", "truncated": false}, "after_length": 623, "after_sha256": "a2bfc6c047b1e5b3a9558b53cc11f9d989ac889daf4a0bac601f7425da4e66ca", "annex": "I", "before": {"end": 623, "start": 0, "text": "Le tableau suivant regroupe les effets indésirables observés chez 151 patients ayant reçu 400/200 mg de rezafungine, présentés par classe de systèmes d’organes et selon les termes préférentiels MedDRA, avec une fréquence correspondant à très fréquent (≥ 1/10), fréquent (≥ 1/100, < 1/10), peu fréquent (≥ 1/1 000, < 1/100), rare (≥ 1/10 000, < 1/1 000), très rare (< 1/10 000) et provenant des notifications spontanées à une fréquence indéterminée (qui ne peut être estimée sur la base des données disponibles). Au sein de chaque groupe de fréquence, les effets indésirables sont présentés par ordre décroissant de gravité.", "truncated": false}, "before_length": 623, "before_sha256": "e03d2070dbca780b32712c7155ba779f301ef2097fa9521150ea1bc9f3c6fd78", "change_kind": "content", "change_operations": [{"after_end": 69, "after_start": 67, "before_end": 69, "before_start": 67, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6871cff73dc1c2935491dffb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.8", "section_type": "adverse_reactions", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 176}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-68f86c880aae62c181eaf2d9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2711}
{"after": {"end": 20, "start": 0, "text": "medwiss.info@bms.com", "truncated": false}, "after_length": 20, "after_sha256": "bc2238e490f9b59d01a00ccab422d2de7eb7937e564268c4e82d2e78b72b3340", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-69051afe3592c45d46d1f2da", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3209}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "customercontactuk@gsk.com", "truncated": false}, "before_length": 25, "before_sha256": "73834f2ec2786ba4565d1820e07d2bb38952e8214867b143e05286042d58b0b0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6913707338e19d4576315719", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2925}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 18, "start": 0, "text": "Tel: +371 67364000", "truncated": false}, "before_length": 18, "before_sha256": "21ddc6b31d7ab71afd38527566dee76815de95af90fb8ad680511b873e113c71", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 18, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 18, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-69b04cff2ded8360f7c1f737", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9559}
{"after": {"end": 31, "start": 0, "text": "Bristol-Myers Squibb Aktiebolag", "truncated": false}, "after_length": 31, "after_sha256": "18b315bcb0bae7d4352ec0e47ec43f18641696fe38dba2d6458c7c2188f9abdc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 31, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 31}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-69b34a647c17dbff8b3d917e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3299}
{"after": {"end": 33, "start": 0, "text": "medinfo.latvia@swixxbiopharma.com", "truncated": false}, "after_length": 33, "after_sha256": "c0a77882a6e33a348e9fb5e2a3006e8250b7d628f17c35efbaf3212a5e6e1c2d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-69ded06f2596d79ddeb8e08c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3309}
{"after": {"end": 23, "start": 0, "text": "medinfo.denmark@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "b9a121278c8c2cc6f9be9c7a9fab0d3dee3fadaac431fdd8d5efa352410f5389", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6a0d15213b8d4a0d2cb38423", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2835}
{"after": {"end": 21, "start": 0, "text": "Tel: + 46 8 704 71 00", "truncated": false}, "after_length": 21, "after_sha256": "313eaeeb04c88c002b748323fb801826225906f557247264c0fcb9fc87c873fc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6a23cbf40e3833c7852da7c3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3300}
{"after": {"end": 34, "start": 0, "text": "Microcrystalline cellulose (E 460)", "truncated": false}, "after_length": 34, "after_sha256": "de7c67d3d713890e1f6f813752424bba1caafb74f59ed0a38f79a0071d09be55", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6a248e1b2347e57cb8f64539", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1339}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 143, "start": 0, "text": "If you have any questions or problems with your Tempo Pen, contact your healthcare professional for help or contact your local Lilly affiliate.", "truncated": false}, "before_length": 143, "before_sha256": "a570884dc7c2d66837fbaf62eb1cf2c18e6d64a51e09c5468248ef7ecb867bd6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 143, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 143, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6a3ae482f5fc8a939fdc2271", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9806}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 13, "start": 0, "text": "Ethyl alcohol", "truncated": false}, "before_length": 13, "before_sha256": "65204f1699bc5f1931f52d7bdbaaa90acbc69403dccc22a20a1a9d41cee94b4a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6a4ccec656d99fb91fdd8263", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1372}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 33, "start": 0, "text": "Hydroxyde d’ammonium (E 527) 28 %", "truncated": false}, "before_length": 33, "before_sha256": "6e6ed725554fe0a19e5bb57fdb78565d4f79bc6c29dd82e49cf74e29d40b980b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6a4df6ea3da582a2ac952b5f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1921}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 47 67 55 53 50", "truncated": false}, "after_length": 21, "after_sha256": "d1b594f6660af0e3776951e66e526813a270ea883650a47e68423146b1d67dd7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6a59a16545eff0635f2dcee4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2549}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 21, "start": 0, "text": "Contenu de la capsule", "truncated": false}, "before_length": 21, "before_sha256": "4073cb3568492709e7e2a75b3d0979fa2ab484c8002ac067f9980083b1791d24", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6a6c38623edbfc02f5db986a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1905}
{"after": {"end": 5, "start": 0, "text": "Norge", "truncated": false}, "after_length": 5, "after_sha256": "882f535a7da00cd72aec9957f14113085717f72c791945420043b48876276628", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6a6e982fcd345b14c42996a1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2541}
{"after": {"end": 167, "start": 0, "text": "The MAH shall provide yearly updates on any new information concerning the effects of Vyndaqel on disease progression and its longterm safety in non Val30Met patients.", "truncated": false}, "after_length": 167, "after_sha256": "673b01bfd640dc3a6eb64f4cb5472b9d05e63a00fd8d0f03646a866ebf21d217", "annex": "I", "before": {"end": 168, "start": 0, "text": "The MAH shall provide yearly updates on any new information concerning the effects of Vyndaqel on disease progression and its long term safety in non Val30Met patients.", "truncated": false}, "before_length": 168, "before_sha256": "ad23dd76e139798fc3cf17c7053ff67ddf44660858558bdcff4db5d0e25ef67a", "change_kind": "unassigned", "change_operations": [{"after_end": 130, "after_start": 130, "before_end": 131, "before_start": 130, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6a8aa82fd30a381195ebeb49", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1539}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 364, "start": 0, "text": "Neither niraparib nor M1 is a substrate of organic anion transporter 1 (OAT1), 3 (OAT3), and organic cation transporter 2 (OCT2). No dose adjustment for Zejula is required when administered concomitantly with medicinal products known to inhibit OAT1 (e.g. probenecid) or OAT3 (e.g. probenecid, diclofenac), or OCT2 uptake transporters (e.g. cimetidine, quinidine).", "truncated": false}, "before_length": 364, "before_sha256": "366f4c7c7eb84f02fa7025f4541754e40c96eeafe5799b46ec13fdce85dd7e26", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 364, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 364, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6acd29fac2a8db87f0c99f87", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1107}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 12, "start": 0, "text": "County Kerry", "truncated": false}, "before_length": 12, "before_sha256": "eb7356a4494d39c472b712704605178f5a5ec97da0fc0b32f904fa38c0a2cdcc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6ad09792f6977d5cd2bdfad6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1705}
{"after": {"end": 46, "start": 0, "text": "Bristol-Myers Squibb Marketing Services S.R.L.", "truncated": false}, "after_length": 46, "after_sha256": "6c38be302b7d5963ce12172acd656a3cb654f698a1ffaa2a83410a1393313cb6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 46, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 46}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6ad4eab1261c14b57e26b6d9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2894}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma UAB", "truncated": false}, "after_length": 19, "after_sha256": "0fa5997c653449c2ebe445618eaeedc027096662095bc4bf48a609ec757f79cd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6ae8b44f534e5f91f2612b4f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3172}
{"after": {"end": 66, "start": 0, "text": "Le comprimé doit être avalé entier, sans le croquer, ni le couper.", "truncated": false}, "after_length": 66, "after_sha256": "29174d7af73c020cbc1926ac2fdad66e219b9031133a35479655f86b6f97c094", "annex": "IIIA", "before": {"end": 73, "start": 0, "text": "La capsule molle doit être avalée entière, sans la croquer, ni la couper.", "truncated": false}, "before_length": 73, "before_sha256": "72a98f35c72b20babb64365881e0e6ea3d7d307634b2ee5a3d8f01ac73b2f476", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 1, "before_end": 2, "before_start": 1, "kind": "replace"}, {"after_end": 6, "after_start": 4, "before_end": 5, "before_start": 4, "kind": "replace"}, {"after_end": 9, "after_start": 7, "before_end": 11, "before_start": 6, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 16, "before_start": 12, "kind": "replace"}, {"after_end": 27, "after_start": 27, "before_end": 33, "before_start": 32, "kind": "delete"}, {"after_end": 33, "after_start": 32, "before_end": 39, "before_start": 38, "kind": "replace"}, {"after_end": 34, "after_start": 34, "before_end": 41, "before_start": 40, "kind": "delete"}, {"after_end": 43, "after_start": 42, "before_end": 50, "before_start": 49, "kind": "replace"}, {"after_end": 58, "after_start": 57, "before_end": 65, "before_start": 64, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6b6737f526aa3134859825b3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3642}
{"after": {"end": 36, "start": 0, "text": "Oy Bristol-Myers Squibb (Finland) Ab", "truncated": false}, "after_length": 36, "after_sha256": "aca51731c0a07e098261a8dac11eaa8c8eafa1001f72c007b85c510385b01809", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6b6b68fee5070c7761f1f7ac", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3289}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Irlande", "truncated": false}, "before_length": 7, "before_sha256": "a8cdfff5dbbda1b070a2acb339b6f0aa20b6230d9b5500c9ce066eaa89bc9a64", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6b9ea926c896b7595358dcc8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2006}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6ba0db7a00e510e42b82fcf8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2625}
{"after": {"end": 22, "start": 0, "text": "medinfo.norway@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c4c553c0f2dbe6456fca075a3e80411c07f0926b9866f5334ba99d71d96198e2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6be2aaeb209b455228966031", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2544}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6bf8b1ccca9197e1693073c9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3366}
{"after": {"end": 6, "start": 0, "text": "Polska", "truncated": false}, "after_length": 6, "after_sha256": "d1974e0e3e575b6dadb40f080dae05025f574cb23e5cababcac0f50cf2619549", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c19339ff9725110b110d954", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3241}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 59, "start": 0, "text": "Getting the Tempo Pen ready to use (Please see user manual)", "truncated": false}, "before_length": 59, "before_sha256": "fcf48fca2180c698850608eb2549a1cb9440ba43134006b7ded4fca6f98b4664", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 59, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 59, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c3a07663bdac36f819dd627", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9315}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Eli Lilly and Company (Ireland) Limited", "truncated": false}, "before_length": 39, "before_sha256": "0555e8a06c0ef36afd955d945d4997f04834690c546541adf74802bac524a0e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c4f436d12846be804339740", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3410}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "D-90429 Nuremberg", "truncated": false}, "before_length": 17, "before_sha256": "e947a9c523ae55d462208c17464751e497403938b7fe52dead7696ca6851269b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c61d198b379305b3f942388", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3856}
{"after": {"end": 296, "start": 0, "text": "Un repas riche en matières grasses concomitant n’a pas modifié de manière significative les paramètres pharmacocinétiques du niraparib après administration de 300 mg de niraparib gélule (Cmax diminuée de 22 % et ASCinf augmentée de 10 % par rapport à des conditions de jeûne ; voir rubrique 4.2).", "truncated": false}, "after_length": 296, "after_sha256": "d5ebdf307ff155c7a41be4a997be67a68f6614310b0c1707e840af14a9c53b1d", "annex": "I", "before": {"end": 186, "start": 0, "text": "Un repas riche en matières grasses concomitant n’a pas modifié de manière significative les paramètres pharmacocinétiques du niraparib après administration de 300 mg de niraparib gélule.", "truncated": false}, "before_length": 186, "before_sha256": "16e1c35a842305d1e3b22f6f06fe72f1e02bda5fba35e66c643f0e187831da73", "change_kind": "content", "change_operations": [{"after_end": 295, "after_start": 185, "before_end": 185, "before_start": 185, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 110}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c636963f50fe317e678648c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 783}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 48 22 2606400", "truncated": false}, "after_length": 21, "after_sha256": "91ea111aa679f6773d6dedcb0b0a2558a35b3e3387196cb6b3c71a9a8806c141", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c76be117cd5286a1f7c2f27", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3243}
{"after": {"end": 24, "start": 0, "text": "portugal.medinfo@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "9ec8b32b2035c90c423af74fa150dca23880201d448d46da35a42d2a862c8345", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c76d86e224c612130f58cbf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2580}
{"after": {"end": 5, "start": 0, "text": "Malta", "truncated": false}, "after_length": 5, "after_sha256": "71e9eb10755c8232974d186a560f7658a1ccbdd3097877dfa1ad3436af90d46a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c7a8bfdbe772eafa44cac49", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2521}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Sími + 354 540 8000", "truncated": false}, "before_length": 19, "before_sha256": "f4cdd754bf961df3d7e2d222a8a0eff31ddb973016b3192b9e5fa539dc3491ea", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c7e88fc924316be9bf91ff6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9536}
{"after": {"end": 21, "start": 0, "text": "Τηλ: + 30 210 6074300", "truncated": false}, "after_length": 21, "after_sha256": "c10bf95f55d88eadacbbac2970ab7bef5bd625d01122a54ba6a3bd30eae65368", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c80c4fef04cdcbbeb9be5ff", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2864}
{"after": {"end": 22, "start": 0, "text": "medinfo.norway@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c4c553c0f2dbe6456fca075a3e80411c07f0926b9866f5334ba99d71d96198e2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c913dd0d617bab4b182b4fa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2856}
{"after": {"end": 22, "start": 0, "text": "Teл.: + 359 2 4942 480", "truncated": false}, "after_length": 22, "after_sha256": "71df057e61352cd6e548ee210b03d0adc43d1e9ef00311b1d7ac8fce15871b09", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c97e5f845f1fda722256267", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2498}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 524, "start": 0, "text": "Bien qu’une inhibition du CYP3A4 dans le foie ne soit pas attendue, le potentiel d’inhibition de CYP3A4 au niveau intestinal n’a pas été établi à des concentrations significatives de niraparib. Par conséquent, la prudence est recommandée lorsque le niraparib est administré en concomitance avec des substances actives dont le métabolisme est dépendant du CYP3A4 et, notamment, celles ayant une plage thérapeutique étroite (par exemple, ciclosporine, tacrolimus, alfentanil, ergotamine, pimozide, quétiapine et halofantrine).", "truncated": false}, "before_length": 524, "before_sha256": "64a9295d5cb0793e9d62f4cf05b5ea7b24672d5005554ac415c2421bacbd1201", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 524, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 524, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6c9f9bb5e61b9c927e70bcbd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1148}
{"after": {"end": 30, "start": 0, "text": "Stéarate de magnésium (E 470b)", "truncated": false}, "after_length": 30, "after_sha256": "7ba4701dc559de66bade4e7c79639cde42f09abbbaeb5842e7cc483528e24510", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 30, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 30}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6cb1bb34f84ae1add51fad98", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1886}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 5, "start": 0, "text": "Label", "truncated": false}, "before_length": 5, "before_sha256": "0e66373f45dcf3dd656151e519f7ee5e3d558d9c22cb87df339bbdd2b6c6a3c1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 5, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6cdd0e5ff7776d7c40f22595", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9588}
{"after": {"end": 16, "start": 0, "text": "A.M. Mangion Ltd", "truncated": false}, "after_length": 16, "after_sha256": "24f7ac6ac947e8ef3e36c6f6c1f51219647e1477dfe330121521ec39faf6cb0c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6ce8e05551fa0850dc41a347", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3199}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Luxembourg/Luxemburg", "truncated": false}, "before_length": 20, "before_sha256": "28ac4fa3aba2dfb4b228bd072edb8cc818b04e6f4b87f37114caa6154e0e706b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6d0708c47a8a10c75a243352", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9467}
{"after": {"end": 8, "start": 0, "text": "Hrvatska", "truncated": false}, "after_length": 8, "after_sha256": "08c5546cc42a9be9368bdd6a99ed02c97b9163c173b1e97dd49b785cb49740bc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6d0e26d7e3c935359317b0fd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2582}
{"after": {"end": 19, "start": 0, "text": "Tel: + 371 66164750", "truncated": false}, "after_length": 19, "after_sha256": "113b9b6ac49a6f4bdbe379f2d1e85b2d125b75611b91111c888ec73bacdd0230", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6d2beb2bf83a578d23ae9405", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2944}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 15, "start": 0, "text": "EU/1/96/007/047", "truncated": false}, "before_length": 15, "before_sha256": "f30ca5758e9452ea84ad3bb59494b72b6dc498c88b510a424c09118ac6b49046", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6da386a6dd8b773fb1a118a6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "8", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 570}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Prime before each injection.", "truncated": false}, "before_length": 28, "before_sha256": "fc0ab5431f461d947fc1fb82451832354c9c2d8b7c59b9989b6bc12ef8795461", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6dafc039186aaf5daa944dcb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9659}
{"after": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "after_length": 7, "after_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6dbb6324c9ff1cf034dba3ec", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2938}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 84, "start": 0, "text": "Niraparib as a substrate of hepatic uptake transporters (OATP1B1, OATP1B3, and OCT1)", "truncated": false}, "before_length": 84, "before_sha256": "ae8ceef2229c49d648160877d0eae34404352c95ab6a0d646e313b18edf48ee1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 84, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 84, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6dff89ceca6e86592c037747", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1103}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 29, "start": 0, "text": "1. DÉNOMINATION DU MÉDICAMENT", "truncated": false}, "before_length": 29, "before_sha256": "e533e060c1472b188c6fc8bed504465df54df678055a3148f2bcc1dd51ea944c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 29, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 29, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6e05297f5be92c59fecfe009", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1103}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Reporting of side effects", "truncated": false}, "before_length": 25, "before_sha256": "0c7fd7c15ce183d5c60761ded0eda2ca1b2e44094c41b0acc598f5c68c835bd3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6e2c76779aba5d3e7b45312f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9380}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "Humalog Tempo Pen", "truncated": false}, "before_length": 17, "before_sha256": "328b8ad146aa9789b611fca56a42e321b79e5aecd24d0cc297eae30f99fae229", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6e2fa86975566fc158979c31", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4864}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Tel: + 353-(0) 1 661 4377", "truncated": false}, "before_length": 25, "before_sha256": "48fde288146f4033a2172164570180a8f875f4e361fcf85a8e43ff77834511cc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6e3d606e4ca01c4653d452e7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3122}
{"after": {"end": 33, "start": 0, "text": "medinfo.latvia@swixxbiopharma.com", "truncated": false}, "after_length": 33, "after_sha256": "c0a77882a6e33a348e9fb5e2a3006e8250b7d628f17c35efbaf3212a5e6e1c2d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6e959ea3169c84c1cc5e55a2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2941}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 67, "start": 0, "text": "5 pens of 3 ml. Component of a multipack, can’t be sold separately.", "truncated": false}, "before_length": 67, "before_sha256": "b2ee0b601a61f376096876cbe9c63686162e77e0087adc237c336761182ac729", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 67, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 67, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6ed21af4e96bb787873a377b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4805}
{"after": {"end": 24, "start": 0, "text": "portugal.medinfo@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "9ec8b32b2035c90c423af74fa150dca23880201d448d46da35a42d2a862c8345", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6f40000a6fc1c9c58a71ef29", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2574}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 50, "start": 0, "text": "DES TERMES DES AUTORISATIONS DE MISE SUR LE MARCHÉ", "truncated": false}, "before_length": 50, "before_sha256": "903bb45a1b7886b51dc795eb5d870ef367f3f6b04c33c742569a6e4ed036ed7c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 50, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 50, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6f4b43b1a0f942dc818d153e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3492}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 48, "start": 0, "text": "PVC/PA/alu/PVCalu perforated unit dose blisters.", "truncated": false}, "before_length": 48, "before_sha256": "ab94e31948ec333695ebfefa3aa196bf09db0a6e1504f0dc221e542aebae0868", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 48, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 48, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6f4fb89bff59790c10d85e7b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.5", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1396}
{"after": {"end": 8, "start": 0, "text": "Portugal", "truncated": false}, "after_length": 8, "after_sha256": "4c7de2c3da6dc0ae8f9d13b107718a913859359bd30166d077c867577953865d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6f543882525c866b3ea3259a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2883}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "OUTER CARTON (with blue box) multipack – Tempo Pen", "truncated": false}, "before_length": 50, "before_sha256": "25984fc190442af731f91eb0741133d0eaa8f9e9c29939ac33aff28e25c26084", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 50, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 50, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6f7d697fd9c27eb9126fb21f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4683}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Mylan IRE Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "35f93c261e1c23366cb104ad58005b2a5415120196df611fa95117f89eb960ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-6fcb0c795e16489ce68858bf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3676}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "Keep out of the sight and reach of children", "truncated": false}, "before_length": 43, "before_sha256": "034982a6fd4368f93bb56faf8a1eeaa94e38c9c9c5e4ffcc97d89ccfdbbe07fb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-701c76bb7fe618a5568a8e4c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4618}
{"after": {"end": 15, "start": 0, "text": "infomed@bms.com", "truncated": false}, "after_length": 15, "after_sha256": "66e67860f3e4742344d5e1cd7f07326ac1d6946e02f492fa89340b12edd31c8f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-704e553ef3cead8e75648131", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2885}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 68, "start": 0, "text": "• Inject your insulin as your healthcare professional has shown you.", "truncated": false}, "before_length": 68, "before_sha256": "ccab5685b5507e2508c0fc8b0f729a86cd95521eba6225f12fed19042d9cd858", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 68, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 68, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-707729fae86d82a7f6fa2fb2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9733}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 111, "start": 0, "text": "Neither niraparib nor M1 is an inhibitor of organic anion transport polypeptide 1B1 (OATP1B1) or 1B3 (OATP1B3).", "truncated": false}, "before_length": 111, "before_sha256": "90aa5ff75a1911a8128d5e8890d88ddf52fe34f52914f93856e3ce3df12a02ad", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 111, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 111, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-70c33e61e40f73dea9463d9a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1132}
{"after": {"end": 27, "start": 0, "text": "BristolMyers Squibb Denmark", "truncated": false}, "after_length": 27, "after_sha256": "85c703b06a34e371377fa6cfd59a679937926bebf7b34695c0e53e3bc9733ded", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-70d68a96320d75328350009d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2833}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Preparing Humalog Tempo Pen", "truncated": false}, "before_length": 27, "before_sha256": "ba4564c561a0a87f6d94a7be1ef21a18ec2d257ec7084ee5d0984b6eeb4a8127", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-710bc9049a3116f85d4876c9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9312}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Mylan IRE Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "35f93c261e1c23366cb104ad58005b2a5415120196df611fa95117f89eb960ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7124b5360096b5d889a1d9ee", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3696}
{"after": {"end": 21, "start": 0, "text": "Tel: + 46 8 704 71 00", "truncated": false}, "after_length": 21, "after_sha256": "313eaeeb04c88c002b748323fb801826225906f557247264c0fcb9fc87c873fc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-712a568024ff613ab3de6a2d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2935}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 695, "start": 0, "text": "The Tempo Pen is designed to work with the Tempo Smart Button. The Tempo Smart Button is an optional product that can be attached to the Tempo Pen dose knob and aids in transmitting Humalog dose information from the Tempo Pen to a compatible mobile application. The Tempo Pen injects insulin with or without the Tempo Smart Button attached. Your Smart Button must be attached to a Tempo Pen to record or transfer dose data. Push the Smart Button straight down on the dose knob until you hear a snap or feel the Smart Button snap into place. To transmit data to the mobile application, follow the instructions provided with the Tempo Smart Button and the instructions with the mobile application.", "truncated": false}, "before_length": 695, "before_sha256": "b7778d34b8a1e34e7f613c7792e74e1ada71a775f9c0654546ccb578a64deb2d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 695, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 695, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-715580e40d3967cbb0667ef0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9580}
{"after": {"end": 23, "start": 0, "text": "Tel: + 351 21 440 70 00", "truncated": false}, "after_length": 23, "after_sha256": "051a50965400ccbc97e96d9606564d6ef751251b31d5cd81aa4f430414a32099", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-715c0b1c7d1e2aef0271cc0f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2579}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-715eba98da1916b12210eb09", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2909}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Autriche", "truncated": false}, "before_length": 8, "before_sha256": "dea55da9d453f7a5125a553d05297c736f00626d1baa09e099247c0e7937d0cf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-71678b51b20ca35c3dded51d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2766}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Mylan IRE Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "35f93c261e1c23366cb104ad58005b2a5415120196df611fa95117f89eb960ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-71859eab3b9417633725963c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3345}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 2, "start": 0, "text": "PC", "truncated": false}, "before_length": 2, "before_sha256": "21d017c40a91c15748f0b98cd826ba445d2d3fe227e310bfd58dcb6c431826a0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-71a3b621ba86697a1c1f4448", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4675}
{"after": {"end": 578, "start": 0, "text": "[1] Twosided 95 % confidence intervals (CIs) for the observed differences in cure rates (rezafungin minus caspofungin) is calculated using the unadjusted methodology of Miettinen and Nurminen except for global cure at day 14 which is calculated adjusting for the two randomisation strata (diagnosis [candidaemia only; invasive candidiasis] and APACHE II score/ANC [APACHE II score ≥ 20 OR ANC < 500 cells/mm3; APACHE II score < 20 AND ANC ≥ 500 cells/mm3] at screening) using methodology of Miettinen and Nurminen. CochranMantelHaenszel weights are used for the stratum weights.", "truncated": false}, "after_length": 578, "after_sha256": "f019dd06284220af52157fede879f9dbcee983096b72358344abb31019368fab", "annex": "I", "before": {"end": 466, "start": 0, "text": "[1] Twosided 95 % confidence intervals (CIs) for the observed differences in cure rates (rezafungin minus caspofungin) is calculated adjusting for the two randomisation strata (diagnosis [candidaemia only; invasive candidiasis] and APACHE II score/ANC [APACHE II score ≥ 20 OR ANC < 500 cells/mm3; APACHE II score < 20 AND ANC ≥ 500 cells/mm3] at screening) using methodology of Miettinen and Nurminen. CochranMantelHaenszel weights are used for the stratum weights.", "truncated": false}, "before_length": 466, "before_sha256": "0330acdfcf663da859036513b88c2613dd0a7d73282ab61944386ec4a2ce12bd", "change_kind": "content", "change_operations": [{"after_end": 245, "after_start": 133, "before_end": 133, "before_start": 133, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 112}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-71c00e356552bd459af71707", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 314}
{"after": {"end": 119, "start": 0, "text": "Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, fast-acting, ATC code: A10AB04", "truncated": false}, "after_length": 119, "after_sha256": "c6d622fe1f983ccb643ee4367c391611652049e856c2e5d3b624c90a31d1b383", "annex": "I", "before": {"end": 120, "start": 0, "text": "Pharmacotherapeutic group : Drugs used in diabetes, insulins and analogues for injection, fast-acting, ATC code: A10AB04", "truncated": false}, "before_length": 120, "before_sha256": "234d0bf37751bc80c31249ffcda6862a6ebdff3273e1b91439350e2cdd95a7b5", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 25, "before_end": 26, "before_start": 25, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-71c85683e61630df7f1eb4cf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 320}
{"after": {"end": 110, "start": 0, "text": "Marketing Authorisation Holder: Eli Lilly Nederland B.V., Orteliuslaan 1000, 3528 BD Utrecht, The Netherlands.", "truncated": false}, "after_length": 110, "after_sha256": "e2ef698638f86423386a55d95b0167d0a5ee39297d86c39e1c4a1335b36f2d1c", "annex": "IIIA", "before": {"end": 110, "start": 0, "text": "Marketing Authorisation Holder: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.", "truncated": false}, "before_length": 110, "before_sha256": "31bde930103fd90462092a47ede6325cfe7229cd2cfce1a06a1e8fbb3caea2e0", "change_kind": "administrative", "change_operations": [{"after_end": 67, "after_start": 58, "before_end": 59, "before_start": 58, "kind": "replace"}, {"after_end": 69, "after_start": 68, "before_end": 62, "before_start": 60, "kind": "replace"}, {"after_end": 70, "after_start": 70, "before_end": 72, "before_start": 63, "kind": "delete"}, {"after_end": 75, "after_start": 71, "before_end": 75, "before_start": 73, "kind": "replace"}, {"after_end": 84, "after_start": 83, "before_end": 84, "before_start": 83, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7204fee27e8c198532a63ff0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3027}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 22, "start": 0, "text": "Povidone (K-valeur 90)", "truncated": false}, "before_length": 22, "before_sha256": "c093a7c3c851448d335ba3e73369f22c98ac61fc25adaa4f2a1666c7135a068f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-721605211ff1e6b682b3ebba", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1909}
{"after": {"end": 20, "start": 0, "text": "Swixx Biopharma EOOD", "truncated": false}, "after_length": 20, "after_sha256": "27f5284d414219f28c8c91886b89df13d6ef413ca05a03cdd596d9c697d6c0ea", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-722ee3d81a6fbe723c5ec9f6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2809}
{"after": {"end": 20, "start": 0, "text": "Tel: + 370 52 369140", "truncated": false}, "after_length": 20, "after_sha256": "8a995c3bfc3c0427235c993d1d1f2ebdd1b1443c434cbb3e015f99728e5b363f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7237a374c8e97cd316e263b9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2809}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "8055 Graz", "truncated": false}, "before_length": 9, "before_sha256": "765f51a390983de920b9a586c4589caab5f6398576531f438fd8301227c9ccb2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7267914e254d81b9b8853483", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2439}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 20, "start": 0, "text": "Novartis Pharma GmbH", "truncated": false}, "before_length": 20, "before_sha256": "bae642239c19e15ed2be9a6c4c5123c7ef0f4e0a79a5ece5f8c2cf22e6047d3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-726da64e8861708af332c2ef", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1642}
{"after": {"end": 22, "start": 0, "text": "medinfo.sweden@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "b564c1a351ab9a2c3f444753cdc78f0306131b829474e9874a876fc1a90d4b7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-727eaba13d1a2f0dcbb455bf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2624}
{"after": {"end": 50, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht The Netherlands", "truncated": false}, "after_length": 50, "after_sha256": "de386d3b3aeebba1dff0a070ffc767173cbc1fa354dbcd29dd86469dc23d8ff6", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "Papendorpseweg 83, 3528 BJ Utrecht The Netherlands", "truncated": false}, "before_length": 50, "before_sha256": "5d621ef45df9c1911e6b63f15edb513d80fad3ee63f11fe58a733f65b67cd3cd", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}, {"after_end": 26, "after_start": 25, "before_end": 26, "before_start": 25, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-728fe6e34f6cbab4526b0459", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1737}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 48 22 2606400", "truncated": false}, "after_length": 21, "after_sha256": "91ea111aa679f6773d6dedcb0b0a2558a35b3e3387196cb6b3c71a9a8806c141", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-729aeac9d2958a6d87011543", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2563}
{"after": {"end": 135, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency: https://www.ema.europa.eu.", "truncated": false}, "after_length": 135, "after_sha256": "225b9d1c01da7e586aba026377e9e00375718774c3ae46bbcffa8602c23a36fe", "annex": "I", "before": {"end": 134, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu.", "truncated": false}, "before_length": 134, "before_sha256": "61558209063cd956cbee2d3a9247324f155af242c6c749330921fce6e94d2d67", "change_kind": "technical", "change_operations": [{"after_end": 114, "after_start": 113, "before_end": 113, "before_start": 113, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-72afb115255df5160ff67e88", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1429}
{"after": {"end": 6, "start": 0, "text": "Danska", "truncated": false}, "after_length": 6, "after_sha256": "99ab62517b3bb8298a9c40a2538a2769b0c2c8637a432d58e84bd537a117f8d4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-72b0907e232eca789f4e22c6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2107}
{"after": {"end": 20, "start": 0, "text": "Luxembourg/Luxemburg", "truncated": false}, "after_length": 20, "after_sha256": "28ac4fa3aba2dfb4b228bd072edb8cc818b04e6f4b87f37114caa6154e0e706b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-72b1fc25b7bf9ee1fee67356", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2817}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 13, "start": 0, "text": "Roonstraße 25", "truncated": false}, "before_length": 13, "before_sha256": "72b80df998792e1d92189a290d82759fb839b17a555226b67f667c759822bfa7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-72f5c64e3489e64cd0855a90", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1672}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 44, "start": 0, "text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING", "truncated": false}, "before_length": 44, "before_sha256": "d78bb4e96a3f9f8cb58e27de8d08d455cdf9166cf22b388c3242f9a0b13158ed", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 44, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 44, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-72fd9124a5a3574a5bf4bd6e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4779}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 69, "start": 0, "text": "Le CHMP approuve les conclusions scientifiques formulées par le PRAC.", "truncated": false}, "before_length": 69, "before_sha256": "90c7bcf5bda957d755e24ac4a267c2580e64de699683322d8f07b6bc87a9570e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 69, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 69, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-734f3820441436fef0c2ebad", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3499}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "GlaxoSmithKline (Ireland) Limited", "truncated": false}, "before_length": 33, "before_sha256": "aab443afe73fcfeb3384251d62635faa955ab6ace3c6efeb3f1cf79dfb706da8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7391f02f9132648c8c162a59", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2923}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Tel: +44 (0) 1844 347333", "truncated": false}, "before_length": 24, "before_sha256": "3e66f974ec29433df45716bf73117a6d11dd49271609c4d153b59d502de5d353", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7397070febeb4bab4a1579c0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2163}
{"after": {"end": 56, "start": 0, "text": "https://www.ema.europa.eu/en/medicines/human/EPAR/viagra", "truncated": false}, "after_length": 56, "after_sha256": "886313ea21a179beab5d08069efa9bdd90016fe9ff52ceb2200ea200bdc1503a", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 56, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 56}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-73985231c557ccb6052a0c92", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 8}
{"after": {"end": 239, "start": 0, "text": "Ce document constitue les informations sur le produit approuvées pour Viagra, les modifications apportées depuis la procédure précédente qui ont une incidence sur les informations sur le produit (EMA/VR/0000247514) étant mises en évidence.", "truncated": false}, "after_length": 239, "after_sha256": "54a9ca1305f3d239f85d2870e301d39d3cd880b9a614e3db9f30729324eaa4aa", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 239, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 239}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-73b2c6329a86cca50cbe6b29", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 0}
{"after": {"end": 27, "start": 0, "text": "CPO Pharmaceuticals Limited", "truncated": false}, "after_length": 27, "after_sha256": "94b644443752e2cb52916b23f8141fbd44c47055b3416af333e12ac18e101b87", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "GPA Pharmaceuticals Ltd", "truncated": false}, "before_length": 23, "before_sha256": "ece7127e303c91e9501d2cedd822476265aae86acb9f96ef1553ab3a6954afe1", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 21, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-73df36287c57befe3a07574c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2700}
{"after": {"end": 34, "start": 0, "text": "medinfo.croatia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "59c47394700ad787801e8ce1b033fc5d63a885ddfc680677ae6b5acd89bb7df3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-74123e62b252fefc65eb6ee9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2579}
{"after": {"end": 21, "start": 0, "text": "Tlf.: +45 46 77 10 10", "truncated": false}, "after_length": 21, "after_sha256": "66cf81daaff5b98d25568a26e39568c1152e032702922190ca55773ed6810712", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tlf: +45 46 77 10 10", "truncated": false}, "before_length": 20, "before_sha256": "5ca1f3f0b7d8416ed7580c67d57829d1753a6533f0f8398906780d8735aed67e", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-742a999f25b1e894cc80e903", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1573}
{"after": {"end": 9, "start": 0, "text": "Danemarca", "truncated": false}, "after_length": 9, "after_sha256": "aa62ca811afd7d8cbf62b0601ca860863bdb18df68b1426acf2862cb7a82b5ac", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7431310c3b725e0ba0f942a0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2099}
{"after": {"end": 119, "start": 0, "text": "For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:", "truncated": false}, "after_length": 119, "after_sha256": "96e8e519927e4ccd767c33018abc0bb77c29439563f16049ac8a6e6cef005737", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 119, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 119}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-747e8e147cc8117eb4aedc8a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2484}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 26, "start": 0, "text": "Tél: +33-(0) 1 55 49 34 34", "truncated": false}, "before_length": 26, "before_sha256": "920e9ba3ce137de0cc5e42d5ec3d00da23272a9b69b8496b1bd29a4a69dffbd0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 26, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 26, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-74ae91a7fa0e5d99585aaea7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9514}
{"after": {"end": 48, "start": 0, "text": "Date de première autorisation : 22 décembre 2023", "truncated": false}, "after_length": 48, "after_sha256": "05483f3bf95adb6f918633b1fe840cdd6be02855385e6dfd3eed545f0827f5b4", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 48, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 48}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-74c0313f6f4cff71fb5a2575", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "9", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 500}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 47 67 55 53 50", "truncated": false}, "after_length": 21, "after_sha256": "d1b594f6660af0e3776951e66e526813a270ea883650a47e68423146b1d67dd7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-74d7d355caf64f5259f9ae2b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3223}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 109, "start": 0, "text": "if you are allergic to insulin lispro or any of the other ingredients of this medicine (listed in section 6).", "truncated": false}, "before_length": 109, "before_sha256": "b91f603781be027b23d511f01a0095fdfe0f73532137b5008eed68dabf76354f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 109, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 109, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-752c622e7247e22e47b2a4e5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9248}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7539a8127bce23a8c5121119", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2819}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 73, "start": 0, "text": "Humalog 100 units/ml Tempo Pen solution for injection in a pre-filled pen", "truncated": false}, "before_length": 73, "before_sha256": "51230eb86540e3f2989a8d72fae57656b7c456fc2ba7375eaa3efbd8b0d89f0f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 73, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 73, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-756b3c1b3cc7959533f4360c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9570}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 13, "start": 0, "text": "Roonstraße 25", "truncated": false}, "before_length": 13, "before_sha256": "72b80df998792e1d92189a290d82759fb839b17a555226b67f667c759822bfa7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-75bf098f3f928a29c60760eb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1699}
{"after": {"end": 23, "start": 0, "text": "medinfo.denmark@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "b9a121278c8c2cc6f9be9c7a9fab0d3dee3fadaac431fdd8d5efa352410f5389", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-75d51fde7167461b25bdd727", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2519}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "• flushed face • fruity smell on the breath", "truncated": false}, "before_length": 43, "before_sha256": "8b08bbe395ed328d7803fdcd5dd83472dd4c1caf438feedc993890d3772372b1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7602768f54377074535a7f7c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9412}
{"after": {"end": 110, "start": 0, "text": "Inhibition of efflux transporters [Pglycoprotein (Pgp), Breast Cancer Resistance Protein (BCRP) and MATE1/2K)]", "truncated": false}, "after_length": 110, "after_sha256": "8ec1f0fef7b24929a6ba32079327b864ea79271bdba5289d5bde7e9fdf227490", "annex": "I", "before": {"end": 70, "start": 0, "text": "Inhibition of efflux transporters (Pgp, BCRP, BSEP, MRP2, and MATE1/2)", "truncated": false}, "before_length": 70, "before_sha256": "6826a53539720fe1cc594a1ca96e6e5eeb2dd43966d509b4a1c1e453ea174613", "change_kind": "content", "change_operations": [{"after_end": 49, "after_start": 34, "before_end": 34, "before_start": 34, "kind": "insert"}, {"after_end": 54, "after_start": 53, "before_end": 38, "before_start": 38, "kind": "insert"}, {"after_end": 90, "after_start": 56, "before_end": 40, "before_start": 40, "kind": "insert"}, {"after_end": 95, "after_start": 94, "before_end": 57, "before_start": 44, "kind": "replace"}, {"after_end": 108, "after_start": 107, "before_end": 69, "before_start": 69, "kind": "insert"}, {"after_end": 110, "after_start": 109, "before_end": 70, "before_start": 70, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 53}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7606256d350b584f7f3d3e84", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 259}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "insulin lispro", "truncated": false}, "before_length": 14, "before_sha256": "1ca88cfa41606b28145f703442bf3c0e5efa0967c7177f9c26ed091d4c7a140d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7620cef6290dc8ebbd201d92", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9212}
{"after": {"end": 40, "start": 0, "text": "Tel: 1 800 749 749 (+ 353 (0)1 483 3625)", "truncated": false}, "after_length": 40, "after_sha256": "0509d2a1806f188ecbce2c353425cb70d883d4c07f6e695eacf4b8a2ec65feef", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 40, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 40}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-762e1834adc95743b0807f36", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2900}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Eli Lilly Sweden AB", "truncated": false}, "before_length": 19, "before_sha256": "7966c6171f922571b5ca3761e19527dd4ecc65d58d788ce1a1e50d8023dad57b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-764642bdcb7e73169c89532b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9555}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 55, "start": 0, "text": "If seal is broken before first use, contact pharmacist.", "truncated": false}, "before_length": 55, "before_sha256": "e4b082e0ea1464322d7477fe94374a5412bfd6df5066e8ea45e2c2fc275f2f7d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 55, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 55, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-765292d036114a758c9e362b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4859}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 364, "start": 0, "text": "Neither niraparib nor M1 is a substrate of organic anion transporter 1 (OAT1), 3 (OAT3), and organic cation transporter 2 (OCT2). No dose adjustment for Zejula is required when administered concomitantly with medicinal products known to inhibit OAT1 (e.g. probenecid) or OAT3 (e.g. probenecid, diclofenac), or OCT2 uptake transporters (e.g. cimetidine, quinidine).", "truncated": false}, "before_length": 364, "before_sha256": "366f4c7c7eb84f02fa7025f4541754e40c96eeafe5799b46ec13fdce85dd7e26", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 364, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 364, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-765bc2b3f888ff7f94fcf957", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 244}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 39, "start": 0, "text": "Eli Lilly and Company (Ireland) Limited", "truncated": false}, "before_length": 39, "before_sha256": "0555e8a06c0ef36afd955d945d4997f04834690c546541adf74802bac524a0e4", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-765f854da183b225d4172858", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2879}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 29, "start": 0, "text": "9. SPECIAL STORAGE CONDITIONS", "truncated": false}, "before_length": 29, "before_sha256": "1c7900d8ae1746afe2ef2b4a26d399b6054dc430f41e340e45f1f881197f01b2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 29, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 29, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-767c70b908ef5c2987be506e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4629}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "insulin lispro", "truncated": false}, "before_length": 14, "before_sha256": "1ca88cfa41606b28145f703442bf3c0e5efa0967c7177f9c26ed091d4c7a140d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-76ac7c12908b4e5f78594828", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4788}
{"after": {"end": 186, "start": 0, "text": "Les groupes de patients présentant les antécédents cardiovasculaires suivants n'ayant pas été inclus dans les essais cliniques, l'utilisation du tadalafil est donc contre-indiquée chez :", "truncated": false}, "after_length": 186, "after_sha256": "12897ebac488b9c0ec08b6d6e4e08efea42f93f0d107419b4cb095a34e6506dc", "annex": "I", "before": {"end": 185, "start": 0, "text": "Les groupes de patients présentant les antécédents cardiovasculaires suivants n'ayant pas été inclus dans les essais cliniques, l'utilisation du tadalafil est donc contre-indiquée chez:", "truncated": false}, "before_length": 185, "before_sha256": "d468f6cc052c008888e897b05eb327cbdaaeb5f54a13a7662fe55805bacdc728", "change_kind": "content", "change_operations": [{"after_end": 185, "after_start": 184, "before_end": 184, "before_start": 184, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-76c75e34e2e5948bd68d0700", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 10 mg comprimés pelliculés CIALIS 20 mg comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.3", "section_type": "contraindication", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1177}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "steroids,", "truncated": false}, "before_length": 9, "before_sha256": "69d06fcb0691dccd6720b3cace1157e7654aae444652d86bd667cebfbc6b6dd6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-76d28c7595ea81379d55c6b1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9271}
{"after": {"end": 5, "start": 0, "text": "Eesti", "truncated": false}, "after_length": 5, "after_sha256": "ed7477d6100948d0d4e6b914d9769159823c21b23bf4846b1676338b9b439b72", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-771a46eadc65df29ec584d36", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3213}
{"after": {"end": 21, "start": 0, "text": "Tel: + 386 1 2355 100", "truncated": false}, "after_length": 21, "after_sha256": "dac6f0be4f23d749d801d499c013eab48028544c9f89af72365ef4fdc2e94efc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7733432616b92073368b6ea6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3273}
{"after": {"end": 22, "start": 0, "text": "Teл.: + 359 2 4942 480", "truncated": false}, "after_length": 22, "after_sha256": "71df057e61352cd6e548ee210b03d0adc43d1e9ef00311b1d7ac8fce15871b09", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7773cfa3d7d9b573d3f3c772", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3175}
{"after": {"end": 16, "start": 0, "text": "4. NUMÉRO DU LOT", "truncated": false}, "after_length": 16, "after_sha256": "213d44967f2b19d21f4f51c47374c967e28b81413f5de0f45dea5ffece1c90aa", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-778d67cfc96a1f1348b1b1ff", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1123}
{"after": {"end": 26, "start": 0, "text": "9 x 10 film-coated tablets", "truncated": false}, "after_length": 26, "after_sha256": "fe87fad687c0ee45bbd2096b55f71086de7085fdd33caed9b5e0a83e9c4c75b2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-77ad6fc69cec9cb60f16e9f5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2299}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Novartis Pharma GmbH", "truncated": false}, "before_length": 20, "before_sha256": "bae642239c19e15ed2be9a6c4c5123c7ef0f4e0a79a5ece5f8c2cf22e6047d3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-77af683824ede5195a92a86a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3822}
{"after": {"end": 13, "start": 0, "text": "Suomi/Finland", "truncated": false}, "after_length": 13, "after_sha256": "5bea43a11ae0d0e9706443422f6eb9b6107624ceb18d16ec89005011c62699dd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 13, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-77beaf9449c33b59f9247f95", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3288}
{"after": {"end": 8, "start": 0, "text": "Hrvatska", "truncated": false}, "after_length": 8, "after_sha256": "08c5546cc42a9be9368bdd6a99ed02c97b9163c173b1e97dd49b785cb49740bc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7808e29d65e7d8147d3d4e93", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2576}
{"after": {"end": 252, "start": 0, "text": "Ce document constitue les informations sur le produit approuvées pour Cialis, les modifications apportées depuis la procédure précédente qui ont une incidence sur les informations sur le produit (EMEA/H/C/PSUSA/00002841/202210) étant mises en évidence.", "truncated": false}, "after_length": 252, "after_sha256": "1461b2ea39a1e22f892296f7124f3b5cc87db6b9e8926649a41ee181b11bd601", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 252, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 252}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-78164bef452165ebecb9d599", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 0}
{"after": {"end": 19, "start": 0, "text": "Slovenská republika", "truncated": false}, "after_length": 19, "after_sha256": "8667151da5d74cf45a2b263a2f7b38e944fd51f34b51e08d79151f123b8f10b2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-781d635208cefe9725792b51", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2917}
{"after": {"end": 49, "start": 0, "text": "BOÎTE POUR CONDITIONNEMENT EN PLAQUETTES DE 61 MG", "truncated": false}, "after_length": 49, "after_sha256": "b000f7d49df7f5eb078cc04b2283ca8186fa4c28daf70cd9b3ebac2c7ffda0f0", "annex": "IIIA", "before": {"end": 5, "start": 0, "text": "BOÎTE", "truncated": false}, "before_length": 5, "before_sha256": "87dff9ff284c36fc29669cde2f65fdf3551f30f3eca961e0b0d1a0f773301277", "change_kind": "content", "change_operations": [{"after_end": 49, "after_start": 5, "before_end": 5, "before_start": 5, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 44}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7821b341a2f6f11a287c05d4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2786}
{"after": {"end": 39, "start": 0, "text": "Bristol-Myers Squibb Pharmaceuticals uc", "truncated": false}, "after_length": 39, "after_sha256": "ab72fdea8b5fe2eaa4c98886b1cf7afbfde7133a0ee1d1e04fc9d573c1885b5c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 39, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 39}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-78371bf0f66003a858896e5f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3264}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 148, "start": 0, "text": "This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.", "truncated": false}, "before_length": 148, "before_sha256": "69c6c73d53f90eb333be72d97ffe34f32e0380705260f8ef68d28cbef95ceaa4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 148, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 148, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-783cf0b8925593deff06ad07", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9219}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb A.E.", "truncated": false}, "after_length": 25, "after_sha256": "43a0521fcec8db403e6fb060ae3b147a3107583a8df9b3a28208c9a4bd0d8fba", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-78651cb193bb42b4da145fcb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2859}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Step 14:", "truncated": false}, "before_length": 8, "before_sha256": "362a1bdcbc640197ad605a2cd94cebe1fdd0eb8d1da718fe5c9f9f0361996069", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-787564226ee121e8f55e9fa2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9777}
{"after": {"end": 21, "start": 0, "text": "Τηλ: + 30 210 6074300", "truncated": false}, "after_length": 21, "after_sha256": "c10bf95f55d88eadacbbac2970ab7bef5bd625d01122a54ba6a3bd30eae65368", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-788feda1872b8d0358643e93", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3228}
{"after": {"end": 20, "start": 0, "text": "Swixx Biopharma EOOD", "truncated": false}, "after_length": 20, "after_sha256": "27f5284d414219f28c8c91886b89df13d6ef413ca05a03cdd596d9c697d6c0ea", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-789d0d30f98bb5e61d8f97f7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3174}
{"after": {"end": 105, "start": 0, "text": "There are insufficient data across races to conclude on the impact of race on niraparib pharmacokinetics.", "truncated": false}, "after_length": 105, "after_sha256": "07850a5a0e876287443d9ba639ad6ca909cfba75d953fdce319de3808f7e2f7d", "annex": "I", "before": {"end": 104, "start": 0, "text": "There is insufficient data across races to conclude on the impact of race on niraparib pharmacokinetics.", "truncated": false}, "before_length": 104, "before_sha256": "368aa8e1f7371818b5eda591ce70ddc0e6b56681412fa1bd0573b8eaf4036b77", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 6, "before_end": 8, "before_start": 6, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-78d4cce9f7bfdc050a23e5a8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1665}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Novartis Pharma GmbH", "truncated": false}, "before_length": 20, "before_sha256": "bae642239c19e15ed2be9a6c4c5123c7ef0f4e0a79a5ece5f8c2cf22e6047d3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-78eaa7965caa2ac7b62bf7f1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3430}
{"after": {"end": 22, "start": 0, "text": "medinfo.norway@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c4c553c0f2dbe6456fca075a3e80411c07f0926b9866f5334ba99d71d96198e2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7904ce4220876335f0e41224", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2550}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 91, "start": 0, "text": "some angiotensin converting enzyme (ACE) inhibitors (for example captopril, enalapril), and", "truncated": false}, "before_length": 91, "before_sha256": "a7a49917849a4a344e77146cd232f066d02ab52e14c30341bd06f7f83289fc98", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 91, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 91, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7905aed55d332077940405a1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9281}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: + 353 18711600", "truncated": false}, "before_length": 19, "before_sha256": "f39469e1bbd519f10406ae27e104b0e2fb101791df45c4e53cc539ee02b84821", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7931c840666feadf7beebfa3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2713}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 238, "start": 0, "text": "Excipients: glycerol, zinc oxide, dibasic sodium phosphate 7 H20 with m-cresol as a preservative in water for injections. Sodium hydroxide and/or hydrochloric acid may have been used to adjust acidity. See leaflet for further information.", "truncated": false}, "before_length": 238, "before_sha256": "219cd265f69c3cedd04f6e16fbaf3d05818947596178a2daeaf3c614ba2fbebf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 238, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 238, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-79422ff4c481c4ec8d3cae08", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4798}
{"after": {"end": 10, "start": 0, "text": "Excipients", "truncated": false}, "after_length": 10, "after_sha256": "4eb806067f42ea6d1295212c67a84650b548bacfd28d5a90b568721c534f821d", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 10}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7956176cf49d2019c9ed5d88", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1006}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Oy Eli Lilly Finland Ab", "truncated": false}, "before_length": 23, "before_sha256": "ad2790fc92e09c7e5d7fca228bd3066505e74ea97b8f34495cbb07054e746fa8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-796e0e74732baeb748975800", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9547}
{"after": {"end": 110, "start": 0, "text": "Marketing Authorisation Holder: Eli Lilly Nederland B.V., Orteliuslaan 1000, 3528 BD Utrecht, The Netherlands.", "truncated": false}, "after_length": 110, "after_sha256": "e2ef698638f86423386a55d95b0167d0a5ee39297d86c39e1c4a1335b36f2d1c", "annex": "IIIA", "before": {"end": 110, "start": 0, "text": "Marketing Authorisation Holder: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.", "truncated": false}, "before_length": 110, "before_sha256": "31bde930103fd90462092a47ede6325cfe7229cd2cfce1a06a1e8fbb3caea2e0", "change_kind": "administrative", "change_operations": [{"after_end": 67, "after_start": 58, "before_end": 59, "before_start": 58, "kind": "replace"}, {"after_end": 69, "after_start": 68, "before_end": 62, "before_start": 60, "kind": "replace"}, {"after_end": 70, "after_start": 70, "before_end": 72, "before_start": 63, "kind": "delete"}, {"after_end": 75, "after_start": 71, "before_end": 75, "before_start": 73, "kind": "replace"}, {"after_end": 84, "after_start": 83, "before_end": 84, "before_start": 83, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7980ed152b2ba4b012ff04f9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2740}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 78, "start": 0, "text": "Niraparib comme substrat des transporteurs d’influx rénal (OAT1, OAT3 et OCT2)", "truncated": false}, "before_length": 78, "before_sha256": "80f020949a0f01b4d11dc9505c0b86b5fe9d8348231794b0ed57493efcae634e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 78, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 78, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-79810e731be8097b466d9495", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1140}
{"after": {"end": 76, "start": 0, "text": "Poudre pour solution à diluer pour perfusion (poudre pour solution à diluer)", "truncated": false}, "after_length": 76, "after_sha256": "01e2017704beeeb351003ff0a6e3cef6d88a202a6d498ee1a7cda516856ffaad", "annex": "I", "before": {"end": 44, "start": 0, "text": "Poudre pour solution à diluer pour perfusion", "truncated": false}, "before_length": 44, "before_sha256": "a422a160d7a01b0484fca10a52078fdeb8bd5d29abd4046566112dcf12b03510", "change_kind": "content", "change_operations": [{"after_end": 76, "after_start": 44, "before_end": 44, "before_start": 44, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 32}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-79834d8a8a231c3ec74dbcd3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "3", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 46}
{"after": {"end": 30, "start": 0, "text": "Bristol-Myers Squibb Norway AS", "truncated": false}, "after_length": 30, "after_sha256": "4d312e57cb670ef0ce508bd73d4efdf4538b212e677408590a67036924ff5e9b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 30, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 30}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-79a988ecc0176af33ae155bc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2854}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 36 1 301 9797", "truncated": false}, "after_length": 21, "after_sha256": "646ee39f31e338f4b9b710096409242010a836db8c907826a18abfa5703a4854", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7a01d532c1865266cc6677f9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2825}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 73, "start": 0, "text": "Humalog 100 units/ml Tempo Pen solution for injection in a pre-filled pen", "truncated": false}, "before_length": 73, "before_sha256": "51230eb86540e3f2989a8d72fae57656b7c456fc2ba7375eaa3efbd8b0d89f0f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 73, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 73, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7a051ec6d11acab4fcc655f8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 35}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "• Wipe the rubber seal with a swab.", "truncated": false}, "before_length": 35, "before_sha256": "c6d886e5d8836f7f723dbed2f640afba7cc5984b7edac4e1adfce458bd8def3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7a442fab444d76e220bde150", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9637}
{"after": {"end": 18, "start": 0, "text": "Swixx Biopharma OÜ", "truncated": false}, "after_length": 18, "after_sha256": "94bc5f3c43fc9da5715250d66202d3b6e108127762e4f8e413b99fc19e24a395", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 18, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 18}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7a466523d1d967ec913fdc2c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2537}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 78, "start": 0, "text": "Eli Lilly Nederland B.V., Orteliuslaan 1000, 3528 BD Utrecht, The Netherlands.", "truncated": false}, "before_length": 78, "before_sha256": "14c6caa35deafa952d9a908f7f7ad455bea4499a5e41bda5d0233d9b99e4566a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 78, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 78, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7a707a2009d501523035f1c3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9447}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "C. Illness", "truncated": false}, "before_length": 10, "before_sha256": "8a2dafeeb41e20c45f225e99454b78547f3e3b97ff8573e40b9d420a3de0cd19", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7a98068a4a1a372b68d371cd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9417}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7aa04a1a5bd0f5d7320ee7e0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2549}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 74, "start": 0, "text": "Inhibition des transporteurs d’influx hépatique (OATP1B1, OATP1B3 et OCT1)", "truncated": false}, "before_length": 74, "before_sha256": "7feac6cb4618682c18d8c767f7a58d331af0b0563c8ed485582f430c32c70698", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 74, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 74, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7aa2de089077a11848e46c51", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 277}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 111, "start": 0, "text": "• Hold your Pen with the needle pointing up. Tap the cartridge holder gently to collect air bubbles at the top.", "truncated": false}, "before_length": 111, "before_sha256": "68fcb54bcece78ce1b0f3da33a7e854524b5d86b3ab89bdc0502072282fd74d9", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 111, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 111, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7aa83ad729f482d3cd106326", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9667}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 17, "start": 0, "text": "D-90429 Nuremberg", "truncated": false}, "before_length": 17, "before_sha256": "e947a9c523ae55d462208c17464751e497403938b7fe52dead7696ca6851269b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7b0d0222babc78d8c8117924", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1673}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 88, "start": 0, "text": "The first symptoms of low blood sugar usually come on quickly and include the following:", "truncated": false}, "before_length": 88, "before_sha256": "80e2730ffa6c8ec3316325bbda23751c58002a31fb8786625cc1a2ece22eda45", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 88, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7b10f276812d4a7786f04ea0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9396}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Eli Lilly Nederland B.V.", "truncated": false}, "before_length": 24, "before_sha256": "58e60ac126dd39b4930580291c64d7770a0db93150c4173b7e7d8a8642fe64e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7b2a96b5bcd49e0f9e18c33e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4641}
{"after": {"end": 15, "start": 0, "text": "infomed@bms.com", "truncated": false}, "after_length": 15, "after_sha256": "66e67860f3e4742344d5e1cd7f07326ac1d6946e02f492fa89340b12edd31c8f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7b43fdd4761cf69b5cfc8384", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3249}
{"after": {"end": 32, "start": 0, "text": "Takeda Farmacéutica España, S.A.", "truncated": false}, "after_length": 32, "after_sha256": "e4011321ff84bc97a3a57c2ef4c7b74b6b015f8e8d044046ef1d15c72f7e4b3d", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "Takeda Farmacéutica España S.A", "truncated": false}, "before_length": 30, "before_sha256": "6702486f6992447e37b2164fef2f973a83c8960354f82d5166db99d6bdb3bad8", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 26, "before_end": 26, "before_start": 26, "kind": "insert"}, {"after_end": 32, "after_start": 31, "before_end": 30, "before_start": 30, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7b5585ad768ebbccd9aa188c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1637}
{"after": {"end": 11, "start": 0, "text": "Deutschland", "truncated": false}, "after_length": 11, "after_sha256": "af6e56aacd8097c3fb7597b08ecb3d87a040f6ab58067a4b8ff9f5b747adb9be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7b60a26e9b3d7b9784f99e11", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3203}
{"after": {"end": 22, "start": 0, "text": "Тел.: +359 2 44 55 400", "truncated": false}, "after_length": 22, "after_sha256": "94028dcda4157759850e99c37d94dc37a770042b9b66033cfa2fc452d7aeb2af", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Тел: +359 2 44 55 400", "truncated": false}, "before_length": 21, "before_sha256": "6374e24291111ea27904f41925595739c88615b1e085f7a9f606a90b47ed1647", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7bad60b49f62a06f9e09315c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005403", "medicine_name": "Sugammadex Mylan", "medicine_slug": "sugammadex-mylan", "observed_at": "2026-10-12T13:36:03Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "3d1f09d9bcfb1d2bba4f610b61ad692a3a78dc1ae2800f83497a954f8545d5a0", "source_snapshot_id": "source-ccd6e4297624ea024166e969", "source_updated_at": "2026-06-12", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/sugammadex-mylan-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1457}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 54, "start": 0, "text": "• Store unused Pens in the refrigerator at 2°C to 8°C.", "truncated": false}, "before_length": 54, "before_sha256": "8e3736264fa48c15449b877f05dced66475b7df5995f762cc8b69855c508458a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 54, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 54, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7bb291edbd25ff72d92a4014", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9788}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 92, "start": 0, "text": "• Always use a new needle for each injection to help prevent infections and blocked needles.", "truncated": false}, "before_length": 92, "before_sha256": "4447a0aa46e558ee4fd53d940a48d6c09bafe76b6f17507f2f9281e833ce06c1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 92, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 92, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7be156a180cadbcb078e1d0c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9632}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 275, "start": 0, "text": "Read the instructions for use before you startusing your insulin and each time you get another Humalog Tempo Pen. There may be new information. This information does not take the place of talking to your healthcare professional about your medical condition or your treatment.", "truncated": false}, "before_length": 275, "before_sha256": "a22ff16b03b494257d22a92032090d4e187993167bcfba0ea226d5c19f095365", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 275, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 275, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7bf14607cd65b27bf94be5fa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9577}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 59, "start": 0, "text": "2. NOM DU TITULAIRE DE L’AUTORISATION DE MISE SUR LE MARCHÉ", "truncated": false}, "before_length": 59, "before_sha256": "58a43e7e9a772309fbc8304f6233d73a1ebb638a46821bf43b883ad8e52974a5", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 59, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 59, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7c0eb75ee19898f4b84e91fd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1110}
{"after": {"end": 53, "start": 0, "text": "Poussez le comprimé à travers la feuille d’aluminium.", "truncated": false}, "after_length": 53, "after_sha256": "a29f365abf741b14f16caca93c4920e7c8275bc1783027190e27500459ef92d4", "annex": "IIIA", "before": {"end": 52, "start": 0, "text": "Poussez la capsule à travers la feuille d’aluminium.", "truncated": false}, "before_length": 52, "before_sha256": "0bb801bab8fbcc7efe4c7da5e920d83c154aff04cf1b5e9f781425e909f4cf65", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 9, "before_end": 10, "before_start": 9, "kind": "replace"}, {"after_end": 14, "after_start": 12, "before_end": 13, "before_start": 12, "kind": "replace"}, {"after_end": 19, "after_start": 15, "before_end": 18, "before_start": 14, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7c1a6004cf4cdba47282eaa7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3648}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Tel. +370 (5) 2649600", "truncated": false}, "before_length": 21, "before_sha256": "f1efe00b150f168e1fa7ddd63b3a65d7cad099c08fc3ff541483a315c5cc3324", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7cb023052fcca628544071c4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9461}
{"after": {"end": 8, "start": 0, "text": "Hrvatska", "truncated": false}, "after_length": 8, "after_sha256": "08c5546cc42a9be9368bdd6a99ed02c97b9163c173b1e97dd49b785cb49740bc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7cba20fbd0c2ebe3231ab510", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3256}
{"after": {"end": 60, "start": 0, "text": "Each film-coated tablet contains 61 mg micronized tafamidis.", "truncated": false}, "after_length": 60, "after_sha256": "37f61635b05b680d7f7724f48db7209c7ddd5bc3b732f00952264cb6a5f1101f", "annex": "IIIA", "before": {"end": 54, "start": 0, "text": "Each soft capsule contains 61 mg micronized tafamidis.", "truncated": false}, "before_length": 54, "before_sha256": "7436f24a4ea6e84d2e0dccfad30fbda3e36d4b362b0f7c5b2a1cdd04afbe6fe5", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 5, "before_end": 6, "before_start": 5, "kind": "replace"}, {"after_end": 13, "after_start": 12, "before_end": 8, "before_start": 7, "kind": "replace"}, {"after_end": 16, "after_start": 14, "before_end": 9, "before_start": 9, "kind": "insert"}, {"after_end": 18, "after_start": 17, "before_end": 11, "before_start": 10, "kind": "replace"}, {"after_end": 20, "after_start": 19, "before_end": 15, "before_start": 12, "kind": "replace"}, {"after_end": 23, "after_start": 22, "before_end": 17, "before_start": 17, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7cd56ace1322e85a07909612", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2288}
{"after": {"end": 23, "start": 0, "text": "medinfo.austria@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "80539556a138e6e0b8efab6b438c21ba77b592fc3c2d28fdfaea7dc2bb3248d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7ce4d18918354dffde20bb83", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3231}
{"after": {"end": 19, "start": 0, "text": "Tel: + 372 640 1030", "truncated": false}, "after_length": 19, "after_sha256": "fe728e641eb3fdbddc9ef5e84d4bceb9a2fe5bf5a11cd739c9346c67f55cc34e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7cf2eb7e3a85bf5b174c184d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3215}
{"after": {"end": 38, "start": 0, "text": "BristolMyers Squibb Pharmaceuticals uc", "truncated": false}, "after_length": 38, "after_sha256": "78edaf732c95d13a5ec5ba0a04740553812606cbf3d2047b91d484b5e76e8b52", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7d04d7790eca6cf55bbf50e8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3267}
{"after": {"end": 272, "start": 0, "text": "The other ingredients are: microcrystalline cellulose (E 460), lactose monohydrate (E 24) [see section 2 “Vyndaqel contains lactose monohydrate”], crospovidone (E 1202), magnesium stearate (E 470b), calcium carbonate, isomalt, hypromellose, and medium-chain triglycerides.", "truncated": false}, "after_length": 272, "after_sha256": "5121f76ebbf0370e94060086da835474ff02d91ded2e1b6bd1e152ce3b6cb328", "annex": "IIIA", "before": {"end": 445, "start": 0, "text": "The other ingredients are: gelatine (E 441), glycerine (E 422), sorbitol (E 420) [see section 2 “Vyndaqel contains sorbitol”], mannitol (E 421), sorbitan, red iron oxide (E 172), purified water, macrogol 400 (E 1521), polysorbate 20 (E 432), povidone (K-value 90), butylated hydroxytoluene (E321), ethyl alcohol, isopropyl alcohol, polyvinyl acetate phthalate, propylene glycol (E 1520), titanium dioxide (E 171), and ammonium hydroxide (E 527).", "truncated": false}, "before_length": 445, "before_sha256": "4237936dc3ea6881d1998c05537a9acc5728d73414574574606fcf5209c2e02f", "change_kind": "content", "change_operations": [{"after_end": 45, "after_start": 27, "before_end": 28, "before_start": 27, "kind": "replace"}, {"after_end": 52, "after_start": 47, "before_end": 34, "before_start": 30, "kind": "replace"}, {"after_end": 60, "after_start": 58, "before_end": 42, "before_start": 40, "kind": "replace"}, {"after_end": 63, "after_start": 63, "before_end": 46, "before_start": 45, "kind": "delete"}, {"after_end": 76, "after_start": 64, "before_end": 47, "before_start": 47, "kind": "insert"}, {"after_end": 78, "after_start": 77, "before_end": 50, "before_start": 48, "kind": "replace"}, {"after_end": 81, "after_start": 79, "before_end": 53, "before_start": 51, "kind": "replace"}, {"after_end": 87, "after_start": 86, "before_end": 58, "before_start": 58, "kind": "insert"}, {"after_end": 88, "after_start": 88, "before_end": 79, "before_start": 59, "kind": "delete"}, {"after_end": 127, "after_start": 124, "before_end": 120, "before_start": 115, "kind": "replace"}, {"after_end": 143, "after_start": 129, "before_end": 123, "before_start": 122, "kind": "replace"}, {"after_end": 147, "after_start": 147, "before_end": 197, "before_start": 127, "kind": "delete"}, {"after_end": 150, "after_start": 150, "before_end": 222, "before_start": 200, "kind": "delete"}, {"after_end": 151, "after_start": 151, "before_end": 242, "before_start": 223, "kind": "delete"}, {"after_end": 162, "after_start": 161, "before_end": 259, "before_start": 252, "kind": "replace"}, {"after_end": 165, "after_start": 163, "before_end": 261, "before_start": 260, "kind": "replace"}, {"after_end": 167, "after_start": 166, "before_end": 262, "before_start": 262, "kind": "insert"}, {"after_end": 177, "after_start": 170, "before_end": 266, "before_start": 265, "kind": "replace"}, {"after_end": 181, "after_start": 178, "before_end": 267, "before_start": 267, "kind": "insert"}, {"after_end": 185, "after_start": 182, "before_end": 270, "before_start": 268, "kind": "replace"}, {"after_end": 187, "after_start": 187, "before_end": 288, "before_start": 272, "kind": "delete"}, {"after_end": 196, "after_start": 191, "before_end": 295, "before_start": 292, "kind": "replace"}, {"after_end": 200, "after_start": 199, "before_end": 304, "before_start": 298, "kind": "replace"}, {"after_end": 211, "after_start": 203, "before_end": 307, "before_start": 307, "kind": "insert"}, {"after_end": 216, "after_start": 212, "before_end": 311, "before_start": 308, "kind": "replace"}, {"after_end": 229, "after_start": 221, "before_end": 316, "before_start": 316, "kind": "insert"}, {"after_end": 234, "after_start": 232, "before_end": 321, "before_start": 319, "kind": "replace"}, {"after_end": 235, "after_start": 235, "before_end": 324, "before_start": 322, "kind": "delete"}, {"after_end": 236, "after_start": 236, "before_end": 326, "before_start": 325, "kind": "delete"}, {"after_end": 238, "after_start": 237, "before_end": 344, "before_start": 327, "kind": "replace"}, {"after_end": 239, "after_start": 239, "before_end": 412, "before_start": 345, "kind": "delete"}, {"after_end": 245, "after_start": 245, "before_end": 419, "before_start": 418, "kind": "delete"}, {"after_end": 248, "after_start": 246, "before_end": 423, "before_start": 420, "kind": "replace"}, {"after_end": 257, "after_start": 251, "before_end": 426, "before_start": 426, "kind": "insert"}, {"after_end": 263, "after_start": 258, "before_end": 428, "before_start": 427, "kind": "replace"}, {"after_end": 266, "after_start": 264, "before_end": 430, "before_start": 429, "kind": "replace"}, {"after_end": 267, "after_start": 267, "before_end": 433, "before_start": 431, "kind": "delete"}, {"after_end": 271, "after_start": 270, "before_end": 444, "before_start": 436, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 293, "chars_inserted": 120}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7d0ea6050538b77184dd4cfb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3191}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 70, "start": 0, "text": "Inhibition of hepatic uptake transporters (OATP1B1, OATP1B3, and OCT1)", "truncated": false}, "before_length": 70, "before_sha256": "a7f0c1a3e7985235db8ba8fec6c3494aa04c3616ec52a69f29e540581f019c7e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 70, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 70, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7d32a91307b23d5972dd4348", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 268}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 146, "start": 0, "text": "Once the Tempo Pen is empty, do not use it again. Please get rid of it carefully - your pharmacist or diabetes nurse will tell you how to do this.", "truncated": false}, "before_length": 146, "before_sha256": "efc2bc0653c6aeb847eb7d421570735942775d36d0d8a940f3e9b42183a24699", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 146, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 146, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7d57232b06ba3ca77f80ca4b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9333}
{"after": {"end": 19, "start": 0, "text": "Tel: + 356 23976333", "truncated": false}, "after_length": 19, "after_sha256": "f8bfa43651e282e3e99ee42fa339e414e57dea721306efb985d46dcd3b4656c4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7d5c8fa2fedab2f48d3e2d5c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2529}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 41, "start": 0, "text": "Package leaflet: Information for the user", "truncated": false}, "before_length": 41, "before_sha256": "b6986acd5fcd0810c8e128d8e30a00ceaf146ccc2ef4d6c0280b65c1ab484727", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 41, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 41, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7d6ae31395b267621320306a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9209}
{"after": {"end": 9, "start": 0, "text": "Slovenija", "truncated": false}, "after_length": 9, "after_sha256": "fa267dd198bd52b588eff3ae1ccd7c7ea1ac67b4d621fd44e50742c91809cac3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7dcfcb4b8c242c67ff5d984a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2597}
{"after": {"end": 6, "start": 0, "text": "Danska", "truncated": false}, "after_length": 6, "after_sha256": "99ab62517b3bb8298a9c40a2538a2769b0c2c8637a432d58e84bd537a117f8d4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7ddb985ff835c0bc35c1c19b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1818}
{"after": {"end": 6, "start": 0, "text": "Ísland", "truncated": false}, "after_length": 6, "after_sha256": "5801902efe8b92c2ace1332f4cca2ea1fcb704712e2fe7ca66654d2a826e8451", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7e1e679802c92974cc4771de", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2602}
{"after": {"end": 34, "start": 0, "text": "12. MARKETING AUTHORISATION NUMBER", "truncated": false}, "after_length": 34, "after_sha256": "a60532285d3f2ae8ae6f1bf2efe60e8f4d80a3914ffa0fe294c7a05c7841017d", "annex": "IIIA", "before": {"end": 37, "start": 0, "text": "12. MARKETING AUTHORISATION NUMBER(S)", "truncated": false}, "before_length": 37, "before_sha256": "b6071fb293faef2077f6465142b105eff6f52c83477531a9aef260fa8ed61e46", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 34, "before_end": 37, "before_start": 34, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7e4b5e5c6386f0793470a5f5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 844}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7eeacfc66bdf81d39c72c8c3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3695}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 39, "start": 0, "text": "Eli Lilly and Company (Ireland) Limited", "truncated": false}, "before_length": 39, "before_sha256": "0555e8a06c0ef36afd955d945d4997f04834690c546541adf74802bac524a0e4", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7efff3e5cb265cb16adbec9c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2577}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 37, "start": 0, "text": "14. GENERAL CLASSIFICATION FOR SUPPLY", "truncated": false}, "before_length": 37, "before_sha256": "0a2c9dd7ac0be92910d87b1a1b036337a62217a1d8517a2e70dc3f3b7965f761", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 37, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 37, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7f0181f6636ed659f6b76236", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4854}
{"after": {"end": 36, "start": 0, "text": "medinfo.lithuania@swixxbiopharma.com", "truncated": false}, "after_length": 36, "after_sha256": "70eec294d332a04f9bd82459b443a88e19b0dcce5bbd50491f56763531b2b260", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7f596b828196a5e1ac346606", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2494}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 74, "start": 0, "text": "Humalog 100 units/ml Tempo Pen solution for injection in a pre-filled pen.", "truncated": false}, "before_length": 74, "before_sha256": "681e3f199b7a72b3c8bc686d56555487fc74fe2563a9431031432ecd772e378d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 74, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 74, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7f6f84920c7cbf547082b7ad", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4589}
{"after": {"end": 8, "start": 0, "text": "България", "truncated": false}, "after_length": 8, "after_sha256": "a7215e5aa55f878990c076bb8195d75ca42044d4d5c7d2ba90af610508b643d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7f9c408fa9ea4909e0a292d6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2812}
{"after": {"end": 170, "start": 0, "text": "Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’autorisation de mise sur le marché :", "truncated": false}, "after_length": 170, "after_sha256": "3d33a6b4a45572c6d201e5b64d04d70230f33eb5f235e4cf7ed24c3872500500", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 170, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 170}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7fa118c30b226ff999617368", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3164}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 32, "start": 0, "text": "2. STATEMENT OF ACTIVE SUBSTANCE", "truncated": false}, "before_length": 32, "before_sha256": "9e169b908eb1d9fc1ed6e233dacad6af86b2c8a043fa81faef38a02382a9c8e3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7fad33dac028fa42d800d7a6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4692}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 568, "start": 0, "text": "Le niraparib est un substrat de la glycoprotéine-P (P-gp) et de la protéine de résistance du cancer du sein (BCRP). Toutefois, en raison de sa perméabilité et biodisponibilité élevées, le risque d’interactions cliniquement importantes avec des médicaments qui inhibent ces transporteurs est peu probable. Par conséquent, aucun ajustement posologique n’est nécessaire pour Zejula en cas d’administration concomitante avec des médicaments connus pour inhiber la P-gp (par exemple, amiodarone, vérapamil) ou la BCRP (par exemple, osimertinib, velpatasvir et eltrombopag).", "truncated": false}, "before_length": 568, "before_sha256": "8e59b2ae8ea8ecdc6fd3867003a36d4c2b3f377e5bec56c892aa1d39d64417d6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 568, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 568, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7fb324b5664204bad41547ba", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1133}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tel: +385 1 2350 999", "truncated": false}, "before_length": 20, "before_sha256": "890539c6ca43e117a19df0a571456dcf766866bcff856b64b548f75cca9aeb16", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7fb549ef9b9e087ade0b77ff", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9521}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 91, "start": 0, "text": "• Always check the number in the dose window to make sure you have dialed the correct dose.", "truncated": false}, "before_length": 91, "before_sha256": "04ba471d7afb140873120ea063e631facd11dae0604a8cf73c5154d52c45e732", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 91, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 91, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7fb84410be1ee089b03c5f8f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9697}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "17. UNIQUE IDENTIFIER – 2D BARCODE", "truncated": false}, "before_length": 34, "before_sha256": "bc158365115e0908119e4f2782a562abac5f0b5b80024210ee67676cff8a06c5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7fd3259d0682c7141b34ce65", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4867}
{"after": {"end": 38, "start": 0, "text": "EU/1/11/717/005 30 film-coated tablets", "truncated": false}, "after_length": 38, "after_sha256": "db46bc39fd4a8ca1c74223f761123caf16e77d087421149a141b563275a86ff4", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "EU/1/11/717/003", "truncated": false}, "before_length": 15, "before_sha256": "33df5f48219bd2551b78dae07893271e4475ba3b184a73338ee9e17e4dfb94cf", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 14, "before_end": 14, "before_start": 14, "kind": "insert"}, {"after_end": 38, "after_start": 17, "before_end": 15, "before_start": 15, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-7ff99cbf38add0e97d4ccd73", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2342}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Millmount Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "4327529987c61beb05b89459f321ff89fd08e90a03878c8a0e235da0308d7dad", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-800d4d1775dbe691980269bc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3719}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 25, "start": 0, "text": "Tel: + 353-(0) 1 661 4377", "truncated": false}, "before_length": 25, "before_sha256": "48fde288146f4033a2172164570180a8f875f4e361fcf85a8e43ff77834511cc", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-80219b3046d1094665362c20", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2578}
{"after": {"end": 45, "start": 0, "text": "Plaquettes thermoformées OPA/Al/PVC-aluminium", "truncated": false}, "after_length": 45, "after_sha256": "b2e58949883373e0abfdc1ef32d60d2aa5cd7d6f02802e6a7ba445f22d433fe2", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 45, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 45}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-804f7537de08fb119dbb393e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.5", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1937}
{"after": {"end": 454, "start": 0, "text": "Les expositions systémiques (Cmax et ASC) au niraparib ont augmenté de manière proportionnelle à la dose lorsque la dose de niraparib augmentait de 30 mg à 400 mg. La biodisponibilité absolue du niraparib est d’environ 73 %, ce qui indique un effet de premier passage minime. Dans une analyse pharmacocinétique de population du niraparib, la variabilité inter-individuelle de la biodisponibilité a été estimée à un coefficient de variation (CV) de 33,8%.", "truncated": false}, "after_length": 454, "after_sha256": "517b99eb2ae3a46feb32efad88450befe30b81e95659ea6e1a790f31d1d5d4c5", "annex": "I", "before": {"end": 452, "start": 0, "text": "Les expositions systémiques (Cmax et ASC) au niraparib ont augmenté de manière proportionnelle à la dose lorsque la dose de niraparib augmentait de 30 mg à 400 mg. La biodisponibilité absolue du niraparib est d’environ 73 %, ce qui indique un effet de premier passage minime. Dans une analyse pharmacocinétique de population du niraparib, la variabilité inter-individuelle de la biodisponibilité a été estimée à un coefficient de variation (CV) de 31%.", "truncated": false}, "before_length": 452, "before_sha256": "954430188db72d4f9a08f21b3b99a9822e8a9f52845514360e8d9b61756e847d", "change_kind": "content", "change_operations": [{"after_end": 452, "after_start": 449, "before_end": 450, "before_start": 449, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-805262aefb87b31079ef26ad", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1669}
{"after": {"end": 10, "start": 0, "text": "Österreich", "truncated": false}, "after_length": 10, "after_sha256": "b1b763860d4f30c2e1feafdcd57b714a1422b4fbc1a93d94969118a0faa65288", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 10}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-80710cbbb72a105e49cf16ec", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2551}
{"after": {"end": 18, "start": 0, "text": "Orteliuslaan 1000,", "truncated": false}, "after_length": 18, "after_sha256": "21c621c6366151fa349c8db45d9fcbb9c94e9eb157e7b6a12761b6c45f5a91c4", "annex": "I", "before": {"end": 18, "start": 0, "text": "Papendorpseweg 83,", "truncated": false}, "before_length": 18, "before_sha256": "93fe807c935894269f90415a7510e03bd5cb998b5478f2bec793675a6a09dafb", "change_kind": "administrative", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-80879da936fa5afc8bbefc0f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 2,5 mg comprimés pelliculés", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 522}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "Injecting Humalog", "truncated": false}, "before_length": 17, "before_sha256": "7f313f080c7e6f6a6484b9a0056b69ca4cbb1471a5bf95e0c870f4eb92d67984", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-80e98cb91b6b27074a2f9d57", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9321}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-80f797ee094cb9e0ca36024f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2805}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "13. BATCH NUMBER", "truncated": false}, "before_length": 16, "before_sha256": "1ba2d71652baaf680bf61f6637402598f74e8e74757862c33639fc0867a99221", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-812e25a71f48e9765d14b0cd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4849}
{"after": {"end": 27, "start": 0, "text": "Puh/Tel: + 358 9 251 21 230", "truncated": false}, "after_length": 27, "after_sha256": "115859cfeab013cc7da2aa72c6645b7c1a35594595b929820235610cd0afa5fd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8162dbaf54eb16f7b529761b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2613}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 49, "start": 0, "text": "Keep this leaflet. You may need to read it again.", "truncated": false}, "before_length": 49, "before_sha256": "c4a6121ec44900abf9772238558f2142a4ece9923633523fa27f2b8cd9466cb8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 49, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 49, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-816437750aca0f5b5e9a3598", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9217}
{"after": {"end": 173, "start": 0, "text": "L'âge (entre 26 et 91 ans) n'était pas un facteur significatif pour la clairance ou le volume de distribution du niraparib dans l’analyse pharmacocinétique de la population.", "truncated": false}, "after_length": 173, "after_sha256": "0f14a661f03236089e889e8e153938c492e8260dce5bc3bced6b7d394775ace2", "annex": "I", "before": {"end": 338, "start": 0, "text": "Il a été montré que l’augmentation de l’âge diminuait la clairance du niraparib dans l’analyse pharmacocinétique de la population. L'exposition moyenne chez une patiente de 91 ans a été estimée comme étant 23% plus élevée que celle d’une patiente de 30 ans. L’impact de l’âge n’est pas considéré comme justifiant un ajustement de la dose.", "truncated": false}, "before_length": 338, "before_sha256": "25a8d04fe5ab378bca24a3692ce31b9d2663c8dc0ee2a5fc295c0f1ba1c3619a", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 0, "before_end": 40, "before_start": 0, "kind": "replace"}, {"after_end": 8, "after_start": 6, "before_end": 48, "before_start": 44, "kind": "replace"}, {"after_end": 31, "after_start": 9, "before_end": 50, "before_start": 49, "kind": "replace"}, {"after_end": 67, "after_start": 34, "before_end": 53, "before_start": 53, "kind": "insert"}, {"after_end": 109, "after_start": 80, "before_end": 66, "before_start": 66, "kind": "insert"}, {"after_end": 172, "after_start": 172, "before_end": 337, "before_start": 129, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 253, "chars_inserted": 88}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-81c0829920903a47bc893c7f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1708}
{"after": {"end": 20, "start": 0, "text": "Tel.: +36 1 270 7030", "truncated": false}, "after_length": 20, "after_sha256": "a564f4fa4b8be19fcbef34e4106edaf1c07c01ff8075a559b95e72eacd6d9cfc", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: +36 1 270 7030", "truncated": false}, "before_length": 19, "before_sha256": "27e72abd8e26e77216333bd8200693839a8af4734b977e191c58c7a24b081026", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-81cf7da7224383b7018f81fc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1568}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 58, "start": 0, "text": "11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "truncated": false}, "before_length": 58, "before_sha256": "f673fc8d85353a41392579def66f2174386940ef53d65631a983cd19732f9497", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 58, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 58, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-81dca1b0fdd772139efc373b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4639}
{"after": {"end": 89, "start": 0, "text": "La substance active est tafamidis. Chaque comprimé contient 61 mg de tafamidis micronisé.", "truncated": false}, "after_length": 89, "after_sha256": "fdfc2adc60835b2486625e87c6288d5b495910be214142c3fc29aa2c063cb38f", "annex": "IIIA", "before": {"end": 88, "start": 0, "text": "La substance active est tafamidis. Chaque capsule contient 61 mg de tafamidis micronisé.", "truncated": false}, "before_length": 88, "before_sha256": "788a05d645c23b65cc90a68cf429ce31aa7ec7031038209af2da2082cde06fe0", "change_kind": "content", "change_operations": [{"after_end": 45, "after_start": 43, "before_end": 44, "before_start": 43, "kind": "replace"}, {"after_end": 50, "after_start": 46, "before_end": 49, "before_start": 45, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-821ae482a601368fe4fed82e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3692}
{"after": {"end": 110, "start": 0, "text": "Inhibition of efflux transporters [Pglycoprotein (Pgp), Breast Cancer Resistance Protein (BCRP) and MATE1/2K)]", "truncated": false}, "after_length": 110, "after_sha256": "8ec1f0fef7b24929a6ba32079327b864ea79271bdba5289d5bde7e9fdf227490", "annex": "I", "before": {"end": 70, "start": 0, "text": "Inhibition of efflux transporters (Pgp, BCRP, BSEP, MRP2, and MATE1/2)", "truncated": false}, "before_length": 70, "before_sha256": "6826a53539720fe1cc594a1ca96e6e5eeb2dd43966d509b4a1c1e453ea174613", "change_kind": "content", "change_operations": [{"after_end": 49, "after_start": 34, "before_end": 34, "before_start": 34, "kind": "insert"}, {"after_end": 54, "after_start": 53, "before_end": 38, "before_start": 38, "kind": "insert"}, {"after_end": 90, "after_start": 56, "before_end": 40, "before_start": 40, "kind": "insert"}, {"after_end": 95, "after_start": 94, "before_end": 57, "before_start": 44, "kind": "replace"}, {"after_end": 108, "after_start": 107, "before_end": 69, "before_start": 69, "kind": "insert"}, {"after_end": 110, "after_start": 109, "before_end": 70, "before_start": 70, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 53}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8231804f806c0f1fb29a6ebd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1122}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 12, "start": 0, "text": "Manufacturer", "truncated": false}, "before_length": 12, "before_sha256": "1af384c577f294d4164a7ea49f3021259e2b92802eac577722d14066b2bbd5ce", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8255c31194ba03db2ac275a8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2742}
{"after": {"end": 13, "start": 0, "text": "Suomi/Finland", "truncated": false}, "after_length": 13, "after_sha256": "5bea43a11ae0d0e9706443422f6eb9b6107624ceb18d16ec89005011c62699dd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 13, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-825b398dad4fb3e9e9a1ecff", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2927}
{"after": {"end": 32, "start": 0, "text": "5. MODE ET VOIE D’ADMINISTRATION", "truncated": false}, "after_length": 32, "after_sha256": "bc33d9ee3a64cfa7a5fdcce95a03584999505e063543ab6e48cb29eed4742fdd", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "5. MODE ET VOIE(S) D’ADMINISTRATION", "truncated": false}, "before_length": 35, "before_sha256": "17ac57bd750cd275d807d869c838dbc4c562eeea8645350ff1655752eaa2921f", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 15, "before_end": 18, "before_start": 15, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-828dba0114ec7f628ffeae93", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 924}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 122, "start": 0, "text": "Read all of this leaflet carefully before you start using this medicine because it contains important information for you.", "truncated": false}, "before_length": 122, "before_sha256": "b72eef5002a11830ce7d83488794ff19928e2eeb26eb1ac13d5be73396e1763e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 122, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 122, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-82934d8c58f267ac71202208", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9216}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 18, "start": 0, "text": "• Pen colour: Blue", "truncated": false}, "before_length": 18, "before_sha256": "b2bec451d7e804ffba523ab1697c58c094e95870909ae000b74203ddeb805416", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 18, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 18, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-82a6ec1248643a1d61c20c58", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9620}
{"after": {"end": 135, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency https://www.ema.europa.eu/.", "truncated": false}, "after_length": 135, "after_sha256": "3c74f634f1dbc9f08897b33e0ea95036324616df9ff3f17282cc79a52cb99608", "annex": "I", "before": {"end": 134, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/.", "truncated": false}, "before_length": 134, "before_sha256": "96536f36542fc44ff8d90ae9f46567670b8287c2f485df2d108dc671e3becaea", "change_kind": "technical", "change_operations": [{"after_end": 113, "after_start": 112, "before_end": 112, "before_start": 112, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-82e5a715547d914d66966163", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "Baraclude 0.5 mg film-coated tablets Baraclude 1 mg film-coated tablets", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 935}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Killorglin", "truncated": false}, "before_length": 10, "before_sha256": "2606b5fb607427b1a532d8cab1195d0515b4a8cf56f0eff6628b2ac9a5a04655", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-831640f6c2f3d98c5cda2145", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1704}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 78, "start": 0, "text": "Inhibition des CYP (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 et CYP3A4)", "truncated": false}, "before_length": 78, "before_sha256": "196c71870b34b303fee071ff2b3f9be117b50cbdd0de57b2a547924e74f29851", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 78, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 78, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8329c5980bb125e072b18499", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1145}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 63, "start": 0, "text": "• you have trouble with your kidneys or liver which gets worse.", "truncated": false}, "before_length": 63, "before_sha256": "bd07465ac7f57fb91ab64778f0c043f0669fc1efdde37155a858dc37abb6d3c0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 63, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 63, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-83336923a353c6eb60a37a41", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9392}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "Hafnerstraße 36", "truncated": false}, "before_length": 15, "before_sha256": "2fcce2f98396d52bbfd5728e1a018b4f5e6a7c25edffb18410df25f808883c4f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8351e5ff7ba449f87a4895ed", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3124}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 66, "start": 0, "text": "Do not freeze. Do not expose to excessive heat or direct sunlight.", "truncated": false}, "before_length": 66, "before_sha256": "1c580aa2802ea4add64b3f99b24021870334c9d6fdba3dc7d0e7ecbae4f0d248", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 66, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 66, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-836112ea5b56d94a02518932", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4830}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "4. PHARMACEUTICAL FORM AND CONTENTS", "truncated": false}, "before_length": 35, "before_sha256": "103cfd4c3e9c7bb9b46998faaa21a391b50f062b5f82b4f79f73e1aa06fb67fc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-838ba37728172c7ebd2839ae", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4702}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Stamullen", "truncated": false}, "before_length": 9, "before_sha256": "abbbb3884efa82e3e41f0c4736af27e92f074d1c3610575a24e8e99760795e42", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-83c5655451787f0baf033b8d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3218}
{"after": {"end": 21, "start": 0, "text": "Τηλ: + 30 210 6074300", "truncated": false}, "after_length": 21, "after_sha256": "c10bf95f55d88eadacbbac2970ab7bef5bd625d01122a54ba6a3bd30eae65368", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-83ceae4f117b09ac4d7e10c1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3225}
{"after": {"end": 29, "start": 0, "text": "BristolMyers Squibb Norway AS", "truncated": false}, "after_length": 29, "after_sha256": "01226c5fbcee79cbe7d5ae55b232342409f6c95196e05bb842acfae228db69c9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 29, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 29}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-840dcc491d0eabbe0c60a451", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2858}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "EU/1/96/007/046", "truncated": false}, "before_length": 15, "before_sha256": "d6805fafeecf40e7708c6ada66c100190e8836086d3506065a754a470e2e72de", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-841214f19782a0489c1a067b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4648}
{"after": {"end": 72, "start": 0, "text": "No clinical drug interaction studies have been performed with niraparib.", "truncated": false}, "after_length": 72, "after_sha256": "6497ce75858893a99379d8912488927c233205e9d9e9a08a4c2385c4889aed3a", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 72, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 72}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-84766909d8e3af84286fa5e2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 227}
{"after": {"end": 22, "start": 0, "text": "Tlf.: + 45 36 35 91 00", "truncated": false}, "after_length": 22, "after_sha256": "ee5cfc7acaf9dfe8868ac7e8cd8079d0cb8f85922089533a08d33e515be7aea6", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Tlf: + 45 36 35 91 00", "truncated": false}, "before_length": 21, "before_sha256": "18d8cf6a57f2048255a4474230a78ae1192c8bd63af3a4aa0c409cccfeafcba9", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-847b5ba4df5967d3016b8bd7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2908}
{"after": {"end": 26, "start": 0, "text": "informacion.medica@bms.com", "truncated": false}, "after_length": 26, "after_sha256": "ecc8b3fc203c9400ed5a39531e5dadc0b28244ff3abb21ff0a801eeffc0a5d0e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-84ae2564ad03e240cf9ca4b4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3239}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 52, "start": 0, "text": "Niraparib as a substrate of CYPs (CYP1A2 and CYP3A4)", "truncated": false}, "before_length": 52, "before_sha256": "50bf48c4524b451355f2f57145fac01e84ee2fd05c93837310996800019bff63", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 52, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 52, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-84c6b260a41126415d382618", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1095}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 66, "start": 0, "text": "Do not freeze. Do not expose to excessive heat or direct sunlight.", "truncated": false}, "before_length": 66, "before_sha256": "1c580aa2802ea4add64b3f99b24021870334c9d6fdba3dc7d0e7ecbae4f0d248", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 66, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 66, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-84dca7e7bb0be2c964c29f1d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4731}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 37, "start": 0, "text": "Other medicines and Humalog Tempo Pen", "truncated": false}, "before_length": 37, "before_sha256": "db53b41b5037a3c800ab403716d4476e7342ef05345eca783a55dd1bfc2797d5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 37, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 37, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-84fd5e3b01bb85693997a4d4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9268}
{"after": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l'Agence européenne des médicaments : https://www.ema.europa.eu", "truncated": false}, "after_length": 150, "after_sha256": "7a57f3971964eb7bea4ed295986ca64649117ce6b1ea800c91cdf0ed4877b711", "annex": "III", "before": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l'Agence européenne des médicaments : http://www.ema.europa.eu.", "truncated": false}, "before_length": 150, "before_sha256": "6272fb3d1bf208f727e3ec8521cb6d15c24e42031d06a96b3c4d43ff5b48aa11", "change_kind": "technical", "change_operations": [{"after_end": 130, "after_start": 129, "before_end": 129, "before_start": 129, "kind": "insert"}, {"after_end": 150, "after_start": 150, "before_end": 150, "before_start": 149, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-84ff969302ff25a02f796516", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3173}
{"after": {"end": 16, "start": 0, "text": "pv@ammangion.com", "truncated": false}, "after_length": 16, "after_sha256": "53f45568239cbb258daee24319c4e0fde3bfc6917d09b88019c1cb8329ded177", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-851f4150026bd8f81bc51090", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2524}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 78, "start": 0, "text": "Alcohol and some medicines can affect your blood sugar levels (see section 2).", "truncated": false}, "before_length": 78, "before_sha256": "879024636312013e6c8b85bc3db91c9880c51512952dca3a32199183bd262e99", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 78, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 78, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-855739782d1c75b1216e7ad8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9394}
{"after": {"end": 18, "start": 0, "text": "Orteliuslaan 1000,", "truncated": false}, "after_length": 18, "after_sha256": "21c621c6366151fa349c8db45d9fcbb9c94e9eb157e7b6a12761b6c45f5a91c4", "annex": "III", "before": {"end": 18, "start": 0, "text": "Papendorpseweg 83,", "truncated": false}, "before_length": 18, "before_sha256": "93fe807c935894269f90415a7510e03bd5cb998b5478f2bec793675a6a09dafb", "change_kind": "unassigned", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-855e26a1798d79018e1d5da9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2196}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "ТП \"Ели Лили Недерланд\" Б.В. - България", "truncated": false}, "before_length": 39, "before_sha256": "c07970a61f72226aef64d75c44b8c7f9e3f8c631d5898cf17e1de3cbccc6ca61", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-856dddc7c2f6822fe115e0a5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9464}
{"after": {"end": 19, "start": 0, "text": "Tel: + 372 640 1030", "truncated": false}, "after_length": 19, "after_sha256": "fe728e641eb3fdbddc9ef5e84d4bceb9a2fe5bf5a11cd739c9346c67f55cc34e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-85a3977a584731023e7b33ff", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2544}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 235, "start": 0, "text": "On the basis of the scientific conclusions for tadalafil the CHMP is of the opinion that the benefit-risk balance of the medicinal product(s) containing tadalafil is unchanged subject to the proposed changes to the product information.", "truncated": false}, "before_length": 235, "before_sha256": "d8114e708e5167535a89f7f657319fbd6af2b123deb93588fb75e00d30ebfbad", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 235, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 235, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-85ab29a50a6f54d47299dc28", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3466}
{"after": {"end": 9, "start": 0, "text": "60 (52.2)", "truncated": false}, "after_length": 9, "after_sha256": "402fae837da8e0ecf9577bc065f86eabf01b28c0233eed7e301bd95617b5d475", "annex": "I", "before": {"end": 13, "start": 0, "text": "60 (52 (55.9)", "truncated": false}, "before_length": 13, "before_sha256": "e493fd5319d0dc6ddbccffc3b276aaa459c84248303ca7db59cd8f5da15413e9", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 6, "before_end": 10, "before_start": 6, "kind": "delete"}, {"after_end": 8, "after_start": 7, "before_end": 12, "before_start": 11, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-85d3e7c22f02f7d1ccad5f85", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 298}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "Using Humalog in an infusion pump", "truncated": false}, "before_length": 33, "before_sha256": "8fb3cb4b50c2cdf13cbe36df1049070557a6d2ce4fea01a351b3b9fda9db7bac", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-85d4f81d5c1e00e6304790e7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9339}
{"after": {"end": 149, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments https://www.ema.europa.eu.", "truncated": false}, "after_length": 149, "after_sha256": "0e6b9f35caaf0258b468a6e9a53665f0ec5536787f68eefee5f242bf64add02e", "annex": "I", "before": {"end": 148, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments http://www.ema.europa.eu.", "truncated": false}, "before_length": 148, "before_sha256": "8781a4dba25cf8cb978f0efd517b11bd29ec42e3e0fffadb61d4b9c2e7362806", "change_kind": "technical", "change_operations": [{"after_end": 128, "after_start": 127, "before_end": 127, "before_start": 127, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-85fbc0f8c3a45f1e1b37039f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 2,5 mg comprimés pelliculés", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 540}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Vistor hf.", "truncated": false}, "before_length": 10, "before_sha256": "4b40dfc2a19551f982dad779994a624f3432207c4666bbd66f0ec59c2f229b32", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 7, "before_end": 7, "before_start": 7, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-86055314aa07e9d62ccca97a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2581}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 137, "start": 0, "text": "10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "truncated": false}, "before_length": 137, "before_sha256": "21a44745bd9deea05c5c3551ddef2c63129d14d622db066ae2815a039a68f3d2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 137, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 137, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-86099b340ee1a3b0775a2cb9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4636}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-862d2f8e9a72ff50f82e087e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2935}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 67, "start": 0, "text": "• Keep your Pen and needles out of the sight and reach of children.", "truncated": false}, "before_length": 67, "before_sha256": "3e5d337630072bedd7ef905180a9ddd2659a5a53190e7aadaeeb5c0aacf796d2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 67, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 67, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8659df8764c8e365c6d7b770", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9795}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb Kft.", "truncated": false}, "after_length": 25, "after_sha256": "8eee29e152f27da674ed6460d204f723bf6a9c596f41572a08e4e678a83674cb", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-865b4def62edf0ee1975c471", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2512}
{"after": {"end": 13, "start": 0, "text": "Suomi/Finland", "truncated": false}, "after_length": 13, "after_sha256": "5bea43a11ae0d0e9706443422f6eb9b6107624ceb18d16ec89005011c62699dd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 13, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8671dacc3da82a86a72ed9cd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2611}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 82, "start": 0, "text": "– If you see “0” in the dose window, you have received the full amount you dialed.", "truncated": false}, "before_length": 82, "before_sha256": "63ae036da9ce2e8d50ef0c431deb1affc2243e1225a0acd765801a39432540dc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 82, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 82, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-867947b1e2b9651034650f34", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9760}
{"after": {"end": 36, "start": 0, "text": "Oy Bristol-Myers Squibb (Finland) Ab", "truncated": false}, "after_length": 36, "after_sha256": "aca51731c0a07e098261a8dac11eaa8c8eafa1001f72c007b85c510385b01809", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-86827af69620e3752a256090", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2924}
{"after": {"end": 72, "start": 0, "text": "No clinical drug interaction studies have been performed with niraparib.", "truncated": false}, "after_length": 72, "after_sha256": "6497ce75858893a99379d8912488927c233205e9d9e9a08a4c2385c4889aed3a", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 72, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 72}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-86851a782304af74f870930c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1090}
{"after": {"end": 37, "start": 0, "text": "5. METHOD AND ROUTE OF ADMINISTRATION", "truncated": false}, "after_length": 37, "after_sha256": "9c671e90ead72d031e0489d7a17c0d517e69200aed5e01a6faffa73ca5420b69", "annex": "IIIA", "before": {"end": 40, "start": 0, "text": "5. METHOD AND ROUTE(S) OF ADMINISTRATION", "truncated": false}, "before_length": 40, "before_sha256": "40d13857ade903416a15c2c141baf03ce80cf78bfa856e2b5de7f7b195b6d9bb", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 19, "before_end": 22, "before_start": 19, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8685e001c33722194d5c0cac", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1007}
{"after": {"end": 12, "start": 0, "text": "Hypromellose", "truncated": false}, "after_length": 12, "after_sha256": "4835393d8e6e34469c5491a7556150383b0b67ce36cd620552e7bdd53e2cdd83", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8693bd2159bfb5657c1fd9b0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1892}
{"after": {"end": 51, "start": 0, "text": "Le comprimé peut être pris avec ou sans nourriture.", "truncated": false}, "after_length": 51, "after_sha256": "c5381a262e437d6c95f6c9c8791087fbdad82f757e94a4f24f1047e1f0e2bc15", "annex": "IIIA", "before": {"end": 51, "start": 0, "text": "La capsule peut être prise avec ou sans nourriture.", "truncated": false}, "before_length": 51, "before_sha256": "dc2d5a07bab61fc06fea596d1989a3206b4f7c1d895599c39a1176a056bcf8e9", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 1, "before_end": 2, "before_start": 1, "kind": "replace"}, {"after_end": 6, "after_start": 4, "before_end": 5, "before_start": 4, "kind": "replace"}, {"after_end": 11, "after_start": 7, "before_end": 10, "before_start": 6, "kind": "replace"}, {"after_end": 26, "after_start": 26, "before_end": 26, "before_start": 25, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-869c378b14f5de332e68426a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3643}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 27, "start": 0, "text": "Acétophtalate de polyvinyle", "truncated": false}, "before_length": 27, "before_sha256": "a9cea55c033a59c796cda4861f7166c0709436f51c8174cb0e91ecc42c10508c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-86af5b36b0d4f4bd0da1637b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1918}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb A.E.", "truncated": false}, "after_length": 24, "after_sha256": "10b1fadbbe52c3072f4ba1903512a3a4f5cd6eb487bf016dde5246419ff972b0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-86c958a6263aaf858f3e1f90", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2553}
{"after": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "after_length": 7, "after_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-86f45b1fdc9d8e5e6e05fd55", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2626}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 22, "start": 0, "text": "Polysorbate 20 (E 432)", "truncated": false}, "before_length": 22, "before_sha256": "0ee813d934008cf7cf6398095de99b6669ab4ef22e81209ed44fe94a3563fe89", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-87083edd734e49fb0feb30b4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1908}
{"after": {"end": 195, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu. There are also links to other websites about rare diseases and treatments.", "truncated": false}, "after_length": 195, "after_sha256": "e42431f19137f25751f79959abc59a227f0a4c34da0dd813ed26479ff4433729", "annex": "IIIA", "before": {"end": 194, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu. There are also links to other websites about rare diseases and treatments.", "truncated": false}, "before_length": 194, "before_sha256": "8032deb09254a9567585ec6f5f774f7b8a848f64efbd81d02585081efe19be26", "change_kind": "technical", "change_operations": [{"after_end": 99, "after_start": 98, "before_end": 98, "before_start": 98, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8715f4ae55fa34711970752c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3356}
{"after": {"end": 20, "start": 0, "text": "Tel: +371 670 35 775", "truncated": false}, "after_length": 20, "after_sha256": "b680bf9f05ed1e4cf39b4fe148b3422de6b07719e12a6f388508a09cc4a5af9c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8733e7b6a505d04cba5fdb0b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3238}
{"after": {"end": 5, "start": 0, "text": "Eesti", "truncated": false}, "after_length": 5, "after_sha256": "ed7477d6100948d0d4e6b914d9769159823c21b23bf4846b1676338b9b439b72", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8737d81f4ebb595c02a30639", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2848}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 50, "start": 0, "text": "Inhibition des UDP-glucuronosyltransférases (UGTs)", "truncated": false}, "before_length": 50, "before_sha256": "444842122a8ae03f61cf2e5f44f57b6ed3b1a34f91b407176b95a5a576d5f2c5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 50, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 50, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-873a45682cfe93decc5ea123", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1150}
{"after": {"end": 23, "start": 0, "text": "België/Belgique/Belgien", "truncated": false}, "after_length": 23, "after_sha256": "4646bb1028d1508f87afd915f6c144536b764795c7df5858f4eaa35881bb797d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-874033a6ff79840be417990f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3166}
{"after": {"end": 25, "start": 0, "text": "Tel: + 40 (0)21 272 16 19", "truncated": false}, "after_length": 25, "after_sha256": "502a8c5996880f462bf382bf033fc5a4e73041db59d3a638fd11052ee7eef1a8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8776cb1891057c68d807842d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2589}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8777eeeecdb9183a44ef7499", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2913}
{"after": {"end": 35, "start": 0, "text": "medinfo.bulgaria@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7905c486c458386eb1a26649ec5c649de6cbd59270b3b28715f74ada40ed9166", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-877a9dab12adb950d39169ba", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2499}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "Medicinal product subject to medical prescription.", "truncated": false}, "before_length": 50, "before_sha256": "f59e60a405cd29d8de0d0cfa2c4fd5c87e80574c3dbf7354e143c03cfe8789e6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 50, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 50, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-87c9ed61805a5492fd5db47e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1057}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 78, "start": 0, "text": "• The Pen will not let you dial more than the number of units left in the Pen.", "truncated": false}, "before_length": 78, "before_sha256": "f9132795bfe8e267a9d4d146e6bfda07350d9089adc7140c2910c36f2d2bc8d4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 78, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 78, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-87d3f37b045dbd458adbde98", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9727}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 212, "start": 0, "text": "The Tempo Pen contains a magnet. If you have a medical device fitted, such as a heart pacemaker, this may not work correctly if the Tempo Pen is held too close. The magnetic field extends to approximately 1.5 cm.", "truncated": false}, "before_length": 212, "before_sha256": "c1fd07e8eb6ef1806853cc9217e70141ec643f7c5d96085ce48fd4cdbfbd2f38", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 212, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 212, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-87f943dbef891fd1fd5073e9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9262}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "Roonstraße 25", "truncated": false}, "before_length": 13, "before_sha256": "72b80df998792e1d92189a290d82759fb839b17a555226b67f667c759822bfa7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8819935d609b9d8190c58150", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3855}
{"after": {"end": 84, "start": 0, "text": "La dose recommandée est un comprimé de Vyndaqel 61 mg (tafamidis) une fois par jour.", "truncated": false}, "after_length": 84, "after_sha256": "3b7b0a3447344db7b5253245157bd7fa5dcf884d17242a67094ef0cd119cf938", "annex": "IIIA", "before": {"end": 84, "start": 0, "text": "La dose recommandée est une capsule de Vyndaqel 61 mg (tafamidis) une fois par jour.", "truncated": false}, "before_length": 84, "before_sha256": "b07fe1c09cfdfaaf28abf6f1858322334f240de377d659b67baac2feaf34032b", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 26, "before_end": 27, "before_start": 26, "kind": "delete"}, {"after_end": 30, "after_start": 28, "before_end": 30, "before_start": 29, "kind": "replace"}, {"after_end": 35, "after_start": 31, "before_end": 35, "before_start": 31, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-882eef9dcfb568c53e636ffa", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3635}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 284, "start": 0, "text": "Humalog Tempo Pen is used to treat diabetes. Humalog works more quickly than normal human insulin because the insulin molecule has been changed slightly in comparison to human insulin. Insulin lispro is closely related to human insulin which is a natural hormone made by the pancreas.", "truncated": false}, "before_length": 284, "before_sha256": "61097a4632306a30de0657ea875e5cf559d5f67b75cd780d04678942f4c9d9c5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 284, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 284, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-885d3ab843768b521981a45e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9233}
{"after": {"end": 21, "start": 0, "text": "Τηλ: + 30 210 6074300", "truncated": false}, "after_length": 21, "after_sha256": "c10bf95f55d88eadacbbac2970ab7bef5bd625d01122a54ba6a3bd30eae65368", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-88ae6f3ffbb9f4b24e82a405", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2548}
{"after": {"end": 32, "start": 0, "text": "BristolMyers Squibb spol. s r.o.", "truncated": false}, "after_length": 32, "after_sha256": "f17626bd52e917e0c6a35193744c7dbe6c722322ff29e81192cd072e33f2d41f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 32, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 32}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-88b2ba9b761c59c176a538ea", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2513}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 54, "start": 0, "text": "What you need to know before you use Humalog Tempo Pen", "truncated": false}, "before_length": 54, "before_sha256": "dd0a2f063e6276e6f68ccf72e3e005f7178a0990b088eb441da07cc454cdbff0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 54, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 54, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-88cae68407a0dabe868e2dd4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9224}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "insulin lispro", "truncated": false}, "before_length": 14, "before_sha256": "1ca88cfa41606b28145f703442bf3c0e5efa0967c7177f9c26ed091d4c7a140d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-88d555297565f83c0f7c1280", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4689}
{"after": {"end": 134, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency https://www.ema.europa.eu.", "truncated": false}, "after_length": 134, "after_sha256": "9f2a855337f11701b0cd4191c51820fa5a70b201b2e0721ba6acd34544486f89", "annex": "I", "before": {"end": 133, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.", "truncated": false}, "before_length": 133, "before_sha256": "eabdb61a543e11ee016c5c43ada549964199ddf9e287a2eb3256e15d4a87fe4a", "change_kind": "technical", "change_operations": [{"after_end": 113, "after_start": 112, "before_end": 112, "before_start": 112, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-88e84d4019666c6a9e7fc4aa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 2.5 mg film-coated tablets", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 527}
{"after": {"end": 20, "start": 0, "text": "Luxembourg/Luxemburg", "truncated": false}, "after_length": 20, "after_sha256": "28ac4fa3aba2dfb4b228bd072edb8cc818b04e6f4b87f37114caa6154e0e706b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-890f03d83b7d350dd9b0fe60", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3178}
{"after": {"end": 115, "start": 0, "text": "Informez votre médecin ou pharmacien si vous prenez, avez récemment pris ou pourriez prendre tout autre médicament.", "truncated": false}, "after_length": 115, "after_sha256": "92fd0f79172627ef67d6eb52cb8e0b893e3d8475206e8a2a20a770e78f25c1f3", "annex": "IIIA", "before": {"end": 114, "start": 0, "text": "Informez votre médecin ou pharmacien si vous prenez, avez récemment pris ou pourriez prendre tout autre médicament", "truncated": false}, "before_length": 114, "before_sha256": "a4a97bb39078cc8525ea04c5565208350d1784776b888db25e2aa631228db0a3", "change_kind": "content", "change_operations": [{"after_end": 115, "after_start": 114, "before_end": 114, "before_start": 114, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-891ccdb1a47602dec1ba45f9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2289}
{"after": {"end": 5, "start": 0, "text": "Дания", "truncated": false}, "after_length": 5, "after_sha256": "15c4c56ca2ad5dd4518ae08c37f15cbda6da8ac77d78fb2b6e974b7d6667351e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-892a8b77bc3ee46b810b8960", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1751}
{"after": {"end": 50, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht The Netherlands", "truncated": false}, "after_length": 50, "after_sha256": "de386d3b3aeebba1dff0a070ffc767173cbc1fa354dbcd29dd86469dc23d8ff6", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "Papendorpseweg 83, 3528 BJ Utrecht The Netherlands", "truncated": false}, "before_length": 50, "before_sha256": "5d621ef45df9c1911e6b63f15edb513d80fad3ee63f11fe58a733f65b67cd3cd", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}, {"after_end": 26, "after_start": 25, "before_end": 26, "before_start": 25, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-897d4d5be37bc96d2bd03dd3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1873}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "B. Hyperglycaemia and diabetic ketoacidosis", "truncated": false}, "before_length": 43, "before_sha256": "2b08e7c3e64368707ab2fcc6bbb8c3dfeef2e5087bd0b9da7f26a42f75deb662", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-89aa5c5645d351324518d058", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9403}
{"after": {"end": 22, "start": 0, "text": "Teл.: + 359 2 4942 480", "truncated": false}, "after_length": 22, "after_sha256": "71df057e61352cd6e548ee210b03d0adc43d1e9ef00311b1d7ac8fce15871b09", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-89b59fc96074b5425d2b0b8f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2814}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-89d4b26ecbb5ec9f87606b14", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2583}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Step 9:", "truncated": false}, "before_length": 7, "before_sha256": "1cc979d854eed069bfe33f43d3ad626670811268c9ff8d25fd179d322f9f88ef", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a02d3be8bc1b876cf04dcf3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9737}
{"after": {"end": 22, "start": 0, "text": "medinfo.norway@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c4c553c0f2dbe6456fca075a3e80411c07f0926b9866f5334ba99d71d96198e2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a299bc37fa1e994fd836627", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3221}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 17, "start": 0, "text": "Humalog Tempo Pen", "truncated": false}, "before_length": 17, "before_sha256": "328b8ad146aa9789b611fca56a42e321b79e5aecd24d0cc297eae30f99fae229", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a2f80a6ef120f588b1df60e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.6", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 546}
{"after": {"end": 33, "start": 0, "text": "Bristol-Myers Squibb spol. s r.o.", "truncated": false}, "after_length": 33, "after_sha256": "3abea3460809987d2906fa40ab370a496bbee801d456a93f8afaeb35776f9233", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a30db6ae36ddea1f75f7631", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3184}
{"after": {"end": 250, "start": 0, "text": "The KwikPen and Junior KwikPen are only suitable for subcutaneous injections. Humalog in cartridges is only suitable for subcutaneous injections from a Lilly reusable pen or compatible pump systems for continuous subcutaneous insulin infusion (CSII).", "truncated": false}, "after_length": 250, "after_sha256": "30315ebab35f51e01d32d53346eb9db94b15a869c091a67777b0c58de52cdbb1", "annex": "I", "before": {"end": 260, "start": 0, "text": "The KwikPen,Junior KwikPen and Tempo Pen are only suitable for subcutaneous injections. Humalog in cartridges is only suitable for subcutaneous injections from a Lilly reusable pen or compatible pump systems for continuous subcutaneous insulin infusion (CSII).", "truncated": false}, "before_length": 260, "before_sha256": "4f176e01522d8f39999f22d6ab3e565f4dbece9ace56845e4b1b77dc027a54f2", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 11, "before_end": 12, "before_start": 11, "kind": "replace"}, {"after_end": 27, "after_start": 27, "before_end": 37, "before_start": 23, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a31fc04d0e26d6f81437bb9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 111}
{"after": {"end": 34, "start": 0, "text": "medinfo.croatia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "59c47394700ad787801e8ce1b033fc5d63a885ddfc680677ae6b5acd89bb7df3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a5e4516fe253d758ca25f5c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2895}
{"after": {"end": 16, "start": 0, "text": "3.5 (-9.4, 16.2)", "truncated": false}, "after_length": 16, "after_sha256": "b9e7b1a168bc4cd6185c881790555bfd9f9356982dd2107ca2af57bb64fd5161", "annex": "I", "before": {"end": 17, "start": 0, "text": "3.8 (-10.5, 17.9)", "truncated": false}, "before_length": 17, "before_sha256": "de61656386a3e51fae19c2c1ebf4319720c81b10d9ae12c42e7cdf3575d480a7", "change_kind": "content", "change_operations": [{"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 7, "after_start": 6, "before_end": 8, "before_start": 6, "kind": "replace"}, {"after_end": 9, "after_start": 8, "before_end": 10, "before_start": 9, "kind": "replace"}, {"after_end": 13, "after_start": 12, "before_end": 14, "before_start": 13, "kind": "replace"}, {"after_end": 15, "after_start": 14, "before_end": 16, "before_start": 15, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a77e80f997a43f35e6e511b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 300}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 27, "start": 0, "text": "Fresenius Kabi Austria GmbH", "truncated": false}, "before_length": 27, "before_sha256": "fa59d2b0c9ce4abc55a3051cb227907a12a3a3e7fc63908aaebeb76ac9f651ef", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a7b2d1c02bc8530f86320c6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1705}
{"after": {"end": 134, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency https://www.ema.europa.eu.", "truncated": false}, "after_length": 134, "after_sha256": "9f2a855337f11701b0cd4191c51820fa5a70b201b2e0721ba6acd34544486f89", "annex": "I", "before": {"end": 133, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.", "truncated": false}, "before_length": 133, "before_sha256": "eabdb61a543e11ee016c5c43ada549964199ddf9e287a2eb3256e15d4a87fe4a", "change_kind": "technical", "change_operations": [{"after_end": 113, "after_start": 112, "before_end": 112, "before_start": 112, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a83cc5dff6bd123269b7ed3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 10 mg film-coated tablets CIALIS 20 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1564}
{"after": {"end": 23, "start": 0, "text": "medinfo.austria@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "80539556a138e6e0b8efab6b438c21ba77b592fc3c2d28fdfaea7dc2bb3248d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a8c86d2e51d256317c2bd54", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3234}
{"after": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "after_length": 7, "after_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8a97b0121c34e9b57b6e2ec4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3306}
{"after": {"end": 57, "start": 0, "text": "The tablet should be swallowed whole, not crushed or cut.", "truncated": false}, "after_length": 57, "after_sha256": "a973155cfffa40a6ffd84dc485ed17abd571314118b04f08acb4befd4ef49e57", "annex": "IIIA", "before": {"end": 63, "start": 0, "text": "The soft capsule should be swallowed whole, not crushed or cut.", "truncated": false}, "before_length": 63, "before_sha256": "0faa3186ddb65610fe0f4eddcc00881a75df98df43e1e8e6464869e503c83558", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 4, "before_end": 7, "before_start": 4, "kind": "delete"}, {"after_end": 5, "after_start": 5, "before_end": 10, "before_start": 8, "kind": "delete"}, {"after_end": 7, "after_start": 6, "before_end": 14, "before_start": 11, "kind": "replace"}, {"after_end": 10, "after_start": 9, "before_end": 16, "before_start": 16, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8ac554b58fc8ebbdc572bd39", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3138}
{"after": {"end": 23, "start": 0, "text": "Medinfo.hungary@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "a92bd76e7f8465b69646a33e5e8846376b2ea19fe10f20ea413789237a8d815a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8b207ce5f4cb590dcb624615", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2520}
{"after": {"end": 69, "start": 0, "text": "Multipack containing three pre-filled syringes and three 25G needles.", "truncated": false}, "after_length": 69, "after_sha256": "029da2c47fcfeb7c22b168c83e97ff55101f925764245dc5ce0bccc84c27b65d", "annex": "IIIA", "before": {"end": 68, "start": 0, "text": "Multipack containing three pre-filled syringes and three 25G needles", "truncated": false}, "before_length": 68, "before_sha256": "7544ada281f7e8a03fbb40e3732a645ef2b4c202e0c41d63377523bb78932c54", "change_kind": "content", "change_operations": [{"after_end": 69, "after_start": 68, "before_end": 68, "before_start": 68, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8b2d91d7e4a49ac7c78f567f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 903}
{"after": {"end": 50, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht The Netherlands", "truncated": false}, "after_length": 50, "after_sha256": "de386d3b3aeebba1dff0a070ffc767173cbc1fa354dbcd29dd86469dc23d8ff6", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "Papendorpseweg 83, 3528 BJ Utrecht The Netherlands", "truncated": false}, "before_length": 50, "before_sha256": "5d621ef45df9c1911e6b63f15edb513d80fad3ee63f11fe58a733f65b67cd3cd", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}, {"after_end": 26, "after_start": 25, "before_end": 26, "before_start": 25, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8b3b6c57d4bff1d884ded790", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2130}
{"after": {"end": 14, "start": 0, "text": "ne 25G needle.", "truncated": false}, "after_length": 14, "after_sha256": "f3ba628efdfaf6ec9bd9907e40c956f4fc1ff92604c517178430b50faafc2f5e", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "One 25G needle", "truncated": false}, "before_length": 14, "before_sha256": "953675de6fd7313d5abc3191d56e313ff38671395addfd4d35033d8106ca1b5b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "delete"}, {"after_end": 14, "after_start": 13, "before_end": 14, "before_start": 14, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8b3c2d8edd21ba22c11369e0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 803}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 18, "start": 0, "text": "Tel: +372 6817 280", "truncated": false}, "before_length": 18, "before_sha256": "114b36f319940763b90952f320e2ddc2cb01f14cc93c20f146cdfb5d37e3031d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 18, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 18, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8b4ee9b9339cb065e33116b6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9493}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "Hafnerstraße 36", "truncated": false}, "before_length": 15, "before_sha256": "2fcce2f98396d52bbfd5728e1a018b4f5e6a7c25edffb18410df25f808883c4f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8b66e1525fc70b127f8e1918", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2764}
{"after": {"end": 26, "start": 0, "text": "BristolMyers Squibb GesmbH", "truncated": false}, "after_length": 26, "after_sha256": "45a0d9cd544a5f19296a3fa84647df081ac4cb2a9c4935681d9f34e18f6803a7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8b7c4e7e7ed904c213b4b51f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3232}
{"after": {"end": 19, "start": 0, "text": "Lactose monohydraté", "truncated": false}, "after_length": 19, "after_sha256": "a27344b3f47c612e4669b8543ac65683b07657a3e8390c9d3356bd0bd7ee9738", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8b995b659e101c180e87df26", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1291}
{"after": {"end": 20, "start": 0, "text": "Tel: + 370 52 369140", "truncated": false}, "after_length": 20, "after_sha256": "8a995c3bfc3c0427235c993d1d1f2ebdd1b1443c434cbb3e015f99728e5b363f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8bb7d67273679835f086236a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2499}
{"after": {"end": 21, "start": 0, "text": "Tel: + 39 06 50 39 61", "truncated": false}, "after_length": 21, "after_sha256": "6ac0b442dd41c62cad589a5c348c5781354f651196f78692c420568d264ff7f0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8be09bea32306d8f5976284b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3288}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovenia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "fce1e60bbc59ee3c381de461f412175da197c866a89ba45b24c7794f59b5c833", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8be549a4563b3a0fcb84558a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2906}
{"after": {"end": 73, "start": 0, "text": "Powder for concentrate for solution for infusion (powder for concentrate)", "truncated": false}, "after_length": 73, "after_sha256": "27e4d1808382a515deee2f2f4d0f570da0059f99a1ad6a7f273215fcbbbdee0f", "annex": "I", "before": {"end": 48, "start": 0, "text": "Powder for concentrate for solution for infusion", "truncated": false}, "before_length": 48, "before_sha256": "a394d52809170d281062904127db2248647cb872bb52a4fab428e393d37d5feb", "change_kind": "content", "change_operations": [{"after_end": 73, "after_start": 48, "before_end": 48, "before_start": 48, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8c165aeaa49babc0beed7327", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "3", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 45}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Irlande", "truncated": false}, "before_length": 7, "before_sha256": "a8cdfff5dbbda1b070a2acb339b6f0aa20b6230d9b5500c9ce066eaa89bc9a64", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8c41832b3f456abc5599c564", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3723}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Stamullen", "truncated": false}, "before_length": 9, "before_sha256": "abbbb3884efa82e3e41f0c4736af27e92f074d1c3610575a24e8e99760795e42", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8c494ee2c3ce14821a42592d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3721}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 9, "start": 0, "text": "ANNEXE IV", "truncated": false}, "before_length": 9, "before_sha256": "5623d2bfc35b28c1d982ab389e6c5fa37f50e40d0b9b737593e164d081c1191d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8c6a99c14649127d004c762a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3489}
{"after": {"end": 27, "start": 0, "text": "Puh/Tel: + 358 9 251 21 230", "truncated": false}, "after_length": 27, "after_sha256": "115859cfeab013cc7da2aa72c6645b7c1a35594595b929820235610cd0afa5fd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8c770715150fff5117d7e2cb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3290}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 12, "start": 0, "text": "Phadisco Ltd", "truncated": false}, "before_length": 12, "before_sha256": "575176bfea81700f606f9613021aac67ce002fffe6a107bbe12564560d894421", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8ca12ae2beff56f2e44dd2a5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9551}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 45, "start": 0, "text": "• Do not recycle the filled sharps container.", "truncated": false}, "before_length": 45, "before_sha256": "eb283daa903742ef79e72ced5ce2e5700967e520393b6ad64d2c0dd3cd4dd580", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 45, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 45, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8ccf13243a09e0ac788eab9a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9783}
{"after": {"end": 8, "start": 0, "text": "Portugal", "truncated": false}, "after_length": 8, "after_sha256": "4c7de2c3da6dc0ae8f9d13b107718a913859359bd30166d077c867577953865d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8cdecf19a23ad2f313c2d843", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3251}
{"after": {"end": 26, "start": 0, "text": "informacion.medica@bms.com", "truncated": false}, "after_length": 26, "after_sha256": "ecc8b3fc203c9400ed5a39531e5dadc0b28244ff3abb21ff0a801eeffc0a5d0e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8d1f13042fee21dbdaa8c0fe", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2565}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 93, "start": 0, "text": "Before the first use store your Humalog Tempo Pen in a refrigerator (2C – 8C). Do not freeze.", "truncated": false}, "before_length": 93, "before_sha256": "1e2f57b0bf319a8469d75ece24f93ff90950be21db0fa65e34a4ea3f97a91404", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 93, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 93, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8d33c15e0074dfe3040641ab", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9423}
{"after": {"end": 23, "start": 0, "text": "medinfo.romania@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "9ae697b67f3c854a077ca894d99400f1de79e31bd9bf61321fc7c4030bf8a213", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8d48e73a939caf6804d611e2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3261}
{"after": {"end": 23, "start": 0, "text": "Medinfo.hungary@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "a92bd76e7f8465b69646a33e5e8846376b2ea19fe10f20ea413789237a8d815a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8d5e546328693cd58b1111fb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2826}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 2, "start": 0, "text": "SN", "truncated": false}, "before_length": 2, "before_sha256": "19ac753101c8870b8e667480a40dcf1e7f224832e76d8e55aeb7b182a3ca7082", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8d6b81854a8bdcd0366f42b7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4676}
{"after": {"end": 6, "start": 0, "text": "España", "truncated": false}, "after_length": 6, "after_sha256": "f85c9fe36948469b69f31fb5026694619ce4dc122757ece67c8584ff8f2ac008", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8db920c6e8dec3b5b25bb709", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2562}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Eli Lilly Nederland B.V.", "truncated": false}, "before_length": 24, "before_sha256": "58e60ac126dd39b4930580291c64d7770a0db93150c4173b7e7d8a8642fe64e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8dbf4141f47cb462af654460", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4740}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Subcutaneous use", "truncated": false}, "before_length": 16, "before_sha256": "363fd22613abec178143cdac0b1a34f04ee8ccdaa7d6988b3722fa7540374cde", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8ddc28ee559c557b8cd72258", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4712}
{"after": {"end": 22, "start": 0, "text": "Tel: + 421 2 20833 600", "truncated": false}, "after_length": 22, "after_sha256": "06545090f6b6777d6143e84f408247cee2424d81a40db0a2693eff093cfe9ec8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8e1e3c30806810d753921e63", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2915}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 118, "start": 0, "text": "Once in use pens may be used for up to 28 days. Pens in use should be stored below 30C and should not be refrigerated.", "truncated": false}, "before_length": 118, "before_sha256": "5e0de42f5447f77b92faef6ecfe53fdea23a714da6b654f20c1a75cdad7b12ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 118, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 118, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8e2dcd222959c9a3cd62201c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4831}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 7, "start": 0, "text": "Germany", "truncated": false}, "before_length": 7, "before_sha256": "80db4ccdca106d37b920206331fcfe3e9e50a9e763d89b54ce3ad5ac8cf30f03", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8e701a64b8984db89274aa23", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1645}
{"after": {"end": 27, "start": 0, "text": "BristolMyers Squibb Denmark", "truncated": false}, "after_length": 27, "after_sha256": "85c703b06a34e371377fa6cfd59a679937926bebf7b34695c0e53e3bc9733ded", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8e90f3824cb91d95a7ccc1ac", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2523}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 70, "start": 0, "text": "“beta2 stimulants” (for example ritodrine, salbutamol or terbutaline),", "truncated": false}, "before_length": 70, "before_sha256": "9857eafca8719376644d872c54fa097dc4560a210826091607200b14bd1750fa", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 70, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 70, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8e9c2cc5fde2db13b17cc573", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9277}
{"after": {"end": 28, "start": 0, "text": "One pre-filled syringe and o", "truncated": false}, "after_length": 28, "after_sha256": "94a91700da38318bb36656ba28e3b104dc59731c97bbe2a61d039695f30d9c22", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "One pre-filled syringe", "truncated": false}, "before_length": 22, "before_sha256": "e84cf3d8838722a3e61a077ed015aab814e58c727fb946a2c14a8d53c53a78f6", "change_kind": "content", "change_operations": [{"after_end": 28, "after_start": 22, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8e9c83c2214f2ddf0656f09b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 802}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Eli Lilly Hrvatska d.o.o.", "truncated": false}, "before_length": 25, "before_sha256": "afe80b588c23476485285898586168548b003fa949c862d54d913d0c6b5fa1eb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8eafcbd328ddce55ed05413b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9520}
{"after": {"end": 20, "start": 0, "text": "medwiss.info@bms.com", "truncated": false}, "after_length": 20, "after_sha256": "bc2238e490f9b59d01a00ccab422d2de7eb7937e564268c4e82d2e78b72b3340", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8ec328825fe0bbb186959915", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2841}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Eli Lilly Benelux S.A./N.V.", "truncated": false}, "before_length": 27, "before_sha256": "f7a78bd0bea08a17a3aa98df48b777639261f6c4cd78368c6205ce433c2dc675", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8f0d1b8524253394c9f5daab", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9468}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb B.V.", "truncated": false}, "after_length": 24, "after_sha256": "8a52d28077ffdb6f185a0238531f595238f56634dd4dc98f89f75a288910ebf4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8f48f6baf705b5c6f115843a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2848}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht", "truncated": false}, "before_length": 34, "before_sha256": "46a90fc46ae308c2beeb35ead613fcf3ade5a51e2217a834de3fa5972dab9eec", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8f50be089befbac2026bb6f2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4642}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8f5c0ab81984926e8d0a2753", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3167}
{"after": {"end": 6, "start": 0, "text": "Polska", "truncated": false}, "after_length": 6, "after_sha256": "d1974e0e3e575b6dadb40f080dae05025f574cb23e5cababcac0f50cf2619549", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8f6a215c97e651205fcb4492", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2877}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8f6fad1ff2953c3b167084dd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3675}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Document revision date:", "truncated": false}, "before_length": 23, "before_sha256": "1ac39e9c32572818d5f6993b82a63f26d6d50eeabcff72c59b96e953f1eaf7f1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8fb7543a6013cb28ada102d9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9808}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 92, "start": 0, "text": "If you have any further questions on the use of this product, ask your doctor or pharmacist.", "truncated": false}, "before_length": 92, "before_sha256": "80f08cf2e0b02c4a6bce6124a31a333e80bc6a71416bf3429dfc2e0da3c25067", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 92, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 92, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8fb8bc6a69f14e1ed6cdb401", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9360}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 238, "start": 0, "text": "Excipients: glycerol, zinc oxide, dibasic sodium phosphate 7 H20 with m-cresol as a preservative in water for injections. Sodium hydroxide and/or hydrochloric acid may have been used to adjust acidity. See leaflet for further information.", "truncated": false}, "before_length": 238, "before_sha256": "219cd265f69c3cedd04f6e16fbaf3d05818947596178a2daeaf3c614ba2fbebf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 238, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 238, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8fc8428c9b653a992b249051", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4600}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 413, "start": 0, "text": "The Tempo Pen is designed to work with the Tempo Smart Button. The optional additional feature Tempo Smart Button is a product available for the Tempo Pen, which may be used for transmitting dose information to a mobile application. The Tempo Pen can be used with or without the Tempo Smart Button attached. See instructions provided with the Tempo Smart Button and the mobile application for further information.", "truncated": false}, "before_length": 413, "before_sha256": "a86473f5016cac1e6c945b608f0efd609304e2a17366648071673b8f1dbee969", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 413, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 413, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-8fcc5932349be6178fd2e809", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9336}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "If you use more Humalog than you should", "truncated": false}, "before_length": 39, "before_sha256": "5402732cf3cea33bec401b1f655a4ba33ab6531bcb395491441e47b11a49f2d4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-90054f12d37de055d9927698", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9342}
{"after": {"end": 19, "start": 0, "text": "Tel: + 371 66164750", "truncated": false}, "after_length": 19, "after_sha256": "113b9b6ac49a6f4bdbe379f2d1e85b2d125b75611b91111c888ec73bacdd0230", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-90197d1993027d4a95a5c854", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3308}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 456, "start": 0, "text": "Le niraparib est un substrat des carboxylestérases (CE) et des UDP-glucuronosyltransférases (UGT) in vivo. Le métabolisme oxydatif du niraparib est minime in vivo. Aucun ajustement posologique n’est nécessaire pour Zejula en cas d’administration concomitante avec des médicaments connus pour inhiber des enzymes CYP (par exemple, itraconazole, ritonavir et clarithromycine) ou induire des enzymes CYP (par exemple rifampicine, carbamazépine et phénytoïne).", "truncated": false}, "before_length": 456, "before_sha256": "0b12e0761fe652022abfaed7cd1c21e560115781f62aec20a464d44cda1d0acd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 456, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 456, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-903ac5435d5ba1d956402ef5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 242}
{"after": {"end": 24, "start": 0, "text": "Tel: + 31 (0)30 300 2222", "truncated": false}, "after_length": 24, "after_sha256": "df26f07876232a3ba50861e46ee103ea04d50c8b384a64d52078fdc518ae52ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9043e2573756985b45ed6fca", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3210}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 29, "start": 0, "text": "• Choose your injection site.", "truncated": false}, "before_length": 29, "before_sha256": "9f0bf3224f3e644c7480018c619b0f567b49231f77c6da06c901a35b279b6f26", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 29, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 29, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-90515d1e287ee060ff319339", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9738}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "GlaxoSmithKline (Ireland) Limited", "truncated": false}, "before_length": 33, "before_sha256": "aab443afe73fcfeb3384251d62635faa955ab6ace3c6efeb3f1cf79dfb706da8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-905e8fdd428620d1e8634016", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2547}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 7, "start": 0, "text": "Anaemia", "truncated": false}, "before_length": 7, "before_sha256": "a529975952aa7b0f0d8545643872b846a33592327c62368f447cc46805d40f1a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-90a6af1d3ae922e5c4a3c4aa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.8", "section_type": "adverse_reactions", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 188}
{"after": {"end": 102, "start": 0, "text": "Le comprimé pelliculé contient du lactose monohydraté (E 24). Voir la notice pour plus d’informations.", "truncated": false}, "after_length": 102, "after_sha256": "51813c33c8507bc7fddb26559eedd46c53c9f097b67510661c65090c433222d8", "annex": "IIIA", "before": {"end": 81, "start": 0, "text": "La capsule contient du sorbitol (E 420). Voir la notice pour plus d’informations.", "truncated": false}, "before_length": 81, "before_sha256": "99952f0d0ccd242f3a824f8102134c0575924b1f8dd6de6e0e6745288cdbafc8", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 1, "before_end": 2, "before_start": 1, "kind": "replace"}, {"after_end": 6, "after_start": 4, "before_end": 5, "before_start": 4, "kind": "replace"}, {"after_end": 18, "after_start": 7, "before_end": 7, "before_start": 6, "kind": "replace"}, {"after_end": 21, "after_start": 20, "before_end": 10, "before_start": 9, "kind": "replace"}, {"after_end": 37, "after_start": 34, "before_end": 28, "before_start": 23, "kind": "replace"}, {"after_end": 53, "after_start": 39, "before_end": 31, "before_start": 30, "kind": "replace"}, {"after_end": 58, "after_start": 57, "before_end": 35, "before_start": 35, "kind": "insert"}, {"after_end": 59, "after_start": 59, "before_end": 38, "before_start": 36, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-90b31d4fede93681b3f452de", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2804}
{"after": {"end": 35, "start": 0, "text": "Oy BristolMyers Squibb (Finland) Ab", "truncated": false}, "after_length": 35, "after_sha256": "ec1e651ed7eac79d1bf600f594e4c106251ee62cf1c76346a86d003d9870c3c9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-90ce6b297e2155f301ce14a2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2618}
{"after": {"end": 19, "start": 0, "text": "Slovenská republika", "truncated": false}, "after_length": 19, "after_sha256": "8667151da5d74cf45a2b263a2f7b38e944fd51f34b51e08d79151f123b8f10b2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-90eafd5a70e34e7af2f984b2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3281}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 145, "start": 0, "text": "Do not use this medicine after the expiry date which is stated on the label and the carton. The expiry date refers to the last day of that month.", "truncated": false}, "before_length": 145, "before_sha256": "dda4bdc7ef8c9074dfff940f92a5f6ec523fc0580a8799b99d1fe25bdb6020e5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 145, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 145, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-911bd2192ef279880cb30a1d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9429}
{"after": {"end": 119, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu", "truncated": false}, "after_length": 119, "after_sha256": "0f2b81ab8009e1a279ca008eb6e21bdb2e532de63aef52b62bdac980c49555d4", "annex": "IIIA", "before": {"end": 93, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site:", "truncated": false}, "before_length": 93, "before_sha256": "1c2e788d78bca4cef615d8e7fe8e0268db2345fae4c6f39add7db65e179edffe", "change_kind": "content", "change_operations": [{"after_end": 119, "after_start": 93, "before_end": 93, "before_start": 93, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-911d75c6a997f23f3d8ed074", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2542}
{"after": {"end": 20, "start": 0, "text": "Tel: + 370 52 369140", "truncated": false}, "after_length": 20, "after_sha256": "8a995c3bfc3c0427235c993d1d1f2ebdd1b1443c434cbb3e015f99728e5b363f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9145cadf74d1b46bef46df80", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2805}
{"after": {"end": 10, "start": 0, "text": "Österreich", "truncated": false}, "after_length": 10, "after_sha256": "b1b763860d4f30c2e1feafdcd57b714a1422b4fbc1a93d94969118a0faa65288", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 10}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-91474ab4d182c3baa2794541", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2867}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 41, "start": 0, "text": "• nervousness or shakiness • feeling sick", "truncated": false}, "before_length": 41, "before_sha256": "8b6a639b582c881e1acce20105bb3d0bdf614d84262cf5d03887f53d3c325198", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 41, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 41, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-914db0e14013d16952572494", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9398}
{"after": {"end": 11, "start": 0, "text": "Deutschland", "truncated": false}, "after_length": 11, "after_sha256": "af6e56aacd8097c3fb7597b08ecb3d87a040f6ab58067a4b8ff9f5b747adb9be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-915187e3482e76a3434e55e9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2532}
{"after": {"end": 28, "start": 0, "text": "Film-coated tablet (tablet).", "truncated": false}, "after_length": 28, "after_sha256": "e7b917a50d40aa12a96357a3f32fa6287ec45603306735c00c32f84a0add9a65", "annex": "I", "before": {"end": 13, "start": 0, "text": "Soft capsule.", "truncated": false}, "before_length": 13, "before_sha256": "510860ce51c8fd76e3a5b33c7213699ee05155b1323b440d561b1dd20259b89a", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 17, "after_start": 7, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 21, "after_start": 19, "before_end": 6, "before_start": 5, "kind": "replace"}, {"after_end": 23, "after_start": 22, "before_end": 10, "before_start": 7, "kind": "replace"}, {"after_end": 27, "after_start": 25, "before_end": 12, "before_start": 12, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9161ef14325c33e16ff70350", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "3", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 936}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Tél/Tel: + 32-(0)2 548 84 84", "truncated": false}, "before_length": 28, "before_sha256": "0ea6c3d792328cdb3ad266c1aab6ba94ad02b214a39db7b75eff8aceade0438c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-91767be720bf3c6495395d04", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9469}
{"after": {"end": 50, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht The Netherlands", "truncated": false}, "after_length": 50, "after_sha256": "de386d3b3aeebba1dff0a070ffc767173cbc1fa354dbcd29dd86469dc23d8ff6", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "Papendorpseweg 83, 3528 BJ Utrecht The Netherlands", "truncated": false}, "before_length": 50, "before_sha256": "5d621ef45df9c1911e6b63f15edb513d80fad3ee63f11fe58a733f65b67cd3cd", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}, {"after_end": 26, "after_start": 25, "before_end": 26, "before_start": 25, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-91f95ec0485216950685892f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2003}
{"after": {"end": 24, "start": 0, "text": "portugal.medinfo@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "9ec8b32b2035c90c423af74fa150dca23880201d448d46da35a42d2a862c8345", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-92090a5ca7fef98486510852", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3254}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 121, "start": 0, "text": "This Pen is not recommended for use by the blind or visually impaired without the help of someone trained to use the Pen.", "truncated": false}, "before_length": 121, "before_sha256": "24e80378c2a7c49ce12e8fd6cc2b5e92918bf34282b6baec5712396c2944ef81", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 121, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 121, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-924ca484872ec8fc7a50869c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9582}
{"after": {"end": 22, "start": 0, "text": "medinfo.sweden@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "b564c1a351ab9a2c3f444753cdc78f0306131b829474e9874a876fc1a90d4b7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-92598ae0b37d03a0c2982c54", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2936}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 29, "start": 0, "text": "Disposing of Pens and Needles", "truncated": false}, "before_length": 29, "before_sha256": "81d9751a652278e3819d91e61b9e32f177431973787ed9d99c2794a28edb6f4a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 29, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 29, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-92632a817ed85644b0548bae", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9781}
{"after": {"end": 10, "start": 0, "text": "Österreich", "truncated": false}, "after_length": 10, "after_sha256": "b1b763860d4f30c2e1feafdcd57b714a1422b4fbc1a93d94969118a0faa65288", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 10}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9279f01f9bd73e215e3a4d7f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2557}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-927c0e898cbe2fd59278e6f5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2908}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9297f480e39f912a59d58b41", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3180}
{"after": {"end": 26, "start": 0, "text": "79108 Freiburg Im Breisgau", "truncated": false}, "after_length": 26, "after_sha256": "36aa85132e620e5dadf560baf495a4070b1cda958d67c2e643770ef4ac19a172", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-92a8a6fc8e111bdcbf8d56d4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2037}
{"after": {"end": 19, "start": 0, "text": "Slovenská republika", "truncated": false}, "after_length": 19, "after_sha256": "8667151da5d74cf45a2b263a2f7b38e944fd51f34b51e08d79151f123b8f10b2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-92acd6ec7799fa4f0db23382", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2607}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 43, "start": 0, "text": "Effet d’autres médicaments sur le niraparib", "truncated": false}, "before_length": 43, "before_sha256": "cd2d4ed7c8713ef0c5d60fd35cefd144c8e5f2cab753bdb99dd88a549ff7918f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-92b4ba0330b4d941f6b8fc31", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1127}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Inner Needle Shield", "truncated": false}, "before_length": 19, "before_sha256": "7957a67fbadd9cf58d11201c1bd12910c1c1592dbb3f2411769457404f70811c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-93031ea2983ee44aeb9d02ec", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9614}
{"after": {"end": 121, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu/.", "truncated": false}, "after_length": 121, "after_sha256": "9d8d2148d2215735c1ca8ac769a2e0cd013fc2a2447a452d6c72e4b8fec48c3e", "annex": "IIIA", "before": {"end": 120, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/.", "truncated": false}, "before_length": 120, "before_sha256": "b7d3bba3c3d744d927e6d05f81a5139a00b9d5c4dcbc4adcdfb1949c5602b310", "change_kind": "technical", "change_operations": [{"after_end": 99, "after_start": 98, "before_end": 98, "before_start": 98, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-930e15366b09ebd38c177c38", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2949}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 17, "start": 0, "text": "Isopropyl alcohol", "truncated": false}, "before_length": 17, "before_sha256": "2e964343b8e3310d140256874612fb9b9cc411517b2c2963d1880a64b0e90437", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9313836220fe451b81b23057", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1373}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 16, "start": 0, "text": "Mannitol (E 421)", "truncated": false}, "before_length": 16, "before_sha256": "9d090257c0ab6334a6f70770003677d80dc9143d07f9048a126b9fb07f946ccf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-931e07838db84aa05e697f43", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1360}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 128, "start": 0, "text": "For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:", "truncated": false}, "before_length": 128, "before_sha256": "11bcc55726eb2dcba7f61130f5b246f60d64f42c42862d69cc2d93195e48decb", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 128, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 128, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9322168ed75dac1ca9fbcb5f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9453}
{"after": {"end": 19, "start": 0, "text": "Induction du CYP1A2", "truncated": false}, "after_length": 19, "after_sha256": "dc2a2f47db9a8b47978dcbba3f3e471302ae6ac7ec0c15cee90895809c9b02e8", "annex": "I", "before": {"end": 36, "start": 0, "text": "Induction des CYP (CYP1A2 et CYP3A4)", "truncated": false}, "before_length": 36, "before_sha256": "a491c555296ca52a1c725d3932d8048b310cd2ce362417cf0e03701a10d08a21", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 11, "before_end": 13, "before_start": 11, "kind": "replace"}, {"after_end": 13, "after_start": 13, "before_end": 19, "before_start": 14, "kind": "delete"}, {"after_end": 19, "after_start": 19, "before_end": 36, "before_start": 25, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 18, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9338ded8a0043257448b56bf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 265}
{"after": {"end": 22, "start": 0, "text": "Tlf.: + 45 36 35 91 00", "truncated": false}, "after_length": 22, "after_sha256": "ee5cfc7acaf9dfe8868ac7e8cd8079d0cb8f85922089533a08d33e515be7aea6", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Tlf: + 45 36 35 91 00", "truncated": false}, "before_length": 21, "before_sha256": "18d8cf6a57f2048255a4474230a78ae1192c8bd63af3a4aa0c409cccfeafcba9", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9360f0803b7dfd38500f8d48", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2829}
{"after": {"end": 7, "start": 0, "text": "Sverige", "truncated": false}, "after_length": 7, "after_sha256": "3a7d70b4edb982a403e97d77681309e5fb1032b12d727aa1e92b145b069b9aa4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-936d7c30afe353a512ce19e2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2627}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "Block 7, City North Business Campus", "truncated": false}, "before_length": 35, "before_sha256": "60bfb84fd0a0344daf8d2ba906704ff97de4b5b33f66d72a6caa0462690c35f7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-93f36d261237659faab59483", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3217}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "4. PHARMACEUTICAL FORM AND CONTENTS", "truncated": false}, "before_length": 35, "before_sha256": "103cfd4c3e9c7bb9b46998faaa21a391b50f062b5f82b4f79f73e1aa06fb67fc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9409ee85027f4b0bd28953db", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4801}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 127, "start": 0, "text": "Ni le niraparib ni M1 ne sont des inhibiteurs des polypeptides de transport d’anions organiques 1B1 (OATP1B1) ou 1B3 (OATP1B3).", "truncated": false}, "before_length": 127, "before_sha256": "d30e46470239e601cf85f378461d0944ec1779ece162fb2846cdec5f6a7555be", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 127, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 127, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9430cdce386a9fd9a62b30c9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 278}
{"after": {"end": 35, "start": 0, "text": "decreased red blood cells (anaemia)", "truncated": false}, "after_length": 35, "after_sha256": "32d316607e49ab5b6ad5885c3751925b2432f2778ea2abec4e467790f36e5ea1", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9454ae3f5866da2e800cdd46", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 893}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-94705b22bbbf0a1ede24b469", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2592}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma SIA", "truncated": false}, "after_length": 19, "after_sha256": "6da5006887c3e11cf19ecbe52bdc7a386838e93f6e63f315e575cb7df7747f15", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-94ad9dd02829227d56169d4c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2943}
{"after": {"end": 23, "start": 0, "text": "Tel: + 351 21 440 70 00", "truncated": false}, "after_length": 23, "after_sha256": "051a50965400ccbc97e96d9606564d6ef751251b31d5cd81aa4f430414a32099", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-94be3c233253f03eeb514c03", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3250}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Solution for injection.", "truncated": false}, "before_length": 23, "before_sha256": "f96c7ce4de1e08aa045db6e55fef8c3a01b890a853a3ee8570ad1f9ba2ca6c55", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-94c19efcb49e7e6d87570df6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4803}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 98, "start": 0, "text": "Le CHMP recommande que les termes de la/des autorisation(s) de mise sur le marché soient modifiés.", "truncated": false}, "before_length": 98, "before_sha256": "814445cd01b1f96232572044ddd66f4350cafdd933e820b4d83b946474ffc969", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 98, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 98, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-94f23ec3c7e2e321ea72bd44", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3505}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 58, "start": 0, "text": "What Humalog Tempo Pen looks like and contents of the pack", "truncated": false}, "before_length": 58, "before_sha256": "187db75e805a0facdc7b57f0af96f28787962fcc1d3bb5827ed808e263593be7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 58, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 58, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-95039bb990c3e9b4cb3479e2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9442}
{"after": {"end": 153, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments : https ://www.ema.europa.eu/.", "truncated": false}, "after_length": 153, "after_sha256": "65ae7b3bd019e142fef6b9251772e6f7b7562315079db4fd990a412be7072e5e", "annex": "IIIA", "before": {"end": 152, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments : http ://www.ema.europa.eu/.", "truncated": false}, "before_length": 152, "before_sha256": "347cbe234d1ed584927826eb1e1aa61869dce0c3b5079dd6d460e816260d16b1", "change_kind": "content", "change_operations": [{"after_end": 130, "after_start": 129, "before_end": 129, "before_start": 129, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-958a8ff73f6387c7e223470e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2642}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 11, "start": 0, "text": "octreotide,", "truncated": false}, "before_length": 11, "before_sha256": "7e1f04901142fac198ec0a6a78be2b0f65b2047b9725f37210a4d0eaeb424e90", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 11, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 11, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-95a18105185da4a0cb91e99d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9276}
{"after": {"end": 19, "start": 0, "text": "Tel: + 371 66164750", "truncated": false}, "after_length": 19, "after_sha256": "113b9b6ac49a6f4bdbe379f2d1e85b2d125b75611b91111c888ec73bacdd0230", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-95b7e9110ed4b86593e78bf7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2940}
{"after": {"end": 18, "start": 0, "text": "Swixx Biopharma OÜ", "truncated": false}, "after_length": 18, "after_sha256": "94bc5f3c43fc9da5715250d66202d3b6e108127762e4f8e413b99fc19e24a395", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 18, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 18}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-95ca07656c3b9b3be8f38ece", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3217}
{"after": {"end": 120, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu.", "truncated": false}, "after_length": 120, "after_sha256": "4531b88088f201341aeac319894fe4addc485ddec7289bfb799fa5bfa043c6bb", "annex": "IIIA", "before": {"end": 119, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.", "truncated": false}, "before_length": 119, "before_sha256": "253f2622a30bdfc9897323503e26a15d261cb9d4155934bd9ad1b75da0a2cd9a", "change_kind": "technical", "change_operations": [{"after_end": 99, "after_start": 98, "before_end": 98, "before_start": 98, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-965d180679a262dbe178f48d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2931}
{"after": {"end": 21, "start": 0, "text": "Tel: + 39 06 50 39 61", "truncated": false}, "after_length": 21, "after_sha256": "6ac0b442dd41c62cad589a5c348c5781354f651196f78692c420568d264ff7f0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-96c6e6d3156a347e3082325a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2614}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "Tel: + 421 220 663 111", "truncated": false}, "before_length": 22, "before_sha256": "a3b9b28762eada3588f6a4fb3bff211d70dc45689e82d0e626fd475100555d0d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9705ff5d5c179b9191008fdd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9540}
{"after": {"end": 7, "start": 0, "text": "România", "truncated": false}, "after_length": 7, "after_sha256": "633e193d7e05828a893d02a6273755ed0d417cc14abf5ecfc2b6328c71ddcc7e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-97072cf6373667ebe410a790", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2581}
{"after": {"end": 19, "start": 0, "text": "Tel: + 372 640 1030", "truncated": false}, "after_length": 19, "after_sha256": "fe728e641eb3fdbddc9ef5e84d4bceb9a2fe5bf5a11cd739c9346c67f55cc34e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-971632d7b16a55009e86bcac", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2850}
{"after": {"end": 250, "start": 0, "text": "Le niraparib est un substrat de la P-gp et la BCRP. Cependant, en raison de la haute perméabilité et biodisponibilité du niraparib, le risque d’interactions cliniquement significatives avec des médicaments inhibant ces transporteurs est peu probable.", "truncated": false}, "after_length": 250, "after_sha256": "a92c721a672e8bb34fbcd040e5e986d7207ed4bcbf6f6ecd21c5c552d4b5406c", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 250, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 250}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9744065955af7ec338f183e0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 805}
{"after": {"end": 35, "start": 0, "text": "Oy BristolMyers Squibb (Finland) Ab", "truncated": false}, "after_length": 35, "after_sha256": "ec1e651ed7eac79d1bf600f594e4c106251ee62cf1c76346a86d003d9870c3c9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-97524fb320de49eb032d32e2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2928}
{"after": {"end": 32, "start": 0, "text": "2. STATEMENT OF ACTIVE SUBSTANCE", "truncated": false}, "after_length": 32, "after_sha256": "9e169b908eb1d9fc1ed6e233dacad6af86b2c8a043fa81faef38a02382a9c8e3", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "2. STATEMENT OF ACTIVE SUBSTANCE(S)", "truncated": false}, "before_length": 35, "before_sha256": "a98caee7a99385f0fdf38e1fb123885d279b9ccfdb6ba18007e43f93a9a479ee", "change_kind": "content", "change_operations": [{"after_end": 32, "after_start": 32, "before_end": 35, "before_start": 32, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-978e5d39c96a134f63533723", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 788}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 15, "start": 0, "text": "EU/1/96/007/046", "truncated": false}, "before_length": 15, "before_sha256": "d6805fafeecf40e7708c6ada66c100190e8836086d3506065a754a470e2e72de", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-97a45b7220c078bf54697a4b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "8", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 569}
{"after": {"end": 7, "start": 0, "text": "Danmark", "truncated": false}, "after_length": 7, "after_sha256": "b2bebaaf55198f3166a7d7089112d30e245d6cf4a3249ae87b597fa988e7f1be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-97a74529f66a8869bf430de0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2516}
{"after": {"end": 6, "start": 0, "text": "France", "truncated": false}, "after_length": 6, "after_sha256": "7a1ca4ef7515f7276bae7230545829c27810c9d9e98ab2c06066bee6270d5153", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-97aa211e265925418ac6d4f5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3243}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Step 11:", "truncated": false}, "before_length": 8, "before_sha256": "32fd326a50893dd2da102146ed0f4ae9b023446ca80a8d0cec121a562f3c976e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-97c0e946ae2b8ba3baf18d86", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9756}
{"after": {"end": 37, "start": 0, "text": "BristolMyers Squibb Polska Sp. z o.o.", "truncated": false}, "after_length": 37, "after_sha256": "879c6157ffdbde9480d5a62d5589e727166123ced2dd83568a6d587ba5052589", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-97cab2769a2a880405828310", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2568}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Instructions for use", "truncated": false}, "before_length": 20, "before_sha256": "ee73c9b52901f2e34700585882d94e127e4841d2ff2e1320fd6c8b620507b37b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-97cdcf9a575dada6c261861a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9568}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Fresenius Kabi Austria GmbH", "truncated": false}, "before_length": 27, "before_sha256": "fa59d2b0c9ce4abc55a3051cb227907a12a3a3e7fc63908aaebeb76ac9f651ef", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-97ec8e42b605b7201aa4caab", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3162}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 427, "start": 0, "text": "Ni le niraparib ni M1 ne sont des substrats des polypeptides de transport d’anions organiques 1B1 (OATP1B1), 1B3 (OATP1B3), ou du transporteur de cations organiques 1 (OCT1). Aucun ajustement posologique n’est nécessaire pour Zejula en cas d’administration concomitante avec des médicaments connus pour inhiber les transporteurs d’influx OATP1B1 ou 1B3 (par exemple, gemfibrozil, ritonavir) ou OCT1 (par exemple, dolutégravir).", "truncated": false}, "before_length": 427, "before_sha256": "f0b7979c4e12236e95d231238e34abd6671ff08555dabb0de4964c79956d70a3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 427, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 427, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-97fd8860feb419c887f97a32", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 250}
{"after": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "after_length": 7, "after_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9848b2475d7011181597eea2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2898}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 325, "start": 0, "text": "If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.", "truncated": false}, "before_length": 325, "before_sha256": "30277424da0f28fdafa9da24dd2114b1933ae62fb847a96ba2b263de8cd0251d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 325, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 325, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-985fe3fe079a3a07a6216abb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9381}
{"after": {"end": 586, "start": 0, "text": "This document is the approved product information for Viagra, with the changes since the previous procedure affecting the product information (EMA/VR/0000247514) tracked.For more information, see the European Medicines Agency’s website: https://www.ema.europa.eu/en/medicines/human/EPAR/viagraThis document is the approved product information for Viagra, with the changes since the previous procedure affecting the product information (EMA/VR/0000247514) tracked.For more information, see the European Medicines Agency’s website: https://www.ema.europa.eu/en/medicines/human/EPAR/viagra", "truncated": false}, "after_length": 586, "after_sha256": "426a4c34132c2ff4d7967d1e504830248812e488f3b50c0cc54374146462ee85", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 586, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 586}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-986635588dc4ad6bfac8a154", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 0}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "12. MARKETING AUTHORISATION NUMBER", "truncated": false}, "before_length": 34, "before_sha256": "a60532285d3f2ae8ae6f1bf2efe60e8f4d80a3914ffa0fe294c7a05c7841017d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-988dd87521135ae839e0991b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4745}
{"after": {"end": 120, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu.", "truncated": false}, "after_length": 120, "after_sha256": "4531b88088f201341aeac319894fe4addc485ddec7289bfb799fa5bfa043c6bb", "annex": "IIIA", "before": {"end": 193, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu. There are also links to other websites about rare diseases and treatments.", "truncated": false}, "before_length": 193, "before_sha256": "6bfca471cfd89e125a1848605c16ff55fd788531e5a6c1c278d76bf3f9ef873e", "change_kind": "content", "change_operations": [{"after_end": 88, "after_start": 87, "before_end": 87, "before_start": 87, "kind": "insert"}, {"after_end": 99, "after_start": 98, "before_end": 97, "before_start": 97, "kind": "insert"}, {"after_end": 119, "after_start": 119, "before_end": 192, "before_start": 117, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 75, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-989e1dfeaf0cea367641efba", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1694}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 52, "start": 0, "text": "• rash over the whole body • blood pressure dropping", "truncated": false}, "before_length": 52, "before_sha256": "c631faa6e2c8a85f22ee6701f62972c61fb6f298902d64e085fd97fb4333a461", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 52, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 52, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-98a5587e3722af6d50c9603e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9368}
{"after": {"end": 31, "start": 0, "text": "Caspofungin (C) (N = 117) n (%)", "truncated": false}, "after_length": 31, "after_sha256": "5de2e06aba8bcdb4d0d556244274589738f7d54b8b4eabae6f9940e510d182b7", "annex": "I", "before": {"end": 30, "start": 0, "text": "Caspofungin (C) (N = 94) n (%)", "truncated": false}, "before_length": 30, "before_sha256": "2797d24c7fffaabcc2751e2ae62ce78579d48d7e5ac52b85b7ba4774c57c32bd", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 21, "before_end": 23, "before_start": 21, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-98a863fa0a378fb20a0b326c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 290}
{"after": {"end": 27, "start": 0, "text": "3 x 10 comprimés pelliculés", "truncated": false}, "after_length": 27, "after_sha256": "21dc67ecbecee02a6241ddb55734a8190fd01cc58dfcfc791e60dbc8ea7cb79e", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "30 x 1 capsules molles.", "truncated": false}, "before_length": 23, "before_sha256": "dd834e302416f015e96c467da16c0c38102979dc80a64652eb90aae094bde7dd", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 1, "before_end": 2, "before_start": 1, "kind": "delete"}, {"after_end": 6, "after_start": 5, "before_end": 6, "before_start": 6, "kind": "insert"}, {"after_end": 10, "after_start": 8, "before_end": 9, "before_start": 8, "kind": "replace"}, {"after_end": 15, "after_start": 11, "before_end": 10, "before_start": 10, "kind": "insert"}, {"after_end": 23, "after_start": 16, "before_end": 11, "before_start": 11, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 14, "before_start": 13, "kind": "replace"}, {"after_end": 27, "after_start": 27, "before_end": 23, "before_start": 15, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 11, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-98b2d0bc5d4ce9ea17d86c43", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2809}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Outer Needle Shield", "truncated": false}, "before_length": 19, "before_sha256": "822bed85d73d47b0ec53c6176d6f3f220551b6905c2df969acd957d28be3ef6e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-98c5f3dcbf4cae33591922d0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9613}
{"after": {"end": 12, "start": 0, "text": "Id-Danimarka", "truncated": false}, "after_length": 12, "after_sha256": "ac04b6efb22ef48cbffb5f129ff3db14dac1293a9618775a5e7a6cb07d57fc19", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9903174efaa28770384002d5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1749}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 36, "start": 0, "text": "Store in a refrigerator (2°C - 8°C).", "truncated": false}, "before_length": 36, "before_sha256": "da46e7ec5af6b520bf23f97fab0435900e7b6407916f2e228ee83266f9359e2a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 36, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 36, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-99039906f4066a014aabef15", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4730}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-990e43d5d5ded330f30d57fb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3459}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 47, "start": 0, "text": "Effect of other medicinal products on niraparib", "truncated": false}, "before_length": 47, "before_sha256": "6864403957b3778828df6588077232300cfc94cd5cfefe63a69918773792e39c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 47, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 47, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9954ec5e9a7ecd516f14d59a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 230}
{"after": {"end": 19, "start": 0, "text": "Induction of CYP1A2", "truncated": false}, "after_length": 19, "after_sha256": "3f2dc05ae7c0c872372289005d50f8282ea3dd7be7d15db38d66a65c5fe78779", "annex": "I", "before": {"end": 37, "start": 0, "text": "Induction of CYPs (CYP1A2 and CYP3A4)", "truncated": false}, "before_length": 37, "before_sha256": "98a6a007ab8ff57755d117f717d991b9b46f1ea83d107ebcfe8e98dbddbf1d19", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 16, "before_end": 22, "before_start": 16, "kind": "delete"}, {"after_end": 19, "after_start": 19, "before_end": 37, "before_start": 25, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 18, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9963151b8b2da14bf7e1cf7a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 256}
{"after": {"end": 32, "start": 0, "text": "5. MODE ET VOIE D’ADMINISTRATION", "truncated": false}, "after_length": 32, "after_sha256": "bc33d9ee3a64cfa7a5fdcce95a03584999505e063543ab6e48cb29eed4742fdd", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "5. MODE ET VOIE(S) D’ADMINISTRATION", "truncated": false}, "before_length": 35, "before_sha256": "17ac57bd750cd275d807d869c838dbc4c562eeea8645350ff1655752eaa2921f", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 15, "before_end": 18, "before_start": 15, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-99a21d21c965deebbbd8924b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 827}
{"after": {"end": 26, "start": 0, "text": "KwikPen and Junior KwikPen", "truncated": false}, "after_length": 26, "after_sha256": "3913a6d0d2219ed08ae62130ad9aa232e96a26e416a39269a9c987d6167adda1", "annex": "I", "before": {"end": 36, "start": 0, "text": "KwikPen,Junior KwikPen and Tempo Pen", "truncated": false}, "before_length": 36, "before_sha256": "ba4a4f11990b07707779628d04b91d5cb69a340601b9d5c262f4161ca7dd8f66", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 7, "before_end": 8, "before_start": 7, "kind": "replace"}, {"after_end": 23, "after_start": 23, "before_end": 33, "before_start": 19, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-99ba8a6bee5212dfb37cc8d2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.4", "section_type": "storage", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 411}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 89, "start": 0, "text": "Severe allergy is rare (may affect up to 1 in 1,000 people). The symptoms are as follows:", "truncated": false}, "before_length": 89, "before_sha256": "2747ddb549344beb409aacffc1bd08d825067cf1dba7bf85aa9b33d1f39fa8a1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 89, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 89, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-99bf7a60a8dae014f1024aab", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9367}
{"after": {"end": 5, "start": 0, "text": "Eesti", "truncated": false}, "after_length": 5, "after_sha256": "ed7477d6100948d0d4e6b914d9769159823c21b23bf4846b1676338b9b439b72", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-99dfcceb10382d64212ecb3a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2542}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 409, "start": 0, "text": "If your blood sugar levels are well controlled by your current insulin therapy, you may not feel the warning symptoms when your blood sugar is falling too low. Warning signs are listed in section 4 of this leaflet. You must think carefully about when to have your meals, how often to exercise and how much to do. You must also keep a close watch on your blood sugar levels by testing your blood glucose often.", "truncated": false}, "before_length": 409, "before_sha256": "243784941ee5e26ff5b94dee60e695dfcf77f4824b7a1d4a4c475ba5a366938c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 409, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 409, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-99eba3cb1f3cd9af208f4379", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9252}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 289, "start": 0, "text": "In vitro, le niraparib inhibe faiblement le transporteur de cations organiques 1 (OCT1) avec un IC50 = 34,4 µM. La prudence est recommandée lorsque le niraparib est administré en concomitance avec des substances actives qui subissent un transport d’absorption par OCT1 comme la metformine.", "truncated": false}, "before_length": 289, "before_sha256": "78ddb18067d666d53aef85b22571691db3eded899b788c55de14b9c20ed04ebb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 289, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 289, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-99f9abe569876047c932123d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 280}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Killorglin", "truncated": false}, "before_length": 10, "before_sha256": "2606b5fb607427b1a532d8cab1195d0515b4a8cf56f0eff6628b2ac9a5a04655", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9a23a69ff51c33bd44ce0de1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1728}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 42, "start": 0, "text": "Médicament soumis à prescription médicale.", "truncated": false}, "before_length": 42, "before_sha256": "750563bceec650756547672930cecdeae621fc507c505c9da059b6b3a66df134", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 42, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 42, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9a23c642f9057e92d2bec5fc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 875}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 11, "start": 0, "text": "Hoge Wei 10", "truncated": false}, "before_length": 11, "before_sha256": "ba5c0cab58e83e9dc6ec41e55e6acc00077e1be63c8a1ed970723221f2f12ba4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 11, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 11, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9a23cdc239741b4fd631c9ac", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3210}
{"after": {"end": 35, "start": 0, "text": "BristolMyers Squibb GmbH & Co. KGaA", "truncated": false}, "after_length": 35, "after_sha256": "35ff9638226ceee7106ecbdfa1f34c1363018c276e5f126171bb1c80c9dbf877", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9a5bc19ad597173d763d3417", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2533}
{"after": {"end": 23, "start": 0, "text": "medinfo.finland@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "7029ed3ac062d546eacefe48107a23caa5547edd30d7c30335f744035bfb4ec6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9a5d4c8cff3aa7f8ad036adc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2614}
{"after": {"end": 37, "start": 0, "text": "5. METHOD AND ROUTE OF ADMINISTRATION", "truncated": false}, "after_length": 37, "after_sha256": "9c671e90ead72d031e0489d7a17c0d517e69200aed5e01a6faffa73ca5420b69", "annex": "IIIA", "before": {"end": 40, "start": 0, "text": "5. METHOD AND ROUTE(S) OF ADMINISTRATION", "truncated": false}, "before_length": 40, "before_sha256": "40d13857ade903416a15c2c141baf03ce80cf78bfa856e2b5de7f7b195b6d9bb", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 19, "before_end": 22, "before_start": 19, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9a67058d1a42ce2900ea65c3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 906}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "– The Pen dials 1 unit at a time.", "truncated": false}, "before_length": 33, "before_sha256": "59c8bdf90465c3e431d318b1a3dcfcc4e3b27e2903965392614f5a3b4bf4b4f2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9a955c13d8ce1c05c7b4e017", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9689}
{"after": {"end": 21, "start": 0, "text": "medinfo.czech@bms.com", "truncated": false}, "after_length": 21, "after_sha256": "7d80d4bfa363423e385e42b079e9a90210b1f5d622fbfe8ab954e6684db7cffd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9abc451c2a95bc1f4a4eff77", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2515}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 14, "start": 0, "text": "Purified water", "truncated": false}, "before_length": 14, "before_sha256": "102fa07af368b7a7b2de98b708bb6a1e101a885482b8b1e7fd945f3a91f8f2b4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9abda764d1dff4964a394a2d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1361}
{"after": {"end": 15, "start": 0, "text": "Česká republika", "truncated": false}, "after_length": 15, "after_sha256": "c768c215f215c71e7ffcbffe06cb1a66fa3c379a86285d5da65cef3c627bc09d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9b0b7a4a396331f873bc2c6a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2818}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 49, "start": 0, "text": "- Do you have trouble with your kidneys or liver?", "truncated": false}, "before_length": 49, "before_sha256": "7387988306f639cc00dc51afdda67e790697b5f949e889447acb4f237cf1ce34", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 49, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 49, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9b14cc7753880b9ce6564c52", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9256}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 102, "start": 0, "text": "– If you normally need to give 2 injections for your full dose, be sure to give your second injection.", "truncated": false}, "before_length": 102, "before_sha256": "eb8bc0726e90745cbdf1a0fcda9dcf84696136e481fa3a7554b18539b4808362", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 102, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 102, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9b4a353f4a9e9fbcde2e3398", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9763}
{"after": {"end": 8, "start": 0, "text": "Portugal", "truncated": false}, "after_length": 8, "after_sha256": "4c7de2c3da6dc0ae8f9d13b107718a913859359bd30166d077c867577953865d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9b6abded3d073baa049b9030", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2887}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "8055 Graz", "truncated": false}, "before_length": 9, "before_sha256": "765f51a390983de920b9a586c4589caab5f6398576531f438fd8301227c9ccb2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9bc300d6d258f1421700fce5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2765}
{"after": {"end": 32, "start": 0, "text": "BristolMyers Squibb spol. s r.o.", "truncated": false}, "after_length": 32, "after_sha256": "f17626bd52e917e0c6a35193744c7dbe6c722322ff29e81192cd072e33f2d41f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 32, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 32}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9bc85023b63e058d491f9f22", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3187}
{"after": {"end": 35, "start": 0, "text": "medinfo.bulgaria@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7905c486c458386eb1a26649ec5c649de6cbd59270b3b28715f74ada40ed9166", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9bdc49b5e2539b1531e03c24", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2815}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 49, "start": 0, "text": "Inhibition of UDP-glucuronosyltransferases (UGTs)", "truncated": false}, "before_length": 49, "before_sha256": "89cff031758125e9578d4c56981b1915e08d9f97c87ba058c995744d19ea7e55", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 49, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 49, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9bfe31c37a8aa7a61e77eb3f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1116}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "K32 YD60", "truncated": false}, "before_length": 8, "before_sha256": "a912431ef5bf5f07d79f78dbc42126d9eabca27a661f0e9817b1e916e549ace1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9c0d0a455a4a4325db95e230", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3219}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "KeepThrow AwayKeepThrow Away", "truncated": false}, "before_length": 28, "before_sha256": "243d7cc409c71fad1ae647620316b0ae8eb72a43ca7d846d4115966b40e15e4a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9c455d5ad942dfb194dd1da5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9652}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "Troubleshooting", "truncated": false}, "before_length": 15, "before_sha256": "c3af076f92c5ed8dcb0d0b0d36dd120bc31b68264efea96cf8019ca19f1c13a3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9c5b75a19ebddeb1874ca907", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9800}
{"after": {"end": 6, "start": 0, "text": "Italia", "truncated": false}, "after_length": 6, "after_sha256": "a7ca3e3d756601d5a22a4c0d8629da0c0ce425e5be526078d3e4583737150f52", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9c609a90081279e91332f9bf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2922}
{"after": {"end": 22, "start": 0, "text": "Tel: + 420 221 016 111", "truncated": false}, "after_length": 22, "after_sha256": "4d518854d9706e629e406bc93cfad10898d14ad223a3d403070c562115da215f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9c63aad9ebb70af106fa2f0b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2824}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht", "truncated": false}, "before_length": 34, "before_sha256": "46a90fc46ae308c2beeb35ead613fcf3ade5a51e2217a834de3fa5972dab9eec", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9c6e10aced9a2371b4796b2e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4741}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 137, "start": 0, "text": "10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "truncated": false}, "before_length": 137, "before_sha256": "21a44745bd9deea05c5c3551ddef2c63129d14d622db066ae2815a039a68f3d2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 137, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 137, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9caf4fc8bedaaa70bad7d329", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4834}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 96, "start": 0, "text": "• Replace the Pen cap by lining up the cap clip with the dose indicator and pushing straight on.", "truncated": false}, "before_length": 96, "before_sha256": "871cd75f52111653e01d667f1adab8412f7beb73b723455cd55d54e15f668639", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 96, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 96, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9cbd173dba9be12010cd7151", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9778}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "• Dose Knob: Burgundy", "truncated": false}, "before_length": 21, "before_sha256": "4b15d8c2a827d01adb5dc17568a32489c1760c848d39e685532c86123c2e0537", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9cd849c60d03611cd674c647", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9621}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 6, "start": 0, "text": "Ελλάδα", "truncated": false}, "before_length": 6, "before_sha256": "e6f7401e81c9b2a3c1f082d0c9a0183287a6f7b4ecded4f4d3ac5e1efefa9ce5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 6, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9d2e00e90dfd8042701421bd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9498}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 26, "start": 0, "text": "Driving and using machines", "truncated": false}, "before_length": 26, "before_sha256": "e3e025cc2bc4326c686682f5b09e418ac87957742f9bc708412867485c418455", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 26, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 26, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9d366a389f00b5f4d6fde03b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9293}
{"after": {"end": 8, "start": 0, "text": "България", "truncated": false}, "after_length": 8, "after_sha256": "a7215e5aa55f878990c076bb8195d75ca42044d4d5c7d2ba90af610508b643d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9d48993881c80109ae52cd8d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2808}
{"after": {"end": 228, "start": 0, "text": "Il a été montré que l’augmentation du poids augmentait le volume de distribution du niraparib dans l’analyse pharmacocinétique de la population. Il n’a pas été identifié d’impact du poids sur la clairance ou l’exposition totale.", "truncated": false}, "after_length": 228, "after_sha256": "8a2e346bc00610d9dbf5468f4981248de861be03513bb764750566bd8dddc7bf", "annex": "I", "before": {"end": 330, "start": 0, "text": "Il a été montré que l’augmentation du poids augmentait le volume de distribution du niraparib dans l’analyse pharmacocinétique de la population. Il n’a pas été identifié d’impact du poids sur la clairance ou l’exposition totale. Un ajustement de la dose en fonction du poids n’est pas justifié d’un point de vue pharmacocinétique.", "truncated": false}, "before_length": 330, "before_sha256": "2282b1e3eb034edc7fb19812debd03aeec5eb5e9831a1bb023f185f88e1a3b2f", "change_kind": "content", "change_operations": [{"after_end": 228, "after_start": 228, "before_end": 330, "before_start": 228, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 102, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9d58499369c1daa60a6deea9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 820}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Τηλ: +357 22 715000", "truncated": false}, "before_length": 19, "before_sha256": "b327908325a273086e61ac2a9a0952d4c70438fec1d5720701fe78afad2afa39", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9d65dcbc84488fd0b0a3971b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9552}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Eli Lilly and Company (Ireland) Limited", "truncated": false}, "before_length": 39, "before_sha256": "0555e8a06c0ef36afd955d945d4997f04834690c546541adf74802bac524a0e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9d6fbf50983e3522fb607db7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2537}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 60, "start": 0, "text": "1. NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION", "truncated": false}, "before_length": 60, "before_sha256": "90beea80355511f097699f4362a4b3ef5f6c11c0c6eada7b8b50672b0a7b25a7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 60, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 60, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9d880339d15c1629461dce32", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4880}
{"after": {"end": 322, "start": 0, "text": "In vitro, le niraparib induit le CYP1A2. Par conséquent, la prudence est recommandée lorsque le niraparib est administré en concomitance avec des substances actives dont le métabolisme est dépendant du CYP1A2 et, notamment, celles ayant une plage thérapeutique étroite (par exemple, clozapine, théophylline et ropinirole).", "truncated": false}, "after_length": 322, "after_sha256": "44268a2c6559ffc47aa2120e9b3202ae81633e63848bcc8f9fe659f7999d332a", "annex": "I", "before": {"end": 537, "start": 0, "text": "Ni le niraparib ni M1 ne sont des inducteurs du CYP3A4 in vitro. In vitro, le niraparib induit faiblement le CYP1A2 aux concentrations élevées et l’importance clinique de cet effet ne doit pas être totalement négligée. M1 n’est pas un inducteur du CYP1A2. Par conséquent, la prudence est recommandée lorsque le niraparib est administré en concomitance avec des substances actives dont le métabolisme est dépendant du CYP1A2 et, notamment, celles ayant une plage thérapeutique étroite (par exemple, clozapine, théophylline et ropinirole).", "truncated": false}, "before_length": 537, "before_sha256": "ab84b53ba8f7cd768fbbbfeb2987ca69345d616e1abfee4554a6181b26d75315", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 65, "before_start": 0, "kind": "delete"}, {"after_end": 30, "after_start": 30, "before_end": 99, "before_start": 95, "kind": "delete"}, {"after_end": 32, "after_start": 32, "before_end": 247, "before_start": 101, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 215, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9d8b71dfc7b3d0153874098a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 266}
{"after": {"end": 26, "start": 0, "text": "Tél: + 33 (0)1 58 83 84 96", "truncated": false}, "after_length": 26, "after_sha256": "331bde6d3ceed373ca2a62d0d499d6fe72853e6ae69fb08f092c7712a9ad1d3e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9d97d8cdea0eba49e22e485a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3245}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "13. BATCH NUMBER", "truncated": false}, "before_length": 16, "before_sha256": "1ba2d71652baaf680bf61f6637402598f74e8e74757862c33639fc0867a99221", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9db467f7daaaf34bed4e6ccc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4750}
{"after": {"end": 7, "start": 0, "text": "Anaemia", "truncated": false}, "after_length": 7, "after_sha256": "a529975952aa7b0f0d8545643872b846a33592327c62368f447cc46805d40f1a", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9dd3e6e8ccb5f9dd4423ed12", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.8", "section_type": "adverse_reactions", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 187}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9de9174f39ce338bfd1547e3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2816}
{"after": {"end": 148, "start": 0, "text": "- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.", "truncated": false}, "after_length": 148, "after_sha256": "83eb861e535ff13130c29b9c24263ab913918d9b9cfe519b39e44cd67ac566a2", "annex": "IIIA", "before": {"end": 147, "start": 0, "text": "- If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.", "truncated": false}, "before_length": 147, "before_sha256": "82fb98e2451cf3b9db05ce0757461ba53acd0c1c96d5e608a0745fa19e4f2536", "change_kind": "content", "change_operations": [{"after_end": 30, "after_start": 29, "before_end": 29, "before_start": 29, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9dff73f987f8b680a9b551cb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1181}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 36 1 301 9797", "truncated": false}, "after_length": 21, "after_sha256": "646ee39f31e338f4b9b710096409242010a836db8c907826a18abfa5703a4854", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9e0cfea0272af54fe6b957a9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3190}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 12, "start": 0, "text": "Manufacturer", "truncated": false}, "before_length": 12, "before_sha256": "1af384c577f294d4164a7ea49f3021259e2b92802eac577722d14066b2bbd5ce", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9e35ae67fa40a4cc90bff13c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9449}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 12, "start": 0, "text": "Manufacturer", "truncated": false}, "before_length": 12, "before_sha256": "1af384c577f294d4164a7ea49f3021259e2b92802eac577722d14066b2bbd5ce", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9e64d27316142215285a3cf9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2436}
{"after": {"end": 9, "start": 0, "text": "67 (57.3)", "truncated": false}, "after_length": 9, "after_sha256": "9da634023b3654fbe3a7a363264f4a0753eccc952e2325757663dffb020a37a6", "annex": "I", "before": {"end": 10, "start": 0, "text": "(57 (60.6)", "truncated": false}, "before_length": 10, "before_sha256": "d9afd63c0ea3caecb445f07bdda4fd9e2c411c0fe757b86fb789a5bc76ad601c", "change_kind": "content", "change_operations": [{"after_end": 3, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}, {"after_end": 6, "after_start": 6, "before_end": 7, "before_start": 3, "kind": "delete"}, {"after_end": 8, "after_start": 7, "before_end": 9, "before_start": 8, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 4}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9e737257db6fac160afa0491", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 303}
{"after": {"end": 27, "start": 0, "text": "informacja.medyczna@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "fd724a87ca0b5fd348792afb72bf17e76991a1b17ad813c04854601dd7b9576a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9e7ffb69517a42b8485763a8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2876}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "oral hypoglycaemics,", "truncated": false}, "before_length": 20, "before_sha256": "db74aa3359fd8a6055021b03170bf1ebe6b5e032b940971593b2fc877355789f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9e8c918119a2c1c81f1d7d37", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9273}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 25, "start": 0, "text": "Tel: + 353-(0) 1 661 4377", "truncated": false}, "before_length": 25, "before_sha256": "48fde288146f4033a2172164570180a8f875f4e361fcf85a8e43ff77834511cc", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9e92890de7c9c618b6e173b8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3461}
{"after": {"end": 66, "start": 0, "text": "For more information, see the European Medicines Agency’s website:", "truncated": false}, "after_length": 66, "after_sha256": "8da7088a6eca66a2ae1a2bd8189afa46fa290c56c54c0076ee93bf891abacdcc", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 66, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 66}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9ea25f26ae0edc4624b4abef", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "3. LIST OF EXCIPIENTS", "truncated": false}, "before_length": 21, "before_sha256": "9d67e3a2807c422a6c85b6670fe9327da5d28f65a26959822e496f531655744d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9edd34b7503bed1dcff209de", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4598}
{"after": {"end": 27, "start": 0, "text": "BristolMyers Squibb Denmark", "truncated": false}, "after_length": 27, "after_sha256": "85c703b06a34e371377fa6cfd59a679937926bebf7b34695c0e53e3bc9733ded", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9efb62e80c1bdd0c65c804ba", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3197}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9f01d8e579bdedbbeb1811f8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3276}
{"after": {"end": 5, "start": 0, "text": "Taani", "truncated": false}, "after_length": 5, "after_sha256": "b71f1b4c32927bd5f0694b003e2d1c67809beb4e798f042c99d04d09792a3a6f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9f0d0be93a8f12bdb69a0e6e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2062}
{"after": {"end": 69, "start": 0, "text": "Le niraparib est un inducteur du CYP1A2 in vitro (voir rubrique 4.5).", "truncated": false}, "after_length": 69, "after_sha256": "025d086ee13cd8fcd5559dd9399f3d414e84d8c0186de8614ce1a6315508dad6", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 69, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 69}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9f3466292e7ed8f5ead646c2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1691}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Danmark", "truncated": false}, "before_length": 7, "before_sha256": "b2bebaaf55198f3166a7d7089112d30e245d6cf4a3249ae87b597fa988e7f1be", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9f43c4dcbb36b80b7f107d1d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9477}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 99, "start": 0, "text": "6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "truncated": false}, "before_length": 99, "before_sha256": "455a982fe3bc6ba1eb2be1f3bcfd8517f2afe6d320280030b823f73d0bf6a1d6", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 99, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 99, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9f45cbc9003536e63caad904", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4814}
{"after": {"end": 12, "start": 0, "text": "Magyarország", "truncated": false}, "after_length": 12, "after_sha256": "5206a7f7063a77a35861f95e022dafc37f3b3cf27ed423b1118e3fe580841b19", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9f6b8de133353f66ebb83533", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2827}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "before_length": 7, "before_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9fc13caa85875962e87c50e0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1006}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "LEO Laboratories Ltd", "truncated": false}, "before_length": 20, "before_sha256": "88c803e41685f3f9af10a32ea47829718c391a3d4b0b4b43a151753aa8cf8bbc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-9fc6c3efef0a00b86958fc29", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2162}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Vistor hf.", "truncated": false}, "before_length": 10, "before_sha256": "4b40dfc2a19551f982dad779994a624f3432207c4666bbd66f0ec59c2f229b32", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 7, "before_end": 7, "before_start": 7, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a0322a238737754d02156880", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1677}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 26, "start": 0, "text": "If you stop using Humalog.", "truncated": false}, "before_length": 26, "before_sha256": "d125d4f42fcb36e86f02e88c9e46dbc2735a54bdc036ca3f2a313d7a3f775ebb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 26, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 26, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a05cb844d1e79468d1b92ed2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9357}
{"after": {"end": 62, "start": 0, "text": "Titulaire de l’Autorisation de mise sur le marché et fabricant", "truncated": false}, "after_length": 62, "after_sha256": "5eb30fa63ee39d5d0a9744c66dc0cac4f6a5cbcfe786b3057e9cfb022517a46f", "annex": "IIIA", "before": {"end": 49, "start": 0, "text": "Titulaire de l’Autorisation de mise sur le marché", "truncated": false}, "before_length": 49, "before_sha256": "e6862501ae974515f409229ac48889a881f5d48257cce71c9b21dd7551f5c918", "change_kind": "administrative", "change_operations": [{"after_end": 62, "after_start": 49, "before_end": 49, "before_start": 49, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a063c91b397ba3f2d97fd089", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3155}
{"after": {"end": 26, "start": 0, "text": "Bristol-Myers Squibb, S.A.", "truncated": false}, "after_length": 26, "after_sha256": "bcb96132907136675c68fa09511b755bbd39c0ca74a2983c8bbb77830f8f61b2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a069685794bb865360a812d2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2869}
{"after": {"end": 320, "start": 0, "text": "Si vous avez oublié de prendre une dose, prenez votre comprimé dès que vous vous en souvenez. S’il ne reste qu’environ 6 heures avant votre prochaine prise, ne prenez pas la dose oubliée et prenez la dose suivante à l’heure habituelle. Ne prenez pas de dose double pour compenser la dose que vous avez oublié de prendre.", "truncated": false}, "after_length": 320, "after_sha256": "6ef311cb8455d1131497cdcce69ba0ba2334f72cd975dcfc30c84ee40264346e", "annex": "IIIA", "before": {"end": 319, "start": 0, "text": "Si vous avez oublié de prendre une dose, prenez votre capsule dès que vous vous en souvenez. S’il ne reste qu’environ 6 heures avant votre prochaine prise, ne prenez pas la dose oubliée et prenez la dose suivante à l’heure habituelle. Ne prenez pas de dose double pour compenser la dose que vous avez oublié de prendre.", "truncated": false}, "before_length": 319, "before_sha256": "0f82e5f0d376b797f9c1f5618541341bf48d5c4f7f3a9bc3af9749586ecc535d", "change_kind": "content", "change_operations": [{"after_end": 57, "after_start": 55, "before_end": 56, "before_start": 55, "kind": "replace"}, {"after_end": 62, "after_start": 58, "before_end": 61, "before_start": 57, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a077e4a4f61a748e5489eb20", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3656}
{"after": {"end": 8, "start": 0, "text": "5. AUTRE", "truncated": false}, "after_length": 8, "after_sha256": "745dd9ad706e66baade8a4bb326ef37abec32db7189b3516bbcfe36aa6cd5b8c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a08c0958683c8d3a48236885", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1129}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 232, "start": 0, "text": "In vitro, niraparib weakly inhibits the organic cation transporter 1 (OCT1) with an IC50 = 34.4 µM. Caution is recommended when niraparib is combined with active substances that undergo an uptake transport by OCT1 such as metformin.", "truncated": false}, "before_length": 232, "before_sha256": "c300a256f55d940a469ab088f2a01f49c2d496184068ea5273335a0bd9c84e51", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 232, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 232, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a08e3e217b64435986646405", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 271}
{"after": {"end": 8, "start": 0, "text": "Portugal", "truncated": false}, "after_length": 8, "after_sha256": "4c7de2c3da6dc0ae8f9d13b107718a913859359bd30166d077c867577953865d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a091b5de7938e09eec7f97a5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2577}
{"after": {"end": 9, "start": 0, "text": "Nederland", "truncated": false}, "after_length": 9, "after_sha256": "8a869db3fa453526573e4f2c956528743cf246af5d1b5eac4879257589776797", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a09768a719504e86a0b3a604", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2843}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 161, "start": 0, "text": "Neither niraparib nor M1 is an inhibitor of any active substancemetabolising CYP enzymes, namely CYP1A1/2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5.", "truncated": false}, "before_length": 161, "before_sha256": "e3d1e536d915c8822f15fdf6c57b149152d6ef61e737d8266b907d4510e6fd7d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 161, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 161, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a0a14191dbede9deedcf7b55", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 249}
{"after": {"end": 584, "start": 0, "text": "Dans l’analyse pharmacocinétique d’une population de patientes ayant une insuffisance rénale légère (clairance à la créatinine 60-90 mL/min) ou modérée (clairance à la créatinine 30-60 mL/min), la clairance du niraparib a été légèrement réduite, comparativement aux individus ayant une fonction rénale normale. Cette différence d’exposition n’est pas considérée comme justifiant un ajustement posologique. Aucune patiente avec insuffisance rénale sévère préexistante ou d’insuffisance rénale terminale sous hémodialyse n’a été identifiée dans les études cliniques (voir rubrique 4.2).", "truncated": false}, "after_length": 584, "after_sha256": "9a0d8eb054c569ac53038919105d0fb07a4f58d0bd3a40bc3399f4659d5bf85d", "annex": "I", "before": {"end": 725, "start": 0, "text": "Dans l’analyse pharmacocinétique d’une population de patientes ayant une insuffisance rénale légère (clairance à la créatinine 60-90 mL/min) ou modérée (clairance à la créatinine 30-60 mL/min), la clairance du niraparib a été légèrement réduite, comparativement aux individus ayant une fonction rénale normale (7-17% d’exposition plus élevée chez les insuffisants rénaux légers et 17-38% d’exposition plus élevée chez les insuffisants rénaux modérés). Cette différence d’exposition n’est pas considérée comme justifiant un ajustement posologique. Aucune patiente avec insuffisance rénale sévère préexistante ou d’insuffisance rénale terminale sous hémodialyse n’a été identifiée dans les études cliniques (voir rubrique 4.2).", "truncated": false}, "before_length": 725, "before_sha256": "78634fa1454d66d6e09bf0887d5c9af2a94aaa6ae68eba7da7770d3a695cda8a", "change_kind": "content", "change_operations": [{"after_end": 309, "after_start": 309, "before_end": 450, "before_start": 309, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 141, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a0be8c578a55555d69d771dc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 814}
{"after": {"end": 38, "start": 0, "text": "N.V. Bristol-Myers Squibb Belgium S.A.", "truncated": false}, "after_length": 38, "after_sha256": "aed62c6e6383ee3130a6851382813dabc668847cc45474eecb9eae19fd27a962", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a0d5ac19af4e3ef4b6589333", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2502}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 12, "start": 0, "text": "Magyarország", "truncated": false}, "before_length": 12, "before_sha256": "5206a7f7063a77a35861f95e022dafc37f3b3cf27ed423b1118e3fe580841b19", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a0ee40efc80cd28d69875359", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9474}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 118, "start": 0, "text": "Once in use pens may be used for up to 28 days. Pens in use should be stored below 30C and should not be refrigerated.", "truncated": false}, "before_length": 118, "before_sha256": "5e0de42f5447f77b92faef6ecfe53fdea23a714da6b654f20c1a75cdad7b12ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 118, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 118, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a0ff9ada29b6a9977250bfb1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4732}
{"after": {"end": 25, "start": 0, "text": "Tel: + 40 (0)21 272 16 19", "truncated": false}, "after_length": 25, "after_sha256": "502a8c5996880f462bf382bf033fc5a4e73041db59d3a638fd11052ee7eef1a8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a1098eae8bd57b31d6788be8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2895}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 62, "start": 0, "text": "Inhibition of renal uptake transporters (OAT1, OAT3, and OCT2)", "truncated": false}, "before_length": 62, "before_sha256": "41e234d73fda72d7ba37f2cda7c32abda0c5bc32f55191182f8cb08285dad024", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 62, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 62, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a139d2903c3644c4728e1fbc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 273}
{"after": {"end": 31, "start": 0, "text": "Bristol-Myers Squibb Aktiebolag", "truncated": false}, "after_length": 31, "after_sha256": "18b315bcb0bae7d4352ec0e47ec43f18641696fe38dba2d6458c7c2188f9abdc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 31, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 31}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a16ac8dbd86f5326ec80ff6f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2622}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: + 353 18711600", "truncated": false}, "before_length": 19, "before_sha256": "f39469e1bbd519f10406ae27e104b0e2fb101791df45c4e53cc539ee02b84821", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a1b5e2a9c090da50f440c6b8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2696}
{"after": {"end": 30, "start": 0, "text": "Rezafungin (R) (N = 115) n (%)", "truncated": false}, "after_length": 30, "after_sha256": "645c1c85b979ff5fb31e55e81ea5c192eac951f4daea0408e626304601923e82", "annex": "I", "before": {"end": 29, "start": 0, "text": "Rezafungin (R) (N = 93) n (%)", "truncated": false}, "before_length": 29, "before_sha256": "79ef66c90c9a9741022c6a6fa7c276d3173c7fddac676c96c124e135776d42e9", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 20, "before_end": 22, "before_start": 20, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a1b95c78d1273476e433d6e4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 289}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "3. LIST OF EXCIPIENTS", "truncated": false}, "before_length": 21, "before_sha256": "9d67e3a2807c422a6c85b6670fe9327da5d28f65a26959822e496f531655744d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a1d4f8ce7458569dd9a474bc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4697}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb Kft.", "truncated": false}, "after_length": 24, "after_sha256": "4abe932008f2c73ead9e4e160ff0712dc599168363223ab6a9c2b7e9e433c4d7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a1e3c3b0d98665a45f3ebb8b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2518}
{"after": {"end": 63, "start": 0, "text": "Each film-coated tablet contains 61 mg of micronized tafamidis.", "truncated": false}, "after_length": 63, "after_sha256": "740b4b5a613f62786adcf9013a71e85bb59e07407e92a99d3eff193eaf056f9f", "annex": "I", "before": {"end": 57, "start": 0, "text": "Each soft capsule contains 61 mg of micronized tafamidis.", "truncated": false}, "before_length": 57, "before_sha256": "a093be4cc44a620c14417071dd3a8b3421a5ae1abf56d9778f7f3cef0bc78609", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 5, "before_end": 6, "before_start": 5, "kind": "replace"}, {"after_end": 13, "after_start": 12, "before_end": 8, "before_start": 7, "kind": "replace"}, {"after_end": 16, "after_start": 14, "before_end": 9, "before_start": 9, "kind": "insert"}, {"after_end": 18, "after_start": 17, "before_end": 11, "before_start": 10, "kind": "replace"}, {"after_end": 20, "after_start": 19, "before_end": 15, "before_start": 12, "kind": "replace"}, {"after_end": 23, "after_start": 22, "before_end": 17, "before_start": 17, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a20dcdfc1c610ede37ee0bc2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "2", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 925}
{"after": {"end": 36, "start": 0, "text": "Bristol-Myers Squibb GmbH & Co. KGaA", "truncated": false}, "after_length": 36, "after_sha256": "ad8ff4e5d779e654815cece3aff395170ae92937b281de17f06549278ae2dc0d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a24149db09e4c1143151d890", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2527}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "• Always carry sugar with you.", "truncated": false}, "before_length": 30, "before_sha256": "d48a43d1d72e0b992d86f886233865a519d7e61c03f74e67bbe6bde464c61d5e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 30, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 30, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a2474549fea9dcda06daaf94", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9355}
{"after": {"end": 22, "start": 0, "text": "Tel: + 34 91 456 53 00", "truncated": false}, "after_length": 22, "after_sha256": "c59845f4e2b4a96548adda4dbf16851ff33a89874560e491da6b05aee33b646a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a25eee544769924e71da1aee", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2874}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a2acb4b95d331f05613f6ac2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2576}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "before_length": 7, "before_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a2cbf8ea1e02870959069988", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9557}
{"after": {"end": 393, "start": 0, "text": "Le niraparib est un inhibiteur de MATE 1 et 2K in vitro. Les concentrations plasmatiques de metformine peuvent augmenter lorsqu'elle est administrée en concomitance avec le niraparib. Une surveillance étroite de la glycémie est recommandée lors de l'initiation ou de l'arrêt du niraparib chez les patients recevant de la metformine. Un ajustement de la dose de metformine peut être nécessaire.", "truncated": false}, "after_length": 393, "after_sha256": "3e29b40be5583e08ccff721cf52f11fc3e805a0484b799bb0c5c54e71c8681a6", "annex": "I", "before": {"end": 271, "start": 0, "text": "Le niraparib est un inhibiteur de MATE 1 et 2 avec un IC50 de 0,18 µM et ≤ 0,14 µM, respectivement. Une augmentation des concentrations plasmatiques de médicaments étant substrats de ces transporteurs (p. ex. metformine), administrés en concomitance, ne peut être exclue.", "truncated": false}, "before_length": 271, "before_sha256": "31fc8aa74180f3064c9721255feb9e7c8304d4d6f8e42242e20d4621767155fd", "change_kind": "content", "change_operations": [{"after_end": 46, "after_start": 45, "before_end": 45, "before_start": 45, "kind": "insert"}, {"after_end": 48, "after_start": 47, "before_end": 52, "before_start": 46, "kind": "replace"}, {"after_end": 52, "after_start": 50, "before_end": 71, "before_start": 54, "kind": "replace"}, {"after_end": 53, "after_start": 53, "before_end": 84, "before_start": 72, "kind": "delete"}, {"after_end": 55, "after_start": 54, "before_end": 98, "before_start": 85, "kind": "replace"}, {"after_end": 58, "after_start": 57, "before_end": 118, "before_start": 100, "kind": "replace"}, {"after_end": 93, "after_start": 93, "before_end": 210, "before_start": 153, "kind": "delete"}, {"after_end": 136, "after_start": 102, "before_end": 221, "before_start": 219, "kind": "replace"}, {"after_end": 148, "after_start": 147, "before_end": 233, "before_start": 232, "kind": "replace"}, {"after_end": 164, "after_start": 164, "before_end": 250, "before_start": 249, "kind": "delete"}, {"after_end": 369, "after_start": 165, "before_end": 251, "before_start": 251, "kind": "insert"}, {"after_end": 385, "after_start": 382, "before_end": 264, "before_start": 264, "kind": "insert"}, {"after_end": 391, "after_start": 386, "before_end": 269, "before_start": 265, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 131, "chars_inserted": 253}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a2cf995649e3dc85ffb26a19", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1161}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 214, "start": 0, "text": "Humalog is already dissolved in water, so you do not need to mix it. But you must use it only if it looks like water. It must be clear, have no colour and no solid pieces in it. Check each time you inject yourself.", "truncated": false}, "before_length": 214, "before_sha256": "cedb9b47917a4fdb7929da8a33ffd3234f49d864437130494c3a47860b27c6c2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 214, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 214, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a303a518a1330831229e4079", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9313}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 45 45 93 05 06", "truncated": false}, "after_length": 21, "after_sha256": "61983c14390c5d0df2153e10740a9b1eb429e8c0b05c3ebe705431c827a32b81", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a30642cc4bbd77d2a2656d8a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3195}
{"after": {"end": 155, "start": 0, "text": "Vyndaqel est indiqué dans le traitement de l’amylose à transthyrétine de type sauvage chez les patients adultes présentant une cardiomyopathie (ATTRwt-CM).", "truncated": false}, "after_length": 155, "after_sha256": "a71bb522730e097a6e3cb885c92e8b4ff515ede584d7dea5ac12e2404f35966e", "annex": "I", "before": {"end": 168, "start": 0, "text": "Vyndaqel est indiqué dans le traitement de l’amylose à transthyrétine de type sauvage ou héréditaire chez les patients adultes présentant une cardiomyopathie (ATTR-CM).", "truncated": false}, "before_length": 168, "before_sha256": "74eabb5ddd81feebb5f24c685976d0c80470b38c2c5140c4c94c1b119aec88cb", "change_kind": "content", "change_operations": [{"after_end": 86, "after_start": 86, "before_end": 101, "before_start": 86, "kind": "delete"}, {"after_end": 150, "after_start": 148, "before_end": 163, "before_start": 163, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a351399baad25098954f0df1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.1", "section_type": "indication", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1229}
{"after": {"end": 23, "start": 0, "text": "{BLISTER DE PROTECTION}", "truncated": false}, "after_length": 23, "after_sha256": "54d1f31fee8d225aa1d6a4d248de79e7d762e6812f9fb5545fb6597cccde2914", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a3b77ed4010ef9f061f06335", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1097}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "D-90429 Nuremberg", "truncated": false}, "before_length": 17, "before_sha256": "e947a9c523ae55d462208c17464751e497403938b7fe52dead7696ca6851269b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a3c6751044f84bb4ec1e9413", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3465}
{"after": {"end": 117, "start": 0, "text": "Niraparib is an inhibitor of P-gp, BCRP, MATE1/2K and organic cation transporter 1 (OCT1) in vitro (see section 4.5).", "truncated": false}, "after_length": 117, "after_sha256": "fe6cdfadc654a86407c34968439e7d7f6230ef0081d958a1359b6b81515d868a", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 117, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 117}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a3c9981945dbac99357c2c4f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1650}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 45, "start": 0, "text": "6. Contents of the pack and other information", "truncated": false}, "before_length": 45, "before_sha256": "381c2d977f039c7791983899f4478fb76623de100b6a709c62071f2e00b51ef3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 45, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 45, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a3ff941c4d153da4c615e03b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9436}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Tel: + 351-21-4126600", "truncated": false}, "before_length": 21, "before_sha256": "a5135973c42b4f752208a77fa2a10b59519c7ff04b5c5e95da6a8fa3fd4a3479", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a4516857f7ba00d35011608f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9518}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 524, "start": 0, "text": "Bien qu’une inhibition du CYP3A4 dans le foie ne soit pas attendue, le potentiel d’inhibition de CYP3A4 au niveau intestinal n’a pas été établi à des concentrations significatives de niraparib. Par conséquent, la prudence est recommandée lorsque le niraparib est administré en concomitance avec des substances actives dont le métabolisme est dépendant du CYP3A4 et, notamment, celles ayant une plage thérapeutique étroite (par exemple, ciclosporine, tacrolimus, alfentanil, ergotamine, pimozide, quétiapine et halofantrine).", "truncated": false}, "before_length": 524, "before_sha256": "64a9295d5cb0793e9d62f4cf05b5ea7b24672d5005554ac415c2421bacbd1201", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 524, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 524, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a4818d2936a832c82bddcdf3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 260}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Step 7:", "truncated": false}, "before_length": 7, "before_sha256": "014297996a3b938e517499db76e49e183bc7f5be385ac1da47a2055458a7ef98", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a494a7d8cb7151fbfd41c6ab", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9669}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 144, "start": 0, "text": "• Put used needles in a sharps container or a hard plastic container with a secure lid. Do not throw needles directly into your household waste.", "truncated": false}, "before_length": 144, "before_sha256": "1b399b9f41e4ac5ac2a911e47d34e5b38c5899c0017a4255e3e61ddc47edfc8f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 144, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 144, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a50cdb5adc328fb76c89941c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9782}
{"after": {"end": 416, "start": 0, "text": "The systemic exposures (Cmax and AUC) to niraparib increased in a doseproportional manner when the dose of niraparib increased from 30 mg to 400 mg. The absolute bioavailability of niraparib is approximately 73%, indicating minimal first pass effect. In a population pharmacokinetic analysis of niraparib, the inter-individual variability in bioavailability was estimated to a coefficient of variation (CV) of 33.8%.", "truncated": false}, "after_length": 416, "after_sha256": "9a7e9cc7b17d2f059c31af50053cdff0600612921f683ba257415a30c3e8a30a", "annex": "I", "before": {"end": 414, "start": 0, "text": "The systemic exposures (Cmax and AUC) to niraparib increased in a doseproportional manner when the dose of niraparib increased from 30 mg to 400 mg. The absolute bioavailability of niraparib is approximately 73%, indicating minimal first pass effect. In a population pharmacokinetic analysis of niraparib, the inter-individual variability in bioavailability was estimated to a coefficient of variation (CV) of 31%.", "truncated": false}, "before_length": 414, "before_sha256": "d9eff7d08ee151d2c4e9589da47e005c61a980a5055b23e009bcd4801382c76f", "change_kind": "content", "change_operations": [{"after_end": 414, "after_start": 411, "before_end": 412, "before_start": 411, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a545d42453b347ca1eb9d0f9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 759}
{"after": {"end": 15, "start": 0, "text": "3528 BD Utrecht", "truncated": false}, "after_length": 15, "after_sha256": "4ea402b0be2ffd43624e79f5ad9706ad796af820c845df2a7158d607c083d913", "annex": "I", "before": {"end": 15, "start": 0, "text": "3528 BJ Utrecht", "truncated": false}, "before_length": 15, "before_sha256": "c83d25e8ea65101ad8ea274a07e2114705ecd244e7a6dba61eb7b4d1ba592ecb", "change_kind": "administrative", "change_operations": [{"after_end": 7, "after_start": 6, "before_end": 7, "before_start": 6, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a55e93c134e18fdaf140dd44", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 2,5 mg comprimés pelliculés", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 523}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 7, "start": 0, "text": "Austria", "truncated": false}, "before_length": 7, "before_sha256": "c9cab0238debc6e55498e2c0963a1d8e25bd29c95ddd53a3fff841ee636b6bc5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a56b5280325a19b5fec4138d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1681}
{"after": {"end": 5, "start": 0, "text": "Дания", "truncated": false}, "after_length": 5, "after_sha256": "15c4c56ca2ad5dd4518ae08c37f15cbda6da8ac77d78fb2b6e974b7d6667351e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a590a7f5fb89069837a13e6b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2027}
{"after": {"end": 16, "start": 0, "text": "pv@ammangion.com", "truncated": false}, "after_length": 16, "after_sha256": "53f45568239cbb258daee24319c4e0fde3bfc6917d09b88019c1cb8329ded177", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a5992189a5ce4a6a4d06bb45", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2840}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "EU/1/96/007/047", "truncated": false}, "before_length": 15, "before_sha256": "f30ca5758e9452ea84ad3bb59494b72b6dc498c88b510a424c09118ac6b49046", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a5af1a706801afe86c468407", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4846}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "frequent episodes of hypoglycaemia", "truncated": false}, "before_length": 34, "before_sha256": "9bd2670401b4e14f061f90a129cbe3e4248f8a90a195bfb21c8094dd67998334", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a5dc4e9f0e8ba950d4d09951", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9295}
{"after": {"end": 34, "start": 0, "text": "medinfo.croatia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "59c47394700ad787801e8ce1b033fc5d63a885ddfc680677ae6b5acd89bb7df3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a5ff37c66e321354e91d6541", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3256}
{"after": {"end": 19, "start": 0, "text": "Tel: + 356 23976333", "truncated": false}, "after_length": 19, "after_sha256": "f8bfa43651e282e3e99ee42fa339e414e57dea721306efb985d46dcd3b4656c4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a6851450b612bfcfbd95e876", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2523}
{"after": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "after_length": 7, "after_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a690f371ed04f25a42f1498d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3266}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 116, "start": 0, "text": "If you get any side effects talk to your doctor. This includes any possible side effects not listed in this leaflet.", "truncated": false}, "before_length": 116, "before_sha256": "10d9901d1108ba63a24ca473d26c6d8e6ba7b9a6f02c8d7ee5edf84ffa4b37bc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 116, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 116, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a693bddf9313c45b0fe6db7b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1495}
{"after": {"end": 24, "start": 0, "text": "Tel: + 31 (0)30 300 2222", "truncated": false}, "after_length": 24, "after_sha256": "df26f07876232a3ba50861e46ee103ea04d50c8b384a64d52078fdc518ae52ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a6a4587c3f1b1b3d0537220e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2539}
{"after": {"end": 8, "start": 0, "text": "Hrvatska", "truncated": false}, "after_length": 8, "after_sha256": "08c5546cc42a9be9368bdd6a99ed02c97b9163c173b1e97dd49b785cb49740bc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a6a77319c540dd0c6f87adac", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3253}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 6, "start": 0, "text": "Needle", "truncated": false}, "before_length": 6, "before_sha256": "8f1913f50e8a3aa0c0dda27a4e376cf45ea2dad8013d83c224c5366e5bb91b28", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 6, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a71826067345cef598b545c3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9615}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "What is in this leaflet", "truncated": false}, "before_length": 23, "before_sha256": "c21bffcdfbfe045f962ac7403de4697fb84f03b0fe7d8037e50fd9f31d819192", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a75c7968ad5269657cfae834", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9222}
{"after": {"end": 27, "start": 0, "text": "Bristol-Myers Squibb GesmbH", "truncated": false}, "after_length": 27, "after_sha256": "4916681fe99630afcd464062529e9edf6fd8370e6c9aae947ff9ed0076180f67", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a788fb071c61b57d0bec3b38", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3229}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 258, "start": 0, "text": "If you change the type of insulin you use (for example from a human or animal insulin to a Humalog product), you may have to take more or less than before. This might just be for the first injection or it may be a gradual change over several weeks or months.", "truncated": false}, "before_length": 258, "before_sha256": "9a3a54248910f11a06e5de3fbb58f6fa79af62e801955889a2142cf22e3ce413", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 258, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 258, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a797ac6ba9830d9b2db441bf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9309}
{"after": {"end": 32, "start": 0, "text": "Caspofungine (C) (N = 117) n (%)", "truncated": false}, "after_length": 32, "after_sha256": "39e583a6a0e8ddc64a462790f0cbf2db1645017e2e62aa92905e4e7481fb3111", "annex": "I", "before": {"end": 31, "start": 0, "text": "Caspofungine (C) (N = 94) n (%)", "truncated": false}, "before_length": 31, "before_sha256": "3ece1e73f4e765db67a365e9dfc10283c421cf668c95c1247ce850eaccb9716e", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 22, "before_end": 24, "before_start": 22, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a7beeaaaebae15ec9b2689ac", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 293}
{"after": {"end": 6, "start": 0, "text": "Danska", "truncated": false}, "after_length": 6, "after_sha256": "99ab62517b3bb8298a9c40a2538a2769b0c2c8637a432d58e84bd537a117f8d4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a7c86af94823a33826c5489f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1794}
{"after": {"end": 21, "start": 0, "text": "Tlf.: +45 46 77 10 10", "truncated": false}, "after_length": 21, "after_sha256": "66cf81daaff5b98d25568a26e39568c1152e032702922190ca55773ed6810712", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tlf: +45 46 77 10 10", "truncated": false}, "before_length": 20, "before_sha256": "5ca1f3f0b7d8416ed7580c67d57829d1753a6533f0f8398906780d8735aed67e", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a819f22639de4d0fb9c26dfa", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1599}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: + 353 18711600", "truncated": false}, "before_length": 19, "before_sha256": "f39469e1bbd519f10406ae27e104b0e2fb101791df45c4e53cc539ee02b84821", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a86bf8c68ac55439681ae80d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4011}
{"after": {"end": 23, "start": 0, "text": "Medinfo.hungary@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "a92bd76e7f8465b69646a33e5e8846376b2ea19fe10f20ea413789237a8d815a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a87ea3212c4e116b38ace03e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2830}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Pfizer Service Company BV", "truncated": false}, "before_length": 25, "before_sha256": "6d0e726cfdc1afe8527891b46cdc3cc61a445bad75ceb250725385c322d4383d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a905f2a718ed98150a5a138b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3209}
{"after": {"end": 7, "start": 0, "text": "Sverige", "truncated": false}, "after_length": 7, "after_sha256": "3a7d70b4edb982a403e97d77681309e5fb1032b12d727aa1e92b145b069b9aa4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a920ae9eb4115c9b562337e7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2933}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "D-90429 Nuremberg", "truncated": false}, "before_length": 17, "before_sha256": "e947a9c523ae55d462208c17464751e497403938b7fe52dead7696ca6851269b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a92ea9fe26a071b9e170dd23", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3432}
{"after": {"end": 20, "start": 0, "text": "Swixx Biopharma EOOD", "truncated": false}, "after_length": 20, "after_sha256": "27f5284d414219f28c8c91886b89df13d6ef413ca05a03cdd596d9c697d6c0ea", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a93f0c1ca7568b1d1847d745", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2503}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 75, "start": 0, "text": "One ml solution contains 100 units of insulin lispro (equivalent to 3.5mg).", "truncated": false}, "before_length": 75, "before_sha256": "d45056525c174b2d13b93fffa7adca4d954d1856702e361c282a00031f17e769", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 75, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 75, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a9689d0d230dedea73ba3e77", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4694}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 87, "start": 0, "text": "To remove capsule: tear off one individual blister and push through the aluminium foil.", "truncated": false}, "before_length": 87, "before_sha256": "2bfaa47e64746703c820a8ec130bbd0105bebe166e8e2edb53a5cc23decb4e39", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 87, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 87, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a9789c3ecd0e06ef77879f98", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2306}
{"after": {"end": 32, "start": 0, "text": "BristolMyers Squibb spol. s r.o.", "truncated": false}, "after_length": 32, "after_sha256": "f17626bd52e917e0c6a35193744c7dbe6c722322ff29e81192cd072e33f2d41f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 32, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 32}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a97b5dfbea41165bde6a74dc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2823}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 81, "start": 0, "text": "– If you do not see insulin, repeat the priming steps, but not more than 4 times.", "truncated": false}, "before_length": 81, "before_sha256": "4f9d353323b761787379af1541bcc4c9f0980834e001699588f3f05ac942e509", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 81, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 81, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a98ee2e5aae4ae668de2d004", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9672}
{"after": {"end": 37, "start": 0, "text": "N.V. BristolMyers Squibb Belgium S.A.", "truncated": false}, "after_length": 37, "after_sha256": "feeebdb54667cd864ac3ce52dc07c49e265c3b042233fe6691e3f074fda776c2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a9a73b77049e514a569094a9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3167}
{"after": {"end": 15, "start": 0, "text": "Česká republika", "truncated": false}, "after_length": 15, "after_sha256": "c768c215f215c71e7ffcbffe06cb1a66fa3c379a86285d5da65cef3c627bc09d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-a9b260021e17a2376c8d7156", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3186}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 304, "start": 0, "text": "Niraparib is not a substrate of bile salt export pump (BSEP), or multidrug resistance-associated protein 2 (MRP2). The major primary metabolite M1 is not a substrate of Pgp, BCRP, BSEP, or MRP2. Niraparib is not a substrate of multidrug and toxin extrusion (MATE)-1 or 2, while M1 is a substrate of both.", "truncated": false}, "before_length": 304, "before_sha256": "429d9cdcc71934daac751187e7059f0aa2457c476abfe3cb404524a4443a66e3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 304, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 304, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aa1156ac028a82da366aa96b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 238}
{"after": {"end": 6, "start": 0, "text": "Danija", "truncated": false}, "after_length": 6, "after_sha256": "bc6a7343d3e198e003189dc965ded9d843ad23a091832eaa358b67171d90166d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aa34580a44cdb31bea1ef3c0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2046}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Tel: +44 (0) 2830 640 902", "truncated": false}, "before_length": 25, "before_sha256": "b88b96210695837bad06b797847554435ccbba7fa290892fcb6eb47dd56a6625", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aa56fcbf3f6d57c7e7ed3e98", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1686}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 7, "start": 0, "text": "Germany", "truncated": false}, "before_length": 7, "before_sha256": "80db4ccdca106d37b920206331fcfe3e9e50a9e763d89b54ce3ad5ac8cf30f03", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aa64553296c0b8208ebd64da", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1672}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aa844dd6b9d0f8df1a167790", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2904}
{"after": {"end": 22, "start": 0, "text": "medinfo.sweden@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "b564c1a351ab9a2c3f444753cdc78f0306131b829474e9874a876fc1a90d4b7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aa8def900d54e7ba4e55e4ac", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3301}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb A.E.", "truncated": false}, "after_length": 24, "after_sha256": "10b1fadbbe52c3072f4ba1903512a3a4f5cd6eb487bf016dde5246419ff972b0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aab3444e6d76922aa0c5f98c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2863}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 6, "start": 0, "text": "Polska", "truncated": false}, "before_length": 6, "before_sha256": "d1974e0e3e575b6dadb40f080dae05025f574cb23e5cababcac0f50cf2619549", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 6, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aadfb255511b06cf42bae0ed", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9509}
{"after": {"end": 20, "start": 0, "text": "Luxembourg/Luxemburg", "truncated": false}, "after_length": 20, "after_sha256": "28ac4fa3aba2dfb4b228bd072edb8cc818b04e6f4b87f37114caa6154e0e706b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ab35d35f9774731d0b441e35", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2507}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Solution for injection.", "truncated": false}, "before_length": 23, "before_sha256": "f96c7ce4de1e08aa045db6e55fef8c3a01b890a853a3ee8570ad1f9ba2ca6c55", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ab3fd8ed67f52d8735121f57", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4704}
{"after": {"end": 21, "start": 0, "text": "Tel: + 386 1 2355 100", "truncated": false}, "after_length": 21, "after_sha256": "dac6f0be4f23d749d801d499c013eab48028544c9f89af72365ef4fdc2e94efc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ab4abbc7572996040dd0aedd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2593}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 55, "start": 0, "text": "If seal is broken before first use, contact pharmacist.", "truncated": false}, "before_length": 55, "before_sha256": "e4b082e0ea1464322d7477fe94374a5412bfd6df5066e8ea45e2c2fc275f2f7d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 55, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 55, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ab4de1afa68b08d4702023b8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4661}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ab51a85d958db96f3d0dc301", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3269}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "D-90429 Nuremberg", "truncated": false}, "before_length": 17, "before_sha256": "e947a9c523ae55d462208c17464751e497403938b7fe52dead7696ca6851269b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ab59712c72b80abf55cebb40", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3824}
{"after": {"end": 6, "start": 0, "text": "France", "truncated": false}, "after_length": 6, "after_sha256": "7a1ca4ef7515f7276bae7230545829c27810c9d9e98ab2c06066bee6270d5153", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ab6b3b70a6a52c09edef75f5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3246}
{"after": {"end": 7, "start": 0, "text": "România", "truncated": false}, "after_length": 7, "after_sha256": "633e193d7e05828a893d02a6273755ed0d417cc14abf5ecfc2b6328c71ddcc7e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ab6dc50cfe8ea68ac7581473", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3258}
{"after": {"end": 33, "start": 0, "text": "medinfo.latvia@swixxbiopharma.com", "truncated": false}, "after_length": 33, "after_sha256": "c0a77882a6e33a348e9fb5e2a3006e8250b7d628f17c35efbaf3212a5e6e1c2d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aba0318c8e1315c2cfaf16e2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3306}
{"after": {"end": 27, "start": 0, "text": "CPO Pharmaceuticals Limited", "truncated": false}, "after_length": 27, "after_sha256": "94b644443752e2cb52916b23f8141fbd44c47055b3416af333e12ac18e101b87", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "GPA Pharmaceuticals Ltd", "truncated": false}, "before_length": 23, "before_sha256": "ece7127e303c91e9501d2cedd822476265aae86acb9f96ef1553ab3a6954afe1", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 21, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aba9ee9f4eef7ebbe34c9b57", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3027}
{"after": {"end": 129, "start": 0, "text": "Conditionnements : un conditionnement de 3 x 10 comprimés pelliculés et un conditionnement contenant 9 x 10 comprimés pelliculés.", "truncated": false}, "after_length": 129, "after_sha256": "f7d74e2d355eb5223099905336c2c38f36670cc468a8e2850ec538d18a22bc55", "annex": "I", "before": {"end": 145, "start": 0, "text": "Conditionnements : un conditionnement de 30 x 1 capsules molles et un conditionnement multiple contenant 90 (3 boîtes de 30 x 1) capsules molles.", "truncated": false}, "before_length": 145, "before_sha256": "e9257a999a0df29ae17700d1c87df1398fee3aa9d10088abfd8334d36edf65a7", "change_kind": "content", "change_operations": [{"after_end": 42, "after_start": 42, "before_end": 43, "before_start": 42, "kind": "delete"}, {"after_end": 47, "after_start": 46, "before_end": 47, "before_start": 47, "kind": "insert"}, {"after_end": 51, "after_start": 49, "before_end": 50, "before_start": 49, "kind": "replace"}, {"after_end": 56, "after_start": 52, "before_end": 51, "before_start": 51, "kind": "insert"}, {"after_end": 64, "after_start": 57, "before_end": 52, "before_start": 52, "kind": "insert"}, {"after_end": 67, "after_start": 66, "before_end": 62, "before_start": 54, "kind": "replace"}, {"after_end": 91, "after_start": 91, "before_end": 95, "before_start": 86, "kind": "delete"}, {"after_end": 102, "after_start": 102, "before_end": 123, "before_start": 106, "kind": "delete"}, {"after_end": 107, "after_start": 106, "before_end": 128, "before_start": 127, "kind": "replace"}, {"after_end": 111, "after_start": 109, "before_end": 131, "before_start": 130, "kind": "replace"}, {"after_end": 116, "after_start": 112, "before_end": 132, "before_start": 132, "kind": "insert"}, {"after_end": 124, "after_start": 117, "before_end": 133, "before_start": 133, "kind": "insert"}, {"after_end": 127, "after_start": 126, "before_end": 143, "before_start": 135, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 46, "chars_inserted": 30}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ac0b5ca2fe7559e0ed628674", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.5", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1940}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "Puh/Tel: + 358-(0) 9 85 45 250", "truncated": false}, "before_length": 30, "before_sha256": "eab151eaeee5922b122678a9b1271577b3208e64946502dad3e1f87396e36c67", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 30, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 30, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ac49bbedb7d76c2b8adc28aa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9548}
{"after": {"end": 49, "start": 0, "text": "BristolMyers Squibb Farmacêutica Portuguesa, S.A.", "truncated": false}, "after_length": 49, "after_sha256": "320289b9df354f466bcd06811a5bc06e5246b53241d28a0499699328d55fe681", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 49, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 49}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ac801fcdddb5600c058ce964", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2578}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Step 3:", "truncated": false}, "before_length": 7, "before_sha256": "4f47bbe8198b05880409b72ee6a9b26592d1b2380f286b2008b1622389a2587c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ac8fcc8fb4d8c0249103ad40", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9646}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 275, "start": 0, "text": "A few people who have had hypoglycaemia after switching from animal insulin to human insulin have reported that the early warning symptoms were less obvious or different. If you often have hypoglycaemia or have difficulty recognising it, please discuss this with your doctor.", "truncated": false}, "before_length": 275, "before_sha256": "a3119eea0609a22f06ce735eaef09fe76398017304f39e41e3e6f722035f9da9", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 275, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 275, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-acd470253fe5b4cb1f6af419", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9253}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 45 45 93 05 06", "truncated": false}, "after_length": 21, "after_sha256": "61983c14390c5d0df2153e10740a9b1eb429e8c0b05c3ebe705431c827a32b81", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-acdffe22211103001b279564", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2518}
{"after": {"end": 22, "start": 0, "text": "Tlf.: + 45 36 35 91 00", "truncated": false}, "after_length": 22, "after_sha256": "ee5cfc7acaf9dfe8868ac7e8cd8079d0cb8f85922089533a08d33e515be7aea6", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Tlf: + 45 36 35 91 00", "truncated": false}, "before_length": 21, "before_sha256": "18d8cf6a57f2048255a4474230a78ae1192c8bd63af3a4aa0c409cccfeafcba9", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aceba9f287075b6b3846cb4a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2453}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Austria", "truncated": false}, "before_length": 7, "before_sha256": "c9cab0238debc6e55498e2c0963a1d8e25bd29c95ddd53a3fff841ee636b6bc5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-acfda7bb631cbcd0ea3843f2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2440}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ad00215f2379419cc6803a69", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3168}
{"after": {"end": 13, "start": 0, "text": "1932 Zaventem", "truncated": false}, "after_length": 13, "after_sha256": "cffe4475a5de91da7a3a6363a4d41ccfd1405766d95ae182d89bf39b29686221", "annex": "II", "before": {"end": 13, "start": 0, "text": "1930 Zaventem", "truncated": false}, "before_length": 13, "before_sha256": "ed9ea9385e3e50f6278214da5d7483a8543c36d1261df263d35022c5936c74db", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 4, "before_start": 3, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ad36fc5ba4a1b976c39884ea", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1472}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ad9385404be067a0e67b5136", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2510}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "• not taking your Humalog or other insulin;", "truncated": false}, "before_length": 43, "before_sha256": "c28216101aeb5b39c0bb628b1fe60856fdeecc7628d1b0236b4928b01d4aa433", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ad9914d29404174223c2e3a4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9405}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 21, "start": 0, "text": "Macrogol 400 (E 1521)", "truncated": false}, "before_length": 21, "before_sha256": "e706c372cbe268a129abfe719a7a7498e83b3f218b4477352a0e8f6a8820f6f7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-adc6364a24cb7e2b906df3d6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1365}
{"after": {"end": 428, "start": 0, "text": "Les données d'efficacité de tafamidis 61 mg ne sont pas disponibles car cette formulation n'a pas été évaluée dans l'étude de phase III randomisée en double aveugle, contrôlée contre placebo. La biodisponibilité relative de tafamidis 61 mg est similaire à celle de tafamidis méglumine 80 mg à l'état d'équilibre (voir rubrique 5.2). La biodisponibilité relative du comprimé de 61 mg est similaire à celle de la capsule de 61 mg.", "truncated": false}, "after_length": 428, "after_sha256": "e82abfc333f5473a2e9d5c168374c5a32888178f396e68bb1012d2cfa6d8c122", "annex": "I", "before": {"end": 332, "start": 0, "text": "Les données d'efficacité de tafamidis 61 mg ne sont pas disponibles car cette formulation n'a pas été évaluée dans l'étude de phase III randomisée en double aveugle, contrôlée contre placebo. La biodisponibilité relative de tafamidis 61 mg est similaire à celle de tafamidis méglumine 80 mg à l'état d'équilibre (voir rubrique 5.2).", "truncated": false}, "before_length": 332, "before_sha256": "0a492216d413099af820feaeca02dc7a88ded5d970dca27a189f97fb39cafd2d", "change_kind": "content", "change_operations": [{"after_end": 428, "after_start": 332, "before_end": 332, "before_start": 332, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 96}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-adc7e9c3e40c0d393de79441", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1814}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 21, "start": 0, "text": "Povidone (K-value 90)", "truncated": false}, "before_length": 21, "before_sha256": "b11b2319d7a72d8a1b8a3f2599ba6b4ae2dcbb88662954210e043084abfc0e53", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-add3d80479b5db01dfe9ad22", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1367}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-adf135d7f91bf9aaa312ab4e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2555}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "Dose Indicator", "truncated": false}, "before_length": 14, "before_sha256": "0192badfbf8e8efb029509d5151fa34c76c38b55c3055a41fe3ccb54ca09ebab", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-adf32adf17fb1902fea4037f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9589}
{"after": {"end": 116, "start": 0, "text": "Si votre médecin vous a informé(e) d’une intolérance à certains sucres, contactez-le avant de prendre ce médicament.", "truncated": false}, "after_length": 116, "after_sha256": "9e78d1420567baf162d440fb9cb4f41ff125708f2ac43dd0aedc4e8f675d48be", "annex": "IIIA", "before": {"end": 108, "start": 0, "text": "Ce médicament ne contient pas plus de 44 mg de sorbitol par capsule. Le sorbitol est une source de fructose.", "truncated": false}, "before_length": 108, "before_sha256": "af83c892c2aac4f0995ca2a9c0f33d588f558d22d9fd4de530b30e974288782a", "change_kind": "content", "change_operations": [{"after_end": 103, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 115, "after_start": 115, "before_end": 107, "before_start": 13, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 95, "chars_inserted": 103}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ae18f6cdf7679d654dedf382", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3628}
{"after": {"end": 32, "start": 0, "text": "5. MODE ET VOIE D’ADMINISTRATION", "truncated": false}, "after_length": 32, "after_sha256": "bc33d9ee3a64cfa7a5fdcce95a03584999505e063543ab6e48cb29eed4742fdd", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "5. MODE ET VOIE(S) D’ADMINISTRATION", "truncated": false}, "before_length": 35, "before_sha256": "17ac57bd750cd275d807d869c838dbc4c562eeea8645350ff1655752eaa2921f", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 15, "before_end": 18, "before_start": 15, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ae20cdf4aeefb199e1f177c8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1024}
{"after": {"end": 7, "start": 0, "text": "Sverige", "truncated": false}, "after_length": 7, "after_sha256": "3a7d70b4edb982a403e97d77681309e5fb1032b12d727aa1e92b145b069b9aa4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ae2a5ca5d33c6485725e3799", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3301}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "Humalog Tempo Pen", "truncated": false}, "before_length": 17, "before_sha256": "328b8ad146aa9789b611fca56a42e321b79e5aecd24d0cc297eae30f99fae229", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ae448b2eec4b4a8fd0c791b1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4763}
{"after": {"end": 21, "start": 0, "text": "Tel: + 385 1 2078 500", "truncated": false}, "after_length": 21, "after_sha256": "d2c4badf1d52e4fa4d9876ca25a250b52d706e4108687e5034656c1b419f6ddc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ae7cdfc5ebd62cd047109cc0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2894}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 223, "start": 0, "text": "Niraparib did not exhibit inhibitory effect against the UGT isoforms (UGT1A1, UGT1A4, UGT1A9, and UGT2B7) up to 200 µM in vitro. Therefore, the potential for a clinically relevant inhibition of UGTs by niraparib is minimal.", "truncated": false}, "before_length": 223, "before_sha256": "85822242d0333c2d22a649b353f65d9e63864039bbe602d4bd040008880bd287", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 223, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 223, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ae875ebdab5e1dc2eb2a268a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1117}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 131, "start": 0, "text": "Taking into account the PRAC Assessment Report on the PSUR(s) for tadalafil, the scientific conclusions of the CHMP are as follows:", "truncated": false}, "before_length": 131, "before_sha256": "44d0f67d3f5d31ac5f6a61fb9b6acb6622819f49a674822d4b52c176c8cddd95", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 131, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 131, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ae91b1fc8df682342664af17", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3458}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "România", "truncated": false}, "before_length": 7, "before_sha256": "633e193d7e05828a893d02a6273755ed0d417cc14abf5ecfc2b6328c71ddcc7e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ae93d8ba4d225ef150b90e85", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9523}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 25, "start": 0, "text": "Tel: + 353-(0) 1 661 4377", "truncated": false}, "before_length": 25, "before_sha256": "48fde288146f4033a2172164570180a8f875f4e361fcf85a8e43ff77834511cc", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aea2f4aec1a42f0b4e2965a5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3169}
{"after": {"end": 62, "start": 0, "text": "Titulaire de l’Autorisation de mise sur le marché et fabricant", "truncated": false}, "after_length": 62, "after_sha256": "5eb30fa63ee39d5d0a9744c66dc0cac4f6a5cbcfe786b3057e9cfb022517a46f", "annex": "IIIA", "before": {"end": 49, "start": 0, "text": "Titulaire de l’Autorisation de mise sur le marché", "truncated": false}, "before_length": 49, "before_sha256": "e6862501ae974515f409229ac48889a881f5d48257cce71c9b21dd7551f5c918", "change_kind": "administrative", "change_operations": [{"after_end": 62, "after_start": 49, "before_end": 49, "before_start": 49, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aea41723c52ac6dfb07d1177", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2756}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 141, "start": 0, "text": "Ni le niraparib ni M1 n'inhibent les transporteurs d’anions organiques 1 (OAT1), 3 (OAT3), ou le transporteur de cations organiques 2 (OCT2).", "truncated": false}, "before_length": 141, "before_sha256": "c5358487d37c8934ce7fe8e5390cdc56c34a5b1f2af9234b8eb23b859af5113f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 141, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 141, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aea6220b57f950a53723b9fb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1171}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 38, "start": 0, "text": "7. OTHER SPECIAL WARNING, IF NECESSARY", "truncated": false}, "before_length": 38, "before_sha256": "e919358c9e0b9ff346b04639304671281eb70c785a813ad49fe510af23b56a9e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 38, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 38, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aec3b63e05e7a71b3917ca30", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4819}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 84, "start": 0, "text": "Niraparib as a substrate of hepatic uptake transporters (OATP1B1, OATP1B3, and OCT1)", "truncated": false}, "before_length": 84, "before_sha256": "ae8ceef2229c49d648160877d0eae34404352c95ab6a0d646e313b18edf48ee1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 84, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 84, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aeca9c2c31196f4a21a41995", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 240}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Charles de Giorgio Ltd.", "truncated": false}, "before_length": 23, "before_sha256": "f7a1850ea859a9a79f0ed724d315c08917cddf1691ff97d5cd57dcb8a99e4fb5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aecee8f6c5535d5ea41da336", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9482}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 65, "start": 0, "text": "The CHMP agrees with the scientific conclusions made by the PRAC.", "truncated": false}, "before_length": 65, "before_sha256": "94a1f6e67f2001f37ce96a58d2c36da690a2f85baa7ddba3921c28757ea2d985", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 65, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 65, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aed354718cdfedefaf90e090", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3462}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: + 353 18711600", "truncated": false}, "before_length": 19, "before_sha256": "f39469e1bbd519f10406ae27e104b0e2fb101791df45c4e53cc539ee02b84821", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aef6eb30ac11dc3e22e8c0bd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3040}
{"after": {"end": 15, "start": 0, "text": "3528 BD Utrecht", "truncated": false}, "after_length": 15, "after_sha256": "4ea402b0be2ffd43624e79f5ad9706ad796af820c845df2a7158d607c083d913", "annex": "III", "before": {"end": 15, "start": 0, "text": "3528 BJ Utrecht", "truncated": false}, "before_length": 15, "before_sha256": "c83d25e8ea65101ad8ea274a07e2114705ecd244e7a6dba61eb7b4d1ba592ecb", "change_kind": "unassigned", "change_operations": [{"after_end": 7, "after_start": 6, "before_end": 7, "before_start": 6, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aefa55f2b42f4309c6488fc7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2064}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb B.V.", "truncated": false}, "after_length": 24, "after_sha256": "8a52d28077ffdb6f185a0238531f595238f56634dd4dc98f89f75a288910ebf4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aefeab9d06677a37f1c6f4bd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2538}
{"after": {"end": 23, "start": 0, "text": "medinfo.romania@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "9ae697b67f3c854a077ca894d99400f1de79e31bd9bf61321fc7c4030bf8a213", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-aefef25caef95b09b47cb1a5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2896}
{"after": {"end": 15, "start": 0, "text": "The Netherlands", "truncated": false}, "after_length": 15, "after_sha256": "91729ff7107ee698fe168dc62d5b2020678fcfcf55b4ea9065982ce1d071ba31", "annex": "I", "before": {"end": 50, "start": 0, "text": "Papendorpseweg 83, 3528 BJ Utrecht The Netherlands", "truncated": false}, "before_length": 50, "before_sha256": "5d621ef45df9c1911e6b63f15edb513d80fad3ee63f11fe58a733f65b67cd3cd", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-af39bd7c7919ecbacb71b13b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 5 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1031}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Mylan IRE Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "35f93c261e1c23366cb104ad58005b2a5415120196df611fa95117f89eb960ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-af5cc13d79c5e4fe2ddae202", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3367}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-afab385b7f9b1e776738466b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2504}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Step 13:", "truncated": false}, "before_length": 8, "before_sha256": "1c5a75492ab7d1428285e8b9c6358db276fd64392d1e275531b256cb372760f3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-afc736d394328ba5d5aa8b8f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9773}
{"after": {"end": 15, "start": 0, "text": "EU/1/11/717/006", "truncated": false}, "after_length": 15, "after_sha256": "a08ed53f52d65c5f05bdcf27397724f7615d8003a675ade1f45fdf4bbba7c262", "annex": "I", "before": {"end": 15, "start": 0, "text": "EU/1/11/717/004", "truncated": false}, "before_length": 15, "before_sha256": "504bdd871418930e05e7d6ed3f63cd7189dd149e55fbc7ab999b12b6e6d54e4c", "change_kind": "administrative", "change_operations": [{"after_end": 15, "after_start": 14, "before_end": 15, "before_start": 14, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b0036d80f04fe51020fec6aa", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "8", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1960}
{"after": {"end": 7, "start": 0, "text": "Isomalt", "truncated": false}, "after_length": 7, "after_sha256": "9b5e5e9c1ee74dd3d0dacee863fbd31e5a4c7a8b9cbb411b37c80a4ec97c513d", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b02596d1db340bb038f28dee", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1891}
{"after": {"end": 40, "start": 0, "text": "Vyndaqel contient du lactose monohydraté", "truncated": false}, "after_length": 40, "after_sha256": "f535833a12c10b42582b4bae6c5017ead956dde8c84c122ab11d46d455d642fb", "annex": "IIIA", "before": {"end": 29, "start": 0, "text": "Vyndaqel contient du sorbitol", "truncated": false}, "before_length": 29, "before_sha256": "3aca6015b8f0cfe34b5a4dc93830c605c611177450a86f39baa87b7cdd0bd53a", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 21, "before_end": 26, "before_start": 21, "kind": "replace"}, {"after_end": 40, "after_start": 26, "before_end": 29, "before_start": 28, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 17}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b0430c71ebe5590231a87be5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3626}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 6, "start": 0, "text": "• Swab", "truncated": false}, "before_length": 6, "before_sha256": "769df15150b2b135497fa721f07f96247f3d815fe69b7d63e2d046043ad8efa7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 6, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b07c6fda1dd186d67be63685", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9626}
{"after": {"end": 298, "start": 0, "text": "Zejula peut influencer le fonctionnement d'autres médicaments. Il est particulièrement important que vous mentionniez tout médicament contenant la substance active, la metformine (utilisée pour réduire le taux de sucre dans le sang), car votre médecin pourrait devoir ajuster la dose de metformine.", "truncated": false}, "after_length": 298, "after_sha256": "c1826af2adacd7a1ce2f1d60bdfacacf264435166f694366dd85bf19e0e42431", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 298, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 298}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b09089f3ac708d7e8bf5138e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2688}
{"after": {"end": 6, "start": 0, "text": "Danska", "truncated": false}, "after_length": 6, "after_sha256": "99ab62517b3bb8298a9c40a2538a2769b0c2c8637a432d58e84bd537a117f8d4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b0b2c0ee81d9a233e3a19501", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2094}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 134, "start": 0, "text": "If you take less Humalog than you need or are unsure how much you have injected, a high blood sugar may occur. Check your blood sugar.", "truncated": false}, "before_length": 134, "before_sha256": "c89738c41f3d8083a1bcdc2dc6a7c5dd52b8cd7a6473cbe7b3b56c9b9be6108d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 134, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 134, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b0c7f8c3f8b2699ecdc9c2a1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9348}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 17, "start": 0, "text": "Glycérine (E 422)", "truncated": false}, "before_length": 17, "before_sha256": "15db2d37ee0824e89538635de23bcacb5f186a77e55e9db4144cab86a7bf0a3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b0e408a02d24ecaebd3eb98f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1898}
{"after": {"end": 23, "start": 0, "text": "medinfo.denmark@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "b9a121278c8c2cc6f9be9c7a9fab0d3dee3fadaac431fdd8d5efa352410f5389", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b1415cdb7d6e8ba638b55aaf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2525}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 65, "start": 0, "text": "If you have any further questions, ask your doctor or pharmacist.", "truncated": false}, "before_length": 65, "before_sha256": "ace0a8c0f7e47b49fb5399d67b8f9a6378429b4d7480b2c0739e1bb9139e1e69", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 65, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 65, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b142256ec9ec42b14fb61566", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9218}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 106, "start": 0, "text": "• Ask your healthcare professional about options to dispose of the pens and the sharps container properly.", "truncated": false}, "before_length": 106, "before_sha256": "df4e51caedb960d514c75eb661971b9baed23a16a9af3c2c9242c54972a66b95", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 106, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 106, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b145e7a020bb92a4de3807eb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9784}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 2, "start": 0, "text": "PC", "truncated": false}, "before_length": 2, "before_sha256": "21d017c40a91c15748f0b98cd826ba445d2d3fe227e310bfd58dcb6c431826a0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b18871c08e8a6a6f0470abe3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4773}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 494, "start": 0, "text": "The Tempo Pen is designed to work with the Tempo Smart Button. The Tempo Smart Button is an optional product that can be attached to the Tempo Pen dose knob and aids in transmitting Humalog dose information from the Tempo Pen to a compatible mobile application. The Tempo Pen injects insulin with or without the Tempo Smart Button attached. To transmit data to the mobile application, follow the instructions provided with the Tempo Smart Button and the instructions with the mobile application", "truncated": false}, "before_length": 494, "before_sha256": "2c881021babea38bbb1f27271ffd2697d3ce6c549aced3d65fe723ba598c8126", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 494, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 494, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b196d2b59e946db4b8f40a7f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.6", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 548}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "• feeling sleepy • no appetite", "truncated": false}, "before_length": 30, "before_sha256": "41954f665b63f1877ddbdb4debc21a4f3d3c197a43abd44fc67a1eedecb17888", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 30, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 30, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b1cec67eda81159719b5ad34", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9411}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 56, "start": 0, "text": "• You can give from 1 to 60 units in a single injection.", "truncated": false}, "before_length": 56, "before_sha256": "8405079a5570139a66979184f776a22a6654fd4580c7777a94505777c4b5cb3d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 56, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 56, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b252c1c82074e71ed2b8d938", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9682}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 12, "start": 0, "text": "County Kerry", "truncated": false}, "before_length": 12, "before_sha256": "eb7356a4494d39c472b712704605178f5a5ec97da0fc0b32f904fa38c0a2cdcc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b2629acd1d27e90735549c49", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1729}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b26a1e13d354ea98cfe7727d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2911}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 68, "start": 0, "text": "– Your needle may be blocked. Put on a new needle and prime the Pen.", "truncated": false}, "before_length": 68, "before_sha256": "76c34e8d0081b401672545197496ad5dde657b8eb822417ba67144c3cbd26ba0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 68, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 68, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b2ab8f0c7ddfae132fcd93f6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9804}
{"after": {"end": 25, "start": 0, "text": "82152 Martinsried/Planegg", "truncated": false}, "after_length": 25, "after_sha256": "1b4b3faa4a786e9ef580373ac19892e77a10c82d03848e97213c1099ad57fb08", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b2ba906dc5ca13ae065bf129", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1703}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b2ed8e0faef1040b54fbc342", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4018}
{"after": {"end": 119, "start": 0, "text": "For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:", "truncated": false}, "after_length": 119, "after_sha256": "96e8e519927e4ccd767c33018abc0bb77c29439563f16049ac8a6e6cef005737", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 119, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 119}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b2ef119eafe9c1bbf6e268fb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3161}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "Hafnerstraße 36", "truncated": false}, "before_length": 15, "before_sha256": "2fcce2f98396d52bbfd5728e1a018b4f5e6a7c25edffb18410df25f808883c4f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b310f5e28270a97c27611d5c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3163}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Mylan IRE Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "35f93c261e1c23366cb104ad58005b2a5415120196df611fa95117f89eb960ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b311024e09794bf25c3db4ab", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3039}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 37, "start": 0, "text": "Eli Lilly farmacevtska družba, d.o.o.", "truncated": false}, "before_length": 37, "before_sha256": "7941501a724d4206d17f04783736ebb3ec550dca9bc44c1ab4a0d0bd27c69729", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 37, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 37, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b32b62631805b5e78926ab49", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9531}
{"after": {"end": 26, "start": 0, "text": "3 x 10 film-coated tablets", "truncated": false}, "after_length": 26, "after_sha256": "c7aca0b267890176e167b8ab9a97d76022c692633690b451c18551364c5d6999", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "30 x 1 soft capsules", "truncated": false}, "before_length": 20, "before_sha256": "67f3125227f86a2a72e6b91a472dfe3658b97e6d425741a78e9bc54560833e1d", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 1, "before_end": 2, "before_start": 1, "kind": "delete"}, {"after_end": 6, "after_start": 5, "before_end": 6, "before_start": 6, "kind": "insert"}, {"after_end": 13, "after_start": 7, "before_end": 8, "before_start": 7, "kind": "replace"}, {"after_end": 15, "after_start": 14, "before_end": 10, "before_start": 9, "kind": "replace"}, {"after_end": 18, "after_start": 16, "before_end": 11, "before_start": 11, "kind": "insert"}, {"after_end": 20, "after_start": 19, "before_end": 13, "before_start": 12, "kind": "replace"}, {"after_end": 22, "after_start": 21, "before_end": 17, "before_start": 14, "kind": "replace"}, {"after_end": 25, "after_start": 24, "before_end": 19, "before_start": 19, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b337054ddfddf1eb0068009d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2298}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Storing your Pen", "truncated": false}, "before_length": 16, "before_sha256": "87c8a3089c16a4ce54901cc7b00a7dde288d1dcfaceb75af612736bd54bd51c1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b37f68041ea76193d1df884d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9786}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "15. INSTRUCTIONS ON USE", "truncated": false}, "before_length": 23, "before_sha256": "f8a07f0f5a6fad5f13ef5dcced3946c03a5890329dd08710b94d8c5258ad3e23", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b39ae95067ace5fa692a84f1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4758}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 78, "start": 0, "text": "– A drop of insulin at the needle tip is normal. It will not affect your dose.", "truncated": false}, "before_length": 78, "before_sha256": "d82537c1710c899660bdaa3ebb521a35dc2559e3507bd2e0fef501b05a48c5c2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 78, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 78, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b3c1c5a859896bd9e824a5bc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9758}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Portugal", "truncated": false}, "before_length": 8, "before_sha256": "4c7de2c3da6dc0ae8f9d13b107718a913859359bd30166d077c867577953865d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b3cababa7eb706d74a120bd6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9516}
{"after": {"end": 34, "start": 0, "text": "Vyndaqel 61 mg film-coated tablets", "truncated": false}, "after_length": 34, "after_sha256": "0ab1707af4a63192366906aad4f1c11a8821c9edf7f91b23f417bf90186d02d2", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Vyndaqel 61 mg soft capsules", "truncated": false}, "before_length": 28, "before_sha256": "49bdba5164eda37f05fe333e01328a0bed1d697f60d2a6f5cdbb879ef3b76026", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 15, "before_end": 16, "before_start": 15, "kind": "replace"}, {"after_end": 23, "after_start": 22, "before_end": 18, "before_start": 17, "kind": "replace"}, {"after_end": 26, "after_start": 24, "before_end": 19, "before_start": 19, "kind": "insert"}, {"after_end": 28, "after_start": 27, "before_end": 21, "before_start": 20, "kind": "replace"}, {"after_end": 30, "after_start": 29, "before_end": 25, "before_start": 22, "kind": "replace"}, {"after_end": 33, "after_start": 32, "before_end": 27, "before_start": 27, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b3d641fc45163b3d486cc0b8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3050}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovenia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "fce1e60bbc59ee3c381de461f412175da197c866a89ba45b24c7794f59b5c833", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b4029f353b35563faa987a4a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2910}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 364, "start": 0, "text": "Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible, if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).", "truncated": false}, "before_length": 364, "before_sha256": "648e48ca74272eb493f014ccadb5d7a33cd6c4b2a9e5328a868aecaef49ef4e0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 364, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 364, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b40fc1cc5b994a1eaceb6202", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9260}
{"after": {"end": 12, "start": 0, "text": "Magyarország", "truncated": false}, "after_length": 12, "after_sha256": "5206a7f7063a77a35861f95e022dafc37f3b3cf27ed423b1118e3fe580841b19", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b445e92a16174fd3956cf078", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2823}
{"after": {"end": 5, "start": 0, "text": "Eesti", "truncated": false}, "after_length": 5, "after_sha256": "ed7477d6100948d0d4e6b914d9769159823c21b23bf4846b1676338b9b439b72", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b4a6f57b3931b692de9ee45a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2536}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b4d539d5a0152ced5ce415c9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2137}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 232, "start": 0, "text": "In vitro, niraparib weakly inhibits the organic cation transporter 1 (OCT1) with an IC50 = 34.4 µM. Caution is recommended when niraparib is combined with active substances that undergo an uptake transport by OCT1 such as metformin.", "truncated": false}, "before_length": 232, "before_sha256": "c300a256f55d940a469ab088f2a01f49c2d496184068ea5273335a0bd9c84e51", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 232, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 232, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b4ed2caaf04f795e5a76d1c7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1134}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "Keep out of the sight and reach of children", "truncated": false}, "before_length": 43, "before_sha256": "034982a6fd4368f93bb56faf8a1eeaa94e38c9c9c5e4ffcc97d89ccfdbbe07fb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b4eed887705b27a4c36dff61", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4816}
{"after": {"end": 47, "start": 0, "text": "Marketing Authorisation Holder and Manufacturer", "truncated": false}, "after_length": 47, "after_sha256": "4542f9bb3095abea29e124e5e4ba8ada603cefe01cb57b9ddc98b99054dc2887", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "Marketing Authorisation Holder", "truncated": false}, "before_length": 30, "before_sha256": "49b1d8044839391ca09e6bef9f9460184c586c4da018732ac3a7e596cf20e965", "change_kind": "administrative", "change_operations": [{"after_end": 47, "after_start": 30, "before_end": 30, "before_start": 30, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 17}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b4f7741ab00f8f53b6728c40", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3115}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b508d2d0bb13811fa8789555", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2597}
{"after": {"end": 79, "start": 0, "text": "The recommended dose is one Vyndaqel 61 mg (tafamidis) tablet taken once a day.", "truncated": false}, "after_length": 79, "after_sha256": "9ecb368e9b8c6efbb642ec0a8f65360a7d3feebb294efd7d2bae02e75928397f", "annex": "IIIA", "before": {"end": 80, "start": 0, "text": "The recommended dose is one Vyndaqel 61 mg (tafamidis) capsule taken once a day.", "truncated": false}, "before_length": 80, "before_sha256": "de5adc79a9f493cc808a7c994ac2e7a2fe722bf0b460a35b432d5f7a769f60a0", "change_kind": "content", "change_operations": [{"after_end": 56, "after_start": 55, "before_end": 56, "before_start": 55, "kind": "replace"}, {"after_end": 58, "after_start": 57, "before_end": 60, "before_start": 57, "kind": "replace"}, {"after_end": 61, "after_start": 60, "before_end": 62, "before_start": 62, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b516d8894633de74db7d2693", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3131}
{"after": {"end": 320, "start": 0, "text": "Co-administration of tafamidis with substrates of the breast cancer resistant protein (BCRP) may increase exposure to the BCRP substrate. In case of co-administration, patients should be monitored for BCRP substrate related adverse reactions, and dose reduction of the BCRP substrate may be considered (see section 4.5).", "truncated": false}, "after_length": 320, "after_sha256": "15eaa44eb8cfd4e6b10899b3dac5c7dd99ecfc0a615c915b464cf3a63f5aa864", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 320, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 320}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b551193b7828fb36f9237a79", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 999}
{"after": {"end": 142, "start": 0, "text": "You should not take more tablets than your doctor tells you to. If you take more tablets than you have been told to take, contact your doctor.", "truncated": false}, "after_length": 142, "after_sha256": "5be4e350cacc2ca8e3f063d0426bc5faf97a2a677b0209ce4935e1acba471704", "annex": "IIIA", "before": {"end": 144, "start": 0, "text": "You should not take more capsules than your doctor tells you to. If you take more capsules than you have been told to take, contact your doctor.", "truncated": false}, "before_length": 144, "before_sha256": "b63ec73cff3f13d8ded8f52990ea7d5e4791e98b7eb1bb9a8b52cbb3ffdbbd85", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 25, "before_end": 26, "before_start": 25, "kind": "replace"}, {"after_end": 28, "after_start": 27, "before_end": 30, "before_start": 27, "kind": "replace"}, {"after_end": 31, "after_start": 30, "before_end": 32, "before_start": 32, "kind": "insert"}, {"after_end": 82, "after_start": 81, "before_end": 83, "before_start": 82, "kind": "replace"}, {"after_end": 84, "after_start": 83, "before_end": 87, "before_start": 84, "kind": "replace"}, {"after_end": 87, "after_start": 86, "before_end": 89, "before_start": 89, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b57a18dee1d8ae75919be6fb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3148}
{"after": {"end": 17, "start": 0, "text": "0.4 (-10.8, 11.6)", "truncated": false}, "after_length": 17, "after_sha256": "b1a2b47bf56b988ab90951a1198d52e36fbe819027790bdceb089c427c13f50d", "annex": "I", "before": {"end": 16, "start": 0, "text": "2.4 (-9.7, 14.4)", "truncated": false}, "before_length": 16, "before_sha256": "f3b4139a21e978a271bd9cf1d9fc960c1216e824703d53ed5c2cd3e573c7185d", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 8, "after_start": 6, "before_end": 7, "before_start": 6, "kind": "replace"}, {"after_end": 10, "after_start": 9, "before_end": 9, "before_start": 8, "kind": "replace"}, {"after_end": 14, "after_start": 13, "before_end": 13, "before_start": 12, "kind": "replace"}, {"after_end": 16, "after_start": 15, "before_end": 15, "before_start": 14, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b59163de64c37abb9638d0f8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 312}
{"after": {"end": 26, "start": 0, "text": "79108 Freiburg Im Breisgau", "truncated": false}, "after_length": 26, "after_sha256": "36aa85132e620e5dadf560baf495a4070b1cda958d67c2e643770ef4ac19a172", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b5951618a2e763cd2ca14324", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1495}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 44, "start": 0, "text": "Keep out of the sight and reach of children.", "truncated": false}, "before_length": 44, "before_sha256": "77d4932f12dcf39f8aadf34b35b6d27ac2c4d8ef32c24993dd4f241b38acbbee", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 44, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 44, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b59dac2667aa823d7ba68db1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9427}
{"after": {"end": 341, "start": 0, "text": "Après une dose orale unique de 300 mg de niraparib, la demi-vie terminale moyenne (t½) du niraparib était comprise entre 44 et 54 heures (environ 2 jours) selon les études. Dans une analyse pharmacocinétique de population, la clairance totale apparente (CL/F) du niraparib était de 15,9 L/h chez les patientes atteintes de cancer (CV 24,0%).", "truncated": false}, "after_length": 341, "after_sha256": "4e6f520db62d21af9c2b61d02e3e43d3cf23d7d791727208be397f072d96de0e", "annex": "I", "before": {"end": 324, "start": 0, "text": "Après une dose orale unique de 300 mg de niraparib, la demi-vie terminale moyenne (t½) du niraparib était comprise entre 48 et 51 heures (environ 2 jours). Dans une analyse pharmacocinétique de population, la clairance totale apparente (CL/F) du niraparib était de 16,5 L/h chez les patientes atteintes de cancer (CV 23,4%).", "truncated": false}, "before_length": 324, "before_sha256": "1707f42e4e2e91305ba2e767c1067d1352e343641ff6e360cc022edf6f68496d", "change_kind": "content", "change_operations": [{"after_end": 123, "after_start": 122, "before_end": 123, "before_start": 122, "kind": "replace"}, {"after_end": 129, "after_start": 128, "before_end": 129, "before_start": 128, "kind": "replace"}, {"after_end": 171, "after_start": 154, "before_end": 154, "before_start": 154, "kind": "insert"}, {"after_end": 284, "after_start": 283, "before_end": 267, "before_start": 266, "kind": "replace"}, {"after_end": 286, "after_start": 285, "before_end": 269, "before_start": 268, "kind": "replace"}, {"after_end": 336, "after_start": 335, "before_end": 319, "before_start": 318, "kind": "replace"}, {"after_end": 338, "after_start": 337, "before_end": 321, "before_start": 320, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b5b724584efa1d764db4e271", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 797}
{"after": {"end": 18, "start": 0, "text": "0,4 (-10,8 ; 11,6)", "truncated": false}, "after_length": 18, "after_sha256": "7ef624854ab4694271527aeaa2acc693eea212b60c644f6dac1c8c2ef6403621", "annex": "I", "before": {"end": 16, "start": 0, "text": "2,4 (9,7 ; 14,4)", "truncated": false}, "before_length": 16, "before_sha256": "a4a3bad18215c5d6c6482db6d7fb28415d3bb38e69a06b4efdee232d1c80200a", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 8, "after_start": 5, "before_end": 6, "before_start": 5, "kind": "replace"}, {"after_end": 10, "after_start": 9, "before_end": 8, "before_start": 7, "kind": "replace"}, {"after_end": 15, "after_start": 14, "before_end": 13, "before_start": 12, "kind": "replace"}, {"after_end": 17, "after_start": 16, "before_end": 15, "before_start": 14, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b63e55816cba5d62bab5e587", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 318}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 90, "start": 0, "text": "The plunger only moves a little with each injection, and you may not notice that it moves.", "truncated": false}, "before_length": 90, "before_sha256": "78338e72e29b6bece0f3b6c2befd0659bd26a55c886f67e4082c52c317f1bd3d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 90, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 90, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b63e5c274caae05fa3fe0a94", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9764}
{"after": {"end": 149, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments https://www.ema.europa.eu.", "truncated": false}, "after_length": 149, "after_sha256": "0e6b9f35caaf0258b468a6e9a53665f0ec5536787f68eefee5f242bf64add02e", "annex": "I", "before": {"end": 149, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments http://www.ema.europa.eu/.", "truncated": false}, "before_length": 149, "before_sha256": "16e6f5615757ceabad4641121cdcfa0a0ce3e97da03a8f65c0b7b47a6899d4ba", "change_kind": "technical", "change_operations": [{"after_end": 128, "after_start": 127, "before_end": 127, "before_start": 127, "kind": "insert"}, {"after_end": 148, "after_start": 148, "before_end": 148, "before_start": 147, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b645323833ddcbbe4e61a392", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 5 mg comprimés pelliculés", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1080}
{"after": {"end": 45, "start": 0, "text": "BristolMyers Squibb Marketing Services S.R.L.", "truncated": false}, "after_length": 45, "after_sha256": "be5fd3873d4974ef82d9deb306b94597f94cda5438931529a5b099349d1f12da", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 45, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 45}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b64765f4d64f3afb4b06cf5d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2898}
{"after": {"end": 34, "start": 0, "text": "Vyndaqel 61 mg film-coated tablets", "truncated": false}, "after_length": 34, "after_sha256": "0ab1707af4a63192366906aad4f1c11a8821c9edf7f91b23f417bf90186d02d2", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Vyndaqel 61 mg soft capsules", "truncated": false}, "before_length": 28, "before_sha256": "49bdba5164eda37f05fe333e01328a0bed1d697f60d2a6f5cdbb879ef3b76026", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 15, "before_end": 16, "before_start": 15, "kind": "replace"}, {"after_end": 23, "after_start": 22, "before_end": 18, "before_start": 17, "kind": "replace"}, {"after_end": 26, "after_start": 24, "before_end": 19, "before_start": 19, "kind": "insert"}, {"after_end": 28, "after_start": 27, "before_end": 21, "before_start": 20, "kind": "replace"}, {"after_end": 30, "after_start": 29, "before_end": 25, "before_start": 22, "kind": "replace"}, {"after_end": 33, "after_start": 32, "before_end": 27, "before_start": 27, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b64db86606e6997276ea5f6f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2386}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 2, "start": 0, "text": "Or", "truncated": false}, "before_length": 2, "before_sha256": "0568bd03b8eb6cca2799770a3cb2b2d342e9ae7a8032e8aac7b948341807d7c4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b6670953db805e77b867fb69", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3214}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 16, "start": 0, "text": "Alcool éthylique", "truncated": false}, "before_length": 16, "before_sha256": "b5f4016f11e32df7062112a3da9e6203a99a0f27f6f315a3281b5a115e4cb5e5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b67bc2d4bb705be3031b9435", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1914}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Germany", "truncated": false}, "before_length": 7, "before_sha256": "80db4ccdca106d37b920206331fcfe3e9e50a9e763d89b54ce3ad5ac8cf30f03", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b6bd039c7ac27683817e7e89", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3433}
{"after": {"end": 37, "start": 0, "text": "Pfizer Manufacturing Deutschland GmbH", "truncated": false}, "after_length": 37, "after_sha256": "05eb44563bffe7fe97a2f09d11f944fd95fd6f2dc741d803023bdfefb6a52439", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b6e65ce75e199415fe1d60cc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1493}
{"after": {"end": 16, "start": 0, "text": "pv@ammangion.com", "truncated": false}, "after_length": 16, "after_sha256": "53f45568239cbb258daee24319c4e0fde3bfc6917d09b88019c1cb8329ded177", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b75b8f3886bcba269ef02c60", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3201}
{"after": {"end": 19, "start": 0, "text": "ne aiguille de 25G.", "truncated": false}, "after_length": 19, "after_sha256": "5474415452fa0a5387436c651699fa9d9fbdfa48e3b8368bb2c86b6d3cc857e2", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Une aiguille de 25G", "truncated": false}, "before_length": 19, "before_sha256": "a72ea50316cd8ca6de9da562a4d9e01fb686b78f9e38e0c1d5ee62a4fb020434", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "delete"}, {"after_end": 19, "after_start": 18, "before_end": 19, "before_start": 19, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b7856603bf99c6934ee22277", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 824}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b78bb3b2c5e7620073081648", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2546}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Step 6:", "truncated": false}, "before_length": 7, "before_sha256": "7fdd1c091a9943008899e67dd1d806f3b96a3cc1d648eb05fd26638c1060d517", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b7e2a86ef9b670917efe2bf7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9666}
{"after": {"end": 20, "start": 0, "text": "Viatris Germany GmbH", "truncated": false}, "after_length": 20, "after_sha256": "4c2f2a211c5c41870eee98c700979da5e888736aac1a795ab787143446de83ca", "annex": "II", "before": {"end": 18, "start": 0, "text": "Mylan Germany GmbH", "truncated": false}, "before_length": 18, "before_sha256": "d7a3f7e30e2672617d153ba93a8cf1c2908da6e7dcfe6d206314ed71d4e5405a", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "replace"}, {"after_end": 7, "after_start": 3, "before_end": 5, "before_start": 4, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b7f9aed9701c631cf96797c4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005403", "medicine_name": "Sugammadex Mylan", "medicine_slug": "sugammadex-mylan", "observed_at": "2026-10-12T13:36:03Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "3d1f09d9bcfb1d2bba4f610b61ad692a3a78dc1ae2800f83497a954f8545d5a0", "source_snapshot_id": "source-ccd6e4297624ea024166e969", "source_updated_at": "2026-06-12", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/sugammadex-mylan-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 896}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Tel: + 44 (0)800 221441", "truncated": false}, "before_length": 23, "before_sha256": "61482b81443a3ca39c7759aba2468d8a55e72bb438cb673a32ba3b1dac130262", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b7fba74fb956c115f0e94dd4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2548}
{"after": {"end": 26, "start": 0, "text": "Tél: + 33 (0)1 58 83 84 96", "truncated": false}, "after_length": 26, "after_sha256": "331bde6d3ceed373ca2a62d0d499d6fe72853e6ae69fb08f092c7712a9ad1d3e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b7fc5232af6b5b935ae31688", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2880}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "GlaxoSmithKline (Ireland) Limited", "truncated": false}, "before_length": 33, "before_sha256": "aab443afe73fcfeb3384251d62635faa955ab6ace3c6efeb3f1cf79dfb706da8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b80ad57f423dad5078ce61e4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3015}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma s.r.o.", "truncated": false}, "after_length": 22, "after_sha256": "e26ccdddfb0893074547931bd19474d6541a45958e27c35b776e8f18abf48a36", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b81ecde016509d7da293515f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2602}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 128, "start": 0, "text": "If you use less Humalog than you need, a high blood sugar may occur. Do not change your insulin unless your doctor tells you to.", "truncated": false}, "before_length": 128, "before_sha256": "ffa7500fe7d91ec5f013bc3703f84d7f58c0dd5038a9da0b5ca0d472efee74cd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 128, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 128, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b8432d293a34f26cc63373db", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9358}
{"after": {"end": 11, "start": 0, "text": "Deutschland", "truncated": false}, "after_length": 11, "after_sha256": "af6e56aacd8097c3fb7597b08ecb3d87a040f6ab58067a4b8ff9f5b747adb9be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b849e773885fa65651b57efa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2526}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 27, "start": 0, "text": "Polyvinyl acetate phthalate", "truncated": false}, "before_length": 27, "before_sha256": "b491118fca56545124c5e4ae964c22b59375f814107f731e8988cf9ad7653a65", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b891facf90816cd30bff7dcc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1376}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 20, "start": 0, "text": "Novartis Pharma GmbH", "truncated": false}, "before_length": 20, "before_sha256": "bae642239c19e15ed2be9a6c4c5123c7ef0f4e0a79a5ece5f8c2cf22e6047d3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b89bf92ce3d864ddd5989bf1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1698}
{"after": {"end": 43, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht Pays-Bas", "truncated": false}, "after_length": 43, "after_sha256": "5ad64eea087c05f92e591c89db00e99e8b23fd93d759d787c9fa4ac6829e7502", "annex": "III", "before": {"end": 43, "start": 0, "text": "Papendorpseweg 83, 3528 BJ Utrecht Pays-Bas", "truncated": false}, "before_length": 43, "before_sha256": "2ff8bcc9830507f63dba8a77d1aaeef88302446a200f1fe6ecefbad29b5ae46f", "change_kind": "unassigned", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}, {"after_end": 26, "after_start": 25, "before_end": 26, "before_start": 25, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b8c1fc4aa86dd919a8decaad", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1796}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "Block 7, City North Business Campus", "truncated": false}, "before_length": 35, "before_sha256": "60bfb84fd0a0344daf8d2ba906704ff97de4b5b33f66d72a6caa0462690c35f7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b8e292180369bd01cb94a920", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3720}
{"after": {"end": 6, "start": 0, "text": "Danska", "truncated": false}, "after_length": 6, "after_sha256": "99ab62517b3bb8298a9c40a2538a2769b0c2c8637a432d58e84bd537a117f8d4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b9458316158bc7f1ada9942b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2131}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 237, "start": 0, "text": "Le niraparib n’a pas montré d’effet inhibiteur sur les isoformes UGT (UGT1A1, UGT1A4, UGT1A9, et UGT2B7) jusqu’à 200 µM in vitro. Par conséquent, le potentiel d’une inhibition cliniquement pertinente des UGTs par le niraparib est minime.", "truncated": false}, "before_length": 237, "before_sha256": "c2857c82815bea6c36ecb1c43ea95de23cd0b692b565463efc801e80cb030364", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 237, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 237, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b95ec7ceecb86f9f992314ae", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1151}
{"after": {"end": 151, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l'Agence européenne des médicaments: https://www.ema.europa.eu/.", "truncated": false}, "after_length": 151, "after_sha256": "0fdb18f76e0fc0d499c19c313b4318a5fdaec05bbf5bab070f378778b614c3ec", "annex": "I", "before": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l'Agence européenne des médicaments: http://www.ema.europa.eu/.", "truncated": false}, "before_length": 150, "before_sha256": "5e4b7520fc746fefd50ec6df0c7b84c6e86b417666dc139878d8cfc9b8fd251f", "change_kind": "technical", "change_operations": [{"after_end": 129, "after_start": 128, "before_end": 128, "before_start": 128, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b9728f254628834f54eacf12", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1840}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "18. UNIQUE IDENTIFIER - HUMAN READABLE DATA", "truncated": false}, "before_length": 43, "before_sha256": "f53a050d196b2672592e40916a0229bf083d27961b6b2f41758dcee0da55378d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b97c6664d0aa5945b63c943e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4673}
{"after": {"end": 6, "start": 0, "text": "Danska", "truncated": false}, "after_length": 6, "after_sha256": "99ab62517b3bb8298a9c40a2538a2769b0c2c8637a432d58e84bd537a117f8d4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b992bfbb999e606c9bc47171", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1831}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Tel: + 353-(0) 1 661 4377", "truncated": false}, "before_length": 25, "before_sha256": "48fde288146f4033a2172164570180a8f875f4e361fcf85a8e43ff77834511cc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b9b3007c19cd8bb496df13d7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9528}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 38, "start": 0, "text": "7. OTHER SPECIAL WARNING, IF NECESSARY", "truncated": false}, "before_length": 38, "before_sha256": "e919358c9e0b9ff346b04639304671281eb70c785a813ad49fe510af23b56a9e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 38, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 38, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b9c5843833682aca681d95d7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4621}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 88, "start": 0, "text": "(Example: 25 units shown in the dose window)(Example: 25 units shown in the dose window)", "truncated": false}, "before_length": 88, "before_sha256": "6f934bdcf5add4aaf48af2329d7555b7cd3e1f3876f10bdea02aacc16d482c3c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 88, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b9c5edb8229dfaca6eaf4283", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9717}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 29, "start": 0, "text": "9. SPECIAL STORAGE CONDITIONS", "truncated": false}, "before_length": 29, "before_sha256": "1c7900d8ae1746afe2ef2b4a26d399b6054dc430f41e340e45f1f881197f01b2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 29, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 29, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b9c77853595bef2e1d28e05d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4728}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 498, "start": 0, "text": "In view of available data on serous central chorioretinopathy from the literature and spontaneous reports including in some cases a close temporal relationship, a positive de-challenge and/or re-challenge and in view of a plausible mechanism of action, the PRAC considers a causal relationship between tadalafil and central serous chorioretinopathy is at least a reasonable possibility. The PRAC concluded that the product information of products containing tadalafil should be amended accordingly.", "truncated": false}, "before_length": 498, "before_sha256": "2252b3ae85b870c15ba61b458a98bb06a1e532022230452527c58b862ea95ac2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 498, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 498, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b9cc3760734e4deb0b717604", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3460}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 458, "start": 0, "text": "Even though inhibition of CYP3A4 in the liver is not expected, the potential to inhibit CYP3A4 at the intestinal level has not been established at relevant niraparib concentrations. Therefore, caution is recommended when niraparib is combined with active substances the metabolism of which is CYP3A4dependent and, notably, those having a narrow therapeutic range (e.g. ciclosporin, tacrolimus, alfentanil, ergotamine, pimozide, quetiapine, and halofantrine).", "truncated": false}, "before_length": 458, "before_sha256": "2bad0da07584e0408ccab09e2cb1988d6e4081ead9f5c9e5b97ce829403c448f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 458, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 458, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-b9d63e168277bf19c6ba1d20", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 251}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Germany", "truncated": false}, "before_length": 7, "before_sha256": "80db4ccdca106d37b920206331fcfe3e9e50a9e763d89b54ce3ad5ac8cf30f03", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ba3101947b7e104e69d05cc5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3825}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 26, "start": 0, "text": "16. INFORMATION IN BRAILLE", "truncated": false}, "before_length": 26, "before_sha256": "c69cdeadf8c5d34e36f9bf5d6949c41517313f63407e7b6ac6908bbe7ad76cfd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 26, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 26, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ba44eab0fd56c33cd32bd848", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4761}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ba9f915419b5ea55647e23e6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2801}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Subcutaneous use", "truncated": false}, "before_length": 16, "before_sha256": "363fd22613abec178143cdac0b1a34f04ee8ccdaa7d6988b3722fa7540374cde", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bafa1fc1cf56188fc895b73c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4811}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 47 67 55 53 50", "truncated": false}, "after_length": 21, "after_sha256": "d1b594f6660af0e3776951e66e526813a270ea883650a47e68423146b1d67dd7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bb0cf2d6cfae637afab9a965", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2859}
{"after": {"end": 27, "start": 0, "text": "CPO Pharmaceuticals Limited", "truncated": false}, "after_length": 27, "after_sha256": "94b644443752e2cb52916b23f8141fbd44c47055b3416af333e12ac18e101b87", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "GPA Pharmaceuticals Ltd", "truncated": false}, "before_length": 23, "before_sha256": "ece7127e303c91e9501d2cedd822476265aae86acb9f96ef1553ab3a6954afe1", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 21, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bb21ccce39c392e2b9e25019", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3341}
{"after": {"end": 39, "start": 0, "text": "Push tablet through the aluminium foil.", "truncated": false}, "after_length": 39, "after_sha256": "8240c731a8b2501a24a7042fd07a6370447c500c0430a2185c64110615c9da5e", "annex": "IIIA", "before": {"end": 40, "start": 0, "text": "Push capsule through the aluminium foil.", "truncated": false}, "before_length": 40, "before_sha256": "8ba9a49790900c02d8a4655115055a8fadbfd6882ee22fa830ada10db0f0bbe0", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 5, "before_end": 6, "before_start": 5, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 10, "before_start": 7, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 12, "before_start": 12, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bb5bae9c67e371efa6867545", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3144}
{"after": {"end": 19, "start": 0, "text": "Tel: + 356 23976333", "truncated": false}, "after_length": 19, "after_sha256": "f8bfa43651e282e3e99ee42fa339e414e57dea721306efb985d46dcd3b4656c4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bb8b6e3e5d4723edf4089355", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3203}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 75, "start": 0, "text": "One ml solution contains 100 units of insulin lispro (equivalent to 3.5mg).", "truncated": false}, "before_length": 75, "before_sha256": "d45056525c174b2d13b93fffa7adca4d954d1856702e361c282a00031f17e769", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 75, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 75, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bc06e8bf66131382214614a3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4595}
{"after": {"end": 21, "start": 0, "text": "Tel: + 386 1 2355 100", "truncated": false}, "after_length": 21, "after_sha256": "dac6f0be4f23d749d801d499c013eab48028544c9f89af72365ef4fdc2e94efc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bc2ba999c78a97929a0c3317", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2905}
{"after": {"end": 7, "start": 0, "text": "Germany", "truncated": false}, "after_length": 7, "after_sha256": "80db4ccdca106d37b920206331fcfe3e9e50a9e763d89b54ce3ad5ac8cf30f03", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bc37b7d9a1228f34317570fa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1496}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 141, "start": 0, "text": "Ni le niraparib ni M1 n'inhibent les transporteurs d’anions organiques 1 (OAT1), 3 (OAT3), ou le transporteur de cations organiques 2 (OCT2).", "truncated": false}, "before_length": 141, "before_sha256": "c5358487d37c8934ce7fe8e5390cdc56c34a5b1f2af9234b8eb23b859af5113f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 141, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 141, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bc415edf7baa2cb4af121a63", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 283}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 52, "start": 0, "text": "Niraparib as a substrate of CYPs (CYP1A2 and CYP3A4)", "truncated": false}, "before_length": 52, "before_sha256": "50bf48c4524b451355f2f57145fac01e84ee2fd05c93837310996800019bff63", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 52, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 52, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bc52493441d4f5ac6b2126ac", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 232}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bc582e433fda9d53960edaa3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2922}
{"after": {"end": 23, "start": 0, "text": "Tel: + 351 21 440 70 00", "truncated": false}, "after_length": 23, "after_sha256": "051a50965400ccbc97e96d9606564d6ef751251b31d5cd81aa4f430414a32099", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bc62efd8c0369c115d981850", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2573}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bc79f04542a20ad700cbcfc3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2599}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 16, "start": 0, "text": "Capsule contents", "truncated": false}, "before_length": 16, "before_sha256": "1afb64cac8536dac94f0d87825d6f167f6f00d1e39c2717b71b45d686439c904", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bc822f2b76b2e6047d0863d1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1363}
{"after": {"end": 11, "start": 0, "text": "Deutschland", "truncated": false}, "after_length": 11, "after_sha256": "af6e56aacd8097c3fb7597b08ecb3d87a040f6ab58067a4b8ff9f5b747adb9be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bc95989f28f2364fffce683a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2838}
{"after": {"end": 22, "start": 0, "text": "medinfo.sweden@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "b564c1a351ab9a2c3f444753cdc78f0306131b829474e9874a876fc1a90d4b7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bca8b75054b8ba166abb45f4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3304}
{"after": {"end": 36, "start": 0, "text": "Vyndaqel 61 mg, comprimés pelliculés", "truncated": false}, "after_length": 36, "after_sha256": "70d3e9c94874ff78e6ff1e940cdf64cbf06bd8e778cf4abb4c78ce4ca876c4cb", "annex": "I", "before": {"end": 31, "start": 0, "text": "Vyndaqel 61 mg, capsules molles", "truncated": false}, "before_length": 31, "before_sha256": "d2f9e9daee0a55f7e5e88fddbba4b5456460e01edb642a0357e0b087ef8086af", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 17, "before_end": 18, "before_start": 17, "kind": "replace"}, {"after_end": 24, "after_start": 20, "before_end": 19, "before_start": 19, "kind": "insert"}, {"after_end": 32, "after_start": 25, "before_end": 20, "before_start": 20, "kind": "insert"}, {"after_end": 35, "after_start": 34, "before_end": 30, "before_start": 22, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bcb2b58b8216d483b46c6589", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1202}
{"after": {"end": 419, "start": 0, "text": "In vitro, le niraparib est un inhibiteur de la BCRP. Une interaction cliniquement significative avec les substrats de la BCRP ne peut être exclue. Il est donc recommandé de faire preuve de prudence lorsque le niraparib est associé à des substrats de la BCRP (par exemple, l'irinotécan, la rosuvastatine, la simvastatine, l'atorvastatine et le méthotrexate) en raison du risque d'augmentation de l'exposition systémique.", "truncated": false}, "after_length": 419, "after_sha256": "39e9cc8e68693438f616bc2523b125cc3954fc50a386c73d855becee50c9a7eb", "annex": "I", "before": {"end": 199, "start": 0, "text": "Par conséquent, la prudence est recommandée lorsque le niraparib est administré en concomitance avec des substrats de la BCRP (irinotécan, rosuvastatine, simvastatine, atorvastatine et méthotrexate).", "truncated": false}, "before_length": 199, "before_sha256": "40f2ced5faf5cb8768105f50432ee516fcebc7e58aa90ba8d48424a9b45b8aec", "change_kind": "content", "change_operations": [{"after_end": 18, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 22, "after_start": 20, "before_end": 3, "before_start": 3, "kind": "insert"}, {"after_end": 28, "after_start": 23, "before_end": 6, "before_start": 4, "kind": "replace"}, {"after_end": 38, "after_start": 29, "before_end": 10, "before_start": 7, "kind": "replace"}, {"after_end": 42, "after_start": 39, "before_end": 11, "before_start": 11, "kind": "insert"}, {"after_end": 43, "after_start": 43, "before_end": 15, "before_start": 12, "kind": "delete"}, {"after_end": 61, "after_start": 47, "before_end": 20, "before_start": 19, "kind": "replace"}, {"after_end": 75, "after_start": 62, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 115, "after_start": 76, "before_end": 22, "before_start": 22, "kind": "insert"}, {"after_end": 126, "after_start": 117, "before_end": 24, "before_start": 24, "kind": "insert"}, {"after_end": 141, "after_start": 127, "before_end": 25, "before_start": 25, "kind": "insert"}, {"after_end": 144, "after_start": 142, "before_end": 26, "before_start": 26, "kind": "insert"}, {"after_end": 149, "after_start": 145, "before_end": 27, "before_start": 27, "kind": "insert"}, {"after_end": 158, "after_start": 153, "before_end": 31, "before_start": 31, "kind": "insert"}, {"after_end": 196, "after_start": 169, "before_end": 42, "before_start": 42, "kind": "insert"}, {"after_end": 228, "after_start": 224, "before_end": 72, "before_start": 70, "kind": "replace"}, {"after_end": 229, "after_start": 229, "before_end": 78, "before_start": 73, "kind": "delete"}, {"after_end": 232, "after_start": 231, "before_end": 100, "before_start": 80, "kind": "replace"}, {"after_end": 274, "after_start": 259, "before_end": 127, "before_start": 127, "kind": "insert"}, {"after_end": 288, "after_start": 285, "before_end": 138, "before_start": 138, "kind": "insert"}, {"after_end": 307, "after_start": 304, "before_end": 154, "before_start": 154, "kind": "insert"}, {"after_end": 323, "after_start": 321, "before_end": 168, "before_start": 168, "kind": "insert"}, {"after_end": 343, "after_start": 340, "before_end": 185, "before_start": 185, "kind": "insert"}, {"after_end": 418, "after_start": 356, "before_end": 198, "before_start": 198, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 37, "chars_inserted": 257}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bcb58e9a50ac268b3928d706", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 271}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Fresenius Kabi Austria GmbH", "truncated": false}, "before_length": 27, "before_sha256": "fa59d2b0c9ce4abc55a3051cb227907a12a3a3e7fc63908aaebeb76ac9f651ef", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bd2c6ccfcfa34ec3983ac330", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2743}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 43, "start": 0, "text": "Effet d’autres médicaments sur le niraparib", "truncated": false}, "before_length": 43, "before_sha256": "cd2d4ed7c8713ef0c5d60fd35cefd144c8e5f2cab753bdb99dd88a549ff7918f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bd4b1333d63b5d25babbae9f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 239}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 47, "start": 0, "text": "Use a clean needle. (Needles are not included).", "truncated": false}, "before_length": 47, "before_sha256": "4241f20da7e7039db0044a4d4e4d98559f2e68f6a6dcac30e8f4380384c4d16a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 47, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 47, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bd591637ed42a5f52b000876", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9318}
{"after": {"end": 21, "start": 0, "text": "3. DATE DE PÉREMPTION", "truncated": false}, "after_length": 21, "after_sha256": "85c6f427b593f0849a14f3b4eddc1cc1e7c620b6f728e9b76a2d41d644c8e1a2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bd61ddc7a5dc5cb64dd9314e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1117}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "4. NUMÉRO DU LOT", "truncated": false}, "before_length": 16, "before_sha256": "213d44967f2b19d21f4f51c47374c967e28b81413f5de0f45dea5ffece1c90aa", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bd92f5866e498eae3e9f9a1f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1122}
{"after": {"end": 6, "start": 0, "text": "Κύπρος", "truncated": false}, "after_length": 6, "after_sha256": "7f8ef8a379e33810aefd13f344f489d85e8902de6fdcd1b46a4e856985b5e14e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-be09e82fec1cf626e7ac7756", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3296}
{"after": {"end": 15, "start": 0, "text": "The Netherlands", "truncated": false}, "after_length": 15, "after_sha256": "91729ff7107ee698fe168dc62d5b2020678fcfcf55b4ea9065982ce1d071ba31", "annex": "I", "before": {"end": 50, "start": 0, "text": "Papendorpseweg 83, 3528 BJ Utrecht The Netherlands", "truncated": false}, "before_length": 50, "before_sha256": "5d621ef45df9c1911e6b63f15edb513d80fad3ee63f11fe58a733f65b67cd3cd", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-be0df118ce47449b0c001918", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 2.5 mg film-coated tablets", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 510}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "beta-blockers, or", "truncated": false}, "before_length": 17, "before_sha256": "b0eb29da0354f30ef8c731bcb8bce2fd600d8f8bd539e833f3c48fd9037db190", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-be14e67220f7e5287b9ab593", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9278}
{"after": {"end": 16, "start": 0, "text": "pv@ammangion.com", "truncated": false}, "after_length": 16, "after_sha256": "53f45568239cbb258daee24319c4e0fde3bfc6917d09b88019c1cb8329ded177", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-be3a33fdfda8c328fca23e05", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3204}
{"after": {"end": 15, "start": 0, "text": "infomed@bms.com", "truncated": false}, "after_length": 15, "after_sha256": "66e67860f3e4742344d5e1cd7f07326ac1d6946e02f492fa89340b12edd31c8f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-be4c5cd9731666d05b1ae5e7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3246}
{"after": {"end": 33, "start": 0, "text": "medicalinformation.italia@bms.com", "truncated": false}, "after_length": 33, "after_sha256": "7fa3fd14eb9bcefdd405cdea61ff603a046dbbe0f3ada36eb2fd672402b4e33b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-be68096179c380f084f99da1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2921}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "12. MARKETING AUTHORISATION NUMBER", "truncated": false}, "before_length": 34, "before_sha256": "a60532285d3f2ae8ae6f1bf2efe60e8f4d80a3914ffa0fe294c7a05c7841017d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-be750c9fd59fded12ad3b065", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4646}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 17, "start": 0, "text": "Glycerine (E 422)", "truncated": false}, "before_length": 17, "before_sha256": "9a1e37e43631ca49415ba5afb16e4bee78a97a972148a1ac1d0c00b72da64262", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-beb11003510075eaa735e3d0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1356}
{"after": {"end": 5, "start": 0, "text": "Malta", "truncated": false}, "after_length": 5, "after_sha256": "71e9eb10755c8232974d186a560f7658a1ccbdd3097877dfa1ad3436af90d46a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bed405065f14e0f45a867a6b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3198}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 158, "start": 0, "text": "The content of sorbitol in medicinal products for oral use may affect the bioavailability of other medicinal products for oral use administered concomitantly.", "truncated": false}, "before_length": 158, "before_sha256": "1930bafaab799515f1da11f3a274539510d9766f12f8f2b30e0e881cd0edf9c4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 158, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 158, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-befc2e95c95533ad50485127", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1005}
{"after": {"end": 6, "start": 0, "text": "Italia", "truncated": false}, "after_length": 6, "after_sha256": "a7ca3e3d756601d5a22a4c0d8629da0c0ce425e5be526078d3e4583737150f52", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bf19ef62ba1a37cef9496b46", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2606}
{"after": {"end": 9, "start": 0, "text": "Slovenija", "truncated": false}, "after_length": 9, "after_sha256": "fa267dd198bd52b588eff3ae1ccd7c7ea1ac67b4d621fd44e50742c91809cac3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bf7e1e882c15bc279b6b6b69", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2907}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Step 8:", "truncated": false}, "before_length": 7, "before_sha256": "c9314781ac6bde61d493edfaf05ec15a2dbbdcf624126c53f6deb449d8eb35dc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bf7fa8344fd79b6a17b64cfa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9687}
{"after": {"end": 16, "start": 0, "text": "A.M. Mangion Ltd", "truncated": false}, "after_length": 16, "after_sha256": "24f7ac6ac947e8ef3e36c6f6c1f51219647e1477dfe330121521ec39faf6cb0c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bfc21b7ee3107a546ad797e6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2522}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 65, "start": 0, "text": "SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE VARIATION TO THE TERMS", "truncated": false}, "before_length": 65, "before_sha256": "11d75fd316319121d7ae29c305a5ed86386ad06de95d5249b2c30ad7ef7ac397", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 65, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 65, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bfcde140b47bd8bb7af6a087", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3442}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb A.E.", "truncated": false}, "after_length": 24, "after_sha256": "10b1fadbbe52c3072f4ba1903512a3a4f5cd6eb487bf016dde5246419ff972b0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bfe05b9801a3413de01752c4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3297}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Eli Lilly Italia S.p.A.", "truncated": false}, "before_length": 23, "before_sha256": "5793fe6bf9d7fb4bdfe3bcf9ea15ea4276e72e1ef19a76f9e0b36f4f533bd17c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bfe1b0ebd57bb81051a857bc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9543}
{"after": {"end": 22, "start": 0, "text": "Тел.: +359 2 44 55 400", "truncated": false}, "after_length": 22, "after_sha256": "94028dcda4157759850e99c37d94dc37a770042b9b66033cfa2fc452d7aeb2af", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Тел: +359 2 44 55 400", "truncated": false}, "before_length": 21, "before_sha256": "6374e24291111ea27904f41925595739c88615b1e085f7a9f606a90b47ed1647", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-bfeee621b5fd3e7ea823ff49", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005403", "medicine_name": "Sugammadex Mylan", "medicine_slug": "sugammadex-mylan", "observed_at": "2026-10-12T13:36:04Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "6c5163463373c99ccc880a476c1bf5361b2063cd7b687e079043070b6fb0e7f5", "source_snapshot_id": "source-c456b260a6ea2676dbd096d9", "source_updated_at": "2026-06-12", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/sugammadex-mylan-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1478}
{"after": {"end": 15, "start": 0, "text": "Česká republika", "truncated": false}, "after_length": 15, "after_sha256": "c768c215f215c71e7ffcbffe06cb1a66fa3c379a86285d5da65cef3c627bc09d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c0689c00e015f0eb49cee3cc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2822}
{"after": {"end": 35, "start": 0, "text": "medinfo.bulgaria@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7905c486c458386eb1a26649ec5c649de6cbd59270b3b28715f74ada40ed9166", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c085d97f04b2757a3156e4f2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3176}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 170, "start": 0, "text": "The active substance is insulin lispro. Each ml of solution contains 100 units (U) of insulin lispro. Each pre-filled pen (3 ml) contains 300 units (U) of insulin lispro.", "truncated": false}, "before_length": 170, "before_sha256": "fb77cf4bb8bd148967991ec354dc2c5c4e7c5213ac45eb267583b5aa174d9808", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 170, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 170, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c09057b6ad362fe9ee04fe91", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9439}
{"after": {"end": 27, "start": 0, "text": "informacja.medyczna@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "fd724a87ca0b5fd348792afb72bf17e76991a1b17ad813c04854601dd7b9576a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c0b6d3893bf05d17770a3692", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3244}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 36 1 301 9797", "truncated": false}, "after_length": 21, "after_sha256": "646ee39f31e338f4b9b710096409242010a836db8c907826a18abfa5703a4854", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c0ccaa00a3095053cb97b9d3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2829}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 119, "start": 0, "text": "• Unused Pens may be used until the expiration date printed on the label, if the Pen has been kept in the refrigerator.", "truncated": false}, "before_length": 119, "before_sha256": "c1a0aefc1580f14e4bdffe79f90d4629f27362778697bdcd60973f2b20438cf5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 119, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 119, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c12727486c0f302a2d3bf56b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9790}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tel: + 356 25600 500", "truncated": false}, "before_length": 20, "before_sha256": "d4e22aef4cf071166f3a65cc8994cf0e96675401df60b9ecd441be6dfacc97ec", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c1440b5d3c7cd256a6f6954e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9483}
{"after": {"end": 140, "start": 0, "text": "Pour plus d’informations, voir le site web de l’Agence européenne des médicaments : https://www.ema.europa.eu/en/medicines/human/EPAR/cialis", "truncated": false}, "after_length": 140, "after_sha256": "ea09ae6882f88bb0bef12225b178ab9af4aa4d3017851a4ed64e9b9677547973", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 140, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 140}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c14bdf87769b42b073c79fef", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb B.V.", "truncated": false}, "after_length": 24, "after_sha256": "8a52d28077ffdb6f185a0238531f595238f56634dd4dc98f89f75a288910ebf4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c16aa40deda37b9df0fc075d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3212}
{"after": {"end": 26, "start": 0, "text": "Bristol-Myers Squibb, S.A.", "truncated": false}, "after_length": 26, "after_sha256": "bcb96132907136675c68fa09511b755bbd39c0ca74a2983c8bbb77830f8f61b2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c17e4cfef8bdac36dc9a914d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2557}
{"after": {"end": 139, "start": 0, "text": "If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.", "truncated": false}, "after_length": 139, "after_sha256": "47c56fc0e6318f977b62c7e9ecba189a843262bb65ad30e745876458fe55e5b9", "annex": "IIIA", "before": {"end": 101, "start": 0, "text": "This medicine contains no more than 44 mg sorbitol in each capsule. Sorbitol is a source of fructose.", "truncated": false}, "before_length": 101, "before_sha256": "ed19521ed55449afb7c1f187c38758383ce4fa4a6575d7b670ea492eefd6b28f", "change_kind": "content", "change_operations": [{"after_end": 117, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 128, "after_start": 128, "before_end": 18, "before_start": 12, "kind": "delete"}, {"after_end": 129, "after_start": 129, "before_end": 49, "before_start": 19, "kind": "delete"}, {"after_end": 131, "after_start": 131, "before_end": 61, "before_start": 51, "kind": "delete"}, {"after_end": 133, "after_start": 132, "before_end": 69, "before_start": 62, "kind": "replace"}, {"after_end": 135, "after_start": 134, "before_end": 94, "before_start": 70, "kind": "replace"}, {"after_end": 138, "after_start": 138, "before_end": 100, "before_start": 97, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 81, "chars_inserted": 119}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c18bd2c6ce6e85ba35d997d4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3124}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c1ab6b9c35fe7177eae3e830", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2804}
{"after": {"end": 5, "start": 0, "text": "Eesti", "truncated": false}, "after_length": 5, "after_sha256": "ed7477d6100948d0d4e6b914d9769159823c21b23bf4846b1676338b9b439b72", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c1d03004f3423af630d2d833", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2852}
{"after": {"end": 5, "start": 0, "text": "Taani", "truncated": false}, "after_length": 5, "after_sha256": "b71f1b4c32927bd5f0694b003e2d1c67809beb4e798f042c99d04d09792a3a6f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c1dacfe383d7bb31aa743ab4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2086}
{"after": {"end": 7, "start": 0, "text": "Lietuva", "truncated": false}, "after_length": 7, "after_sha256": "5109820f748796128b8bafd3806d05511bc89ad77fc3cda960facf37a639bc7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c1db9ee7d22c686f3783ee74", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3168}
{"after": {"end": 6, "start": 0, "text": "Ελλάδα", "truncated": false}, "after_length": 6, "after_sha256": "e6f7401e81c9b2a3c1f082d0c9a0183287a6f7b4ecded4f4d3ac5e1efefa9ce5", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c1e3e9a50a83663608f58b56", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2552}
{"after": {"end": 38, "start": 0, "text": "Tel: 0800 0752002 (+ 49 89 121 42 350)", "truncated": false}, "after_length": 38, "after_sha256": "a6e565b385c2fd58348adaaec0d48f14b092e8ceadc07f5c2358d6c3e3ac6b0f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c1e921423a935d3e091c4279", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2840}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c21f95c9facf0b7339869068", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1710}
{"after": {"end": 15, "start": 0, "text": "EU/1/11/717/005", "truncated": false}, "after_length": 15, "after_sha256": "81a4108a0a7961243eb6144ff36a6ce7023bcae35cf56e9a83919daf0987eaea", "annex": "I", "before": {"end": 15, "start": 0, "text": "EU/1/11/717/003", "truncated": false}, "before_length": 15, "before_sha256": "33df5f48219bd2551b78dae07893271e4475ba3b184a73338ee9e17e4dfb94cf", "change_kind": "administrative", "change_operations": [{"after_end": 15, "after_start": 14, "before_end": 15, "before_start": 14, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c25d80c303eb27a8c9ae495d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "8", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1959}
{"after": {"end": 153, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments : https ://www.ema.europa.eu/.", "truncated": false}, "after_length": 153, "after_sha256": "65ae7b3bd019e142fef6b9251772e6f7b7562315079db4fd990a412be7072e5e", "annex": "IIIA", "before": {"end": 152, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments : http ://www.ema.europa.eu/.", "truncated": false}, "before_length": 152, "before_sha256": "347cbe234d1ed584927826eb1e1aa61869dce0c3b5079dd6d460e816260d16b1", "change_kind": "content", "change_operations": [{"after_end": 130, "after_start": 129, "before_end": 129, "before_start": 129, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c278e2028ffa2742911878d8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3318}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Slovenská republika", "truncated": false}, "before_length": 19, "before_sha256": "8667151da5d74cf45a2b263a2f7b38e944fd51f34b51e08d79151f123b8f10b2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c285e67addd132093606fe73", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9538}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 44, "start": 0, "text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING", "truncated": false}, "before_length": 44, "before_sha256": "d78bb4e96a3f9f8cb58e27de8d08d455cdf9166cf22b388c3242f9a0b13158ed", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 44, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 44, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c28ba7b8e381db405339c096", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4583}
{"after": {"end": 7, "start": 0, "text": "Sverige", "truncated": false}, "after_length": 7, "after_sha256": "3a7d70b4edb982a403e97d77681309e5fb1032b12d727aa1e92b145b069b9aa4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c2943426b66b7aa2528d9575", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2621}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c29a665138cfc25ab706ceb5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2495}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Allemagne", "truncated": false}, "before_length": 9, "before_sha256": "6b58dbd6a994339b48d8446597da22402857b3409613459c7e3a293788fbe66a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c2a8488736625fd0e6e24c65", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3466}
{"after": {"end": 20, "start": 0, "text": "medwiss.info@bms.com", "truncated": false}, "after_length": 20, "after_sha256": "bc2238e490f9b59d01a00ccab422d2de7eb7937e564268c4e82d2e78b72b3340", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c2c8e534dae9910f9aca8cb9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2535}
{"after": {"end": 21, "start": 0, "text": "Tel: + 386 1 2355 100", "truncated": false}, "after_length": 21, "after_sha256": "dac6f0be4f23d749d801d499c013eab48028544c9f89af72365ef4fdc2e94efc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c2cdd8eb3a43e6c361f20c2c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2599}
{"after": {"end": 8, "start": 0, "text": "Hrvatska", "truncated": false}, "after_length": 8, "after_sha256": "08c5546cc42a9be9368bdd6a99ed02c97b9163c173b1e97dd49b785cb49740bc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c2f12b77d599c3e1088c3bb5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2892}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 29, "start": 0, "text": "Hydroxytoluène butylé (E 321)", "truncated": false}, "before_length": 29, "before_sha256": "572ff1d46de5ad8a455cd4b19e421102224129dd5fbcf2d74a2b08e5b79d1a88", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 29, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 29, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c2faf2dad60f4aa1cf7dc9c0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1910}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Eli Lilly Slovakia s.r.o.", "truncated": false}, "before_length": 25, "before_sha256": "3006360ebc6e665f447e4a3040fe4b1d496113e1d8ce664b1008c40e81d9152c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c3121443fcadda7bddb0c902", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9539}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c35109a19c2562647b96a7b1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2893}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 108, "start": 0, "text": "• If you cannot remove the Pen cap, gently twist the cap back and forth, and then pull the cap straight off.", "truncated": false}, "before_length": 108, "before_sha256": "e7930fd5a4e4d28de0b7b9e12494871878b1319836bb2b6f26b40a5074f00d56", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 108, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 108, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c35c260c960b93aea779533c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9801}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Step 5:", "truncated": false}, "before_length": 7, "before_sha256": "e8703e3b527f4acc320594518548584da02e76c37e2cbdc56b0557849d33e6d0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c372d0df2f8cedb42074a2cc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9663}
{"after": {"end": 24, "start": 0, "text": "Bristol-Myers Squibb SAS", "truncated": false}, "after_length": 24, "after_sha256": "b0b0c212e0ecdb35fbea1089157d2aee4526bb7547bc4dc40b2231ed4929cb66", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c3a4ab261005bf35262902b3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2567}
{"after": {"end": 22, "start": 0, "text": "Teл.: + 359 2 4942 480", "truncated": false}, "after_length": 22, "after_sha256": "71df057e61352cd6e548ee210b03d0adc43d1e9ef00311b1d7ac8fce15871b09", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c3b3c804b85f62b3c63e845c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2810}
{"after": {"end": 7, "start": 0, "text": "Danmark", "truncated": false}, "after_length": 7, "after_sha256": "b2bebaaf55198f3166a7d7089112d30e245d6cf4a3249ae87b597fa988e7f1be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c3b5097d86080fdc849adf41", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2832}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "customercontactuk@gsk.com", "truncated": false}, "before_length": 25, "before_sha256": "73834f2ec2786ba4565d1820e07d2bb38952e8214867b143e05286042d58b0b0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c3b63dd4f2aae5a795e3347c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3017}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c3c5c2c472af643b2af1912b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4009}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 109, "start": 0, "text": "• Unscrew the capped needle and dispose of it as described below (see disposing of Pens and needles section).", "truncated": false}, "before_length": 109, "before_sha256": "a2d6356cced230f461f0a1b40f0d39ca1899859cde59d584497e8d5c9a92c417", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 109, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 109, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c3e8b248eab0fad185e22cf2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9774}
{"after": {"end": 20, "start": 0, "text": "Tel: +371 670 35 775", "truncated": false}, "after_length": 20, "after_sha256": "b680bf9f05ed1e4cf39b4fe148b3422de6b07719e12a6f388508a09cc4a5af9c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c42771b4d2dbe97d16102949", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3741}
{"after": {"end": 41, "start": 0, "text": "Package leaflet: Information for the user", "truncated": false}, "after_length": 41, "after_sha256": "b6986acd5fcd0810c8e128d8e30a00ceaf146ccc2ef4d6c0280b65c1ab484727", "annex": "IIIA", "before": {"end": 41, "start": 0, "text": "Package Leaflet: Information for the user", "truncated": false}, "before_length": 41, "before_sha256": "351906859ef3ae51c77a7b51b70965a2620d98475dc8b9d1d6e436f0c160ce5d", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 8, "before_end": 9, "before_start": 8, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c42afa1b880839fee9a991b6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1170}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 36, "start": 0, "text": "Read the package leaflet before use.", "truncated": false}, "before_length": 36, "before_sha256": "5523bc203c0d15a42e51f1f2084990ce77593674ceb9b20d974654fb13a8f72b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 36, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 36, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c44650c91bfb4fa14dd64a53", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4612}
{"after": {"end": 20, "start": 0, "text": "Tel: + 370 52 369140", "truncated": false}, "after_length": 20, "after_sha256": "8a995c3bfc3c0427235c993d1d1f2ebdd1b1443c434cbb3e015f99728e5b363f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c46bf35eeefe558e4b7d1ae1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2493}
{"after": {"end": 281, "start": 0, "text": "REZZAYO est une poudre pour solution à diluer pour perfusion (poudre pour solution à diluer) dans un flacon en verre muni d’un bouchon en caoutchouc et d’une bague en aluminium avec opercule amovible en plastique. C’est une poudre ou un agglomérat, de couleur blanche à jaune pâle.", "truncated": false}, "after_length": 281, "after_sha256": "ba70684104297707b1d8361333db41a78500f4bba8e9f3456c7293fcd149fbb8", "annex": "IIIA", "before": {"end": 249, "start": 0, "text": "REZZAYO est une poudre pour solution à diluer pour perfusion dans un flacon en verre muni d’un bouchon en caoutchouc et d’une bague en aluminium avec opercule amovible en plastique. C’est une poudre ou un agglomérat, de couleur blanche à jaune pâle.", "truncated": false}, "before_length": 249, "before_sha256": "cb53ff299383feff1da06c9865276d7240fee3719eaf040b516d1addcfcb936f", "change_kind": "content", "change_operations": [{"after_end": 93, "after_start": 61, "before_end": 61, "before_start": 61, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 32}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c49aa0db3ea47ee82fda8bdf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 951}
{"after": {"end": 38, "start": 0, "text": "Pfizer Luxembourg SARL filiāle Latvijā", "truncated": false}, "after_length": 38, "after_sha256": "0faf5c92c10d6b843893cb7c41ee4ab7c87fec3cd38cd32c1b8ebce28c790790", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c4a8506efb2d8c94e0f13852", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3237}
{"after": {"end": 6, "start": 0, "text": "Danija", "truncated": false}, "after_length": 6, "after_sha256": "bc6a7343d3e198e003189dc965ded9d843ad23a091832eaa358b67171d90166d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c4b6968b969c22aeb043f355", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1722}
{"after": {"end": 10, "start": 0, "text": "Österreich", "truncated": false}, "after_length": 10, "after_sha256": "b1b763860d4f30c2e1feafdcd57b714a1422b4fbc1a93d94969118a0faa65288", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 10}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c4bd33bc4d494bb2ac629bc1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3231}
{"after": {"end": 6, "start": 0, "text": "Ísland", "truncated": false}, "after_length": 6, "after_sha256": "5801902efe8b92c2ace1332f4cca2ea1fcb704712e2fe7ca66654d2a826e8451", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c4de7d73dc32605ecb8ad440", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3273}
{"after": {"end": 20, "start": 0, "text": "For single use only.", "truncated": false}, "after_length": 20, "after_sha256": "a5ada875adb6848eaca25516e07cc8ac46a6d89e69af6cf0b2b594f698cb77b7", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "For single use only", "truncated": false}, "before_length": 19, "before_sha256": "dbc9028e4a4f8fadc8e9072aeb510f5bb3f16f7cc18756cc47ff76536d24f8f3", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 19, "before_end": 19, "before_start": 19, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c4fff3ae62bd662549927bfd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1011}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 121, "start": 0, "text": "This Pen is not recommended for use by the blind or visually impaired without the help of someone trained to use the Pen.", "truncated": false}, "before_length": 121, "before_sha256": "24e80378c2a7c49ce12e8fd6cc2b5e92918bf34282b6baec5712396c2944ef81", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 121, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 121, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c514f9a38ff1b61cc8fc3eba", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9261}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 57, "start": 0, "text": "Conditionnement de 30 x 1 capsules molles – AVEC BLUE BOX", "truncated": false}, "before_length": 57, "before_sha256": "5bfcb7260799531127a465c0f6eb93aa46e45ea7338e17b572e071fe68c6acd7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 57, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 57, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c52c05a3d9ed5c5f8a2833cc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2788}
{"after": {"end": 19, "start": 0, "text": "Tel: + 356 23976333", "truncated": false}, "after_length": 19, "after_sha256": "f8bfa43651e282e3e99ee42fa339e414e57dea721306efb985d46dcd3b4656c4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c55d4837644a96903e30901f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3200}
{"after": {"end": 13, "start": 0, "text": "Suomi/Finland", "truncated": false}, "after_length": 13, "after_sha256": "5bea43a11ae0d0e9706443422f6eb9b6107624ceb18d16ec89005011c62699dd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 13, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c56b8dd20a29ca0670432d0b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2617}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 441, "start": 0, "text": "Ni le niraparib ni M1 ne sont des substrats des transporteurs d’anions organiques 1 (OAT1), 3 (OAT3), ou du transporteur de cations organiques 2 (OCT2). Aucun ajustement posologique n’est nécessaire pour Zejula en cas d’administration concomitante avec des médicaments connus pour inhiber les transporteurs d’influx OAT1 (par exemple, probénécide) or OAT3 (par exemple, probénécide, diclofénac), ou OCT2 (par exemple, cimétidine, quinidine).", "truncated": false}, "before_length": 441, "before_sha256": "e33e1edbd4252f57f3eadc8ab72e49abb23ca3ae46d8ff594eab50f0d3468f59", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 441, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 441, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c58d9b06457f109b7c8fbec9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1141}
{"after": {"end": 21, "start": 0, "text": "Tlf.: +45 45 26 60 00", "truncated": false}, "after_length": 21, "after_sha256": "6bdd3c845f6a6e520023cbb8b3726e2eefc4bc4ac00ae57245f3055e31d53895", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tlf: +45 45 26 60 00", "truncated": false}, "before_length": 20, "before_sha256": "7932ef9452966b997a4a22618abb01fb644277c9ab041214e6264730772b2d64", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c5cc9cd5a39f869d3fbe3e35", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3053}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma UAB", "truncated": false}, "after_length": 19, "after_sha256": "0fa5997c653449c2ebe445618eaeedc027096662095bc4bf48a609ec757f79cd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c5f8dc1018504289d8aeeac5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3169}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "Tel: + 420 234 664 111", "truncated": false}, "before_length": 22, "before_sha256": "0a12e94bc97841498e8c87570fe0e4817837a6735e0e15c2cd2b38d9aabe9695", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c619e2f839fb6ae6d6c5aafa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9472}
{"after": {"end": 9, "start": 0, "text": "Nederland", "truncated": false}, "after_length": 9, "after_sha256": "8a869db3fa453526573e4f2c956528743cf246af5d1b5eac4879257589776797", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c65c08b9ebf2e6c9efe63a6f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2847}
{"after": {"end": 20, "start": 0, "text": "For single use only.", "truncated": false}, "after_length": 20, "after_sha256": "a5ada875adb6848eaca25516e07cc8ac46a6d89e69af6cf0b2b594f698cb77b7", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "For single use only", "truncated": false}, "before_length": 19, "before_sha256": "dbc9028e4a4f8fadc8e9072aeb510f5bb3f16f7cc18756cc47ff76536d24f8f3", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 19, "before_end": 19, "before_start": 19, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c66e1674b6a5a76cd49b3705", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 910}
{"after": {"end": 124, "start": 0, "text": "Inhibition des transporteurs d’efflux [Glycoprotéine P (P-gp), protéine de résistance du cancer du sein (BCRP) et MATE 1/2K]", "truncated": false}, "after_length": 124, "after_sha256": "0a68f8a888c0a6bc2c92655285ee603f783e6a63ff1743aaa0db237aaddc900a", "annex": "I", "before": {"end": 74, "start": 0, "text": "Inhibition des transporteurs d’efflux (P-gp, BCRP, BSEP, MRP2 et MATE 1/2)", "truncated": false}, "before_length": 74, "before_sha256": "31bd1c27f0909792ef6156a5205b9d8fe29a67f59ec780219483f7b5448d223c", "change_kind": "content", "change_operations": [{"after_end": 55, "after_start": 38, "before_end": 38, "before_start": 38, "kind": "insert"}, {"after_end": 61, "after_start": 60, "before_end": 43, "before_start": 43, "kind": "insert"}, {"after_end": 105, "after_start": 63, "before_end": 45, "before_start": 45, "kind": "insert"}, {"after_end": 110, "after_start": 109, "before_end": 61, "before_start": 49, "kind": "replace"}, {"after_end": 124, "after_start": 122, "before_end": 74, "before_start": 73, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 63}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c681df4053b0b48aab54821e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1156}
{"after": {"end": 38, "start": 0, "text": "Tel: 0800 0752002 (+ 49 89 121 42 350)", "truncated": false}, "after_length": 38, "after_sha256": "a6e565b385c2fd58348adaaec0d48f14b092e8ceadc07f5c2358d6c3e3ac6b0f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c688d6cca15de39f4bfef991", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2844}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Priming your Pen", "truncated": false}, "before_length": 16, "before_sha256": "dea9c77b097b6a2928cb48e2e60c03d02be3fcab910f888f00a405bbef15f14f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c6b3f07f675ac3766089bd0f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9658}
{"after": {"end": 19, "start": 0, "text": "Tel: + 371 66164750", "truncated": false}, "after_length": 19, "after_sha256": "113b9b6ac49a6f4bdbe379f2d1e85b2d125b75611b91111c888ec73bacdd0230", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c6e228b9b1e236f7a3dfa28f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3305}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 120, "start": 0, "text": "Neither niraparib nor M1 inhibits organic anion transporter 1 (OAT1), 3 (OAT3), and organic cation transporter 2 (OCT2).", "truncated": false}, "before_length": 120, "before_sha256": "f6f2d061c01064ef5d285ca755a885e4098aa755acf49533ce90df33c48e3b0f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 120, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 120, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c6ebd50591dcf7a881c93493", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1137}
{"after": {"end": 58, "start": 0, "text": "La dernière date à laquelle cette notice a été révisée est", "truncated": false}, "after_length": 58, "after_sha256": "97ba09ad15943ce981b7df190d53b0a89ece20114c86fe52284fd870a63f7fbd", "annex": "IIIA", "before": {"end": 72, "start": 0, "text": "La dernière date à laquelle cette notice a été révisée est janvier 2026.", "truncated": false}, "before_length": 72, "before_sha256": "0d304a7a48ff0a526a4dadebe96d20dbaeac9ca1a5c4f778727286efedec0110", "change_kind": "content", "change_operations": [{"after_end": 58, "after_start": 58, "before_end": 72, "before_start": 58, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c702d3a8ba9380a7a3ca6277", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1716}
{"after": {"end": 142, "start": 0, "text": "Le niraparib est un inhibiteur de la P-gp, la BCRP, de MATE1/2K et du transporteur cationique organique 1 (OCT1) in vitro (voir rubrique 4.5).", "truncated": false}, "after_length": 142, "after_sha256": "3621b16926d6b878b2c451288585ffa7c84d1766b267c5755ebe38f72b2a62f3", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 142, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 142}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c70a40498f685bc3d39fbc3c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1695}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 51, "start": 0, "text": "2D barcode carrying the unique identifier included.", "truncated": false}, "before_length": 51, "before_sha256": "c70986678c932d8c3e10fe2bfc3ea6ef6401ffe24c9fb906c781f3d0ae81e19c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 51, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 51, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c70ed38b010fe558ff27cd6f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4768}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 16, "start": 0, "text": "Gélatine (E 441)", "truncated": false}, "before_length": 16, "before_sha256": "c9160656b4c0da76db16fedaba1d4367cb89f0214540a7df3ae5bb5a61379017", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c7158e198acdd2bc61fa047f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1897}
{"after": {"end": 5, "start": 0, "text": "Norge", "truncated": false}, "after_length": 5, "after_sha256": "882f535a7da00cd72aec9957f14113085717f72c791945420043b48876276628", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c71dad4130f6ae1ad67b5932", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3218}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 20, "start": 0, "text": "Novartis Pharma GmbH", "truncated": false}, "before_length": 20, "before_sha256": "bae642239c19e15ed2be9a6c4c5123c7ef0f4e0a79a5ece5f8c2cf22e6047d3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c74190bb96ca82df1631dc85", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1671}
{"after": {"end": 32, "start": 0, "text": "2. STATEMENT OF ACTIVE SUBSTANCE", "truncated": false}, "after_length": 32, "after_sha256": "9e169b908eb1d9fc1ed6e233dacad6af86b2c8a043fa81faef38a02382a9c8e3", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "2. STATEMENT OF ACTIVE SUBSTANCE(S)", "truncated": false}, "before_length": 35, "before_sha256": "a98caee7a99385f0fdf38e1fb123885d279b9ccfdb6ba18007e43f93a9a479ee", "change_kind": "content", "change_operations": [{"after_end": 32, "after_start": 32, "before_end": 35, "before_start": 32, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c74268e99f1cc0e08f998544", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 889}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Austria", "truncated": false}, "before_length": 7, "before_sha256": "c9cab0238debc6e55498e2c0963a1d8e25bd29c95ddd53a3fff841ee636b6bc5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c7473604babb5ecb05a0b62d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3126}
{"after": {"end": 38, "start": 0, "text": "Tel: 0800 0752002 (+ 49 89 121 42 350)", "truncated": false}, "after_length": 38, "after_sha256": "a6e565b385c2fd58348adaaec0d48f14b092e8ceadc07f5c2358d6c3e3ac6b0f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c747ef1e1ed83ca3492d3c2e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3208}
{"after": {"end": 7, "start": 0, "text": "KwikPen", "truncated": false}, "after_length": 7, "after_sha256": "159c496db0479974ad161923b2185f40de54d9a8e8df3ef59760e7d3582aeee9", "annex": "I", "before": {"end": 21, "start": 0, "text": "KwikPen and Tempo Pen", "truncated": false}, "before_length": 21, "before_sha256": "1eab04203602f93897de387a82e55b3a2f3c04b6d0b2b10f5c684169ee4c912f", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 7, "before_end": 21, "before_start": 7, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c74802305b52d0af79cc068f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "2", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 50}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 8, "start": 0, "text": "Autriche", "truncated": false}, "before_length": 8, "before_sha256": "dea55da9d453f7a5125a553d05297c736f00626d1baa09e099247c0e7937d0cf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c77aa9202a87f19397b7605f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1708}
{"after": {"end": 13, "start": 0, "text": "1932 Zaventem", "truncated": false}, "after_length": 13, "after_sha256": "cffe4475a5de91da7a3a6363a4d41ccfd1405766d95ae182d89bf39b29686221", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "1930 Zaventem", "truncated": false}, "before_length": 13, "before_sha256": "ed9ea9385e3e50f6278214da5d7483a8543c36d1261df263d35022c5936c74db", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 4, "before_start": 3, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c786fd1ced1c2642ca91fe0e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2902}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 12, "start": 0, "text": "County Kerry", "truncated": false}, "before_length": 12, "before_sha256": "eb7356a4494d39c472b712704605178f5a5ec97da0fc0b32f904fa38c0a2cdcc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c7a78da9b08b2e74136d585c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1005}
{"after": {"end": 523, "start": 0, "text": "Dans les groupes de traitement par rezafungine et caspofungine, 77,0 % et 74,2 % des patients, respectivement, ont reçu un diagnostic final de candidémie uniquement. La plupart d’entre eux avaient un score APACHE II modifié < 20, soit respectivement 84,4 % et 81,5 % des sujets traités par rezafungine et par caspofungine. Dans les groupes traités par rezafungine et par caspofungine, 88,5 % et 91,1 % des patients, respectivement, avaient une numération absolue des neutrophiles (NAN) ≥ 500/mm3 à l’inclusion dans l’étude.", "truncated": false}, "after_length": 523, "after_sha256": "f2ac7e7290db941bd9bd53c2e4ea0b3a5f02ddc9db17720e5b0278825fc587ad", "annex": "I", "before": {"end": 523, "start": 0, "text": "Dans les groupes de traitement par rezafungine et caspofungine, 70,0 % et 68,7 % des patients, respectivement, ont reçu un diagnostic final de candidémie uniquement. La plupart d’entre eux avaient un score APACHE II modifié < 20, soit respectivement 84,0 % et 81,8 % des sujets traités par rezafungine et par caspofungine. Dans les groupes traités par rezafungine et par caspofungine, 88,0 % et 93,9 % des patients, respectivement, avaient une numération absolue des neutrophiles (NAN) ≥ 500/mm3 à l’inclusion dans l’étude.", "truncated": false}, "before_length": 523, "before_sha256": "d61b6371f9f92a2b3d72e94ddd2ba59dda826c1543d26e85e5eb96889fb6f7b9", "change_kind": "content", "change_operations": [{"after_end": 66, "after_start": 65, "before_end": 66, "before_start": 65, "kind": "replace"}, {"after_end": 76, "after_start": 74, "before_end": 76, "before_start": 74, "kind": "replace"}, {"after_end": 78, "after_start": 77, "before_end": 78, "before_start": 77, "kind": "replace"}, {"after_end": 254, "after_start": 253, "before_end": 254, "before_start": 253, "kind": "replace"}, {"after_end": 264, "after_start": 263, "before_end": 264, "before_start": 263, "kind": "replace"}, {"after_end": 389, "after_start": 388, "before_end": 389, "before_start": 388, "kind": "replace"}, {"after_end": 397, "after_start": 396, "before_end": 397, "before_start": 396, "kind": "replace"}, {"after_end": 399, "after_start": 398, "before_end": 399, "before_start": 398, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c7da143e816c9afb748fa939", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 285}
{"after": {"end": 6, "start": 0, "text": "Ελλάδα", "truncated": false}, "after_length": 6, "after_sha256": "e6f7401e81c9b2a3c1f082d0c9a0183287a6f7b4ecded4f4d3ac5e1efefa9ce5", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c7f86143965d24e061f33f94", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2862}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 231, "start": 0, "text": "Always use this medicine exactly as your doctor has told you. You should check with your doctor if you are not sure. To prevent the possible transmission of disease, each pen must be used by you only, even if the needle is changed.", "truncated": false}, "before_length": 231, "before_sha256": "ad1d4968aabc2c3bdd18bfe1cd8036bbef1e9caaed5c0e2d357f5a8c6944134c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 231, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 231, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c8024365f0d0267f582aeb02", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9304}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 26, "start": 0, "text": "16. INFORMATION IN BRAILLE", "truncated": false}, "before_length": 26, "before_sha256": "c69cdeadf8c5d34e36f9bf5d6949c41517313f63407e7b6ac6908bbe7ad76cfd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 26, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 26, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c889c21b8b0e61c979de91e6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4862}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c893131e7a0e12d507016cbe", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3184}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 205, "start": 0, "text": "The Tempo Pen contains a magnet (see section 6.5) that may interfere with the functions of an implantable electronic medical device, such as a pacemaker. The magnetic field extends to approximately 1.5 cm.", "truncated": false}, "before_length": 205, "before_sha256": "6d789bcc7a047336e85d92a5c0ac7b42b7b5cdd592a8603a4d3e5c60c07811cb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 205, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 205, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c89406419de284f20d63097a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 189}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c8b51ed7c4ce9c1e81a60c49", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3181}
{"after": {"end": 21, "start": 0, "text": "Tel: + 46 8 704 71 00", "truncated": false}, "after_length": 21, "after_sha256": "313eaeeb04c88c002b748323fb801826225906f557247264c0fcb9fc87c873fc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c8d6bef0bbd51a82090929aa", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3303}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb Kft.", "truncated": false}, "after_length": 25, "after_sha256": "8eee29e152f27da674ed6460d204f723bf6a9c596f41572a08e4e678a83674cb", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c8eb682d094c8496bf4e61c9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2824}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 146, "start": 0, "text": "If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.", "truncated": false}, "before_length": 146, "before_sha256": "5adfc47b35665cc2ba08b149bcf2202ff8080c9b98f7b256673d1d09595fa682", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 146, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 146, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c904dcaf2fb7769ab98e0a44", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9220}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "13. BATCH NUMBER", "truncated": false}, "before_length": 16, "before_sha256": "1ba2d71652baaf680bf61f6637402598f74e8e74757862c33639fc0867a99221", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c923d031b42b234d69426da1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4651}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovakia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7b73e721c843deabd3a181fa5d110ba6dfbdc9531c8d2e1e6545e547e02a9ef0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c936890dc4a43c992b1a7811", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3284}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 105, "start": 0, "text": "Pour extraire une capsule : découper une alvéole individuelle et pousser à travers le papier d’aluminium.", "truncated": false}, "before_length": 105, "before_sha256": "56c2be53a13b3201bdd52a30b9adef0d8c757c07b26fa55d70470286b6d0433c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 105, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 105, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c951acf59381c9aac3aa5ac0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2817}
{"after": {"end": 135, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency https://www.ema.europa.eu/.", "truncated": false}, "after_length": 135, "after_sha256": "3c74f634f1dbc9f08897b33e0ea95036324616df9ff3f17282cc79a52cb99608", "annex": "I", "before": {"end": 134, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/.", "truncated": false}, "before_length": 134, "before_sha256": "96536f36542fc44ff8d90ae9f46567670b8287c2f485df2d108dc671e3becaea", "change_kind": "technical", "change_operations": [{"after_end": 113, "after_start": 112, "before_end": 112, "before_start": 112, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c9780380a03ea2edeb4274f2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "Baraclude 0.05 mg/ml oral solution", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1838}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "5 pens of 3 ml", "truncated": false}, "before_length": 14, "before_sha256": "0b54cfc303d6f98f200e8da0810bd71bc0db4a21f356747408092df0774ed90c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c985722bdad1f57a313cc300", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4607}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "before_length": 7, "before_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c98f1107d265afd6305f7650", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3346}
{"after": {"end": 376, "start": 0, "text": "Following a singledose administration of 300 mg niraparib, niraparib was measurable in plasma within 30 minutes and the mean peak plasma concentration (Cmax) for niraparib was reached within 3 to 5 hours (ranged 508-875 ng/mL across studies). Following multiple oral doses of niraparib from 30 mg to 400 mg once daily, accumulation of niraparib was approximately 2 to 3 folds.", "truncated": false}, "after_length": 376, "after_sha256": "8d8d4a3fed275e168a478addbc36666d4f33fddabcdf3f2d60630bee84c427fb", "annex": "I", "before": {"end": 386, "start": 0, "text": "Following a singledose administration of 300 mg niraparib under fasting conditions, niraparib was measurable in plasma within 30 minutes and the mean peak plasma concentration (Cmax) for niraparib was reached in about 3 hours [804 ng/mL (% CV: 50.2%)]. Following multiple oral doses of niraparib from 30 mg to 400 mg once daily, accumulation of niraparib was approximately 2 to 3 folds.", "truncated": false}, "before_length": 386, "before_sha256": "7542950a34acfc3e089ccabd7db9666db4cca022e2570aa6e344aa6b1deb441a", "change_kind": "content", "change_operations": [{"after_end": 57, "after_start": 57, "before_end": 82, "before_start": 57, "kind": "delete"}, {"after_end": 188, "after_start": 184, "before_end": 209, "before_start": 209, "kind": "insert"}, {"after_end": 194, "after_start": 191, "before_end": 214, "before_start": 212, "kind": "replace"}, {"after_end": 195, "after_start": 195, "before_end": 217, "before_start": 215, "kind": "delete"}, {"after_end": 197, "after_start": 196, "before_end": 219, "before_start": 218, "kind": "replace"}, {"after_end": 214, "after_start": 204, "before_end": 227, "before_start": 226, "kind": "replace"}, {"after_end": 219, "after_start": 215, "before_end": 230, "before_start": 228, "kind": "replace"}, {"after_end": 232, "after_start": 226, "before_end": 239, "before_start": 237, "kind": "replace"}, {"after_end": 240, "after_start": 233, "before_end": 249, "before_start": 240, "kind": "replace"}, {"after_end": 241, "after_start": 241, "before_end": 251, "before_start": 250, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 45, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c9a5afb7fc1dd146f0d1d628", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 757}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "Icepharma hf.", "truncated": false}, "before_length": 13, "before_sha256": "b10e8b5abc79456615b7bbf170d67bdcdfb8e87e7bd69bed75dffa3ce87100cb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c9b2d8b8c65c1d132a8b6812", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9535}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Fresenius Kabi Austria GmbH", "truncated": false}, "before_length": 27, "before_sha256": "fa59d2b0c9ce4abc55a3051cb227907a12a3a3e7fc63908aaebeb76ac9f651ef", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-c9d24bc8a1152d4356af5fdc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2763}
{"after": {"end": 9, "start": 0, "text": "67 (57,3)", "truncated": false}, "after_length": 9, "after_sha256": "3dca67c957d18353111c83ce4a702760f077ba9db049a2443c0cf79197923785", "annex": "I", "before": {"end": 9, "start": 0, "text": "57 (60,6)", "truncated": false}, "before_length": 9, "before_sha256": "8cd221e65b04481f988344c06ec0003dcdefc4fc1d243810f689020aaf27bb4f", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 6, "after_start": 4, "before_end": 6, "before_start": 4, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 8, "before_start": 7, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 4}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ca01c8e0985ef4e43898f67a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 309}
{"after": {"end": 15, "start": 0, "text": "infomed@bms.com", "truncated": false}, "after_length": 15, "after_sha256": "66e67860f3e4742344d5e1cd7f07326ac1d6946e02f492fa89340b12edd31c8f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ca2ccfcb6b550179b9d2cafa", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2575}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 144, "start": 0, "text": "Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms come on slowly over many hours or days. The symptoms include the following:", "truncated": false}, "before_length": 144, "before_sha256": "8eca685c74846ed8f7556aece934e172594292bcf4ac475ffdc0434e4ee87df5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 144, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 144, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ca5ad8574855b7aaae10e4bc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9410}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 52, "start": 0, "text": "• taking less insulin than your doctor tells you to;", "truncated": false}, "before_length": 52, "before_sha256": "f5179ebbcce9cc753752c8555c9d975b4f2fb36fb243392e15a1a0353de56b78", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 52, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 52, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ca9570d994357d9bc174568d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9406}
{"after": {"end": 29, "start": 0, "text": "BristolMyers Squibb Norway AS", "truncated": false}, "after_length": 29, "after_sha256": "01226c5fbcee79cbe7d5ae55b232342409f6c95196e05bb842acfae228db69c9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 29, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 29}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-caac003dca29564616378927", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2548}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 63, "start": 0, "text": "Les études d’interaction n’ont été réalisées que chez l’adulte.", "truncated": false}, "before_length": 63, "before_sha256": "c5778411640aed1def9826b178c1eb02020867a5d5584de21a18695b9da07758", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 63, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 63, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cabbfb2947e67b5ec8ff3e85", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 285}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Subcutaneous use", "truncated": false}, "before_length": 16, "before_sha256": "363fd22613abec178143cdac0b1a34f04ee8ccdaa7d6988b3722fa7540374cde", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cacb82839c095cf055d2c6cf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4613}
{"after": {"end": 117, "start": 0, "text": "The film-coated tablets should be swallowed whole and not crushed or cut. Vyndaqel may be taken with or without food.", "truncated": false}, "after_length": 117, "after_sha256": "90dd03a423e90d3613322d653a5aeb7d6a456b510226266535d2a7d07eb936c2", "annex": "I", "before": {"end": 111, "start": 0, "text": "The soft capsules should be swallowed whole and not crushed or cut. Vyndaqel may be taken with or without food.", "truncated": false}, "before_length": 111, "before_sha256": "d73129ebbb097a088df4addd2e7f57c646cfe41d432fbb86a876c683ceed6525", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 4, "before_end": 5, "before_start": 4, "kind": "replace"}, {"after_end": 12, "after_start": 11, "before_end": 7, "before_start": 6, "kind": "replace"}, {"after_end": 15, "after_start": 13, "before_end": 8, "before_start": 8, "kind": "insert"}, {"after_end": 17, "after_start": 16, "before_end": 10, "before_start": 9, "kind": "replace"}, {"after_end": 19, "after_start": 18, "before_end": 14, "before_start": 11, "kind": "replace"}, {"after_end": 22, "after_start": 21, "before_end": 16, "before_start": 16, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-caec0ccf429a58cd662c6ee3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 985}
{"after": {"end": 13, "start": 0, "text": "Suomi/Finland", "truncated": false}, "after_length": 13, "after_sha256": "5bea43a11ae0d0e9706443422f6eb9b6107624ceb18d16ec89005011c62699dd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 13, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 13}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cb0515f9bac0d281a44d4b3d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2923}
{"after": {"end": 83, "start": 0, "text": "The active substance is tafamidis. Each tablet contains 61 mg micronized tafamidis.", "truncated": false}, "after_length": 83, "after_sha256": "84e5b0f9f8db9816f8bf05b340485b0c78e49dc2de1105cf52d5a53b7db16cb1", "annex": "IIIA", "before": {"end": 84, "start": 0, "text": "The active substance is tafamidis. Each capsule contains 61 mg micronized tafamidis.", "truncated": false}, "before_length": 84, "before_sha256": "929768783cf6953dc7286647f1b185e7abe262acbd2b712f3261f840a570c36e", "change_kind": "content", "change_operations": [{"after_end": 41, "after_start": 40, "before_end": 41, "before_start": 40, "kind": "replace"}, {"after_end": 43, "after_start": 42, "before_end": 45, "before_start": 42, "kind": "replace"}, {"after_end": 46, "after_start": 45, "before_end": 47, "before_start": 47, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cb084b594c78c2b9ef75f54e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3189}
{"after": {"end": 26, "start": 0, "text": "KwikPen and Junior KwikPen", "truncated": false}, "after_length": 26, "after_sha256": "3913a6d0d2219ed08ae62130ad9aa232e96a26e416a39269a9c987d6167adda1", "annex": "I", "before": {"end": 37, "start": 0, "text": "KwikPen, Junior KwikPen and Tempo Pen", "truncated": false}, "before_length": 37, "before_sha256": "d04123c230090308e5a0e487a2148f9af27a4ede6a449fedc2bee0892ff8e6d6", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 7, "before_end": 8, "before_start": 7, "kind": "replace"}, {"after_end": 23, "after_start": 23, "before_end": 34, "before_start": 20, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 4}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cb1f479772fc280effd513eb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.6", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 517}
{"after": {"end": 32, "start": 0, "text": "Takeda Farmacéutica España, S.A.", "truncated": false}, "after_length": 32, "after_sha256": "e4011321ff84bc97a3a57c2ef4c7b74b6b015f8e8d044046ef1d15c72f7e4b3d", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "Takeda Farmacéutica España S.A", "truncated": false}, "before_length": 30, "before_sha256": "6702486f6992447e37b2164fef2f973a83c8960354f82d5166db99d6bdb3bad8", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 26, "before_end": 26, "before_start": 26, "kind": "insert"}, {"after_end": 32, "after_start": 31, "before_end": 30, "before_start": 30, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cb64a951da44d3f87da86061", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1611}
{"after": {"end": 149, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments https://www.ema.europa.eu.", "truncated": false}, "after_length": 149, "after_sha256": "0e6b9f35caaf0258b468a6e9a53665f0ec5536787f68eefee5f242bf64add02e", "annex": "I", "before": {"end": 149, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments http://www.ema.europa.eu/.", "truncated": false}, "before_length": 149, "before_sha256": "16e6f5615757ceabad4641121cdcfa0a0ce3e97da03a8f65c0b7b47a6899d4ba", "change_kind": "technical", "change_operations": [{"after_end": 128, "after_start": 127, "before_end": 127, "before_start": 127, "kind": "insert"}, {"after_end": 148, "after_start": 148, "before_end": 148, "before_start": 147, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cb7a4fe6eaafdda627166aca", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 10 mg comprimés pelliculés CIALIS 20 mg comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1620}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 13, "start": 0, "text": "Roonstraße 25", "truncated": false}, "before_length": 13, "before_sha256": "72b80df998792e1d92189a290d82759fb839b17a555226b67f667c759822bfa7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cb904323896387a37bd32be4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:19Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "f06e0ab86181a67971595f26988e3c55a451248ed0952f9e7d81fca34c64f211", "source_snapshot_id": "source-e192d7ce131e1645eace610a", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1643}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 63, "start": 0, "text": "• Do not freeze your insulin. Do not use if it has been frozen.", "truncated": false}, "before_length": 63, "before_sha256": "336e12c606be6754ef5cbb6979e8b1fd6da0923455646564e6fdf66fca174719", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 63, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 63, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cbadba5dd2f95226777f939b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9789}
{"after": {"end": 151, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments: https://www.ema.europa.eu/.", "truncated": false}, "after_length": 151, "after_sha256": "e691adff0b240e5894db0c83e35a32f42479841fdc0547e1bafc7a426f383ebe", "annex": "I", "before": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments: http://www.ema.europa.eu/.", "truncated": false}, "before_length": 150, "before_sha256": "2ad93586fcb733b2200f63ea9f94e741bc2d35cdc5f89d5236f368b8b7ac060f", "change_kind": "technical", "change_operations": [{"after_end": 129, "after_start": 128, "before_end": 128, "before_start": 128, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cbb1fef781c741767bfa85f4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 939}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Tel: +44 (0) 1844 347333", "truncated": false}, "before_length": 24, "before_sha256": "3e66f974ec29433df45716bf73117a6d11dd49271609c4d153b59d502de5d353", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cbbb1c10d72c6e171d5aaf6d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1863}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Plunger", "truncated": false}, "before_length": 7, "before_sha256": "fde1966ee04761ffad90d39051cef9ac78f96d8b087d8ec775c337ac0b485056", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cbc5537462af44c8cc77c8af", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9594}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 36, "start": 0, "text": "Store in a refrigerator (2°C - 8°C).", "truncated": false}, "before_length": 36, "before_sha256": "da46e7ec5af6b520bf23f97fab0435900e7b6407916f2e228ee83266f9359e2a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 36, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 36, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cc131d0cacbe56e5da426b4c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4829}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Mylan IRE Healthcare Limited", "truncated": false}, "before_length": 28, "before_sha256": "35f93c261e1c23366cb104ad58005b2a5415120196df611fa95117f89eb960ff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cc248f9bb800732b5caaccf2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4010}
{"after": {"end": 27, "start": 0, "text": "CPO Pharmaceuticals Limited", "truncated": false}, "after_length": 27, "after_sha256": "94b644443752e2cb52916b23f8141fbd44c47055b3416af333e12ac18e101b87", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "GPA Pharmaceuticals Ltd", "truncated": false}, "before_length": 23, "before_sha256": "ece7127e303c91e9501d2cedd822476265aae86acb9f96ef1553ab3a6954afe1", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 21, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cc377159abec7585e88f3055", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3672}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "Tel: + 44 (0)800 221441", "truncated": false}, "before_length": 23, "before_sha256": "61482b81443a3ca39c7759aba2468d8a55e72bb438cb673a32ba3b1dac130262", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cc3b4cb5d6ec936f9ec61243", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2615}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 38, "start": 0, "text": "Pfizer Luxembourg SARL filiāle Latvijā", "truncated": false}, "before_length": 38, "before_sha256": "0faf5c92c10d6b843893cb7c41ee4ab7c87fec3cd38cd32c1b8ebce28c790790", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 38, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 38, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cc405ad26b18bf3d7d9c6a2a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3347}
{"after": {"end": 23, "start": 0, "text": "medinfo.finland@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "7029ed3ac062d546eacefe48107a23caa5547edd30d7c30335f744035bfb4ec6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cc47d2e257935879b63a3ea3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3291}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "before_length": 7, "before_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cc49bd12ec95078a48e34ad5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3220}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb B.V.", "truncated": false}, "after_length": 25, "after_sha256": "0ca7ef7834ca2eb516116ddfb2edb978bd0d58c8673ce6fa611a0719568a6293", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cc5dc203f82ceda33d8ee285", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2532}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "15. INSTRUCTIONS ON USE", "truncated": false}, "before_length": 23, "before_sha256": "f8a07f0f5a6fad5f13ef5dcced3946c03a5890329dd08710b94d8c5258ad3e23", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cc6f85c632d5ec2d2ee96405", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4659}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 46, "start": 0, "text": "• you miss or delay meals or change your diet;", "truncated": false}, "before_length": 46, "before_sha256": "6f8f972d2f856cfe1bf6312b3d1792294c76a68d6dfccb495487e78766246330", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 46, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 46, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cc79b4743e34fd162c50d62f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9388}
{"after": {"end": 33, "start": 0, "text": "medicalinformation.italia@bms.com", "truncated": false}, "after_length": 33, "after_sha256": "7fa3fd14eb9bcefdd405cdea61ff603a046dbbe0f3ada36eb2fd672402b4e33b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ccbbce3cc5be51484c942fda", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2615}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Astellas Ireland Co. Ltd.", "truncated": false}, "before_length": 25, "before_sha256": "1d98a06d2f724f3f69491c40480991ee287d2e3806d862b6ab226d0b620c6885", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ccbca6da0b38bf1a5756e6f6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1703}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 3, "start": 0, "text": "EXP", "truncated": false}, "before_length": 3, "before_sha256": "06a1ad637e7f4fbad56e29164490368f0526f429ee39a31dd1180c3722af1e4e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ccc984c397ee96ebe7c6ba66", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4824}
{"after": {"end": 25, "start": 0, "text": "82152 Martinsried/Planegg", "truncated": false}, "after_length": 25, "after_sha256": "1b4b3faa4a786e9ef580373ac19892e77a10c82d03848e97213c1099ad57fb08", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ccee7510b488e98efc6d1207", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1676}
{"after": {"end": 35, "start": 0, "text": "medinfo.bulgaria@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7905c486c458386eb1a26649ec5c649de6cbd59270b3b28715f74ada40ed9166", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cd5bb28e2b7c70b80aeeffdc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2811}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 621, "start": 0, "text": "Before you make an injection, clean your skin as you have been instructed. Inject under the skin, as you were taught. Do not inject directly into a vein. After your injection, leave the needle in the skin for five seconds to make sure you have taken the whole dose. Do not rub the area you have just injected. Make sure you inject at least half an inch (1 cm) from the last injection and that you ‘rotate’ the places you inject, as you have been taught. It doesn’t matter which injection site you use, either upper arm, thigh, buttock or abdomen, your Humalog injection will still work quicker than soluble human insulin.", "truncated": false}, "before_length": 621, "before_sha256": "39426988589402c4adb2ea04ab0ce984c5343b2790a626b8bd1b6dc3d970ed29", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 621, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 621, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cd5fdc01a76a9ddf90afb9eb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9322}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Killorglin", "truncated": false}, "before_length": 10, "before_sha256": "2606b5fb607427b1a532d8cab1195d0515b4a8cf56f0eff6628b2ac9a5a04655", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cd60fc9669fd867cb41c7aae", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2028}
{"after": {"end": 245, "start": 0, "text": "Les comprimés pelliculés de Vyndaqel sont ronds, de couleur blanche à blanc cassé, portent l’inscription « 61 » sur une face et mesurent 11 mm de diamètre. Vyndaqel est disponible en 2 types de conditionnement de plaquettes OPA/Al/PVC-aluminium.", "truncated": false}, "after_length": 245, "after_sha256": "ffa46a42fb33c434969dd79156496411e1181ef58f6844a2ede8f012590eb439", "annex": "IIIA", "before": {"end": 429, "start": 0, "text": "Les capsules molles de Vyndaqel sont de couleur brun rougeâtre, opaques, de forme oblongue (environ 21 mm), avec l’inscription « VYN 61 » en blanc. Vyndaqel est disponible en 2 types de conditionnement de plaquettes (PVC/PA/alu/PVC-alu) prédécoupées en dose unitaire : un conditionnement de 30 x 1 capsules molles et un conditionnement multiple de 90 capsules molles comprenant 3 boites, contenant chacune 30 x 1 capsules molles.", "truncated": false}, "before_length": 429, "before_sha256": "7ffbb6acfc4a7c1df1b5b3260e5e0d1d3f549f51f7620198cf8acc8aa70344bc", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 5, "before_end": 6, "before_start": 5, "kind": "replace"}, {"after_end": 12, "after_start": 8, "before_end": 7, "before_start": 7, "kind": "insert"}, {"after_end": 20, "after_start": 13, "before_end": 8, "before_start": 8, "kind": "insert"}, {"after_end": 23, "after_start": 22, "before_end": 18, "before_start": 10, "kind": "replace"}, {"after_end": 49, "after_start": 42, "before_end": 37, "before_start": 37, "kind": "insert"}, {"after_end": 63, "after_start": 61, "before_end": 51, "before_start": 49, "kind": "replace"}, {"after_end": 67, "after_start": 64, "before_end": 52, "before_start": 52, "kind": "insert"}, {"after_end": 81, "after_start": 68, "before_end": 62, "before_start": 53, "kind": "replace"}, {"after_end": 83, "after_start": 83, "before_end": 65, "before_start": 64, "kind": "delete"}, {"after_end": 84, "after_start": 84, "before_end": 77, "before_start": 66, "kind": "delete"}, {"after_end": 87, "after_start": 86, "before_end": 92, "before_start": 79, "kind": "replace"}, {"after_end": 90, "after_start": 89, "before_end": 112, "before_start": 94, "kind": "replace"}, {"after_end": 107, "after_start": 107, "before_end": 133, "before_start": 129, "kind": "delete"}, {"after_end": 133, "after_start": 112, "before_end": 138, "before_start": 138, "kind": "insert"}, {"after_end": 136, "after_start": 135, "before_end": 140, "before_start": 140, "kind": "insert"}, {"after_end": 148, "after_start": 137, "before_end": 143, "before_start": 141, "kind": "replace"}, {"after_end": 154, "after_start": 149, "before_end": 146, "before_start": 144, "kind": "replace"}, {"after_end": 225, "after_start": 224, "before_end": 221, "before_start": 216, "kind": "replace"}, {"after_end": 229, "after_start": 228, "before_end": 225, "before_start": 224, "kind": "replace"}, {"after_end": 230, "after_start": 230, "before_end": 227, "before_start": 226, "kind": "delete"}, {"after_end": 240, "after_start": 238, "before_end": 259, "before_start": 235, "kind": "replace"}, {"after_end": 242, "after_start": 242, "before_end": 269, "before_start": 261, "kind": "delete"}, {"after_end": 243, "after_start": 243, "before_end": 283, "before_start": 270, "kind": "delete"}, {"after_end": 244, "after_start": 244, "before_end": 428, "before_start": 284, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 267, "chars_inserted": 83}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cd61c5baae4d872b7435666b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3699}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Allemagne", "truncated": false}, "before_length": 9, "before_sha256": "6b58dbd6a994339b48d8446597da22402857b3409613459c7e3a293788fbe66a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cd73911b221736a6e2aeda9d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3857}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 93, "start": 0, "text": "– inject the amount left in your Pen and then use a new Pen to give the rest of your dose, or", "truncated": false}, "before_length": 93, "before_sha256": "8efaa3ab3dfdf17fed3f8c02753122a7720add25526a4ecefa67d1dd39cfa2cd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 93, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 93, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cd79f4eebe52a2f4a51b1f9e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9729}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cd8561f17861b29a06bd66fc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2494}
{"after": {"end": 6, "start": 0, "text": "España", "truncated": false}, "after_length": 6, "after_sha256": "f85c9fe36948469b69f31fb5026694619ce4dc122757ece67c8584ff8f2ac008", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cda24b5bcd862561c9148b14", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2868}
{"after": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments https://www.ema.europa.eu/.", "truncated": false}, "after_length": 150, "after_sha256": "d22055ed3151684147f06de24cf04fdc5fd5353021fb1a0c528248b821043444", "annex": "IIIA", "before": {"end": 245, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments http://www.ema.europa.eu/. Il existe aussi des liens vers d’autres sites concernant les maladies rares et leur traitement.", "truncated": false}, "before_length": 245, "before_sha256": "634e7c2ccfe0e99272606bf3532dfc16f0a76cba5d93426d7fdad5e7b4452277", "change_kind": "content", "change_operations": [{"after_end": 128, "after_start": 127, "before_end": 127, "before_start": 127, "kind": "insert"}, {"after_end": 149, "after_start": 149, "before_end": 244, "before_start": 148, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 96, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cdc6ea227d6952ed01805bb6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1720}
{"after": {"end": 88, "start": 0, "text": "Pack sizes: a pack of 3 x 10 filmcoated tablets and a pack of 9 x 10 filmcoated tablets.", "truncated": false}, "after_length": 88, "after_sha256": "497f17c9ddc56ee67f2dce9d350e3608a7d43edf3741911ae270344b9863cddc", "annex": "I", "before": {"end": 107, "start": 0, "text": "Pack sizes: a pack of 30 x 1 soft capsules and a multipack containing 90 (3 packs of 30 x 1) soft capsules.", "truncated": false}, "before_length": 107, "before_sha256": "2fbd18ea99b77241a23f4d3e1639db0192e20a341b8e2a799c5f403c34725d48", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 23, "before_end": 24, "before_start": 23, "kind": "delete"}, {"after_end": 28, "after_start": 27, "before_end": 28, "before_start": 28, "kind": "insert"}, {"after_end": 34, "after_start": 29, "before_end": 30, "before_start": 29, "kind": "replace"}, {"after_end": 36, "after_start": 35, "before_end": 32, "before_start": 31, "kind": "replace"}, {"after_end": 39, "after_start": 37, "before_end": 33, "before_start": 33, "kind": "insert"}, {"after_end": 41, "after_start": 40, "before_end": 35, "before_start": 34, "kind": "replace"}, {"after_end": 43, "after_start": 42, "before_end": 39, "before_start": 36, "kind": "replace"}, {"after_end": 46, "after_start": 45, "before_end": 41, "before_start": 41, "kind": "insert"}, {"after_end": 54, "after_start": 54, "before_end": 54, "before_start": 49, "kind": "delete"}, {"after_end": 59, "after_start": 59, "before_end": 82, "before_start": 59, "kind": "delete"}, {"after_end": 63, "after_start": 62, "before_end": 87, "before_start": 85, "kind": "replace"}, {"after_end": 68, "after_start": 67, "before_end": 92, "before_start": 91, "kind": "replace"}, {"after_end": 74, "after_start": 69, "before_end": 94, "before_start": 93, "kind": "replace"}, {"after_end": 76, "after_start": 75, "before_end": 96, "before_start": 95, "kind": "replace"}, {"after_end": 79, "after_start": 77, "before_end": 97, "before_start": 97, "kind": "insert"}, {"after_end": 81, "after_start": 80, "before_end": 99, "before_start": 98, "kind": "replace"}, {"after_end": 83, "after_start": 82, "before_end": 103, "before_start": 100, "kind": "replace"}, {"after_end": 86, "after_start": 85, "before_end": 105, "before_start": 105, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 44, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cddc00b15f9e0b18257255f9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.5", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1398}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "Eli Lilly Lietuva", "truncated": false}, "before_length": 17, "before_sha256": "05c382a64e2609c82c596fdb9399089a2cc347de8957ed9e690bbd5911ba7b38", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ce123e354bfbe84ffa4974cc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9460}
{"after": {"end": 20, "start": 0, "text": "Viatris Germany GmbH", "truncated": false}, "after_length": 20, "after_sha256": "4c2f2a211c5c41870eee98c700979da5e888736aac1a795ab787143446de83ca", "annex": "II", "before": {"end": 18, "start": 0, "text": "Mylan Germany GmbH", "truncated": false}, "before_length": 18, "before_sha256": "d7a3f7e30e2672617d153ba93a8cf1c2908da6e7dcfe6d206314ed71d4e5405a", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "replace"}, {"after_end": 7, "after_start": 3, "before_end": 5, "before_start": 4, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ce18fd1943542e1add9e66cf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005403", "medicine_name": "Sugammadex Mylan", "medicine_slug": "sugammadex-mylan", "observed_at": "2026-10-12T13:36:04Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "6c5163463373c99ccc880a476c1bf5361b2063cd7b687e079043070b6fb0e7f5", "source_snapshot_id": "source-c456b260a6ea2676dbd096d9", "source_updated_at": "2026-06-12", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/sugammadex-mylan-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 907}
{"after": {"end": 37, "start": 0, "text": "BristolMyers Squibb Polska Sp. z o.o.", "truncated": false}, "after_length": 37, "after_sha256": "879c6157ffdbde9480d5a62d5589e727166123ced2dd83568a6d587ba5052589", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ce1d4aa7f52f3cd35a555f3d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3242}
{"after": {"end": 30, "start": 0, "text": "Bristol-Myers Squibb Norway AS", "truncated": false}, "after_length": 30, "after_sha256": "4d312e57cb670ef0ce508bd73d4efdf4538b212e677408590a67036924ff5e9b", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 30, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 30}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ce58794e789a9d84df750519", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3219}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 21, "start": 0, "text": "Macrogol 400 (E 1521)", "truncated": false}, "before_length": 21, "before_sha256": "e706c372cbe268a129abfe719a7a7498e83b3f218b4477352a0e8f6a8820f6f7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ce59ed4c6a56e88efb7367bf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1917}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma UAB", "truncated": false}, "after_length": 19, "after_sha256": "0fa5997c653449c2ebe445618eaeedc027096662095bc4bf48a609ec757f79cd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ce6fa9b0daa4c7633c03e39a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2498}
{"after": {"end": 27, "start": 0, "text": "Magnesium stearate (E 470b)", "truncated": false}, "after_length": 27, "after_sha256": "e0ca810d671e9b48bd45316dc9f09544f62c4ac661b13ea13277faf10571fbe7", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ced3182e0e5ed72b49839d1b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1342}
{"after": {"end": 28, "start": 0, "text": "Une seringue préremplie et u", "truncated": false}, "after_length": 28, "after_sha256": "a6681f2e377bda1cc881672ba7bdef4bc27ffd12593ff5177eaa8da1957e7408", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Une seringue préremplie.", "truncated": false}, "before_length": 24, "before_sha256": "ec4571c4003e17c5a906cc68719727427fb1c0e8b93d602b2d5600fdda9ee205", "change_kind": "content", "change_operations": [{"after_end": 28, "after_start": 23, "before_end": 24, "before_start": 23, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cf398773fd76e4940e9d5591", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 823}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "тел. + 359 2 491 41 40", "truncated": false}, "before_length": 22, "before_sha256": "20ee19fc187fa89591c9d32ee74c794b988deee95480057943bcc3340ad79f21", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cf5b0f349faa9851d5b5fe4e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9465}
{"after": {"end": 7, "start": 0, "text": "Germany", "truncated": false}, "after_length": 7, "after_sha256": "80db4ccdca106d37b920206331fcfe3e9e50a9e763d89b54ce3ad5ac8cf30f03", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cf79d7a81de0712803eddbd8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1677}
{"after": {"end": 27, "start": 0, "text": "Bristol-Myers Squibb S.r.l.", "truncated": false}, "after_length": 27, "after_sha256": "f08fe5c808135fbbe673c4341ecaf78ddf1d45b6db60dc8f7534b838f176c63e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cf7ef8b795e735d3d4352dba", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2607}
{"after": {"end": 45, "start": 0, "text": "BristolMyers Squibb Marketing Services S.R.L.", "truncated": false}, "after_length": 45, "after_sha256": "be5fd3873d4974ef82d9deb306b94597f94cda5438931529a5b099349d1f12da", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 45, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 45}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cfb3d937525eab82e0defd0f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2588}
{"after": {"end": 9, "start": 0, "text": "65 (56.5)", "truncated": false}, "after_length": 9, "after_sha256": "1004e3264a2cb90f3ff43d9d31d97fa22e5eaed9cc59d82afb2add0e0cc02218", "annex": "I", "before": {"end": 10, "start": 0, "text": "(55 (59.1)", "truncated": false}, "before_length": 10, "before_sha256": "31c99c1b336f5a48cac866bb51fb16f0c18fb199e85283e24b27b475916b43ab", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "replace"}, {"after_end": 6, "after_start": 5, "before_end": 7, "before_start": 6, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 9, "before_start": 8, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cfb504f17bda5329d88cd8fc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 302}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb A.E.", "truncated": false}, "after_length": 24, "after_sha256": "10b1fadbbe52c3072f4ba1903512a3a4f5cd6eb487bf016dde5246419ff972b0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cfbd151708971cbc4adb0bf7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3227}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 458, "start": 0, "text": "Even though inhibition of CYP3A4 in the liver is not expected, the potential to inhibit CYP3A4 at the intestinal level has not been established at relevant niraparib concentrations. Therefore, caution is recommended when niraparib is combined with active substances the metabolism of which is CYP3A4dependent and, notably, those having a narrow therapeutic range (e.g. ciclosporin, tacrolimus, alfentanil, ergotamine, pimozide, quetiapine, and halofantrine).", "truncated": false}, "before_length": 458, "before_sha256": "2bad0da07584e0408ccab09e2cb1988d6e4081ead9f5c9e5b97ce829403c448f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 458, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 458, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cfe4c7f607678d0894260f44", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1114}
{"after": {"end": 37, "start": 0, "text": "Vyndaqel contains lactose monohydrate", "truncated": false}, "after_length": 37, "after_sha256": "076ec3f77fcb67434931fbaf8a766e28fe05c205517d97c72de96866567612bd", "annex": "IIIA", "before": {"end": 26, "start": 0, "text": "Vyndaqel contains sorbitol", "truncated": false}, "before_length": 26, "before_sha256": "ed41ba938962b40e628c71b52fb7247379e3deab09e0e7c09e8683f98b9c300e", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 18, "before_end": 23, "before_start": 18, "kind": "replace"}, {"after_end": 37, "after_start": 23, "before_end": 26, "before_start": 25, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 17}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-cff3672ef55d9a56d0bde6a9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3122}
{"after": {"end": 29, "start": 0, "text": "BristolMyers Squibb Norway AS", "truncated": false}, "after_length": 29, "after_sha256": "01226c5fbcee79cbe7d5ae55b232342409f6c95196e05bb842acfae228db69c9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 29, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 29}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d018d1a19ba07dc82bc25b9a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3222}
{"after": {"end": 678, "start": 0, "text": "[1] Les intervalles de confiance (IC) bilatéraux à 95 % pour les différences observées dans les taux de guérison (rezafungine moins caspofungine) sont calculés selon la méthode non ajustée de Miettinen et Nurminen, à l’exception de ceux de la guérison globale au jour 14, qui sont calculés en tenant compte des deux strates de randomisation (diagnostic [candidémie seulement ; candidose invasive] et du score APACHE II/de la NAN [score APACHE II ≥ 20 OU NAN < 500 cellules/mm3 ; score APACHE II < 20 ET NAN ≥ 500 cellules/mm3] à la sélection) selon la méthode de Miettinen et Nurminen. Les pondérations de CochraneMantelHaenszel sont utilisées pour les pondérations des strates.", "truncated": false}, "after_length": 678, "after_sha256": "256d46c7fd11c4a19880ff58cb0688a4480483b4823fb0760a3d0c555c701a22", "annex": "I", "before": {"end": 548, "start": 0, "text": "[1] Les intervalles de confiance (IC) bilatéraux à 95 % pour les différences observées dans les taux de guérison (rezafungine moins caspofungine) sont calculés en tenant compte des deux strates de randomisation (diagnostic [candidémie seulement ; candidose invasive] et du score APACHE II/de la NAN [score APACHE II ≥ 20 OU NAN < 500 cellules/mm3 ; score APACHE II < 20 ET NAN ≥ 500 cellules/mm3] à la sélection) selon la méthode de Miettinen et Nurminen. Les pondérations de CochraneMantelHaenszel sont utilisées pour les pondérations des strates.", "truncated": false}, "before_length": 548, "before_sha256": "116ff3801b8dea53443d6b0ffc5b246a2fcba7e0f85982c526e649d6c304f550", "change_kind": "content", "change_operations": [{"after_end": 290, "after_start": 160, "before_end": 160, "before_start": 160, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 130}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d020470e9ab8973597ebf11f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 320}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 3, "start": 0, "text": "Lot", "truncated": false}, "before_length": 3, "before_sha256": "23ea1b1beb5529f4f4cbe47df67ef01587f29229a112e020eff530d5033fbcff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d024b2697c7ebe47defc2c2e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4897}
{"after": {"end": 21, "start": 0, "text": "medinfo.czech@bms.com", "truncated": false}, "after_length": 21, "after_sha256": "7d80d4bfa363423e385e42b079e9a90210b1f5d622fbfe8ab954e6684db7cffd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d02f8197799a803f9e95a3e4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3186}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 103, "start": 0, "text": "The major primary metabolite M1 does not appear to be an inhibitor of Pgp, BCRP, BSEP, MRP2 or MATE1/2.", "truncated": false}, "before_length": 103, "before_sha256": "4a738731cb95391ab20f8eccf19c9fe68fa565c5ac0f68b32d10138986763e65", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 103, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 103, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d05cddd67b022a15aabf8a8a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 266}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovakia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7b73e721c843deabd3a181fa5d110ba6dfbdc9531c8d2e1e6545e547e02a9ef0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d069409512dd082cce93601c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2916}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 91, "start": 0, "text": "Reddish brown, opaque, oblong (approximately 21 mm) capsule printed with “VYN 61” in white.", "truncated": false}, "before_length": 91, "before_sha256": "d32b10988625e4e557a0478862ab035e00d3e3e2ee071c3042202f5e2e23b9c2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 91, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 91, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d07059ff4b41bb639049ccbf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "3", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 938}
{"after": {"end": 50, "start": 0, "text": "Bristol-Myers Squibb Farmacêutica Portuguesa, S.A.", "truncated": false}, "after_length": 50, "after_sha256": "b45db49b9e7da10994e66b4b07970d30abee33a254211bc6a5f34f1b9db60aa0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 50, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 50}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d0c44cb40f3b049a344c9a47", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2572}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 30, "start": 0, "text": "Ammonium hydroxide (E 527) 28%", "truncated": false}, "before_length": 30, "before_sha256": "7e93aff1922e53b0789b4ee36f07f1e44649f7428461a25e035fed006925fccf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 30, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 30, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d0cead710bab3e3927c194b6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1379}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ Α.Ε.Β.Ε.", "truncated": false}, "before_length": 24, "before_sha256": "2cbdeaeb84435c2c176411922d614ce7637d1b69f42b769b3717bbde1729e4b4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d0d6a8a8d41457ff3922986b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9499}
{"after": {"end": 15, "start": 0, "text": "Česká republika", "truncated": false}, "after_length": 15, "after_sha256": "c768c215f215c71e7ffcbffe06cb1a66fa3c379a86285d5da65cef3c627bc09d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d0e12e24ae3ac156e1a90c1c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2506}
{"after": {"end": 11, "start": 0, "text": "Formycon AG", "truncated": false}, "after_length": 11, "after_sha256": "fccef1aaaa56a3d37990d6179dbede326f4022a38ec5c503d32cfc14c28d9608", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d0f87551880a9c0fec86d850", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1674}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 45 45 93 05 06", "truncated": false}, "after_length": 21, "after_sha256": "61983c14390c5d0df2153e10740a9b1eb429e8c0b05c3ebe705431c827a32b81", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d11364c44f2b168eef8699f4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2830}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "before_length": 7, "before_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d12f5e030da6b1ff8c1b3467", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2030}
{"after": {"end": 24, "start": 0, "text": "medischeafdeling@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "3815a916e71fc353b4410b37e0a85dede1ac350e08b8ab1461a12a1b0da71bb9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d13d5df6682f51289490d8de", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2534}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 120, "start": 0, "text": "Neither niraparib nor M1 inhibits organic anion transporter 1 (OAT1), 3 (OAT3), and organic cation transporter 2 (OCT2).", "truncated": false}, "before_length": 120, "before_sha256": "f6f2d061c01064ef5d285ca755a885e4098aa755acf49533ce90df33c48e3b0f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 120, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 120, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d16b77327c005b83315684aa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 274}
{"after": {"end": 26, "start": 0, "text": "Medium-chain triglycerides", "truncated": false}, "after_length": 26, "after_sha256": "dd199d2b7624b3e00cded213447ec6f4931c7c0b3264df5d6daa4c2bb0293e45", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d1711de7b65da6ddd0a8ffad", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1350}
{"after": {"end": 6, "start": 0, "text": "Polska", "truncated": false}, "after_length": 6, "after_sha256": "d1974e0e3e575b6dadb40f080dae05025f574cb23e5cababcac0f50cf2619549", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d18f85f58fd9e854f4eecdae", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2561}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 86, "start": 0, "text": "The CHMP recommends that the terms of the Marketing Authorisation(s) should be varied.", "truncated": false}, "before_length": 86, "before_sha256": "cbb4f69529a9be6de0d2c00965408c358c7d6304c2a0f7852653b1180bb73b09", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 86, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 86, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d190fa6ccc117ac28b20a8d1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3468}
{"after": {"end": 20, "start": 0, "text": "Carbonate de calcium", "truncated": false}, "after_length": 20, "after_sha256": "3317c74422e40fb7e40fd826abfb72adc5f94714be51ab03bc38e5ad9f9d307b", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d1a5533bda25e85fd852036d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1890}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 57, "start": 0, "text": "• Pull off the outer needle shield. Do not throw it away.", "truncated": false}, "before_length": 57, "before_sha256": "1138c7106389d2699078aee9484ecb2a550781eb593c03dd054ca3b69b62a042", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 57, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 57, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d1a7ee8ecb3076d214ee861d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9650}
{"after": {"end": 21, "start": 0, "text": "Tlf: + 47 67 55 53 50", "truncated": false}, "after_length": 21, "after_sha256": "d1b594f6660af0e3776951e66e526813a270ea883650a47e68423146b1d67dd7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d1d2f0384dc1dacf3cdb1b81", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2543}
{"after": {"end": 38, "start": 0, "text": "Pfizer Luxembourg SARL filiāle Latvijā", "truncated": false}, "after_length": 38, "after_sha256": "0faf5c92c10d6b843893cb7c41ee4ab7c87fec3cd38cd32c1b8ebce28c790790", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d21079e258acd6d57c6c2e15", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3740}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 6, "start": 0, "text": "Italia", "truncated": false}, "before_length": 6, "before_sha256": "a7ca3e3d756601d5a22a4c0d8629da0c0ce425e5be526078d3e4583737150f52", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 6, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d29148c0d0129f642773d068", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9542}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 17, "start": 0, "text": "D-90429 Nuremberg", "truncated": false}, "before_length": 17, "before_sha256": "e947a9c523ae55d462208c17464751e497403938b7fe52dead7696ca6851269b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 17, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 17, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d31b4a3e17fbf2c9487e30ce", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1700}
{"after": {"end": 16, "start": 0, "text": "A.M. Mangion Ltd", "truncated": false}, "after_length": 16, "after_sha256": "24f7ac6ac947e8ef3e36c6f6c1f51219647e1477dfe330121521ec39faf6cb0c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d31d38ebffc6fcb339a61d11", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2838}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 435, "start": 0, "text": "The Tempo Pen is a disposable pre-filled pen containing 3 ml (300 units, 100 units/ml) of insulin lispro. One Tempo Pen contains multiple doses of insulin. The Tempo Pen dials 1 unit at a time. The number of units are displayed in the dose window, always check this before your injection. You can give from 1 to 60 units in a single injection. If your dose is more than 60 units, you will need to give yourself more than one injection.", "truncated": false}, "before_length": 435, "before_sha256": "4adf4752273312d7193bf664ada920a5832f11558f89b685af1260fa3433e775", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 435, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 435, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d356117d7dcbdd1394e1c5ac", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9241}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d360adcb926d689de95730fb", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2878}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "Lilly France.", "truncated": false}, "before_length": 13, "before_sha256": "030d614d929cff863ccf1bd87a7c467a1e843035d0e200a6c48f7d59b0b8f880", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d3777e2f16f8a3e31042861d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9513}
{"after": {"end": 57, "start": 0, "text": "https://www.ema.europa.eu/en/medicines/human/epar/Humalog", "truncated": false}, "after_length": 57, "after_sha256": "0cf421b48f16b4ee4f30d90e18f9f113ff9c0385151b8c2bb7109b5cfe27f0cf", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 57, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 57}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d379224fd058760d8214cd1a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d38485e77a1151643a1211e5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2915}
{"after": {"end": 26, "start": 0, "text": "BristolMyers Squibb S.r.l.", "truncated": false}, "after_length": 26, "after_sha256": "f44e170b34d2109b4908eb0ce3e17a4d6452169164e3f8ef3869b0c2498f1974", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d3849771152f4e395acb9a80", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3287}
{"after": {"end": 16, "start": 0, "text": "pv@ammangion.com", "truncated": false}, "after_length": 16, "after_sha256": "53f45568239cbb258daee24319c4e0fde3bfc6917d09b88019c1cb8329ded177", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d389eee6c32526addbb89ac2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2530}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "In-use Pen", "truncated": false}, "before_length": 10, "before_sha256": "0fdb2fb0eeafa382eb1ae6bdb034a9467539c7cc88dc8f7023fc66fc9442ad57", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d38e63a04e7c0dd942521a61", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9791}
{"after": {"end": 16, "start": 0, "text": "A.M. Mangion Ltd", "truncated": false}, "after_length": 16, "after_sha256": "24f7ac6ac947e8ef3e36c6f6c1f51219647e1477dfe330121521ec39faf6cb0c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d3c3ec13afb2fc225488ae36", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2528}
{"after": {"end": 9, "start": 0, "text": "29 (25,2)", "truncated": false}, "after_length": 9, "after_sha256": "a4dafa149204448ae058df3c21bb6dd989b4a3f79aa8cd14c360625596eeb663", "annex": "I", "before": {"end": 9, "start": 0, "text": "22 (23,7)", "truncated": false}, "before_length": 9, "before_sha256": "a0363c4a7a9fb99f38f1dddffbaed3e0d26223bf17d5e4fb6f3a15778ba85962", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 1, "before_end": 2, "before_start": 1, "kind": "replace"}, {"after_end": 6, "after_start": 5, "before_end": 6, "before_start": 5, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 8, "before_start": 7, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d3c9df6376df5e62b277cda9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 316}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "България", "truncated": false}, "before_length": 8, "before_sha256": "a7215e5aa55f878990c076bb8195d75ca42044d4d5c7d2ba90af610508b643d3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d3cc863044f90a5a44272573", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9463}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d4060679ad04724b9c6e846d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3269}
{"after": {"end": 321, "start": 0, "text": "In vitro, le niraparib est un inhibiteur de la P-gp. Comme aucune donnée clinique n'est disponible, il ne peut être exclu que le niraparib puisse augmenter l'exposition systémique d'autres médicaments transportés par la P-gp qui sont sensibles à l'inhibition intestinale de la P-gp (par exemple, le dabigatran étexilate).", "truncated": false}, "after_length": 321, "after_sha256": "76a01b01f642a05f6fd8f023a19722c42fb168d1532120a95f28fa35d6096936", "annex": "I", "before": {"end": 328, "start": 0, "text": "Le niraparib n’est pas un inhibiteur de la BSEP ou de la MRP2. In vitro, le niraparib inhibe très faiblement la P-gp et la BCRP avec un IC50 = 161 µM et 5,8 µM, respectivement. Par conséquent, bien qu’improbable, une interaction cliniquement significative liée à une inhibition de ces transporteurs d’efflux ne peut être exclue.", "truncated": false}, "before_length": 328, "before_sha256": "157a20315e0fe489d40d113d19f7aebaec70e120aa610f694bc063e98a7db085", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 63, "before_start": 0, "kind": "delete"}, {"after_end": 30, "after_start": 23, "before_end": 86, "before_start": 86, "kind": "insert"}, {"after_end": 37, "after_start": 35, "before_end": 91, "before_start": 91, "kind": "insert"}, {"after_end": 40, "after_start": 38, "before_end": 92, "before_start": 92, "kind": "insert"}, {"after_end": 42, "after_start": 41, "before_end": 103, "before_start": 93, "kind": "replace"}, {"after_end": 43, "after_start": 43, "before_end": 108, "before_start": 104, "kind": "delete"}, {"after_end": 52, "after_start": 51, "before_end": 116, "before_start": 116, "kind": "insert"}, {"after_end": 57, "after_start": 53, "before_end": 117, "before_start": 117, "kind": "insert"}, {"after_end": 58, "after_start": 58, "before_end": 127, "before_start": 118, "kind": "delete"}, {"after_end": 61, "after_start": 60, "before_end": 131, "before_start": 129, "kind": "replace"}, {"after_end": 62, "after_start": 62, "before_end": 213, "before_start": 132, "kind": "delete"}, {"after_end": 67, "after_start": 66, "before_end": 226, "before_start": 217, "kind": "replace"}, {"after_end": 72, "after_start": 69, "before_end": 228, "before_start": 228, "kind": "insert"}, {"after_end": 84, "after_start": 81, "before_end": 238, "before_start": 237, "kind": "replace"}, {"after_end": 86, "after_start": 85, "before_end": 240, "before_start": 239, "kind": "replace"}, {"after_end": 89, "after_start": 88, "before_end": 243, "before_start": 242, "kind": "replace"}, {"after_end": 90, "after_start": 90, "before_end": 289, "before_start": 244, "kind": "delete"}, {"after_end": 97, "after_start": 93, "before_end": 294, "before_start": 292, "kind": "replace"}, {"after_end": 99, "after_start": 98, "before_end": 298, "before_start": 295, "kind": "replace"}, {"after_end": 101, "after_start": 100, "before_end": 304, "before_start": 299, "kind": "replace"}, {"after_end": 102, "after_start": 102, "before_end": 307, "before_start": 305, "kind": "delete"}, {"after_end": 124, "after_start": 121, "before_end": 326, "before_start": 326, "kind": "insert"}, {"after_end": 320, "after_start": 125, "before_end": 327, "before_start": 327, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 238, "chars_inserted": 231}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d40987250b5b871326ac17d7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1157}
{"after": {"end": 167, "start": 0, "text": "Vyndaqel film-coated tablets are 11 mm round white to off-white and embossed with “61” on one side. Vyndaqel is available in two pack sizes of OPA/Al/PVC-alu blisters.", "truncated": false}, "after_length": 167, "after_sha256": "d032d995ca9be3cef90c81952b71d5c983852b4e1d8510e1efebe919ed59cad3", "annex": "IIIA", "before": {"end": 331, "start": 0, "text": "Vyndaqel soft capsules are reddish brown, opaque, oblong (approximately 21 mm) printed with “VYN 61” in white. Vyndaqel is available in two pack sizes of PVC/PA/alu/PVC-alu perforated unit dose blisters: a pack of 30 x 1 soft capsules and a multipack of 90 soft capsules comprising of 3 cartons, each containing 30 x 1soft capsules", "truncated": false}, "before_length": 331, "before_sha256": "7c074ee649eeda80287a61988ed575b1630077cd0134445058530b46f3fa5843", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 9, "before_end": 10, "before_start": 9, "kind": "replace"}, {"after_end": 17, "after_start": 16, "before_end": 12, "before_start": 11, "kind": "replace"}, {"after_end": 20, "after_start": 18, "before_end": 13, "before_start": 13, "kind": "insert"}, {"after_end": 22, "after_start": 21, "before_end": 15, "before_start": 14, "kind": "replace"}, {"after_end": 24, "after_start": 23, "before_end": 19, "before_start": 16, "kind": "replace"}, {"after_end": 27, "after_start": 26, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 34, "after_start": 33, "before_end": 73, "before_start": 27, "kind": "replace"}, {"after_end": 38, "after_start": 38, "before_end": 78, "before_start": 77, "kind": "delete"}, {"after_end": 39, "after_start": 39, "before_end": 80, "before_start": 79, "kind": "delete"}, {"after_end": 47, "after_start": 40, "before_end": 81, "before_start": 81, "kind": "insert"}, {"after_end": 65, "after_start": 48, "before_end": 82, "before_start": 82, "kind": "insert"}, {"after_end": 74, "after_start": 66, "before_end": 84, "before_start": 83, "kind": "replace"}, {"after_end": 83, "after_start": 83, "before_end": 97, "before_start": 93, "kind": "delete"}, {"after_end": 88, "after_start": 87, "before_end": 102, "before_start": 101, "kind": "replace"}, {"after_end": 95, "after_start": 90, "before_end": 106, "before_start": 104, "kind": "replace"}, {"after_end": 97, "after_start": 96, "before_end": 108, "before_start": 107, "kind": "replace"}, {"after_end": 144, "after_start": 143, "before_end": 158, "before_start": 154, "kind": "replace"}, {"after_end": 148, "after_start": 147, "before_end": 162, "before_start": 161, "kind": "replace"}, {"after_end": 149, "after_start": 149, "before_end": 164, "before_start": 163, "kind": "delete"}, {"after_end": 158, "after_start": 158, "before_end": 194, "before_start": 173, "kind": "delete"}, {"after_end": 167, "after_start": 166, "before_end": 331, "before_start": 202, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 219, "chars_inserted": 55}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d444dab021c38ff66efc1dc6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3196}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "5. AUTRE", "truncated": false}, "before_length": 8, "before_sha256": "745dd9ad706e66baade8a4bb326ef37abec32db7189b3516bbcfe36aa6cd5b8c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d448c4269955929f8f9815c8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1128}
{"after": {"end": 25, "start": 0, "text": "BristolMyers Squibb, S.A.", "truncated": false}, "after_length": 25, "after_sha256": "88e5c5115dcefbb042e25eed814626af9715f5463760d1a01269da8ccc06cd7e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d44d8120221dd5ef21f6f9a7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2563}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 48 22 2606400", "truncated": false}, "after_length": 21, "after_sha256": "91ea111aa679f6773d6dedcb0b0a2558a35b3e3387196cb6b3c71a9a8806c141", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d4577ea42dea2f7718bf4103", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3240}
{"after": {"end": 38, "start": 0, "text": "N.V. Bristol-Myers Squibb Belgium S.A.", "truncated": false}, "after_length": 38, "after_sha256": "aed62c6e6383ee3130a6851382813dabc668847cc45474eecb9eae19fd27a962", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d516abab3ef26c58a964e6fd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3164}
{"after": {"end": 37, "start": 0, "text": "N.V. BristolMyers Squibb Belgium S.A.", "truncated": false}, "after_length": 37, "after_sha256": "feeebdb54667cd864ac3ce52dc07c49e265c3b042233fe6691e3f074fda776c2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d521accca2437b182cf03744", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2493}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 53, "start": 0, "text": "• Pull off the inner needle shield and throw it away.", "truncated": false}, "before_length": 53, "before_sha256": "5cbe64aadde42e28acaa810c9a4baf06fca309fdf6dfffebe69f11340b8e11ca", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 53, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 53, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d552bd94d67abc2cb979e806", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9651}
{"after": {"end": 36, "start": 0, "text": "Vyndaqel 61 mg, comprimés pelliculés", "truncated": false}, "after_length": 36, "after_sha256": "70d3e9c94874ff78e6ff1e940cdf64cbf06bd8e778cf4abb4c78ce4ca876c4cb", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 36}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d5559b1905081ae370849715", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2034}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 14, "start": 0, "text": "Purified water", "truncated": false}, "before_length": 14, "before_sha256": "102fa07af368b7a7b2de98b708bb6a1e101a885482b8b1e7fd945f3a91f8f2b4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d5b7dd216a0a45f3773e9eeb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1374}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 70, "start": 0, "text": "• you have an infection or illness (especially diarrhoea or vomiting);", "truncated": false}, "before_length": 70, "before_sha256": "472bb3626a794b4c3e009ba62320ccddbfcf4bea76629ec1506ac121d2a689fc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 70, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 70, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d5d49a3ce93eb15ef195ae4a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9390}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 23, "start": 0, "text": "Enveloppe de la capsule", "truncated": false}, "before_length": 23, "before_sha256": "6e4a7b9a0bc546fc5d972fb413ea50336e5f82b487c76e56ac0ee3bc25921f4e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d605269f394f80d623938070", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1895}
{"after": {"end": 7, "start": 0, "text": "Sverige", "truncated": false}, "after_length": 7, "after_sha256": "3a7d70b4edb982a403e97d77681309e5fb1032b12d727aa1e92b145b069b9aa4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d63a4531e97a5dac5297be0e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3298}
{"after": {"end": 9, "start": 0, "text": "Danemarca", "truncated": false}, "after_length": 9, "after_sha256": "aa62ca811afd7d8cbf62b0601ca860863bdb18df68b1426acf2862cb7a82b5ac", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d63f2366ef079ac90fddbac8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1823}
{"after": {"end": 34, "start": 0, "text": "Orteliuslaan 1000, 3528 BD Utrecht", "truncated": false}, "after_length": 34, "after_sha256": "46a90fc46ae308c2beeb35ead613fcf3ade5a51e2217a834de3fa5972dab9eec", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d657ef2e6ba8aa7510385651", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 5 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "7", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1030}
{"after": {"end": 7, "start": 0, "text": "Lietuva", "truncated": false}, "after_length": 7, "after_sha256": "5109820f748796128b8bafd3806d05511bc89ad77fc3cda960facf37a639bc7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d695258de9fe6b80bc9bd2bc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2497}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 37, "start": 0, "text": "14. GENERAL CLASSIFICATION FOR SUPPLY", "truncated": false}, "before_length": 37, "before_sha256": "0a2c9dd7ac0be92910d87b1a1b036337a62217a1d8517a2e70dc3f3b7965f761", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 37, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 37, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d6b43586192c53366c023de8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4656}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 64, "start": 0, "text": "General information about the safe and effective use of your Pen", "truncated": false}, "before_length": 64, "before_sha256": "bcba84cfa4f798545a9affff90d516ebd469ddb5730f39f880090ab823c71188", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 64, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 64, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d6c5efb0dc2b225fe56c3f32", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9794}
{"after": {"end": 34, "start": 0, "text": "medinfo.croatia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "59c47394700ad787801e8ce1b033fc5d63a885ddfc680677ae6b5acd89bb7df3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d6d37cc4a4841b11661e3009", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3259}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 50, "start": 0, "text": "• Always carry something to show you are diabetic.", "truncated": false}, "before_length": 50, "before_sha256": "4471227fd21f1c444a93539f5aff6a290e7adcf3897643938e54267abe274504", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 50, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 50, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d6dec0f05cad58f5e5dc7508", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9354}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d70444c08bb8b3a8e61dd485", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3165}
{"after": {"end": 19, "start": 0, "text": "Fraunhoferstraße 15", "truncated": false}, "after_length": 19, "after_sha256": "9ccfb7d105423789527cf7311fe43c201269724fe0c57028034980f9b3a83147", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d70ffb037805c3e383e07280", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1702}
{"after": {"end": 30, "start": 0, "text": "BristolMyers Squibb Aktiebolag", "truncated": false}, "after_length": 30, "after_sha256": "9c7a7f4a2d4615c649fd8b61a4a516d07f947239591e0ac22650195cdcec2547", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 30, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 30}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d71c4ae56a54ce06a9ceeeab", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2938}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "customercontactuk@gsk.com", "truncated": false}, "before_length": 25, "before_sha256": "73834f2ec2786ba4565d1820e07d2bb38952e8214867b143e05286042d58b0b0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d73b614188607a3e90d1b2f5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2616}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 86, "start": 0, "text": "• If you need to inject more than the number of units left in the Pen, you may either:", "truncated": false}, "before_length": 86, "before_sha256": "5e49cf92604843ed4ec6911b95492fad9c4a2b53e4e3ae802af500dcb3481021", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 86, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 86, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d75731c860e37e43b543c516", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9728}
{"after": {"end": 18, "start": 0, "text": "Tel.: +48223062447", "truncated": false}, "after_length": 18, "after_sha256": "d28cf2c5f0efd22cd4923b6e6052ea498b235be2df08536c0ede2f879b785b12", "annex": "IIIA", "before": {"end": 17, "start": 0, "text": "Tel: +48223062447", "truncated": false}, "before_length": 17, "before_sha256": "808aeab2c3041d246a9c5b5c09ac20d27f80c3caf2bd78d39636a294c464387a", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d76656ae7e359a85f26830e6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1617}
{"after": {"end": 268, "start": 0, "text": "In vitro, niraparib is an inhibitor of Pgp. As no clinical data are available, it cannot be excluded that niraparib may increase the systemic exposure of other medicines transported by P-gp that are sensitive to intestinal P-gp inhibition (e.g., dabigatran etexilate).", "truncated": false}, "after_length": 268, "after_sha256": "1ec52b7baaeae2125d7176ca834ebbdb89cb108b8ddc040f48dbf3a8965aad5a", "annex": "I", "before": {"end": 288, "start": 0, "text": "Niraparib is not an inhibitor of BSEP or MRP2. In vitro, niraparib inhibits Pgpvery weakly and BCRP with an IC50 = 161 µM and 5.8 µM, respectively. Therefore, a clinically meaningful interaction related to an inhibition of these efflux transporters, although unlikely, cannot be excluded.", "truncated": false}, "before_length": 288, "before_sha256": "d7ab2f4da051aba644982b85f912e2b1236b9d311bf2e31df4b756f2aead03e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 47, "before_start": 0, "kind": "delete"}, {"after_end": 21, "after_start": 21, "before_end": 74, "before_start": 68, "kind": "delete"}, {"after_end": 22, "after_start": 22, "before_end": 205, "before_start": 75, "kind": "delete"}, {"after_end": 33, "after_start": 33, "before_end": 217, "before_start": 216, "kind": "delete"}, {"after_end": 35, "after_start": 34, "before_end": 219, "before_start": 218, "kind": "replace"}, {"after_end": 61, "after_start": 39, "before_end": 223, "before_start": 223, "kind": "insert"}, {"after_end": 66, "after_start": 62, "before_end": 227, "before_start": 224, "kind": "replace"}, {"after_end": 76, "after_start": 68, "before_end": 229, "before_start": 229, "kind": "insert"}, {"after_end": 77, "after_start": 77, "before_end": 248, "before_start": 230, "kind": "delete"}, {"after_end": 80, "after_start": 79, "before_end": 252, "before_start": 250, "kind": "replace"}, {"after_end": 81, "after_start": 81, "before_end": 268, "before_start": 253, "kind": "delete"}, {"after_end": 267, "after_start": 100, "before_end": 287, "before_start": 287, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 223, "chars_inserted": 203}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d7795b415db30ec3135b81bb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 260}
{"after": {"end": 172, "start": 0, "text": "N’utilisez pas ce médicament après la date de péremption indiquée sur l’étiquette et l’emballage après EXP. La date de péremption fait référence au dernier jour de ce mois.", "truncated": false}, "after_length": 172, "after_sha256": "8fc7acb0dc4cfd1c034fdde8f3fd4b02a676985f566cd90dc0f113904db16011", "annex": "IIIA", "before": {"end": 157, "start": 0, "text": "N’utilisez pas ce médicament après la date de péremption indiquée sur l’étiquette après EXP. La date de péremption fait référence au dernier jour de ce mois.", "truncated": false}, "before_length": 157, "before_sha256": "4a98a31be5d045e25b565aec993a06afc7ac91da12c50a60236d9e054d4f53ed", "change_kind": "content", "change_operations": [{"after_end": 97, "after_start": 82, "before_end": 82, "before_start": 82, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d79fe2e91dc4495f852e0a72", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1532}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 180, "start": 0, "text": "Do not use this medicine if you notice the solution is coloured or it has solid pieces in it. You must use it only if it looks like water. Check this each time you inject yourself.", "truncated": false}, "before_length": 180, "before_sha256": "ba76360b589cbce013e63ac74bcc5ee80d9ec4eb028a757242acaadaa59604b7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 180, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 180, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d7bcd7879f77e2edf1b5c6df", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9431}
{"after": {"end": 33, "start": 0, "text": "Τηλ: 800 92666 (+ 30 210 6074300)", "truncated": false}, "after_length": 33, "after_sha256": "3c667c31f7c324c43671bdd5606ccfdb57ec8b49816d058ab68a853627dd20b8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d7be80ce88ea88be9fe92037", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3295}
{"after": {"end": 19, "start": 0, "text": "-1,0 (-13,5 ; 11,6)", "truncated": false}, "after_length": 19, "after_sha256": "60dc1d8195cd58876f509f7e6e8e4ed8cd5ea18469458ca3b257bfda382c7535", "annex": "I", "before": {"end": 17, "start": 0, "text": "1,1 (14,9 ; 12,7)", "truncated": false}, "before_length": 17, "before_sha256": "c070833bb4b1ec9bc5d87e4494f51cb63e62dde794411f8f7bbbcc8f8f0ea302", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}, {"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 7, "after_start": 6, "before_end": 5, "before_start": 5, "kind": "insert"}, {"after_end": 9, "after_start": 8, "before_end": 7, "before_start": 6, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 9, "before_start": 8, "kind": "replace"}, {"after_end": 16, "after_start": 15, "before_end": 14, "before_start": 13, "kind": "replace"}, {"after_end": 18, "after_start": 17, "before_end": 16, "before_start": 15, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d7ca442c513a36c0fc9bc8a5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 310}
{"after": {"end": 294, "start": 0, "text": "Following a single oral 300mg dose of niraparib, the mean terminal halflife (t½) of niraparib ranged from 44 to 54 hours (approximately 2 days) across studies. In a population pharmacokinetic analysis, the apparent total clearance (CL/F) of niraparib was 15.9 L/h in cancer patients (CV 24.0%).", "truncated": false}, "after_length": 294, "after_sha256": "6ed9eb602c4ad59873b7907863feaf3299d2deec12d7f504806df0d01268fd85", "annex": "I", "before": {"end": 279, "start": 0, "text": "Following a single oral 300mg dose of niraparib, the mean terminal halflife (t½) of niraparib ranged from 48 to 51 hours (approximately 2 days). In a population pharmacokinetic analysis, the apparent total clearance (CL/F) of niraparib was 16.5 L/h in cancer patients (CV 23.4%).", "truncated": false}, "before_length": 279, "before_sha256": "ff012a2854ddc75be9783dd91c0bd9b8eae0b82c9636115e2f7e958fc4ada176", "change_kind": "content", "change_operations": [{"after_end": 108, "after_start": 107, "before_end": 108, "before_start": 107, "kind": "replace"}, {"after_end": 114, "after_start": 113, "before_end": 114, "before_start": 113, "kind": "replace"}, {"after_end": 158, "after_start": 143, "before_end": 143, "before_start": 143, "kind": "insert"}, {"after_end": 257, "after_start": 256, "before_end": 242, "before_start": 241, "kind": "replace"}, {"after_end": 259, "after_start": 258, "before_end": 244, "before_start": 243, "kind": "replace"}, {"after_end": 289, "after_start": 288, "before_end": 274, "before_start": 273, "kind": "replace"}, {"after_end": 291, "after_start": 290, "before_end": 276, "before_start": 275, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d7dd4b1a999d34accf15335c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 775}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Selecting your dose", "truncated": false}, "before_length": 19, "before_sha256": "c5f8efe7c6a6a848251870ad59ecb22e54cd16142f79a677c40014e3292d2c86", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d7e71520f6e2442c2e1c149b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9681}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 4, "start": 0, "text": "Dose", "truncated": false}, "before_length": 4, "before_sha256": "6b942766c4e443fa0de85800f1d7310c1d485f6ce3f4e2ee405cb4f61270ddb0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 4, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d7ed1e652bbbc0553cf7767f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9306}
{"after": {"end": 173, "start": 0, "text": "L'âge (entre 26 et 91 ans) n'était pas un facteur significatif pour la clairance ou le volume de distribution du niraparib dans l'analyse pharmacocinétique de la population.", "truncated": false}, "after_length": 173, "after_sha256": "181a26b8a86942495230ec1a60c01fdfc856df94f52711b7f8f4d7b329143596", "annex": "I", "before": {"end": 338, "start": 0, "text": "Il a été montré que l’augmentation de l’âge diminuait la clairance du niraparib dans l’analyse pharmacocinétique de la population. L’exposition moyenne chez une patiente de 91 ans a été estimée comme étant 23% plus élevée que celle d’une patiente de 30 ans. L’impact de l’âge n’est pas considéré comme justifiant un ajustement de la dose.", "truncated": false}, "before_length": 338, "before_sha256": "7d3c2d9442f415bcb59e666806ef4d732c9f45064af4ec4ecf0ae3d620621c5c", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 0, "before_end": 40, "before_start": 0, "kind": "replace"}, {"after_end": 8, "after_start": 6, "before_end": 48, "before_start": 44, "kind": "replace"}, {"after_end": 31, "after_start": 9, "before_end": 50, "before_start": 49, "kind": "replace"}, {"after_end": 67, "after_start": 34, "before_end": 53, "before_start": 53, "kind": "insert"}, {"after_end": 109, "after_start": 80, "before_end": 66, "before_start": 66, "kind": "insert"}, {"after_end": 130, "after_start": 129, "before_end": 87, "before_start": 86, "kind": "replace"}, {"after_end": 172, "after_start": 172, "before_end": 337, "before_start": 129, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 254, "chars_inserted": 89}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d829c2ffdd038a526d35d1c7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 822}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 9, "start": 0, "text": "Slovenija", "truncated": false}, "before_length": 9, "before_sha256": "fa267dd198bd52b588eff3ae1ccd7c7ea1ac67b4d621fd44e50742c91809cac3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d8339ad04a702727c03dfc41", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9530}
{"after": {"end": 24, "start": 0, "text": "Tel: + 31 (0)30 300 2222", "truncated": false}, "after_length": 24, "after_sha256": "df26f07876232a3ba50861e46ee103ea04d50c8b384a64d52078fdc518ae52ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d84e10fb5b8a0641bab88019", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2849}
{"after": {"end": 38, "start": 0, "text": "BristolMyers Squibb Pharmaceuticals uc", "truncated": false}, "after_length": 38, "after_sha256": "78edaf732c95d13a5ec5ba0a04740553812606cbf3d2047b91d484b5e76e8b52", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d867d0ac67ccf2d35176f0d7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2903}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d878fe2273c923334794c710", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3038}
{"after": {"end": 148, "start": 0, "text": "Age (range 26 to 91 years) was not a significant factor on niraparib clearance or volume of distribution in the population pharmacokinetic analysis.", "truncated": false}, "after_length": 148, "after_sha256": "67d977c32d05b3c9c00bbaaf278821fcc730850d7f51d4f789347b8d330dfa88", "annex": "I", "before": {"end": 272, "start": 0, "text": "Increasing age was found to decrease niraparib clearance in the population pharmacokinetic analysis. The average exposure in a 91-year old patient was predicted to be 23% higher than in a 30-year old patient. The impact of age is not considered to warrant dose adjustment.", "truncated": false}, "before_length": 272, "before_sha256": "8f68b3500b1fe794f8017a0c91429e71e2af8d0044bd0ce7d7764f9248c9f1a2", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 21, "after_start": 8, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 23, "before_end": 6, "before_start": 6, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 14, "before_start": 7, "kind": "replace"}, {"after_end": 42, "after_start": 31, "before_end": 19, "before_start": 19, "kind": "insert"}, {"after_end": 46, "after_start": 43, "before_end": 22, "before_start": 20, "kind": "replace"}, {"after_end": 48, "after_start": 47, "before_end": 24, "before_start": 23, "kind": "replace"}, {"after_end": 52, "after_start": 49, "before_end": 25, "before_start": 25, "kind": "insert"}, {"after_end": 55, "after_start": 54, "before_end": 27, "before_start": 27, "kind": "insert"}, {"after_end": 58, "after_start": 56, "before_end": 36, "before_start": 28, "kind": "replace"}, {"after_end": 104, "after_start": 78, "before_end": 56, "before_start": 56, "kind": "insert"}, {"after_end": 147, "after_start": 147, "before_end": 271, "before_start": 99, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 193, "chars_inserted": 69}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d8a2cb3e188d806c8a825fc8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1663}
{"after": {"end": 15, "start": 0, "text": "EU/1/11/717/006", "truncated": false}, "after_length": 15, "after_sha256": "a08ed53f52d65c5f05bdcf27397724f7615d8003a675ade1f45fdf4bbba7c262", "annex": "I", "before": {"end": 15, "start": 0, "text": "EU/1/11/717/004", "truncated": false}, "before_length": 15, "before_sha256": "504bdd871418930e05e7d6ed3f63cd7189dd149e55fbc7ab999b12b6e6d54e4c", "change_kind": "administrative", "change_operations": [{"after_end": 15, "after_start": 14, "before_end": 15, "before_start": 14, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d8a46af90c21e27c3aacd180", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "8", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1418}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 76, "start": 0, "text": "Niraparib as a substrate of renal uptake transporters (OAT1, OAT3, and OCT2)", "truncated": false}, "before_length": 76, "before_sha256": "034c9568bfc4d66b369e9e990b582c6c4a9a86ae4113817124df8b43913cdd33", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 76, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 76, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d8d2e995d92b4a95231d40d2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 243}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 446, "start": 0, "text": "Lipodystrophy is uncommon (may affect up to 1 in 100 people). If you inject insulin too often at the same place, the fatty tissue may either shrink (lipoatrophy) or thicken (lipohypertrophy). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis). The insulin may not work very well if you inject into a lumpy area. Change the injection site with each injection to help prevent these skin changes.", "truncated": false}, "before_length": 446, "before_sha256": "5220d8116156ab633200a4314ae3aeeae7dcaa54e8112301a561989b04f34187", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 446, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 446, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d92838edadb8ef5038ab1aa0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9376}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 6, "start": 0, "text": "Anémie", "truncated": false}, "before_length": 6, "before_sha256": "b6ab55c14cd437a835ac6dfc0957296bc885f42a1da4c36192c5687c655e98a7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 6, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d92df06458d217aae5e6890e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.8", "section_type": "adverse_reactions", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 190}
{"after": {"end": 23, "start": 0, "text": "medinfo.finland@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "7029ed3ac062d546eacefe48107a23caa5547edd30d7c30335f744035bfb4ec6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d92f136a35410087a0ca3123", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2926}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d93846161a25b7767675b959", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2489}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 304, "start": 0, "text": "Niraparib is not a substrate of bile salt export pump (BSEP), or multidrug resistance-associated protein 2 (MRP2). The major primary metabolite M1 is not a substrate of Pgp, BCRP, BSEP, or MRP2. Niraparib is not a substrate of multidrug and toxin extrusion (MATE)-1 or 2, while M1 is a substrate of both.", "truncated": false}, "before_length": 304, "before_sha256": "429d9cdcc71934daac751187e7059f0aa2457c476abfe3cb404524a4443a66e3", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 304, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 304, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d93ee9c4a06c42832dfadc22", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1101}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Autriche", "truncated": false}, "before_length": 8, "before_sha256": "dea55da9d453f7a5125a553d05297c736f00626d1baa09e099247c0e7937d0cf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d94aca219b0168d49d89d67c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3165}
{"after": {"end": 41, "start": 0, "text": "statins (e.g. rosuvastatin, atorvastatin)", "truncated": false}, "after_length": 41, "after_sha256": "d7df12f85a64571c6cae96221bbe8f2a4b065a98686831312d267f26c533980b", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "statins (e.g. rosuvastatin)", "truncated": false}, "before_length": 27, "before_sha256": "c0aa218704bf021bf7723a90c31f16f75e148b861e5f05a926ee084b88d279f6", "change_kind": "content", "change_operations": [{"after_end": 40, "after_start": 26, "before_end": 26, "before_start": 26, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d96790264dbd2af672f7ce18", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3107}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 18, "start": 0, "text": "Further injections", "truncated": false}, "before_length": 18, "before_sha256": "fbba371b63657c0222e29100d54cf30f22e68fa1ca6d7af1182b8f7792081ea2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 18, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 18, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d9710328251fb96e115f16bd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9330}
{"after": {"end": 46, "start": 0, "text": "Bristol-Myers Squibb Marketing Services S.R.L.", "truncated": false}, "after_length": 46, "after_sha256": "6c38be302b7d5963ce12172acd656a3cb654f698a1ffaa2a83410a1393313cb6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 46, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 46}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d9c97c5ed4740ea6fb84e922", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3259}
{"after": {"end": 19, "start": 0, "text": "Tel: + 372 640 1030", "truncated": false}, "after_length": 19, "after_sha256": "fe728e641eb3fdbddc9ef5e84d4bceb9a2fe5bf5a11cd739c9346c67f55cc34e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-d9df4f69f71555d417c9dc3a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2538}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 32, "start": 0, "text": "• Pull the Pen cap straight off.", "truncated": false}, "before_length": 32, "before_sha256": "2f734b1c49bb6a6a2bb57c26fbec040b0251b70626822c071573cb0bf6a378ab", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-da0bb5bbefe1c78304e3720f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9635}
{"after": {"end": 22, "start": 0, "text": "Teл.: + 359 2 4942 480", "truncated": false}, "after_length": 22, "after_sha256": "71df057e61352cd6e548ee210b03d0adc43d1e9ef00311b1d7ac8fce15871b09", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dade41a51be01a130803516b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3178}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 154, "start": 0, "text": "La biodisponibilité des médicaments à usage oral peut être affectée par l’administration concomitante par voie orale de médicaments contenant du sorbitol.", "truncated": false}, "before_length": 154, "before_sha256": "75db72f4a9d365e2eff2ef65d76d4a884c8ed2520b8190a83fdfd7e293c1c817", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 154, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 154, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-db19160650465d17d85eba1c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1287}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 22, "start": 0, "text": "medinfoEMEA@takeda.com", "truncated": false}, "before_length": 22, "before_sha256": "0b528beef8e2100b7b7858e530b1b7c3aef82177c70474bdbac5f59bc1ba4394", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 22, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-db1f87ef37141b5133db972b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1713}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 16, "start": 0, "text": "Sorbitol (E 420)", "truncated": false}, "before_length": 16, "before_sha256": "9556ed1722d15fe272eb3486cc321779c90fde71cfd7a25ebe71ad9c62a53f71", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-db311a3cdd7c244b49eecccd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1901}
{"after": {"end": 38, "start": 0, "text": "Bristol-Myers Squibb Polska Sp. z o.o.", "truncated": false}, "after_length": 38, "after_sha256": "9c8a588d350dd39a6a46453574156c70a2d3d726d29ae6874b04bb3acd6f1d64", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-db5dfa00e485d851870f3c1f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3239}
{"after": {"end": 23, "start": 0, "text": "medinfo.austria@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "80539556a138e6e0b8efab6b438c21ba77b592fc3c2d28fdfaea7dc2bb3248d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-db6218cc54b6c962e6e8b9a7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2554}
{"after": {"end": 20, "start": 0, "text": "For single use only.", "truncated": false}, "after_length": 20, "after_sha256": "a5ada875adb6848eaca25516e07cc8ac46a6d89e69af6cf0b2b594f698cb77b7", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "For single use only", "truncated": false}, "before_length": 19, "before_sha256": "dbc9028e4a4f8fadc8e9072aeb510f5bb3f16f7cc18756cc47ff76536d24f8f3", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 19, "before_end": 19, "before_start": 19, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-db6e7f9f12d99b4247c293d5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 810}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "insulin lispro", "truncated": false}, "before_length": 14, "before_sha256": "1ca88cfa41606b28145f703442bf3c0e5efa0967c7177f9c26ed091d4c7a140d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-db9fc23fe885f570e2ff8969", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9571}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Vistor hf.", "truncated": false}, "before_length": 10, "before_sha256": "4b40dfc2a19551f982dad779994a624f3432207c4666bbd66f0ec59c2f229b32", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 7, "before_end": 7, "before_start": 7, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dbc3af627fa9bdf0d735f581", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2895}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 15, "start": 0, "text": "Hafnerstraße 36", "truncated": false}, "before_length": 15, "before_sha256": "2fcce2f98396d52bbfd5728e1a018b4f5e6a7c25edffb18410df25f808883c4f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dbe466a4312150a93d8ad0f2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1706}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 58, "start": 0, "text": "• Do not use your Pen if any part looks broken or damaged.", "truncated": false}, "before_length": 58, "before_sha256": "91f70477c93bfd15a3c02f9deacdf2c8458fefd28314b28f56e76d9048f52359", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 58, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 58, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dbeaea6d8418c5dcba00e2f5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9796}
{"after": {"end": 28, "start": 0, "text": "Bristol-Myers Squibb Denmark", "truncated": false}, "after_length": 28, "after_sha256": "8501478e0a326a4274e1997e52efffb9adb21eb72ddc27015fc279a4b660a655", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 28, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 28}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dbf08118dee223cfecb4d68d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2829}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 124, "start": 0, "text": "• Throw away the Pen you are using after the time specified in the package leaflet, even if it still has insulin left in it.", "truncated": false}, "before_length": 124, "before_sha256": "c6ef634331870deb44b9672cdb3a29fca4ae07ecd9b25de1add1e4e62d32baaf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 124, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 124, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dbf868e9bb348f433c6982b0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9793}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 64, "start": 0, "text": "Three simple steps to avoid hypoglycaemia or hyperglycaemia are:", "truncated": false}, "before_length": 64, "before_sha256": "e6b8e6eb547553af0e4e910db451606c262ad8ea48e6288ccf7319f38cfa6b1c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 64, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 64, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dbfc0323b4a7d2eb1f65cdc8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9352}
{"after": {"end": 5, "start": 0, "text": "Norge", "truncated": false}, "after_length": 5, "after_sha256": "882f535a7da00cd72aec9957f14113085717f72c791945420043b48876276628", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dc125e5b750a60ec1a99985b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3221}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 153, "start": 0, "text": "• Priming your Pen means removing the air from the needle and cartridge that may collect during normal use and ensures that the Pen is working correctly.", "truncated": false}, "before_length": 153, "before_sha256": "2b0d8276348ab5bc974d644e070e4b155730e14b32b7a08e6412f10509016dae", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 153, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 153, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dc478057fa4b1691f4bbe3b1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9660}
{"after": {"end": 121, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu/.", "truncated": false}, "after_length": 121, "after_sha256": "9d8d2148d2215735c1ca8ac769a2e0cd013fc2a2447a452d6c72e4b8fec48c3e", "annex": "IIIA", "before": {"end": 120, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/.", "truncated": false}, "before_length": 120, "before_sha256": "b7d3bba3c3d744d927e6d05f81a5139a00b9d5c4dcbc4adcdfb1949c5602b310", "change_kind": "technical", "change_operations": [{"after_end": 99, "after_start": 98, "before_end": 98, "before_start": 98, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dc69792bff72b86eb221595b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3314}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 444, "start": 0, "text": "The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work very well if you inject into a lumpy area (See How to use Humalog Tempo Pen). Contact your doctor if you are currently injecting into a lumpy area before you start injecting a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.", "truncated": false}, "before_length": 444, "before_sha256": "a3b1a6faefcb4e3281982c7f29a8100ef0742efec794654e783a1e48d9475952", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 444, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 444, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dc704ffba8ccd32c6415f5bd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9265}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "LEO Laboratories Ltd", "truncated": false}, "before_length": 20, "before_sha256": "88c803e41685f3f9af10a32ea47829718c391a3d4b0b4b43a151753aa8cf8bbc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dc828021d2bb810015b6b0bd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1839}
{"after": {"end": 134, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency https://www.ema.europa.eu.", "truncated": false}, "after_length": 134, "after_sha256": "9f2a855337f11701b0cd4191c51820fa5a70b201b2e0721ba6acd34544486f89", "annex": "I", "before": {"end": 133, "start": 0, "text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.", "truncated": false}, "before_length": 133, "before_sha256": "eabdb61a543e11ee016c5c43ada549964199ddf9e287a2eb3256e15d4a87fe4a", "change_kind": "technical", "change_operations": [{"after_end": 113, "after_start": 112, "before_end": 112, "before_start": 112, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dc93354594b5cb2640da5b14", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "CIALIS 5 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1048}
{"after": {"end": 40, "start": 0, "text": "Tel: 1 800 749 749 (+ 353 (0)1 483 3625)", "truncated": false}, "after_length": 40, "after_sha256": "0509d2a1806f188ecbce2c353425cb70d883d4c07f6e695eacf4b8a2ec65feef", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 40, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 40}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dcae36c0312cb2dd489a9219", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2588}
{"after": {"end": 12, "start": 0, "text": "Magyarország", "truncated": false}, "after_length": 12, "after_sha256": "5206a7f7063a77a35861f95e022dafc37f3b3cf27ed423b1118e3fe580841b19", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dcb49a0fcb9f46975d72d69c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2517}
{"after": {"end": 37, "start": 0, "text": "Pfizer Manufacturing Deutschland GmbH", "truncated": false}, "after_length": 37, "after_sha256": "05eb44563bffe7fe97a2f09d11f944fd95fd6f2dc741d803023bdfefb6a52439", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dd03277b34a26420b7e2017c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2035}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 28, "start": 0, "text": "Printing ink (Opacode white)", "truncated": false}, "before_length": 28, "before_sha256": "c1bceabb7ed8985a58ad96c2bc58b2c7f4954bf22dd3212d0487983cad0903b1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dd35981dfbde8d18293f2bd1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1370}
{"after": {"end": 205, "start": 0, "text": "Sur la base des essais cliniques, les effets indésirables les plus fréquemment rapportés avec la rezafungine ont été l’hypokaliémie, la fièvre, l’anémie et la diarrhée (effets indésirables très fréquents).", "truncated": false}, "after_length": 205, "after_sha256": "f2cc7f403573d7eb90c402e2c7e62ec7497aa2624c90b36d08a4303c0774c9c0", "annex": "I", "before": {"end": 195, "start": 0, "text": "Sur la base des essais cliniques, les effets indésirables les plus fréquemment rapportés avec la rezafungine ont été l’hypokaliémie, la fièvre et la diarrhée (effets indésirables très fréquents).", "truncated": false}, "before_length": 195, "before_sha256": "6d926f91cb06ec14b42c56561059a5ec88498955ee492f700e598eabfc3b430e", "change_kind": "content", "change_operations": [{"after_end": 152, "after_start": 142, "before_end": 142, "before_start": 142, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 10}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dd431fe228ff1752b2a10379", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg poudre pour solution à diluer pour perfusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.8", "section_type": "adverse_reactions", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 170}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dd43fbf873c7d328caf9ef63", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2889}
{"after": {"end": 195, "start": 0, "text": "Increasing weight was found to increase niraparib volume of distribution in the population pharmacokinetic analysis. No impact of weight was identified on niraparib clearance or overall exposure.", "truncated": false}, "after_length": 195, "after_sha256": "8dc9e4df792f34d7888f05d9cd2cf8a2742fb19a243ea13b354055f7c69a0971", "annex": "I", "before": {"end": 291, "start": 0, "text": "Increasing weight was found to increase niraparib volume of distribution in the population pharmacokinetic analysis. No impact of weight was identified on niraparib clearance or overall exposure. Dose adjustment according to body weight is not warranted from a pharmacokinetic point of view.", "truncated": false}, "before_length": 291, "before_sha256": "c60bb3650fcb92999d75f3c9ba5efca6ddeadc9d51fb0b595baf26cd442eec89", "change_kind": "content", "change_operations": [{"after_end": 195, "after_start": 195, "before_end": 291, "before_start": 195, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 96, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dd645361860863f3ee97e090", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1661}
{"after": {"end": 24, "start": 0, "text": "BristolMyers Squibb A.E.", "truncated": false}, "after_length": 24, "after_sha256": "10b1fadbbe52c3072f4ba1903512a3a4f5cd6eb487bf016dde5246419ff972b0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dd72ab9c9c16ecd0da1db952", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2623}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma s.r.o.", "truncated": false}, "after_length": 22, "after_sha256": "e26ccdddfb0893074547931bd19474d6541a45958e27c35b776e8f18abf48a36", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ddb4c32f27149103f3227e76", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2608}
{"after": {"end": 145, "start": 0, "text": "La posologie recommandée est d’un comprimé de Vyndaqel 61 mg (tafamidis), administré par voie orale en une prise journalière (voir rubrique 5.1).", "truncated": false}, "after_length": 145, "after_sha256": "fa81395c5c4c1ec0d1fb4f692fa3b8f9ecca1c40076ef12a96ff7f43703e01c1", "annex": "I", "before": {"end": 146, "start": 0, "text": "La posologie recommandée est d’une capsule de Vyndaqel 61 mg (tafamidis), administrée par voie orale en une prise journalière (voir rubrique 5.1).", "truncated": false}, "before_length": 146, "before_sha256": "224cb3210fc28d65eacbb33b20e83a0919a0bcb8035eee9dceed67f643dd2bae", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 33, "before_end": 34, "before_start": 33, "kind": "delete"}, {"after_end": 37, "after_start": 35, "before_end": 37, "before_start": 36, "kind": "replace"}, {"after_end": 42, "after_start": 38, "before_end": 42, "before_start": 38, "kind": "replace"}, {"after_end": 84, "after_start": 84, "before_end": 85, "before_start": 84, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ddc81945bdc3a1a1a754c1c9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.2", "section_type": "posology", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1239}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Tel: +48 22 440 33 00", "truncated": false}, "before_length": 21, "before_sha256": "18916c54ce9fbf13115b3fcedf3f025bafefb9e0d42b7b76b664fd3d5c827d77", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ddcacfed448fa1423c0239c1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9511}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Eli Lilly Danmark A/S", "truncated": false}, "before_length": 21, "before_sha256": "79e02eb12cb523d0fade17a16d7d3dc9b7c966d1659ee3a16d83c4ca6dd52b1d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ddf228e180f19e5e0c4a4cf6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9478}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Vistor hf.", "truncated": false}, "before_length": 10, "before_sha256": "4b40dfc2a19551f982dad779994a624f3432207c4666bbd66f0ec59c2f229b32", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 7, "before_end": 7, "before_start": 7, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ddfa092209c78f23cbae8861", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2518}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 16, "start": 0, "text": "4 septembre 2025", "truncated": false}, "before_length": 16, "before_sha256": "1bf9da4dd3a6dfba2fee64763d06cf3905ae40629a81ee1d5adfc7f8af8c672f", "change_kind": "administrative", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-de12ebffc14c1d3efc919dd0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "Firazyr 30 mg solution injectable en seringue préremplie", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "10", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 677}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 285, "start": 0, "text": "If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar) is not treated they can be very serious and cause headaches, feeling sick (nausea), being sick (vomiting), loss of fluids (dehydration), unconsciousness, coma or even death (see section 4 “Possible Side Effects”).", "truncated": false}, "before_length": 285, "before_sha256": "f60d98d77ee1cb0702d0afab99499f6fd0aad57c91ec06153e55bf74b3a42622", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 285, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 285, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-de66a4a9922b7afe0ae8b351", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9350}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 126, "start": 0, "text": "• Store the Pen you are currently using at room temperature (below 30°C) and away from dust, food and liquids, heat and light.", "truncated": false}, "before_length": 126, "before_sha256": "73c3b9a9a6477df3d4f54d5e9fe092082d1c0f2b3416c5a82876fe3bbdd3be48", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 126, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 126, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-de67314af72d8c840b68300c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9792}
{"after": {"end": 27, "start": 0, "text": "medical.information@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "bcd3718b99618706058a6edc0bb11799eab0bcc9e7e9396639ede9120d162109", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-de6b0ab44058c6de3ac9fe64", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2901}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 25, "start": 0, "text": "Propylene glycol (E 1520)", "truncated": false}, "before_length": 25, "before_sha256": "8a1680180d675ccf4dd3ea8b19262f66486595bb80a36fe4ff7807aa92362411", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-de75e3fa75498edac8694dcb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1377}
{"after": {"end": 28, "start": 0, "text": "Bristol-Myers Squibb Denmark", "truncated": false}, "after_length": 28, "after_sha256": "8501478e0a326a4274e1997e52efffb9adb21eb72ddc27015fc279a4b660a655", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 28, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 28}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-de79759412fc8b1d7f9bc17d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3194}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-de90a944182c04f58f393781", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2577}
{"after": {"end": 9, "start": 0, "text": "Allemagne", "truncated": false}, "after_length": 9, "after_sha256": "6b58dbd6a994339b48d8446597da22402857b3409613459c7e3a293788fbe66a", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-deaef255efcede0d3f02988f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1704}
{"after": {"end": 17, "start": 0, "text": "Subcutaneous use.", "truncated": false}, "after_length": 17, "after_sha256": "8217ef65631178af796477e15d3ae5d09b5aa20a2ada83115f79b0fb28d140bd", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Subcutaneous use", "truncated": false}, "before_length": 16, "before_sha256": "363fd22613abec178143cdac0b1a34f04ee8ccdaa7d6988b3722fa7540374cde", "change_kind": "content", "change_operations": [{"after_end": 17, "after_start": 16, "before_end": 16, "before_start": 16, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-debab31c7e3216420ce82f30", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 908}
{"after": {"end": 8, "start": 0, "text": "България", "truncated": false}, "after_length": 8, "after_sha256": "a7215e5aa55f878990c076bb8195d75ca42044d4d5c7d2ba90af610508b643d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dec52261f02d8779bc0510dd", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2496}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 48 22 2606400", "truncated": false}, "after_length": 21, "after_sha256": "91ea111aa679f6773d6dedcb0b0a2558a35b3e3387196cb6b3c71a9a8806c141", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dedbdd7878c16b9475414c0a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2879}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 41, "start": 0, "text": "– get a new Pen and inject the full dose.", "truncated": false}, "before_length": 41, "before_sha256": "556e994d860f96e6844cd97490505a602c29ffd1a25007254d096705ed1ff9e8", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 41, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 41, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dee1216d65e17ebcfcc19f3c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9730}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-df0a0f07902588373c462468", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3169}
{"after": {"end": 5, "start": 0, "text": "Taani", "truncated": false}, "after_length": 5, "after_sha256": "b71f1b4c32927bd5f0694b003e2d1c67809beb4e798f042c99d04d09792a3a6f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-df3614790289c38f32aee765", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1786}
{"after": {"end": 6, "start": 0, "text": "France", "truncated": false}, "after_length": 6, "after_sha256": "7a1ca4ef7515f7276bae7230545829c27810c9d9e98ab2c06066bee6270d5153", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-df37ca3b6626f4c590eb5c89", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2572}
{"after": {"end": 20, "start": 0, "text": "medwiss.info@bms.com", "truncated": false}, "after_length": 20, "after_sha256": "bc2238e490f9b59d01a00ccab422d2de7eb7937e564268c4e82d2e78b72b3340", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-df6e813d9c4c917abc9024fb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2529}
{"after": {"end": 20, "start": 0, "text": "Tel.: +36 1 270 7030", "truncated": false}, "after_length": 20, "after_sha256": "a564f4fa4b8be19fcbef34e4106edaf1c07c01ff8075a559b95e72eacd6d9cfc", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: +36 1 270 7030", "truncated": false}, "before_length": 19, "before_sha256": "27e72abd8e26e77216333bd8200693839a8af4734b977e191c58c7a24b081026", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-df83f4f4a6cd182fdbcddf3e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1594}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Possible side effects", "truncated": false}, "before_length": 21, "before_sha256": "6d5457eba8ae835d21fb59ae802b1f84c466b59e2681ea1b435cee8b1a9dc3f4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dfbabf0b2197b0cf369133fb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9226}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 375, "start": 0, "text": "Le niraparib n’est pas un substrat de la pompe d’exportation des sels biliaires (BSEP), ou de la protéine de multirésistance aux médicaments 2 (MRP2). Le métabolite principal M1 n’est pas un substrat de la P-gp, de la BCRP, de la BSEP ou de la MRP2. Le niraparib n’est pas un substrat de MATE 1 ou 2 (« multidrug and toxin extrusion »), alors que M1 est un substrat des deux.", "truncated": false}, "before_length": 375, "before_sha256": "2e0e3f9c45bde19eae51d0459dac350226baf3d5d250f28d4de730140ffb2f82", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 375, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 375, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-dff28366ec862bf46b20df64", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1135}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "5. CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT", "truncated": false}, "before_length": 43, "before_sha256": "93506fb6674d6493b9f974d1ad5ababf910eb5db9ab506c4c3c612a92530fd76", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e00278ea15dcfd3b4cdff562", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4900}
{"after": {"end": 23, "start": 0, "text": "medinfo.denmark@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "b9a121278c8c2cc6f9be9c7a9fab0d3dee3fadaac431fdd8d5efa352410f5389", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e0176b791ab9fdfe20aa2483", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3199}
{"after": {"end": 6, "start": 0, "text": "Ελλάδα", "truncated": false}, "after_length": 6, "after_sha256": "e6f7401e81c9b2a3c1f082d0c9a0183287a6f7b4ecded4f4d3ac5e1efefa9ce5", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e02bc565a65dbfd220826df5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3223}
{"after": {"end": 40, "start": 0, "text": "Tel: 1 800 749 749 (+ 353 (0)1 483 3625)", "truncated": false}, "after_length": 40, "after_sha256": "0509d2a1806f188ecbce2c353425cb70d883d4c07f6e695eacf4b8a2ec65feef", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 40, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 40}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e0b8b330ebf69dcef8b83120", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3268}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 74, "start": 0, "text": "Inhibition des transporteurs d’influx hépatique (OATP1B1, OATP1B3 et OCT1)", "truncated": false}, "before_length": 74, "before_sha256": "7feac6cb4618682c18d8c767f7a58d331af0b0563c8ed485582f430c32c70698", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 74, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 74, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e0b9b71b3d097564ebf7e03b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1165}
{"after": {"end": 5, "start": 0, "text": "Dánia", "truncated": false}, "after_length": 5, "after_sha256": "6b2bf8c68ea8941b06707cb569cdff6f0c6f5f221eb2857ea1bef2fff7977063", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e0c755bc3d07ed5c6edd8ba6", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1740}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e10dd555346b0c147d3d8a92", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3229}
{"after": {"end": 29, "start": 0, "text": "CARTON FOR 61 MG BLISTER PACK", "truncated": false}, "after_length": 29, "after_sha256": "9ad10c2351d667b2d6ec59fe14ebfecd6a50c6f455e71431bd0dc0d19a88c781", "annex": "IIIA", "before": {"end": 6, "start": 0, "text": "CARTON", "truncated": false}, "before_length": 6, "before_sha256": "30e9de43cd647e29c8dc7594a986e5f37248e9182822590e89338fa0bbea259d", "change_kind": "content", "change_operations": [{"after_end": 29, "after_start": 6, "before_end": 6, "before_start": 6, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e1508f1fd19728ff2ba7fd09", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2275}
{"after": {"end": 170, "start": 0, "text": "Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’autorisation de mise sur le marché :", "truncated": false}, "after_length": 170, "after_sha256": "3d33a6b4a45572c6d201e5b64d04d70230f33eb5f235e4cf7ed24c3872500500", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 170, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 170}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e1857b1f7734a1656cc50c65", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2490}
{"after": {"end": 29, "start": 0, "text": "1. DÉNOMINATION DU MÉDICAMENT", "truncated": false}, "after_length": 29, "after_sha256": "e533e060c1472b188c6fc8bed504465df54df678055a3148f2bcc1dd51ea944c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 29, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 29}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e185d58b97e98bce90babf9b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1104}
{"after": {"end": 170, "start": 0, "text": "This document is the approved product information for Viagra, with the changes since the previous procedure affecting the product information (EMA/VR/0000247514) tracked.", "truncated": false}, "after_length": 170, "after_sha256": "57fff72d4fa67b72c3fcbced26b61b897769fc1bfd0d5afb1c1c2dda6bc86ff0", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 170, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 170}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e190c8648ae28b3be45f56b9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 5}
{"after": {"end": 468, "start": 0, "text": "Après administration journalière par voie orale d’un comprimé pelliculé, le pic de concentration maximal (Cmax) est atteint au terme d’une durée médiane (tmax) de 4 heures pour tafamidis 61 mg après une prise à jeun. La vitesse d’absorption est altérée par l’administration concomitante d’un repas riche en matières grasses et en calories, mais la quantité absorbée ne l’est pas. Ces résultats confirment la possibilité d’administrer tafamidis avec ou sans nourriture.", "truncated": false}, "after_length": 468, "after_sha256": "e33804ce02ca81e5b1116f4b5305a1e52d1f4f78239e52445d9cc4eb4fb50583", "annex": "I", "before": {"end": 522, "start": 0, "text": "Après administration journalière par voie orale d’une capsule molle, le pic de concentration maximal (Cmax) est atteint au terme d’une durée médiane (tmax) de 4 heures pour tafamidis 61 mg et de 2 heures pour tafamadis méglumine 80 mg (4 x 20 mg) après une prise à jeun. La vitesse d’absorption est altérée par l’administration concomitante d’un repas riche en matières grasses et en calories, mais la quantité absorbée ne l’est pas. Ces résultats confirment la possibilité d’administrer tafamidis avec ou sans nourriture.", "truncated": false}, "before_length": 522, "before_sha256": "7a07bbd84e36e8b6df0ab4f617f11884642c2e2e51ce46a85867aac41df22811", "change_kind": "content", "change_operations": [{"after_end": 52, "after_start": 52, "before_end": 53, "before_start": 52, "kind": "delete"}, {"after_end": 56, "after_start": 54, "before_end": 56, "before_start": 55, "kind": "replace"}, {"after_end": 68, "after_start": 57, "before_end": 58, "before_start": 57, "kind": "replace"}, {"after_end": 71, "after_start": 70, "before_end": 67, "before_start": 60, "kind": "replace"}, {"after_end": 192, "after_start": 192, "before_end": 246, "before_start": 188, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 68, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e193119dd8c6aa49ceecbe85", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1824}
{"after": {"end": 173, "start": 0, "text": "Vous ne devez pas prendre plus de comprimés que votre médecin ne vous l’a prescrit. Si vous prenez plus de comprimés que ce qui vous a été prescrit, contactez votre médecin.", "truncated": false}, "after_length": 173, "after_sha256": "86bd00dfb6680a6bfadf0e4e65b6f78d7f19f1f0cf1db38d13f32a88744ac430", "annex": "IIIA", "before": {"end": 171, "start": 0, "text": "Vous ne devez pas prendre plus de capsules que votre médecin ne vous l’a prescrit. Si vous prenez plus de capsules que ce qui vous a été prescrit, contactez votre médecin.", "truncated": false}, "before_length": 171, "before_sha256": "30ffa8fef278a22477c4ab24bc2fe1279c5b21b79a7ae57e5f7aef2cada1564c", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 35, "before_end": 36, "before_start": 35, "kind": "replace"}, {"after_end": 42, "after_start": 38, "before_end": 41, "before_start": 37, "kind": "replace"}, {"after_end": 110, "after_start": 108, "before_end": 108, "before_start": 107, "kind": "replace"}, {"after_end": 115, "after_start": 111, "before_end": 113, "before_start": 109, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e1cba5cc79e2aa926931d875", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3652}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 124, "start": 0, "text": "3 ml Tempo Pen: Packs of 5 prefilled pens or a multipack of 10 (2 packs of 5) prefilled pens. Not all packs may be marketed.", "truncated": false}, "before_length": 124, "before_sha256": "0343e0d4740eaa6f934b74ce3df02f95569e5bc5c6ad99a1d4f45b2aefdade1e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 124, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 124, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e1d584e150840c270e15d498", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.5", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 445}
{"after": {"end": 61, "start": 0, "text": "Niraparib is an inducer of CYP1A2 in vitro (see section 4.5).", "truncated": false}, "after_length": 61, "after_sha256": "4d7a22dc60761c836b6ccb06b69c54ee2f3d9e45e883b61c9458576d6cb5e243", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 61, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 61}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e1d71a6b9427f0a64c895416", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 781}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 239, "start": 0, "text": "Tempo Pen is only suitable for injecting just under the skin. Do not use the pen to administer Humalog by a different way. Other forms of Humalog 100 units/ml are available if this is necessary. Speak to your doctor if this applies to you.", "truncated": false}, "before_length": 239, "before_sha256": "bbec5048e9622eda958952899654fa5d3f099c83390d0121d931f479bfc7663d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 239, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 239, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e1ee8157420f8b800a1f2bd4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9340}
{"after": {"end": 96, "start": 0, "text": "The film-coated tablet contains lactose monohydrate (E 24). See leaflet for further information.", "truncated": false}, "after_length": 96, "after_sha256": "5b8495c2666a11b2c22be0fdac9a1f669c4e38a1a33b7412a0c33d7116bd4caf", "annex": "IIIA", "before": {"end": 75, "start": 0, "text": "The capsule contains sorbitol (E 420). See leaflet for further information.", "truncated": false}, "before_length": 75, "before_sha256": "d0fce69ddaab7953116ea4d3314156bcdacf67cc52b85c6034b7e847519c5afb", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 4, "before_end": 4, "before_start": 4, "kind": "insert"}, {"after_end": 11, "after_start": 10, "before_end": 5, "before_start": 5, "kind": "insert"}, {"after_end": 19, "after_start": 12, "before_end": 9, "before_start": 6, "kind": "replace"}, {"after_end": 22, "after_start": 21, "before_end": 11, "before_start": 11, "kind": "insert"}, {"after_end": 35, "after_start": 32, "before_end": 26, "before_start": 21, "kind": "replace"}, {"after_end": 51, "after_start": 37, "before_end": 29, "before_start": 28, "kind": "replace"}, {"after_end": 56, "after_start": 55, "before_end": 33, "before_start": 33, "kind": "insert"}, {"after_end": 57, "after_start": 57, "before_end": 36, "before_start": 34, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 11, "chars_inserted": 32}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e1f394a3d42c8f242dcf6f24", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2293}
{"after": {"end": 6, "start": 0, "text": "Danija", "truncated": false}, "after_length": 6, "after_sha256": "bc6a7343d3e198e003189dc965ded9d843ad23a091832eaa358b67171d90166d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e1f53fc48ef3680fe9471193", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1746}
{"after": {"end": 9, "start": 0, "text": "Allemagne", "truncated": false}, "after_length": 9, "after_sha256": "6b58dbd6a994339b48d8446597da22402857b3409613459c7e3a293788fbe66a", "annex": "II", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e1fb542b30f0f0678d05e16f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2038}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e258af1d2e7e99f71562f667", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1838}
{"after": {"end": 17, "start": 0, "text": "Subcutaneous use.", "truncated": false}, "after_length": 17, "after_sha256": "8217ef65631178af796477e15d3ae5d09b5aa20a2ada83115f79b0fb28d140bd", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Subcutaneous use", "truncated": false}, "before_length": 16, "before_sha256": "363fd22613abec178143cdac0b1a34f04ee8ccdaa7d6988b3722fa7540374cde", "change_kind": "content", "change_operations": [{"after_end": 17, "after_start": 16, "before_end": 16, "before_start": 16, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e279fb80f4e7c2e9e532742e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1009}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 85, "start": 0, "text": "• Continue to hold the Dose knob in and slowly count to 5 before removing the needle.", "truncated": false}, "before_length": 85, "before_sha256": "d5505ff071c6efcd06e49dcdba2bf202a011e18888919fac3f2d1cf41da8f05d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 85, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 85, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e2df18e60b2623a627e350d3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9747}
{"after": {"end": 23, "start": 0, "text": "België/Belgique/Belgien", "truncated": false}, "after_length": 23, "after_sha256": "4646bb1028d1508f87afd915f6c144536b764795c7df5858f4eaa35881bb797d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e2ed741f56b989d563671cdd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2802}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 25, "start": 0, "text": "Conclusions scientifiques", "truncated": false}, "before_length": 25, "before_sha256": "b9dba41fa3c9d3b642cfe755c989781c6765c2e1667b80c2d6fb1f02a6cb6463", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e32308f7f8ea5b73bb3aadaf", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3494}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "LEO Laboratories Ltd", "truncated": false}, "before_length": 20, "before_sha256": "88c803e41685f3f9af10a32ea47829718c391a3d4b0b4b43a151753aa8cf8bbc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e3242814f569d79e9a6b1f2c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1862}
{"after": {"end": 37, "start": 0, "text": "Cartridge, KwikPen and Junior KwikPen", "truncated": false}, "after_length": 37, "after_sha256": "568940d8b89021ebbfeb22c9ed156638df9deb0d5471b90b429e63a147bb4d6e", "annex": "I", "before": {"end": 48, "start": 0, "text": "Cartridge, KwikPen, Junior KwikPen and Tempo Pen", "truncated": false}, "before_length": 48, "before_sha256": "8cd9919dbc31f394fdbef8c86edb6478df294d5867b4cd396c48f7aa27edcdc6", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 18, "before_end": 19, "before_start": 18, "kind": "replace"}, {"after_end": 34, "after_start": 34, "before_end": 45, "before_start": 31, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 4}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e32e268925d19eee0db46c0f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Tempo Pen solution ", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.2", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 378}
{"after": {"end": 7, "start": 0, "text": "Latvija", "truncated": false}, "after_length": 7, "after_sha256": "50b862d01712827e01a8c925a1ee290539baab7a60d18941f764c691cee16618", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e357669c68b0bd09332117fc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2632}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Τηλ: +30 210 629 4600", "truncated": false}, "before_length": 21, "before_sha256": "64b0a21e2693d2b819fd64bc29604fddaa8a0369871ed61590fa44f557ea53ad", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e3582ef4ead340de0ba62e8e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9500}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Step 2:", "truncated": false}, "before_length": 7, "before_sha256": "e1005ce6127453db997d913f3c972acce0e8e747db681704b56e2419f236dc1f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e378fb88836a4e917f6fe9e3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9642}
{"after": {"end": 33, "start": 0, "text": "Τηλ: 800 92666 (+ 30 210 6074300)", "truncated": false}, "after_length": 33, "after_sha256": "3c667c31f7c324c43671bdd5606ccfdb57ec8b49816d058ab68a853627dd20b8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e385846b0332fa51521f34f9", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3298}
{"after": {"end": 27, "start": 0, "text": "Puh/Tel: + 358 9 251 21 230", "truncated": false}, "after_length": 27, "after_sha256": "115859cfeab013cc7da2aa72c6645b7c1a35594595b929820235610cd0afa5fd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e3a51bb0e2ade34d399a33c7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2929}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "6. OTHER", "truncated": false}, "before_length": 8, "before_sha256": "ee01ce9771d796d43ffc9aeaebaee6247c2bec434fba0949a1bb74b7324f2f32", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e3c7a4f2648aff25538e9692", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4905}
{"after": {"end": 18, "start": 0, "text": "Orteliuslaan 1000,", "truncated": false}, "after_length": 18, "after_sha256": "21c621c6366151fa349c8db45d9fcbb9c94e9eb157e7b6a12761b6c45f5a91c4", "annex": "III", "before": {"end": 18, "start": 0, "text": "Papendorpseweg 83,", "truncated": false}, "before_length": 18, "before_sha256": "93fe807c935894269f90415a7510e03bd5cb998b5478f2bec793675a6a09dafb", "change_kind": "unassigned", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e3d3666d5bfff1cdefa663e2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1929}
{"after": {"end": 15, "start": 0, "text": "Études in vitro", "truncated": false}, "after_length": 15, "after_sha256": "ffacd06469f97fd0f1f7f8238b9b241c0b4bd9c0b0c25ee2cc9790f3133c2ac2", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e3f12cfcd96c2b883a29e84b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 801}
{"after": {"end": 6, "start": 0, "text": "Κύπρος", "truncated": false}, "after_length": 6, "after_sha256": "7f8ef8a379e33810aefd13f344f489d85e8902de6fdcd1b46a4e856985b5e14e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e4183e94eb8acd137eb8b3d9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3293}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Supplies needed to give your injection:", "truncated": false}, "before_length": 39, "before_sha256": "34f5cf93ad6f29ead269868ab102fcefbd6ce55ed589694a3f1eaf1c1a6a6328", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e460107aac1deb72a91e1cb4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9623}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 627, "start": 0, "text": "Au vu des données disponibles sur la choriorétinopathie séreuse centrale, issues de la littérature et des rapports spontanés, incluant certains cas ayant une chronologie fortement évocatrice, une évolution favorable à l’arrêt du traitement et/ou une réapparition de l’effet à la reprise du traitement et compte tenu d'un mécanisme d'action plausible, le PRAC considère qu'il y a au moins une possibilité raisonnable qu'un lien de causalité entre le tadalafil et la choriorétinopathie séreuse centrale existe. Le PRAC a conclu que l’information produit des médicaments contenant du tadalafil devait être modifiée en conséquence.", "truncated": false}, "before_length": 627, "before_sha256": "872d16e262896ed3101b686292dd116eae2d4811c60a2e99242caa2b27a35045", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 627, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 627, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e46a87cfb8622fdf0baa34d3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3498}
{"after": {"end": 250, "start": 0, "text": "Le niraparib est un substrat de la P-gp et la BCRP. Cependant, en raison de la haute perméabilité et biodisponibilité du niraparib, le risque d’interactions cliniquement significatives avec des médicaments inhibant ces transporteurs est peu probable.", "truncated": false}, "after_length": 250, "after_sha256": "a92c721a672e8bb34fbcd040e5e986d7207ed4bcbf6f6ecd21c5c552d4b5406c", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 250, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 250}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e47c25c3e64a5255032facbc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1693}
{"after": {"end": 9, "start": 0, "text": "Danemarca", "truncated": false}, "after_length": 9, "after_sha256": "aa62ca811afd7d8cbf62b0601ca860863bdb18df68b1426acf2862cb7a82b5ac", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 9}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e48119705e907d38400b1535", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2123}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 61, "start": 0, "text": "• Always carry an extra Pen in case yours is lost or damaged.", "truncated": false}, "before_length": 61, "before_sha256": "d5c6ad7e3a14a53076c53402108aa6862e18b6c53bd47ece1a1edb7dc54c6806", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 61, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 61, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e4a05bc337cfe09fe8321301", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9797}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "3. LIST OF EXCIPIENTS", "truncated": false}, "before_length": 21, "before_sha256": "9d67e3a2807c422a6c85b6670fe9327da5d28f65a26959822e496f531655744d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e4db75970d98e028b9bf162d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4796}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 139, "start": 0, "text": "• Check the Pen to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.", "truncated": false}, "before_length": 139, "before_sha256": "ccf6d2e5a543886463356a8b167b4ee489dc51afce769da5899f030298389c44", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 139, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 139, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e4e8f0ff4f2623114e824e07", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9630}
{"after": {"end": 23, "start": 0, "text": "medinfo.denmark@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "b9a121278c8c2cc6f9be9c7a9fab0d3dee3fadaac431fdd8d5efa352410f5389", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e4f5efb1090b5dd7d2d46019", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3196}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "insulin lispro", "truncated": false}, "before_length": 14, "before_sha256": "1ca88cfa41606b28145f703442bf3c0e5efa0967c7177f9c26ed091d4c7a140d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e505eb7e6f98c1f00f3a92b8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4883}
{"after": {"end": 12, "start": 0, "text": "Виатрис ЕООД", "truncated": false}, "after_length": 12, "after_sha256": "92f9a32247d19bdb1e65df1219954c43f6ad757cc355e8022e7566c35de78f1a", "annex": "IIIA", "before": {"end": 11, "start": 0, "text": "Майлан ЕООД", "truncated": false}, "before_length": 11, "before_sha256": "5770366f858d91109bdad7a5551dc97b9878455f55713851de8277df30093b62", "change_kind": "content", "change_operations": [{"after_end": 2, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 7, "after_start": 3, "before_end": 6, "before_start": 2, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e563f6f83308b0a5a85e02e3", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005403", "medicine_name": "Sugammadex Mylan", "medicine_slug": "sugammadex-mylan", "observed_at": "2026-10-12T13:36:03Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "3d1f09d9bcfb1d2bba4f610b61ad692a3a78dc1ae2800f83497a954f8545d5a0", "source_snapshot_id": "source-ccd6e4297624ea024166e969", "source_updated_at": "2026-06-12", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/sugammadex-mylan-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1456}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb B.V.", "truncated": false}, "after_length": 25, "after_sha256": "0ca7ef7834ca2eb516116ddfb2edb978bd0d58c8673ce6fa611a0719568a6293", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e569ca8f6885de8383f5eab1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2844}
{"after": {"end": 54, "start": 0, "text": "Plaquettes pour Vyndaqel 61 mg en comprimés pelliculés", "truncated": false}, "after_length": 54, "after_sha256": "fb52718be62094176d63e6242c9d13640491957e60b80c428d06d2eba05b176a", "annex": "IIIA", "before": {"end": 85, "start": 0, "text": "Plaquettes prédécoupées en dose unitaire de 10 x 61 mg de Vyndaqel en capsules molles", "truncated": false}, "before_length": 85, "before_sha256": "bf7c0ad2b2e3c8ebc08bcaef7e52c53c7f7d07eabce86ca4afd358d9073986d5", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 12, "before_end": 17, "before_start": 12, "kind": "delete"}, {"after_end": 14, "after_start": 14, "before_end": 38, "before_start": 19, "kind": "delete"}, {"after_end": 15, "after_start": 15, "before_end": 57, "before_start": 39, "kind": "delete"}, {"after_end": 31, "after_start": 25, "before_end": 67, "before_start": 67, "kind": "insert"}, {"after_end": 37, "after_start": 35, "before_end": 72, "before_start": 71, "kind": "replace"}, {"after_end": 42, "after_start": 38, "before_end": 73, "before_start": 73, "kind": "insert"}, {"after_end": 50, "after_start": 43, "before_end": 74, "before_start": 74, "kind": "insert"}, {"after_end": 53, "after_start": 52, "before_end": 84, "before_start": 76, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 51, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e571fe5cd239005ef8f67cc4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2888}
{"after": {"end": 18, "start": 0, "text": "Orteliuslaan 1000,", "truncated": false}, "after_length": 18, "after_sha256": "21c621c6366151fa349c8db45d9fcbb9c94e9eb157e7b6a12761b6c45f5a91c4", "annex": "III", "before": {"end": 18, "start": 0, "text": "Papendorpseweg 83,", "truncated": false}, "before_length": 18, "before_sha256": "93fe807c935894269f90415a7510e03bd5cb998b5478f2bec793675a6a09dafb", "change_kind": "unassigned", "change_operations": [{"after_end": 9, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 11, "after_start": 10, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 12, "after_start": 12, "before_end": 14, "before_start": 5, "kind": "delete"}, {"after_end": 17, "after_start": 13, "before_end": 17, "before_start": 15, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e5740653a2a90cac6df6a9cd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2063}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 89, "start": 0, "text": "• Push the capped needle straight onto the Pen and twist the needle on until it is tight.", "truncated": false}, "before_length": 89, "before_sha256": "6bab2afa44ce5870dd3b89c6f9ad4d8e97da1c5ef9d1c0a2596fa2fa1a856023", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 89, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 89, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e574e29ab67c31a56146c60e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9647}
{"after": {"end": 393, "start": 0, "text": "Le niraparib est un inhibiteur de MATE 1 et 2K in vitro. Les concentrations plasmatiques de metformine peuvent augmenter lorsqu'elle est administrée en concomitance avec le niraparib. Une surveillance étroite de la glycémie est recommandée lors de l'initiation ou de l'arrêt du niraparib chez les patients recevant de la metformine. Un ajustement de la dose de metformine peut être nécessaire.", "truncated": false}, "after_length": 393, "after_sha256": "3e29b40be5583e08ccff721cf52f11fc3e805a0484b799bb0c5c54e71c8681a6", "annex": "I", "before": {"end": 271, "start": 0, "text": "Le niraparib est un inhibiteur de MATE 1 et 2 avec un IC50 de 0,18 µM et ≤ 0,14 µM, respectivement. Une augmentation des concentrations plasmatiques de médicaments étant substrats de ces transporteurs (p. ex. metformine), administrés en concomitance, ne peut être exclue.", "truncated": false}, "before_length": 271, "before_sha256": "31fc8aa74180f3064c9721255feb9e7c8304d4d6f8e42242e20d4621767155fd", "change_kind": "content", "change_operations": [{"after_end": 46, "after_start": 45, "before_end": 45, "before_start": 45, "kind": "insert"}, {"after_end": 48, "after_start": 47, "before_end": 52, "before_start": 46, "kind": "replace"}, {"after_end": 52, "after_start": 50, "before_end": 71, "before_start": 54, "kind": "replace"}, {"after_end": 53, "after_start": 53, "before_end": 84, "before_start": 72, "kind": "delete"}, {"after_end": 55, "after_start": 54, "before_end": 98, "before_start": 85, "kind": "replace"}, {"after_end": 58, "after_start": 57, "before_end": 118, "before_start": 100, "kind": "replace"}, {"after_end": 93, "after_start": 93, "before_end": 210, "before_start": 153, "kind": "delete"}, {"after_end": 136, "after_start": 102, "before_end": 221, "before_start": 219, "kind": "replace"}, {"after_end": 148, "after_start": 147, "before_end": 233, "before_start": 232, "kind": "replace"}, {"after_end": 164, "after_start": 164, "before_end": 250, "before_start": 249, "kind": "delete"}, {"after_end": 369, "after_start": 165, "before_end": 251, "before_start": 251, "kind": "insert"}, {"after_end": 385, "after_start": 382, "before_end": 264, "before_start": 264, "kind": "insert"}, {"after_end": 391, "after_start": 386, "before_end": 269, "before_start": 265, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 131, "chars_inserted": 253}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e5af5a7f13527f1ff57cc830", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 273}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 129, "start": 0, "text": "– The dose can be corrected by turning the dose knob in either direction until the correct dose lines up with the dose indicator.", "truncated": false}, "before_length": 129, "before_sha256": "549316e1fd6becfc4ab585955cc8408654b65dc9530628f92f9c920aabfece45", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 129, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 129, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e5bae309609eebb363235407", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9693}
{"after": {"end": 36, "start": 0, "text": "Read the package leaflet before use.", "truncated": false}, "after_length": 36, "after_sha256": "5523bc203c0d15a42e51f1f2084990ce77593674ceb9b20d974654fb13a8f72b", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "Read the package leaflet before use", "truncated": false}, "before_length": 35, "before_sha256": "507cbe4bd01d082cb8b1d6b89039f65a5c71739015aad79203bdc9f43571b36e", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 35, "before_end": 35, "before_start": 35, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e5fa9425be5fa15fcb4acbcf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 909}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e61dd0f82e599ca82fc1ee51", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3257}
{"after": {"end": 6, "start": 0, "text": "España", "truncated": false}, "after_length": 6, "after_sha256": "f85c9fe36948469b69f31fb5026694619ce4dc122757ece67c8584ff8f2ac008", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e67f46e163bcae96824ed3f0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2556}
{"after": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "after_length": 7, "after_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e68add98a6c8b951fddf1fd8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2902}
{"after": {"end": 5, "start": 0, "text": "Malta", "truncated": false}, "after_length": 5, "after_sha256": "71e9eb10755c8232974d186a560f7658a1ccbdd3097877dfa1ad3436af90d46a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e6c24455ed5dc1ad4c997a04", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2837}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 34, "start": 0, "text": "OUTER CARTON –Tempo Pen. Pack of 5", "truncated": false}, "before_length": 34, "before_sha256": "4cfb670d7aec531bdda9d14580a68eff3d31c09aa8620b91b935094d749d70fb", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 34, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e6d6dcf14e3edd2d273fed66", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4585}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 291, "start": 0, "text": "Keep your Humalog Tempo Pen in use at room temperature (below 30°C) and discard after 28 days even if some of the solution remains. Do not put it near heat or in the sun. Do not keep the Tempo Pen that you are using in the fridge. The Tempo Pen should not be stored with the needle attached.", "truncated": false}, "before_length": 291, "before_sha256": "bd82ff43199d74b91a9931d98a4c0363c8dda7fa789f019ef9239f2056fe24d0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 291, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 291, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e6e838867b99389829102cf4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9425}
{"after": {"end": 27, "start": 0, "text": "Puh/Tel: + 358 9 251 21 230", "truncated": false}, "after_length": 27, "after_sha256": "115859cfeab013cc7da2aa72c6645b7c1a35594595b929820235610cd0afa5fd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e6f23b448bfa519d114aacde", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3293}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 36, "start": 0, "text": "• Push the dose knob all the way in.", "truncated": false}, "before_length": 36, "before_sha256": "5cc3430aa099ed6b7af3c4e2adb5035b05dcfeb1168613d53ad806305bc121d0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 36, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 36, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e72898dfa01ba5b33c23e691", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9745}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 6, "start": 0, "text": "España", "truncated": false}, "before_length": 6, "before_sha256": "f85c9fe36948469b69f31fb5026694619ce4dc122757ece67c8584ff8f2ac008", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 6, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e72db0d5063b6571108b3e30", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9505}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 196, "start": 0, "text": "L’effet additif de l’administration concomitante de produits contenant du sorbitol (ou du fructose) avec l’apport de sorbitol (ou de fructose) contenu dans l’alimentation doit être pris en compte.", "truncated": false}, "before_length": 196, "before_sha256": "a27fccad5992f7ef797e623813bca3372a18eb0d1b2c7259a3c7944cbdd69fb0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 196, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 196, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e79a163c3f8985addd52c847", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1285}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma SIA", "truncated": false}, "after_length": 19, "after_sha256": "6da5006887c3e11cf19ecbe52bdc7a386838e93f6e63f315e575cb7df7747f15", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e7a211fa9a7a9507beaa048c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3307}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "• headache • cold sweat", "truncated": false}, "before_length": 23, "before_sha256": "be29c298bb2e9922aef0b81ee75277c313adc1480fd0599b9d11d5f494a11b87", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 23, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 23, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e7fae1d1cb18761cdbd2b757", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9399}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 122, "start": 0, "text": "Le principal métabolite M1 ne semble pas être un inhibiteur de la P-gp, de la BCRP, de la BSEP, de la MRP2 ou de MATE 1/2.", "truncated": false}, "before_length": 122, "before_sha256": "abcf35c7a905366472e17d99fd36719eae31c6d77cfc8ea964ea5ae8e5a1319f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 122, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 122, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e802bb66009f5d814945e894", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 275}
{"after": {"end": 7, "start": 0, "text": "Ireland", "truncated": false}, "after_length": 7, "after_sha256": "02bf1dfa9a0365a86223f0e4ac9eaa0517b06b2e9273790f719feda656a247ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e8128b7b372ebe1ea9004e00", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2586}
{"after": {"end": 5, "start": 0, "text": "Norge", "truncated": false}, "after_length": 5, "after_sha256": "882f535a7da00cd72aec9957f14113085717f72c791945420043b48876276628", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e824b577560a16537ad6e1d8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2547}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Step 1:", "truncated": false}, "before_length": 7, "before_sha256": "e21f0c2d445ca8dbe770b14cac70617d3f0697f36f9bb7bcee8ef3a048e278df", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e837d0f21ac5261212188ffc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9634}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 43, "start": 0, "text": "18. UNIQUE IDENTIFIER - HUMAN READABLE DATA", "truncated": false}, "before_length": 43, "before_sha256": "f53a050d196b2672592e40916a0229bf083d27961b6b2f41758dcee0da55378d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 43, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 43, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e89304423b785245da44fb00", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4771}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Belgique", "truncated": false}, "before_length": 8, "before_sha256": "acd6158c38604ea6125cade9ab2752dac3a958113ac6f135b11934329c6cbcd1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e8afd8cc64701f0cfdf4b76e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3715}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 106, "start": 0, "text": "This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’.", "truncated": false}, "before_length": 106, "before_sha256": "52351a549ed55e18835cae7e034a3f042c13ab052ad73d16d1911cb3dc665abf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 106, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 106, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e8ba0b1be3e741d3798ced33", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9299}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "Hafnerstraße 36", "truncated": false}, "before_length": 15, "before_sha256": "2fcce2f98396d52bbfd5728e1a018b4f5e6a7c25edffb18410df25f808883c4f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e8de344b757039894aa5b7be", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:50Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "72682dec564013e59f7286bf58e1bce690a1fbae6a19e73884079bcc1b6a2682", "source_snapshot_id": "source-09c35186fd73b77e66683634", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2456}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 15, "start": 0, "text": "After injecting", "truncated": false}, "before_length": 15, "before_sha256": "4961da648e4622f4306499add22b7cce995a738d9e5100f9efaaa01e7e2c6b5b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e8e23245b09e44fa29259545", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9325}
{"after": {"end": 232, "start": 0, "text": "Zejula can affect how other medicines work. It is particularly important that you mention any medicines containing the active substance, metformin (used to lower blood sugar), as your doctor may need to adjust the dose of metformin.", "truncated": false}, "after_length": 232, "after_sha256": "0a299877fc024062a9f38ecae89279375f22280139a333e9ebe8a87f6617bca5", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 232, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 232}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e8f4e950de6ef1652c617ab5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2244}
{"after": {"end": 416, "start": 0, "text": "The systemic exposures (Cmax and AUC) to niraparib increased in a doseproportional manner when the dose of niraparib increased from 30 mg to 400 mg. The absolute bioavailability of niraparib is approximately 73%, indicating minimal first pass effect. In a population pharmacokinetic analysis of niraparib, the inter-individual variability in bioavailability was estimated to a coefficient of variation (CV) of 33.8%.", "truncated": false}, "after_length": 416, "after_sha256": "9a7e9cc7b17d2f059c31af50053cdff0600612921f683ba257415a30c3e8a30a", "annex": "I", "before": {"end": 414, "start": 0, "text": "The systemic exposures (Cmax and AUC) to niraparib increased in a doseproportional manner when the dose of niraparib increased from 30 mg to 400 mg. The absolute bioavailability of niraparib is approximately 73%, indicating minimal first pass effect. In a population pharmacokinetic analysis of niraparib, the inter-individual variability in bioavailability was estimated to a coefficient of variation (CV) of 31%.", "truncated": false}, "before_length": 414, "before_sha256": "d9eff7d08ee151d2c4e9589da47e005c61a980a5055b23e009bcd4801382c76f", "change_kind": "content", "change_operations": [{"after_end": 414, "after_start": 411, "before_end": 412, "before_start": 411, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e91513f3f3e44b9850b57d36", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1624}
{"after": {"end": 123, "start": 0, "text": "Titulaire de l'Autorisation de mise sur le marché : Eli Lilly Nederland B.V., Orteliuslaan 1000, 3528 BD Utrecht, Pays-Bas.", "truncated": false}, "after_length": 123, "after_sha256": "c9360159827bd94b8452261891b0f98066b989ff2cdfd5b65fd7a73b98e1e192", "annex": "III", "before": {"end": 123, "start": 0, "text": "Titulaire de l'Autorisation de mise sur le marché : Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Pays-Bas.", "truncated": false}, "before_length": 123, "before_sha256": "24244fac23f7c655b5cf0249efb6324cf790a7ba49b33b42d12cc4dbef87a7b4", "change_kind": "administrative", "change_operations": [{"after_end": 87, "after_start": 78, "before_end": 79, "before_start": 78, "kind": "replace"}, {"after_end": 89, "after_start": 88, "before_end": 82, "before_start": 80, "kind": "replace"}, {"after_end": 90, "after_start": 90, "before_end": 92, "before_start": 83, "kind": "delete"}, {"after_end": 95, "after_start": 91, "before_end": 95, "before_start": 93, "kind": "replace"}, {"after_end": 104, "after_start": 103, "before_end": 104, "before_start": 103, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e95bdc511b778c6983a523e5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3074}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Irlande", "truncated": false}, "before_length": 7, "before_sha256": "a8cdfff5dbbda1b070a2acb339b6f0aa20b6230d9b5500c9ce066eaa89bc9a64", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-e9b24a5ebd241e267f6557d3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1706}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 42, "start": 0, "text": "Médicament soumis à prescription médicale.", "truncated": false}, "before_length": 42, "before_sha256": "750563bceec650756547672930cecdeae621fc507c505c9da059b6b3a66df134", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 42, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 42, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ea27455e991cd085502bb0d1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 974}
{"after": {"end": 26, "start": 0, "text": "informacion.medica@bms.com", "truncated": false}, "after_length": 26, "after_sha256": "ecc8b3fc203c9400ed5a39531e5dadc0b28244ff3abb21ff0a801eeffc0a5d0e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ea5927382f0f1b44c3c38091", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3236}
{"after": {"end": 25, "start": 0, "text": "Tel: + 40 (0)21 272 16 19", "truncated": false}, "after_length": 25, "after_sha256": "502a8c5996880f462bf382bf033fc5a4e73041db59d3a638fd11052ee7eef1a8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ea6db3188e3583bcdb63a016", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3260}
{"after": {"end": 7, "start": 0, "text": "Lietuva", "truncated": false}, "after_length": 7, "after_sha256": "5109820f748796128b8bafd3806d05511bc89ad77fc3cda960facf37a639bc7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ea8c2ed4c050de381db7e620", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2491}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 12, "start": 0, "text": "Eau purifiée", "truncated": false}, "before_length": 12, "before_sha256": "749c72b8ea6ef8e2d300b8b62e85a5c5968d249c07631d7100b00874cf8fca47", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eaa589546333bb62597298f2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1903}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 3, "start": 0, "text": "Lot", "truncated": false}, "before_length": 3, "before_sha256": "23ea1b1beb5529f4f4cbe47df67ef01587f29229a112e020eff530d5033fbcff", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 3, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 3, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eab9736aeed758ab6e557d28", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4752}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 90, "start": 0, "text": "Always check the number in the dose window to make sure you have dialled the correct dose.", "truncated": false}, "before_length": 90, "before_sha256": "225ebfee057c757211e4b890d03965d748c5458a95641dbf34e9badfb8290266", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 90, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 90, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eadfe345017c581d58dc05be", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9307}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 57, "start": 0, "text": "2. What you need to know before you use Humalog Tempo Pen", "truncated": false}, "before_length": 57, "before_sha256": "8846fb6f3aedbc5f5a5d4b7a671a4e04b05ff03438721672a22eb235875bdfb4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 57, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 57, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb00b2bcae31a9ce83dd27f0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9244}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 171, "start": 0, "text": "• Continue holding your Pen with needle pointing up. Push the dose knob in until it stops, and “0” is seen in the dose window. Hold the dose knob in and count to 5 slowly.", "truncated": false}, "before_length": 171, "before_sha256": "0fe32a90f1ef8af12442864ab950d66a52995b16db8a8e5348a44a22ebfd2e61", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 171, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 171, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb04ce2b87d74cd5e7e68d28", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9670}
{"after": {"end": 24, "start": 0, "text": "Bristol-Myers Squibb SAS", "truncated": false}, "after_length": 24, "after_sha256": "b0b0c212e0ecdb35fbea1089157d2aee4526bb7547bc4dc40b2231ed4929cb66", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb12edc081c2e3ab53786fd9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3244}
{"after": {"end": 6, "start": 0, "text": "España", "truncated": false}, "after_length": 6, "after_sha256": "f85c9fe36948469b69f31fb5026694619ce4dc122757ece67c8584ff8f2ac008", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb2061159c5b330893f30751", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3233}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tel: +371 670 35 775", "truncated": false}, "before_length": 20, "before_sha256": "b680bf9f05ed1e4cf39b4fe148b3422de6b07719e12a6f388508a09cc4a5af9c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb4cff27ceb3c3b7d6720e6c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3348}
{"after": {"end": 325, "start": 0, "text": "In vitro, niraparib is an inhibitor of BCRP. A clinically relevant interaction with BCRP substrates cannot be excluded. Caution is therefore recommended when niraparib is combined with substrates of BCRP (e.g., irinotecan, rosuvastatin, simvastatin, atorvastatin, and methotrexate) due to risk of increased systemic exposure.", "truncated": false}, "after_length": 325, "after_sha256": "e13cc751b6072100bfb4434921acd1c0a6f6f76d69a62e52ca27f2b3d08b1bd0", "annex": "I", "before": {"end": 150, "start": 0, "text": "Caution isthen recommended when niraparib is combined with substrates of BCRP (irinotecan, rosuvastatin, simvastatin, atorvastatin, and methotrexate).", "truncated": false}, "before_length": 150, "before_sha256": "cd9ab56e7f3c37981a1f06e81bb33077fadc48cb5d289f9a8a49dd7292bd7894", "change_kind": "content", "change_operations": [{"after_end": 120, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}, {"after_end": 131, "after_start": 130, "before_end": 10, "before_start": 10, "kind": "insert"}, {"after_end": 140, "after_start": 134, "before_end": 14, "before_start": 13, "kind": "replace"}, {"after_end": 211, "after_start": 205, "before_end": 79, "before_start": 79, "kind": "insert"}, {"after_end": 324, "after_start": 281, "before_end": 149, "before_start": 149, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 176}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb60ff3e330d6855bd5552ef", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 262}
{"after": {"end": 25, "start": 0, "text": "Tel: + 40 (0)21 272 16 19", "truncated": false}, "after_length": 25, "after_sha256": "502a8c5996880f462bf382bf033fc5a4e73041db59d3a638fd11052ee7eef1a8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb61a830c4c7a6ef68dd97f4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3263}
{"after": {"end": 12, "start": 0, "text": "Hypromellose", "truncated": false}, "after_length": 12, "after_sha256": "4835393d8e6e34469c5491a7556150383b0b67ce36cd620552e7bdd53e2cdd83", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 12, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb667b865b867323d0322529", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1349}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 9, "start": 0, "text": "Sorbitane", "truncated": false}, "before_length": 9, "before_sha256": "bbcad7e3d779f1954928b69a34f7cc71af206d789031d767b6dd35f14d2a273d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb859021076be34e9284b63f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1900}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 51, "start": 0, "text": "Niraparib comme substrat des CYP (CYP1A2 et CYP3A4)", "truncated": false}, "before_length": 51, "before_sha256": "cd69b1f2ca050bb450c26f08263a900933f3b1aa4fc631f37b44ccfebb20ae25", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 51, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 51, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb8cffb20c0032c648832523", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1129}
{"after": {"end": 5, "start": 0, "text": "Дания", "truncated": false}, "after_length": 5, "after_sha256": "15c4c56ca2ad5dd4518ae08c37f15cbda6da8ac77d78fb2b6e974b7d6667351e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 5, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 5}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eb963e3aa3ef609f41c4efda", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2051}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 135, "start": 0, "text": "Hyperglycaemia (too much sugar in the blood) means that your body does not have enough insulin. Hyperglycaemia can be brought about by:", "truncated": false}, "before_length": 135, "before_sha256": "5ede08e85d8445f99511eefbbf0e0dab24a02b64c58be6a9ec7247a1a1d7a21b", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 135, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 135, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ebcde69ab1bef4534fe2f56a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9404}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 19, "start": 0, "text": "Tel: + 353 18711600", "truncated": false}, "before_length": 19, "before_sha256": "f39469e1bbd519f10406ae27e104b0e2fb101791df45c4e53cc539ee02b84821", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 19, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 19, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ebd8e12db2fa79764f7b7044", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4020}
{"after": {"end": 23, "start": 0, "text": "What is in this leaflet", "truncated": false}, "after_length": 23, "after_sha256": "c21bffcdfbfe045f962ac7403de4697fb84f03b0fe7d8037e50fd9f31d819192", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "What is in this leaflet:", "truncated": false}, "before_length": 24, "before_sha256": "a51d947bce9dbbf1aef7bee8615eb30492f0f78a188d22a12c1506c3f7588c3d", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 23, "before_end": 24, "before_start": 23, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ebf21e6ec5c4bf5f925efc3f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1183}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 730, "start": 0, "text": "Humalog 100 units/ml Tempo Pen solution for injection is a sterile, clear, colourless, aqueous solution and contains 100 units of insulin lispro in each millilitre (100 units/ml) solution for injection. Each Humalog Tempo Pen contains 300 units (3 millilitres). The Humalog Tempo Pen comes in a pack of 5 pre-filled pens or a multipack of 2 x 5 pre-filled pens. Not all pack sizes may be marketed. The Humalog 100 units/ml in your pre-filled pen is the same as the Humalog 100 units/ml, which comes in separate Humalog 100 units/ml cartridges. The pre-filled pen simply has a built in cartridge. When the pre-filled pen is empty you cannot use it again. The Tempo Pen contains a magnet (see section 2, \"Warnings and precautions\").", "truncated": false}, "before_length": 730, "before_sha256": "9b8c9b70d480e8d795b39b50ef68991a4ab42edf2ed28ae739404057e44f9c86", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 730, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 730, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ec86344296e6656bacdaf2de", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9443}
{"after": {"end": 38, "start": 0, "text": "BristolMyers Squibb Pharmaceuticals uc", "truncated": false}, "after_length": 38, "after_sha256": "78edaf732c95d13a5ec5ba0a04740553812606cbf3d2047b91d484b5e76e8b52", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ec9072a73ec23b9aee6d707b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2593}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Subcutaneous use", "truncated": false}, "before_length": 16, "before_sha256": "363fd22613abec178143cdac0b1a34f04ee8ccdaa7d6988b3722fa7540374cde", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ecabeb606e208a8203904112", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4884}
{"after": {"end": 23, "start": 0, "text": "medinfo.austria@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "80539556a138e6e0b8efab6b438c21ba77b592fc3c2d28fdfaea7dc2bb3248d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ece10783a6f21560a832ce4d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2866}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ecf749162e46b7c673af4b2b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3277}
{"after": {"end": 311, "start": 0, "text": "Niraparib was moderately protein bound in human plasma (83%), mainly with serum albumin. In a population pharmacokinetic analysis of niraparib, the apparent volume of distribution (Vd/F) was 1,206 L (based on a 70 kg patient) in cancer patients (CV 18.4%), indicating extensive tissue distribution of niraparib.", "truncated": false}, "after_length": 311, "after_sha256": "142cd541b16a2a65c60cf37baac238c566e7f2dc07cb97cc89e14beb962360d7", "annex": "I", "before": {"end": 310, "start": 0, "text": "Niraparib was moderately protein bound in human plasma (83%), mainly with serum albumin. In a population pharmacokinetic analysis of niraparib, the apparent volume of distribution (Vd/F) was 1,311 L (based on a 70 kg patient) in cancer patients (CV 116%), indicating extensive tissue distribution of niraparib.", "truncated": false}, "before_length": 310, "before_sha256": "1a2a3565067a29cf293ee1c19310afa854aa32ae3408e9aa96b109e12b4973ec", "change_kind": "content", "change_operations": [{"after_end": 196, "after_start": 193, "before_end": 196, "before_start": 193, "kind": "replace"}, {"after_end": 253, "after_start": 250, "before_end": 252, "before_start": 250, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ecf7ff938c7e45452719ba9f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1632}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 11, "start": 0, "text": "Deutschland", "truncated": false}, "before_length": 11, "before_sha256": "af6e56aacd8097c3fb7597b08ecb3d87a040f6ab58067a4b8ff9f5b747adb9be", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 11, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 11, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ed9ff915f738420ab6940156", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9484}
{"after": {"end": 59, "start": 0, "text": "2. NOM DU TITULAIRE DE L’AUTORISATION DE MISE SUR LE MARCHÉ", "truncated": false}, "after_length": 59, "after_sha256": "58a43e7e9a772309fbc8304f6233d73a1ebb638a46821bf43b883ad8e52974a5", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "administrative", "change_operations": [{"after_end": 59, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 59}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-edaae7503ac97927ccc924c1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1111}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 50, "start": 0, "text": "Inhibition des UDP-glucuronosyltransférases (UGTs)", "truncated": false}, "before_length": 50, "before_sha256": "444842122a8ae03f61cf2e5f44f57b6ed3b1a34f91b407176b95a5a576d5f2c5", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 50, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 50, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-edd37abf51492d65d1409b2c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 262}
{"after": {"end": 7, "start": 0, "text": "Danmark", "truncated": false}, "after_length": 7, "after_sha256": "b2bebaaf55198f3166a7d7089112d30e245d6cf4a3249ae87b597fa988e7f1be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ede34d84314d430bb804e00c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2828}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb A.E.", "truncated": false}, "after_length": 25, "after_sha256": "43a0521fcec8db403e6fb060ae3b147a3107583a8df9b3a28208c9a4bd0d8fba", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ede62b447e7be8d64caa1d33", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2547}
{"after": {"end": 63, "start": 0, "text": "taux élevé d’éosinophiles sanguins (un type de globules blancs)", "truncated": false}, "after_length": 63, "after_sha256": "0ba3ef596de22b9f2aede706d6ff7393724c00c152919a64ef0c7ae8a42bcad0", "annex": "IIIA", "before": {"end": 64, "start": 0, "text": "taux élevé d’éosinophiles sanguines (un type de globules blancs)", "truncated": false}, "before_length": 64, "before_sha256": "e8e4355f46e2cb8a2a7fad4c94b9665b733a7d30879401ea6b5321873093075a", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 33, "before_end": 34, "before_start": 33, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ee047cc9e2660071bb0747c1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:08Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "416e7b785790d212b05c28155532ef6b6d6ffa88e6b799ae47263a3babdff9f9", "source_snapshot_id": "source-470cd3081161c442709128ab", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 919}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 221, "start": 0, "text": "Always check the pack and the label of the pre-filled pen for the name and type of the insulin when you get it from your pharmacy. Make sure you get the Humalog 100 units/ml Tempo Pen that your doctor has told you to use.", "truncated": false}, "before_length": 221, "before_sha256": "2c6113c26e0d9576aab947f42712721a320a33f77c146b8d73219305323f735c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 221, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 221, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ee0e51470798cc7ca419b3a5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9251}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 7, "start": 0, "text": "Step 4:", "truncated": false}, "before_length": 7, "before_sha256": "3ead1405345a7e2c65b10dc49c54bfc3c2c7c5d76d3d84da4ee867a05f113315", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 7, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 7, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ee22f77c913b1f476b6e6732", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9649}
{"after": {"end": 20, "start": 0, "text": "Sími: + 354 535 7000", "truncated": false}, "after_length": 20, "after_sha256": "66fcdd056ccfbc5ba6d0c26580292977898106c90655c78208bc87c3d941892c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ee31c9bec6308d6eb34855fc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3275}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 238, "start": 0, "text": "Excipients: glycerol, zinc oxide, dibasic sodium phosphate 7 H20 with m-cresol as a preservative in water for injections. Sodium hydroxide and/or hydrochloric acid may have been used to adjust acidity. See leaflet for further information.", "truncated": false}, "before_length": 238, "before_sha256": "219cd265f69c3cedd04f6e16fbaf3d05818947596178a2daeaf3c614ba2fbebf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 238, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 238, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ee419faa71f2987063862c62", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4699}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 96, "start": 0, "text": "If you think you are having this sort of insulin allergy with Humalog, contact a doctor at once.", "truncated": false}, "before_length": 96, "before_sha256": "d4c69c97d075c6d61f441a111be6ae8429c14ed73a0f2f6b081f62b343b4da34", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 96, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 96, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ee97614ee8017365247e688c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9372}
{"after": {"end": 6, "start": 0, "text": "Italia", "truncated": false}, "after_length": 6, "after_sha256": "a7ca3e3d756601d5a22a4c0d8629da0c0ce425e5be526078d3e4583737150f52", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eea09e76d123a345b0ba0c2c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3286}
{"after": {"end": 19, "start": 0, "text": "Induction of CYP1A2", "truncated": false}, "after_length": 19, "after_sha256": "3f2dc05ae7c0c872372289005d50f8282ea3dd7be7d15db38d66a65c5fe78779", "annex": "I", "before": {"end": 37, "start": 0, "text": "Induction of CYPs (CYP1A2 and CYP3A4)", "truncated": false}, "before_length": 37, "before_sha256": "98a6a007ab8ff57755d117f717d991b9b46f1ea83d107ebcfe8e98dbddbf1d19", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 16, "before_end": 22, "before_start": 16, "kind": "delete"}, {"after_end": 19, "after_start": 19, "before_end": 37, "before_start": 25, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 18, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eea76876feff597f6d3e4a0d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1119}
{"after": {"end": 19, "start": 0, "text": "Tel: + 372 640 1030", "truncated": false}, "after_length": 19, "after_sha256": "fe728e641eb3fdbddc9ef5e84d4bceb9a2fe5bf5a11cd739c9346c67f55cc34e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eec493a074419c9b16757634", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2854}
{"after": {"end": 6, "start": 0, "text": "Italia", "truncated": false}, "after_length": 6, "after_sha256": "a7ca3e3d756601d5a22a4c0d8629da0c0ce425e5be526078d3e4583737150f52", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-eec4b962445dff77814bedf6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3283}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 25, "start": 0, "text": "Tel: + 353-(0) 1 661 4377", "truncated": false}, "before_length": 25, "before_sha256": "48fde288146f4033a2172164570180a8f875f4e361fcf85a8e43ff77834511cc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 25, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 25, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ef1792c17a5f3b0afc9800f0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2835}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 42, "start": 0, "text": "Contents of the pack and other information", "truncated": false}, "before_length": 42, "before_sha256": "5029f2025d503eb7a88dff1ad051b74f21fd69032d72299d35688acc2771173f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 42, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 42, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ef26a4a902c462f231dc5744", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9228}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 147, "start": 0, "text": "If you see blood after you take the needle out of your skin, press the injection site lightly with a piece of gauze or a swab. Do not rub the area.", "truncated": false}, "before_length": 147, "before_sha256": "2f3f88974937d2123a55e21515cdb3ca361f73319ce679f2ffb80672982dbef0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 147, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 147, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ef29f7f58c7e7c441e0d3c09", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9765}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 21, "start": 0, "text": "Giving your injection", "truncated": false}, "before_length": 21, "before_sha256": "16e5095419d102a4ef9529e7f43a94012f802eaf34f516303621f13ba77e8956", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 21, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 21, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ef862fcc9ae310ce5ab1f353", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9732}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 144, "start": 0, "text": "Humalog Tempo Pen is only suitable for injecting just under the skin. Speak to your doctor if you need to inject your insulin by another method.", "truncated": false}, "before_length": 144, "before_sha256": "5047f72a1ae2bff9d0f3eb32ce2dd2afdbbc92867c9ca71201517e72d035dc03", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 144, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 144, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-efb140b30df84d4969251855", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9310}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 73, "start": 0, "text": "Humalog 100 units/ml Tempo Pen solution for injection in a pre-filled pen", "truncated": false}, "before_length": 73, "before_sha256": "51230eb86540e3f2989a8d72fae57656b7c456fc2ba7375eaa3efbd8b0d89f0f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 73, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 73, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-efd9035756afff6fa45c3afc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9211}
{"after": {"end": 32, "start": 0, "text": "This leaflet was last revised in", "truncated": false}, "after_length": 32, "after_sha256": "4bafa791d649e51df13e2b5f204437c9d72920aee9439698c1304cf214da3cde", "annex": "IIIA", "before": {"end": 41, "start": 0, "text": "This leaflet was last revised in 01/2026.", "truncated": false}, "before_length": 41, "before_sha256": "2fdc2a5dbabdeddca8b10af7d0d761a4c2b61ed48e5375d2615542c91e21d71a", "change_kind": "content", "change_operations": [{"after_end": 32, "after_start": 32, "before_end": 41, "before_start": 32, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-efe79517e9504ee4eb65306d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1690}
{"after": {"end": 15, "start": 0, "text": "EU/1/11/717/005", "truncated": false}, "after_length": 15, "after_sha256": "81a4108a0a7961243eb6144ff36a6ce7023bcae35cf56e9a83919daf0987eaea", "annex": "I", "before": {"end": 15, "start": 0, "text": "EU/1/11/717/003", "truncated": false}, "before_length": 15, "before_sha256": "33df5f48219bd2551b78dae07893271e4475ba3b184a73338ee9e17e4dfb94cf", "change_kind": "administrative", "change_operations": [{"after_end": 15, "after_start": 14, "before_end": 15, "before_start": 14, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-effd1cbb4016f6e5591e8111", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "8", "section_type": "administrative", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1417}
{"after": {"end": 16, "start": 0, "text": "A.M. Mangion Ltd", "truncated": false}, "after_length": 16, "after_sha256": "24f7ac6ac947e8ef3e36c6f6c1f51219647e1477dfe330121521ec39faf6cb0c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f0172399cd30c3b421511f27", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3202}
{"after": {"end": 26, "start": 0, "text": "informacion.medica@bms.com", "truncated": false}, "after_length": 26, "after_sha256": "ecc8b3fc203c9400ed5a39531e5dadc0b28244ff3abb21ff0a801eeffc0a5d0e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f0735510af7ce89d93b42474", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2559}
{"after": {"end": 294, "start": 0, "text": "Following a single oral 300mg dose of niraparib, the mean terminal halflife (t½) of niraparib ranged from 44 to 54 hours (approximately 2 days) across studies. In a population pharmacokinetic analysis, the apparent total clearance (CL/F) of niraparib was 15.9 L/h in cancer patients (CV 24.0%).", "truncated": false}, "after_length": 294, "after_sha256": "6ed9eb602c4ad59873b7907863feaf3299d2deec12d7f504806df0d01268fd85", "annex": "I", "before": {"end": 279, "start": 0, "text": "Following a single oral 300mg dose of niraparib, the mean terminal halflife (t½) of niraparib ranged from 48 to 51 hours (approximately 2 days). In a population pharmacokinetic analysis, the apparent total clearance (CL/F) of niraparib was 16.5 L/h in cancer patients (CV 23.4%).", "truncated": false}, "before_length": 279, "before_sha256": "ff012a2854ddc75be9783dd91c0bd9b8eae0b82c9636115e2f7e958fc4ada176", "change_kind": "content", "change_operations": [{"after_end": 108, "after_start": 107, "before_end": 108, "before_start": 107, "kind": "replace"}, {"after_end": 114, "after_start": 113, "before_end": 114, "before_start": 113, "kind": "replace"}, {"after_end": 158, "after_start": 143, "before_end": 143, "before_start": 143, "kind": "insert"}, {"after_end": 257, "after_start": 256, "before_end": 242, "before_start": 241, "kind": "replace"}, {"after_end": 259, "after_start": 258, "before_end": 244, "before_start": 243, "kind": "replace"}, {"after_end": 289, "after_start": 288, "before_end": 274, "before_start": 273, "kind": "replace"}, {"after_end": 291, "after_start": 290, "before_end": 276, "before_start": 275, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f078f3f53f6b05297ff1a08a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1640}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 90, "start": 0, "text": "• Tempo Pen compatible Needle (BD [Becton, Dickinson and Company] Pen Needles recommended)", "truncated": false}, "before_length": 90, "before_sha256": "6f33e5397521bf80302764c9032e3a7203904a0ed6e7649eedb8b7270bbc52db", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 90, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 90, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f0860fb9f57e92871f33b074", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9625}
{"after": {"end": 64, "start": 0, "text": "Chaque comprimé pelliculé contient 61 mg de tafamidis micronisé.", "truncated": false}, "after_length": 64, "after_sha256": "339dd9790c9d8505120f5260ea42332d035d9cbe7be60692f47c54e91c7269a8", "annex": "IIIA", "before": {"end": 59, "start": 0, "text": "Chaque capsule molle contient 61 mg de tafamidis micronisé.", "truncated": false}, "before_length": 59, "before_sha256": "62349ebf6caeb411e75699119a0c82956a3808b47d91005ac69c7609bb490345", "change_kind": "content", "change_operations": [{"after_end": 10, "after_start": 8, "before_end": 9, "before_start": 8, "kind": "replace"}, {"after_end": 22, "after_start": 11, "before_end": 11, "before_start": 10, "kind": "replace"}, {"after_end": 25, "after_start": 24, "before_end": 20, "before_start": 13, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 14}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f098ae2f67018fce076fb5f7", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2799}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 118, "start": 0, "text": "– If you do not see “0” in the dose window, do not redial. Insert the needle into your skin and finish your injection.", "truncated": false}, "before_length": 118, "before_sha256": "bfe4ede63ac3a341c88acb3990a288ac02b6e7db1348bc2bb368a0f8cd487ca2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 118, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 118, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f09a0a5485ef407d14c988ae", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9761}
{"after": {"end": 66, "start": 0, "text": "For more information, see the European Medicines Agency’s website:", "truncated": false}, "after_length": 66, "after_sha256": "8da7088a6eca66a2ae1a2bd8189afa46fa290c56c54c0076ee93bf891abacdcc", "annex": "", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "unassigned", "change_operations": [{"after_end": 66, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 66}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f0f7ce5206da6016a1e0b16d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:08:57Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "23c96bf92ed2f18cc3a7616a317f0d01a98fdfc2109ad663665c7989aba7759e", "source_snapshot_id": "source-ccb701a21a3ac0566cd64d01", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 38, "start": 0, "text": "5. METHOD AND ROUTES OF ADMINISTRATION", "truncated": false}, "before_length": 38, "before_sha256": "4df84c8e36dde67c1450d0a07181258f1fc4c471167239340eae51e9760a4f68", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 38, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 38, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f102fdc9d0020fa2f3fdbc86", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4709}
{"after": {"end": 151, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments : https://www.ema.europa.eu.", "truncated": false}, "after_length": 151, "after_sha256": "7c0752c5b7e8f6ae333055b974f1ec09f9c6782a57b413303ad43dd88cc73614", "annex": "IIIA", "before": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments : http://www.ema.europa.eu.", "truncated": false}, "before_length": 150, "before_sha256": "cba14846c320673c759f35d86d6c5f8913374e8c20319aa76bf242842cf27142", "change_kind": "technical", "change_operations": [{"after_end": 130, "after_start": 129, "before_end": 129, "before_start": 129, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f123928d7c4648a742e144af", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2623}
{"after": {"end": 268, "start": 0, "text": "In vitro, niraparib is an inhibitor of Pgp. As no clinical data are available, it cannot be excluded that niraparib may increase the systemic exposure of other medicines transported by P-gp that are sensitive to intestinal P-gp inhibition (e.g., dabigatran etexilate).", "truncated": false}, "after_length": 268, "after_sha256": "1ec52b7baaeae2125d7176ca834ebbdb89cb108b8ddc040f48dbf3a8965aad5a", "annex": "I", "before": {"end": 288, "start": 0, "text": "Niraparib is not an inhibitor of BSEP or MRP2. In vitro, niraparib inhibits Pgpvery weakly and BCRP with an IC50 = 161 µM and 5.8 µM, respectively. Therefore, a clinically meaningful interaction related to an inhibition of these efflux transporters, although unlikely, cannot be excluded.", "truncated": false}, "before_length": 288, "before_sha256": "d7ab2f4da051aba644982b85f912e2b1236b9d311bf2e31df4b756f2aead03e4", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 47, "before_start": 0, "kind": "delete"}, {"after_end": 21, "after_start": 21, "before_end": 74, "before_start": 68, "kind": "delete"}, {"after_end": 22, "after_start": 22, "before_end": 205, "before_start": 75, "kind": "delete"}, {"after_end": 33, "after_start": 33, "before_end": 217, "before_start": 216, "kind": "delete"}, {"after_end": 35, "after_start": 34, "before_end": 219, "before_start": 218, "kind": "replace"}, {"after_end": 61, "after_start": 39, "before_end": 223, "before_start": 223, "kind": "insert"}, {"after_end": 66, "after_start": 62, "before_end": 227, "before_start": 224, "kind": "replace"}, {"after_end": 76, "after_start": 68, "before_end": 229, "before_start": 229, "kind": "insert"}, {"after_end": 77, "after_start": 77, "before_end": 248, "before_start": 230, "kind": "delete"}, {"after_end": 80, "after_start": 79, "before_end": 252, "before_start": 250, "kind": "replace"}, {"after_end": 81, "after_start": 81, "before_end": 268, "before_start": 253, "kind": "delete"}, {"after_end": 267, "after_start": 100, "before_end": 287, "before_start": 287, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 223, "chars_inserted": 203}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f12c4a8963f29ba6aa36e8ef", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1123}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 37, "start": 0, "text": "14. GENERAL CLASSIFICATION FOR SUPPLY", "truncated": false}, "before_length": 37, "before_sha256": "0a2c9dd7ac0be92910d87b1a1b036337a62217a1d8517a2e70dc3f3b7965f761", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 37, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 37, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f16906834ccb95c849e5399d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4755}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma s.r.o.", "truncated": false}, "after_length": 22, "after_sha256": "e26ccdddfb0893074547931bd19474d6541a45958e27c35b776e8f18abf48a36", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f191a8b1b2b2b523ed78471b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2914}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 30, "start": 0, "text": "How to store Humalog Tempo Pen", "truncated": false}, "before_length": 30, "before_sha256": "55c7dcfeb32f3351082e0c377e0d810af3c1485ca9d57929c461d64284ddf3be", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 30, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 30, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f1a3ca1680fef1dda0dc0365", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9227}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 2, "start": 0, "text": "SN", "truncated": false}, "before_length": 2, "before_sha256": "19ac753101c8870b8e667480a40dcf1e7f224832e76d8e55aeb7b182a3ca7082", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f1a70da85d129c55ce5c89e5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4774}
{"after": {"end": 22, "start": 0, "text": "medinfo.norway@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c4c553c0f2dbe6456fca075a3e80411c07f0926b9866f5334ba99d71d96198e2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f1f23f1b6f5e8e9a151afcc0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2860}
{"after": {"end": 182, "start": 0, "text": "Advising female patients to inform their doctor immediately in case of exposure to tafamidis during (or within one month prior to) pregnancy for physicians’ reporting and assessment.", "truncated": false}, "after_length": 182, "after_sha256": "b06350afccb355034f28022a3e3bc9eec0a79d437cdbe95a08f6caf6506cbcf6", "annex": "I", "before": {"end": 180, "start": 0, "text": "Advising female patients to inform their doctor immediately in case of exposure to tafamidis during (or within 1 month prior to) pregnancy for physicians’ reporting and assessment.", "truncated": false}, "before_length": 180, "before_sha256": "5dbf2989f1b557bd066dd6d5d0ed2ff2cccfe2149e8cde51a4bb62a33a943de9", "change_kind": "unassigned", "change_operations": [{"after_end": 114, "after_start": 111, "before_end": 112, "before_start": 111, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f2162c3679ffa73838487c70", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1527}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 14, "start": 0, "text": "8. EXPIRY DATE", "truncated": false}, "before_length": 14, "before_sha256": "d71d14e8d4b94ef3a8f8363df6900202ede93977214348173fe46b41f9ab80aa", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 14, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 14, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f2260270969b127bd52df0fe", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4822}
{"after": {"end": 22, "start": 0, "text": "Tel: + 34 91 456 53 00", "truncated": false}, "after_length": 22, "after_sha256": "c59845f4e2b4a96548adda4dbf16851ff33a89874560e491da6b05aee33b646a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f23d39012ec9e7ed1f5557d0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3238}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 5, "start": 0, "text": "Norge", "truncated": false}, "before_length": 5, "before_sha256": "882f535a7da00cd72aec9957f14113085717f72c791945420043b48876276628", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 5, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f2408ee7cda2344e14f2eba1", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9495}
{"after": {"end": 13, "start": 0, "text": "Hermeslaan 11", "truncated": false}, "after_length": 13, "after_sha256": "6426889eacea87c88f1e0405aad54515d8a889ca0f1b2ab39e2039040651e7d3", "annex": "II", "before": {"end": 11, "start": 0, "text": "Hoge Wei 10", "truncated": false}, "before_length": 11, "before_sha256": "ba5c0cab58e83e9dc6ec41e55e6acc00077e1be63c8a1ed970723221f2f12ba4", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 1, "before_end": 3, "before_start": 1, "kind": "delete"}, {"after_end": 4, "after_start": 2, "before_end": 6, "before_start": 4, "kind": "replace"}, {"after_end": 10, "after_start": 5, "before_end": 8, "before_start": 7, "kind": "replace"}, {"after_end": 13, "after_start": 12, "before_end": 11, "before_start": 10, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f25570e35f8d25ca5e479961", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1471}
{"after": {"end": 21, "start": 0, "text": "Tlf.: +45 45 26 60 00", "truncated": false}, "after_length": 21, "after_sha256": "6bdd3c845f6a6e520023cbb8b3726e2eefc4bc4ac00ae57245f3055e31d53895", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Tlf: +45 45 26 60 00", "truncated": false}, "before_length": 20, "before_sha256": "7932ef9452966b997a4a22618abb01fb644277c9ab041214e6264730772b2d64", "change_kind": "content", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f290de79e55db8d6ebd4d958", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2766}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 16, "start": 0, "text": "Sorbitol (E 420)", "truncated": false}, "before_length": 16, "before_sha256": "9556ed1722d15fe272eb3486cc321779c90fde71cfd7a25ebe71ad9c62a53f71", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 16, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 16, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f294f2cf2381fda3501a38fa", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1359}
{"after": {"end": 20, "start": 0, "text": "Tel: + 43 1 60 14 30", "truncated": false}, "after_length": 20, "after_sha256": "06513bb4e3ff06e9885e8395f2d87e81d050e28b69385dc8158cf331179a64c6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f2d5f55b1864b82f4900cfa7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2553}
{"after": {"end": 24, "start": 0, "text": "portugal.medinfo@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "9ec8b32b2035c90c423af74fa150dca23880201d448d46da35a42d2a862c8345", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f2e2ffc7c610f23a0cd22fc7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3251}
{"after": {"end": 23, "start": 0, "text": "Medinfo.hungary@bms.com", "truncated": false}, "after_length": 23, "after_sha256": "a92bd76e7f8465b69646a33e5e8846376b2ea19fe10f20ea413789237a8d815a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f2edf736a294d64f79ed3023", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3194}
{"after": {"end": 27, "start": 0, "text": "9 x 10 comprimés pelliculés", "truncated": false}, "after_length": 27, "after_sha256": "007ef33cf8e4d640ae2546ede9e9fa81891d3cf41749baf47731a06e8ea3fa22", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f2fbaf78ad536037eaca808d", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2810}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 20, "start": 0, "text": "Alcool isopropylique", "truncated": false}, "before_length": 20, "before_sha256": "81d2cc271f1530012c1791b17f3a131e26fa3adca046fd65ff1049587d1b277e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f313c2b8c428159ad329a6ee", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:11Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg, comprimés pelliculés", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "8d288ee6e274bde6c9200f061e223bc58547e51500d2908a8e2686bd8958ce69", "source_snapshot_id": "source-b945bbd7373f05db1379ceb4", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1915}
{"after": {"end": 25, "start": 0, "text": "Utilisation sous-cutanée.", "truncated": false}, "after_length": 25, "after_sha256": "fff2d0fc9e9003d4a1e00c04e7e0bb5ae61d9cf5d3ad4c04919356b6db350f7c", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Utilisation sous-cutanée", "truncated": false}, "before_length": 24, "before_sha256": "9d4e4e353ddc84d14ff6ab682d5e9b5667e6b3406e44294ca5126a692856c758", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 24, "before_end": 24, "before_start": 24, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f36ce06ae79266fb4e43e020", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 829}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "5. How to store Humalog Tempo Pen", "truncated": false}, "before_length": 33, "before_sha256": "4ba483dfa57c1b523727200da27ab3c2e0154703d13fa3dded04ed2d907b6b70", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f38982a0673eb6dc79f3cf9e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9421}
{"after": {"end": 19, "start": 0, "text": "Tel: + 372 640 1030", "truncated": false}, "after_length": 19, "after_sha256": "fe728e641eb3fdbddc9ef5e84d4bceb9a2fe5bf5a11cd739c9346c67f55cc34e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f3f2c2b180b699c37e4c4375", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3218}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 48, "start": 0, "text": "reduced or absent warning signs of hypoglycaemia", "truncated": false}, "before_length": 48, "before_sha256": "fee5e9f06fb58721541800d6887b4827e5213b68716412dffdf473b7786aff38", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 48, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 48, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f40a75a2d7513f61c37626bf", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9296}
{"after": {"end": 21, "start": 0, "text": "Tel: + 46 8 704 71 00", "truncated": false}, "after_length": 21, "after_sha256": "313eaeeb04c88c002b748323fb801826225906f557247264c0fcb9fc87c873fc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f413da9d02700809c90e58e5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2939}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 6, "start": 0, "text": "France", "truncated": false}, "before_length": 6, "before_sha256": "7a1ca4ef7515f7276bae7230545829c27810c9d9e98ab2c06066bee6270d5153", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 6, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f426106d90015c5d82a96145", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9512}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovenia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "fce1e60bbc59ee3c381de461f412175da197c866a89ba45b24c7794f59b5c833", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f47858baa8740caa85d2d402", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3271}
{"after": {"end": 23, "start": 0, "text": "BristolMyers Squibb SAS", "truncated": false}, "after_length": 23, "after_sha256": "077c1bdf9d06b6ebea2cef6e6ab8ff5604c7feba155cc10d71a17f6fa240342e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f490c43bb01cfa80e11a6b47", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2883}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 73, "start": 0, "text": "Humalog 100 units/ml Tempo Pen solution for injection in a pre-filled pen", "truncated": false}, "before_length": 73, "before_sha256": "51230eb86540e3f2989a8d72fae57656b7c456fc2ba7375eaa3efbd8b0d89f0f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 73, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 73, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f49bdc78c1c88124f72ae3f4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4787}
{"after": {"end": 47, "start": 0, "text": "Blisters for 61 mg Vyndaqel film-coated tablets", "truncated": false}, "after_length": 47, "after_sha256": "42b0f8f2ed4e526b0f623006860d8dc36bc622f6fd6b052bd19fa1567456c7c2", "annex": "IIIA", "before": {"end": 66, "start": 0, "text": "Perforated unit dose blisters of 10 x 61 mg Vyndaqel soft capsules", "truncated": false}, "before_length": 66, "before_sha256": "26bc7a2abf9af493f05a469aa0d1ac766903a77cfeb601948be3a14e3330acff", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 22, "before_start": 0, "kind": "replace"}, {"after_end": 10, "after_start": 9, "before_end": 30, "before_start": 30, "kind": "insert"}, {"after_end": 12, "after_start": 11, "before_end": 37, "before_start": 31, "kind": "replace"}, {"after_end": 34, "after_start": 28, "before_end": 54, "before_start": 53, "kind": "replace"}, {"after_end": 36, "after_start": 35, "before_end": 56, "before_start": 55, "kind": "replace"}, {"after_end": 39, "after_start": 37, "before_end": 57, "before_start": 57, "kind": "insert"}, {"after_end": 41, "after_start": 40, "before_end": 59, "before_start": 58, "kind": "replace"}, {"after_end": 43, "after_start": 42, "before_end": 63, "before_start": 60, "kind": "replace"}, {"after_end": 46, "after_start": 45, "before_end": 65, "before_start": 65, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 34, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f49e6afb6aca0c72fbe0f7af", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2381}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 128, "start": 0, "text": "• The directions regarding needle handling are not intended to replace local, healthcare professional or institutional policies.", "truncated": false}, "before_length": 128, "before_sha256": "2b1752271ecc62b01e419e6f2687a80abb5aa6fef9bc2d8db7219bebc381ed4a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 128, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 128, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f4aea420a44dbbe9fbca9808", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9785}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 20, "start": 0, "text": "Novartis Pharma GmbH", "truncated": false}, "before_length": 20, "before_sha256": "bae642239c19e15ed2be9a6c4c5123c7ef0f4e0a79a5ece5f8c2cf22e6047d3f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 20, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 20, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f4bcf9de4c3e0467ca6804f5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3854}
{"after": {"end": 6, "start": 0, "text": "Italia", "truncated": false}, "after_length": 6, "after_sha256": "a7ca3e3d756601d5a22a4c0d8629da0c0ce425e5be526078d3e4583737150f52", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f4da63d100ed9aa8d0d4369f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2612}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 113, "start": 0, "text": "HUMALOG should look clear and colourless. Do not use if it is cloudy, coloured, or has particles or clumps in it.", "truncated": false}, "before_length": 113, "before_sha256": "2be7962e7eac24ea31e7763bb1c8ccee83ca7873aab0bddc757378c52ce8e1fd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 113, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 113, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f4ec9e4b0730c67194838872", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9638}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 9, "start": 0, "text": "Allemagne", "truncated": false}, "before_length": 9, "before_sha256": "6b58dbd6a994339b48d8446597da22402857b3409613459c7e3a293788fbe66a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 9, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 9, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f52795bb60566e8320fe1a64", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1701}
{"after": {"end": 34, "start": 0, "text": "Vyndaqel 61 mg film-coated tablets", "truncated": false}, "after_length": 34, "after_sha256": "0ab1707af4a63192366906aad4f1c11a8821c9edf7f91b23f417bf90186d02d2", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "Vyndaqel 61 mg soft capsules", "truncated": false}, "before_length": 28, "before_sha256": "49bdba5164eda37f05fe333e01328a0bed1d697f60d2a6f5cdbb879ef3b76026", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 15, "before_end": 16, "before_start": 15, "kind": "replace"}, {"after_end": 23, "after_start": 22, "before_end": 18, "before_start": 17, "kind": "replace"}, {"after_end": 26, "after_start": 24, "before_end": 19, "before_start": 19, "kind": "insert"}, {"after_end": 28, "after_start": 27, "before_end": 21, "before_start": 20, "kind": "replace"}, {"after_end": 30, "after_start": 29, "before_end": 25, "before_start": 22, "kind": "replace"}, {"after_end": 33, "after_start": 32, "before_end": 27, "before_start": 27, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 12}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f52faaf5a9c2b1c4514ef6f0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2282}
{"after": {"end": 22, "start": 0, "text": "Tel: + 421 2 20833 600", "truncated": false}, "after_length": 22, "after_sha256": "06545090f6b6777d6143e84f408247cee2424d81a40db0a2693eff093cfe9ec8", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f56617e65e92fcafe2cd97d7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2603}
{"after": {"end": 20, "start": 0, "text": "Tel: + 43 1 60 14 30", "truncated": false}, "after_length": 20, "after_sha256": "06513bb4e3ff06e9885e8395f2d87e81d050e28b69385dc8158cf331179a64c6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f5797d5ebabe4ae727e00046", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2559}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 24, "start": 0, "text": "Tel: +44 (0) 1844 347333", "truncated": false}, "before_length": 24, "before_sha256": "3e66f974ec29433df45716bf73117a6d11dd49271609c4d153b59d502de5d353", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 24, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 24, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f58117ed4d48dd0168660dd0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1840}
{"after": {"end": 25, "start": 0, "text": "Tél/Tel: + 32 2 352 76 11", "truncated": false}, "after_length": 25, "after_sha256": "faf94c8926d357d68deb65338e3cecd295564d1f1cb42aadaf0ebc86a3764dde", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f59226c50062d896635b5024", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2800}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 89, "start": 0, "text": "– If you need help deciding how to divide up your dose, ask your healthcare professional.", "truncated": false}, "before_length": 89, "before_sha256": "3556b9c634362ae8c3cd6bc751cc8e46e1e58857a1edd77bbd8dd93ac178fece", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 89, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 89, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f5a04f89e3db3de0099c774d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9684}
{"after": {"end": 16, "start": 0, "text": "In vitro studies", "truncated": false}, "after_length": 16, "after_sha256": "41aa47dddd4758362e1877ba29ce7b2a560ad831af5ccdfc6b8e631df39b8c45", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 16}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f5cb6253f4da93bf4cba71cc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 779}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 78, "start": 0, "text": "Niraparib comme substrat des transporteurs d’influx rénal (OAT1, OAT3 et OCT2)", "truncated": false}, "before_length": 78, "before_sha256": "80f020949a0f01b4d11dc9505c0b86b5fe9d8348231794b0ed57493efcae634e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 78, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 78, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f5d0df3ba070516ccdb876a8", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 252}
{"after": {"end": 13, "start": 0, "text": "Hermeslaan 11", "truncated": false}, "after_length": 13, "after_sha256": "6426889eacea87c88f1e0405aad54515d8a889ca0f1b2ab39e2039040651e7d3", "annex": "IIIA", "before": {"end": 11, "start": 0, "text": "Hoge Wei 10", "truncated": false}, "before_length": 11, "before_sha256": "ba5c0cab58e83e9dc6ec41e55e6acc00077e1be63c8a1ed970723221f2f12ba4", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 1, "before_end": 3, "before_start": 1, "kind": "delete"}, {"after_end": 4, "after_start": 2, "before_end": 6, "before_start": 4, "kind": "replace"}, {"after_end": 10, "after_start": 5, "before_end": 8, "before_start": 7, "kind": "replace"}, {"after_end": 13, "after_start": 12, "before_end": 11, "before_start": 10, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f5dd7a01be05324565e0db96", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2592}
{"after": {"end": 33, "start": 0, "text": "medinfo.latvia@swixxbiopharma.com", "truncated": false}, "after_length": 33, "after_sha256": "c0a77882a6e33a348e9fb5e2a3006e8250b7d628f17c35efbaf3212a5e6e1c2d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f5f338c8ffc470388282654c", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2635}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 32, "start": 0, "text": "How to recognize your Tempo Pen:", "truncated": false}, "before_length": 32, "before_sha256": "3965d2a0ecea01cf1ee020660a0d7055e23d82c4aab20be25e8363a9fc82ccbd", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f61dd80ded76f6e5d3043a8a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9619}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IV", "before": {"end": 54, "start": 0, "text": "CONCLUSIONS SCIENTIFIQUES ET MOTIFS DE LA MODIFICATION", "truncated": false}, "before_length": 54, "before_sha256": "923a6f5bb56e88c43a211adca028f81b56da56184220957daa36cc07841bc924", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 54, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 54, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f62089128f04d7caf20d0e4a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3491}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 236, "start": 0, "text": "If you are ill, especially if you feel sick or are sick, the amount of insulin you need may change. Even when you are not eating normally, you still need insulin. Test your urine or blood, follow your ‘sick rules’, and tell your doctor.", "truncated": false}, "before_length": 236, "before_sha256": "5b699e064d8ab4412bceaace7e1ac773a8ac121da54cb6f6d1328b6dc788d032", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 236, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 236, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f63875eb1b64f909a32601fc", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9418}
{"after": {"end": 94, "start": 0, "text": "Aucune étude clinique sur les interactions médicamenteuses n'a été réalisée avec le niraparib.", "truncated": false}, "after_length": 94, "after_sha256": "2b692a66c93b68cb0c7278e688706396e7da6845710f869bb2bf611f7efb7dde", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 94, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 94}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f655d6818a6df53c4d4f4e85", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1126}
{"after": {"end": 19, "start": 0, "text": "Swixx Biopharma UAB", "truncated": false}, "after_length": 19, "after_sha256": "0fa5997c653449c2ebe445618eaeedc027096662095bc4bf48a609ec757f79cd", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 19, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 19}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f67539c3a6217b960e97d4b3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2808}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 196, "start": 0, "text": "The other ingredients are metacresol, glycerol, dibasic sodium phosphate 7 H2O, zinc oxide and water for injections. Sodium hydroxide or hydrochloric acid may have been used to adjust the acidity.", "truncated": false}, "before_length": 196, "before_sha256": "67b39ca6458cb457f194b2bf9d63ad734d3cf4145444db60f0cf7e0436e78589", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 196, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 196, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f6c3c3e2400b32d29bb96c54", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9440}
{"after": {"end": 38, "start": 0, "text": "N.V. Bristol-Myers Squibb Belgium S.A.", "truncated": false}, "after_length": 38, "after_sha256": "aed62c6e6383ee3130a6851382813dabc668847cc45474eecb9eae19fd27a962", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f6f6e16392ce60a1d51ff593", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3179}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "Takeda UK Ltd", "truncated": false}, "before_length": 13, "before_sha256": "baf3815891882f756e27c4ab785d1f1864d45f1a993c33b3d78122dd2499b6e2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f7087bb60f0caedd11034c27", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1711}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "• Pull the needle out of your skin.", "truncated": false}, "before_length": 35, "before_sha256": "d20f88fd47c43e764fb25bd45ab075097542f69048df2ed914fe1fc71749c494", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 35, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 35, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f70d66aac8dd5662c7c85217", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9757}
{"after": {"end": 119, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu", "truncated": false}, "after_length": 119, "after_sha256": "0f2b81ab8009e1a279ca008eb6e21bdb2e532de63aef52b62bdac980c49555d4", "annex": "IIIA", "before": {"end": 93, "start": 0, "text": "Detailed information on this medicine is available on the European Medicines Agency web site:", "truncated": false}, "before_length": 93, "before_sha256": "1c2e788d78bca4cef615d8e7fe8e0268db2345fae4c6f39add7db65e179edffe", "change_kind": "content", "change_operations": [{"after_end": 119, "after_start": 93, "before_end": 93, "before_start": 93, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f73e2ccc38a7354b72ea67e0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3126}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 11, "start": 0, "text": "Unused Pens", "truncated": false}, "before_length": 11, "before_sha256": "0fc2e43ad8134fd21ea9438fb4ccaeb28545eb57ce339e7dc8c9bb333b14bbe7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 11, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 11, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f771696310fd755bc55b104c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9787}
{"after": {"end": 21, "start": 0, "text": "Tel: + 386 1 2355 100", "truncated": false}, "after_length": 21, "after_sha256": "dac6f0be4f23d749d801d499c013eab48028544c9f89af72365ef4fdc2e94efc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f77b71a123969c51c36cb8d4", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2909}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Common problems of diabetes", "truncated": false}, "before_length": 27, "before_sha256": "ed3cf70cf48d67460bf8e0bc036fc6fbede73bfd1238a349e13dce6198d43c3c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f77e03fa9a9d4db2626a18c4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9383}
{"after": {"end": 6, "start": 0, "text": "Dānija", "truncated": false}, "after_length": 6, "after_sha256": "ea1cda0e8df08e5d6b3894d37121d5928828a343cc4691a9a2dc4bf87f7ec80d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f7805e30372a17b1b1fbc70f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2136}
{"after": {"end": 24, "start": 0, "text": "medischeafdeling@bms.com", "truncated": false}, "after_length": 24, "after_sha256": "3815a916e71fc353b4410b37e0a85dede1ac350e08b8ab1461a12a1b0da71bb9", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f7b8bd7b598236a0e4ed8f3a", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2540}
{"after": {"end": 35, "start": 0, "text": "medinfo.slovakia@swixxbiopharma.com", "truncated": false}, "after_length": 35, "after_sha256": "7b73e721c843deabd3a181fa5d110ba6dfbdc9531c8d2e1e6545e547e02a9ef0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 35, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 35}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f7c0ebd0ed2ef08f954d2fda", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3281}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 68, "start": 0, "text": "Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France,", "truncated": false}, "before_length": 68, "before_sha256": "d4d99b4e4a362304c6e48241a549fb7aff20d51147d41153f53b09e4338cf2ed", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 68, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 68, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f7c7b0e03d07354594cfd0af", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9451}
{"after": {"end": 38, "start": 0, "text": "Tel: 0800 0752002 (+ 49 89 121 42 350)", "truncated": false}, "after_length": 38, "after_sha256": "a6e565b385c2fd58348adaaec0d48f14b092e8ceadc07f5c2358d6c3e3ac6b0f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 38, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 38}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f7e1feba4b9365e743ed56f5", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2528}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 32, "start": 0, "text": "Butylated hydroxytoluene (E 321)", "truncated": false}, "before_length": 32, "before_sha256": "b1e970fb802dea27e97995a72fb7d0bb1d52bb7542ade46d7288b363fbbf5bbf", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 32, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 32, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f7edfbc0a6f3393303af61cb", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1368}
{"after": {"end": 15, "start": 0, "text": "infomed@bms.com", "truncated": false}, "after_length": 15, "after_sha256": "66e67860f3e4742344d5e1cd7f07326ac1d6946e02f492fa89340b12edd31c8f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 15, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f7f441441501aeb603add334", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2569}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 482, "start": 0, "text": "Niraparib is a substrate of Pglycoprotein (Pgp) and Breast Cancer Resistance Protein (BCRP). However, due to its high permeability and bioavailability, the risk of clinically relevant interactions with medicinal products that inhibit these transporters is unlikely. Therefore, no dose adjustment for Zejula is required when administered concomitantly with medicinal products known to inhibit Pgp (e.g. amiodarone, verapamil) or BCRP (e.g. osimertinib, velpatasvir, and eltrombopag).", "truncated": false}, "before_length": 482, "before_sha256": "f1fae21894698e3a359cc1396ed1c637eb5cb1f8e0c62d05ebd5b86896b61617", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 482, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 482, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f81d646ee67bc5f82ad0da7d", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 236}
{"after": {"end": 20, "start": 0, "text": "Tel: + 43 1 60 14 30", "truncated": false}, "after_length": 20, "after_sha256": "06513bb4e3ff06e9885e8395f2d87e81d050e28b69385dc8158cf331179a64c6", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f82074207d26e1fbd8b4f90e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2869}
{"after": {"end": 454, "start": 0, "text": "Les expositions systémiques (Cmax et ASC) au niraparib ont augmenté de manière proportionnelle à la dose lorsque la dose de niraparib augmentait de 30 mg à 400 mg. La biodisponibilité absolue du niraparib est d’environ 73 %, ce qui indique un effet de premier passage minime. Dans une analyse pharmacocinétique de population du niraparib, la variabilité inter-individuelle de la biodisponibilité a été estimée à un coefficient de variation (CV) de 33,8%.", "truncated": false}, "after_length": 454, "after_sha256": "517b99eb2ae3a46feb32efad88450befe30b81e95659ea6e1a790f31d1d5d4c5", "annex": "I", "before": {"end": 452, "start": 0, "text": "Les expositions systémiques (Cmax et ASC) au niraparib ont augmenté de manière proportionnelle à la dose lorsque la dose de niraparib augmentait de 30 mg à 400 mg. La biodisponibilité absolue du niraparib est d’environ 73 %, ce qui indique un effet de premier passage minime. Dans une analyse pharmacocinétique de population du niraparib, la variabilité inter-individuelle de la biodisponibilité a été estimée à un coefficient de variation (CV) de 31%.", "truncated": false}, "before_length": 452, "before_sha256": "954430188db72d4f9a08f21b3b99a9822e8a9f52845514360e8d9b61756e847d", "change_kind": "content", "change_operations": [{"after_end": 452, "after_start": 449, "before_end": 450, "before_start": 449, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f8368affb5b8271482a0f1b1", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 781}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 88, "start": 0, "text": "Niraparib comme substrat des transporteurs d’efflux (P-gp, BCRP, BSEP, MRP2 et MATE 1/2)", "truncated": false}, "before_length": 88, "before_sha256": "ae7f06654a170f9eabe1e66a07ffddbe4992241c964cbc85208e9c3ae8ad6a3e", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 88, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 88, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f851af49c3072af5eca2c856", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 244}
{"after": {"end": 34, "start": 0, "text": "medinfo.estonia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "e47c511a7367c6c7b4b4d54b0660bf70577f18e3fe0bcef938db762d7981dd1e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f85dceb5b4ea51fad8b73404", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3216}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 191, "start": 0, "text": "Oedema (e.g. swelling in arms, ankles; fluid retention) has been reported, particularly at the start of insulin therapy or during a change in therapy to improve control of your blood glucose.", "truncated": false}, "before_length": 191, "before_sha256": "d38bbf7bb8906e58de8c1e37d7138175e6995a9202a4228c20771d360e65d89d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 191, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 191, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f86205da2a83383a8e3a3ad4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9378}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 10, "start": 0, "text": "Lilly S.A.", "truncated": false}, "before_length": 10, "before_sha256": "1b61f3b8034897dbabd0c5a89066509b80453d0db759e3f3376e97363f36f1e2", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 10, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 10, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f8e70dae892fccca75995a71", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9506}
{"after": {"end": 36, "start": 0, "text": "Read the package leaflet before use.", "truncated": false}, "after_length": 36, "after_sha256": "5523bc203c0d15a42e51f1f2084990ce77593674ceb9b20d974654fb13a8f72b", "annex": "IIIA", "before": {"end": 35, "start": 0, "text": "Read the package leaflet before use", "truncated": false}, "before_length": 35, "before_sha256": "507cbe4bd01d082cb8b1d6b89039f65a5c71739015aad79203bdc9f43571b36e", "change_kind": "content", "change_operations": [{"after_end": 36, "after_start": 35, "before_end": 35, "before_start": 35, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f9018cb6993eeea1e76863e6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 809}
{"after": {"end": 22, "start": 0, "text": "medinfo.greece@bms.com", "truncated": false}, "after_length": 22, "after_sha256": "c6333c55497395c0b8b73bea635482710f0fd3c8817ddd60794ec55114ce8640", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f9091329c99691767b80be1b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2865}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 2, "start": 0, "text": "NN", "truncated": false}, "before_length": 2, "before_sha256": "15c841dff8407a197a8be456d43283d973c0ba690724b24da5e5d0d6dbc70423", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 2, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f950c2e0ad497670e1f241e2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4775}
{"after": {"end": 21, "start": 0, "text": "Tlf.: +45 45 26 60 00", "truncated": false}, "after_length": 21, "after_sha256": "6bdd3c845f6a6e520023cbb8b3726e2eefc4bc4ac00ae57245f3055e31d53895", "annex": "III", "before": {"end": 20, "start": 0, "text": "Tlf: +45 45 26 60 00", "truncated": false}, "before_length": 20, "before_sha256": "7932ef9452966b997a4a22618abb01fb644277c9ab041214e6264730772b2d64", "change_kind": "unassigned", "change_operations": [{"after_end": 4, "after_start": 3, "before_end": 3, "before_start": 3, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f965f0445ddc0bfea1bf000b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3392}
{"after": {"end": 26, "start": 0, "text": "BristolMyers Squibb GesmbH", "truncated": false}, "after_length": 26, "after_sha256": "45a0d9cd544a5f19296a3fa84647df081ac4cb2a9c4935681d9f34e18f6803a7", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 26, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 26}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f97fb1fa3aa0e0aca48fb4e3", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2868}
{"after": {"end": 7, "start": 0, "text": "Lietuva", "truncated": false}, "after_length": 7, "after_sha256": "5109820f748796128b8bafd3806d05511bc89ad77fc3cda960facf37a639bc7f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f98c0e4e8cb879692b5473de", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2807}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 12, "start": 0, "text": "County Kerry", "truncated": false}, "before_length": 12, "before_sha256": "eb7356a4494d39c472b712704605178f5a5ec97da0fc0b32f904fa38c0a2cdcc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 12, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 12, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f98f3f9a225cafd569beab68", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:17Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "88ea3e7b543c32185b4cb10f519b16c14010d63994766366d4943b3fcc6db072", "source_snapshot_id": "source-3739a5682b5bef388497ee9d", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2029}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 78, "start": 0, "text": "MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES OU LES FILMS THERMOSOUDÉS", "truncated": false}, "before_length": 78, "before_sha256": "936698de91fcb2e7208e9618e06c753fdcba895d52cfdd4bce7b5589a54d64c9", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 78, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 78, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f99251d91e4ed54bb17f9d79", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1098}
{"after": {"end": 21, "start": 0, "text": "Tel: + 39 06 50 39 61", "truncated": false}, "after_length": 21, "after_sha256": "6ac0b442dd41c62cad589a5c348c5781354f651196f78692c420568d264ff7f0", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f9a4ed41e64b40c6775ef231", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2920}
{"after": {"end": 16, "start": 0, "text": "Takeda Pharma OÜ", "truncated": false}, "after_length": 16, "after_sha256": "e9444a2479654caefb4bbb022acc8101ffffafcb8d32eb0944837642964cc91b", "annex": "IIIA", "before": {"end": 16, "start": 0, "text": "Takeda Pharma AS", "truncated": false}, "before_length": 16, "before_sha256": "ca89ccc51987ebdf828ff31b3b63ca2c86d0d7d56200b96706b8e9e4de779862", "change_kind": "content", "change_operations": [{"after_end": 16, "after_start": 14, "before_end": 16, "before_start": 14, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 2}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f9bbefe798a5c3b533c092cc", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "1259eb21e8218d0026e5e8860739b988bdc6edf26b42c8ce0351c898ee79889a", "source_snapshot_id": "source-fed2f7865d777cc52aa00a0f", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1617}
{"after": {"end": 151, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments : https://www.ema.europa.eu.", "truncated": false}, "after_length": 151, "after_sha256": "7c0752c5b7e8f6ae333055b974f1ec09f9c6782a57b413303ad43dd88cc73614", "annex": "IIIA", "before": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne des médicaments : http://www.ema.europa.eu.", "truncated": false}, "before_length": 150, "before_sha256": "cba14846c320673c759f35d86d6c5f8913374e8c20319aa76bf242842cf27142", "change_kind": "technical", "change_operations": [{"after_end": 130, "after_start": 129, "before_end": 129, "before_start": 129, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f9d6ca140031a9debb82099b", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3025}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "II", "before": {"end": 15, "start": 0, "text": "Hafnerstraße 36", "truncated": false}, "before_length": 15, "before_sha256": "2fcce2f98396d52bbfd5728e1a018b4f5e6a7c25edffb18410df25f808883c4f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 15, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f9dfb279322ca51daa713a7a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005805", "medicine_name": "Fymskina", "medicine_slug": "fymskina", "observed_at": "2026-10-12T19:29:47Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "conditions", "section_type": "conditions", "source_provider": "European Medicines Agency", "source_sha256": "e75d7a51093fb4e5b8d3e4c91f3a08711d1706b67ab681c13b3537b03e49282f", "source_snapshot_id": "source-6dd42b0061d687f44f1d489c", "source_updated_at": "2025-07-10", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/fymskina-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1679}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 33, "start": 0, "text": "United Kingdom (Northern Ireland)", "truncated": false}, "before_length": 33, "before_sha256": "9379d82927cdb505cfb186e912177065e56a1314de3a2b914ebbb8b5fe21525a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 33, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 33, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-f9f506382533212c1a933e96", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000899", "medicine_name": "Firazyr", "medicine_slug": "firazyr", "observed_at": "2026-10-12T13:40:55Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 1, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "0325d6b1ed99998c55d22fdb36b4ebd9a5eac2b4e36ae3b0b2d5e7335eea6248", "source_snapshot_id": "source-35cc27f70d724d28bd19021a", "source_updated_at": "2026-04-01", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/firazyr-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1684}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 269, "start": 0, "text": "Prime your Tempo Pen before each use. This checks that insulin comes out and clears the air bubbles from your Tempo Pen. There may still be some small air bubbles left in the pen - these are harmless. But if the air bubbles are too large it may affect the insulin dose.", "truncated": false}, "before_length": 269, "before_sha256": "14fbe1010d341d2a3d79cbc2fb817410253c688f4e15215be0678da81351c64f", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 269, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 269, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fa07cd186ed0601279f60939", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9319}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 48 22 2606400", "truncated": false}, "after_length": 21, "after_sha256": "91ea111aa679f6773d6dedcb0b0a2558a35b3e3387196cb6b3c71a9a8806c141", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fa0b6a234d057923d49adf31", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2875}
{"after": {"end": 27, "start": 0, "text": "medicalinfo.belgium@bms.com", "truncated": false}, "after_length": 27, "after_sha256": "89cc8f80784cf746caf025163997bd0e4c325ac5531f7127e446c8622534141f", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fa55ad7e7b0ff5df5fba15c8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3166}
{"after": {"end": 21, "start": 0, "text": "Tel: + 385 1 2078 500", "truncated": false}, "after_length": 21, "after_sha256": "d2c4badf1d52e4fa4d9876ca25a250b52d706e4108687e5034656c1b419f6ddc", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-faa0d87888a6b748c60eb5d0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3258}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 65, "start": 0, "text": "Inhibition des transporteurs d’influx rénaux (OAT1, OAT3 et OCT2)", "truncated": false}, "before_length": 65, "before_sha256": "ce7d116b56e90382de55c2a6c0148613b81713cd033eb1295972e3784bc3dfbc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 65, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 65, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fab97f4dc2aace3265de338e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg gélules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 282}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 11, "start": 0, "text": "Dose Window", "truncated": false}, "before_length": 11, "before_sha256": "b5741759ec11e4775f3db7384f40ed474c2007ac218300030db32a7ecf73d495", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 11, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 11, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fad24f05c7346b340dc9ba33", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9597}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 56, "start": 0, "text": "All clinical studies have only been performed in adults.", "truncated": false}, "before_length": 56, "before_sha256": "97017a73dc57aaef6eb8436a106d9125aa7de69240ffcd16f6cbbc0f7c549704", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 56, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 56, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fae404fa4dac3551332c397a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1139}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 6, "start": 0, "text": "Ísland", "truncated": false}, "before_length": 6, "before_sha256": "5801902efe8b92c2ace1332f4cca2ea1fcb704712e2fe7ca66654d2a826e8451", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 6, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 6, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fae6a6ad2c46817bd4f0829a", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9534}
{"after": {"end": 11, "start": 0, "text": "Vistor ehf.", "truncated": false}, "after_length": 11, "after_sha256": "7b79f0f888fc32453606a29b908677d0b6c13a510070ab26fe31e12b995d77fe", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-faf647589a9b74c939fc9ed6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3274}
{"after": {"end": 27, "start": 0, "text": "CPO Pharmaceuticals Limited", "truncated": false}, "after_length": 27, "after_sha256": "94b644443752e2cb52916b23f8141fbd44c47055b3416af333e12ac18e101b87", "annex": "IIIA", "before": {"end": 23, "start": 0, "text": "GPA Pharmaceuticals Ltd", "truncated": false}, "before_length": 23, "before_sha256": "ece7127e303c91e9501d2cedd822476265aae86acb9f96ef1553ab3a6954afe1", "change_kind": "content", "change_operations": [{"after_end": 1, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 3, "after_start": 2, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 21, "before_end": 21, "before_start": 21, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 22, "before_start": 22, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 2, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fafa4c357d2562907444ffb0", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000202", "medicine_name": "Viagra", "medicine_slug": "viagra", "observed_at": "2026-10-12T19:09:02Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "8d5af964ee4c3aa7f3f3fd3a3302c85fb6f7ab12d2ab711cefd119b87311996f", "source_snapshot_id": "source-811e4641286f40b071017e0c", "source_updated_at": "2025-09-17", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/viagra-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3356}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 28, "start": 0, "text": "If you forget to use Humalog", "truncated": false}, "before_length": 28, "before_sha256": "304a094ca4c63b7fce739f1a496836df0a81abe3689ae6c4e2648479f55398b7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 28, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 28, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fb55462ec4d3e1ada23722b6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9347}
{"after": {"end": 209, "start": 0, "text": "Women of childbearing potential should use appropriate contraception when taking tafamidis and continue to use appropriate contraception for one-month after stopping treatment with tafamidis (see section 4.6).", "truncated": false}, "after_length": 209, "after_sha256": "89cb5e950ff87adc4b8c627ffa4ce663ef5006e98b1fa046657be79f9d4507b6", "annex": "I", "before": {"end": 207, "start": 0, "text": "Women of childbearing potential should use appropriate contraception when taking tafamidis and continue to use appropriate contraception for 1-month after stopping treatment with tafamidis (see section 4.6).", "truncated": false}, "before_length": 207, "before_sha256": "2b37804fcd520dd65a46c9e508d394c01928f96b9d730b77bcc6e86cce9a31aa", "change_kind": "content", "change_operations": [{"after_end": 144, "after_start": 141, "before_end": 142, "before_start": 141, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fb649f5e4733822096bdc2a0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.4", "section_type": "warning", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 993}
{"after": {"end": 33, "start": 0, "text": "Bristol-Myers Squibb spol. s r.o.", "truncated": false}, "after_length": 33, "after_sha256": "3abea3460809987d2906fa40ab370a496bbee801d456a93f8afaeb35776f9233", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 33, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 33}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fb778f1770ebe5f686ced0c7", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2507}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 8, "start": 0, "text": "Sorbitan", "truncated": false}, "before_length": 8, "before_sha256": "b608c80919982b92e74e3b2cb5f7ef65abf3e7b5c1004b2e7eb84f43589b68c0", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fb9cad4e9e1def0bc45fde78", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1358}
{"after": {"end": 9, "start": 0, "text": "29 (24.8)", "truncated": false}, "after_length": 9, "after_sha256": "00b58731f43107fae36457670994dbb5042ac297971bbc2434e7d43cc093e7cc", "annex": "I", "before": {"end": 10, "start": 0, "text": "(20 (21.3)", "truncated": false}, "before_length": 10, "before_sha256": "811f4bc46e6146109bb319d04e67da612f3c7ad2a4f8f7daf8a29a3a964c7178", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "delete"}, {"after_end": 2, "after_start": 1, "before_end": 3, "before_start": 2, "kind": "replace"}, {"after_end": 6, "after_start": 5, "before_end": 7, "before_start": 6, "kind": "replace"}, {"after_end": 8, "after_start": 7, "before_end": 9, "before_start": 8, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 4, "chars_inserted": 3}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fb9d58106dad3f0a1cc16382", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/005900", "medicine_name": "Rezzayo", "medicine_slug": "rezzayo", "observed_at": "2026-10-12T19:31:05Z", "pipeline_version": "2.0.0", "presentation_label": "REZZAYO 200 mg powder for concentrate for solution for infusion", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.1", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "3abb0738376231ec9d81bd92d416ecc0bc28f697f3ef0a46fb008463970b0f94", "source_snapshot_id": "source-bb3cde635cf7cd6bb8b16e4e", "source_updated_at": "2025-06-18", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/rezzayo-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 311}
{"after": {"end": 123, "start": 0, "text": "Titulaire de l'Autorisation de mise sur le marché : Eli Lilly Nederland B.V., Orteliuslaan 1000, 3528 BD Utrecht, Pays-Bas.", "truncated": false}, "after_length": 123, "after_sha256": "c9360159827bd94b8452261891b0f98066b989ff2cdfd5b65fd7a73b98e1e192", "annex": "III", "before": {"end": 123, "start": 0, "text": "Titulaire de l'Autorisation de mise sur le marché : Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Pays-Bas.", "truncated": false}, "before_length": 123, "before_sha256": "24244fac23f7c655b5cf0249efb6324cf790a7ba49b33b42d12cc4dbef87a7b4", "change_kind": "administrative", "change_operations": [{"after_end": 87, "after_start": 78, "before_end": 79, "before_start": 78, "kind": "replace"}, {"after_end": 89, "after_start": 88, "before_end": 82, "before_start": 80, "kind": "replace"}, {"after_end": 90, "after_start": 90, "before_end": 92, "before_start": 83, "kind": "delete"}, {"after_end": 95, "after_start": 91, "before_end": 95, "before_start": 93, "kind": "replace"}, {"after_end": 104, "after_start": 103, "before_end": 104, "before_start": 103, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fb9e2e0aa7933cde119ae838", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3366}
{"after": {"end": 15, "start": 0, "text": "3528 BD Utrecht", "truncated": false}, "after_length": 15, "after_sha256": "4ea402b0be2ffd43624e79f5ad9706ad796af820c845df2a7158d607c083d913", "annex": "III", "before": {"end": 15, "start": 0, "text": "3528 BJ Utrecht", "truncated": false}, "before_length": 15, "before_sha256": "c83d25e8ea65101ad8ea274a07e2114705ecd244e7a6dba61eb7b4d1ba592ecb", "change_kind": "unassigned", "change_operations": [{"after_end": 7, "after_start": 6, "before_end": 7, "before_start": 6, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fbb611abf71cf38ce91cda00", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1930}
{"after": {"end": 6, "start": 0, "text": "Danska", "truncated": false}, "after_length": 6, "after_sha256": "99ab62517b3bb8298a9c40a2538a2769b0c2c8637a432d58e84bd537a117f8d4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 6, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 6}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fbba8de0b04cf182cb149e17", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000374", "medicine_name": "Protopic", "medicine_slug": "protopic", "observed_at": "2026-10-12T17:29:22Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "711fbe9a99afd915736942f184ef98c48c728283deae177214582db699e96eeb", "source_snapshot_id": "source-e9ff2713d3df6640fcfa0428", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/protopic-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1808}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Ask your doctor for advice.", "truncated": false}, "before_length": 27, "before_sha256": "4335e67030efa3d3208cd35a2cac8ea90595bd9aa0d67c33960ff65acc421068", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fbe5c6c0d1630db813f62436", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9291}
{"after": {"end": 23, "start": 0, "text": "België/Belgique/Belgien", "truncated": false}, "after_length": 23, "after_sha256": "4646bb1028d1508f87afd915f6c144536b764795c7df5858f4eaa35881bb797d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fbeeba4119e641d3aaadfc87", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3163}
{"after": {"end": 8, "start": 0, "text": "България", "truncated": false}, "after_length": 8, "after_sha256": "a7215e5aa55f878990c076bb8195d75ca42044d4d5c7d2ba90af610508b643d3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 8, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 8}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fc3015dbcfb4756909124ff2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3176}
{"after": {"end": 25, "start": 0, "text": "Bristol-Myers Squibb B.V.", "truncated": false}, "after_length": 25, "after_sha256": "0ca7ef7834ca2eb516116ddfb2edb978bd0d58c8673ce6fa611a0719568a6293", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 25, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 25}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fc37daa62354913fad296117", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3209}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 127, "start": 0, "text": "Ni le niraparib ni M1 ne sont des inhibiteurs des polypeptides de transport d’anions organiques 1B1 (OATP1B1) ou 1B3 (OATP1B3).", "truncated": false}, "before_length": 127, "before_sha256": "d30e46470239e601cf85f378461d0944ec1779ece162fb2846cdec5f6a7555be", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 127, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 127, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fcaa9d6fa55b9c21f1d7784e", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:10Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg comprimé pelliculé", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "b9ac50a9ca2c09fdb6d9169e18ba0d635b185f625308a0db885aea657b260534", "source_snapshot_id": "source-00a6bd341ccbdbed2f4fc791", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1166}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 5, "start": 0, "text": "Malta", "truncated": false}, "before_length": 5, "before_sha256": "71e9eb10755c8232974d186a560f7658a1ccbdd3097877dfa1ad3436af90d46a", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 5, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 5, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fcadfa6542ebc3ebc3228820", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9481}
{"after": {"end": 7, "start": 0, "text": "Danmark", "truncated": false}, "after_length": 7, "after_sha256": "b2bebaaf55198f3166a7d7089112d30e245d6cf4a3249ae87b597fa988e7f1be", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fcb59fe0ddde8002613d66cd", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3196}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 64, "start": 0, "text": "MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS", "truncated": false}, "before_length": 64, "before_sha256": "634d13b5cc921426e25c8b6e1b11d3a60b3faa8089a5b3f6fbfc472208ec37ba", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 64, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 64, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fced808c2bd51bc9697ae604", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 4875}
{"after": {"end": 34, "start": 0, "text": "medinfo.croatia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "59c47394700ad787801e8ce1b033fc5d63a885ddfc680677ae6b5acd89bb7df3", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fd67725c32792bdb536b8506", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2585}
{"after": {"end": 22, "start": 0, "text": "Tel: + 34 91 456 53 00", "truncated": false}, "after_length": 22, "after_sha256": "c59845f4e2b4a96548adda4dbf16851ff33a89874560e491da6b05aee33b646a", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fd8011db92a62e48954acff5", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2564}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 348, "start": 0, "text": "You get diabetes if your pancreas does not make enough insulin to control the level of glucose in your blood. Humalog is a substitute for your own insulin and is used to control glucose in the long term. It works very quickly and lasts a shorter time than soluble insulin (2 to 5 hours). You should normally use Humalog within 15 minutes of a meal.", "truncated": false}, "before_length": 348, "before_sha256": "0bfda7b05495a0f3cdbd69e754e24233137bf0eb66b515e6604d9a58b7b5ca3c", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 348, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 348, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fdb24adbd9bca1ab62a21930", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9235}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 47, "start": 0, "text": "Your insulin needs may change if you are taking", "truncated": false}, "before_length": 47, "before_sha256": "968ea2fdd1e08d547eb00521f04b21ec248d319043015c6294e5599a9f6b0011", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 47, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 47, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fdec5b0255ed2663d7086a31", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9269}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 39, "start": 0, "text": "Pen Needle Parts (Needles Not Included)", "truncated": false}, "before_length": 39, "before_sha256": "4ea9d67b17000ca6c97acdcef869ea373209fd8c0998e4bd156baebd8f210818", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fdf01cf2047defc26b56c447", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9602}
{"after": {"end": 27, "start": 0, "text": "Bristol-Myers Squibb GesmbH", "truncated": false}, "after_length": 27, "after_sha256": "4916681fe99630afcd464062529e9edf6fd8370e6c9aae947ff9ed0076180f67", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 27, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 27}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fe05830690a925f348c41c0b", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2864}
{"after": {"end": 23, "start": 0, "text": "België/Belgique/Belgien", "truncated": false}, "after_length": 23, "after_sha256": "4646bb1028d1508f87afd915f6c144536b764795c7df5858f4eaa35881bb797d", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fe30c89ab5e35d5db2f85a21", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2486}
{"after": {"end": 37, "start": 0, "text": "N.V. BristolMyers Squibb Belgium S.A.", "truncated": false}, "after_length": 37, "after_sha256": "feeebdb54667cd864ac3ce52dc07c49e265c3b042233fe6691e3f074fda776c2", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 37, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 37}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fe73a8e6dcf600d78c105fea", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2508}
{"after": {"end": 34, "start": 0, "text": "medinfo.estonia@swixxbiopharma.com", "truncated": false}, "after_length": 34, "after_sha256": "e47c511a7367c6c7b4b4d54b0660bf70577f18e3fe0bcef938db762d7981dd1e", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 34, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 34}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fe93f942ca71324c16387c41", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2851}
{"after": {"end": 23, "start": 0, "text": "Tel: + 351 21 440 70 00", "truncated": false}, "after_length": 23, "after_sha256": "051a50965400ccbc97e96d9606564d6ef751251b31d5cd81aa4f430414a32099", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 23, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 23}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fe96c44f64462316eda86cca", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2889}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 8, "start": 0, "text": "Hrvatska", "truncated": false}, "before_length": 8, "before_sha256": "08c5546cc42a9be9368bdd6a99ed02c97b9163c173b1e97dd49b785cb49740bc", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 8, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 8, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fe9dab0431265cdf9b808b7c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9519}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 27, "start": 0, "text": "Tel. + 49-(0) 6172 273 2222", "truncated": false}, "before_length": 27, "before_sha256": "d2c724b9e3385b81454849fd4ea3587ad717b8482922be98ab506748d5e7fece", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 27, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 27, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fea05fbe3d3379cacf75053e", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9486}
{"after": {"end": 22, "start": 0, "text": "Swixx Biopharma d.o.o.", "truncated": false}, "after_length": 22, "after_sha256": "e850f8ccd2a97ed62def43d584e4e71bbd174123529e9158dbb5597382223b42", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 22, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 22}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-feb046c7e98c2ac959ad9e22", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2598}
{"after": {"end": 11, "start": 0, "text": "Tablet core", "truncated": false}, "after_length": 11, "after_sha256": "e6d6b52cffb54a9a6c6a046c288b67c6fee125892291ac514d4dabde1e9e4b75", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 11, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 11}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-febd579c6cccaeb93f19c19c", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1337}
{"after": {"end": 24, "start": 0, "text": "Tel: + 31 (0)30 300 2222", "truncated": false}, "after_length": 24, "after_sha256": "df26f07876232a3ba50861e46ee103ea04d50c8b384a64d52078fdc518ae52ae", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 24, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 24}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fecc914fbb09f218a98b9180", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2533}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 388, "start": 0, "text": "Niraparib is a substrate of carboxylesterases (CEs) and UDPglucuronosyltransferases (UGTs) in vivo. Oxidative metabolism of niraparib is minimal in vivo. No dose adjustment for Zejula is required when administered concomitantly with medicinal products known to inhibit (e.g. itraconazole, ritonavir, and clarithromycin) or induce CYP enzymes (e.g. rifampin, carbamazepine, and phenytoin).", "truncated": false}, "before_length": 388, "before_sha256": "84bc46b6b0dd077561ee7718c51b3a3306816acb4958db29a815b5b97d3a204d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 388, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 388, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fedd67c2c7ce34888de53cf4", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg film-coated tablets", "presentation_occurrence": 2, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1096}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 205, "start": 0, "text": "– If you still do not think you received the full amount you dialed for your injection, do not start over or repeat that injection. Monitor your blood glucose as instructed by your healthcare professional.", "truncated": false}, "before_length": 205, "before_sha256": "91ad3caa266452ea43c73626a9592b2cba0b456702f7d0e0a55b7bbc14b8fcd1", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 205, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 205, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-feddfa257eb670abca599e2f", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9762}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "III", "before": {"end": 39, "start": 0, "text": "Eli Lilly and Company (Ireland) Limited", "truncated": false}, "before_length": 39, "before_sha256": "0555e8a06c0ef36afd955d945d4997f04834690c546541adf74802bac524a0e4", "change_kind": "unassigned", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 39, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 39, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-feecb09cb7f0735626e7b92f", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3460}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 13, "start": 0, "text": "Roonstraße 25", "truncated": false}, "before_length": 13, "before_sha256": "72b80df998792e1d92189a290d82759fb839b17a555226b67f667c759822bfa7", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 13, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 13, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ff1b4b6c9a49215bb569e115", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000670", "medicine_name": "Exjade", "medicine_slug": "exjade", "observed_at": "2026-10-12T19:02:21Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "2272fb11deba250d29c0e240dccd3db008ddde53f2b35df08da7e1936e9141cb", "source_snapshot_id": "source-53499b0dc424d91754b53435", "source_updated_at": "2026-02-05", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/exjade-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3464}
{"after": {"end": 52, "start": 0, "text": "anti-clotting medicines (e.g. apixaban, rivaroxaban)", "truncated": false}, "after_length": 52, "after_sha256": "f538d67b91f96fc361401036224cf577d492f74b14a60dfd326ab8029b0e86e5", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 52, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 52}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ff34b421df7c7347a7204cb2", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3108}
{"after": {"end": 39, "start": 0, "text": "Bristol-Myers Squibb Pharmaceuticals uc", "truncated": false}, "after_length": 39, "after_sha256": "ab72fdea8b5fe2eaa4c98886b1cf7afbfde7133a0ee1d1e04fc9d573c1885b5c", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 39, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 39}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ff376d32ed92c6f9356b2ef9", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2587}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "I", "before": {"end": 56, "start": 0, "text": "All clinical studies have only been performed in adults.", "truncated": false}, "before_length": 56, "before_sha256": "97017a73dc57aaef6eb8436a106d9125aa7de69240ffcd16f6cbbc0f7c549704", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 56, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 56, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ff5f98a8a111e7552c76d062", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "4.5", "section_type": "interaction", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 276}
{"after": {"end": 7, "start": 0, "text": "Sverige", "truncated": false}, "after_length": 7, "after_sha256": "3a7d70b4edb982a403e97d77681309e5fb1032b12d727aa1e92b145b069b9aa4", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 7}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ff65229f5e7d76065dd13600", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2937}
{"after": {"end": 17, "start": 0, "text": "Calcium carbonate", "truncated": false}, "after_length": 17, "after_sha256": "c2b48534e7867fee380abb76e3dec3b5d459319f4e66ca67f74dc8f774f9844d", "annex": "I", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 17, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 17}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ff6ffac60b2606a344be43f8", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/002294", "medicine_name": "Vyndaqel", "medicine_slug": "vyndaqel", "observed_at": "2026-10-12T13:28:10Z", "pipeline_version": "2.0.0", "presentation_label": "Vyndaqel 61 mg film-coated tablets", "presentation_occurrence": 3, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "6.1", "section_type": "quality_presentation", "source_provider": "European Medicines Agency", "source_sha256": "49f7a15e429dfe4458da421d40a163cd320a285c43539da1058aa6781b57bb54", "source_snapshot_id": "source-3456bb4aee43034a7e5c7a84", "source_updated_at": "2026-08-27", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/vyndaqel-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 1347}
{"after": {"end": 110, "start": 0, "text": "Marketing Authorisation Holder: Eli Lilly Nederland B.V., Orteliuslaan 1000, 3528 BD Utrecht, The Netherlands.", "truncated": false}, "after_length": 110, "after_sha256": "e2ef698638f86423386a55d95b0167d0a5ee39297d86c39e1c4a1335b36f2d1c", "annex": "IIIA", "before": {"end": 110, "start": 0, "text": "Marketing Authorisation Holder: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.", "truncated": false}, "before_length": 110, "before_sha256": "31bde930103fd90462092a47ede6325cfe7229cd2cfce1a06a1e8fbb3caea2e0", "change_kind": "administrative", "change_operations": [{"after_end": 67, "after_start": 58, "before_end": 59, "before_start": 58, "kind": "replace"}, {"after_end": 69, "after_start": 68, "before_end": 62, "before_start": 60, "kind": "replace"}, {"after_end": 70, "after_start": 70, "before_end": 72, "before_start": 63, "kind": "delete"}, {"after_end": 75, "after_start": 71, "before_end": 75, "before_start": 73, "kind": "replace"}, {"after_end": 84, "after_start": 83, "before_end": 84, "before_start": 83, "kind": "replace"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 15, "chars_inserted": 15}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ff8a55d7a8965574046b6ea0", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:56Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "722d63a5f1170b27dd9650e183ec452623ef1f21e259351573b7cb5af3d32c66", "source_snapshot_id": "source-975f17cea1f76284ed13afe9", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3316}
{"after": {"end": 21, "start": 0, "text": "Tel.: + 48 22 2606400", "truncated": false}, "after_length": 21, "after_sha256": "91ea111aa679f6773d6dedcb0b0a2558a35b3e3387196cb6b3c71a9a8806c141", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 21, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 21}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ffa586f0ce513b494beb74a2", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:14Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": null, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "aa5b0dee07499082e70e7c5a8f298d6575fb7357fde9596d6b438a2c46274736", "source_snapshot_id": "source-b2fdd9a7f3718161026d4f23", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2569}
{"after": {"end": 20, "start": 0, "text": "medwiss.info@bms.com", "truncated": false}, "after_length": 20, "after_sha256": "bc2238e490f9b59d01a00ccab422d2de7eb7937e564268c4e82d2e78b72b3340", "annex": "IIIA", "before": {"end": 0, "start": 0, "text": "", "truncated": false}, "before_length": 0, "before_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "change_kind": "content", "change_operations": [{"after_end": 20, "after_start": 0, "before_end": 0, "before_start": 0, "kind": "insert"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 0, "chars_inserted": 20}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ffaf6fa3b6278a7477801407", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000623", "medicine_name": "Baraclude", "medicine_slug": "baraclude", "observed_at": "2026-10-12T17:29:09Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 2, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "f10f0c3380dd5394a41d0de6cc6679f956225fe6667f58e63e9770e4ade0a571", "source_snapshot_id": "source-86834b025af0f621e97e14d8", "source_updated_at": "2025-12-03", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/baraclude-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 3206}
{"after": {"end": 148, "start": 0, "text": "Age (range 26 to 91 years) was not a significant factor on niraparib clearance or volume of distribution in the population pharmacokinetic analysis.", "truncated": false}, "after_length": 148, "after_sha256": "67d977c32d05b3c9c00bbaaf278821fcc730850d7f51d4f789347b8d330dfa88", "annex": "I", "before": {"end": 272, "start": 0, "text": "Increasing age was found to decrease niraparib clearance in the population pharmacokinetic analysis. The average exposure in a 91-year old patient was predicted to be 23% higher than in a 30-year old patient. The impact of age is not considered to warrant dose adjustment.", "truncated": false}, "before_length": 272, "before_sha256": "8f68b3500b1fe794f8017a0c91429e71e2af8d0044bd0ce7d7764f9248c9f1a2", "change_kind": "content", "change_operations": [{"after_end": 7, "after_start": 0, "before_end": 1, "before_start": 0, "kind": "replace"}, {"after_end": 21, "after_start": 8, "before_end": 4, "before_start": 2, "kind": "replace"}, {"after_end": 24, "after_start": 23, "before_end": 6, "before_start": 6, "kind": "insert"}, {"after_end": 26, "after_start": 25, "before_end": 14, "before_start": 7, "kind": "replace"}, {"after_end": 42, "after_start": 31, "before_end": 19, "before_start": 19, "kind": "insert"}, {"after_end": 46, "after_start": 43, "before_end": 22, "before_start": 20, "kind": "replace"}, {"after_end": 48, "after_start": 47, "before_end": 24, "before_start": 23, "kind": "replace"}, {"after_end": 52, "after_start": 49, "before_end": 25, "before_start": 25, "kind": "insert"}, {"after_end": 55, "after_start": 54, "before_end": 27, "before_start": 27, "kind": "insert"}, {"after_end": 58, "after_start": 56, "before_end": 36, "before_start": 28, "kind": "replace"}, {"after_end": 104, "after_start": 78, "before_end": 56, "before_start": 56, "kind": "insert"}, {"after_end": 147, "after_start": 147, "before_end": 271, "before_start": 99, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": true, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 193, "chars_inserted": 69}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ffcc29ed8b0ae097788168b6", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/004249", "medicine_name": "Zejula", "medicine_slug": "zejula", "observed_at": "2026-10-12T19:24:07Z", "pipeline_version": "2.0.0", "presentation_label": "Zejula 100 mg hard capsules", "presentation_occurrence": 1, "presentation_status": "heading_extracted_unverified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "5.2", "section_type": "pharmacology", "source_provider": "European Medicines Agency", "source_sha256": "1cdf4857019a599f9322b37ea8f12778e2a47cb4798afa090d96c875ee1d154d", "source_snapshot_id": "source-0ea0916f1ee4fe01ea3b5e96", "source_updated_at": "2025-07-15", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/zejula-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 799}
{"after": {"end": 0, "start": 0, "text": "", "truncated": false}, "after_length": 0, "after_sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855", "annex": "IIIA", "before": {"end": 254, "start": 0, "text": "Local allergy is common (may affect up to 1 in 10 people). Some people get redness, swelling or itching around the area of the insulin injection. This usually clears up in anything from a few days to a few weeks. If this happens to you, tell your doctor.", "truncated": false}, "before_length": 254, "before_sha256": "2486493331d81cc74106096ddfc8a63d9bce9cba037035b81b32023e0b66ee4d", "change_kind": "content", "change_operations": [{"after_end": 0, "after_start": 0, "before_end": 254, "before_start": 0, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 254, "chars_inserted": 0}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-ffcfea6932fd31b29da0f899", "language": "en", "medical_validation": false, "medicine_id": "EMEA/H/C/000088", "medicine_name": "Humalog", "medicine_slug": "humalog", "observed_at": "2026-10-12T13:31:32Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 4, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "labelling", "section_type": "labelling", "source_provider": "European Medicines Agency", "source_sha256": "eaf03b9380d80364b008e46ca00756a4a1fce77de4e5a5b6483b7744a770a5dc", "source_snapshot_id": "source-e6e3f95ea79f1192dbdf1e10", "source_updated_at": "2026-07-13", "source_url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/humalog-epar-product-information-tracked-changes_en.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 9374}
{"after": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l'Agence européenne des médicaments : https://www.ema.europa.eu", "truncated": false}, "after_length": 150, "after_sha256": "7a57f3971964eb7bea4ed295986ca64649117ce6b1ea800c91cdf0ed4877b711", "annex": "III", "before": {"end": 150, "start": 0, "text": "Des informations détaillées sur ce médicament sont disponibles sur le site internet de l'Agence européenne des médicaments : http://www.ema.europa.eu.", "truncated": false}, "before_length": 150, "before_sha256": "6272fb3d1bf208f727e3ec8521cb6d15c24e42031d06a96b3c4d43ff5b48aa11", "change_kind": "technical", "change_operations": [{"after_end": 130, "after_start": 129, "before_end": 129, "before_start": 129, "kind": "insert"}, {"after_end": 150, "after_start": 150, "before_end": 150, "before_start": 149, "kind": "delete"}], "classification_method": "documentary_rules_v2", "clinical_candidate": false, "comparison_basis": "word_tracked_revisions", "derivation_provider": "Medyx", "display_covers_all_edits": true, "edit_alignment_method": "string_sequence_alignment_trimmed_v2", "edit_counts": {"chars_deleted": 1, "chars_inserted": 1}, "extraction_scope": "word/document.xml paragraphs, including table paragraphs", "id": "change-fffdc3956df43d6e82986515", "language": "fr", "medical_validation": false, "medicine_id": "EMEA/H/C/000436", "medicine_name": "Cialis", "medicine_slug": "cialis", "observed_at": "2026-10-12T19:02:59Z", "pipeline_version": "2.0.0", "presentation_label": "", "presentation_occurrence": 3, "presentation_status": "not_identified", "review": {"label": null, "medical_relevance": null, "reviewed_at": null, "reviewer_id": null, "state": "pending"}, "section_code": "", "section_type": "unassigned", "source_provider": "European Medicines Agency", "source_sha256": "77b0be142d1a57e46736bf2948971173869ec0a393c5b4b4af9b6e8151caebac", "source_snapshot_id": "source-4fbb041e667be41fe956bf6f", "source_updated_at": "2026-01-28", "source_url": "https://www.ema.europa.eu/fr/documents/product-information-tracked-changes/cialis-epar-product-information-tracked-changes_fr.docx", "text_normalization": "Tabs, line breaks and whitespace runs become one space; outer whitespace is trimmed.", "word_paragraph_index": 2583}